data_1h4b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1h4b _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.395 0.617 . . . . 50.0 109.368 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -51.35 -39.5 57.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -0.868 . . . . 50.0 109.392 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.84 -41.45 64.26 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.315 -0.866 . . . . 16.66 108.69 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.9 mm-40 -67.07 -47.06 72.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.527 -0.733 . . . . 16.66 109.069 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.513 ' NH2' HG21 ' A' ' 67' ' ' THR . 11.2 mtm180 -65.34 -39.22 92.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.351 -0.843 . . . . 50.0 109.361 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.574 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 43.8 mt-10 -66.05 -41.31 91.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.438 -0.788 . . . . 50.0 109.228 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.4 mtt180 -66.46 -40.42 89.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.455 -0.778 . . . . 50.0 109.104 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.2 mt -70.18 -46.63 71.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.381 -0.824 . . . . 50.0 108.989 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.57 ' CE2' HD13 ' A' ' 26' ' ' ILE . 59.3 t80 -66.01 -35.35 80.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 16.66 109.281 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 19.9 mttt -66.08 -32.7 74.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.845 . . . . 50.0 109.351 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 84' ' ' PHE . 52.7 mtt180 -70.12 -35.45 74.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.877 . . . . 50.0 109.09 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.546 ' CE1' HD13 ' A' ' 31' ' ' LEU . 42.3 m-85 -67.88 -49.07 64.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.385 -0.822 . . . . 16.66 109.338 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.48 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 22.8 t0 -57.75 103.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 16.66 108.75 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.96 -51.49 54.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.274 -0.891 . . . . 50.0 111.185 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -87.78 -26.62 22.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.798 -1.189 . . . . 16.66 109.674 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.48 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 88.56 38.87 6.9 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.79 -1.195 . . . . 16.66 110.14 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -93.72 5.53 51.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.094 -1.239 . . . . 16.66 109.214 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.93 -8.09 73.41 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.485 -1.046 . . . . 16.66 110.485 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.0 pttp -130.13 142.01 50.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.937 -1.331 . . . . 50.0 110.042 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.57 HD13 ' CE2' ' A' ' 15' ' ' PHE . 5.0 mt -111.99 133.91 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.618 -0.676 . . . . 16.66 109.538 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.6 p -106.18 166.75 10.29 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.807 -0.812 . . . . 50.0 108.807 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.88 -45.76 51.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.055 -1.028 . . . . 50.0 108.874 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.12 -40.3 76.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.301 -0.874 . . . . 50.0 109.438 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.479 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.5 mt-10 -74.44 -54.14 8.17 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.211 -0.931 . . . . 16.66 109.373 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.546 HD13 ' CE1' ' A' ' 18' ' ' PHE . 63.1 tp -62.0 -43.03 99.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 16.66 109.044 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -62.41 -44.01 98.24 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.239 -1.545 . . . . 16.66 109.239 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -57.81 -43.48 85.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.355 -1.085 . . . . 50.0 109.729 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.82 -39.67 69.65 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.153 -0.967 . . . . 50.0 108.521 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.525 ' CD1' ' HG ' ' A' ' 31' ' ' LEU . 2.2 mt -59.18 -33.12 70.57 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.595 -0.691 . . . . 99.989999999999995 109.69 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' LEU . 17.7 mttt -44.85 -26.42 0.4 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.999 -1.063 . . . . 99.989999999999995 109.388 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.503 ' CG2' HG22 ' A' ' 83' ' ' ILE . 10.4 t -51.81 -25.54 7.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.244 -0.91 . . . . 99.989999999999995 109.258 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.519 ' CD1' ' CD2' ' A' ' 35' ' ' LEU . 1.5 mt -63.85 -32.74 74.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -0.843 . . . . 50.0 109.308 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.46 5.76 51.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.724 -1.35 . . . . 16.66 109.724 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.76 52.37 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -1.185 . . . . 16.66 109.715 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.464 HD11 ' CD1' ' A' ' 38' ' ' LEU . 13.5 tt -137.56 169.89 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 50.0 109.469 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.59 163.51 32.18 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.647 -0.871 . . . . 16.66 108.647 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.23 -33.51 24.2 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.03 1.82 . . . . 50.0 110.049 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -64.46 -24.96 67.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.675 -0.64 . . . . 50.0 109.892 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -83.12 -37.06 24.27 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.862 -1.149 . . . . 16.66 108.282 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 35' ' ' LEU . 68.9 t -68.57 -36.73 75.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.927 -0.768 . . . . 50.0 108.927 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -67.9 -39.48 83.61 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.8 -0.815 . . . . 50.0 108.8 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.25 -39.6 92.86 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.441 -0.787 . . . . 50.0 109.194 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.423 ' O ' HG13 ' A' ' 53' ' ' ILE . 11.4 mtt -58.57 -43.78 89.53 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.186 -0.946 . . . . 16.66 108.861 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.527 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 57.7 mtp -61.76 -47.95 82.86 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.535 -0.728 . . . . 50.0 109.124 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.72 -20.76 36.65 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.309 -0.869 . . . . 50.0 109.187 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -97.37 -36.51 10.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 16.66 109.123 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.548 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.7 mt -81.8 -32.48 11.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.426 -0.796 . . . . 50.0 109.67 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.7 t0 -60.35 101.42 0.13 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.412 -0.805 . . . . 16.66 108.957 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 60.0 p -70.19 -46.86 63.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 50.0 110.75 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.495 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -86.69 -38.41 17.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.12 -0.987 . . . . 16.66 109.542 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 100.99 28.82 6.72 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.93 -1.128 . . . . 16.66 110.617 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.495 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.0 p-10 -80.37 -3.22 48.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.751 -1.441 . . . . 50.0 109.155 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.527 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.89 -5.07 57.88 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.922 -1.271 . . . . 16.66 109.922 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 40.8 m-85 -134.38 156.95 47.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.016 -1.285 . . . . 50.0 111.298 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 36.3 mm -108.2 130.28 61.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.212 -1.033 . . . . 16.66 108.212 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.6 m -99.95 167.68 10.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.998 -1.064 . . . . 16.66 108.673 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.574 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 41.3 t80 -54.96 -44.49 74.43 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.177 -1.009 . . . . 16.66 108.576 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -58.37 -47.14 84.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.564 -0.71 . . . . 50.0 109.165 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.54 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.7 mt-10 -62.49 -46.54 88.02 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.27 -0.894 . . . . 16.66 109.145 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -60.31 -37.75 81.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 16.66 109.19 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.513 HG21 ' NH2' ' A' ' 11' ' ' ARG . 12.1 m -65.69 -47.59 74.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.388 -0.82 . . . . 50.0 109.09 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -59.39 -40.48 86.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 50.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.06 -37.0 58.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.687 -0.857 . . . . 50.0 108.687 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.42 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -59.16 -31.98 70.47 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.355 -1.498 . . . . 16.66 109.355 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 67' ' ' THR . 59.5 mtm180 -71.06 -31.12 67.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -1.165 . . . . 50.0 109.399 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.49 -20.29 62.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.366 -0.834 . . . . 50.0 109.501 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.518 ' HB3' ' CD1' ' A' ' 76' ' ' LEU . 1.8 m-80 -149.38 54.95 0.97 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.258 -0.901 . . . . 50.0 109.479 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -51.46 -42.6 61.71 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.163 -0.96 . . . . 50.0 108.622 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.21 -20.6 29.24 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.526 -1.43 . . . . 25.0 109.526 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.518 ' CD1' ' HB3' ' A' ' 73' ' ' ASN . 33.2 mt -78.62 -43.7 25.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -1.187 . . . . 50.0 109.175 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.8 mt -61.43 -35.95 79.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 50.0 109.699 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 10.5 mtmm -60.48 -26.96 67.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 50.0 109.382 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -76.21 -37.93 57.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.222 -0.924 . . . . 50.0 109.232 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -78.51 -31.28 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 50.0 109.562 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.88 -14.88 51.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 50.0 109.614 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -96.33 -31.97 12.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.917 . . . . 50.0 108.972 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.503 HG22 ' CG2' ' A' ' 37' ' ' THR . 38.0 mt -58.86 -38.93 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.46 -0.775 . . . . 50.0 109.316 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 17' ' ' ARG . 90.9 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.041 -0.98 . . . . 99.989999999999995 109.471 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 8' ' ' LYS . 77.9 m-20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.437 0.637 . . . . 50.0 109.435 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.434 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 30.6 mtpt -43.21 -36.8 1.88 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.804 . . . . 50.0 109.759 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.23 -46.96 87.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.238 -0.914 . . . . 16.66 108.834 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 14' ' ' ILE . 44.1 mt-10 -68.22 -38.51 81.98 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.887 -0.783 . . . . 16.66 108.887 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.505 ' NH2' HG21 ' A' ' 67' ' ' THR . 13.0 mtm180 -68.37 -39.9 81.62 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.325 -0.859 . . . . 50.0 109.496 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.639 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 13.0 mt-10 -67.4 -41.75 84.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.415 -0.803 . . . . 50.0 109.432 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.8 mtp-105 -66.16 -41.46 90.32 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.3 -0.875 . . . . 50.0 109.299 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 10' ' ' GLU . 38.6 mt -69.83 -45.47 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.247 -0.908 . . . . 50.0 109.023 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.551 ' CE1' HD13 ' A' ' 26' ' ' ILE . 73.8 t80 -63.26 -36.43 83.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.423 -0.911 . . . . 16.66 108.933 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -64.89 -30.78 71.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.384 -0.822 . . . . 50.0 109.08 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 48.2 mtt180 -68.4 -37.09 80.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 50.0 109.12 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.464 ' HB2' HD12 ' A' ' 26' ' ' ILE . 57.3 m-85 -68.67 -50.98 46.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 16.66 109.577 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.47 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 21.6 t0 -55.71 103.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 16.66 108.925 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.6 -50.52 43.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.873 . . . . 50.0 111.118 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -87.02 -30.98 20.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.714 -1.241 . . . . 16.66 109.674 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.47 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 93.94 35.55 6.06 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.764 -1.208 . . . . 16.66 110.205 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.476 ' OD2' ' CG ' ' A' ' 25' ' ' LYS . 34.7 p-10 -90.79 3.7 53.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.257 . . . . 16.66 109.161 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.86 -5.83 72.98 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.48 -1.048 . . . . 16.66 110.48 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.8 pttp -132.0 143.39 50.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.898 -1.354 . . . . 50.0 110.086 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.551 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.2 mt -110.85 133.42 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.375 0.607 . . . . 16.66 109.685 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.45 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 10.5 p -105.83 166.57 10.38 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.491 -0.755 . . . . 50.0 108.973 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.73 -45.78 49.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.01 -1.056 . . . . 50.0 108.843 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -56.77 -41.09 77.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.288 -0.883 . . . . 50.0 109.334 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 60.5 mt-10 -74.5 -54.83 6.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.306 -0.871 . . . . 16.66 109.248 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.519 ' CD2' HD13 ' A' ' 35' ' ' LEU . 7.4 tt -60.5 -45.66 92.98 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.307 -0.871 . . . . 16.66 108.867 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -62.89 -44.74 96.99 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.104 -1.598 . . . . 16.66 109.104 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 24.2 mt-10 -57.65 -42.16 82.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.395 -1.062 . . . . 50.0 109.546 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.88 -39.94 66.0 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.389 -0.967 . . . . 50.0 108.389 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.519 HD13 ' CD2' ' A' ' 31' ' ' LEU . 6.6 mt -58.36 -33.25 69.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.539 -0.725 . . . . 99.989999999999995 109.502 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -44.4 -27.83 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 99.989999999999995 109.579 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.517 ' OG1' ' CG2' ' A' ' 83' ' ' ILE . 6.9 t -50.14 -25.37 3.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.897 . . . . 99.989999999999995 109.111 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.458 HD13 HD21 ' A' ' 35' ' ' LEU . 22.8 mt -62.63 -33.2 74.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.467 -0.771 . . . . 50.0 109.281 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.28 6.39 53.55 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 16.66 109.549 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.63 51.78 0.57 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -1.181 . . . . 16.66 109.473 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.456 HD11 HD13 ' A' ' 38' ' ' LEU . 11.8 tt -137.09 170.97 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.95 . . . . 50.0 109.486 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.99 167.22 16.75 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 16.66 108.873 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.28 -33.74 17.71 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.202 1.934 . . . . 50.0 110.192 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.6 -29.83 70.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.625 . . . . 50.0 110.01 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -81.66 -35.81 29.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.979 -1.076 . . . . 16.66 108.314 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.488 ' CG1' HD21 ' A' ' 31' ' ' LEU . 68.4 t -67.69 -35.87 74.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.045 -0.724 . . . . 50.0 109.045 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -70.65 -37.91 73.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.77 -0.826 . . . . 50.0 108.77 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -67.49 -36.72 81.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.506 -0.746 . . . . 50.0 109.125 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.439 ' O ' HG13 ' A' ' 53' ' ' ILE . 5.5 mtt -60.6 -47.35 86.61 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.259 -0.901 . . . . 16.66 108.749 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.514 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 49.7 mtp -62.17 -47.96 82.18 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 50.0 109.1 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.24 -18.63 27.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.291 -0.881 . . . . 50.0 109.146 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -97.95 -36.15 10.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.777 . . . . 16.66 109.106 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.581 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.4 mt -82.15 -32.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.532 -0.73 . . . . 50.0 109.733 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.9 t0 -58.62 101.31 0.08 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.403 -0.811 . . . . 16.66 109.2 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.469 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 76.8 p -71.07 -47.13 60.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 50.0 110.58 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -85.89 -37.33 19.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.143 -0.973 . . . . 16.66 109.469 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 100.57 28.32 7.14 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.918 -1.135 . . . . 16.66 110.744 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.499 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 9.0 p-10 -80.38 -3.24 48.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.755 -1.438 . . . . 50.0 109.059 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.514 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.76 -3.64 59.08 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.88 -1.288 . . . . 16.66 109.88 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 26.4 m-85 -135.21 157.2 47.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.07 -1.253 . . . . 50.0 111.26 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.543 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 36.6 mm -107.86 129.53 61.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.522 -0.918 . . . . 16.66 108.522 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.18 167.61 10.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.151 -0.968 . . . . 16.66 108.664 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.639 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.5 t80 -54.44 -43.81 71.92 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.113 -1.035 . . . . 16.66 108.526 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -58.26 -50.1 74.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.537 -0.727 . . . . 50.0 109.042 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.543 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 76.6 mt-10 -60.43 -46.41 90.13 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.317 -0.864 . . . . 16.66 109.013 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.564 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 62.0 t80 -62.09 -33.63 74.79 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.041 -0.725 . . . . 16.66 109.041 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.505 HG21 ' NH2' ' A' ' 11' ' ' ARG . 6.4 m -70.12 -48.01 59.35 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.366 -0.834 . . . . 50.0 108.952 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -60.27 -39.05 85.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 50.0 109.304 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.581 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -80.01 -38.53 31.86 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.585 -0.895 . . . . 50.0 108.585 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.522 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -60.69 -25.8 64.02 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.323 -1.511 . . . . 16.66 109.323 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 67' ' ' THR . 69.0 mtm180 -76.8 -35.23 57.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -1.162 . . . . 50.0 109.219 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.04 -17.43 64.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 50.0 109.181 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.446 ' HB2' ' CG ' ' A' ' 76' ' ' LEU . 6.4 p30 -148.03 51.46 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.78 . . . . 50.0 109.219 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 73.3 mtm180 -48.18 -38.17 17.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.242 -0.911 . . . . 50.0 108.704 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.55 -23.6 49.85 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.374 -1.49 . . . . 25.0 109.374 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.446 ' CG ' ' HB2' ' A' ' 73' ' ' ASN . 24.8 mt -77.51 -44.96 27.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -1.101 . . . . 50.0 109.342 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.564 HD23 ' CZ ' ' A' ' 66' ' ' PHE . 19.0 mt -66.89 -21.16 66.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 50.0 109.842 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 30.6 mtmt -80.02 -19.31 47.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.063 -1.023 . . . . 50.0 109.32 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.21 -36.61 16.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -0.827 . . . . 50.0 109.366 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.457 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 85.4 t -71.83 -36.15 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.395 -0.816 . . . . 50.0 108.913 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.41 -49.12 67.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.382 -0.823 . . . . 50.0 109.368 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -62.19 -28.64 69.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.823 . . . . 50.0 109.583 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.517 ' CG2' ' OG1' ' A' ' 37' ' ' THR . 39.9 mt -61.27 -32.42 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -0.968 . . . . 50.0 109.316 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.479 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 17.2 m-85 . . . . . 0 C--N 1.302 -1.498 0 CA-C-O 117.977 -1.011 . . . . 99.989999999999995 109.499 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.284 -0.635 . . . . 50.0 109.284 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -52.44 -36.91 55.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 50.0 109.462 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.26 -46.27 88.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 16.66 108.751 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 14' ' ' ILE . 66.6 mm-40 -66.44 -42.81 87.13 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.911 -0.774 . . . . 16.66 108.911 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.504 ' NH2' HD13 ' A' ' 77' ' ' LEU . 31.7 mtt-85 -65.1 -40.28 94.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.537 -0.727 . . . . 50.0 109.474 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.58 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 49.4 mt-10 -63.85 -40.96 97.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.424 -0.797 . . . . 50.0 109.454 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 2.5 mtt-85 -68.46 -38.93 81.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 50.0 109.105 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 10' ' ' GLU . 29.9 mt -71.31 -45.95 67.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.314 -0.866 . . . . 50.0 109.003 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.578 ' CE1' HD13 ' A' ' 26' ' ' ILE . 68.1 t80 -66.09 -36.07 82.19 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.179 -0.951 . . . . 16.66 109.181 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 39.5 mttt -65.55 -30.5 71.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.289 -0.882 . . . . 50.0 109.113 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -70.29 -37.48 74.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.854 . . . . 50.0 109.007 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.464 ' HB3' HD11 ' A' ' 26' ' ' ILE . 55.5 m-85 -67.56 -48.76 65.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 16.66 109.466 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 23.0 t0 -58.64 103.37 0.15 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 16.66 108.826 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.04 -51.56 37.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 50.0 111.132 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -85.69 -31.14 22.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.724 -1.235 . . . . 16.66 109.672 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 93.83 37.66 5.42 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.748 -1.215 . . . . 16.66 110.321 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.466 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.2 p-10 -93.08 6.37 48.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.042 -1.269 . . . . 16.66 109.207 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.61 -6.37 80.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.49 -1.044 . . . . 16.66 110.49 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.6 pttt -130.05 142.02 50.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.024 -1.28 . . . . 50.0 110.002 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.578 HD13 ' CE1' ' A' ' 15' ' ' PHE . 3.8 mt -112.0 133.22 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.437 0.637 . . . . 16.66 109.443 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.1 p -106.31 168.49 9.11 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.415 -0.803 . . . . 50.0 109.108 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.508 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.49 -46.26 56.87 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.144 -0.973 . . . . 50.0 108.853 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -56.89 -40.31 75.99 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.345 -0.847 . . . . 50.0 109.394 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.489 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.8 mt-10 -75.86 -54.77 6.4 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.267 -0.896 . . . . 16.66 109.122 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.527 ' CD2' HD13 ' A' ' 35' ' ' LEU . 5.7 tt -60.47 -46.88 88.48 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.184 -0.948 . . . . 16.66 108.939 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.509 ' CA ' HG12 ' A' ' 46' ' ' VAL . . . -62.09 -43.1 99.61 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.28 -1.528 . . . . 16.66 109.28 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 5.6 mm-40 -59.68 -41.86 91.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.266 -1.138 . . . . 50.0 110.011 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.38 73.21 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.163 -0.961 . . . . 50.0 108.832 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.537 HD21 ' CD1' ' A' ' 38' ' ' LEU . 12.8 mt -60.64 -30.92 70.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.5 -0.75 . . . . 99.989999999999995 109.798 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -43.73 -26.43 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.987 . . . . 99.989999999999995 109.616 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.496 ' CG2' HG23 ' A' ' 83' ' ' ILE . 6.3 t -52.85 -24.94 10.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.192 -0.942 . . . . 99.989999999999995 109.39 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.537 ' CD1' HD21 ' A' ' 35' ' ' LEU . 5.6 mt -62.38 -32.28 73.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.87 . . . . 50.0 109.269 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.62 6.72 51.4 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.596 -1.402 . . . . 16.66 109.596 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.49 57.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -1.132 . . . . 16.66 109.478 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.47 ' CD1' HD11 ' A' ' 38' ' ' LEU . 11.1 tt -143.38 174.17 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 50.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.9 165.98 25.29 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.304 -0.872 . . . . 16.66 108.82 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -69.43 -33.54 17.61 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.138 1.892 . . . . 50.0 110.132 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -65.07 -24.57 67.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.657 -0.652 . . . . 50.0 110.077 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -82.16 -36.66 27.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.82 -1.175 . . . . 16.66 108.402 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.509 HG12 ' CA ' ' A' ' 32' ' ' GLY . 53.9 t -67.57 -35.64 73.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.563 -0.711 . . . . 50.0 109.145 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -65.72 -39.24 90.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.445 -0.785 . . . . 50.0 109.095 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -67.21 -36.73 82.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.335 -0.853 . . . . 50.0 109.309 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.412 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.3 mtt -61.31 -46.22 91.18 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.183 -0.948 . . . . 16.66 108.774 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.526 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 49.2 mtp -62.56 -48.02 81.31 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.566 -0.709 . . . . 50.0 109.147 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.0 -18.73 36.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 50.0 109.123 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -98.33 -36.5 9.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 16.66 109.175 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.558 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.6 mt -82.08 -32.49 11.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.468 -0.77 . . . . 50.0 109.667 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.48 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.8 t0 -59.51 101.52 0.11 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.349 -0.844 . . . . 16.66 109.038 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.46 ' OG1' ' OE2' ' A' ' 65' ' ' GLU . 61.0 p -68.85 -47.18 66.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -0.875 . . . . 50.0 110.658 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -86.79 -39.1 16.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 16.66 109.448 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.48 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 102.08 28.01 6.7 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.878 -1.153 . . . . 16.66 110.444 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.3 p-10 -79.02 -2.35 39.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.786 -1.42 . . . . 50.0 109.016 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.526 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.35 -2.91 59.47 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.709 -1.357 . . . . 16.66 109.709 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.581 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 25.5 m-85 -136.47 157.57 46.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.086 -1.244 . . . . 50.0 111.376 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.56 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 29.1 mm -109.76 130.24 63.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.565 -0.902 . . . . 16.66 108.565 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -97.64 168.41 10.36 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.133 -0.979 . . . . 16.66 108.599 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.58 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 37.7 t80 -55.36 -43.28 74.91 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.031 -1.043 . . . . 16.66 108.718 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -60.6 -46.4 90.4 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.553 -0.717 . . . . 50.0 109.31 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.56 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 76.7 mt-10 -62.05 -46.83 87.4 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.285 -0.884 . . . . 16.66 109.096 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.572 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 49.8 t80 -61.06 -40.52 93.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.444 -0.785 . . . . 16.66 109.25 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.1 m -64.74 -47.32 78.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.362 -0.837 . . . . 50.0 109.209 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -58.45 -38.46 77.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 50.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.91 -35.57 50.5 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.642 -0.873 . . . . 50.0 108.642 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.14 -29.91 63.26 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.302 -1.519 . . . . 16.66 109.302 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 67' ' ' THR . 83.0 mtm180 -71.51 -29.63 65.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.124 . . . . 50.0 109.165 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' A' ' 73' ' ' ASN . . . -70.41 -21.04 62.88 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.335 -0.853 . . . . 50.0 109.278 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 72' ' ' ALA . 2.4 m-80 -152.1 56.06 0.83 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 50.0 109.299 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -48.71 -38.53 21.77 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.705 -0.85 . . . . 50.0 108.705 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.08 -30.23 63.5 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.329 -1.508 . . . . 25.0 109.329 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.427 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 32.3 mt -69.39 -45.69 68.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -1.085 . . . . 50.0 109.464 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.572 HD23 ' CZ ' ' A' ' 66' ' ' PHE . 25.4 mt -63.68 -23.11 67.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.814 . . . . 50.0 109.902 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -79.97 -18.54 50.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.105 -0.997 . . . . 50.0 109.49 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.65 -33.39 27.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 50.0 109.3 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 t -85.36 -27.9 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.853 . . . . 50.0 109.147 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.16 -16.05 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 50.0 109.597 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -94.34 -32.92 13.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 50.0 109.275 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.496 HG23 ' CG2' ' A' ' 37' ' ' THR . 10.0 mt -58.2 -36.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.366 -0.834 . . . . 50.0 109.35 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.019 -0.991 . . . . 99.989999999999995 109.437 -179.92 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.408 0.623 . . . . 50.0 109.32 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -49.43 -36.41 22.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 50.0 109.6 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.79 -45.68 89.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.307 -0.871 . . . . 16.66 108.715 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.48 ' O ' HG13 ' A' ' 14' ' ' ILE . 67.2 mt-10 -68.2 -40.45 82.17 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.46 -0.775 . . . . 16.66 109.007 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.578 ' NH2' ' CG2' ' A' ' 67' ' ' THR . 46.5 mtm180 -68.07 -39.95 82.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.37 -0.831 . . . . 50.0 109.33 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.572 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 43.3 mt-10 -66.75 -41.84 87.15 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.478 -0.763 . . . . 50.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 13.3 mtp180 -65.63 -40.84 92.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.28 -0.888 . . . . 50.0 109.201 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 10' ' ' GLU . 30.7 mt -70.26 -46.94 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.305 -0.872 . . . . 50.0 108.91 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.568 ' CE2' HD13 ' A' ' 26' ' ' ILE . 53.4 t80 -66.32 -34.99 79.24 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.216 -0.928 . . . . 16.66 108.918 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 55.0 mttm -65.15 -34.27 78.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.366 -0.834 . . . . 50.0 109.392 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.569 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -74.48 -26.11 59.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.895 . . . . 50.0 109.227 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.558 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 23.3 m-85 -73.45 -43.21 60.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 16.66 109.057 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 22.6 t0 -63.72 103.26 0.53 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.334 -0.854 . . . . 16.66 108.757 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.13 64.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.161 -0.962 . . . . 50.0 111.248 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -89.49 -27.18 20.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.727 -1.233 . . . . 16.66 109.705 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 89.66 35.1 8.01 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.096 -1.201 . . . . 16.66 110.096 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.481 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 37.1 p-10 -88.85 4.04 49.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -1.198 . . . . 16.66 109.21 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.99 -5.76 72.47 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.381 -1.087 . . . . 16.66 110.381 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.5 pttp -132.34 143.32 49.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.948 -1.325 . . . . 50.0 110.068 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.568 HD13 ' CE2' ' A' ' 15' ' ' PHE . 6.8 mt -111.46 134.54 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.652 -0.655 . . . . 16.66 109.45 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.5 p -106.61 166.22 10.72 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.299 -0.876 . . . . 50.0 108.712 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.5 -45.6 47.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.041 -1.037 . . . . 50.0 108.843 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.19 75.82 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.363 -0.836 . . . . 50.0 109.521 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.498 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.8 mt-10 -75.82 -54.51 6.81 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.198 -0.939 . . . . 16.66 109.291 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.453 ' HG ' HD11 ' A' ' 35' ' ' LEU . 58.3 tp -61.84 -43.05 99.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 16.66 108.955 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.46 ' HA3' HG23 ' A' ' 46' ' ' VAL . . . -62.27 -44.29 97.89 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.233 -1.547 . . . . 16.66 109.233 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -58.54 -43.23 89.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.308 -1.113 . . . . 50.0 109.724 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.564 ' CB ' ' NH2' ' A' ' 17' ' ' ARG . . . -73.06 -40.73 64.83 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.088 -1.007 . . . . 50.0 108.333 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.453 HD11 ' HG ' ' A' ' 31' ' ' LEU . 7.5 mt -58.64 -32.61 69.21 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.568 -0.707 . . . . 99.989999999999995 109.423 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -44.98 -26.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 99.989999999999995 109.423 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 t -49.17 -24.87 1.88 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 99.989999999999995 109.026 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.515 ' CD1' HD11 ' A' ' 41' ' ' ILE . 16.7 mt -58.87 -33.45 70.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.499 -0.751 . . . . 50.0 109.101 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.06 -0.39 58.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.885 -1.286 . . . . 16.66 109.885 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.07 58.62 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.251 . . . . 16.66 109.965 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 38' ' ' LEU . 10.8 tt -138.1 173.18 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.098 -1.001 . . . . 50.0 109.528 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.27 163.02 40.69 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.642 -0.873 . . . . 16.66 108.642 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.15 -33.27 25.34 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.009 1.806 . . . . 50.0 110.083 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.92 -26.29 68.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.636 -0.665 . . . . 50.0 109.95 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -82.1 -36.87 27.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.855 -1.153 . . . . 16.66 108.431 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.46 HG23 ' HA3' ' A' ' 32' ' ' GLY . 47.1 t -68.96 -36.67 75.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.038 -0.727 . . . . 50.0 109.038 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -65.65 -40.15 92.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.475 -0.766 . . . . 50.0 109.028 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -65.48 -40.89 93.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 50.0 109.257 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.1 mtt -58.68 -43.52 89.99 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.243 -0.911 . . . . 16.66 108.817 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.525 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 31.7 mtp -61.45 -47.55 85.18 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.451 -0.781 . . . . 50.0 109.245 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.04 -20.56 54.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 50.0 109.28 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -95.4 -36.35 11.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.398 -0.814 . . . . 16.66 109.047 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.559 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.4 mt -81.92 -31.46 10.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 50.0 109.699 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.9 t0 -60.93 101.46 0.15 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.439 -0.788 . . . . 16.66 108.989 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.464 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 55.6 p -69.72 -46.1 66.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 50.0 110.71 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.492 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.0 p-10 -87.6 -40.32 14.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.106 -0.996 . . . . 16.66 109.502 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 102.95 29.67 5.73 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.932 -1.128 . . . . 16.66 110.523 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.492 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.8 p-10 -81.41 -3.74 53.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.865 -1.374 . . . . 50.0 109.144 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.525 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.66 -3.41 57.57 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.857 -1.297 . . . . 16.66 109.857 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.573 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.8 m-85 -135.85 156.58 48.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.059 -1.259 . . . . 50.0 111.15 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.548 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 35.0 mm -108.88 129.91 62.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.397 -0.964 . . . . 16.66 108.397 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.55 167.42 10.6 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.057 -1.027 . . . . 16.66 108.812 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.5 t80 -54.21 -43.62 70.94 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.297 -0.961 . . . . 16.66 108.521 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -58.93 -47.9 83.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.525 -0.735 . . . . 50.0 109.085 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.548 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 81.2 mt-10 -62.34 -46.94 86.4 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.288 -0.883 . . . . 16.66 109.119 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.534 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 51.2 t80 -59.52 -39.14 82.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.426 -0.796 . . . . 16.66 109.103 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.578 ' CG2' ' NH2' ' A' ' 11' ' ' ARG . 18.0 m -66.42 -46.68 75.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 50.0 109.089 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.0 -40.76 85.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 50.0 109.246 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.559 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -75.89 -36.8 59.37 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.566 -0.901 . . . . 50.0 108.566 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.409 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -58.96 -34.17 77.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.2 -1.56 . . . . 16.66 109.2 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 67' ' ' THR . 74.4 mtm180 -65.95 -33.48 75.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -1.12 . . . . 50.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.438 ' O ' ' OD1' ' A' ' 73' ' ' ASN . . . -67.68 -20.99 65.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.834 . . . . 50.0 109.301 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.524 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 2.7 m-80 -152.24 56.43 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 50.0 109.162 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -49.6 -37.09 26.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.334 -0.854 . . . . 50.0 108.736 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.37 -31.16 69.33 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.22 -1.552 . . . . 25.0 109.22 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.524 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 50.6 mt -67.26 -44.88 78.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -1.09 . . . . 50.0 109.419 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.534 HD23 ' CZ ' ' A' ' 66' ' ' PHE . 19.9 mt -63.77 -31.43 72.61 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.321 -0.862 . . . . 50.0 109.766 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -64.58 -27.13 68.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 50.0 109.255 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -76.26 -34.65 59.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 50.0 109.517 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.4 t -81.03 -31.22 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 50.0 109.601 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.4 -19.02 64.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 50.0 109.691 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -89.39 -30.57 18.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 50.0 109.137 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.8 mt -64.97 -36.59 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.382 -0.824 . . . . 50.0 109.24 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.569 ' CE1' ' NH2' ' A' ' 17' ' ' ARG . 61.2 m-85 . . . . . 0 C--N 1.302 -1.483 0 CA-C-O 117.99 -1.005 . . . . 99.989999999999995 109.544 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.404 0.621 . . . . 50.0 109.394 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -53.29 -35.92 60.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 50.0 109.196 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 -45.74 90.26 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.853 -0.795 . . . . 16.66 108.853 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.476 ' O ' HG13 ' A' ' 14' ' ' ILE . 59.7 mm-40 -68.53 -40.55 80.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 16.66 108.832 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.509 ' NH1' HG21 ' A' ' 67' ' ' THR . 19.8 mtm180 -68.11 -38.95 82.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.458 -0.776 . . . . 50.0 109.377 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.641 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 8.7 mt-10 -68.03 -39.83 83.01 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.433 -0.792 . . . . 50.0 109.346 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 5.6 mtt180 -67.08 -40.53 87.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.293 -0.879 . . . . 50.0 109.267 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.6 mt -70.28 -46.62 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.383 -0.823 . . . . 50.0 108.865 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.561 ' CE1' HD13 ' A' ' 26' ' ' ILE . 70.5 t80 -63.56 -35.74 81.48 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.339 -0.851 . . . . 16.66 109.097 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -66.19 -30.43 70.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 50.0 109.229 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 74.8 mtt180 -69.17 -38.1 78.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 50.0 109.256 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.464 ' HB2' HD12 ' A' ' 26' ' ' ILE . 67.2 m-85 -67.42 -49.13 65.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 16.66 109.49 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 24.1 t0 -56.48 103.48 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 16.66 108.746 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.91 -51.56 46.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.274 -0.891 . . . . 50.0 111.247 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -86.92 -30.0 21.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.719 -1.238 . . . . 16.66 109.856 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 92.95 37.39 5.73 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.777 -1.202 . . . . 16.66 110.179 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.473 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 37.7 p-10 -92.87 5.38 51.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -1.2 . . . . 16.66 109.243 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.95 -7.01 76.83 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.138 -1.03 . . . . 16.66 110.568 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.1 pttm -130.49 142.25 50.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.908 -1.348 . . . . 50.0 109.872 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.561 HD13 ' CE1' ' A' ' 15' ' ' PHE . 5.1 mt -111.93 133.22 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.36 0.6 . . . . 16.66 109.527 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.9 p -105.02 166.83 10.11 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.856 -0.794 . . . . 50.0 108.856 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.1 -45.29 52.58 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.157 -0.965 . . . . 50.0 108.887 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.39 78.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.317 -0.865 . . . . 50.0 109.474 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.7 mt-10 -74.99 -54.3 7.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.165 -0.959 . . . . 16.66 109.334 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.509 ' CD2' ' C ' ' A' ' 31' ' ' LEU . 1.9 tt -61.94 -43.98 97.71 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.283 -0.886 . . . . 16.66 108.798 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -63.66 -44.48 96.36 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.191 -1.564 . . . . 16.66 109.191 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -59.82 -41.45 91.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.324 -1.104 . . . . 50.0 109.892 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.98 -39.87 68.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.129 -0.982 . . . . 50.0 108.732 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.504 HD13 ' CD2' ' A' ' 31' ' ' LEU . 8.4 mt -60.21 -30.83 69.64 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.5 -0.75 . . . . 99.989999999999995 109.865 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -44.31 -25.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -1.0 . . . . 99.989999999999995 109.865 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.508 ' CG2' HG22 ' A' ' 83' ' ' ILE . 6.6 t -50.77 -23.15 2.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 109.22 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.526 ' CD1' HD11 ' A' ' 41' ' ' ILE . 25.6 mt -60.74 -33.69 73.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 50.0 109.312 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.46 -0.74 59.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.777 -1.329 . . . . 16.66 109.777 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 40' ' ' SER . 2.3 t -155.25 66.45 0.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.114 -1.227 . . . . 16.66 109.654 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.526 HD11 ' CD1' ' A' ' 38' ' ' LEU . 14.2 tt -149.26 168.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.141 -0.974 . . . . 50.0 109.598 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.83 163.9 22.24 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 16.66 108.872 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 49.8 Cg_endo -70.66 -30.7 17.72 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.078 1.852 . . . . 50.0 109.94 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.75 -23.49 66.1 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.54 -0.725 . . . . 50.0 110.078 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -79.87 -35.13 38.57 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.891 -1.13 . . . . 16.66 108.505 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.474 HG23 ' CD1' ' A' ' 35' ' ' LEU . 55.0 t -69.39 -35.75 68.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.909 -0.774 . . . . 50.0 108.909 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 82.7 mttt -62.36 -40.25 95.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.432 -0.792 . . . . 50.0 108.994 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.37 -39.42 92.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.433 -0.792 . . . . 50.0 109.299 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.448 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.9 mtt -59.48 -45.2 92.34 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.239 -0.913 . . . . 16.66 108.854 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.52 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 50.1 mtp -62.27 -48.68 78.83 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.439 -0.788 . . . . 50.0 109.122 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.7 -19.02 24.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 50.0 109.362 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -99.78 -36.3 9.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 16.66 109.306 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.582 HG12 ' CD2' ' A' ' 69' ' ' PHE . 80.2 mt -82.5 -32.93 10.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.451 -0.781 . . . . 50.0 109.816 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.7 t0 -59.52 101.23 0.1 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.289 -0.882 . . . . 16.66 108.999 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 54.6 p -66.19 -46.37 77.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 50.0 110.64 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.483 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -88.85 -42.18 12.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 16.66 109.634 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.484 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 104.14 29.82 5.31 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.203 -1.159 . . . . 16.66 110.203 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.483 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 13.0 p-10 -80.46 -2.45 45.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.983 -1.304 . . . . 50.0 109.134 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.52 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 100.04 -3.47 57.05 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.767 -1.333 . . . . 16.66 109.767 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 30.6 m-85 -137.01 156.35 48.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.006 -1.291 . . . . 50.0 111.49 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.536 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 25.5 mm -109.67 130.68 62.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.308 -0.997 . . . . 16.66 108.308 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 m -99.47 168.7 9.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.023 -1.048 . . . . 16.66 108.714 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.641 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 36.5 t80 -54.97 -43.44 73.5 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.169 -1.012 . . . . 16.66 108.655 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -59.92 -48.63 80.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.608 -0.683 . . . . 50.0 109.237 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.536 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 79.6 mt-10 -60.6 -47.03 88.02 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.291 -0.881 . . . . 16.66 109.064 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -63.18 -32.66 74.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.437 -0.789 . . . . 16.66 109.255 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.509 HG21 ' NH1' ' A' ' 11' ' ' ARG . 51.9 m -68.26 -49.11 62.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 50.0 109.302 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -59.35 -36.9 76.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.26 -0.9 . . . . 50.0 109.381 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.582 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.74 -37.5 41.12 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.494 -0.928 . . . . 50.0 108.494 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.528 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -58.69 -29.2 63.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.197 -1.561 . . . . 16.66 109.197 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 67' ' ' THR . 80.5 mtm180 -71.3 -33.12 69.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.348 -1.089 . . . . 50.0 109.051 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.35 -20.81 65.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.832 . . . . 50.0 109.273 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.456 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 7.8 m-80 -146.24 58.37 1.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.396 -0.815 . . . . 50.0 109.114 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 65.9 mtm180 -51.35 -37.58 48.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 50.0 108.922 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.37 -27.82 70.01 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.348 -1.501 . . . . 25.0 109.348 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.456 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 22.4 mt -69.07 -45.38 70.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.387 -1.067 . . . . 50.0 109.67 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.528 ' CD1' ' HA2' ' A' ' 70' ' ' GLY . 4.3 mt -70.38 -19.41 63.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.389 -0.819 . . . . 50.0 109.874 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 40.7 mtmt -80.02 -27.05 39.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.104 -0.997 . . . . 50.0 109.508 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -91.41 -43.12 9.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 50.0 109.507 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.4 p -59.58 -45.46 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.776 0.798 . . . . 50.0 109.105 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.552 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -48.78 -38.33 21.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.716 -0.615 . . . . 50.0 109.85 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -69.58 -24.8 63.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 50.0 109.602 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.508 HG22 ' CG2' ' A' ' 37' ' ' THR . 13.6 mt -64.26 -45.43 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.383 -0.823 . . . . 50.0 109.556 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.461 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 80.1 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.02 -0.99 . . . . 99.989999999999995 109.362 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.233 -0.654 . . . . 50.0 109.233 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -52.02 -36.91 51.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.429 -0.794 . . . . 50.0 109.387 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.99 -46.16 85.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.567 -0.901 . . . . 16.66 108.567 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 14' ' ' ILE . 64.9 mt-10 -67.73 -39.52 84.25 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.854 -0.795 . . . . 16.66 108.854 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.41 ' NH1' ' HG ' ' A' ' 77' ' ' LEU . 55.2 mtt-85 -65.96 -40.4 91.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 50.0 109.336 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.565 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 44.0 mt-10 -64.86 -40.43 95.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.412 -0.805 . . . . 50.0 109.228 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 65.4 mtp180 -67.52 -40.48 85.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.347 -0.846 . . . . 50.0 109.236 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 10' ' ' GLU . 22.0 mt -70.37 -45.23 75.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.363 -0.835 . . . . 50.0 108.906 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 26' ' ' ILE . 63.7 t80 -64.52 -36.03 82.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.273 -0.892 . . . . 16.66 109.008 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -65.76 -30.19 70.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.368 -0.832 . . . . 50.0 109.147 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 49.7 mtt85 -71.35 -34.76 70.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 50.0 109.22 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.576 ' CE1' HD13 ' A' ' 31' ' ' LEU . 42.9 m-85 -72.83 -47.98 41.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.418 -0.801 . . . . 16.66 109.432 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 24.7 t0 -59.22 103.28 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 16.66 108.499 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 -51.72 51.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.891 . . . . 50.0 111.426 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -87.7 -26.14 23.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.754 -1.216 . . . . 16.66 109.799 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 88.04 38.57 7.3 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.747 -1.216 . . . . 16.66 110.091 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.481 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -92.84 5.43 51.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -1.215 . . . . 16.66 109.206 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.09 -7.54 72.89 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.346 -1.101 . . . . 16.66 110.346 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 35.5 pttt -130.37 142.23 50.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.927 -1.337 . . . . 50.0 110.023 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.575 HD13 ' CE2' ' A' ' 15' ' ' PHE . 5.9 mt -112.33 134.22 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.63 -0.669 . . . . 16.66 109.39 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.427 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 17.8 p -107.21 167.64 9.77 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.36 -0.837 . . . . 50.0 108.823 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.513 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.28 -45.99 54.86 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.046 -1.034 . . . . 50.0 108.823 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.16 74.29 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.349 -0.844 . . . . 50.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.5 mt-10 -77.14 -54.17 6.85 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -0.947 . . . . 16.66 109.321 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.576 HD13 ' CE1' ' A' ' 18' ' ' PHE . 32.3 tp -63.12 -41.76 99.4 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.202 -0.936 . . . . 16.66 108.93 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.492 ' CA ' HG13 ' A' ' 46' ' ' VAL . . . -64.6 -44.9 94.37 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.199 -1.56 . . . . 16.66 109.199 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -59.07 -41.84 88.91 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.346 -1.091 . . . . 50.0 109.709 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.96 -40.2 65.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.161 -0.962 . . . . 50.0 108.554 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.458 HD11 ' CG2' ' A' ' 46' ' ' VAL . 11.3 mt -60.69 -31.22 70.49 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.52 -0.738 . . . . 99.989999999999995 109.564 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' LEU . 5.3 mttt -45.53 -25.56 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.018 -1.051 . . . . 99.989999999999995 109.48 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.525 ' CG2' HG22 ' A' ' 83' ' ' ILE . 9.6 t -52.04 -23.78 5.74 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.916 . . . . 99.989999999999995 109.183 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.405 HD13 HD21 ' A' ' 35' ' ' LEU . 9.2 mt -59.49 -33.27 71.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.352 -0.843 . . . . 50.0 109.216 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.13 0.75 57.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.719 -1.352 . . . . 16.66 109.719 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 t -154.72 64.64 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -1.204 . . . . 16.66 109.711 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.3 tt -147.09 175.6 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 50.0 109.42 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.91 164.52 34.54 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.254 -0.903 . . . . 16.66 108.781 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 46.7 Cg_endo -69.21 -33.27 19.07 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.117 1.878 . . . . 50.0 110.142 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -66.75 -22.86 66.04 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.25 -0.58 . . . . 50.0 110.102 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -82.33 -39.66 22.51 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.883 -1.135 . . . . 16.66 108.398 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.492 HG13 ' CA ' ' A' ' 32' ' ' GLY . 67.2 t -65.66 -35.91 76.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.69 -0.855 . . . . 50.0 108.69 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 81.4 mttt -67.17 -39.73 86.48 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.909 -0.774 . . . . 50.0 108.909 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.13 -40.92 91.03 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.428 -0.795 . . . . 50.0 109.183 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.434 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.9 mtt -59.65 -44.3 93.59 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.21 -0.931 . . . . 16.66 108.868 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.518 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 28.1 mtp -61.69 -47.15 86.6 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -0.762 . . . . 50.0 109.128 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.75 -22.07 44.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 50.0 109.141 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.19 -35.95 12.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 16.66 108.989 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 69' ' ' PHE . 85.6 mt -80.77 -30.95 12.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.47 -0.769 . . . . 50.0 109.438 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.486 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.1 t0 -61.04 100.78 0.12 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.465 -0.772 . . . . 16.66 109.027 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.494 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 60.7 p -71.41 -46.5 60.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.288 -0.883 . . . . 50.0 110.436 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -31.02 22.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.135 -0.978 . . . . 16.66 109.534 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.486 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 93.11 28.31 12.05 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.847 -1.168 . . . . 16.66 110.222 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.8 -2.94 55.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.93 -1.335 . . . . 50.0 109.414 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.47 -7.12 59.59 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.999 -1.096 . . . . 16.66 110.457 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.581 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 42.1 m-85 -133.76 155.83 49.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.895 -1.356 . . . . 50.0 111.23 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.539 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 28.6 mm -106.68 127.81 61.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.516 -0.92 . . . . 16.66 108.516 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.53 166.27 12.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.158 -0.964 . . . . 16.66 108.626 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.565 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 35.8 t80 -54.3 -41.96 69.54 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.085 -1.009 . . . . 16.66 108.588 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -61.42 -49.68 75.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.969 -0.752 . . . . 50.0 108.969 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.539 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 33.9 mt-10 -58.28 -47.21 84.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 16.66 109.023 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.571 ' CZ ' HD12 ' A' ' 77' ' ' LEU . 63.6 t80 -61.48 -40.48 94.71 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.52 -0.737 . . . . 16.66 109.294 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.42 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 13.3 m -65.16 -47.04 78.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.405 -0.809 . . . . 50.0 109.242 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -59.72 -37.79 79.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 50.0 109.349 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.555 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.71 -37.42 41.53 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.264 -0.897 . . . . 50.0 108.703 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.415 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -60.64 -28.9 68.63 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.361 -1.496 . . . . 16.66 109.361 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 67' ' ' THR . 67.8 mtm180 -73.3 -34.54 65.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -1.126 . . . . 50.0 109.24 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.83 -17.71 65.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 50.0 109.341 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.499 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 2.2 m-80 -148.33 55.28 1.03 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 50.0 109.275 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HG3' ' N ' ' A' ' 75' ' ' GLY . 10.4 ptm180 -50.58 -41.42 54.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 50.0 108.806 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 74' ' ' ARG . . . -54.38 -20.2 15.45 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.343 -1.503 . . . . 25.0 109.343 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.499 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 48.5 mt -80.02 -43.0 22.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.313 -1.11 . . . . 50.0 109.373 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.8 mm? -61.27 -41.15 96.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.468 -0.77 . . . . 50.0 109.82 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.7 mtpp -63.05 -38.4 91.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 50.0 109.378 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -73.48 -49.44 26.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.41 -0.806 . . . . 50.0 109.57 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.1 p -66.05 -43.17 92.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.372 -0.83 . . . . 50.0 109.589 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.534 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.25 -39.74 45.85 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.225 -0.59 . . . . 50.0 109.884 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 34.9 mttm -66.86 -26.02 66.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.935 . . . . 50.0 109.686 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.525 HG22 ' CG2' ' A' ' 37' ' ' THR . 8.2 mt -63.17 -45.22 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 50.0 109.466 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.467 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 92.1 m-85 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.997 -1.001 . . . . 99.989999999999995 109.435 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.465 ' HB3' ' NH1' ' A' ' 11' ' ' ARG . 59.3 m-20 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.3 -0.63 . . . . 50.0 109.3 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -50.39 -37.48 37.77 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.437 -0.789 . . . . 50.0 109.359 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.99 -45.23 79.07 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.476 -0.935 . . . . 16.66 108.476 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.449 ' O ' HG13 ' A' ' 14' ' ' ILE . 53.0 mt-10 -65.44 -45.35 84.13 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.908 -0.775 . . . . 16.66 108.908 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.465 ' NH1' ' HB3' ' A' ' 7' ' ' ASP . 41.9 mtt180 -63.08 -40.93 99.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.395 -0.815 . . . . 50.0 109.395 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.558 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 7.4 mt-10 -64.88 -43.49 92.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.428 -0.795 . . . . 50.0 109.407 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.6 mtt180 -65.94 -41.36 91.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.888 . . . . 50.0 109.13 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 10' ' ' GLU . 26.0 mt -69.74 -44.53 79.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.302 -0.874 . . . . 50.0 109.19 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.577 ' CE2' HD13 ' A' ' 26' ' ' ILE . 62.0 t80 -66.91 -35.96 81.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.167 -0.958 . . . . 16.66 109.258 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -63.95 -32.4 73.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 50.0 109.383 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 62.7 mtt180 -70.88 -37.15 73.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 50.0 109.047 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.523 ' HB3' ' CD1' ' A' ' 26' ' ' ILE . 33.8 m-85 -68.43 -47.0 68.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 16.66 109.595 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.479 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 22.6 t0 -62.52 103.44 0.41 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 16.66 108.937 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.21 -50.88 43.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 50.0 111.213 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -86.34 -31.09 21.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.714 -1.241 . . . . 16.66 109.688 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.479 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 93.94 36.48 5.76 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.805 -1.188 . . . . 16.66 110.27 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.473 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.6 p-10 -92.02 4.01 53.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.074 -1.25 . . . . 16.66 109.377 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.78 -6.15 73.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.367 -1.093 . . . . 16.66 110.367 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 10.1 pttm -131.32 143.02 50.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.926 -1.338 . . . . 50.0 109.991 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.577 HD13 ' CE2' ' A' ' 15' ' ' PHE . 4.6 mt -111.97 133.64 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.462 0.648 . . . . 16.66 109.645 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.444 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 13.3 p -106.67 167.97 9.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.473 -0.767 . . . . 50.0 108.947 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.38 -46.35 56.0 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.066 -1.021 . . . . 50.0 108.822 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -56.31 -40.89 75.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.309 -0.869 . . . . 50.0 109.441 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.3 mt-10 -75.19 -54.44 7.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.23 -0.919 . . . . 16.66 109.251 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.53 ' CD2' HD11 ' A' ' 35' ' ' LEU . 7.2 tt -60.35 -45.27 94.08 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.295 -0.878 . . . . 16.66 108.799 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.503 ' CA ' HG12 ' A' ' 46' ' ' VAL . . . -63.21 -45.03 96.18 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.048 -1.621 . . . . 16.66 109.048 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 16.8 mt-10 -57.13 -42.89 81.77 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.329 -1.1 . . . . 50.0 109.579 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.06 -39.95 65.47 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.133 -0.979 . . . . 50.0 108.379 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.53 HD11 ' CD2' ' A' ' 31' ' ' LEU . 5.3 mt -59.16 -33.04 70.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.599 -0.688 . . . . 99.989999999999995 109.6 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -44.64 -26.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.076 -1.015 . . . . 99.989999999999995 109.455 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.493 ' CG2' HG22 ' A' ' 83' ' ' ILE . 8.5 t -53.11 -25.53 13.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 99.989999999999995 109.363 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.449 HD13 HD21 ' A' ' 35' ' ' LEU . 20.5 mt -61.31 -32.34 72.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 50.0 109.151 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.3 9.76 44.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.591 -1.404 . . . . 16.66 109.591 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.54 51.35 0.51 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -1.184 . . . . 16.66 109.444 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.424 HD11 HD13 ' A' ' 38' ' ' LEU . 5.5 tt -140.08 175.82 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 50.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.2 167.37 19.05 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.344 -0.848 . . . . 16.66 108.825 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.96 -34.41 17.44 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.972 1.782 . . . . 50.0 110.028 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.81 -29.24 70.03 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.711 -0.618 . . . . 50.0 109.919 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -80.87 -38.8 27.48 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.999 -1.063 . . . . 16.66 108.214 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.503 HG12 ' CA ' ' A' ' 32' ' ' GLY . 47.9 t -63.73 -36.97 78.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.023 -0.732 . . . . 50.0 109.023 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -70.23 -37.38 74.97 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.761 -0.829 . . . . 50.0 108.761 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.517 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.3 t60 -67.46 -37.75 83.41 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.347 -0.846 . . . . 50.0 109.203 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.402 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.3 mtt -60.93 -46.76 89.4 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.092 -1.005 . . . . 16.66 108.871 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.512 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 38.9 mtp -61.74 -47.64 84.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.537 -0.727 . . . . 50.0 109.213 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.03 -19.58 45.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 50.0 109.469 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.433 ' CD ' ' NE2' ' A' ' 48' ' ' HIS . 26.8 mt-10 -97.24 -35.8 10.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 16.66 109.108 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.558 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.6 mt -81.87 -32.5 11.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 50.0 109.658 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.481 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 20.4 t0 -59.11 101.37 0.09 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.352 -0.842 . . . . 16.66 109.094 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 46.5 p -69.54 -46.19 67.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.222 -0.924 . . . . 50.0 110.584 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.489 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -87.48 -38.13 16.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.967 . . . . 16.66 109.456 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.481 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 101.06 27.93 7.13 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.993 -1.099 . . . . 16.66 110.581 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.489 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 p-10 -79.45 -2.24 41.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.768 -1.43 . . . . 50.0 109.079 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.512 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.86 -4.97 59.5 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.996 -1.242 . . . . 16.66 109.996 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 28.1 m-85 -134.7 157.48 46.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.029 -1.277 . . . . 50.0 111.259 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.549 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 29.9 mm -108.59 128.17 64.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.172 -1.047 . . . . 16.66 108.172 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 m -94.54 169.56 10.11 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.143 -0.973 . . . . 16.66 108.761 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.558 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 33.0 t80 -56.34 -43.22 78.84 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.223 -0.923 . . . . 16.66 108.943 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -62.53 -44.83 95.38 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.594 -0.691 . . . . 50.0 109.219 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.549 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 55.1 mt-10 -62.17 -47.43 84.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 16.66 109.157 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -62.65 -36.12 81.82 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.398 -0.814 . . . . 16.66 109.296 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.7 m -68.4 -47.16 68.05 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.29 -0.881 . . . . 50.0 109.148 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 71' ' ' ARG . 74.2 m-20 -58.95 -36.75 75.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 50.0 109.307 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.31 -36.48 53.99 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.496 -0.927 . . . . 50.0 108.496 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.514 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -58.02 -30.48 63.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.109 -1.597 . . . . 16.66 109.109 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.518 ' NH2' ' OD1' ' A' ' 68' ' ' ASP . 52.2 mtm180 -69.18 -30.75 69.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -1.067 . . . . 50.0 108.928 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.66 -21.66 63.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.441 -0.787 . . . . 50.0 109.261 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.431 ' CB ' HD13 ' A' ' 76' ' ' LEU . 2.4 m-80 -150.58 57.01 0.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.392 -0.818 . . . . 50.0 109.192 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 7.0 ptp85 -49.27 -36.99 22.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.284 -0.885 . . . . 50.0 108.781 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.439 ' HA3' ' HE2' ' A' ' 78' ' ' LYS . . . -60.34 -30.38 71.09 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.294 -1.522 . . . . 25.0 109.294 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.431 HD13 ' CB ' ' A' ' 73' ' ' ASN . 30.7 mt -68.39 -45.57 72.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -1.081 . . . . 50.0 109.485 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.514 ' CD1' ' HA2' ' A' ' 70' ' ' GLY . 17.4 mt -65.17 -19.43 65.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 50.0 109.678 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 10.6 mtmm -79.54 -21.02 45.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 50.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.1 -40.63 13.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.926 . . . . 50.0 109.37 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 1.4 p -71.97 -38.48 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.469 -0.769 . . . . 50.0 109.339 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.448 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -59.77 -14.81 16.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.66 -0.65 . . . . 50.0 109.703 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 48.6 mttp -98.17 -30.47 12.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.175 -0.953 . . . . 50.0 109.093 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.493 HG22 ' CG2' ' A' ' 37' ' ' THR . 8.3 mt -56.09 -30.32 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.43 -0.794 . . . . 50.0 109.3 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.956 -1.021 . . . . 99.989999999999995 109.487 179.875 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.333 -0.617 . . . . 50.0 109.333 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -49.62 -37.01 26.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.444 -0.785 . . . . 50.0 109.342 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.47 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.75 -46.01 85.08 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.709 -0.848 . . . . 16.66 108.709 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.476 ' O ' HG13 ' A' ' 14' ' ' ILE . 60.2 mt-10 -67.29 -38.54 85.2 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.921 -0.77 . . . . 16.66 108.921 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.9 mtt-85 -67.37 -41.48 84.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.341 -0.85 . . . . 50.0 109.388 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.637 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 9.8 mt-10 -64.94 -42.61 94.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.616 -0.678 . . . . 50.0 109.451 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 70.0 mtp180 -64.93 -41.49 95.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 50.0 109.316 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 10' ' ' GLU . 18.7 mt -69.45 -46.02 77.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.407 -0.808 . . . . 50.0 109.034 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.586 ' CE2' HD13 ' A' ' 26' ' ' ILE . 59.0 t80 -63.62 -35.6 81.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.313 -0.867 . . . . 16.66 109.254 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -65.84 -31.86 73.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.827 . . . . 50.0 109.281 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 48.4 mtt180 -70.68 -33.66 71.15 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.29 -0.882 . . . . 50.0 109.183 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.549 ' CE1' HD13 ' A' ' 31' ' ' LEU . 45.2 m-85 -71.9 -49.12 40.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.348 -0.845 . . . . 16.66 109.498 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.481 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 25.7 t0 -57.88 103.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 16.66 108.646 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.18 -52.2 50.41 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.314 -0.866 . . . . 50.0 111.399 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -87.84 -23.49 23.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.84 -1.162 . . . . 16.66 109.688 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.481 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 84.84 41.3 7.72 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.001 -1.24 . . . . 16.66 110.001 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.7 p-10 -96.35 5.5 50.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.255 . . . . 16.66 109.267 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.24 -9.63 69.72 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.451 -1.06 . . . . 16.66 110.451 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.0 pttp -129.27 141.62 51.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.908 -1.348 . . . . 50.0 109.966 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.586 HD13 ' CE2' ' A' ' 15' ' ' PHE . 5.4 mt -112.67 134.31 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.693 -0.629 . . . . 16.66 109.444 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.4 p -105.75 166.94 10.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.74 -0.837 . . . . 50.0 108.74 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.04 -45.22 51.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.028 -1.045 . . . . 50.0 108.825 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -58.12 -39.2 78.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.401 -0.812 . . . . 50.0 109.524 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.1 mt-10 -75.26 -54.32 7.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.218 -0.926 . . . . 16.66 109.265 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.549 HD13 ' CE1' ' A' ' 18' ' ' PHE . 34.7 tp -62.38 -42.69 99.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 16.66 108.957 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.513 ' CA ' HG13 ' A' ' 46' ' ' VAL . . . -63.67 -44.67 96.06 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.189 -1.564 . . . . 16.66 109.189 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 29.1 mt-10 -58.28 -42.2 86.06 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.312 -1.111 . . . . 50.0 109.655 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.56 -40.42 61.68 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.38 -0.97 . . . . 50.0 108.38 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.461 HD11 ' CG2' ' A' ' 46' ' ' VAL . 10.5 mt -60.52 -31.43 70.5 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.592 -0.692 . . . . 99.989999999999995 109.578 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -47.21 -23.71 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 99.989999999999995 109.527 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.437 HG22 HG23 ' A' ' 83' ' ' ILE . 10.3 t -52.15 -22.85 4.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 99.989999999999995 109.218 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.513 ' CD1' HD11 ' A' ' 41' ' ' ILE . 87.8 mt -63.0 -32.07 73.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.479 -0.763 . . . . 50.0 109.288 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.23 7.13 50.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.674 -1.37 . . . . 16.66 109.674 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 40' ' ' SER . 4.8 t -154.75 55.63 0.67 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -1.203 . . . . 16.66 109.653 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.513 HD11 ' CD1' ' A' ' 38' ' ' LEU . 9.0 tt -142.87 176.29 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 50.0 109.538 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.52 163.94 39.42 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.857 . . . . 16.66 108.697 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.49 -33.72 21.97 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.164 1.91 . . . . 50.0 110.209 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -65.87 -24.05 66.78 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.581 -0.699 . . . . 50.0 109.972 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -82.13 -38.52 24.64 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.944 -1.097 . . . . 16.66 108.393 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.513 HG13 ' CA ' ' A' ' 32' ' ' GLY . 42.8 t -68.45 -37.35 77.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.02 -0.733 . . . . 50.0 109.02 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -66.16 -40.28 90.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.372 -0.83 . . . . 50.0 108.941 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -64.87 -40.04 94.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.43 -0.794 . . . . 50.0 109.217 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.438 ' O ' HG13 ' A' ' 53' ' ' ILE . 7.1 mtt -57.61 -43.13 84.5 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.184 -0.947 . . . . 16.66 108.857 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.518 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 47.3 mtp -62.06 -48.0 82.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.561 -0.712 . . . . 50.0 109.266 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.58 -20.55 33.11 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.299 -0.876 . . . . 50.0 109.128 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -97.42 -36.42 10.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.455 -0.778 . . . . 16.66 109.184 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.565 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.5 mt -81.62 -32.45 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.352 -0.843 . . . . 50.0 109.569 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.475 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.7 t0 -59.74 101.41 0.11 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.393 -0.817 . . . . 16.66 109.047 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.462 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 67.6 p -70.71 -47.11 61.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 50.0 110.751 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.3 p-10 -86.54 -36.61 18.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.082 -1.011 . . . . 16.66 109.556 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 99.86 28.71 7.25 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.881 -1.152 . . . . 16.66 110.76 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.7 p-10 -81.03 -3.32 51.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.714 -1.463 . . . . 50.0 109.124 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.1 -4.47 58.85 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.855 -1.298 . . . . 16.66 109.855 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 44.3 m-85 -134.08 156.37 48.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.057 -1.261 . . . . 50.0 111.093 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.553 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 31.5 mm -108.16 129.88 61.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.142 -1.059 . . . . 16.66 108.142 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.5 166.51 11.48 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.103 -0.998 . . . . 16.66 108.709 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.637 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 34.6 t80 -53.48 -42.53 67.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.186 -1.006 . . . . 16.66 108.546 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -60.5 -49.33 77.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.618 -0.676 . . . . 50.0 109.25 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.553 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 75.3 mt-10 -59.86 -47.0 87.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 16.66 109.15 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -62.66 -36.23 82.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 16.66 109.223 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 21.7 m -67.81 -47.92 67.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 50.0 109.013 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.32 -37.93 79.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.4 -0.813 . . . . 50.0 109.249 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.566 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -77.04 -37.26 55.11 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.503 -0.925 . . . . 50.0 108.503 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.415 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -58.61 -29.73 64.44 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.247 -1.541 . . . . 16.66 109.247 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 67' ' ' THR . 77.2 mtm180 -70.4 -30.84 67.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -1.127 . . . . 50.0 109.056 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.18 63.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.421 -0.799 . . . . 50.0 109.363 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.514 ' HB2' ' CG ' ' A' ' 76' ' ' LEU . 4.6 p30 -149.7 56.73 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 50.0 109.189 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.486 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 12.8 ptm180 -49.57 -37.13 26.16 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.386 -0.821 . . . . 50.0 108.843 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.33 -27.06 71.1 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.73 -1.348 . . . . 25.0 109.73 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.514 ' CG ' ' HB2' ' A' ' 73' ' ' ASN . 12.6 mt -66.24 -46.73 76.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -1.184 . . . . 50.0 109.653 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' A' ' 74' ' ' ARG . 0.4 OUTLIER -59.84 -41.16 90.78 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.377 -0.827 . . . . 50.0 109.375 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -59.23 -30.12 68.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 50.0 109.392 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 49.9 t0 -71.22 -36.8 71.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 50.0 109.38 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.93 -27.73 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.385 -0.822 . . . . 50.0 109.421 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 77' ' ' LEU . . . -62.13 -18.74 61.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 50.0 109.719 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 37.5 pttt -95.48 -31.05 13.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 50.0 109.309 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 79' ' ' ASP . 9.3 mt -57.88 -33.64 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.856 . . . . 50.0 109.448 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.075 -0.964 . . . . 99.989999999999995 109.494 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.371 -0.603 . . . . 50.0 109.371 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -50.11 -36.86 31.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.808 . . . . 50.0 109.45 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -56.73 -45.57 81.85 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.612 -0.885 . . . . 16.66 108.612 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 14' ' ' ILE . 49.0 mt-10 -67.1 -38.64 86.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.448 -0.782 . . . . 16.66 109.066 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 67' ' ' THR . 74.5 mtt-85 -67.29 -40.71 86.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 50.0 109.429 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.572 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 37.8 mt-10 -65.45 -41.62 93.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.441 -0.787 . . . . 50.0 109.5 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 58.5 mtp85 -67.42 -40.66 85.55 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.23 -0.919 . . . . 50.0 109.277 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 10' ' ' GLU . 42.7 mt -70.54 -44.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.289 -0.882 . . . . 50.0 109.151 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.573 ' CE2' HD13 ' A' ' 26' ' ' ILE . 50.1 t80 -68.22 -35.57 78.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.207 -0.933 . . . . 16.66 109.278 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 52.9 mttt -64.33 -31.79 73.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.373 -0.829 . . . . 50.0 109.261 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.503 ' NH2' ' O ' ' A' ' 84' ' ' PHE . 52.4 mtt180 -72.21 -35.71 68.97 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.901 . . . . 50.0 109.17 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CB ' HD12 ' A' ' 26' ' ' ILE . 37.1 m-85 -68.75 -45.31 71.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 16.66 109.531 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 25.7 t0 -64.45 103.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 16.66 108.779 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.73 -52.13 47.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.233 -0.917 . . . . 50.0 111.21 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -85.57 -26.08 26.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.746 -1.221 . . . . 16.66 109.56 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 86.99 42.92 6.15 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.936 -1.126 . . . . 16.66 110.49 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.487 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 41.1 p-10 -99.44 6.0 46.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.25 . . . . 16.66 109.33 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 62' ' ' SER . . . 94.03 -10.88 71.55 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.485 -1.046 . . . . 16.66 110.485 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' CD2' ' A' ' 60' ' ' PHE . 14.3 pttp -126.69 140.45 52.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.926 -1.338 . . . . 50.0 109.891 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.573 HD13 ' CE2' ' A' ' 15' ' ' PHE . 3.3 mt -113.8 134.18 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.571 -0.706 . . . . 16.66 109.424 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.462 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 25.9 p -107.47 170.53 7.92 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.435 -0.791 . . . . 50.0 109.011 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.518 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -51.14 -47.76 61.98 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.118 -0.989 . . . . 50.0 109.028 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.31 -38.45 71.29 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.335 -0.853 . . . . 50.0 109.485 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.474 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 54.8 mt-10 -77.56 -54.49 6.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.251 -0.905 . . . . 16.66 109.154 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.532 ' CD2' HD13 ' A' ' 35' ' ' LEU . 7.5 tt -60.01 -46.11 90.55 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.212 -0.93 . . . . 16.66 108.853 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.505 ' HA3' ' CG2' ' A' ' 46' ' ' VAL . . . -61.36 -43.95 98.69 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.076 -1.61 . . . . 16.66 109.076 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 16.2 mt-10 -57.06 -44.42 83.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.433 -1.04 . . . . 50.0 109.823 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.26 -39.28 75.08 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.187 -0.946 . . . . 50.0 108.646 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 31' ' ' LEU . 8.7 mt -58.7 -32.03 68.79 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.421 -0.799 . . . . 99.989999999999995 109.628 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -42.43 -26.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.177 -0.952 . . . . 99.989999999999995 109.84 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.517 ' CG2' HG23 ' A' ' 83' ' ' ILE . 6.3 t -49.44 -24.84 2.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.182 -0.949 . . . . 99.989999999999995 109.155 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.519 HD11 ' CD1' ' A' ' 41' ' ' ILE . 2.0 mt -61.28 -36.39 79.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 50.0 109.315 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.7 -3.33 64.4 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.498 -1.441 . . . . 16.66 109.498 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.74 67.7 0.63 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -1.168 . . . . 16.66 109.657 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.519 ' CD1' HD11 ' A' ' 38' ' ' LEU . 13.3 tt -149.35 168.25 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 50.0 109.545 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.54 167.32 12.42 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 16.66 109.221 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.67 -28.76 16.81 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.276 1.984 . . . . 50.0 109.849 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.25 -28.67 68.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.597 -0.689 . . . . 50.0 109.774 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -80.76 -34.57 34.18 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.069 -1.019 . . . . 16.66 108.353 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.515 HG23 ' CD1' ' A' ' 35' ' ' LEU . 53.5 t -66.51 -35.42 74.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.108 -0.701 . . . . 50.0 109.108 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -69.06 -37.97 78.81 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.758 -0.83 . . . . 50.0 108.758 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.534 ' CD2' ' HG3' ' A' ' 52' ' ' GLU . 14.8 t-160 -68.07 -39.65 82.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.496 -0.752 . . . . 50.0 109.087 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.44 ' HE2' HD12 ' A' ' 35' ' ' LEU . 4.4 mtt -61.9 -47.11 86.43 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.141 -0.975 . . . . 16.66 108.614 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.519 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 48.9 mtp -63.01 -48.3 79.41 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.046 -0.724 . . . . 50.0 109.046 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.72 -17.81 25.96 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.307 -0.871 . . . . 50.0 108.996 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.534 ' HG3' ' CD2' ' A' ' 48' ' ' HIS . 22.7 mt-10 -98.78 -36.2 9.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 16.66 109.203 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.559 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.4 mt -82.23 -32.45 10.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.457 -0.777 . . . . 50.0 109.669 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.9 t0 -58.4 100.69 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.441 -0.787 . . . . 16.66 109.126 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.466 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 59.1 p -70.0 -46.57 64.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.298 -0.876 . . . . 50.0 110.463 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.91 -31.53 22.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.11 -0.994 . . . . 16.66 109.571 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.484 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 93.06 28.53 11.7 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.801 -1.19 . . . . 16.66 110.189 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.48 -3.07 55.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.94 -1.33 . . . . 50.0 109.402 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.519 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 100.44 -8.34 58.56 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.053 -1.07 . . . . 16.66 110.465 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CD2' ' HD2' ' A' ' 25' ' ' LYS . 33.9 m-85 -132.81 155.98 47.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.842 -1.387 . . . . 50.0 111.256 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.532 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 32.0 mm -107.43 129.59 61.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.348 -0.982 . . . . 16.66 108.348 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.9 OUTLIER -95.7 166.91 11.59 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.175 -0.953 . . . . 16.66 108.644 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 32.2 t80 -55.76 -42.86 76.06 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.128 -0.983 . . . . 16.66 108.741 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -62.43 -47.29 84.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.507 -0.745 . . . . 50.0 109.07 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.532 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 51.7 mt-10 -58.54 -48.09 82.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 16.66 108.974 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -59.54 -39.31 83.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.448 -0.782 . . . . 16.66 109.346 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.518 ' O ' ' NH1' ' A' ' 11' ' ' ARG . 16.4 m -65.28 -45.99 82.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.457 -0.777 . . . . 50.0 109.238 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -59.62 -40.07 86.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 50.0 109.515 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.559 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -73.0 -36.53 67.04 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.252 -0.905 . . . . 50.0 108.778 179.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.422 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -58.63 -34.45 76.57 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.389 -1.484 . . . . 16.66 109.389 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -65.86 -29.09 69.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -1.137 . . . . 50.0 109.277 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.67 -22.09 60.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 50.0 109.147 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.55 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 1.8 m-80 -150.24 58.69 0.96 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.428 -0.795 . . . . 50.0 108.997 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -50.76 -39.94 53.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.284 -0.885 . . . . 50.0 108.788 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.23 -29.9 69.69 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.342 -1.503 . . . . 25.0 109.342 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.55 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 28.1 mt -66.92 -45.72 77.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 50.0 109.482 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.8 mt -60.85 -37.19 81.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 50.0 109.635 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.5 mtmt -62.41 -24.19 67.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 50.0 109.427 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -77.87 -36.36 49.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 50.0 109.527 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -83.58 -29.46 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.836 . . . . 50.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.459 ' HB2' HD12 ' A' ' 14' ' ' ILE . . . -61.33 -16.54 47.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 50.0 109.607 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -95.19 -30.66 13.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 50.0 109.223 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.517 HG23 ' CG2' ' A' ' 37' ' ' THR . 8.3 mt -58.86 -36.29 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 50.0 109.332 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.503 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 96.3 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.974 -1.012 . . . . 99.989999999999995 109.499 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.27 -0.641 . . . . 50.0 109.27 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -48.79 -36.63 17.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.369 -0.832 . . . . 50.0 109.586 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.23 -46.75 87.63 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.26 -0.9 . . . . 16.66 108.638 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 14' ' ' ILE . 57.0 mt-10 -68.08 -38.99 83.0 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.823 -0.806 . . . . 16.66 108.823 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.503 ' NH2' HD13 ' A' ' 77' ' ' LEU . 59.5 mtt-85 -67.99 -40.9 82.97 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.461 -0.774 . . . . 50.0 109.458 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.579 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 22.7 mt-10 -65.71 -40.86 92.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 50.0 109.524 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 15.1 mtp85 -68.18 -40.45 82.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 50.0 109.353 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 10' ' ' GLU . 34.6 mt -71.31 -43.46 73.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.328 -0.858 . . . . 50.0 109.012 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.577 ' CE2' HD13 ' A' ' 26' ' ' ILE . 63.6 t80 -67.39 -36.42 81.28 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.191 -0.943 . . . . 16.66 109.089 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -65.65 -29.67 70.27 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.29 -0.881 . . . . 50.0 109.062 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 28.9 mtt180 -71.24 -37.08 72.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.361 -0.837 . . . . 50.0 109.088 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.571 ' CD1' HD13 ' A' ' 31' ' ' LEU . 43.4 m-85 -69.66 -48.48 59.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -0.797 . . . . 16.66 109.488 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 24.4 t0 -59.18 103.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 16.66 108.713 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -51.39 55.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 50.0 111.273 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -87.87 -29.24 21.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.782 -1.199 . . . . 16.66 109.845 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 92.34 35.85 6.46 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.783 -1.198 . . . . 16.66 110.178 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.477 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.7 p-10 -90.43 4.76 50.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.252 . . . . 16.66 109.284 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.5 -6.73 74.79 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.347 -1.101 . . . . 16.66 110.347 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 15.4 pttt -130.43 141.89 50.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.996 -1.296 . . . . 50.0 110.027 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.577 HD13 ' CE2' ' A' ' 15' ' ' PHE . 5.0 mt -112.31 134.03 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.588 -0.695 . . . . 16.66 109.398 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.427 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 12.9 p -106.79 167.54 9.8 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.392 -0.818 . . . . 50.0 108.899 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.502 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.48 -45.55 56.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.059 -1.026 . . . . 50.0 108.909 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.6 -39.43 76.8 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.328 -0.858 . . . . 50.0 109.598 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.483 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.5 mt-10 -75.05 -53.98 7.95 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.224 -0.923 . . . . 16.66 109.439 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.571 HD13 ' CD1' ' A' ' 18' ' ' PHE . 31.9 tp -62.37 -42.25 99.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.209 -0.932 . . . . 16.66 108.911 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -64.35 -45.33 93.67 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.115 -1.594 . . . . 16.66 109.115 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -57.73 -42.96 84.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -1.104 . . . . 50.0 109.539 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.57 -39.95 64.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.417 -0.957 . . . . 50.0 108.417 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.526 HD12 ' CE ' ' A' ' 49' ' ' MET . 10.3 mt -61.62 -32.77 72.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.578 -0.701 . . . . 99.989999999999995 109.672 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -46.87 -24.55 0.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 99.989999999999995 109.644 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.53 ' CG2' HG22 ' A' ' 83' ' ' ILE . 11.6 t -51.95 -21.52 3.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 99.989999999999995 109.266 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.5 mt -66.64 -29.58 69.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.361 -0.837 . . . . 50.0 109.294 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.75 8.89 50.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 16.66 109.585 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.82 60.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -1.167 . . . . 16.66 109.61 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.73 173.32 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 50.0 109.525 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.38 162.96 37.08 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.712 -0.847 . . . . 16.66 108.712 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.03 -32.49 21.48 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.09 1.86 . . . . 50.0 110.012 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.25 -22.11 64.78 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.642 -0.661 . . . . 50.0 110.043 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -79.99 -36.83 35.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.93 -1.106 . . . . 16.66 108.465 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.519 ' CG2' HD11 ' A' ' 35' ' ' LEU . 54.2 t -68.72 -36.34 73.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.968 -0.753 . . . . 50.0 108.968 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -64.92 -39.9 94.22 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.896 -0.779 . . . . 50.0 108.896 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.55 -43.37 90.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 50.0 109.116 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.526 ' CE ' HD12 ' A' ' 35' ' ' LEU . 70.1 mtm -59.32 -43.39 92.7 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.174 -0.954 . . . . 16.66 108.932 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.516 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 32.4 mtp -61.53 -47.23 86.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.493 -0.754 . . . . 50.0 109.058 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.02 -22.58 50.44 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.318 -0.864 . . . . 50.0 109.116 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.91 -35.89 12.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 16.66 108.942 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.549 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.6 mt -81.09 -30.09 11.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.591 -0.693 . . . . 50.0 109.534 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.4 t0 -62.42 101.36 0.23 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.386 -0.821 . . . . 16.66 109.105 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.47 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 74.0 p -71.65 -47.95 50.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.862 . . . . 50.0 110.614 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 4.2 p-10 -85.85 -33.83 21.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.141 -0.975 . . . . 16.66 109.728 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 97.31 27.4 9.29 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.911 -1.138 . . . . 16.66 111.053 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 p-10 -80.62 -2.5 46.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.725 -1.456 . . . . 50.0 109.248 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.516 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.01 -4.16 60.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.003 -1.239 . . . . 16.66 110.003 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 39.7 m-85 -134.46 156.12 49.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.26 . . . . 50.0 111.125 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 34.3 mm -106.83 128.95 61.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.34 -0.985 . . . . 16.66 108.34 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -96.25 169.51 9.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.083 -1.011 . . . . 16.66 108.832 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.579 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 35.7 t80 -55.8 -43.88 77.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.128 -0.983 . . . . 16.66 108.73 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -60.31 -48.38 82.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.462 -0.774 . . . . 50.0 109.185 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.54 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 63.5 mt-10 -59.91 -46.5 89.18 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.357 -0.839 . . . . 16.66 109.11 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.432 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 56.5 t80 -62.35 -36.53 82.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.443 -0.786 . . . . 16.66 109.079 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 28.9 m -68.51 -48.27 64.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.8 . . . . 50.0 108.979 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -58.08 -37.75 75.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.319 -0.863 . . . . 50.0 109.249 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -78.73 -35.87 44.14 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.41 -0.959 . . . . 50.0 108.41 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.5 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -58.63 -33.9 74.22 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.888 -1.685 . . . . 16.66 108.888 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 67' ' ' THR . 82.1 mtm180 -64.86 -32.3 73.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -1.078 . . . . 50.0 108.53 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.55 -2.54 58.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.538 -0.726 . . . . 50.0 109.227 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.526 ' CA ' HD11 ' A' ' 76' ' ' LEU . 68.4 m-80 -151.69 48.42 0.8 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.311 -0.868 . . . . 50.0 108.668 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -57.8 -47.04 83.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.342 -0.849 . . . . 50.0 108.877 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.2 -21.16 38.46 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.135 -1.586 . . . . 25.0 109.135 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.526 HD11 ' CA ' ' A' ' 73' ' ' ASN . 6.8 mp -79.94 -43.82 21.43 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -1.116 . . . . 50.0 109.366 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.503 HD13 ' NH2' ' A' ' 11' ' ' ARG . 5.9 mt -69.2 -22.38 63.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 50.0 109.968 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -80.03 -26.19 39.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 50.0 109.716 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -89.57 -40.66 12.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.1 -1.0 . . . . 50.0 109.586 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.9 p -67.78 -43.36 86.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.383 -0.823 . . . . 50.0 109.515 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.538 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.96 -37.66 45.86 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.673 -0.642 . . . . 50.0 109.919 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.21 -26.86 67.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 50.0 109.542 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.53 HG22 ' CG2' ' A' ' 37' ' ' THR . 7.8 mt -60.63 -43.9 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.236 -0.915 . . . . 50.0 109.362 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.46 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 89.6 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.961 -1.019 . . . . 99.989999999999995 109.463 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.445 0.64 . . . . 50.0 109.363 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -50.62 -36.94 37.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 50.0 109.403 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.15 -46.16 89.1 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.782 -0.822 . . . . 16.66 108.782 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.9 mm-40 -66.38 -44.06 84.17 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.957 -0.757 . . . . 16.66 108.957 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.507 ' NH2' HD13 ' A' ' 77' ' ' LEU . 36.6 mtt-85 -64.95 -39.52 93.62 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.435 -0.79 . . . . 50.0 109.416 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.57 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 13.0 mt-10 -66.21 -42.14 89.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 50.0 109.542 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 47.5 mtp180 -67.01 -40.81 87.36 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.299 -0.876 . . . . 50.0 109.214 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 81' ' ' ALA . 25.8 mt -70.29 -44.54 77.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.359 -0.838 . . . . 50.0 109.033 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' A' ' 26' ' ' ILE . 52.7 t80 -66.72 -35.38 79.97 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.281 -0.887 . . . . 16.66 109.041 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -64.44 -31.34 72.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 50.0 109.388 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 64.8 mtt180 -72.53 -36.07 68.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -0.929 . . . . 50.0 109.15 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.557 ' CD1' HD11 ' A' ' 31' ' ' LEU . 34.4 m-85 -68.72 -45.01 72.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 16.66 109.389 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 22.5 t0 -63.37 103.22 0.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 16.66 108.756 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.445 ' HB1' ' HG2' ' A' ' 30' ' ' GLU . . . -66.17 -51.2 60.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.254 -0.904 . . . . 50.0 111.299 -178.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -89.23 -27.27 20.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.659 -1.276 . . . . 16.66 109.762 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 89.95 35.68 7.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.032 -1.227 . . . . 16.66 110.032 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.468 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 35.5 p-10 -89.52 3.71 51.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -1.2 . . . . 16.66 109.277 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.19 -6.28 68.73 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.367 -1.093 . . . . 16.66 110.367 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.5 pttp -132.37 143.48 49.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.911 -1.346 . . . . 50.0 110.149 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.532 HD13 ' CE2' ' A' ' 15' ' ' PHE . 6.4 mt -111.41 135.06 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 121.426 0.632 . . . . 16.66 109.53 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.434 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 11.4 p -107.77 166.4 10.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.877 -0.786 . . . . 50.0 108.877 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.523 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.81 -45.63 50.21 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.185 -0.947 . . . . 50.0 108.876 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 -38.81 75.99 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.317 -0.864 . . . . 50.0 109.602 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.494 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.2 mt-10 -75.61 -54.1 7.53 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.12 -0.987 . . . . 16.66 109.496 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.557 HD11 ' CD1' ' A' ' 18' ' ' PHE . 14.5 tp -64.03 -38.95 92.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.123 -0.986 . . . . 16.66 108.876 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -66.02 -46.48 80.82 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.993 -1.643 . . . . 16.66 108.993 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -57.27 -42.79 82.31 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.326 -1.102 . . . . 50.0 109.478 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.63 -40.22 63.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.416 -0.957 . . . . 50.0 108.416 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.439 HD11 HG21 ' A' ' 46' ' ' VAL . 5.0 mt -59.94 -32.84 71.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.644 -0.66 . . . . 99.989999999999995 109.595 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -45.61 -25.67 0.5 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.034 -1.041 . . . . 99.989999999999995 109.351 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.522 ' CG2' HG22 ' A' ' 83' ' ' ILE . 11.7 t -50.87 -23.74 3.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.282 -0.886 . . . . 99.989999999999995 109.184 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.525 ' CD1' HD11 ' A' ' 41' ' ' ILE . 22.5 mt -62.15 -32.58 73.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.813 . . . . 50.0 109.264 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.0 6.43 52.67 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.643 -1.383 . . . . 16.66 109.643 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.18 56.63 0.65 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -1.213 . . . . 16.66 109.605 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 38' ' ' LEU . 8.9 tt -142.47 175.25 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -0.962 . . . . 50.0 109.512 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.75 165.71 25.36 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.349 -0.844 . . . . 16.66 108.759 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.426 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 47.4 Cg_endo -69.42 -33.74 17.23 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.09 1.86 . . . . 50.0 110.172 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.17 -22.37 65.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.699 -0.625 . . . . 50.0 110.178 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -82.99 -39.53 21.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.822 -1.173 . . . . 16.66 108.452 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.439 HG21 HD11 ' A' ' 35' ' ' LEU . 75.1 t -66.03 -36.02 76.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.786 -0.82 . . . . 50.0 108.786 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 23.3 mttm -67.6 -39.9 84.79 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.782 -0.822 . . . . 50.0 108.782 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -65.71 -39.51 91.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.407 -0.808 . . . . 50.0 109.149 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.424 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.8 mtt -58.46 -44.77 89.39 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.176 -0.953 . . . . 16.66 108.718 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.523 ' SD ' ' N ' ' A' ' 28' ' ' ALA . 58.1 mtp -62.32 -48.03 81.66 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.524 -0.735 . . . . 50.0 109.188 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.06 -20.17 23.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.301 -0.874 . . . . 50.0 109.05 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -97.14 -35.8 10.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 16.66 109.025 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.573 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.5 mt -81.74 -31.74 11.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.446 -0.784 . . . . 50.0 109.592 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.465 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.3 t0 -60.42 101.24 0.12 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.341 -0.85 . . . . 16.66 109.187 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.466 ' OG1' ' OE2' ' A' ' 65' ' ' GLU . 37.9 p -72.13 -45.03 62.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.374 -0.829 . . . . 50.0 110.582 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.2 p-10 -87.35 -38.92 15.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 16.66 109.485 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 102.17 29.28 6.12 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.86 -1.162 . . . . 16.66 110.675 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.499 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p-10 -81.92 -4.12 55.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.819 -1.401 . . . . 50.0 109.014 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.513 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.1 -2.36 57.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.816 -1.314 . . . . 16.66 109.816 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 31.4 m-85 -136.86 156.59 48.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -1.232 . . . . 50.0 111.275 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.528 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 33.3 mm -106.93 127.24 62.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.328 -0.99 . . . . 16.66 108.328 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.2 167.71 11.38 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.075 -1.016 . . . . 16.66 108.762 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.57 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.3 t80 -55.09 -43.08 73.64 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.154 -0.966 . . . . 16.66 108.693 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.74 -49.3 78.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.976 -0.75 . . . . 50.0 108.976 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 22.5 mt-10 -58.3 -47.31 84.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.836 . . . . 16.66 109.027 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.6 -37.97 85.85 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.52 -0.737 . . . . 16.66 109.306 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 31.2 m -65.74 -47.73 74.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.845 . . . . 50.0 109.257 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -60.38 -38.84 85.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 50.0 109.359 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.13 -38.37 56.87 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.281 -1.007 . . . . 50.0 108.281 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.486 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -56.81 -28.84 57.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.056 -1.617 . . . . 16.66 109.056 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 67' ' ' THR . 78.7 mtm180 -70.39 -29.65 66.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -1.098 . . . . 50.0 108.832 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.65 -23.42 63.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.781 . . . . 50.0 109.155 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.518 ' CB ' HD13 ' A' ' 76' ' ' LEU . 1.7 m-80 -148.83 58.17 1.04 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 50.0 108.991 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -50.63 -30.86 14.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 50.0 108.894 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.17 -30.9 79.01 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.202 -1.559 . . . . 25.0 109.202 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.518 HD13 ' CB ' ' A' ' 73' ' ' ASN . 63.7 mt -66.57 -43.56 84.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -1.071 . . . . 50.0 109.491 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.515 ' N ' HD21 ' A' ' 77' ' ' LEU . 5.3 mt -69.55 -26.49 64.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.415 -0.803 . . . . 50.0 109.862 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -79.37 -24.59 42.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.01 -1.057 . . . . 50.0 109.217 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -92.01 -45.13 8.48 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.393 -0.817 . . . . 50.0 109.333 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.6 p -61.17 -44.52 98.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.808 0.813 . . . . 50.0 109.048 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.545 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -51.49 -39.82 58.32 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.731 -0.606 . . . . 50.0 109.53 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -59.65 -30.8 68.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 50.0 109.702 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.522 HG22 ' CG2' ' A' ' 37' ' ' THR . 41.9 mt -59.37 -32.43 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 50.0 109.43 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 9.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.062 -0.971 . . . . 99.989999999999995 109.439 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.344 -0.613 . . . . 50.0 109.344 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -52.8 -36.48 58.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.477 -0.764 . . . . 50.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 13' ' ' ARG . . . -58.68 -45.18 89.98 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.642 -0.873 . . . . 16.66 108.642 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 14' ' ' ILE . 66.7 mt-10 -67.41 -43.49 81.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.838 -0.801 . . . . 16.66 108.838 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.457 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 35.1 mtt-85 -66.24 -39.42 89.52 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.484 -0.76 . . . . 50.0 109.346 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.571 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 14.8 mt-10 -66.98 -41.02 87.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.474 -0.766 . . . . 50.0 109.373 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.4 mtt180 -68.46 -40.16 81.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.358 -0.839 . . . . 50.0 109.117 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.9 mt -70.72 -44.73 76.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.411 -0.805 . . . . 50.0 109.059 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 26' ' ' ILE . 75.0 t80 -65.43 -36.23 83.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 16.66 109.029 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -66.05 -29.48 69.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 50.0 109.151 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 84' ' ' PHE . 33.7 mtt180 -70.46 -39.15 74.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 50.0 109.066 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.551 ' CE1' HD13 ' A' ' 31' ' ' LEU . 46.6 m-85 -68.44 -48.5 64.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 16.66 109.316 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 26.5 t0 -57.36 103.48 0.13 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 16.66 108.604 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -52.28 57.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 50.0 111.457 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 23' ' ' ASP . 31.8 p-10 -88.84 -21.97 23.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.826 -1.171 . . . . 16.66 109.768 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 82.66 40.48 9.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.876 -1.29 . . . . 16.66 109.876 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.5 p-10 -94.11 4.15 54.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -1.221 . . . . 16.66 109.247 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.88 -9.41 65.91 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.516 -1.034 . . . . 16.66 110.516 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 7.6 pttt -130.74 142.69 50.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.932 -1.334 . . . . 50.0 110.118 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.567 HD13 ' CE1' ' A' ' 15' ' ' PHE . 7.6 mt -112.82 134.05 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.409 -0.589 . . . . 16.66 109.409 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.438 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 25.0 p -107.8 168.96 8.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 50.0 108.846 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.509 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.56 -47.18 57.86 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.06 -1.025 . . . . 50.0 108.933 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.39 70.2 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.481 -0.762 . . . . 50.0 109.704 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 55.5 mt-10 -78.39 -53.5 7.2 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.111 -0.993 . . . . 16.66 109.477 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.551 HD13 ' CE1' ' A' ' 18' ' ' PHE . 54.6 tp -63.22 -40.43 97.46 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.175 -0.953 . . . . 16.66 108.976 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.521 ' CA ' HG13 ' A' ' 46' ' ' VAL . . . -64.07 -45.13 94.66 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.162 -1.575 . . . . 16.66 109.162 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -58.64 -42.94 89.48 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.195 -1.179 . . . . 50.0 109.703 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.54 -40.68 61.56 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.053 -1.029 . . . . 50.0 108.404 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.426 HD13 ' HG ' ' A' ' 31' ' ' LEU . 9.5 mt -60.73 -33.13 72.45 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.546 -0.721 . . . . 99.989999999999995 109.463 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -47.12 -24.4 0.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.081 -1.012 . . . . 99.989999999999995 109.437 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.514 ' CG2' HG22 ' A' ' 83' ' ' ILE . 12.2 t -52.54 -22.61 5.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 99.989999999999995 109.19 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.3 mt -61.07 -31.66 71.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -0.832 . . . . 50.0 109.224 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.66 3.52 54.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.733 -1.347 . . . . 16.66 109.733 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.76 65.04 0.59 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -1.197 . . . . 16.66 109.71 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.9 tt -149.63 170.24 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 50.0 109.411 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.66 162.95 28.2 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.311 -0.868 . . . . 16.66 108.706 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.76 -32.4 23.38 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.003 1.802 . . . . 50.0 110.18 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.0 -23.56 65.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.604 -0.685 . . . . 50.0 109.915 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -81.0 -38.92 26.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.887 -1.133 . . . . 16.66 108.298 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.521 HG13 ' CA ' ' A' ' 32' ' ' GLY . 53.8 t -66.09 -36.38 77.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.579 -0.897 . . . . 50.0 108.579 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -69.54 -39.54 77.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.479 -0.934 . . . . 50.0 108.479 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.52 -41.42 88.83 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.96 -0.755 . . . . 50.0 108.96 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.8 mtt -59.05 -44.92 91.86 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.259 -0.9 . . . . 16.66 108.622 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.513 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 30.1 mtp -60.39 -46.13 91.06 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.521 -0.737 . . . . 50.0 109.061 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.77 -23.5 52.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.8 . . . . 50.0 109.316 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -92.84 -35.95 13.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 16.66 108.799 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.58 HG12 ' CD2' ' A' ' 69' ' ' PHE . 84.7 mt -80.37 -29.34 12.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.545 -0.722 . . . . 50.0 109.478 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.2 t0 -63.8 101.6 0.38 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.446 -0.784 . . . . 16.66 109.196 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 76.1 p -73.95 -46.72 42.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.292 -0.88 . . . . 50.0 110.868 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 7.5 p-10 -86.14 -31.24 21.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.069 -1.02 . . . . 16.66 109.645 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 94.73 27.42 11.42 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.798 -1.191 . . . . 16.66 111.066 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.6 p-10 -82.32 -3.49 55.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.73 -1.453 . . . . 50.0 109.321 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.513 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.93 -5.71 59.76 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.243 -1.143 . . . . 16.66 110.243 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.574 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 37.0 m-85 -133.5 155.04 50.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.942 -1.328 . . . . 50.0 111.039 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.545 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 34.5 mm -105.24 127.44 59.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.254 -1.017 . . . . 16.66 108.254 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.3 167.62 11.42 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.2 -0.937 . . . . 16.66 108.91 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.571 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.6 t80 -54.58 -42.77 71.45 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.057 -1.027 . . . . 16.66 108.651 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -60.7 -49.47 77.36 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.115 -0.698 . . . . 50.0 109.115 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.545 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 45.6 mt-10 -58.88 -46.79 86.99 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 16.66 109.013 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -63.74 -36.58 84.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.507 -0.745 . . . . 16.66 109.288 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 52.8 m -66.35 -48.68 69.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.321 -0.862 . . . . 50.0 109.209 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' ' NH1' ' A' ' 71' ' ' ARG . 67.8 m-20 -61.79 -37.38 84.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 50.0 109.3 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.58 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -72.71 -40.15 66.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.538 -0.912 . . . . 50.0 108.538 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.496 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -56.13 -29.19 55.58 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.141 -1.584 . . . . 16.66 109.141 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.484 ' NH1' ' OD1' ' A' ' 68' ' ' ASP . 23.2 mtm180 -71.1 -21.49 62.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 50.0 109.054 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.71 -24.44 38.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.439 -0.788 . . . . 50.0 109.34 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.58 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 2.8 m-80 -145.22 57.68 1.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.861 . . . . 50.0 109.393 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -51.31 -38.72 54.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.894 . . . . 50.0 108.762 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.22 -27.53 65.38 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.316 -1.514 . . . . 25.0 109.316 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.58 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 39.7 mt -69.73 -44.8 69.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -1.093 . . . . 50.0 109.476 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 8.9 mp -63.38 -40.26 96.75 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.422 -0.799 . . . . 50.0 110.002 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 14.4 mtmt -65.83 -20.08 66.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 50.0 109.344 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.36 -53.85 3.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 50.0 109.535 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.2 p -65.89 -44.8 92.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.369 -0.832 . . . . 50.0 109.452 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.558 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -53.67 -36.65 62.37 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.59 -0.693 . . . . 50.0 109.725 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 17.5 mttt -66.95 -25.47 66.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 50.0 109.663 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.514 HG22 ' CG2' ' A' ' 37' ' ' THR . 8.1 mt -59.63 -42.48 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.904 . . . . 50.0 109.444 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.512 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 88.7 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.015 -0.993 . . . . 99.989999999999995 109.47 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.222 -0.658 . . . . 50.0 109.222 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -52.78 -36.15 57.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.366 -0.833 . . . . 50.0 109.223 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.59 -45.78 84.83 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.587 -0.894 . . . . 16.66 108.587 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 14' ' ' ILE . 56.2 mt-10 -66.33 -44.65 82.72 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.881 -0.785 . . . . 16.66 108.881 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.57 ' NH1' ' CG2' ' A' ' 67' ' ' THR . 75.2 mtm180 -64.52 -38.85 92.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.533 -0.73 . . . . 50.0 109.436 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.619 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 34.8 mt-10 -65.91 -42.34 90.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.329 -0.857 . . . . 50.0 109.469 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 16.9 mtp180 -66.82 -40.17 87.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.281 -0.887 . . . . 50.0 109.218 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 10' ' ' GLU . 30.2 mt -70.17 -46.27 72.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.392 -0.818 . . . . 50.0 108.967 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.565 ' CE1' HD13 ' A' ' 26' ' ' ILE . 70.2 t80 -62.43 -35.58 79.68 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.274 -0.891 . . . . 16.66 108.934 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 60.1 mttm -66.56 -30.06 70.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.858 . . . . 50.0 109.15 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 47.2 mtt180 -68.92 -37.71 79.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.339 -0.851 . . . . 50.0 109.16 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.556 ' CE1' HD13 ' A' ' 31' ' ' LEU . 55.4 m-85 -68.96 -50.41 49.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.785 . . . . 16.66 109.489 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 23.8 t0 -54.66 103.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 16.66 108.651 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.13 -52.03 52.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.274 -0.891 . . . . 50.0 111.29 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -87.88 -23.64 23.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.745 -1.222 . . . . 16.66 109.592 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 84.72 41.47 7.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.034 -1.226 . . . . 16.66 110.034 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.2 p-10 -96.16 5.84 50.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.047 -1.267 . . . . 16.66 109.295 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -9.01 71.19 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.454 -1.058 . . . . 16.66 110.454 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.2 pttp -129.55 141.86 50.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.319 . . . . 50.0 109.808 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.565 HD13 ' CE1' ' A' ' 15' ' ' PHE . 5.5 mt -112.61 134.31 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.687 -0.633 . . . . 16.66 109.381 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.441 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 18.1 p -106.41 167.33 9.91 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.662 -0.866 . . . . 50.0 108.662 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.94 -45.63 51.42 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.12 -0.988 . . . . 50.0 108.997 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.85 -38.45 75.7 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.25 -0.907 . . . . 50.0 109.529 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.2 mt-10 -76.41 -54.31 6.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.163 -0.961 . . . . 16.66 109.281 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.556 HD13 ' CE1' ' A' ' 18' ' ' PHE . 29.0 tp -62.73 -42.09 99.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 16.66 108.912 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -63.85 -44.9 95.46 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.201 -1.559 . . . . 16.66 109.201 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.99 -42.95 86.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.307 -1.113 . . . . 50.0 109.699 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.89 -40.02 63.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.359 -0.978 . . . . 50.0 108.359 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.472 ' CD1' HG23 ' A' ' 46' ' ' VAL . 12.5 mt -60.76 -32.48 71.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.65 -0.656 . . . . 99.989999999999995 109.566 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -46.5 -24.64 0.55 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.082 -1.012 . . . . 99.989999999999995 109.443 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.449 HG22 HG22 ' A' ' 83' ' ' ILE . 10.3 t -51.81 -22.72 3.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.276 -0.89 . . . . 99.989999999999995 109.261 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.494 HD11 ' CD1' ' A' ' 41' ' ' ILE . 21.6 mt -60.2 -33.24 71.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.381 -0.824 . . . . 50.0 109.38 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.21 3.21 56.31 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.633 -1.387 . . . . 16.66 109.633 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.44 61.57 0.62 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -1.181 . . . . 16.66 109.594 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.494 ' CD1' HD11 ' A' ' 38' ' ' LEU . 10.3 tt -146.31 174.54 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 50.0 109.539 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.34 164.47 29.94 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 16.66 108.768 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.54 -32.77 18.81 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.091 1.861 . . . . 50.0 110.241 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.38 -22.85 65.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.654 -0.654 . . . . 50.0 110.055 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -82.34 -38.95 23.49 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.904 -1.123 . . . . 16.66 108.544 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 35' ' ' LEU . 42.2 t -68.05 -37.35 78.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.779 -0.823 . . . . 50.0 108.779 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -66.15 -40.09 90.31 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.829 -0.804 . . . . 50.0 108.829 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.472 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.9 t60 -64.54 -39.47 93.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.454 -0.779 . . . . 50.0 109.128 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.448 ' O ' HG13 ' A' ' 53' ' ' ILE . 13.2 mtt -56.54 -43.15 79.61 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.101 -1.0 . . . . 16.66 108.552 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.519 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 82.3 mtp -61.51 -48.4 81.22 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.944 -0.761 . . . . 50.0 108.944 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.72 -22.08 12.88 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.246 -0.908 . . . . 50.0 109.134 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -99.11 -36.85 9.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 16.66 109.231 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.573 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.9 mt -80.25 -33.49 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.434 -0.791 . . . . 50.0 109.617 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.471 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.6 t0 -59.97 101.47 0.12 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.351 -0.843 . . . . 16.66 109.099 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.53 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 81.8 p -73.76 -47.41 39.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 50.0 110.819 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 7.1 p-10 -85.72 -31.81 22.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.945 . . . . 16.66 109.681 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 95.19 27.65 10.65 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.888 -1.148 . . . . 16.66 111.001 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.1 p-10 -81.66 -3.79 54.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.768 -1.431 . . . . 50.0 109.342 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.519 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.46 -5.43 58.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.14 -1.184 . . . . 16.66 110.14 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 45.2 m-85 -133.1 154.83 50.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.998 -1.295 . . . . 50.0 110.971 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 34.7 mm -105.31 128.73 59.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.364 -0.976 . . . . 16.66 108.364 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.6 165.88 11.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.188 -0.945 . . . . 16.66 108.836 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.619 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.9 t80 -53.56 -43.09 68.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.095 -1.003 . . . . 16.66 108.542 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -59.07 -46.78 87.4 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.09 -0.707 . . . . 50.0 109.09 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.54 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 64.0 mt-10 -63.78 -46.99 82.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.853 . . . . 16.66 109.068 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.463 ' CE1' HD12 ' A' ' 77' ' ' LEU . 27.3 t80 -65.84 -29.03 69.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.428 -0.795 . . . . 16.66 109.182 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.57 ' CG2' ' NH1' ' A' ' 11' ' ' ARG . 63.0 m -69.87 -49.96 47.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.42 -0.8 . . . . 50.0 109.329 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.49 -35.83 81.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 50.0 109.385 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -75.79 -41.18 53.61 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.384 -0.969 . . . . 50.0 108.384 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.522 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -60.56 -30.03 71.02 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.002 -1.639 . . . . 16.66 109.002 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.488 ' HG3' ' NH1' ' A' ' 11' ' ' ARG . 68.4 mtp180 -66.91 -37.25 84.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.445 -1.033 . . . . 50.0 108.826 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.44 -19.02 65.69 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.133 -0.691 . . . . 50.0 109.133 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 76' ' ' LEU . 18.4 m-80 -145.94 53.29 1.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 50.0 109.318 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -49.5 -36.15 22.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 50.0 108.739 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.516 ' HA3' ' CE ' ' A' ' 78' ' ' LYS . . . -61.54 -19.71 58.26 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.398 -1.481 . . . . 25.0 109.398 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 73' ' ' ASN . 25.0 mt -78.33 -44.86 24.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.393 -1.063 . . . . 50.0 109.291 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.522 ' CD1' ' HA2' ' A' ' 70' ' ' GLY . 3.8 mt -71.15 -24.2 62.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.473 -0.767 . . . . 50.0 110.142 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.516 ' CE ' ' HA3' ' A' ' 75' ' ' GLY . 6.7 ptpt -80.06 -28.79 39.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.959 -1.088 . . . . 50.0 109.0 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -87.37 -44.68 11.19 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.488 -0.758 . . . . 50.0 109.274 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 5.4 p -58.71 -44.78 90.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.868 0.842 . . . . 50.0 108.946 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.55 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.5 -41.13 53.07 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.165 -0.614 . . . . 50.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -59.43 -32.25 70.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 50.0 109.499 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 83' ' ' ILE . 26.9 mt -57.44 -32.65 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 50.0 109.278 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.477 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 8.9 m-85 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.96 -1.019 . . . . 99.989999999999995 109.488 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.378 -0.601 . . . . 50.0 109.378 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -48.34 -36.1 13.75 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.429 -0.795 . . . . 50.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.37 -46.38 88.81 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.395 -0.816 . . . . 16.66 108.98 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.474 ' O ' HG13 ' A' ' 14' ' ' ILE . 61.7 mt-10 -66.78 -41.09 88.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.401 -0.812 . . . . 16.66 108.981 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -66.16 -41.1 90.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.453 -0.779 . . . . 50.0 109.452 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.546 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 8.6 mt-10 -64.6 -41.51 96.18 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.519 -0.738 . . . . 50.0 109.399 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 62.1 mtp180 -67.01 -40.6 87.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 50.0 109.273 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 10' ' ' GLU . 31.9 mt -70.55 -44.46 76.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.397 -0.814 . . . . 50.0 108.986 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.582 ' CE2' HD13 ' A' ' 26' ' ' ILE . 58.7 t80 -66.65 -36.2 81.99 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.295 -0.878 . . . . 16.66 109.065 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -65.5 -30.67 71.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 50.0 108.983 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 52.0 mtt85 -70.62 -36.16 73.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.411 -0.806 . . . . 50.0 109.114 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.562 ' CD1' HD11 ' A' ' 31' ' ' LEU . 36.3 m-85 -68.21 -49.22 62.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.823 . . . . 16.66 109.432 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.475 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 23.6 t0 -57.58 103.43 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 16.66 108.715 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.3 -51.3 54.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 50.0 111.26 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -87.31 -30.49 20.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.733 -1.229 . . . . 16.66 109.793 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 93.59 35.6 6.14 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.819 -1.181 . . . . 16.66 110.232 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.483 ' OD2' ' NZ ' ' A' ' 25' ' ' LYS . 38.1 p-10 -90.46 3.96 52.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.246 . . . . 16.66 109.285 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.02 -6.51 72.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.431 -1.068 . . . . 16.66 110.431 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HD3' ' CG ' ' A' ' 60' ' ' PHE . 2.3 ptpp? -131.08 142.65 50.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.944 -1.327 . . . . 50.0 109.939 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.582 HD13 ' CE2' ' A' ' 15' ' ' PHE . 6.1 mt -112.15 133.73 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.605 -0.684 . . . . 16.66 109.652 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.1 p -105.53 166.06 10.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.383 -0.823 . . . . 50.0 108.867 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.92 -44.82 50.48 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.987 -1.071 . . . . 50.0 108.699 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -58.14 -39.77 79.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.189 -0.945 . . . . 50.0 109.347 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.8 mt-10 -74.67 -54.63 7.05 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.132 -0.98 . . . . 16.66 109.24 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.562 HD11 ' CD1' ' A' ' 18' ' ' PHE . 29.9 tp -62.31 -42.31 99.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.145 -0.972 . . . . 16.66 108.94 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -63.92 -45.33 94.38 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.96 -1.656 . . . . 16.66 108.96 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 10.3 mt-10 -56.15 -44.33 79.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.418 -1.048 . . . . 50.0 109.457 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.53 -39.31 67.63 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.331 -0.988 . . . . 50.0 108.331 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.455 HD11 HG21 ' A' ' 46' ' ' VAL . 6.7 mt -59.26 -32.93 70.45 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.545 -0.722 . . . . 99.989999999999995 109.412 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -44.79 -26.03 0.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 99.989999999999995 109.474 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.459 ' OG1' HG22 ' A' ' 83' ' ' ILE . 8.7 t -52.55 -25.04 9.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 99.989999999999995 109.232 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.458 ' CD1' HD11 ' A' ' 41' ' ' ILE . 23.7 mt -57.99 -35.96 71.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 50.0 109.165 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.87 1.97 60.28 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.681 -1.367 . . . . 16.66 109.681 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.15 52.53 0.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.092 -1.24 . . . . 16.66 109.754 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.458 HD11 ' CD1' ' A' ' 38' ' ' LEU . 11.7 tt -136.47 171.77 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 50.0 109.589 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.23 165.89 23.62 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.751 -0.833 . . . . 16.66 108.751 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.91 -33.79 19.17 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.042 1.828 . . . . 50.0 110.188 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -62.1 -28.9 69.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.585 -0.697 . . . . 50.0 109.956 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -81.76 -36.11 28.88 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.949 -1.094 . . . . 16.66 108.288 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.455 HG21 HD11 ' A' ' 35' ' ' LEU . 57.7 t -68.09 -36.59 75.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.948 -0.76 . . . . 50.0 108.948 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -68.88 -38.92 80.0 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.795 -0.817 . . . . 50.0 108.795 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -65.92 -39.78 90.86 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.471 -0.768 . . . . 50.0 109.299 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.443 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.9 mtt -59.19 -44.59 92.22 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.117 -0.989 . . . . 16.66 108.841 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 28' ' ' ALA . 29.3 mtp -62.43 -48.13 81.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.421 -0.799 . . . . 50.0 109.15 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.62 -20.14 30.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 50.0 109.097 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -97.44 -36.47 10.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 16.66 109.199 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.57 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.6 mt -80.78 -31.93 12.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.413 -0.804 . . . . 50.0 109.576 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.48 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.0 t0 -61.76 101.38 0.19 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.439 -0.788 . . . . 16.66 108.938 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 39.6 p -67.95 -45.18 74.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.874 . . . . 50.0 110.461 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.9 p-10 -88.79 -42.71 11.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 16.66 109.642 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.48 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 104.88 30.21 4.93 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.188 -1.165 . . . . 16.66 110.188 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.8 p-10 -81.31 -3.06 51.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.919 -1.342 . . . . 50.0 109.233 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.503 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.6 -1.13 58.3 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.795 -1.322 . . . . 16.66 109.795 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.584 ' CG ' ' HD3' ' A' ' 25' ' ' LYS . 51.1 m-85 -137.44 155.66 49.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -1.233 . . . . 50.0 111.284 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.542 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 30.9 mm -109.83 129.57 64.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.222 -1.029 . . . . 16.66 108.222 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.02 168.13 10.47 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.057 -1.027 . . . . 16.66 108.815 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.546 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 32.4 t80 -54.83 -43.19 72.77 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.102 -0.999 . . . . 16.66 108.728 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -61.1 -46.81 89.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.545 -0.722 . . . . 50.0 109.235 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.542 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 75.0 mt-10 -61.65 -47.67 84.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 16.66 109.198 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.495 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 60.0 t80 -61.44 -36.86 81.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 16.66 109.444 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.471 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 23.1 m -65.54 -47.27 76.45 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.259 -0.901 . . . . 50.0 109.344 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -60.92 -38.87 87.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 50.0 109.6 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.57 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -77.37 -38.6 49.75 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.136 -0.977 . . . . 50.0 108.77 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.417 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -60.36 -32.32 76.81 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.935 -1.666 . . . . 16.66 108.935 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 67' ' ' THR . 64.6 mtp180 -70.97 -34.26 71.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -1.027 . . . . 50.0 109.259 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.47 -4.61 56.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 50.0 109.512 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.517 ' HB3' ' CD1' ' A' ' 76' ' ' LEU . 69.1 m-80 -150.0 46.31 0.92 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.262 -0.899 . . . . 50.0 108.798 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -55.44 -48.87 73.79 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.54 -0.911 . . . . 50.0 108.54 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.27 -24.91 24.2 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.146 -1.581 . . . . 25.0 109.146 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 73' ' ' ASN . 7.1 mp -78.81 -44.67 22.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -1.15 . . . . 50.0 109.357 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.495 HD23 ' CZ ' ' A' ' 66' ' ' PHE . 21.2 mt -60.1 -39.6 86.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.444 -0.785 . . . . 50.0 109.409 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 32.8 mtpt -56.06 -28.23 56.72 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.294 -0.879 . . . . 50.0 109.326 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 52.9 t0 -75.67 -39.19 57.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.381 -0.824 . . . . 50.0 109.775 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -64.85 -37.55 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 50.0 109.378 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.468 ' N ' HG11 ' A' ' 80' ' ' VAL . . . -72.78 -4.26 30.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.556 -0.715 . . . . 50.0 109.65 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 14.4 mttm -74.28 -35.13 63.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 50.0 109.255 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.531 HG22 HD11 ' A' ' 83' ' ' ILE . 35.2 mt -76.75 -32.68 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.309 -0.869 . . . . 50.0 109.453 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 5.4 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.975 -1.012 . . . . 99.989999999999995 109.454 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.435 0.636 . . . . 50.0 109.463 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -44.68 -35.22 2.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.797 . . . . 50.0 109.599 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.59 -45.28 85.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 16.66 108.963 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 14' ' ' ILE . 63.6 mt-10 -67.52 -42.92 82.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.507 -0.746 . . . . 16.66 109.056 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.502 ' NH2' HG21 ' A' ' 67' ' ' THR . 18.2 mtm180 -65.73 -39.19 90.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.506 -0.746 . . . . 50.0 109.421 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 77.7 mt-10 -66.76 -41.36 87.88 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.386 -0.821 . . . . 50.0 109.525 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mtp180 -66.9 -40.7 87.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.339 -0.85 . . . . 50.0 109.234 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.5 mt -70.37 -45.11 76.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.358 -0.839 . . . . 50.0 109.029 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.576 ' CE2' HD13 ' A' ' 26' ' ' ILE . 63.0 t80 -64.98 -35.8 82.34 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.227 -0.92 . . . . 16.66 109.112 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -65.99 -30.37 70.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 50.0 109.268 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 59.1 mtt85 -71.36 -35.08 71.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -0.912 . . . . 50.0 108.974 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.473 ' HB3' HD11 ' A' ' 26' ' ' ILE . 35.8 m-85 -67.56 -49.77 61.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 16.66 109.299 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.471 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 21.5 t0 -56.02 103.11 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.87 . . . . 16.66 108.804 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.05 -51.07 59.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.951 . . . . 50.0 111.028 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -87.78 -31.17 19.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.756 -1.215 . . . . 16.66 109.633 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 94.7 34.92 6.06 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.795 -1.193 . . . . 16.66 110.385 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.481 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 41.3 p-10 -89.85 5.5 45.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.003 -1.292 . . . . 16.66 109.258 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.85 -4.91 79.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.282 -1.127 . . . . 16.66 110.282 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.526 ' HB2' ' CB ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -131.08 142.51 50.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.921 -1.341 . . . . 50.0 109.931 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.576 HD13 ' CE2' ' A' ' 15' ' ' PHE . 7.5 mt -111.34 134.56 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.523 -0.735 . . . . 16.66 109.497 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.5 p -107.67 166.71 10.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.725 -0.842 . . . . 50.0 108.725 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.93 -45.56 51.27 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.048 -1.032 . . . . 50.0 108.799 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.29 76.33 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.205 -0.934 . . . . 50.0 109.493 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.482 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.1 mt-10 -75.9 -54.48 6.83 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.152 -0.968 . . . . 16.66 109.354 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.473 ' HG ' ' CD1' ' A' ' 35' ' ' LEU . 9.6 tp -62.15 -42.44 99.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 16.66 108.817 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -64.2 -45.89 92.41 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.841 -1.704 . . . . 16.66 108.841 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.88 -44.27 78.0 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.394 -1.063 . . . . 50.0 109.375 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.11 -39.9 63.06 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.112 -1.07 . . . . 50.0 108.112 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.499 ' CD2' HD13 ' A' ' 38' ' ' LEU . 6.5 mt -59.55 -29.86 68.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.527 -0.733 . . . . 99.989999999999995 109.548 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -45.25 -24.4 0.27 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 99.989999999999995 109.652 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.508 HG22 ' CG2' ' A' ' 83' ' ' ILE . 9.3 t -51.69 -24.39 5.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.215 -0.928 . . . . 99.989999999999995 109.204 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.499 HD13 ' CD2' ' A' ' 35' ' ' LEU . 6.4 mt -62.57 -45.88 90.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.39 -0.819 . . . . 50.0 109.266 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.06 -34.53 3.74 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.746 -1.342 . . . . 16.66 109.746 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.7 p -116.79 52.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -1.188 . . . . 16.66 109.598 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 tp -126.68 164.31 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 50.0 109.501 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.69 163.47 23.95 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.523 -0.917 . . . . 16.66 108.523 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.0 -34.13 23.98 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.941 1.761 . . . . 50.0 110.181 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.28 -20.19 63.91 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.658 -0.651 . . . . 50.0 110.399 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -83.08 -40.64 19.58 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.729 -1.232 . . . . 16.66 108.562 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.448 HG13 ' CA ' ' A' ' 32' ' ' GLY . 41.8 t -65.2 -36.98 79.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.764 -0.828 . . . . 50.0 108.764 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -68.31 -39.7 81.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.793 -0.817 . . . . 50.0 108.793 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.499 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.2 t60 -66.13 -40.23 90.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.423 -0.798 . . . . 50.0 109.056 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.446 ' O ' HG13 ' A' ' 53' ' ' ILE . 15.5 mtm -59.44 -44.74 92.86 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.265 -0.897 . . . . 16.66 108.877 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 28' ' ' ALA . 31.1 mtp -62.51 -47.37 84.25 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.585 -0.697 . . . . 50.0 109.197 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.25 -20.1 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 50.0 108.915 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.499 ' OE2' ' NE2' ' A' ' 48' ' ' HIS . 35.4 mt-10 -95.27 -35.55 11.76 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.986 -0.746 . . . . 16.66 108.986 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.576 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.4 mt -81.89 -31.05 10.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.53 -0.731 . . . . 50.0 109.501 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.47 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 17.3 t0 -61.93 101.09 0.18 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.442 -0.786 . . . . 16.66 109.172 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.452 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 28.3 p -68.46 -43.42 77.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 50.0 110.426 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.1 p-10 -89.85 -46.86 8.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 16.66 109.821 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 108.81 31.71 3.31 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.935 -1.266 . . . . 16.66 109.935 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.7 p-10 -82.69 -5.24 58.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.027 -1.278 . . . . 50.0 109.057 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.452 ' O ' ' HE3' ' A' ' 50' ' ' MET . . . 100.08 -0.3 56.13 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.724 -1.35 . . . . 16.66 109.724 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.526 ' CB ' ' HB2' ' A' ' 25' ' ' LYS . 41.3 m-85 -139.28 156.07 47.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.996 -1.297 . . . . 50.0 111.482 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.541 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 31.4 mm -109.08 129.23 64.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.147 -1.057 . . . . 16.66 108.147 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.1 167.32 10.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.991 -1.068 . . . . 16.66 108.72 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 37.9 t80 -53.35 -42.67 67.05 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.077 -1.049 . . . . 16.66 108.473 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -59.42 -50.66 73.08 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.107 -0.701 . . . . 50.0 109.107 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.541 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 80.2 mt-10 -60.28 -46.38 90.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.354 -0.841 . . . . 16.66 109.023 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.579 ' CZ ' HD12 ' A' ' 77' ' ' LEU . 80.3 t80 -64.66 -35.77 82.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 16.66 109.479 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.502 HG21 ' NH2' ' A' ' 11' ' ' ARG . 21.0 m -67.51 -48.95 65.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.394 -0.816 . . . . 50.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.413 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 77.1 m-20 -62.02 -36.07 80.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -0.901 . . . . 50.0 109.339 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.576 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -74.61 -39.57 62.08 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.669 -0.863 . . . . 50.0 108.669 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.476 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -59.33 -29.05 65.44 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.423 -1.471 . . . . 16.66 109.423 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 67' ' ' THR . 62.6 mtm180 -71.83 -32.28 67.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -1.115 . . . . 50.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.38 -21.08 62.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.34 -0.85 . . . . 50.0 109.343 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.521 ' HB3' ' CD1' ' A' ' 76' ' ' LEU . 31.8 m-80 -140.92 61.02 1.51 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.406 -0.809 . . . . 50.0 109.131 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -52.64 -42.88 65.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.67 -0.863 . . . . 50.0 108.67 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.19 -22.58 29.83 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.352 -1.499 . . . . 25.0 109.352 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 73' ' ' ASN . 47.2 mt -79.97 -43.56 21.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -1.124 . . . . 50.0 109.336 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.579 HD12 ' CZ ' ' A' ' 66' ' ' PHE . 1.1 mm? -61.19 -36.98 81.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.455 -0.778 . . . . 50.0 109.578 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.6 mtmm -73.81 -28.14 61.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.258 -0.901 . . . . 50.0 109.026 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -80.21 -45.3 18.26 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.37 -0.831 . . . . 50.0 109.105 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 76' ' ' LEU . 46.5 t -68.56 -41.32 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 50.0 109.376 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.441 ' HB3' HD12 ' A' ' 14' ' ' ILE . . . -51.4 -46.91 63.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 50.0 109.425 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 22.7 mttm -59.64 -29.25 67.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.345 -0.847 . . . . 50.0 109.34 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.508 ' CG2' HG22 ' A' ' 37' ' ' THR . 59.5 mt -66.73 -35.97 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 50.0 109.394 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 12.5 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.962 -1.018 . . . . 99.989999999999995 109.503 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.39 0.614 . . . . 50.0 109.369 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -49.15 -35.78 17.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 50.0 109.293 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -53.44 -43.11 67.78 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.572 -0.899 . . . . 16.66 108.572 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.478 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.4 mt-10 -68.51 -39.8 81.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.012 -0.736 . . . . 16.66 109.012 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.5 mtt-85 -67.33 -41.24 85.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.452 -0.78 . . . . 50.0 109.38 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.608 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 60.8 mt-10 -65.07 -39.91 93.91 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.567 -0.708 . . . . 50.0 109.311 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 24.3 mtp180 -67.63 -40.37 84.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.451 -0.781 . . . . 50.0 109.187 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 10' ' ' GLU . 24.6 mt -70.54 -45.62 73.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.365 -0.834 . . . . 50.0 109.015 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.572 ' CE1' HD13 ' A' ' 26' ' ' ILE . 67.8 t80 -64.87 -35.97 82.85 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.295 -0.878 . . . . 16.66 108.975 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 46.1 mttt -65.81 -30.3 70.91 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.324 -0.86 . . . . 50.0 108.983 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 32.7 mtt180 -70.06 -36.09 74.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.831 . . . . 50.0 108.903 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.466 ' HB2' HD12 ' A' ' 26' ' ' ILE . 48.3 m-85 -70.38 -51.41 29.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.438 -0.789 . . . . 16.66 109.487 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 24.8 t0 -56.12 103.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 16.66 108.747 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.42 -52.07 50.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 50.0 111.278 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -87.34 -23.46 24.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.725 -1.235 . . . . 16.66 109.722 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 83.95 41.59 8.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.084 -1.206 . . . . 16.66 110.084 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.482 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.5 p-10 -96.17 5.38 51.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.129 -1.218 . . . . 16.66 109.122 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.06 -9.68 70.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.569 -1.012 . . . . 16.66 110.569 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.588 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.1 pttm -129.65 142.01 50.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.853 -1.381 . . . . 50.0 110.162 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.572 HD13 ' CE1' ' A' ' 15' ' ' PHE . 9.7 mt -112.78 133.6 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.736 -0.602 . . . . 16.66 109.457 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 p -106.12 168.95 8.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.332 -0.855 . . . . 50.0 108.912 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.488 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.27 -46.56 55.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.076 -1.015 . . . . 50.0 109.047 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.5 74.34 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.274 -0.891 . . . . 50.0 109.543 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.2 mt-10 -75.96 -54.03 7.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.137 -0.977 . . . . 16.66 109.269 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.497 ' CD2' HD13 ' A' ' 35' ' ' LEU . 6.9 tt -61.44 -44.84 96.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.253 -0.904 . . . . 16.66 108.969 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' HA3' HG23 ' A' ' 46' ' ' VAL . . . -61.87 -43.79 98.72 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.113 -1.595 . . . . 16.66 109.113 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -56.3 -44.19 79.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -1.096 . . . . 50.0 109.766 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.15 75.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.173 -0.954 . . . . 50.0 108.572 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.497 HD13 ' CD2' ' A' ' 31' ' ' LEU . 9.6 mt -59.02 -35.06 72.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.505 -0.747 . . . . 99.989999999999995 109.929 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.6 mttm -43.86 -27.41 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.135 -0.978 . . . . 99.989999999999995 109.535 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.525 ' CG2' HG23 ' A' ' 83' ' ' ILE . 7.3 t -53.68 -26.51 23.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 99.989999999999995 109.407 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.457 HD13 HD21 ' A' ' 35' ' ' LEU . 21.5 mt -63.94 -33.76 76.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 50.0 109.32 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.43 6.84 50.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.573 -1.411 . . . . 16.66 109.573 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.8 t -154.3 50.77 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.045 -1.268 . . . . 16.66 109.653 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 tp -136.49 154.12 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 50.0 109.243 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.43 165.83 12.86 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 16.66 108.697 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.19 -32.64 20.51 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.058 1.838 . . . . 50.0 109.989 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -62.68 -27.74 69.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.661 -0.649 . . . . 50.0 110.052 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -80.75 -36.56 31.81 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.973 -1.079 . . . . 16.66 108.36 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.468 HG23 ' HA3' ' A' ' 32' ' ' GLY . 74.8 t -64.33 -38.6 82.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.689 -0.856 . . . . 50.0 108.689 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -72.44 -36.75 68.63 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.41 -0.959 . . . . 50.0 108.41 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.471 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 4.0 t60 -67.71 -37.18 81.9 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.939 -0.763 . . . . 50.0 108.939 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.424 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.7 mtt -60.29 -48.23 82.64 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.228 -0.92 . . . . 16.66 108.58 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 28' ' ' ALA . 42.2 mtp -61.61 -48.29 81.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.922 -0.77 . . . . 50.0 108.922 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.72 -19.73 18.24 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.445 -0.784 . . . . 50.0 109.193 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.409 ' OE2' ' NE2' ' A' ' 48' ' ' HIS . 37.6 mt-10 -100.46 -37.03 9.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.89 . . . . 16.66 109.317 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.525 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.8 mt -80.29 -34.02 14.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.392 -0.818 . . . . 50.0 109.563 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.0 t0 -58.77 101.52 0.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.455 -0.778 . . . . 16.66 109.005 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.466 ' OG1' ' OE2' ' A' ' 65' ' ' GLU . 71.1 p -70.02 -47.67 61.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.829 . . . . 50.0 110.922 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.486 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.6 p-10 -86.95 -37.42 17.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.134 -0.979 . . . . 16.66 109.544 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.479 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 100.56 27.97 7.32 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.834 -1.174 . . . . 16.66 110.771 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.486 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 15.6 p-10 -79.58 -2.1 40.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.811 -1.405 . . . . 50.0 109.11 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' ' HE3' ' A' ' 50' ' ' MET . . . 99.46 -6.26 59.16 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.981 -1.248 . . . . 16.66 109.981 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.588 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 28.4 m-85 -133.84 156.16 48.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.003 -1.293 . . . . 50.0 111.373 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.546 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 27.3 mm -107.99 129.97 61.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.217 -1.031 . . . . 16.66 108.217 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.8 m -96.93 167.13 11.27 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.051 -1.03 . . . . 16.66 108.636 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.608 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 36.2 t80 -54.4 -42.29 70.25 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.077 -1.014 . . . . 16.66 108.523 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -61.21 -47.94 83.79 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.515 -0.741 . . . . 50.0 109.286 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.546 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 68.1 mt-10 -60.68 -46.85 88.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.254 -0.904 . . . . 16.66 108.943 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.485 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 57.3 t80 -59.54 -40.88 88.69 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.491 -0.755 . . . . 16.66 109.147 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.456 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.7 m -64.17 -46.51 83.68 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.468 -0.77 . . . . 50.0 109.159 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.59 -39.63 80.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 50.0 109.344 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.541 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -79.95 -36.37 36.32 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.486 -0.931 . . . . 50.0 108.486 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 77' ' ' LEU . . . -60.4 -31.55 74.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.083 -1.607 . . . . 16.66 109.083 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 67' ' ' THR . 64.4 mtm180 -70.34 -35.23 73.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.416 -1.049 . . . . 50.0 109.057 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.68 -2.55 50.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.394 -0.816 . . . . 50.0 109.455 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.526 ' HB3' ' CD2' ' A' ' 76' ' ' LEU . 69.4 m-80 -149.22 46.88 0.98 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.235 -0.916 . . . . 50.0 108.873 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -56.31 -48.51 76.54 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.521 -0.918 . . . . 50.0 108.521 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.24 -24.6 29.91 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.057 -1.617 . . . . 25.0 109.057 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 73' ' ' ASN . 6.5 mp -79.7 -45.12 19.56 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.335 -1.097 . . . . 50.0 109.326 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.485 HD23 ' CZ ' ' A' ' 66' ' ' PHE . 20.9 mt -62.67 -36.61 83.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.804 . . . . 50.0 109.845 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -67.13 -21.23 65.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 50.0 109.607 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.97 -34.55 29.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 50.0 109.476 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.474 ' HA ' HG13 ' A' ' 83' ' ' ILE . 25.1 t -78.39 -33.13 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 50.0 109.743 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.41 -46.46 62.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 50.0 110.128 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -63.91 -24.55 67.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 50.0 109.576 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.525 HG23 ' CG2' ' A' ' 37' ' ' THR . 8.5 mt -66.31 -47.55 83.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.343 -0.848 . . . . 50.0 109.673 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.017 -0.992 . . . . 99.989999999999995 109.446 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.466 -0.568 . . . . 50.0 109.466 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -52.6 -37.4 58.12 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.383 -0.823 . . . . 50.0 109.274 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.12 -45.13 87.82 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.32 -0.863 . . . . 16.66 108.701 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.4 mt-10 -66.61 -45.81 77.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.818 -0.808 . . . . 16.66 108.818 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.467 ' NH2' ' CG ' ' A' ' 71' ' ' ARG . 13.7 mtt-85 -64.13 -39.37 93.89 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.447 -0.783 . . . . 50.0 109.336 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 15.9 mt-10 -65.76 -41.16 92.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.555 -0.716 . . . . 50.0 109.104 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.463 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 14.7 mtp180 -67.33 -40.55 85.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 50.0 109.014 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 10' ' ' GLU . 29.1 mt -70.12 -45.94 74.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.454 -0.779 . . . . 50.0 108.942 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.572 ' CE2' HD13 ' A' ' 26' ' ' ILE . 59.5 t80 -66.05 -35.99 82.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.376 -0.827 . . . . 16.66 109.119 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 21.8 mttt -64.48 -31.28 72.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 50.0 109.19 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 40.7 mtt180 -73.29 -33.15 65.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 50.0 109.222 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.518 ' CB ' HD12 ' A' ' 26' ' ' ILE . 37.5 m-85 -71.37 -45.11 63.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 16.66 109.29 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.473 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 24.8 t0 -63.09 103.16 0.44 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.252 -0.905 . . . . 16.66 108.798 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -52.05 60.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.227 -0.921 . . . . 50.0 111.247 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -88.1 -22.44 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.737 -1.227 . . . . 16.66 109.577 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.473 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 82.8 42.76 8.06 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.236 -1.146 . . . . 16.66 110.236 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.494 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.4 p-10 -97.63 5.93 48.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.126 -1.22 . . . . 16.66 109.269 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.87 -10.11 70.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.517 -1.033 . . . . 16.66 110.517 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 14.2 pttp -128.62 141.38 51.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.825 -1.397 . . . . 50.0 110.031 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.572 HD13 ' CE2' ' A' ' 15' ' ' PHE . 4.9 mt -113.53 134.55 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.662 -0.649 . . . . 16.66 109.365 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.453 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 26.6 p -108.03 169.65 8.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.395 -0.816 . . . . 50.0 108.895 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.7 -47.77 58.89 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.113 -0.992 . . . . 50.0 109.023 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.36 68.99 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.372 -0.83 . . . . 50.0 109.683 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.482 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 55.2 mt-10 -79.07 -53.44 7.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 16.66 109.298 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.514 ' CD2' HD11 ' A' ' 35' ' ' LEU . 4.6 tt -62.1 -42.28 99.06 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.291 -0.881 . . . . 16.66 108.83 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.432 ' HA3' HG23 ' A' ' 46' ' ' VAL . . . -63.91 -45.7 93.44 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.023 -1.631 . . . . 16.66 109.023 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -56.03 -43.06 77.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -1.1 . . . . 50.0 109.395 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.66 -39.9 66.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.292 -1.003 . . . . 50.0 108.292 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 38' ' ' LEU . 2.2 mt -59.15 -33.53 71.0 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.605 -0.684 . . . . 99.989999999999995 109.625 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -44.16 -26.43 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.1 -1.0 . . . . 99.989999999999995 109.551 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.527 ' CG2' HG22 ' A' ' 83' ' ' ILE . 8.0 t -48.87 -24.39 1.44 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.217 -0.927 . . . . 99.989999999999995 109.064 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.52 HD13 ' CD2' ' A' ' 35' ' ' LEU . 21.1 mt -66.63 -31.2 71.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.477 -0.764 . . . . 50.0 109.163 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.51 9.37 43.66 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.436 -1.466 . . . . 16.66 109.436 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' A' ' 40' ' ' SER . 9.7 t -156.07 49.15 0.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -1.143 . . . . 16.66 109.587 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.511 HD11 ' CD1' ' A' ' 38' ' ' LEU . 12.4 tt -137.32 169.41 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.257 -0.902 . . . . 50.0 109.475 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.95 166.66 16.98 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.92 . . . . 16.66 109.051 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.69 -32.65 18.41 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.175 1.916 . . . . 50.0 110.189 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -61.63 -29.05 69.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.648 -0.658 . . . . 50.0 110.016 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -81.43 -36.89 28.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.926 -1.109 . . . . 16.66 108.193 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.463 HG12 HD21 ' A' ' 31' ' ' LEU . 55.9 t -65.21 -34.7 72.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.968 -0.753 . . . . 50.0 108.968 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -69.45 -38.39 77.77 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.908 -0.775 . . . . 50.0 108.908 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -68.49 -38.5 81.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.462 -0.774 . . . . 50.0 108.933 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 mtt -62.25 -47.79 82.81 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.306 -0.871 . . . . 16.66 108.792 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.524 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 27.2 mtp -61.62 -46.55 89.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.449 -0.782 . . . . 50.0 109.159 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.24 -19.65 55.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 50.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.61 -35.63 12.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.355 -0.841 . . . . 16.66 108.879 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.8 mt -82.42 -30.92 9.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.561 -0.712 . . . . 50.0 109.669 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.491 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.6 t0 -59.67 101.35 0.11 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.38 -0.825 . . . . 16.66 109.064 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.519 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 71.0 p -72.82 -47.18 48.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -0.89 . . . . 50.0 110.543 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -29.97 24.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.181 -0.949 . . . . 16.66 109.514 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.491 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 92.02 28.19 14.28 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.893 -1.146 . . . . 16.66 110.35 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.14 -3.22 57.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.963 -1.316 . . . . 50.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.524 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.52 -7.29 59.6 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.962 -1.113 . . . . 16.66 110.526 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.6 m-85 -133.02 155.25 49.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.002 -1.293 . . . . 50.0 111.025 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.529 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 34.0 mm -106.24 128.09 60.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.333 -0.988 . . . . 16.66 108.333 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.0 m -94.16 166.11 12.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.235 -0.916 . . . . 16.66 108.602 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.576 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 34.5 t80 -54.48 -42.37 70.63 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.071 -1.018 . . . . 16.66 108.558 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -61.11 -49.47 77.14 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.098 -0.704 . . . . 50.0 109.098 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.529 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 28.8 mt-10 -58.1 -47.27 83.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 16.66 109.09 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' A' ' 77' ' ' LEU . 61.3 t80 -62.08 -40.47 95.94 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.531 -0.731 . . . . 16.66 109.305 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 16.3 m -64.33 -47.32 79.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.353 -0.842 . . . . 50.0 109.099 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.478 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 87.8 m-20 -59.31 -37.77 78.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 50.0 109.424 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.556 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -76.51 -36.76 57.58 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.529 -0.915 . . . . 50.0 108.529 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.13 -30.84 64.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.303 -1.519 . . . . 16.66 109.303 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 68' ' ' ASP . 72.3 mtm180 -69.26 -30.43 68.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -1.108 . . . . 50.0 109.071 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.22 -21.7 64.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -0.809 . . . . 50.0 109.286 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.501 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 2.1 m-80 -149.97 60.12 0.99 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.354 -0.841 . . . . 50.0 108.957 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -50.68 -38.61 47.68 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.737 -0.838 . . . . 50.0 108.737 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.24 -32.29 67.42 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.251 -1.54 . . . . 25.0 109.251 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.501 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 28.2 mt -64.46 -43.8 93.1 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.316 -1.108 . . . . 50.0 109.366 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.578 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.9 mm? -61.41 -41.91 97.9 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.426 -0.796 . . . . 50.0 109.679 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 19.2 mtmm -65.13 -27.66 68.89 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.263 -0.898 . . . . 50.0 109.512 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.66 -50.29 7.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.92 . . . . 50.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.6 p -64.33 -44.5 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.468 -0.77 . . . . 50.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.542 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -48.82 -40.48 29.44 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.54 -0.725 . . . . 50.0 109.385 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 27.2 mttp -65.47 -26.47 67.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 50.0 109.563 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.527 HG22 ' CG2' ' A' ' 37' ' ' THR . 35.0 mt -62.22 -32.7 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 50.0 109.423 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.528 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 5.1 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.001 -0.999 . . . . 99.989999999999995 109.488 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.428 0.632 . . . . 50.0 109.341 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -51.52 -36.54 45.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 50.0 109.455 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.88 -46.17 88.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.277 -0.89 . . . . 16.66 108.665 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 14' ' ' ILE . 67.9 mm-40 -66.5 -43.95 83.9 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.389 -0.819 . . . . 16.66 108.867 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -64.5 -39.52 93.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.413 -0.804 . . . . 50.0 109.493 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.571 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 13.8 mt-10 -64.06 -40.0 95.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 50.0 109.416 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 21.1 mtp-105 -70.06 -38.22 75.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 50.0 109.034 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.5 mt -71.54 -44.91 70.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.371 -0.831 . . . . 50.0 108.888 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.563 ' CE1' HD13 ' A' ' 26' ' ' ILE . 69.6 t80 -69.23 -36.19 76.93 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.231 -0.918 . . . . 16.66 109.159 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 37.4 mttt -64.99 -30.53 71.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 50.0 109.027 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 65.8 mmt-85 -70.65 -39.14 73.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.365 -0.834 . . . . 50.0 109.005 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.464 ' HB2' HD12 ' A' ' 26' ' ' ILE . 43.6 m-85 -66.21 -47.73 72.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.832 . . . . 16.66 109.344 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 20.4 t0 -60.08 103.15 0.2 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 16.66 108.73 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 -50.6 40.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 50.0 111.092 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -87.3 -30.54 20.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.808 -1.182 . . . . 16.66 109.671 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 93.27 33.41 7.24 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.069 -1.213 . . . . 16.66 110.069 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.481 ' OD2' ' CG ' ' A' ' 25' ' ' LYS . 34.8 p-10 -86.76 5.42 36.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.266 . . . . 16.66 109.115 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.95 -3.93 77.79 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.374 -1.09 . . . . 16.66 110.374 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 3.7 pttm -133.67 143.99 48.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.948 -1.325 . . . . 50.0 110.244 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.563 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.3 mt -110.43 132.67 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.459 0.647 . . . . 16.66 109.752 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.459 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 13.0 p -106.56 166.48 10.53 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.917 -0.772 . . . . 50.0 108.917 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.08 -44.98 52.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.124 -0.985 . . . . 50.0 109.032 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -57.19 -39.9 76.31 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.358 -0.838 . . . . 50.0 109.541 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 60.5 mt-10 -75.7 -54.28 7.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.214 -0.929 . . . . 16.66 109.248 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.49 ' CD2' HD13 ' A' ' 35' ' ' LEU . 6.3 tt -61.78 -43.66 98.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.13 -0.981 . . . . 16.66 108.853 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' CA ' HG12 ' A' ' 46' ' ' VAL . . . -63.76 -44.79 95.75 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.009 -1.636 . . . . 16.66 109.009 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 30.1 mt-10 -58.45 -42.23 86.93 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.474 -1.015 . . . . 50.0 109.661 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.55 -39.72 67.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.322 -0.992 . . . . 50.0 108.322 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.49 HD13 ' CD2' ' A' ' 31' ' ' LEU . 3.3 mt -58.23 -31.82 67.73 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.519 -0.738 . . . . 99.989999999999995 109.544 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -45.15 -25.81 0.4 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 99.989999999999995 109.479 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.495 ' OG1' ' CG2' ' A' ' 83' ' ' ILE . 11.6 t -52.94 -26.29 14.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 109.374 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.433 HD13 HD21 ' A' ' 35' ' ' LEU . 26.5 mt -65.35 -29.99 70.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -0.836 . . . . 50.0 109.237 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.66 9.0 42.94 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.734 -1.346 . . . . 16.66 109.734 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.5 49.6 0.54 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.089 -1.242 . . . . 16.66 109.811 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.9 tp -133.31 165.36 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.251 -0.905 . . . . 50.0 109.344 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.87 164.67 16.83 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.168 -0.957 . . . . 16.66 108.741 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.65 -33.72 21.0 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.062 1.841 . . . . 50.0 110.012 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -64.12 -26.0 68.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.592 -0.692 . . . . 50.0 109.955 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.42 -38.62 26.21 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.821 -1.175 . . . . 16.66 108.401 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.531 HG12 ' CA ' ' A' ' 32' ' ' GLY . 61.7 t -63.93 -36.53 77.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.765 -0.828 . . . . 50.0 108.765 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -73.04 -37.52 66.85 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.413 -0.958 . . . . 50.0 108.413 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -68.02 -38.58 82.75 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.922 -0.769 . . . . 50.0 108.922 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.2 mtt -60.88 -47.45 86.34 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.241 -0.912 . . . . 16.66 108.635 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 28' ' ' ALA . 50.6 mtp -60.93 -46.15 91.85 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.141 -0.688 . . . . 50.0 109.141 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.72 -21.01 53.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 50.0 109.194 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -95.89 -36.48 11.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 16.66 109.126 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.55 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.4 mt -80.86 -32.39 12.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.534 -0.729 . . . . 50.0 109.536 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 22.7 t0 -60.41 100.5 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.354 -0.841 . . . . 16.66 109.053 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.457 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 56.6 p -68.04 -46.44 71.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.307 -0.871 . . . . 50.0 110.616 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.502 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 1.7 p-10 -86.37 -37.97 17.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 16.66 109.44 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 100.36 27.03 7.88 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 120.037 -1.078 . . . . 16.66 110.555 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.502 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 7.9 p-10 -78.41 -1.58 34.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.743 -1.446 . . . . 50.0 109.051 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.494 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.52 -4.82 60.1 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.123 -1.191 . . . . 16.66 110.123 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 24.9 m-85 -135.68 157.55 46.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.033 -1.275 . . . . 50.0 111.482 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.552 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 31.5 mm -109.04 129.65 63.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.504 -0.924 . . . . 16.66 108.504 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.2 m -96.42 170.26 9.35 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.095 -1.003 . . . . 16.66 108.637 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.571 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.1 t80 -56.42 -43.97 79.93 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.133 -0.979 . . . . 16.66 108.694 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -60.44 -49.4 77.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.531 -0.731 . . . . 50.0 109.154 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.552 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.9 mt-10 -58.45 -46.07 87.31 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.267 -0.896 . . . . 16.66 109.219 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -63.52 -35.37 80.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 16.66 109.331 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 31.6 m -66.21 -48.41 70.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.444 -0.785 . . . . 50.0 109.279 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.57 -36.26 75.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.356 -0.84 . . . . 50.0 109.394 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.57 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -77.95 -37.14 48.22 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.433 -0.951 . . . . 50.0 108.433 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.424 ' O ' HD22 ' A' ' 77' ' ' LEU . . . -56.46 -27.92 54.75 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.994 -1.643 . . . . 16.66 108.994 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 67' ' ' THR . 82.1 mtm180 -71.49 -27.34 63.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -1.135 . . . . 50.0 108.806 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.19 60.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.441 -0.787 . . . . 50.0 109.291 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.475 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 2.4 m-80 -144.49 59.83 1.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.356 -0.84 . . . . 50.0 109.248 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.482 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 97.3 mtt180 -52.57 -21.63 4.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 50.0 109.123 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.8 -26.74 60.03 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.36 -1.496 . . . . 25.0 109.36 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.475 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 72.1 mt -73.06 -45.02 59.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -1.099 . . . . 50.0 109.618 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -64.41 -42.94 95.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.376 -0.828 . . . . 50.0 109.806 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.9 mtmt -65.37 -34.12 77.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 50.0 109.484 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -79.32 -46.46 17.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 50.0 109.498 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.8 p -64.18 -43.89 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 50.0 109.192 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.548 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.08 -37.92 35.89 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.733 -0.604 . . . . 50.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 61.2 mttp -70.65 -26.43 63.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 50.0 109.413 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.56 HG23 ' CE1' ' A' ' 84' ' ' PHE . 28.3 mt -62.78 -31.23 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 50.0 109.237 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.56 ' CE1' HG23 ' A' ' 83' ' ' ILE . 5.6 m-85 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.965 -1.017 . . . . 99.989999999999995 109.474 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 8' ' ' LYS . 81.3 m-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.4 0.619 . . . . 50.0 109.627 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 16.2 mttt -43.35 -35.91 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.442 -0.786 . . . . 50.0 109.78 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 12' ' ' GLU . . . -60.9 -45.87 92.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 16.66 109.058 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 14' ' ' ILE . 73.6 mt-10 -70.67 -34.84 72.44 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.383 -0.823 . . . . 16.66 108.822 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.497 ' NH1' HG22 ' A' ' 67' ' ' THR . 70.3 mtm180 -72.31 -40.65 67.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.364 -0.835 . . . . 50.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.567 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 24.6 pt-20 -68.95 -38.34 79.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.291 -0.881 . . . . 50.0 109.184 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.4 mtp180 -66.8 -41.83 86.95 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.889 . . . . 50.0 109.303 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 10' ' ' GLU . 27.4 mt -69.97 -46.01 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.278 -0.889 . . . . 50.0 109.032 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.583 ' CE2' HD13 ' A' ' 26' ' ' ILE . 60.1 t80 -64.62 -35.17 80.13 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.349 -0.844 . . . . 16.66 109.209 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 51.2 mttt -65.78 -31.72 72.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 50.0 109.385 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 65.7 mtt180 -70.68 -36.11 73.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 50.0 109.163 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.496 ' CE1' HD13 ' A' ' 31' ' ' LEU . 43.1 m-85 -66.04 -47.31 74.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.395 -0.816 . . . . 16.66 109.375 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 24.3 t0 -59.79 103.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.279 -0.888 . . . . 16.66 108.848 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.75 -51.67 53.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.179 -0.951 . . . . 50.0 111.191 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -86.59 -28.39 23.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.718 -1.239 . . . . 16.66 109.672 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 90.53 39.14 6.01 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.89 -1.148 . . . . 16.66 110.373 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.482 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.7 p-10 -95.02 5.63 51.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -1.221 . . . . 16.66 109.291 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.59 -8.1 77.09 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.486 -1.046 . . . . 16.66 110.486 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 14.1 pttt -128.54 141.35 51.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.95 -1.324 . . . . 50.0 109.929 -179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.583 HD13 ' CE2' ' A' ' 15' ' ' PHE . 5.6 mt -112.59 133.19 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.655 -0.653 . . . . 16.66 109.528 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 p -103.59 166.18 10.58 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.618 -0.882 . . . . 50.0 108.618 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.516 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.18 -44.39 52.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.062 -1.024 . . . . 50.0 108.81 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.54 82.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.354 -0.841 . . . . 50.0 109.419 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.478 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.8 mt-10 -74.25 -54.73 7.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -0.932 . . . . 16.66 109.275 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.496 HD13 ' CE1' ' A' ' 18' ' ' PHE . 40.1 tp -61.92 -43.63 98.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.181 -0.95 . . . . 16.66 108.929 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -62.48 -43.82 98.48 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.084 -1.606 . . . . 16.66 109.084 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -56.49 -44.0 80.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.285 -1.127 . . . . 50.0 109.531 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.72 -39.4 66.96 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.364 -0.976 . . . . 50.0 108.364 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.468 ' CD1' HG23 ' A' ' 46' ' ' VAL . 6.9 mt -59.66 -32.61 70.62 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.532 -0.73 . . . . 99.989999999999995 109.522 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.6 -24.4 0.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 99.989999999999995 109.532 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.7 t -52.93 -23.78 7.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.183 -0.948 . . . . 99.989999999999995 109.151 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.48 HD13 ' CD1' ' A' ' 41' ' ' ILE . 25.5 mt -62.77 -31.81 72.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.42 -0.8 . . . . 50.0 109.343 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.69 6.58 51.17 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 16.66 109.564 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.24 55.15 0.64 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.183 -1.186 . . . . 16.66 109.521 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.48 ' CD1' HD13 ' A' ' 38' ' ' LEU . 12.0 tt -140.53 171.33 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 50.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.52 165.2 27.9 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.714 -0.847 . . . . 16.66 108.714 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.82 -33.47 20.54 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.052 1.834 . . . . 50.0 110.232 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -64.97 -25.3 67.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.708 -0.62 . . . . 50.0 110.149 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' OE1' HG13 ' A' ' 41' ' ' ILE . 94.0 mt-10 -82.59 -38.61 23.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.888 -1.132 . . . . 16.66 108.344 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.468 HG23 ' CD1' ' A' ' 35' ' ' LEU . 41.4 t -65.76 -36.12 76.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.824 -0.806 . . . . 50.0 108.824 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -66.24 -39.14 89.31 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.973 -0.751 . . . . 50.0 108.973 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.495 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.4 t60 -66.92 -41.24 87.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.412 -0.805 . . . . 50.0 109.135 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.465 ' CE ' HD12 ' A' ' 35' ' ' LEU . 48.0 mtm -60.17 -44.92 94.65 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.241 -0.912 . . . . 16.66 108.923 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.529 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 20.1 mtp -61.98 -47.17 86.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.528 -0.733 . . . . 50.0 109.231 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.33 -19.13 54.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 50.0 109.068 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.456 ' OE2' ' NE2' ' A' ' 48' ' ' HIS . 35.8 mt-10 -95.92 -36.72 10.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 16.66 108.975 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.578 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.7 mt -81.33 -32.41 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.476 -0.765 . . . . 50.0 109.482 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.482 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 20.9 t0 -60.66 100.49 0.11 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.399 -0.813 . . . . 16.66 108.905 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.462 ' OG1' ' OE2' ' A' ' 65' ' ' GLU . 71.0 p -66.81 -46.89 73.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.324 -0.86 . . . . 50.0 110.771 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.484 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.9 p-10 -87.94 -40.81 13.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.178 -0.951 . . . . 16.66 109.559 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 103.32 28.99 5.86 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.919 -1.134 . . . . 16.66 110.314 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.484 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.6 p-10 -79.8 -2.79 44.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.862 -1.375 . . . . 50.0 109.135 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.529 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.7 -3.96 57.73 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.783 -1.327 . . . . 16.66 109.783 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 32.4 m-85 -135.91 156.1 49.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.077 -1.249 . . . . 50.0 111.279 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.541 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 29.4 mm -108.89 130.99 60.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.463 -0.94 . . . . 16.66 108.463 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 m -99.58 168.02 10.22 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.988 -1.07 . . . . 16.66 108.775 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.567 ' CE1' ' HA ' ' A' ' 12' ' ' GLU . 36.1 t80 -54.88 -43.73 73.44 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.247 -0.981 . . . . 16.66 108.673 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -59.83 -49.81 76.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.568 -0.707 . . . . 50.0 109.115 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.541 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.5 mt-10 -58.81 -47.29 85.31 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.271 -0.893 . . . . 16.66 108.974 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.445 ' CZ ' HD13 ' A' ' 77' ' ' LEU . 58.7 t80 -63.07 -33.21 74.95 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.401 -0.812 . . . . 16.66 109.241 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.497 HG22 ' NH1' ' A' ' 11' ' ' ARG . 79.7 m -67.24 -49.17 65.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 50.0 109.107 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' OD1' ' NH2' ' A' ' 71' ' ' ARG . 59.4 m-20 -59.26 -36.95 76.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 50.0 109.291 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.578 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -79.46 -37.79 36.11 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.414 -0.958 . . . . 50.0 108.414 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.419 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -60.38 -32.51 77.52 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.096 -1.602 . . . . 16.66 109.096 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.407 ' NH2' ' OD1' ' A' ' 68' ' ' ASP . 65.6 mtm180 -66.16 -36.93 84.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -1.106 . . . . 50.0 108.917 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.04 -19.65 65.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.482 -0.761 . . . . 50.0 109.154 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' LEU . 3.3 m-80 -145.81 55.23 1.18 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 50.0 109.231 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.446 ' HA ' HD21 ' A' ' 77' ' ' LEU . 8.5 ptp85 -49.87 -35.36 23.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -0.848 . . . . 50.0 108.721 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.407 ' HA3' ' HE2' ' A' ' 78' ' ' LYS . . . -65.92 -27.34 72.71 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.492 -1.443 . . . . 25.0 109.492 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ASN . 14.9 mt -67.92 -46.86 70.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.109 . . . . 50.0 109.507 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 74' ' ' ARG . 0.4 OUTLIER -62.9 -42.72 99.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.354 -0.841 . . . . 50.0 109.681 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HE2' ' HA3' ' A' ' 75' ' ' GLY . 32.3 mtmt -61.88 -31.83 72.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 50.0 109.39 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.419 ' O ' HG13 ' A' ' 83' ' ' ILE . 29.7 t0 -76.05 -37.82 57.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.306 -0.871 . . . . 50.0 109.385 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.465 ' HA ' HG13 ' A' ' 83' ' ' ILE . 46.0 t -73.3 -39.1 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 50.0 109.401 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.81 -44.26 59.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.403 -0.81 . . . . 50.0 109.891 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -65.6 -26.73 67.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 50.0 109.463 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.465 HG13 ' HA ' ' A' ' 80' ' ' VAL . 7.9 mt -65.39 -48.2 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.831 . . . . 50.0 109.633 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.015 -0.993 . . . . 99.989999999999995 109.42 179.942 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.362 0.601 . . . . 50.0 109.573 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.478 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 39.5 mttp -45.92 -36.31 5.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 50.0 109.326 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.19 91.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.411 -0.806 . . . . 16.66 108.877 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.479 ' O ' HG13 ' A' ' 14' ' ' ILE . 65.5 mt-10 -68.97 -37.02 78.54 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.963 -0.754 . . . . 16.66 108.963 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.505 ' NH2' HG21 ' A' ' 67' ' ' THR . 12.6 mtm180 -70.37 -40.76 73.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.366 -0.834 . . . . 50.0 109.238 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.628 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 38.9 mt-10 -66.65 -41.05 88.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.458 -0.776 . . . . 50.0 109.268 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 13.7 mtp180 -65.37 -41.62 93.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.29 -0.881 . . . . 50.0 109.328 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.5 ' CD1' ' HB1' ' A' ' 81' ' ' ALA . 22.9 mt -69.59 -45.98 76.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.267 -0.896 . . . . 50.0 109.074 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.583 ' CE1' HD13 ' A' ' 26' ' ' ILE . 67.2 t80 -66.06 -35.79 81.47 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.242 -0.911 . . . . 16.66 109.333 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -65.6 -33.39 75.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.211 -0.931 . . . . 50.0 109.325 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 53.6 mtt85 -69.94 -34.53 73.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 50.0 109.238 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.53 ' CB ' HD12 ' A' ' 26' ' ' ILE . 34.1 m-85 -69.85 -47.54 62.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 16.66 109.538 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 25.6 t0 -58.65 103.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 16.66 108.747 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.14 -52.19 50.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.223 -0.923 . . . . 50.0 111.275 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -87.34 -22.02 25.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.747 -1.221 . . . . 16.66 109.483 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 82.53 43.92 7.63 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.271 -1.132 . . . . 16.66 110.271 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.49 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.2 p-10 -99.61 7.0 45.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.082 -1.246 . . . . 16.66 109.236 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.04 -10.88 71.52 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.545 -1.022 . . . . 16.66 110.545 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.6 pttp -127.47 140.77 51.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.866 -1.373 . . . . 50.0 109.975 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.583 HD13 ' CE1' ' A' ' 15' ' ' PHE . 5.4 mt -113.24 134.1 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.6 -0.688 . . . . 16.66 109.395 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.2 p -105.75 168.23 9.24 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.6 -0.889 . . . . 50.0 108.6 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.498 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.34 -46.23 55.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.973 -1.079 . . . . 50.0 108.969 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.38 -38.98 75.1 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.297 -0.877 . . . . 50.0 109.584 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.478 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 56.5 mt-10 -75.58 -53.9 7.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.175 -0.953 . . . . 16.66 109.437 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.49 HD11 ' CD1' ' A' ' 18' ' ' PHE . 9.6 tp -62.51 -42.12 99.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 16.66 108.941 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -62.88 -44.37 97.54 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.079 -1.608 . . . . 16.66 109.079 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -56.86 -44.23 81.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -1.064 . . . . 50.0 109.673 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.39 -39.36 68.05 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.435 -0.95 . . . . 50.0 108.435 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.488 HD11 ' CG2' ' A' ' 46' ' ' VAL . 11.4 mt -58.65 -33.62 70.29 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.548 -0.72 . . . . 99.989999999999995 109.46 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -45.18 -25.72 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 99.989999999999995 109.474 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.465 ' CG2' HG23 ' A' ' 83' ' ' ILE . 7.7 t -52.27 -25.32 9.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.898 . . . . 99.989999999999995 109.305 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 41' ' ' ILE . 39.7 mt -62.17 -31.86 72.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.398 -0.814 . . . . 50.0 109.157 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.56 6.84 51.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.605 -1.398 . . . . 16.66 109.605 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.99 56.41 0.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.164 -1.198 . . . . 16.66 109.6 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.524 ' CD1' HD11 ' A' ' 38' ' ' LEU . 11.6 tt -141.5 172.35 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.971 . . . . 50.0 109.635 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.92 166.24 21.36 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.344 -0.847 . . . . 16.66 108.754 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.79 -33.66 16.03 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.02 1.813 . . . . 50.0 109.952 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.38 -25.97 68.53 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.61 -0.681 . . . . 50.0 109.969 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -80.88 -37.48 29.73 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.876 -1.14 . . . . 16.66 108.329 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.488 ' CG2' HD11 ' A' ' 35' ' ' LEU . 51.9 t -65.0 -36.8 78.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.949 -0.76 . . . . 50.0 108.949 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -68.19 -38.86 82.46 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.762 -0.829 . . . . 50.0 108.762 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -66.7 -41.04 88.68 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.464 -0.772 . . . . 50.0 109.011 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.41 ' O ' HG13 ' A' ' 53' ' ' ILE . 11.8 mtt -60.82 -45.92 92.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.213 -0.929 . . . . 16.66 108.881 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.526 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 34.7 mtp -61.87 -48.25 81.35 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.014 -0.736 . . . . 50.0 109.014 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.62 -20.42 32.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.87 . . . . 50.0 109.172 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -96.86 -35.99 10.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.324 -0.86 . . . . 16.66 109.099 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.562 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.2 mt -82.38 -30.53 9.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.538 -0.726 . . . . 50.0 109.783 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 50' ' ' MET . 18.3 t0 -61.3 101.38 0.16 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.38 -0.825 . . . . 16.66 109.291 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 82.6 p -73.68 -48.16 34.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -0.916 . . . . 50.0 110.851 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 17.1 p-10 -85.0 -28.6 25.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 16.66 109.972 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 91.19 27.91 16.85 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.847 -1.168 . . . . 16.66 110.632 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.474 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 8.9 p-10 -83.36 -4.4 58.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.895 -1.356 . . . . 50.0 109.502 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.526 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 100.11 -7.65 58.78 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.969 -1.11 . . . . 16.66 110.35 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.573 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 43.2 m-85 -131.11 153.37 49.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.016 -1.285 . . . . 50.0 110.918 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.535 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 36.3 mm -104.33 129.5 56.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.183 -1.043 . . . . 16.66 108.183 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.78 165.45 11.94 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.143 -0.973 . . . . 16.66 108.779 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 35.3 t80 -53.61 -42.49 67.76 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.224 -0.99 . . . . 16.66 108.564 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -60.31 -48.56 81.22 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.529 -0.732 . . . . 50.0 109.218 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.535 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 62.0 mt-10 -60.25 -47.3 86.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 16.66 109.1 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -62.72 -35.52 80.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.517 -0.74 . . . . 16.66 109.19 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.505 HG21 ' NH2' ' A' ' 11' ' ' ARG . 12.5 m -67.07 -48.48 68.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.357 -0.839 . . . . 50.0 109.138 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -60.4 -38.24 83.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 50.0 109.237 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.562 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.17 -38.45 51.69 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.505 -0.924 . . . . 50.0 108.505 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -58.17 -27.72 60.49 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.183 -1.567 . . . . 16.66 109.183 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' THR . 58.8 mtm180 -72.53 -31.73 65.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -1.137 . . . . 50.0 108.989 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.1 -20.46 64.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.414 -0.804 . . . . 50.0 109.312 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.522 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 2.9 m-80 -149.93 56.74 0.96 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -0.863 . . . . 50.0 109.32 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 69.8 mtt180 -50.18 -38.53 40.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 50.0 108.796 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.44 -19.08 39.4 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.432 -1.467 . . . . 25.0 109.432 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.522 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 43.9 mt -79.52 -43.73 22.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -1.058 . . . . 50.0 109.395 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 77' ' ' LEU . 5.4 mt -70.79 -15.92 62.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.475 -0.766 . . . . 50.0 109.743 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 43.1 mtpt -80.02 -29.27 39.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.15 -0.969 . . . . 50.0 109.206 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.14 -47.35 8.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 50.0 109.529 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.9 p -62.31 -42.55 95.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.371 -0.831 . . . . 50.0 109.304 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.533 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -52.24 -35.96 51.09 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.746 -0.596 . . . . 50.0 110.2 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -75.45 -24.36 57.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.092 -1.005 . . . . 50.0 109.771 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.469 HG13 ' HA ' ' A' ' 80' ' ' VAL . 10.9 mt -59.07 -38.66 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.273 -0.892 . . . . 50.0 109.546 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.438 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 93.1 m-85 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 118.038 -0.982 . . . . 99.989999999999995 109.425 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.351 -0.611 . . . . 50.0 109.351 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -49.22 -36.34 19.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.825 . . . . 50.0 109.516 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.15 -46.66 87.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.257 -0.902 . . . . 16.66 108.752 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.471 ' O ' HG13 ' A' ' 14' ' ' ILE . 59.6 mm-40 -67.28 -40.37 86.14 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.801 -0.814 . . . . 16.66 108.801 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 45.4 mtt-85 -65.81 -40.49 91.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.557 -0.714 . . . . 50.0 109.649 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.614 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 35.6 mt-10 -64.89 -39.79 94.09 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 50.0 109.571 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 53.2 mtp180 -69.24 -39.26 78.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 50.0 109.21 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.5 mt -71.59 -45.2 68.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.315 -0.866 . . . . 50.0 108.957 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.581 ' CE1' HD13 ' A' ' 26' ' ' ILE . 76.2 t80 -64.48 -36.47 84.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.114 -0.991 . . . . 16.66 108.864 179.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 33.5 mttt -66.12 -28.81 69.09 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.392 -0.818 . . . . 50.0 108.88 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 35.2 mtt85 -68.85 -39.17 80.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 50.0 109.08 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.462 ' HB2' HD12 ' A' ' 26' ' ' ILE . 54.5 m-85 -68.52 -51.33 44.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.458 -0.776 . . . . 16.66 109.373 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 23.5 t0 -54.08 103.14 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -0.842 . . . . 16.66 108.814 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.68 -51.67 46.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.198 -0.939 . . . . 50.0 111.278 -178.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -86.73 -27.48 23.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.812 -1.18 . . . . 16.66 109.693 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 89.28 39.26 6.44 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.145 -1.182 . . . . 16.66 110.145 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -94.34 6.22 49.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.086 -1.244 . . . . 16.66 109.193 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.85 -7.43 76.89 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.513 -1.035 . . . . 16.66 110.513 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 11.7 pttp -130.43 142.32 50.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.891 -1.358 . . . . 50.0 109.971 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.581 HD13 ' CE1' ' A' ' 15' ' ' PHE . 5.5 mt -112.53 133.51 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.613 -0.679 . . . . 16.66 109.567 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 p -105.83 168.22 9.26 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.359 -0.838 . . . . 50.0 108.897 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.2 -46.53 54.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.059 -1.025 . . . . 50.0 108.781 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.28 -41.42 75.85 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.337 -0.852 . . . . 50.0 109.38 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.497 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.8 mt-10 -73.92 -54.08 8.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.187 -0.946 . . . . 16.66 109.302 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.532 ' CD2' HD13 ' A' ' 35' ' ' LEU . 6.6 tt -59.65 -45.89 90.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.218 -0.926 . . . . 16.66 108.9 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.481 ' CA ' HG12 ' A' ' 46' ' ' VAL . . . -61.54 -43.93 98.65 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.559 -1.417 . . . . 16.66 109.559 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -58.04 -40.69 81.56 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.286 -1.126 . . . . 50.0 109.82 -179.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.83 -39.12 69.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.097 -1.002 . . . . 50.0 108.736 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 31' ' ' LEU . 16.0 mt -59.71 -31.86 69.99 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.499 -0.751 . . . . 99.989999999999995 110.116 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.7 mttt -43.55 -28.53 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.08 -1.012 . . . . 99.989999999999995 109.577 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -52.82 -26.97 16.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 99.989999999999995 109.226 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.28 -33.64 69.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.328 -0.857 . . . . 50.0 109.257 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.08 2.0 57.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.773 -1.331 . . . . 16.66 109.773 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.15 57.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -1.18 . . . . 16.66 109.624 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.5 tt -139.1 169.24 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.133 -0.979 . . . . 50.0 109.719 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.81 165.93 21.27 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.774 -0.824 . . . . 16.66 108.774 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.2 -33.53 18.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.03 1.82 . . . . 50.0 110.146 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -63.16 -27.82 69.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.613 -0.68 . . . . 50.0 110.113 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.17 -36.14 30.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.93 -1.106 . . . . 16.66 108.389 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.515 HG23 ' CD1' ' A' ' 35' ' ' LEU . 76.4 t -66.41 -35.04 73.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.098 -0.704 . . . . 50.0 109.098 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -67.95 -38.05 82.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.872 -0.788 . . . . 50.0 108.872 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -67.15 -37.8 84.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.424 -0.797 . . . . 50.0 109.226 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.423 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.6 mtt -61.75 -46.81 88.03 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.196 -0.94 . . . . 16.66 108.854 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.524 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 35.2 mtp -61.96 -47.87 82.94 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.492 -0.755 . . . . 50.0 109.085 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.79 -19.48 41.32 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.365 -0.835 . . . . 50.0 109.231 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -97.42 -36.15 10.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 16.66 109.029 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.565 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.8 mt -82.05 -32.13 10.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.515 -0.741 . . . . 50.0 109.797 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.483 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.0 t0 -59.19 101.63 0.1 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.245 -0.91 . . . . 16.66 108.965 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.511 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 80.9 p -71.04 -48.1 54.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 50.0 110.754 -178.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -85.79 -30.83 22.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.161 -0.962 . . . . 16.66 109.518 -179.585 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.483 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 92.84 27.91 13.26 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.862 -1.161 . . . . 16.66 110.343 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD2' ' OD1' ' A' ' 56' ' ' ASP . 1.4 p30 -81.87 -2.23 50.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.328 . . . . 50.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.524 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.89 -8.57 59.64 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.044 -1.074 . . . . 16.66 110.56 179.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.581 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 36.4 m-85 -132.95 156.17 47.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.948 -1.325 . . . . 50.0 111.24 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.542 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 25.5 mm -107.6 129.05 62.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.432 -0.951 . . . . 16.66 108.432 178.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.85 167.41 11.27 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.033 -1.042 . . . . 16.66 108.647 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.614 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 34.2 t80 -54.52 -42.57 71.0 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.025 -1.047 . . . . 16.66 108.545 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -60.52 -49.71 76.46 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.576 -0.702 . . . . 50.0 109.165 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.542 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 61.2 mt-10 -58.91 -46.8 87.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.258 -0.901 . . . . 16.66 109.08 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -63.86 -35.66 81.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.442 -0.786 . . . . 16.66 109.346 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.7 m -66.22 -48.69 69.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.37 -0.832 . . . . 50.0 109.166 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -59.88 -34.98 73.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 50.0 109.395 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.565 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -79.81 -37.65 34.69 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.422 -0.955 . . . . 50.0 108.422 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.434 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -57.88 -27.64 59.61 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.067 -1.613 . . . . 16.66 109.067 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -71.37 -32.2 68.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.445 -1.032 . . . . 50.0 108.811 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.43 -20.94 66.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.463 -0.773 . . . . 50.0 109.276 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.519 ' CB ' HD13 ' A' ' 76' ' ' LEU . 1.6 m-80 -152.12 55.89 0.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -0.84 . . . . 50.0 109.137 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 4.1 ptm180 -48.45 -34.11 10.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.877 . . . . 50.0 108.769 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.62 -31.7 75.92 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.347 -1.501 . . . . 25.0 109.347 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.519 HD13 ' CB ' ' A' ' 73' ' ' ASN . 65.7 mt -66.13 -44.46 84.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -1.147 . . . . 50.0 109.582 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.508 ' N ' HD21 ' A' ' 77' ' ' LEU . 4.6 mt -71.39 -19.13 62.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 50.0 109.843 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 14.5 mtmt -79.96 -28.37 39.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.177 -0.952 . . . . 50.0 109.271 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.92 -46.09 8.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 50.0 109.38 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.2 p -58.44 -44.19 88.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.803 0.811 . . . . 50.0 108.988 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.545 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -51.25 -38.45 52.7 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.297 -0.561 . . . . 50.0 109.767 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -68.77 -27.28 65.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 50.0 109.614 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.452 HG13 ' HA ' ' A' ' 80' ' ' VAL . 8.4 mt -60.66 -43.31 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.31 -0.869 . . . . 50.0 109.422 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.037 -0.982 . . . . 99.989999999999995 109.415 179.895 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.472 ' OD2' ' NH2' ' A' ' 74' ' ' ARG . 79.4 m-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.392 0.615 . . . . 50.0 109.465 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.438 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 11.5 mttt -43.69 -37.48 2.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 50.0 109.633 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -60.53 -46.02 91.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 16.66 108.91 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.482 ' O ' HG13 ' A' ' 14' ' ' ILE . 83.9 mt-10 -69.02 -35.84 77.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.476 -0.765 . . . . 16.66 108.976 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' NH2' HG21 ' A' ' 67' ' ' THR . 17.0 mtm180 -70.12 -40.45 74.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 50.0 109.309 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.633 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 59.5 mt-10 -66.6 -41.9 87.71 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.394 -0.816 . . . . 50.0 109.411 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 18.9 mtp180 -66.47 -41.31 89.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 50.0 109.457 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 10' ' ' GLU . 41.8 mt -70.04 -43.94 78.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.237 -0.915 . . . . 50.0 109.059 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.583 ' CE1' HD13 ' A' ' 26' ' ' ILE . 70.2 t80 -64.35 -35.98 82.64 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.203 -0.936 . . . . 16.66 109.123 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -66.39 -30.43 70.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 50.0 109.12 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 60.0 mtt85 -69.32 -36.92 77.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 50.0 109.129 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CE1' ' CD1' ' A' ' 31' ' ' LEU . 46.1 m-85 -69.4 -50.82 42.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.421 -0.799 . . . . 16.66 109.475 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 23.6 t0 -55.32 103.43 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 16.66 108.685 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.64 -51.53 48.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.269 -0.894 . . . . 50.0 111.307 -178.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -87.5 -27.59 22.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.759 -1.213 . . . . 16.66 109.753 -179.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 90.23 38.2 6.42 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.767 -1.206 . . . . 16.66 110.242 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.481 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.8 p-10 -93.34 6.33 48.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.252 . . . . 16.66 109.192 179.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.6 -7.72 77.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.402 -1.079 . . . . 16.66 110.402 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 24.9 pttt -129.56 141.67 50.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.935 -1.332 . . . . 50.0 109.997 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.583 HD13 ' CE1' ' A' ' 15' ' ' PHE . 5.7 mt -111.85 133.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.642 -0.661 . . . . 16.66 109.547 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.9 p -105.87 166.28 10.59 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.759 -0.83 . . . . 50.0 108.759 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.09 -45.19 52.42 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.049 -1.032 . . . . 50.0 108.841 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.79 -39.55 77.8 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.331 -0.856 . . . . 50.0 109.517 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.2 mt-10 -74.65 -54.17 7.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.157 -0.965 . . . . 16.66 109.398 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.573 ' CD1' ' CE1' ' A' ' 18' ' ' PHE . 30.3 tp -61.77 -43.35 99.02 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.262 -0.899 . . . . 16.66 108.954 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 46' ' ' VAL . . . -62.71 -44.51 97.4 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.139 -1.584 . . . . 16.66 109.139 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 28.8 mt-10 -58.8 -42.74 89.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.355 -1.085 . . . . 50.0 109.868 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.79 -40.24 66.07 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.098 -1.001 . . . . 50.0 108.406 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.518 HD11 ' CG2' ' A' ' 46' ' ' VAL . 10.7 mt -58.71 -28.63 66.0 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.61 -0.681 . . . . 99.989999999999995 109.553 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 2.4 mtmt -44.04 -26.19 0.27 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 109.615 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.425 ' OG1' HG23 ' A' ' 83' ' ' ILE . 6.6 t -51.94 -26.31 10.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.306 -0.872 . . . . 99.989999999999995 109.195 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.9 mt -58.73 -37.19 75.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.438 -0.789 . . . . 50.0 109.199 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.98 -5.6 61.89 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.836 -1.305 . . . . 16.66 109.836 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.7 t -152.0 59.77 0.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.044 -1.268 . . . . 16.66 109.779 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.3 tp -134.0 157.2 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.152 -0.968 . . . . 50.0 109.485 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.11 160.02 27.65 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.461 -0.94 . . . . 16.66 108.461 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.77 -31.97 30.93 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 121.93 1.753 . . . . 50.0 110.066 178.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -72.15 -17.92 61.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.603 -0.685 . . . . 50.0 110.177 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -80.94 -37.51 29.34 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.815 -1.178 . . . . 16.66 108.28 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.518 ' CG2' HD11 ' A' ' 35' ' ' LEU . 65.6 t -68.23 -35.88 72.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.821 -0.807 . . . . 50.0 108.821 179.299 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -65.19 -40.4 94.17 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.797 -0.816 . . . . 50.0 108.797 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.481 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.7 t60 -66.03 -42.33 89.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.484 -0.76 . . . . 50.0 109.051 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.419 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.9 mtt -58.45 -44.42 89.19 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.249 -0.907 . . . . 16.66 108.71 179.482 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.531 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 34.6 mtp -61.69 -46.69 88.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.572 -0.705 . . . . 50.0 109.182 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.82 -21.36 41.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 50.0 109.042 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.85 -36.32 11.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.46 -0.775 . . . . 16.66 109.076 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.572 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.7 mt -80.59 -31.98 12.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.43 -0.794 . . . . 50.0 109.566 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.6 t0 -61.42 101.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.5 -0.75 . . . . 16.66 109.066 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.466 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 60.3 p -67.5 -46.42 72.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.269 -0.894 . . . . 50.0 110.692 -179.038 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -88.28 -41.41 12.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 16.66 109.56 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 103.67 29.54 5.56 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.964 -1.112 . . . . 16.66 110.346 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 13.3 p-10 -80.61 -2.57 46.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.877 -1.367 . . . . 50.0 109.112 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.531 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.72 -3.58 57.56 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.943 -1.263 . . . . 16.66 109.943 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.2 m-85 -137.0 156.82 47.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.023 -1.281 . . . . 50.0 111.336 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.546 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 25.1 mm -109.46 130.31 62.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.418 -0.956 . . . . 16.66 108.418 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -99.38 168.52 9.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.057 -1.027 . . . . 16.66 108.571 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.633 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.6 t80 -54.8 -43.73 73.16 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.022 -1.071 . . . . 16.66 108.609 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -58.66 -47.54 84.11 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.626 -0.671 . . . . 50.0 109.261 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.546 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 80.8 mt-10 -62.97 -46.54 87.22 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.29 -0.881 . . . . 16.66 109.221 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -63.81 -32.89 74.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 16.66 109.212 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.511 HG21 ' NH2' ' A' ' 11' ' ' ARG . 31.2 m -67.28 -49.35 64.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 50.0 109.171 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -59.74 -36.46 76.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.31 -0.869 . . . . 50.0 109.137 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.577 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -78.1 -38.91 43.02 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.504 -0.925 . . . . 50.0 108.504 179.706 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.446 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -57.49 -28.65 59.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.038 -1.625 . . . . 16.66 109.038 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 67' ' ' THR . 22.7 mtm180 -70.64 -31.91 69.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -1.076 . . . . 50.0 108.851 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.93 -23.51 62.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 50.0 109.238 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.494 ' CB ' HD11 ' A' ' 76' ' ' LEU . 15.5 m-80 -140.48 58.3 1.57 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 50.0 109.223 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.472 ' NH2' ' OD2' ' A' ' 7' ' ' ASP . 58.3 mtp180 -52.66 -34.86 53.6 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.328 -0.858 . . . . 50.0 108.998 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 78' ' ' LYS . . . -67.97 -24.25 74.42 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.48 -1.448 . . . . 25.0 109.48 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.494 HD11 ' CB ' ' A' ' 73' ' ' ASN . 14.6 mt -71.72 -45.99 60.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -1.148 . . . . 50.0 109.489 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.46 HD21 ' HA ' ' A' ' 74' ' ' ARG . 0.3 OUTLIER -62.86 -42.97 99.95 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.327 -0.858 . . . . 50.0 109.677 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 37.0 pttt -68.36 -31.24 70.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 50.0 109.247 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.454 ' O ' HG13 ' A' ' 83' ' ' ILE . 35.3 m-20 -74.78 -36.8 62.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.333 -0.854 . . . . 50.0 109.256 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.47 ' HA ' HG13 ' A' ' 83' ' ' ILE . 21.9 t -79.26 -35.64 17.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 50.0 109.22 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.97 -42.76 63.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.426 -0.796 . . . . 50.0 109.841 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -69.28 -26.08 64.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 50.0 109.573 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.47 HG13 ' HA ' ' A' ' 80' ' ' VAL . 13.7 mt -63.53 -45.19 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.866 . . . . 50.0 109.527 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.05 -0.976 . . . . 99.989999999999995 109.397 179.966 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.45 -0.574 . . . . 50.0 109.45 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.514 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 13.3 mttp -49.57 -36.09 22.68 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.401 -0.812 . . . . 50.0 109.262 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.25 -46.35 90.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 16.66 108.755 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 14' ' ' ILE . 69.2 mt-10 -69.02 -37.81 78.85 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.876 -0.787 . . . . 16.66 108.876 179.386 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.514 ' NH2' ' HG2' ' A' ' 8' ' ' LYS . 10.8 mtm180 -69.57 -40.28 76.86 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.329 -0.857 . . . . 50.0 109.414 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.579 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 54.2 mt-10 -66.68 -39.73 88.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.406 -0.809 . . . . 50.0 109.476 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -69.11 -39.73 78.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 50.0 109.163 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 10' ' ' GLU . 45.4 mt -71.44 -44.13 71.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.334 -0.854 . . . . 50.0 109.063 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.58 ' CE1' HD13 ' A' ' 26' ' ' ILE . 68.7 t80 -69.91 -36.1 75.11 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.133 -0.979 . . . . 16.66 109.115 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 56.6 mttm -65.83 -31.5 72.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.329 -0.857 . . . . 50.0 109.031 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -71.37 -35.8 71.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 50.0 109.011 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.527 ' CB ' HD12 ' A' ' 26' ' ' ILE . 33.7 m-85 -67.83 -47.58 68.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 16.66 109.243 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 24.3 t0 -59.09 103.36 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 16.66 108.624 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.85 -51.32 56.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 50.0 111.257 -178.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -87.18 -30.64 20.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.739 -1.226 . . . . 16.66 109.872 -179.307 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 93.46 35.6 6.18 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.702 -1.237 . . . . 16.66 110.15 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.479 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.2 p-10 -90.28 4.75 49.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -1.184 . . . . 16.66 109.172 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.91 -6.26 76.55 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.432 -1.067 . . . . 16.66 110.432 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.5 pttp -131.26 142.58 50.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.93 -1.335 . . . . 50.0 110.079 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.58 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.9 mt -112.23 132.86 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.695 -0.628 . . . . 16.66 109.421 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.4 p -104.94 167.76 9.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.339 -0.851 . . . . 50.0 108.963 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.23 -45.34 53.85 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.138 -0.976 . . . . 50.0 108.987 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.53 -40.83 79.67 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.374 -0.829 . . . . 50.0 109.318 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.3 mt-10 -74.01 -54.57 7.59 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.271 -0.893 . . . . 16.66 109.218 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.515 ' CD2' HD13 ' A' ' 35' ' ' LEU . 5.6 tt -59.7 -46.58 88.65 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.209 -0.932 . . . . 16.66 108.806 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.517 ' CA ' HG13 ' A' ' 46' ' ' VAL . . . -60.83 -42.93 99.73 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.45 -1.46 . . . . 16.66 109.45 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -57.98 -41.83 83.78 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.336 -1.096 . . . . 50.0 109.881 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' CB ' ' CD1' ' A' ' 18' ' ' PHE . . . -71.26 -39.02 71.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.15 -0.969 . . . . 50.0 108.719 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.533 ' CD1' HG23 ' A' ' 46' ' ' VAL . 21.3 mt -59.77 -34.62 73.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.54 -0.725 . . . . 99.989999999999995 110.034 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 8.8 mttt -43.78 -28.12 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 99.989999999999995 109.53 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.518 ' OG1' ' CG2' ' A' ' 83' ' ' ILE . 6.6 t -52.48 -25.74 11.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.288 -0.883 . . . . 99.989999999999995 109.208 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.44 -30.36 71.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.301 -0.874 . . . . 50.0 109.317 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.97 6.37 52.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.738 -1.345 . . . . 16.66 109.738 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 t -154.58 58.67 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.164 -1.198 . . . . 16.66 109.713 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.0 tt -144.25 168.42 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.963 . . . . 50.0 109.47 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.41 166.04 20.18 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 16.66 108.786 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.45 -33.4 17.86 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.089 1.859 . . . . 50.0 110.085 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -62.68 -27.86 69.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.662 -0.649 . . . . 50.0 109.908 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -81.73 -35.89 29.21 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.833 -1.167 . . . . 16.66 108.255 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.533 HG23 ' CD1' ' A' ' 35' ' ' LEU . 79.3 t -67.1 -35.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.028 -0.73 . . . . 50.0 109.028 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -68.6 -38.02 80.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.854 -0.795 . . . . 50.0 108.854 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -67.05 -37.04 83.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 50.0 109.132 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.413 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.4 mtt -60.86 -47.56 85.83 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.272 -0.892 . . . . 16.66 108.811 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.525 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 56.5 mtp -61.28 -47.31 86.59 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.566 -0.709 . . . . 50.0 109.125 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.81 -20.74 37.91 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.292 -0.88 . . . . 50.0 109.171 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -98.93 -37.39 9.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 16.66 109.244 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.574 HG12 ' CD2' ' A' ' 69' ' ' PHE . 85.5 mt -80.35 -33.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.471 -0.768 . . . . 50.0 109.685 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.6 t0 -60.44 101.55 0.14 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.405 -0.809 . . . . 16.66 108.891 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.467 HG22 ' HG2' ' A' ' 65' ' ' GLU . 71.8 p -66.53 -47.9 71.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 50.0 110.785 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.2 p-10 -87.57 -38.8 15.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.106 -0.996 . . . . 16.66 109.452 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 101.12 27.65 7.24 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.945 -1.121 . . . . 16.66 110.492 179.403 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 15.6 p-10 -78.45 -0.75 30.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.865 -1.373 . . . . 50.0 109.224 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.525 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.47 -4.84 58.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.015 -1.234 . . . . 16.66 110.015 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 27.0 m-85 -136.86 157.17 47.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.926 -1.337 . . . . 50.0 111.34 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.541 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 23.1 mm -110.08 131.35 61.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.466 -0.939 . . . . 16.66 108.466 178.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 170.82 8.27 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.045 -1.035 . . . . 16.66 108.521 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.579 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 36.2 t80 -56.09 -44.45 79.02 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.121 -1.032 . . . . 16.66 108.657 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -59.04 -49.35 78.23 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.492 -0.755 . . . . 50.0 109.229 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.541 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 78.4 mt-10 -60.23 -46.49 89.59 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.261 -0.899 . . . . 16.66 109.265 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -63.6 -34.07 77.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.418 -0.802 . . . . 16.66 109.337 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.501 HG21 ' NH2' ' A' ' 11' ' ' ARG . 19.6 m -66.56 -48.97 67.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.843 . . . . 50.0 109.203 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -58.85 -36.22 74.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 50.0 109.24 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.574 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -79.88 -37.16 35.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.585 -0.894 . . . . 50.0 108.585 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.525 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -60.15 -28.71 67.05 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.383 -1.487 . . . . 16.66 109.383 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 67' ' ' THR . 75.5 mtm180 -72.68 -34.69 67.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 50.0 109.198 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.82 -18.98 65.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.434 -0.791 . . . . 50.0 109.298 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.49 ' HB3' ' CG ' ' A' ' 76' ' ' LEU . 29.4 m-80 -144.4 56.74 1.3 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.263 -0.898 . . . . 50.0 109.222 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 98.3 mtt180 -51.46 -40.3 59.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.713 -0.847 . . . . 50.0 108.713 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.442 ' HA3' ' HE3' ' A' ' 78' ' ' LYS . . . -60.27 -25.98 63.29 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.454 -1.459 . . . . 25.0 109.454 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.49 ' CG ' ' HB3' ' A' ' 73' ' ' ASN . 18.6 mt -72.7 -45.55 58.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -1.161 . . . . 50.0 109.43 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' CD1' ' HA2' ' A' ' 70' ' ' GLY . 10.5 mt -68.67 -16.46 63.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 50.0 109.777 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 18.6 mtmt -80.05 -24.35 40.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 50.0 109.322 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -91.99 -48.32 6.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.273 -0.892 . . . . 50.0 109.408 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.547 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.3 p -59.15 -44.33 91.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.388 -0.82 . . . . 50.0 109.178 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.547 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -49.62 -40.86 40.69 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.115 -0.634 . . . . 50.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -64.11 -25.74 68.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 50.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.518 ' CG2' ' OG1' ' A' ' 37' ' ' THR . 20.8 mm -66.79 -36.1 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 50.0 109.414 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.009 -0.996 . . . . 99.989999999999995 109.458 -179.999 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.296 -0.631 . . . . 50.0 109.296 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -51.18 -36.14 39.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 50.0 109.432 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.7 -45.53 85.57 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.655 -0.869 . . . . 16.66 108.655 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 14' ' ' ILE . 58.9 mt-10 -66.43 -43.82 84.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.955 -0.758 . . . . 16.66 108.955 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.477 ' NH2' ' HG2' ' A' ' 71' ' ' ARG . 20.0 mtt-85 -64.49 -39.74 94.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -0.782 . . . . 50.0 109.46 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.568 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 31.6 mt-10 -64.35 -41.62 96.65 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.48 -0.762 . . . . 50.0 109.286 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 52.0 mtp85 -67.99 -39.77 83.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.307 -0.871 . . . . 50.0 109.173 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.502 ' CD1' ' HB1' ' A' ' 81' ' ' ALA . 21.1 mt -70.52 -44.45 76.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.394 -0.816 . . . . 50.0 109.044 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.576 ' CE1' HD13 ' A' ' 26' ' ' ILE . 68.5 t80 -66.66 -36.1 81.73 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.243 -0.911 . . . . 16.66 109.141 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 22.6 mtpt -65.4 -30.22 71.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.352 -0.843 . . . . 50.0 109.089 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.515 ' NH2' ' O ' ' A' ' 84' ' ' PHE . 31.5 mtt180 -71.88 -35.22 69.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 50.0 109.057 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.527 ' CB ' HD12 ' A' ' 26' ' ' ILE . 31.0 m-85 -69.45 -48.77 59.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.448 -0.783 . . . . 16.66 109.298 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 23.2 t0 -58.74 103.09 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.917 . . . . 16.66 108.662 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.57 -51.82 52.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.128 -0.982 . . . . 50.0 111.239 -178.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -86.65 -27.9 23.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.748 -1.22 . . . . 16.66 109.565 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 89.33 38.1 6.83 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.862 -1.161 . . . . 16.66 110.215 179.021 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.474 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.4 p-10 -92.39 5.91 48.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -1.217 . . . . 16.66 109.142 179.168 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.88 -7.13 76.96 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.472 -1.051 . . . . 16.66 110.472 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 15.7 pttt -130.74 142.34 50.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.886 -1.361 . . . . 50.0 110.047 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.576 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.9 mt -112.3 133.23 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.724 -0.61 . . . . 16.66 109.447 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.7 p -106.93 169.74 8.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -0.891 . . . . 50.0 109.054 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.51 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.8 -46.76 59.85 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.108 -0.995 . . . . 50.0 108.985 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.19 74.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.266 -0.896 . . . . 50.0 109.467 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.489 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.4 mt-10 -75.56 -54.22 7.35 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.207 -0.933 . . . . 16.66 109.239 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.526 ' CD2' HD13 ' A' ' 35' ' ' LEU . 7.0 tt -59.58 -46.77 87.93 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.212 -0.93 . . . . 16.66 108.847 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' HA3' HG23 ' A' ' 46' ' ' VAL . . . -60.88 -43.33 99.43 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.461 -1.456 . . . . 16.66 109.461 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.32 -41.36 84.38 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.437 -1.037 . . . . 50.0 109.826 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.35 -39.81 67.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.166 -0.959 . . . . 50.0 108.726 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.526 HD13 ' CD2' ' A' ' 31' ' ' LEU . 14.1 mt -59.55 -32.28 70.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.446 -0.784 . . . . 99.989999999999995 109.832 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.6 mtmt -43.7 -26.32 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.065 -1.022 . . . . 99.989999999999995 109.632 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.463 ' CG2' HG23 ' A' ' 83' ' ' ILE . 7.6 t -52.4 -25.8 10.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 99.989999999999995 109.244 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.494 ' CD1' HD21 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -65.72 -31.86 73.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.372 -0.83 . . . . 50.0 109.201 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.07 11.04 43.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.479 -1.449 . . . . 16.66 109.479 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.33 50.02 0.56 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.242 -1.152 . . . . 16.66 109.54 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 tt -136.95 172.99 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 50.0 109.288 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.78 166.58 19.36 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 16.66 108.696 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.16 -33.81 18.01 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.089 1.859 . . . . 50.0 110.184 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -64.08 -26.14 68.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.635 -0.665 . . . . 50.0 110.117 -179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -82.52 -40.11 21.48 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.814 -1.179 . . . . 16.66 108.173 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.476 HG23 HD13 ' A' ' 35' ' ' LEU . 55.2 t -62.22 -35.93 71.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.692 -0.855 . . . . 50.0 108.692 179.199 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -69.62 -37.37 76.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.752 -0.833 . . . . 50.0 108.752 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.575 ' CD2' ' HG3' ' A' ' 52' ' ' GLU . 13.7 t-160 -67.35 -36.81 82.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.506 -0.746 . . . . 50.0 109.261 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.442 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.4 mtt -61.39 -46.79 88.7 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.18 -0.95 . . . . 16.66 108.789 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.522 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 43.0 mtp -62.26 -48.32 80.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.493 -0.755 . . . . 50.0 109.056 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.93 -19.38 29.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 50.0 109.209 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.575 ' HG3' ' CD2' ' A' ' 48' ' ' HIS . 23.1 mt-10 -99.65 -36.93 9.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 16.66 109.143 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.526 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.7 mt -80.47 -33.4 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.456 -0.777 . . . . 50.0 109.501 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.48 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.6 t0 -59.82 101.69 0.13 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.302 -0.874 . . . . 16.66 108.849 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 49.5 p -68.5 -46.36 69.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 50.0 110.736 -178.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.489 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -88.09 -38.88 15.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 16.66 109.539 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.48 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 101.61 28.34 6.73 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.019 -1.086 . . . . 16.66 110.523 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.489 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.4 p-10 -79.57 -2.0 40.45 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.783 -1.422 . . . . 50.0 109.13 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.522 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.34 -5.59 59.01 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.048 -1.221 . . . . 16.66 110.048 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 31.6 m-85 -134.99 156.59 48.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.008 -1.29 . . . . 50.0 111.407 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.555 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 22.1 mm -109.21 129.8 63.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.365 -0.976 . . . . 16.66 108.365 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -96.26 167.4 11.21 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.083 -1.01 . . . . 16.66 108.55 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.568 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 34.0 t80 -54.32 -42.39 70.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.014 -1.054 . . . . 16.66 108.442 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -61.19 -47.58 85.49 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.584 -0.697 . . . . 50.0 109.335 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.555 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 74.9 mt-10 -61.71 -47.02 87.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.244 -0.91 . . . . 16.66 109.2 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.553 ' CZ ' HD12 ' A' ' 77' ' ' LEU . 80.7 t80 -61.69 -39.11 90.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 16.66 109.375 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.459 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 15.9 m -66.27 -46.53 76.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.414 -0.804 . . . . 50.0 109.325 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -59.01 -36.53 75.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 50.0 109.64 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -78.66 -35.32 45.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.234 -0.917 . . . . 50.0 108.69 179.972 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.28 -28.79 64.91 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.385 -1.486 . . . . 16.66 109.385 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.477 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 35.9 mtm180 -73.46 -30.63 63.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -1.172 . . . . 50.0 109.253 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.47 -15.85 61.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 50.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.514 ' HB2' ' CD1' ' A' ' 76' ' ' LEU . 5.0 p30 -149.56 54.98 0.96 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 50.0 109.189 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -51.19 -43.16 61.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.368 -0.832 . . . . 50.0 108.791 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.85 -24.38 19.15 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.174 -1.57 . . . . 25.0 109.174 179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.514 ' CD1' ' HB2' ' A' ' 73' ' ' ASN . 41.9 mt -80.05 -43.49 21.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -1.091 . . . . 50.0 109.394 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.6 mm? -61.96 -40.03 94.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.411 -0.805 . . . . 50.0 109.845 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 43.3 mtpt -66.19 -33.63 76.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 50.0 109.653 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.19 -46.83 22.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 50.0 109.463 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.8 p -72.63 -40.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.79 0.805 . . . . 50.0 109.393 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 77' ' ' LEU . . . -53.69 -33.96 57.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.744 -0.597 . . . . 50.0 110.487 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 77.1 mttt -79.88 -22.98 42.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.018 . . . . 50.0 109.789 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.467 HG13 ' HA ' ' A' ' 80' ' ' VAL . 10.1 mt -57.59 -35.9 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 50.0 109.48 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.515 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 95.1 m-85 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.021 -0.99 . . . . 99.989999999999995 109.534 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.336 0.589 . . . . 50.0 109.457 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -48.53 -36.3 15.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.363 -0.836 . . . . 50.0 109.355 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -56.38 -45.19 80.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.597 -0.89 . . . . 16.66 108.597 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.483 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.4 mt-10 -68.09 -38.61 82.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.47 -0.769 . . . . 16.66 108.947 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.8 mtt-85 -67.49 -40.58 85.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 50.0 109.387 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.621 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 33.2 mt-10 -64.9 -40.98 95.93 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.442 -0.786 . . . . 50.0 109.354 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 59.7 mtp180 -68.27 -39.54 82.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 50.0 109.154 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 10' ' ' GLU . 33.5 mt -70.93 -45.06 75.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.391 -0.818 . . . . 50.0 109.006 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 26' ' ' ILE . 67.2 t80 -64.86 -35.86 82.5 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 16.66 108.903 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -66.56 -29.42 69.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.32 -0.862 . . . . 50.0 108.962 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 39.2 mtt85 -70.04 -36.61 75.14 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.362 -0.836 . . . . 50.0 109.006 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.461 ' HB2' HD12 ' A' ' 26' ' ' ILE . 51.6 m-85 -70.22 -51.18 32.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.448 -0.782 . . . . 16.66 109.352 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 22.8 t0 -55.47 103.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 16.66 108.744 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.27 48.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.89 . . . . 50.0 111.196 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -87.06 -28.39 22.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.749 -1.219 . . . . 16.66 109.71 -179.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 90.13 37.4 6.73 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.801 -1.19 . . . . 16.66 110.216 178.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.473 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.7 p-10 -91.42 5.49 49.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -1.22 . . . . 16.66 109.157 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.09 -6.2 75.95 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.401 -1.08 . . . . 16.66 110.401 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 16.9 pttt -131.25 142.53 50.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.959 -1.318 . . . . 50.0 110.001 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.579 HD13 ' CE1' ' A' ' 15' ' ' PHE . 5.9 mt -112.52 133.55 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.639 -0.663 . . . . 16.66 109.495 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.0 p -106.47 167.8 9.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.866 . . . . 50.0 108.934 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.15 -45.53 53.29 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.072 -1.017 . . . . 50.0 108.93 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -57.22 -41.4 79.43 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.218 -0.926 . . . . 50.0 109.259 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.5 mt-10 -74.35 -54.85 6.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.346 -0.846 . . . . 16.66 109.001 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.527 ' CD2' HD13 ' A' ' 35' ' ' LEU . 6.1 tt -58.57 -48.58 80.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.869 . . . . 16.66 108.771 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.467 ' HA3' HG23 ' A' ' 46' ' ' VAL . . . -60.02 -43.44 98.2 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.308 -1.517 . . . . 16.66 109.308 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 19.0 mt-10 -56.81 -42.92 80.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.307 -1.114 . . . . 50.0 109.706 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.1 -39.41 68.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.116 -0.99 . . . . 50.0 108.502 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.527 HD13 ' CD2' ' A' ' 31' ' ' LEU . 14.0 mt -59.88 -33.3 71.65 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.56 -0.713 . . . . 99.989999999999995 109.865 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.4 mttm -43.97 -26.45 0.28 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 99.989999999999995 109.593 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.518 ' CG2' HG22 ' A' ' 83' ' ' ILE . 7.0 t -51.9 -24.56 6.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.286 -0.884 . . . . 99.989999999999995 109.288 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.503 ' CD1' HD21 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -61.84 -33.16 73.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 50.0 109.226 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.34 2.48 54.49 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.81 -1.316 . . . . 16.66 109.81 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.09 56.2 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.07 -1.253 . . . . 16.66 110.024 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.439 HD11 HD11 ' A' ' 38' ' ' LEU . 7.3 tt -138.38 167.54 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 50.0 109.41 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.17 165.18 17.0 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.617 -0.883 . . . . 16.66 108.617 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.21 -32.28 21.17 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.115 1.876 . . . . 50.0 110.192 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -64.22 -25.77 68.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.713 -0.617 . . . . 50.0 110.077 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.408 ' OE1' HG13 ' A' ' 41' ' ' ILE . 92.3 mt-10 -81.91 -41.3 21.1 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.854 -1.154 . . . . 16.66 108.133 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 35' ' ' LEU . 69.3 t -62.76 -35.8 72.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.959 -0.756 . . . . 50.0 108.959 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -68.42 -38.21 81.01 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.754 -0.832 . . . . 50.0 108.754 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -66.71 -35.97 81.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.389 -0.819 . . . . 50.0 109.245 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.436 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.2 mtt -60.86 -46.67 89.69 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.147 -0.971 . . . . 16.66 108.622 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.527 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 53.5 mtp -61.92 -48.88 78.46 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.928 -0.767 . . . . 50.0 108.928 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.11 -21.67 13.8 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.282 -0.886 . . . . 50.0 109.177 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -98.5 -36.37 9.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 16.66 109.19 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.561 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.2 mt -81.22 -30.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.548 -0.72 . . . . 50.0 109.766 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.2 t0 -61.66 101.84 0.22 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.439 -0.788 . . . . 16.66 109.363 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.49 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 71.6 p -73.54 -47.78 38.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.28 -0.888 . . . . 50.0 110.868 -179.017 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 10.9 p-10 -85.45 -29.5 24.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.037 -1.039 . . . . 16.66 109.821 -179.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 92.59 27.07 15.64 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.837 -1.173 . . . . 16.66 110.836 178.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.482 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p-10 -82.06 -2.68 52.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.785 -1.42 . . . . 50.0 109.424 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.527 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.3 -5.08 60.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.345 -1.102 . . . . 16.66 110.345 179.284 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 43.0 m-85 -134.28 153.69 51.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.987 -1.302 . . . . 50.0 111.093 -179.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 33.0 mm -105.05 128.62 58.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.516 -0.92 . . . . 16.66 108.516 178.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 m -94.87 167.2 11.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.159 -0.963 . . . . 16.66 108.613 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.621 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 35.5 t80 -54.78 -42.6 71.93 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.059 -1.025 . . . . 16.66 108.625 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -60.74 -48.46 81.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.561 -0.712 . . . . 50.0 109.166 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.54 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 42.8 mt-10 -59.83 -46.9 87.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 16.66 109.224 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.572 ' CZ ' HD12 ' A' ' 77' ' ' LEU . 59.4 t80 -62.49 -38.63 90.65 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.492 -0.755 . . . . 16.66 109.398 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.462 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 16.6 m -66.04 -47.62 73.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.392 -0.818 . . . . 50.0 109.341 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.14 -36.7 75.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 50.0 109.463 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.561 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.82 -36.72 56.71 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.656 -0.868 . . . . 50.0 108.656 179.929 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.13 -31.09 64.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.209 -1.556 . . . . 16.66 109.209 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 67' ' ' THR . 71.6 mtp180 -67.7 -31.17 70.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -1.066 . . . . 50.0 108.957 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.56 -21.9 64.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.506 -0.746 . . . . 50.0 109.356 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.477 ' HB2' ' CG ' ' A' ' 76' ' ' LEU . 4.4 p30 -150.11 58.54 0.97 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 50.0 109.052 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -50.65 -38.2 44.95 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.29 -0.881 . . . . 50.0 108.685 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.16 -32.67 67.76 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.233 -1.547 . . . . 25.0 109.233 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.477 ' CG ' ' HB2' ' A' ' 73' ' ' ASN . 19.0 mt -64.12 -43.38 95.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.446 -1.032 . . . . 50.0 109.372 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.9 mm? -61.13 -40.29 93.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 50.0 109.786 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 15.1 mtpt -63.66 -33.93 76.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 50.0 109.623 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 79' ' ' ASP . 58.4 t0 -78.75 -49.27 13.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 50.0 109.556 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.7 p -64.56 -44.71 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 50.0 109.749 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.546 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -49.64 -39.94 37.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.683 -0.635 . . . . 50.0 109.776 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 75.1 mttt -69.91 -25.19 63.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 50.0 109.615 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.518 HG22 ' CG2' ' A' ' 37' ' ' THR . 9.4 mt -65.03 -44.67 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 50.0 109.561 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.982 -1.008 . . . . 99.989999999999995 109.492 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.66 -28.56 22.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 109.497 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -68.97 133.19 47.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 25.0 109.391 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.462 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -110.05 170.05 5.74 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 50.0 109.457 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 45.5 Cg_endo -68.36 -22.54 39.42 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.562 2.175 . . . . 50.0 111.002 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -62.51 -40.02 95.4 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.516 -0.74 . . . . 25.0 109.189 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.22 -47.23 86.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 50.0 109.368 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -51.35 -39.5 57.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -0.868 . . . . 50.0 109.392 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.84 -41.45 64.26 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.315 -0.866 . . . . 16.66 108.69 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.9 mm-40 -67.07 -47.06 72.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.527 -0.733 . . . . 16.66 109.069 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.513 ' NH2' HG21 ' A' ' 67' ' ' THR . 11.2 mtm180 -65.34 -39.22 92.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.351 -0.843 . . . . 50.0 109.361 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.574 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 43.8 mt-10 -66.05 -41.31 91.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.438 -0.788 . . . . 50.0 109.228 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.4 mtt180 -66.46 -40.42 89.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.455 -0.778 . . . . 50.0 109.104 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.2 mt -70.18 -46.63 71.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.381 -0.824 . . . . 50.0 108.989 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.57 ' CE2' HD13 ' A' ' 26' ' ' ILE . 59.3 t80 -66.01 -35.35 80.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 16.66 109.281 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 19.9 mttt -66.08 -32.7 74.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.845 . . . . 50.0 109.351 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 84' ' ' PHE . 52.7 mtt180 -70.12 -35.45 74.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.877 . . . . 50.0 109.09 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.546 ' CE1' HD13 ' A' ' 31' ' ' LEU . 42.3 m-85 -67.88 -49.07 64.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.385 -0.822 . . . . 16.66 109.338 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.48 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 22.8 t0 -57.75 103.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 16.66 108.75 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.96 -51.49 54.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.274 -0.891 . . . . 50.0 111.185 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -87.78 -26.62 22.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.798 -1.189 . . . . 16.66 109.674 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.48 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 88.56 38.87 6.9 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.79 -1.195 . . . . 16.66 110.14 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -93.72 5.53 51.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.094 -1.239 . . . . 16.66 109.214 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.93 -8.09 73.41 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.485 -1.046 . . . . 16.66 110.485 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.0 pttp -130.13 142.01 50.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.937 -1.331 . . . . 50.0 110.042 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.57 HD13 ' CE2' ' A' ' 15' ' ' PHE . 5.0 mt -111.99 133.91 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.618 -0.676 . . . . 16.66 109.538 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.6 p -106.18 166.75 10.29 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.807 -0.812 . . . . 50.0 108.807 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.88 -45.76 51.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.055 -1.028 . . . . 50.0 108.874 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.12 -40.3 76.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.301 -0.874 . . . . 50.0 109.438 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.479 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.5 mt-10 -74.44 -54.14 8.17 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.211 -0.931 . . . . 16.66 109.373 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.546 HD13 ' CE1' ' A' ' 18' ' ' PHE . 63.1 tp -62.0 -43.03 99.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 16.66 109.044 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -62.41 -44.01 98.24 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.239 -1.545 . . . . 16.66 109.239 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -57.81 -43.48 85.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.355 -1.085 . . . . 50.0 109.729 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.82 -39.67 69.65 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.153 -0.967 . . . . 50.0 108.521 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.525 ' CD1' ' HG ' ' A' ' 31' ' ' LEU . 2.2 mt -59.18 -33.12 70.57 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.595 -0.691 . . . . 99.989999999999995 109.69 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' LEU . 17.7 mttt -44.85 -26.42 0.4 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.999 -1.063 . . . . 99.989999999999995 109.388 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.503 ' CG2' HG22 ' A' ' 83' ' ' ILE . 10.4 t -51.81 -25.54 7.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.244 -0.91 . . . . 99.989999999999995 109.258 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.519 ' CD1' ' CD2' ' A' ' 35' ' ' LEU . 1.5 mt -63.85 -32.74 74.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -0.843 . . . . 50.0 109.308 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.46 5.76 51.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.724 -1.35 . . . . 16.66 109.724 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.76 52.37 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -1.185 . . . . 16.66 109.715 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.464 HD11 ' CD1' ' A' ' 38' ' ' LEU . 13.5 tt -137.56 169.89 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 50.0 109.469 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.59 163.51 32.18 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.647 -0.871 . . . . 16.66 108.647 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.23 -33.51 24.2 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.03 1.82 . . . . 50.0 110.049 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -64.46 -24.96 67.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.675 -0.64 . . . . 50.0 109.892 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -83.12 -37.06 24.27 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.862 -1.149 . . . . 16.66 108.282 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 35' ' ' LEU . 68.9 t -68.57 -36.73 75.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.927 -0.768 . . . . 50.0 108.927 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -67.9 -39.48 83.61 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.8 -0.815 . . . . 50.0 108.8 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.25 -39.6 92.86 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.441 -0.787 . . . . 50.0 109.194 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.423 ' O ' HG13 ' A' ' 53' ' ' ILE . 11.4 mtt -58.57 -43.78 89.53 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.186 -0.946 . . . . 16.66 108.861 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.527 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 57.7 mtp -61.76 -47.95 82.86 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.535 -0.728 . . . . 50.0 109.124 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.72 -20.76 36.65 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.309 -0.869 . . . . 50.0 109.187 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -97.37 -36.51 10.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 16.66 109.123 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.548 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.7 mt -81.8 -32.48 11.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.426 -0.796 . . . . 50.0 109.67 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.7 t0 -60.35 101.42 0.13 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.412 -0.805 . . . . 16.66 108.957 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 60.0 p -70.19 -46.86 63.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 50.0 110.75 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.495 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -86.69 -38.41 17.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.12 -0.987 . . . . 16.66 109.542 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 100.99 28.82 6.72 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.93 -1.128 . . . . 16.66 110.617 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.495 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.0 p-10 -80.37 -3.22 48.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.751 -1.441 . . . . 50.0 109.155 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.527 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.89 -5.07 57.88 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.922 -1.271 . . . . 16.66 109.922 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 40.8 m-85 -134.38 156.95 47.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.016 -1.285 . . . . 50.0 111.298 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 36.3 mm -108.2 130.28 61.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.212 -1.033 . . . . 16.66 108.212 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.6 m -99.95 167.68 10.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.998 -1.064 . . . . 16.66 108.673 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.574 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 41.3 t80 -54.96 -44.49 74.43 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.177 -1.009 . . . . 16.66 108.576 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -58.37 -47.14 84.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.564 -0.71 . . . . 50.0 109.165 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.54 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.7 mt-10 -62.49 -46.54 88.02 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.27 -0.894 . . . . 16.66 109.145 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -60.31 -37.75 81.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 16.66 109.19 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.513 HG21 ' NH2' ' A' ' 11' ' ' ARG . 12.1 m -65.69 -47.59 74.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.388 -0.82 . . . . 50.0 109.09 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -59.39 -40.48 86.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 50.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.06 -37.0 58.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.687 -0.857 . . . . 50.0 108.687 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.42 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -59.16 -31.98 70.47 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.355 -1.498 . . . . 16.66 109.355 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 67' ' ' THR . 59.5 mtm180 -71.06 -31.12 67.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -1.165 . . . . 50.0 109.399 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.49 -20.29 62.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.366 -0.834 . . . . 50.0 109.501 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.518 ' HB3' ' CD1' ' A' ' 76' ' ' LEU . 1.8 m-80 -149.38 54.95 0.97 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.258 -0.901 . . . . 50.0 109.479 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -51.46 -42.6 61.71 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.163 -0.96 . . . . 50.0 108.622 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.21 -20.6 29.24 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.526 -1.43 . . . . 25.0 109.526 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.518 ' CD1' ' HB3' ' A' ' 73' ' ' ASN . 33.2 mt -78.62 -43.7 25.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -1.187 . . . . 50.0 109.175 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.8 mt -61.43 -35.95 79.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 50.0 109.699 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 10.5 mtmm -60.48 -26.96 67.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 50.0 109.382 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -76.21 -37.93 57.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.222 -0.924 . . . . 50.0 109.232 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -78.51 -31.28 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 50.0 109.562 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.88 -14.88 51.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 50.0 109.614 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -96.33 -31.97 12.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.917 . . . . 50.0 108.972 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.503 HG22 ' CG2' ' A' ' 37' ' ' THR . 38.0 mt -58.86 -38.93 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.46 -0.775 . . . . 50.0 109.316 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 17' ' ' ARG . 90.9 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.041 -0.98 . . . . 99.989999999999995 109.471 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.442 ' HB1' ' OD1' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 3' ' ' ASP . 84.1 m-20 -79.19 -21.44 46.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.442 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 45.7 p30 -51.08 179.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.226 -0.921 . . . . 25.0 109.559 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.461 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -135.51 165.97 32.2 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 50.0 109.375 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 43.3 Cg_endo -67.0 -21.46 49.52 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.463 2.108 . . . . 50.0 110.94 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -60.14 -46.34 89.99 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.527 -0.733 . . . . 25.0 109.252 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.443 ' CG ' ' NE2' ' A' ' 4' ' ' HIS . 77.9 m-20 -56.62 -54.12 49.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 50.0 109.435 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.434 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 30.6 mtpt -43.21 -36.8 1.88 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.804 . . . . 50.0 109.759 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.23 -46.96 87.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.238 -0.914 . . . . 16.66 108.834 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 14' ' ' ILE . 44.1 mt-10 -68.22 -38.51 81.98 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.887 -0.783 . . . . 16.66 108.887 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.505 ' NH2' HG21 ' A' ' 67' ' ' THR . 13.0 mtm180 -68.37 -39.9 81.62 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.325 -0.859 . . . . 50.0 109.496 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.639 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 13.0 mt-10 -67.4 -41.75 84.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.415 -0.803 . . . . 50.0 109.432 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.8 mtp-105 -66.16 -41.46 90.32 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.3 -0.875 . . . . 50.0 109.299 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 10' ' ' GLU . 38.6 mt -69.83 -45.47 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.247 -0.908 . . . . 50.0 109.023 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.551 ' CE1' HD13 ' A' ' 26' ' ' ILE . 73.8 t80 -63.26 -36.43 83.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.423 -0.911 . . . . 16.66 108.933 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -64.89 -30.78 71.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.384 -0.822 . . . . 50.0 109.08 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 48.2 mtt180 -68.4 -37.09 80.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 50.0 109.12 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.464 ' HB2' HD12 ' A' ' 26' ' ' ILE . 57.3 m-85 -68.67 -50.98 46.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 16.66 109.577 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.47 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 21.6 t0 -55.71 103.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 16.66 108.925 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.6 -50.52 43.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.873 . . . . 50.0 111.118 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -87.02 -30.98 20.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.714 -1.241 . . . . 16.66 109.674 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 93.94 35.55 6.06 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.764 -1.208 . . . . 16.66 110.205 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.476 ' OD2' ' CG ' ' A' ' 25' ' ' LYS . 34.7 p-10 -90.79 3.7 53.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.257 . . . . 16.66 109.161 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.86 -5.83 72.98 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.48 -1.048 . . . . 16.66 110.48 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.8 pttp -132.0 143.39 50.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.898 -1.354 . . . . 50.0 110.086 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.551 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.2 mt -110.85 133.42 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.375 0.607 . . . . 16.66 109.685 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.45 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 10.5 p -105.83 166.57 10.38 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.491 -0.755 . . . . 50.0 108.973 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.73 -45.78 49.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.01 -1.056 . . . . 50.0 108.843 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -56.77 -41.09 77.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.288 -0.883 . . . . 50.0 109.334 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 60.5 mt-10 -74.5 -54.83 6.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.306 -0.871 . . . . 16.66 109.248 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.519 ' CD2' HD13 ' A' ' 35' ' ' LEU . 7.4 tt -60.5 -45.66 92.98 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.307 -0.871 . . . . 16.66 108.867 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -62.89 -44.74 96.99 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.104 -1.598 . . . . 16.66 109.104 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 24.2 mt-10 -57.65 -42.16 82.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.395 -1.062 . . . . 50.0 109.546 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.88 -39.94 66.0 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.389 -0.967 . . . . 50.0 108.389 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.519 HD13 ' CD2' ' A' ' 31' ' ' LEU . 6.6 mt -58.36 -33.25 69.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.539 -0.725 . . . . 99.989999999999995 109.502 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -44.4 -27.83 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 99.989999999999995 109.579 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.517 ' OG1' ' CG2' ' A' ' 83' ' ' ILE . 6.9 t -50.14 -25.37 3.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.897 . . . . 99.989999999999995 109.111 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.458 HD13 HD21 ' A' ' 35' ' ' LEU . 22.8 mt -62.63 -33.2 74.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.467 -0.771 . . . . 50.0 109.281 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.28 6.39 53.55 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 16.66 109.549 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.63 51.78 0.57 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -1.181 . . . . 16.66 109.473 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.456 HD11 HD13 ' A' ' 38' ' ' LEU . 11.8 tt -137.09 170.97 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.95 . . . . 50.0 109.486 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.99 167.22 16.75 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 16.66 108.873 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.28 -33.74 17.71 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.202 1.934 . . . . 50.0 110.192 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.6 -29.83 70.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.625 . . . . 50.0 110.01 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -81.66 -35.81 29.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.979 -1.076 . . . . 16.66 108.314 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.488 ' CG1' HD21 ' A' ' 31' ' ' LEU . 68.4 t -67.69 -35.87 74.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.045 -0.724 . . . . 50.0 109.045 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -70.65 -37.91 73.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.77 -0.826 . . . . 50.0 108.77 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -67.49 -36.72 81.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.506 -0.746 . . . . 50.0 109.125 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.439 ' O ' HG13 ' A' ' 53' ' ' ILE . 5.5 mtt -60.6 -47.35 86.61 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.259 -0.901 . . . . 16.66 108.749 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.514 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 49.7 mtp -62.17 -47.96 82.18 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 50.0 109.1 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.24 -18.63 27.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.291 -0.881 . . . . 50.0 109.146 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -97.95 -36.15 10.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.777 . . . . 16.66 109.106 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.581 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.4 mt -82.15 -32.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.532 -0.73 . . . . 50.0 109.733 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.9 t0 -58.62 101.31 0.08 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.403 -0.811 . . . . 16.66 109.2 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.469 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 76.8 p -71.07 -47.13 60.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 50.0 110.58 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -85.89 -37.33 19.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.143 -0.973 . . . . 16.66 109.469 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 100.57 28.32 7.14 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.918 -1.135 . . . . 16.66 110.744 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.499 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 9.0 p-10 -80.38 -3.24 48.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.755 -1.438 . . . . 50.0 109.059 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.514 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.76 -3.64 59.08 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.88 -1.288 . . . . 16.66 109.88 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 26.4 m-85 -135.21 157.2 47.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.07 -1.253 . . . . 50.0 111.26 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.543 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 36.6 mm -107.86 129.53 61.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.522 -0.918 . . . . 16.66 108.522 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.18 167.61 10.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.151 -0.968 . . . . 16.66 108.664 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.639 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.5 t80 -54.44 -43.81 71.92 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.113 -1.035 . . . . 16.66 108.526 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -58.26 -50.1 74.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.537 -0.727 . . . . 50.0 109.042 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.543 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 76.6 mt-10 -60.43 -46.41 90.13 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.317 -0.864 . . . . 16.66 109.013 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.564 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 62.0 t80 -62.09 -33.63 74.79 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.041 -0.725 . . . . 16.66 109.041 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.505 HG21 ' NH2' ' A' ' 11' ' ' ARG . 6.4 m -70.12 -48.01 59.35 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.366 -0.834 . . . . 50.0 108.952 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -60.27 -39.05 85.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 50.0 109.304 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.581 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -80.01 -38.53 31.86 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.585 -0.895 . . . . 50.0 108.585 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.522 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -60.69 -25.8 64.02 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.323 -1.511 . . . . 16.66 109.323 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 67' ' ' THR . 69.0 mtm180 -76.8 -35.23 57.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -1.162 . . . . 50.0 109.219 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.04 -17.43 64.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 50.0 109.181 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.446 ' HB2' ' CG ' ' A' ' 76' ' ' LEU . 6.4 p30 -148.03 51.46 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.78 . . . . 50.0 109.219 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 73.3 mtm180 -48.18 -38.17 17.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.242 -0.911 . . . . 50.0 108.704 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.55 -23.6 49.85 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.374 -1.49 . . . . 25.0 109.374 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.446 ' CG ' ' HB2' ' A' ' 73' ' ' ASN . 24.8 mt -77.51 -44.96 27.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -1.101 . . . . 50.0 109.342 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.564 HD23 ' CZ ' ' A' ' 66' ' ' PHE . 19.0 mt -66.89 -21.16 66.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 50.0 109.842 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 30.6 mtmt -80.02 -19.31 47.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.063 -1.023 . . . . 50.0 109.32 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.21 -36.61 16.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -0.827 . . . . 50.0 109.366 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.457 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 85.4 t -71.83 -36.15 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.395 -0.816 . . . . 50.0 108.913 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.41 -49.12 67.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.382 -0.823 . . . . 50.0 109.368 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -62.19 -28.64 69.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.823 . . . . 50.0 109.583 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.517 ' CG2' ' OG1' ' A' ' 37' ' ' THR . 39.9 mt -61.27 -32.42 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -0.968 . . . . 50.0 109.316 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.479 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 17.2 m-85 . . . . . 0 C--N 1.302 -1.498 0 CA-C-O 117.977 -1.011 . . . . 99.989999999999995 109.499 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -93.37 104.3 16.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -123.14 117.99 26.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 25.0 109.468 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.497 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -112.79 172.1 3.8 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 50.0 109.386 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.2 Cg_endo -68.43 -22.64 38.84 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.565 2.177 . . . . 50.0 111.064 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -62.83 -40.48 97.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.402 -0.811 . . . . 25.0 109.222 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.66 -40.87 98.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.3 -0.875 . . . . 50.0 109.284 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -52.44 -36.91 55.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 50.0 109.462 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.26 -46.27 88.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 16.66 108.751 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 14' ' ' ILE . 66.6 mm-40 -66.44 -42.81 87.13 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.911 -0.774 . . . . 16.66 108.911 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.504 ' NH2' HD13 ' A' ' 77' ' ' LEU . 31.7 mtt-85 -65.1 -40.28 94.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.537 -0.727 . . . . 50.0 109.474 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.58 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 49.4 mt-10 -63.85 -40.96 97.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.424 -0.797 . . . . 50.0 109.454 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 2.5 mtt-85 -68.46 -38.93 81.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 50.0 109.105 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 10' ' ' GLU . 29.9 mt -71.31 -45.95 67.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.314 -0.866 . . . . 50.0 109.003 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.578 ' CE1' HD13 ' A' ' 26' ' ' ILE . 68.1 t80 -66.09 -36.07 82.19 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.179 -0.951 . . . . 16.66 109.181 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 39.5 mttt -65.55 -30.5 71.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.289 -0.882 . . . . 50.0 109.113 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -70.29 -37.48 74.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.854 . . . . 50.0 109.007 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.464 ' HB3' HD11 ' A' ' 26' ' ' ILE . 55.5 m-85 -67.56 -48.76 65.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 16.66 109.466 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 23.0 t0 -58.64 103.37 0.15 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 16.66 108.826 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.04 -51.56 37.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 50.0 111.132 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -85.69 -31.14 22.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.724 -1.235 . . . . 16.66 109.672 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 93.83 37.66 5.42 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.748 -1.215 . . . . 16.66 110.321 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.466 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.2 p-10 -93.08 6.37 48.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.042 -1.269 . . . . 16.66 109.207 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.61 -6.37 80.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.49 -1.044 . . . . 16.66 110.49 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.6 pttt -130.05 142.02 50.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.024 -1.28 . . . . 50.0 110.002 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.578 HD13 ' CE1' ' A' ' 15' ' ' PHE . 3.8 mt -112.0 133.22 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.437 0.637 . . . . 16.66 109.443 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.1 p -106.31 168.49 9.11 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.415 -0.803 . . . . 50.0 109.108 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.508 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.49 -46.26 56.87 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.144 -0.973 . . . . 50.0 108.853 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -56.89 -40.31 75.99 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.345 -0.847 . . . . 50.0 109.394 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.489 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.8 mt-10 -75.86 -54.77 6.4 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.267 -0.896 . . . . 16.66 109.122 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.527 ' CD2' HD13 ' A' ' 35' ' ' LEU . 5.7 tt -60.47 -46.88 88.48 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.184 -0.948 . . . . 16.66 108.939 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.509 ' CA ' HG12 ' A' ' 46' ' ' VAL . . . -62.09 -43.1 99.61 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.28 -1.528 . . . . 16.66 109.28 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 5.6 mm-40 -59.68 -41.86 91.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.266 -1.138 . . . . 50.0 110.011 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.38 73.21 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.163 -0.961 . . . . 50.0 108.832 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.537 HD21 ' CD1' ' A' ' 38' ' ' LEU . 12.8 mt -60.64 -30.92 70.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.5 -0.75 . . . . 99.989999999999995 109.798 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -43.73 -26.43 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.987 . . . . 99.989999999999995 109.616 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.496 ' CG2' HG23 ' A' ' 83' ' ' ILE . 6.3 t -52.85 -24.94 10.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.192 -0.942 . . . . 99.989999999999995 109.39 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.537 ' CD1' HD21 ' A' ' 35' ' ' LEU . 5.6 mt -62.38 -32.28 73.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.87 . . . . 50.0 109.269 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.62 6.72 51.4 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.596 -1.402 . . . . 16.66 109.596 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.49 57.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -1.132 . . . . 16.66 109.478 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.47 ' CD1' HD11 ' A' ' 38' ' ' LEU . 11.1 tt -143.38 174.17 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 50.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.9 165.98 25.29 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.304 -0.872 . . . . 16.66 108.82 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -69.43 -33.54 17.61 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.138 1.892 . . . . 50.0 110.132 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -65.07 -24.57 67.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.657 -0.652 . . . . 50.0 110.077 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -82.16 -36.66 27.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.82 -1.175 . . . . 16.66 108.402 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.509 HG12 ' CA ' ' A' ' 32' ' ' GLY . 53.9 t -67.57 -35.64 73.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.563 -0.711 . . . . 50.0 109.145 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -65.72 -39.24 90.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.445 -0.785 . . . . 50.0 109.095 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -67.21 -36.73 82.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.335 -0.853 . . . . 50.0 109.309 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.412 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.3 mtt -61.31 -46.22 91.18 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.183 -0.948 . . . . 16.66 108.774 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.526 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 49.2 mtp -62.56 -48.02 81.31 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.566 -0.709 . . . . 50.0 109.147 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.0 -18.73 36.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 50.0 109.123 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -98.33 -36.5 9.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 16.66 109.175 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.558 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.6 mt -82.08 -32.49 11.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.468 -0.77 . . . . 50.0 109.667 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.48 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.8 t0 -59.51 101.52 0.11 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.349 -0.844 . . . . 16.66 109.038 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.46 ' OG1' ' OE2' ' A' ' 65' ' ' GLU . 61.0 p -68.85 -47.18 66.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -0.875 . . . . 50.0 110.658 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -86.79 -39.1 16.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 16.66 109.448 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.48 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 102.08 28.01 6.7 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.878 -1.153 . . . . 16.66 110.444 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.3 p-10 -79.02 -2.35 39.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.786 -1.42 . . . . 50.0 109.016 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.526 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.35 -2.91 59.47 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.709 -1.357 . . . . 16.66 109.709 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 25.5 m-85 -136.47 157.57 46.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.086 -1.244 . . . . 50.0 111.376 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.56 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 29.1 mm -109.76 130.24 63.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.565 -0.902 . . . . 16.66 108.565 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -97.64 168.41 10.36 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.133 -0.979 . . . . 16.66 108.599 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.58 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 37.7 t80 -55.36 -43.28 74.91 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.031 -1.043 . . . . 16.66 108.718 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -60.6 -46.4 90.4 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.553 -0.717 . . . . 50.0 109.31 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.56 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 76.7 mt-10 -62.05 -46.83 87.4 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.285 -0.884 . . . . 16.66 109.096 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.572 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 49.8 t80 -61.06 -40.52 93.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.444 -0.785 . . . . 16.66 109.25 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.1 m -64.74 -47.32 78.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.362 -0.837 . . . . 50.0 109.209 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -58.45 -38.46 77.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 50.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.91 -35.57 50.5 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.642 -0.873 . . . . 50.0 108.642 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.14 -29.91 63.26 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.302 -1.519 . . . . 16.66 109.302 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 67' ' ' THR . 83.0 mtm180 -71.51 -29.63 65.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.124 . . . . 50.0 109.165 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' A' ' 73' ' ' ASN . . . -70.41 -21.04 62.88 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.335 -0.853 . . . . 50.0 109.278 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 72' ' ' ALA . 2.4 m-80 -152.1 56.06 0.83 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 50.0 109.299 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -48.71 -38.53 21.77 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.705 -0.85 . . . . 50.0 108.705 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.08 -30.23 63.5 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.329 -1.508 . . . . 25.0 109.329 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.427 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 32.3 mt -69.39 -45.69 68.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -1.085 . . . . 50.0 109.464 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.572 HD23 ' CZ ' ' A' ' 66' ' ' PHE . 25.4 mt -63.68 -23.11 67.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.814 . . . . 50.0 109.902 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -79.97 -18.54 50.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.105 -0.997 . . . . 50.0 109.49 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.65 -33.39 27.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 50.0 109.3 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 t -85.36 -27.9 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.853 . . . . 50.0 109.147 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.16 -16.05 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 50.0 109.597 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -94.34 -32.92 13.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 50.0 109.275 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.496 HG23 ' CG2' ' A' ' 37' ' ' THR . 10.0 mt -58.2 -36.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.366 -0.834 . . . . 50.0 109.35 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.019 -0.991 . . . . 99.989999999999995 109.437 -179.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -115.02 83.82 1.97 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.19 -0.944 . . . . 0.0 109.49 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.05 120.91 30.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 25.0 109.451 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.475 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -118.12 171.05 5.5 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.185 -0.947 . . . . 50.0 109.417 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.8 Cg_endo -68.99 -22.76 35.16 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.645 2.23 . . . . 50.0 110.979 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -61.61 -38.82 89.02 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.438 -0.788 . . . . 25.0 109.107 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -57.6 -46.32 84.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.429 -0.794 . . . . 50.0 109.32 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -49.43 -36.41 22.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 50.0 109.6 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.79 -45.68 89.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.307 -0.871 . . . . 16.66 108.715 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.48 ' O ' HG13 ' A' ' 14' ' ' ILE . 67.2 mt-10 -68.2 -40.45 82.17 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.46 -0.775 . . . . 16.66 109.007 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.578 ' NH2' ' CG2' ' A' ' 67' ' ' THR . 46.5 mtm180 -68.07 -39.95 82.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.37 -0.831 . . . . 50.0 109.33 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.572 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 43.3 mt-10 -66.75 -41.84 87.15 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.478 -0.763 . . . . 50.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 13.3 mtp180 -65.63 -40.84 92.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.28 -0.888 . . . . 50.0 109.201 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 10' ' ' GLU . 30.7 mt -70.26 -46.94 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.305 -0.872 . . . . 50.0 108.91 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.568 ' CE2' HD13 ' A' ' 26' ' ' ILE . 53.4 t80 -66.32 -34.99 79.24 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.216 -0.928 . . . . 16.66 108.918 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 55.0 mttm -65.15 -34.27 78.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.366 -0.834 . . . . 50.0 109.392 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.569 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -74.48 -26.11 59.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.895 . . . . 50.0 109.227 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.558 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 23.3 m-85 -73.45 -43.21 60.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 16.66 109.057 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 22.6 t0 -63.72 103.26 0.53 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.334 -0.854 . . . . 16.66 108.757 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.13 64.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.161 -0.962 . . . . 50.0 111.248 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -89.49 -27.18 20.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.727 -1.233 . . . . 16.66 109.705 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 89.66 35.1 8.01 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.096 -1.201 . . . . 16.66 110.096 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 37.1 p-10 -88.85 4.04 49.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -1.198 . . . . 16.66 109.21 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.99 -5.76 72.47 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.381 -1.087 . . . . 16.66 110.381 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.5 pttp -132.34 143.32 49.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.948 -1.325 . . . . 50.0 110.068 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.568 HD13 ' CE2' ' A' ' 15' ' ' PHE . 6.8 mt -111.46 134.54 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.652 -0.655 . . . . 16.66 109.45 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.5 p -106.61 166.22 10.72 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.299 -0.876 . . . . 50.0 108.712 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.5 -45.6 47.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.041 -1.037 . . . . 50.0 108.843 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.19 75.82 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.363 -0.836 . . . . 50.0 109.521 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.498 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.8 mt-10 -75.82 -54.51 6.81 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.198 -0.939 . . . . 16.66 109.291 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.453 ' HG ' HD11 ' A' ' 35' ' ' LEU . 58.3 tp -61.84 -43.05 99.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 16.66 108.955 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.46 ' HA3' HG23 ' A' ' 46' ' ' VAL . . . -62.27 -44.29 97.89 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.233 -1.547 . . . . 16.66 109.233 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -58.54 -43.23 89.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.308 -1.113 . . . . 50.0 109.724 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.564 ' CB ' ' NH2' ' A' ' 17' ' ' ARG . . . -73.06 -40.73 64.83 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.088 -1.007 . . . . 50.0 108.333 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.453 HD11 ' HG ' ' A' ' 31' ' ' LEU . 7.5 mt -58.64 -32.61 69.21 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.568 -0.707 . . . . 99.989999999999995 109.423 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -44.98 -26.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 99.989999999999995 109.423 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 t -49.17 -24.87 1.88 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 99.989999999999995 109.026 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.515 ' CD1' HD11 ' A' ' 41' ' ' ILE . 16.7 mt -58.87 -33.45 70.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.499 -0.751 . . . . 50.0 109.101 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.06 -0.39 58.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.885 -1.286 . . . . 16.66 109.885 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.07 58.62 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.251 . . . . 16.66 109.965 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 38' ' ' LEU . 10.8 tt -138.1 173.18 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.098 -1.001 . . . . 50.0 109.528 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.27 163.02 40.69 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.642 -0.873 . . . . 16.66 108.642 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.15 -33.27 25.34 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.009 1.806 . . . . 50.0 110.083 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.92 -26.29 68.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.636 -0.665 . . . . 50.0 109.95 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -82.1 -36.87 27.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.855 -1.153 . . . . 16.66 108.431 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.46 HG23 ' HA3' ' A' ' 32' ' ' GLY . 47.1 t -68.96 -36.67 75.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.038 -0.727 . . . . 50.0 109.038 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -65.65 -40.15 92.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.475 -0.766 . . . . 50.0 109.028 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -65.48 -40.89 93.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 50.0 109.257 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.1 mtt -58.68 -43.52 89.99 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.243 -0.911 . . . . 16.66 108.817 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.525 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 31.7 mtp -61.45 -47.55 85.18 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.451 -0.781 . . . . 50.0 109.245 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.04 -20.56 54.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 50.0 109.28 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -95.4 -36.35 11.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.398 -0.814 . . . . 16.66 109.047 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.559 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.4 mt -81.92 -31.46 10.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 50.0 109.699 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.9 t0 -60.93 101.46 0.15 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.439 -0.788 . . . . 16.66 108.989 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.464 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 55.6 p -69.72 -46.1 66.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 50.0 110.71 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.492 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.0 p-10 -87.6 -40.32 14.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.106 -0.996 . . . . 16.66 109.502 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 102.95 29.67 5.73 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.932 -1.128 . . . . 16.66 110.523 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.492 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.8 p-10 -81.41 -3.74 53.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.865 -1.374 . . . . 50.0 109.144 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.525 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.66 -3.41 57.57 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.857 -1.297 . . . . 16.66 109.857 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.573 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.8 m-85 -135.85 156.58 48.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.059 -1.259 . . . . 50.0 111.15 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.548 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 35.0 mm -108.88 129.91 62.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.397 -0.964 . . . . 16.66 108.397 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.55 167.42 10.6 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.057 -1.027 . . . . 16.66 108.812 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.5 t80 -54.21 -43.62 70.94 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.297 -0.961 . . . . 16.66 108.521 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -58.93 -47.9 83.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.525 -0.735 . . . . 50.0 109.085 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.548 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 81.2 mt-10 -62.34 -46.94 86.4 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.288 -0.883 . . . . 16.66 109.119 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.534 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 51.2 t80 -59.52 -39.14 82.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.426 -0.796 . . . . 16.66 109.103 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.578 ' CG2' ' NH2' ' A' ' 11' ' ' ARG . 18.0 m -66.42 -46.68 75.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 50.0 109.089 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.0 -40.76 85.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 50.0 109.246 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.559 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -75.89 -36.8 59.37 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.566 -0.901 . . . . 50.0 108.566 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.409 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -58.96 -34.17 77.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.2 -1.56 . . . . 16.66 109.2 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 67' ' ' THR . 74.4 mtm180 -65.95 -33.48 75.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -1.12 . . . . 50.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.438 ' O ' ' OD1' ' A' ' 73' ' ' ASN . . . -67.68 -20.99 65.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.834 . . . . 50.0 109.301 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.524 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 2.7 m-80 -152.24 56.43 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 50.0 109.162 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -49.6 -37.09 26.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.334 -0.854 . . . . 50.0 108.736 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.37 -31.16 69.33 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.22 -1.552 . . . . 25.0 109.22 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.524 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 50.6 mt -67.26 -44.88 78.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -1.09 . . . . 50.0 109.419 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.534 HD23 ' CZ ' ' A' ' 66' ' ' PHE . 19.9 mt -63.77 -31.43 72.61 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.321 -0.862 . . . . 50.0 109.766 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -64.58 -27.13 68.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 50.0 109.255 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -76.26 -34.65 59.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 50.0 109.517 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.4 t -81.03 -31.22 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 50.0 109.601 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.4 -19.02 64.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 50.0 109.691 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -89.39 -30.57 18.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 50.0 109.137 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.8 mt -64.97 -36.59 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.382 -0.824 . . . . 50.0 109.24 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.569 ' CE1' ' NH2' ' A' ' 17' ' ' ARG . 61.2 m-85 . . . . . 0 C--N 1.302 -1.483 0 CA-C-O 117.99 -1.005 . . . . 99.989999999999995 109.544 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 40.0 p30 -83.47 -8.98 59.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.525 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -64.35 147.66 52.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 25.0 109.442 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.536 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -114.2 174.24 2.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.289 -0.882 . . . . 50.0 109.236 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 47.7 Cg_endo -69.16 -22.5 34.75 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.506 2.137 . . . . 50.0 111.335 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -62.63 -43.85 97.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.411 -0.805 . . . . 25.0 109.346 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -57.69 -41.22 81.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 50.0 109.394 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -53.29 -35.92 60.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 50.0 109.196 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 -45.74 90.26 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.853 -0.795 . . . . 16.66 108.853 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.476 ' O ' HG13 ' A' ' 14' ' ' ILE . 59.7 mm-40 -68.53 -40.55 80.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 16.66 108.832 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.509 ' NH1' HG21 ' A' ' 67' ' ' THR . 19.8 mtm180 -68.11 -38.95 82.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.458 -0.776 . . . . 50.0 109.377 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.641 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 8.7 mt-10 -68.03 -39.83 83.01 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.433 -0.792 . . . . 50.0 109.346 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 5.6 mtt180 -67.08 -40.53 87.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.293 -0.879 . . . . 50.0 109.267 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.6 mt -70.28 -46.62 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.383 -0.823 . . . . 50.0 108.865 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.561 ' CE1' HD13 ' A' ' 26' ' ' ILE . 70.5 t80 -63.56 -35.74 81.48 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.339 -0.851 . . . . 16.66 109.097 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -66.19 -30.43 70.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 50.0 109.229 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 74.8 mtt180 -69.17 -38.1 78.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 50.0 109.256 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.464 ' HB2' HD12 ' A' ' 26' ' ' ILE . 67.2 m-85 -67.42 -49.13 65.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 16.66 109.49 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 24.1 t0 -56.48 103.48 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 16.66 108.746 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.91 -51.56 46.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.274 -0.891 . . . . 50.0 111.247 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -86.92 -30.0 21.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.719 -1.238 . . . . 16.66 109.856 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 92.95 37.39 5.73 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.777 -1.202 . . . . 16.66 110.179 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.473 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 37.7 p-10 -92.87 5.38 51.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -1.2 . . . . 16.66 109.243 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.95 -7.01 76.83 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.138 -1.03 . . . . 16.66 110.568 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.1 pttm -130.49 142.25 50.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.908 -1.348 . . . . 50.0 109.872 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.561 HD13 ' CE1' ' A' ' 15' ' ' PHE . 5.1 mt -111.93 133.22 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.36 0.6 . . . . 16.66 109.527 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.9 p -105.02 166.83 10.11 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.856 -0.794 . . . . 50.0 108.856 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.1 -45.29 52.58 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.157 -0.965 . . . . 50.0 108.887 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.39 78.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.317 -0.865 . . . . 50.0 109.474 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.7 mt-10 -74.99 -54.3 7.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.165 -0.959 . . . . 16.66 109.334 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.509 ' CD2' ' C ' ' A' ' 31' ' ' LEU . 1.9 tt -61.94 -43.98 97.71 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.283 -0.886 . . . . 16.66 108.798 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -63.66 -44.48 96.36 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.191 -1.564 . . . . 16.66 109.191 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -59.82 -41.45 91.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.324 -1.104 . . . . 50.0 109.892 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.98 -39.87 68.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.129 -0.982 . . . . 50.0 108.732 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.504 HD13 ' CD2' ' A' ' 31' ' ' LEU . 8.4 mt -60.21 -30.83 69.64 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.5 -0.75 . . . . 99.989999999999995 109.865 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -44.31 -25.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -1.0 . . . . 99.989999999999995 109.865 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.508 ' CG2' HG22 ' A' ' 83' ' ' ILE . 6.6 t -50.77 -23.15 2.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 109.22 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.526 ' CD1' HD11 ' A' ' 41' ' ' ILE . 25.6 mt -60.74 -33.69 73.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 50.0 109.312 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.46 -0.74 59.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.777 -1.329 . . . . 16.66 109.777 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 40' ' ' SER . 2.3 t -155.25 66.45 0.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.114 -1.227 . . . . 16.66 109.654 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.526 HD11 ' CD1' ' A' ' 38' ' ' LEU . 14.2 tt -149.26 168.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.141 -0.974 . . . . 50.0 109.598 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.83 163.9 22.24 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 16.66 108.872 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 49.8 Cg_endo -70.66 -30.7 17.72 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.078 1.852 . . . . 50.0 109.94 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.75 -23.49 66.1 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.54 -0.725 . . . . 50.0 110.078 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -79.87 -35.13 38.57 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.891 -1.13 . . . . 16.66 108.505 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.474 HG23 ' CD1' ' A' ' 35' ' ' LEU . 55.0 t -69.39 -35.75 68.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.909 -0.774 . . . . 50.0 108.909 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 82.7 mttt -62.36 -40.25 95.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.432 -0.792 . . . . 50.0 108.994 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.37 -39.42 92.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.433 -0.792 . . . . 50.0 109.299 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.448 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.9 mtt -59.48 -45.2 92.34 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.239 -0.913 . . . . 16.66 108.854 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.52 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 50.1 mtp -62.27 -48.68 78.83 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.439 -0.788 . . . . 50.0 109.122 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.7 -19.02 24.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 50.0 109.362 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -99.78 -36.3 9.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 16.66 109.306 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.582 HG12 ' CD2' ' A' ' 69' ' ' PHE . 80.2 mt -82.5 -32.93 10.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.451 -0.781 . . . . 50.0 109.816 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.7 t0 -59.52 101.23 0.1 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.289 -0.882 . . . . 16.66 108.999 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 54.6 p -66.19 -46.37 77.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 50.0 110.64 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -88.85 -42.18 12.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 16.66 109.634 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.484 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 104.14 29.82 5.31 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.203 -1.159 . . . . 16.66 110.203 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.483 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 13.0 p-10 -80.46 -2.45 45.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.983 -1.304 . . . . 50.0 109.134 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.52 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 100.04 -3.47 57.05 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.767 -1.333 . . . . 16.66 109.767 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 30.6 m-85 -137.01 156.35 48.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.006 -1.291 . . . . 50.0 111.49 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.536 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 25.5 mm -109.67 130.68 62.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.308 -0.997 . . . . 16.66 108.308 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 m -99.47 168.7 9.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.023 -1.048 . . . . 16.66 108.714 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.641 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 36.5 t80 -54.97 -43.44 73.5 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.169 -1.012 . . . . 16.66 108.655 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -59.92 -48.63 80.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.608 -0.683 . . . . 50.0 109.237 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.536 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 79.6 mt-10 -60.6 -47.03 88.02 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.291 -0.881 . . . . 16.66 109.064 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -63.18 -32.66 74.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.437 -0.789 . . . . 16.66 109.255 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.509 HG21 ' NH1' ' A' ' 11' ' ' ARG . 51.9 m -68.26 -49.11 62.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 50.0 109.302 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -59.35 -36.9 76.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.26 -0.9 . . . . 50.0 109.381 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.582 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.74 -37.5 41.12 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.494 -0.928 . . . . 50.0 108.494 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.528 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -58.69 -29.2 63.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.197 -1.561 . . . . 16.66 109.197 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 67' ' ' THR . 80.5 mtm180 -71.3 -33.12 69.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.348 -1.089 . . . . 50.0 109.051 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.35 -20.81 65.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.832 . . . . 50.0 109.273 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.456 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 7.8 m-80 -146.24 58.37 1.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.396 -0.815 . . . . 50.0 109.114 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 65.9 mtm180 -51.35 -37.58 48.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 50.0 108.922 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.37 -27.82 70.01 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.348 -1.501 . . . . 25.0 109.348 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.456 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 22.4 mt -69.07 -45.38 70.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.387 -1.067 . . . . 50.0 109.67 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.528 ' CD1' ' HA2' ' A' ' 70' ' ' GLY . 4.3 mt -70.38 -19.41 63.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.389 -0.819 . . . . 50.0 109.874 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 40.7 mtmt -80.02 -27.05 39.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.104 -0.997 . . . . 50.0 109.508 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -91.41 -43.12 9.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 50.0 109.507 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.4 p -59.58 -45.46 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.776 0.798 . . . . 50.0 109.105 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.552 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -48.78 -38.33 21.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.716 -0.615 . . . . 50.0 109.85 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -69.58 -24.8 63.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 50.0 109.602 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.508 HG22 ' CG2' ' A' ' 37' ' ' THR . 13.6 mt -64.26 -45.43 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.383 -0.823 . . . . 50.0 109.556 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.461 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 80.1 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.02 -0.99 . . . . 99.989999999999995 109.362 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -88.16 8.24 27.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 109.496 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -91.64 111.56 23.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 25.0 109.542 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.525 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -123.43 173.92 4.01 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.285 -0.884 . . . . 50.0 109.128 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.8 Cg_endo -68.61 -22.99 37.16 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.555 2.17 . . . . 50.0 111.34 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -63.39 -37.64 88.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.351 -0.843 . . . . 25.0 109.191 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.4 -41.95 94.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.393 -0.817 . . . . 50.0 109.233 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -52.02 -36.91 51.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.429 -0.794 . . . . 50.0 109.387 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.99 -46.16 85.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.567 -0.901 . . . . 16.66 108.567 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 14' ' ' ILE . 64.9 mt-10 -67.73 -39.52 84.25 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.854 -0.795 . . . . 16.66 108.854 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.41 ' NH1' ' HG ' ' A' ' 77' ' ' LEU . 55.2 mtt-85 -65.96 -40.4 91.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 50.0 109.336 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.565 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 44.0 mt-10 -64.86 -40.43 95.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.412 -0.805 . . . . 50.0 109.228 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 65.4 mtp180 -67.52 -40.48 85.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.347 -0.846 . . . . 50.0 109.236 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 10' ' ' GLU . 22.0 mt -70.37 -45.23 75.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.363 -0.835 . . . . 50.0 108.906 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 26' ' ' ILE . 63.7 t80 -64.52 -36.03 82.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.273 -0.892 . . . . 16.66 109.008 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -65.76 -30.19 70.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.368 -0.832 . . . . 50.0 109.147 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 49.7 mtt85 -71.35 -34.76 70.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 50.0 109.22 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.576 ' CE1' HD13 ' A' ' 31' ' ' LEU . 42.9 m-85 -72.83 -47.98 41.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.418 -0.801 . . . . 16.66 109.432 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 24.7 t0 -59.22 103.28 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 16.66 108.499 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 -51.72 51.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.891 . . . . 50.0 111.426 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -87.7 -26.14 23.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.754 -1.216 . . . . 16.66 109.799 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 88.04 38.57 7.3 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.747 -1.216 . . . . 16.66 110.091 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -92.84 5.43 51.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -1.215 . . . . 16.66 109.206 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.09 -7.54 72.89 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.346 -1.101 . . . . 16.66 110.346 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 35.5 pttt -130.37 142.23 50.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.927 -1.337 . . . . 50.0 110.023 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.575 HD13 ' CE2' ' A' ' 15' ' ' PHE . 5.9 mt -112.33 134.22 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.63 -0.669 . . . . 16.66 109.39 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.427 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 17.8 p -107.21 167.64 9.77 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.36 -0.837 . . . . 50.0 108.823 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.513 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.28 -45.99 54.86 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.046 -1.034 . . . . 50.0 108.823 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.16 74.29 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.349 -0.844 . . . . 50.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.5 mt-10 -77.14 -54.17 6.85 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -0.947 . . . . 16.66 109.321 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.576 HD13 ' CE1' ' A' ' 18' ' ' PHE . 32.3 tp -63.12 -41.76 99.4 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.202 -0.936 . . . . 16.66 108.93 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.492 ' CA ' HG13 ' A' ' 46' ' ' VAL . . . -64.6 -44.9 94.37 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.199 -1.56 . . . . 16.66 109.199 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -59.07 -41.84 88.91 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.346 -1.091 . . . . 50.0 109.709 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.96 -40.2 65.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.161 -0.962 . . . . 50.0 108.554 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.458 HD11 ' CG2' ' A' ' 46' ' ' VAL . 11.3 mt -60.69 -31.22 70.49 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.52 -0.738 . . . . 99.989999999999995 109.564 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' LEU . 5.3 mttt -45.53 -25.56 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.018 -1.051 . . . . 99.989999999999995 109.48 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.525 ' CG2' HG22 ' A' ' 83' ' ' ILE . 9.6 t -52.04 -23.78 5.74 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.916 . . . . 99.989999999999995 109.183 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.405 HD13 HD21 ' A' ' 35' ' ' LEU . 9.2 mt -59.49 -33.27 71.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.352 -0.843 . . . . 50.0 109.216 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.13 0.75 57.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.719 -1.352 . . . . 16.66 109.719 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 t -154.72 64.64 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -1.204 . . . . 16.66 109.711 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.3 tt -147.09 175.6 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 50.0 109.42 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.91 164.52 34.54 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.254 -0.903 . . . . 16.66 108.781 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 46.7 Cg_endo -69.21 -33.27 19.07 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.117 1.878 . . . . 50.0 110.142 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -66.75 -22.86 66.04 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.25 -0.58 . . . . 50.0 110.102 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -82.33 -39.66 22.51 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.883 -1.135 . . . . 16.66 108.398 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.492 HG13 ' CA ' ' A' ' 32' ' ' GLY . 67.2 t -65.66 -35.91 76.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.69 -0.855 . . . . 50.0 108.69 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 81.4 mttt -67.17 -39.73 86.48 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.909 -0.774 . . . . 50.0 108.909 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.13 -40.92 91.03 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.428 -0.795 . . . . 50.0 109.183 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.434 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.9 mtt -59.65 -44.3 93.59 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.21 -0.931 . . . . 16.66 108.868 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.518 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 28.1 mtp -61.69 -47.15 86.6 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -0.762 . . . . 50.0 109.128 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.75 -22.07 44.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 50.0 109.141 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.19 -35.95 12.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 16.66 108.989 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 69' ' ' PHE . 85.6 mt -80.77 -30.95 12.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.47 -0.769 . . . . 50.0 109.438 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.486 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.1 t0 -61.04 100.78 0.12 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.465 -0.772 . . . . 16.66 109.027 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.494 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 60.7 p -71.41 -46.5 60.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.288 -0.883 . . . . 50.0 110.436 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -31.02 22.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.135 -0.978 . . . . 16.66 109.534 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.486 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 93.11 28.31 12.05 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.847 -1.168 . . . . 16.66 110.222 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.8 -2.94 55.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.93 -1.335 . . . . 50.0 109.414 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.47 -7.12 59.59 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.999 -1.096 . . . . 16.66 110.457 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 42.1 m-85 -133.76 155.83 49.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.895 -1.356 . . . . 50.0 111.23 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.539 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 28.6 mm -106.68 127.81 61.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.516 -0.92 . . . . 16.66 108.516 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.53 166.27 12.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.158 -0.964 . . . . 16.66 108.626 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.565 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 35.8 t80 -54.3 -41.96 69.54 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.085 -1.009 . . . . 16.66 108.588 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -61.42 -49.68 75.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.969 -0.752 . . . . 50.0 108.969 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.539 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 33.9 mt-10 -58.28 -47.21 84.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 16.66 109.023 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.571 ' CZ ' HD12 ' A' ' 77' ' ' LEU . 63.6 t80 -61.48 -40.48 94.71 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.52 -0.737 . . . . 16.66 109.294 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.42 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 13.3 m -65.16 -47.04 78.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.405 -0.809 . . . . 50.0 109.242 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -59.72 -37.79 79.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 50.0 109.349 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.555 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.71 -37.42 41.53 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.264 -0.897 . . . . 50.0 108.703 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.415 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -60.64 -28.9 68.63 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.361 -1.496 . . . . 16.66 109.361 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 67' ' ' THR . 67.8 mtm180 -73.3 -34.54 65.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -1.126 . . . . 50.0 109.24 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.83 -17.71 65.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 50.0 109.341 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.499 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 2.2 m-80 -148.33 55.28 1.03 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 50.0 109.275 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HG3' ' N ' ' A' ' 75' ' ' GLY . 10.4 ptm180 -50.58 -41.42 54.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 50.0 108.806 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 74' ' ' ARG . . . -54.38 -20.2 15.45 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.343 -1.503 . . . . 25.0 109.343 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.499 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 48.5 mt -80.02 -43.0 22.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.313 -1.11 . . . . 50.0 109.373 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.8 mm? -61.27 -41.15 96.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.468 -0.77 . . . . 50.0 109.82 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.7 mtpp -63.05 -38.4 91.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 50.0 109.378 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -73.48 -49.44 26.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.41 -0.806 . . . . 50.0 109.57 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.1 p -66.05 -43.17 92.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.372 -0.83 . . . . 50.0 109.589 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.534 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.25 -39.74 45.85 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.225 -0.59 . . . . 50.0 109.884 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 34.9 mttm -66.86 -26.02 66.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.935 . . . . 50.0 109.686 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.525 HG22 ' CG2' ' A' ' 37' ' ' THR . 8.2 mt -63.17 -45.22 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 50.0 109.466 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.467 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 92.1 m-85 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.997 -1.001 . . . . 99.989999999999995 109.435 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -82.63 -8.75 59.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.561 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.76 119.62 12.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 25.0 109.488 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.48 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -111.31 170.9 4.78 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 50.0 109.325 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.1 Cg_endo -67.16 -22.65 46.74 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.543 2.162 . . . . 50.0 111.079 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -63.96 -35.39 80.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 25.0 109.032 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' HB3' ' NH1' ' A' ' 11' ' ' ARG . 59.3 m-20 -58.67 -45.94 88.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.329 -0.857 . . . . 50.0 109.3 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -50.39 -37.48 37.77 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.437 -0.789 . . . . 50.0 109.359 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.99 -45.23 79.07 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.476 -0.935 . . . . 16.66 108.476 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.449 ' O ' HG13 ' A' ' 14' ' ' ILE . 53.0 mt-10 -65.44 -45.35 84.13 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.908 -0.775 . . . . 16.66 108.908 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.465 ' NH1' ' HB3' ' A' ' 7' ' ' ASP . 41.9 mtt180 -63.08 -40.93 99.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.395 -0.815 . . . . 50.0 109.395 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.558 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 7.4 mt-10 -64.88 -43.49 92.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.428 -0.795 . . . . 50.0 109.407 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.6 mtt180 -65.94 -41.36 91.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.888 . . . . 50.0 109.13 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 10' ' ' GLU . 26.0 mt -69.74 -44.53 79.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.302 -0.874 . . . . 50.0 109.19 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.577 ' CE2' HD13 ' A' ' 26' ' ' ILE . 62.0 t80 -66.91 -35.96 81.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.167 -0.958 . . . . 16.66 109.258 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -63.95 -32.4 73.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 50.0 109.383 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 62.7 mtt180 -70.88 -37.15 73.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 50.0 109.047 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.523 ' HB3' ' CD1' ' A' ' 26' ' ' ILE . 33.8 m-85 -68.43 -47.0 68.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 16.66 109.595 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.479 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 22.6 t0 -62.52 103.44 0.41 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 16.66 108.937 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.21 -50.88 43.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 50.0 111.213 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -86.34 -31.09 21.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.714 -1.241 . . . . 16.66 109.688 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.479 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 93.94 36.48 5.76 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.805 -1.188 . . . . 16.66 110.27 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.473 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.6 p-10 -92.02 4.01 53.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.074 -1.25 . . . . 16.66 109.377 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.78 -6.15 73.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.367 -1.093 . . . . 16.66 110.367 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 10.1 pttm -131.32 143.02 50.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.926 -1.338 . . . . 50.0 109.991 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.577 HD13 ' CE2' ' A' ' 15' ' ' PHE . 4.6 mt -111.97 133.64 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.462 0.648 . . . . 16.66 109.645 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.444 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 13.3 p -106.67 167.97 9.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.473 -0.767 . . . . 50.0 108.947 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.38 -46.35 56.0 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.066 -1.021 . . . . 50.0 108.822 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -56.31 -40.89 75.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.309 -0.869 . . . . 50.0 109.441 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.3 mt-10 -75.19 -54.44 7.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.23 -0.919 . . . . 16.66 109.251 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.53 ' CD2' HD11 ' A' ' 35' ' ' LEU . 7.2 tt -60.35 -45.27 94.08 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.295 -0.878 . . . . 16.66 108.799 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.503 ' CA ' HG12 ' A' ' 46' ' ' VAL . . . -63.21 -45.03 96.18 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.048 -1.621 . . . . 16.66 109.048 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 16.8 mt-10 -57.13 -42.89 81.77 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.329 -1.1 . . . . 50.0 109.579 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.06 -39.95 65.47 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.133 -0.979 . . . . 50.0 108.379 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.53 HD11 ' CD2' ' A' ' 31' ' ' LEU . 5.3 mt -59.16 -33.04 70.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.599 -0.688 . . . . 99.989999999999995 109.6 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -44.64 -26.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.076 -1.015 . . . . 99.989999999999995 109.455 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.493 ' CG2' HG22 ' A' ' 83' ' ' ILE . 8.5 t -53.11 -25.53 13.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 99.989999999999995 109.363 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.449 HD13 HD21 ' A' ' 35' ' ' LEU . 20.5 mt -61.31 -32.34 72.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 50.0 109.151 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.3 9.76 44.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.591 -1.404 . . . . 16.66 109.591 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.54 51.35 0.51 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -1.184 . . . . 16.66 109.444 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.424 HD11 HD13 ' A' ' 38' ' ' LEU . 5.5 tt -140.08 175.82 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 50.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.2 167.37 19.05 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.344 -0.848 . . . . 16.66 108.825 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.96 -34.41 17.44 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.972 1.782 . . . . 50.0 110.028 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.81 -29.24 70.03 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.711 -0.618 . . . . 50.0 109.919 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -80.87 -38.8 27.48 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.999 -1.063 . . . . 16.66 108.214 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.503 HG12 ' CA ' ' A' ' 32' ' ' GLY . 47.9 t -63.73 -36.97 78.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.023 -0.732 . . . . 50.0 109.023 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -70.23 -37.38 74.97 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.761 -0.829 . . . . 50.0 108.761 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.517 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.3 t60 -67.46 -37.75 83.41 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.347 -0.846 . . . . 50.0 109.203 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.402 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.3 mtt -60.93 -46.76 89.4 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.092 -1.005 . . . . 16.66 108.871 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.512 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 38.9 mtp -61.74 -47.64 84.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.537 -0.727 . . . . 50.0 109.213 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.03 -19.58 45.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 50.0 109.469 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.433 ' CD ' ' NE2' ' A' ' 48' ' ' HIS . 26.8 mt-10 -97.24 -35.8 10.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 16.66 109.108 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.558 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.6 mt -81.87 -32.5 11.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 50.0 109.658 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.481 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 20.4 t0 -59.11 101.37 0.09 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.352 -0.842 . . . . 16.66 109.094 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 46.5 p -69.54 -46.19 67.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.222 -0.924 . . . . 50.0 110.584 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.489 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -87.48 -38.13 16.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.967 . . . . 16.66 109.456 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.481 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 101.06 27.93 7.13 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.993 -1.099 . . . . 16.66 110.581 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.489 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 p-10 -79.45 -2.24 41.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.768 -1.43 . . . . 50.0 109.079 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.512 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.86 -4.97 59.5 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.996 -1.242 . . . . 16.66 109.996 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 28.1 m-85 -134.7 157.48 46.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.029 -1.277 . . . . 50.0 111.259 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.549 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 29.9 mm -108.59 128.17 64.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.172 -1.047 . . . . 16.66 108.172 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 m -94.54 169.56 10.11 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.143 -0.973 . . . . 16.66 108.761 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.558 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 33.0 t80 -56.34 -43.22 78.84 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.223 -0.923 . . . . 16.66 108.943 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -62.53 -44.83 95.38 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.594 -0.691 . . . . 50.0 109.219 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.549 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 55.1 mt-10 -62.17 -47.43 84.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 16.66 109.157 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -62.65 -36.12 81.82 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.398 -0.814 . . . . 16.66 109.296 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.7 m -68.4 -47.16 68.05 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.29 -0.881 . . . . 50.0 109.148 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 71' ' ' ARG . 74.2 m-20 -58.95 -36.75 75.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 50.0 109.307 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.31 -36.48 53.99 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.496 -0.927 . . . . 50.0 108.496 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.514 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -58.02 -30.48 63.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.109 -1.597 . . . . 16.66 109.109 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.518 ' NH2' ' OD1' ' A' ' 68' ' ' ASP . 52.2 mtm180 -69.18 -30.75 69.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -1.067 . . . . 50.0 108.928 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.66 -21.66 63.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.441 -0.787 . . . . 50.0 109.261 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.431 ' CB ' HD13 ' A' ' 76' ' ' LEU . 2.4 m-80 -150.58 57.01 0.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.392 -0.818 . . . . 50.0 109.192 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 7.0 ptp85 -49.27 -36.99 22.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.284 -0.885 . . . . 50.0 108.781 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.439 ' HA3' ' HE2' ' A' ' 78' ' ' LYS . . . -60.34 -30.38 71.09 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.294 -1.522 . . . . 25.0 109.294 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.431 HD13 ' CB ' ' A' ' 73' ' ' ASN . 30.7 mt -68.39 -45.57 72.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -1.081 . . . . 50.0 109.485 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.514 ' CD1' ' HA2' ' A' ' 70' ' ' GLY . 17.4 mt -65.17 -19.43 65.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 50.0 109.678 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 10.6 mtmm -79.54 -21.02 45.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 50.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.1 -40.63 13.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.926 . . . . 50.0 109.37 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 1.4 p -71.97 -38.48 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.469 -0.769 . . . . 50.0 109.339 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.448 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -59.77 -14.81 16.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.66 -0.65 . . . . 50.0 109.703 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 48.6 mttp -98.17 -30.47 12.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.175 -0.953 . . . . 50.0 109.093 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.493 HG22 ' CG2' ' A' ' 37' ' ' THR . 8.3 mt -56.09 -30.32 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.43 -0.794 . . . . 50.0 109.3 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.956 -1.021 . . . . 99.989999999999995 109.487 179.875 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -81.77 6.58 15.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -73.57 126.92 31.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 25.0 109.457 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.496 ' CE1' ' OD1' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -111.49 170.04 5.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 50.0 109.471 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.3 Cg_endo -67.93 -22.72 41.78 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.608 2.205 . . . . 50.0 111.005 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -62.28 -39.63 93.59 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.43 -0.794 . . . . 25.0 109.091 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' OD1' ' CE1' ' A' ' 4' ' ' HIS . 91.5 m-20 -55.24 -46.34 76.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.402 -0.811 . . . . 50.0 109.333 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -49.62 -37.01 26.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.444 -0.785 . . . . 50.0 109.342 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.47 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.75 -46.01 85.08 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.709 -0.848 . . . . 16.66 108.709 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.476 ' O ' HG13 ' A' ' 14' ' ' ILE . 60.2 mt-10 -67.29 -38.54 85.2 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.921 -0.77 . . . . 16.66 108.921 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.9 mtt-85 -67.37 -41.48 84.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.341 -0.85 . . . . 50.0 109.388 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.637 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 9.8 mt-10 -64.94 -42.61 94.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.616 -0.678 . . . . 50.0 109.451 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 70.0 mtp180 -64.93 -41.49 95.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 50.0 109.316 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 10' ' ' GLU . 18.7 mt -69.45 -46.02 77.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.407 -0.808 . . . . 50.0 109.034 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.586 ' CE2' HD13 ' A' ' 26' ' ' ILE . 59.0 t80 -63.62 -35.6 81.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.313 -0.867 . . . . 16.66 109.254 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -65.84 -31.86 73.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.827 . . . . 50.0 109.281 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 48.4 mtt180 -70.68 -33.66 71.15 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.29 -0.882 . . . . 50.0 109.183 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.549 ' CE1' HD13 ' A' ' 31' ' ' LEU . 45.2 m-85 -71.9 -49.12 40.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.348 -0.845 . . . . 16.66 109.498 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.481 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 25.7 t0 -57.88 103.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 16.66 108.646 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.18 -52.2 50.41 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.314 -0.866 . . . . 50.0 111.399 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -87.84 -23.49 23.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.84 -1.162 . . . . 16.66 109.688 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.481 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 84.84 41.3 7.72 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.001 -1.24 . . . . 16.66 110.001 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.7 p-10 -96.35 5.5 50.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.255 . . . . 16.66 109.267 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.24 -9.63 69.72 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.451 -1.06 . . . . 16.66 110.451 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.0 pttp -129.27 141.62 51.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.908 -1.348 . . . . 50.0 109.966 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.586 HD13 ' CE2' ' A' ' 15' ' ' PHE . 5.4 mt -112.67 134.31 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.693 -0.629 . . . . 16.66 109.444 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.4 p -105.75 166.94 10.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.74 -0.837 . . . . 50.0 108.74 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.04 -45.22 51.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.028 -1.045 . . . . 50.0 108.825 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -58.12 -39.2 78.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.401 -0.812 . . . . 50.0 109.524 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.1 mt-10 -75.26 -54.32 7.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.218 -0.926 . . . . 16.66 109.265 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.549 HD13 ' CE1' ' A' ' 18' ' ' PHE . 34.7 tp -62.38 -42.69 99.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 16.66 108.957 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.513 ' CA ' HG13 ' A' ' 46' ' ' VAL . . . -63.67 -44.67 96.06 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.189 -1.564 . . . . 16.66 109.189 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 29.1 mt-10 -58.28 -42.2 86.06 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.312 -1.111 . . . . 50.0 109.655 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.56 -40.42 61.68 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.38 -0.97 . . . . 50.0 108.38 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.461 HD11 ' CG2' ' A' ' 46' ' ' VAL . 10.5 mt -60.52 -31.43 70.5 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.592 -0.692 . . . . 99.989999999999995 109.578 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -47.21 -23.71 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 99.989999999999995 109.527 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.437 HG22 HG23 ' A' ' 83' ' ' ILE . 10.3 t -52.15 -22.85 4.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 99.989999999999995 109.218 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.513 ' CD1' HD11 ' A' ' 41' ' ' ILE . 87.8 mt -63.0 -32.07 73.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.479 -0.763 . . . . 50.0 109.288 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.23 7.13 50.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.674 -1.37 . . . . 16.66 109.674 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 40' ' ' SER . 4.8 t -154.75 55.63 0.67 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -1.203 . . . . 16.66 109.653 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.513 HD11 ' CD1' ' A' ' 38' ' ' LEU . 9.0 tt -142.87 176.29 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 50.0 109.538 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.52 163.94 39.42 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.857 . . . . 16.66 108.697 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.49 -33.72 21.97 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.164 1.91 . . . . 50.0 110.209 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -65.87 -24.05 66.78 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.581 -0.699 . . . . 50.0 109.972 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -82.13 -38.52 24.64 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.944 -1.097 . . . . 16.66 108.393 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.513 HG13 ' CA ' ' A' ' 32' ' ' GLY . 42.8 t -68.45 -37.35 77.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.02 -0.733 . . . . 50.0 109.02 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -66.16 -40.28 90.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.372 -0.83 . . . . 50.0 108.941 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -64.87 -40.04 94.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.43 -0.794 . . . . 50.0 109.217 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.438 ' O ' HG13 ' A' ' 53' ' ' ILE . 7.1 mtt -57.61 -43.13 84.5 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.184 -0.947 . . . . 16.66 108.857 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.518 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 47.3 mtp -62.06 -48.0 82.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.561 -0.712 . . . . 50.0 109.266 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.58 -20.55 33.11 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.299 -0.876 . . . . 50.0 109.128 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -97.42 -36.42 10.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.455 -0.778 . . . . 16.66 109.184 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.565 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.5 mt -81.62 -32.45 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.352 -0.843 . . . . 50.0 109.569 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.475 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.7 t0 -59.74 101.41 0.11 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.393 -0.817 . . . . 16.66 109.047 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.462 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 67.6 p -70.71 -47.11 61.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 50.0 110.751 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.3 p-10 -86.54 -36.61 18.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.082 -1.011 . . . . 16.66 109.556 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 99.86 28.71 7.25 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.881 -1.152 . . . . 16.66 110.76 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.7 p-10 -81.03 -3.32 51.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.714 -1.463 . . . . 50.0 109.124 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.1 -4.47 58.85 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.855 -1.298 . . . . 16.66 109.855 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 44.3 m-85 -134.08 156.37 48.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.057 -1.261 . . . . 50.0 111.093 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.553 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 31.5 mm -108.16 129.88 61.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.142 -1.059 . . . . 16.66 108.142 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.5 166.51 11.48 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.103 -0.998 . . . . 16.66 108.709 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.637 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 34.6 t80 -53.48 -42.53 67.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.186 -1.006 . . . . 16.66 108.546 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -60.5 -49.33 77.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.618 -0.676 . . . . 50.0 109.25 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.553 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 75.3 mt-10 -59.86 -47.0 87.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 16.66 109.15 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -62.66 -36.23 82.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 16.66 109.223 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 21.7 m -67.81 -47.92 67.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 50.0 109.013 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.32 -37.93 79.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.4 -0.813 . . . . 50.0 109.249 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.566 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -77.04 -37.26 55.11 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.503 -0.925 . . . . 50.0 108.503 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.415 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -58.61 -29.73 64.44 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.247 -1.541 . . . . 16.66 109.247 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 67' ' ' THR . 77.2 mtm180 -70.4 -30.84 67.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -1.127 . . . . 50.0 109.056 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.18 63.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.421 -0.799 . . . . 50.0 109.363 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.514 ' HB2' ' CG ' ' A' ' 76' ' ' LEU . 4.6 p30 -149.7 56.73 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 50.0 109.189 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.486 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 12.8 ptm180 -49.57 -37.13 26.16 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.386 -0.821 . . . . 50.0 108.843 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.33 -27.06 71.1 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.73 -1.348 . . . . 25.0 109.73 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.514 ' CG ' ' HB2' ' A' ' 73' ' ' ASN . 12.6 mt -66.24 -46.73 76.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -1.184 . . . . 50.0 109.653 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' A' ' 74' ' ' ARG . 0.4 OUTLIER -59.84 -41.16 90.78 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.377 -0.827 . . . . 50.0 109.375 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -59.23 -30.12 68.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 50.0 109.392 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 49.9 t0 -71.22 -36.8 71.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 50.0 109.38 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.93 -27.73 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.385 -0.822 . . . . 50.0 109.421 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 77' ' ' LEU . . . -62.13 -18.74 61.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 50.0 109.719 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 37.5 pttt -95.48 -31.05 13.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 50.0 109.309 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 79' ' ' ASP . 9.3 mt -57.88 -33.64 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.856 . . . . 50.0 109.448 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.075 -0.964 . . . . 99.989999999999995 109.494 179.964 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -83.84 -9.19 58.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.433 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.16 127.01 29.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 25.0 109.454 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.487 ' CD2' ' CG ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -132.25 166.92 25.13 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 50.0 109.389 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.2 Cg_endo -66.92 -22.3 48.8 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.565 2.177 . . . . 50.0 111.09 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.51 ' NE2' ' HA ' ' A' ' 6' ' ' GLN . 15.7 mm-40 -61.47 -41.89 97.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.523 -0.736 . . . . 25.0 109.288 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.487 ' CG ' ' CD2' ' A' ' 4' ' ' HIS . 85.2 m-20 -61.86 -46.38 89.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.435 -0.79 . . . . 50.0 109.371 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -50.11 -36.86 31.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.808 . . . . 50.0 109.45 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -56.73 -45.57 81.85 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.612 -0.885 . . . . 16.66 108.612 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 14' ' ' ILE . 49.0 mt-10 -67.1 -38.64 86.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.448 -0.782 . . . . 16.66 109.066 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 67' ' ' THR . 74.5 mtt-85 -67.29 -40.71 86.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 50.0 109.429 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.572 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 37.8 mt-10 -65.45 -41.62 93.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.441 -0.787 . . . . 50.0 109.5 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 58.5 mtp85 -67.42 -40.66 85.55 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.23 -0.919 . . . . 50.0 109.277 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 10' ' ' GLU . 42.7 mt -70.54 -44.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.289 -0.882 . . . . 50.0 109.151 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.573 ' CE2' HD13 ' A' ' 26' ' ' ILE . 50.1 t80 -68.22 -35.57 78.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.207 -0.933 . . . . 16.66 109.278 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 52.9 mttt -64.33 -31.79 73.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.373 -0.829 . . . . 50.0 109.261 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.503 ' NH2' ' O ' ' A' ' 84' ' ' PHE . 52.4 mtt180 -72.21 -35.71 68.97 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.901 . . . . 50.0 109.17 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CB ' HD12 ' A' ' 26' ' ' ILE . 37.1 m-85 -68.75 -45.31 71.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 16.66 109.531 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 25.7 t0 -64.45 103.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 16.66 108.779 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.73 -52.13 47.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.233 -0.917 . . . . 50.0 111.21 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -85.57 -26.08 26.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.746 -1.221 . . . . 16.66 109.56 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 86.99 42.92 6.15 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.936 -1.126 . . . . 16.66 110.49 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.487 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 41.1 p-10 -99.44 6.0 46.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.25 . . . . 16.66 109.33 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 62' ' ' SER . . . 94.03 -10.88 71.55 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.485 -1.046 . . . . 16.66 110.485 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' CD2' ' A' ' 60' ' ' PHE . 14.3 pttp -126.69 140.45 52.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.926 -1.338 . . . . 50.0 109.891 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.573 HD13 ' CE2' ' A' ' 15' ' ' PHE . 3.3 mt -113.8 134.18 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.571 -0.706 . . . . 16.66 109.424 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.462 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 25.9 p -107.47 170.53 7.92 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.435 -0.791 . . . . 50.0 109.011 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.518 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -51.14 -47.76 61.98 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.118 -0.989 . . . . 50.0 109.028 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.31 -38.45 71.29 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.335 -0.853 . . . . 50.0 109.485 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.474 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 54.8 mt-10 -77.56 -54.49 6.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.251 -0.905 . . . . 16.66 109.154 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.532 ' CD2' HD13 ' A' ' 35' ' ' LEU . 7.5 tt -60.01 -46.11 90.55 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.212 -0.93 . . . . 16.66 108.853 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.505 ' HA3' ' CG2' ' A' ' 46' ' ' VAL . . . -61.36 -43.95 98.69 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.076 -1.61 . . . . 16.66 109.076 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 16.2 mt-10 -57.06 -44.42 83.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.433 -1.04 . . . . 50.0 109.823 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.26 -39.28 75.08 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.187 -0.946 . . . . 50.0 108.646 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 31' ' ' LEU . 8.7 mt -58.7 -32.03 68.79 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.421 -0.799 . . . . 99.989999999999995 109.628 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -42.43 -26.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.177 -0.952 . . . . 99.989999999999995 109.84 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.517 ' CG2' HG23 ' A' ' 83' ' ' ILE . 6.3 t -49.44 -24.84 2.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.182 -0.949 . . . . 99.989999999999995 109.155 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.519 HD11 ' CD1' ' A' ' 41' ' ' ILE . 2.0 mt -61.28 -36.39 79.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 50.0 109.315 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.7 -3.33 64.4 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.498 -1.441 . . . . 16.66 109.498 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.74 67.7 0.63 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -1.168 . . . . 16.66 109.657 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.519 ' CD1' HD11 ' A' ' 38' ' ' LEU . 13.3 tt -149.35 168.25 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 50.0 109.545 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.54 167.32 12.42 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 16.66 109.221 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.67 -28.76 16.81 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.276 1.984 . . . . 50.0 109.849 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.25 -28.67 68.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.597 -0.689 . . . . 50.0 109.774 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -80.76 -34.57 34.18 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.069 -1.019 . . . . 16.66 108.353 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.515 HG23 ' CD1' ' A' ' 35' ' ' LEU . 53.5 t -66.51 -35.42 74.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.108 -0.701 . . . . 50.0 109.108 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -69.06 -37.97 78.81 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.758 -0.83 . . . . 50.0 108.758 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.534 ' CD2' ' HG3' ' A' ' 52' ' ' GLU . 14.8 t-160 -68.07 -39.65 82.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.496 -0.752 . . . . 50.0 109.087 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.44 ' HE2' HD12 ' A' ' 35' ' ' LEU . 4.4 mtt -61.9 -47.11 86.43 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.141 -0.975 . . . . 16.66 108.614 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.519 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 48.9 mtp -63.01 -48.3 79.41 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.046 -0.724 . . . . 50.0 109.046 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.72 -17.81 25.96 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.307 -0.871 . . . . 50.0 108.996 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.534 ' HG3' ' CD2' ' A' ' 48' ' ' HIS . 22.7 mt-10 -98.78 -36.2 9.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 16.66 109.203 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.559 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.4 mt -82.23 -32.45 10.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.457 -0.777 . . . . 50.0 109.669 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.9 t0 -58.4 100.69 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.441 -0.787 . . . . 16.66 109.126 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.466 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 59.1 p -70.0 -46.57 64.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.298 -0.876 . . . . 50.0 110.463 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.91 -31.53 22.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.11 -0.994 . . . . 16.66 109.571 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.484 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 93.06 28.53 11.7 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.801 -1.19 . . . . 16.66 110.189 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.48 -3.07 55.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.94 -1.33 . . . . 50.0 109.402 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.519 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 100.44 -8.34 58.56 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.053 -1.07 . . . . 16.66 110.465 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CD2' ' HD2' ' A' ' 25' ' ' LYS . 33.9 m-85 -132.81 155.98 47.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.842 -1.387 . . . . 50.0 111.256 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.532 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 32.0 mm -107.43 129.59 61.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.348 -0.982 . . . . 16.66 108.348 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.9 OUTLIER -95.7 166.91 11.59 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.175 -0.953 . . . . 16.66 108.644 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 32.2 t80 -55.76 -42.86 76.06 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.128 -0.983 . . . . 16.66 108.741 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -62.43 -47.29 84.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.507 -0.745 . . . . 50.0 109.07 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.532 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 51.7 mt-10 -58.54 -48.09 82.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 16.66 108.974 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -59.54 -39.31 83.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.448 -0.782 . . . . 16.66 109.346 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.518 ' O ' ' NH1' ' A' ' 11' ' ' ARG . 16.4 m -65.28 -45.99 82.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.457 -0.777 . . . . 50.0 109.238 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -59.62 -40.07 86.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 50.0 109.515 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.559 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -73.0 -36.53 67.04 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.252 -0.905 . . . . 50.0 108.778 179.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.422 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -58.63 -34.45 76.57 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.389 -1.484 . . . . 16.66 109.389 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -65.86 -29.09 69.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -1.137 . . . . 50.0 109.277 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.67 -22.09 60.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 50.0 109.147 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.55 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 1.8 m-80 -150.24 58.69 0.96 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.428 -0.795 . . . . 50.0 108.997 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -50.76 -39.94 53.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.284 -0.885 . . . . 50.0 108.788 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.23 -29.9 69.69 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.342 -1.503 . . . . 25.0 109.342 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.55 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 28.1 mt -66.92 -45.72 77.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 50.0 109.482 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.8 mt -60.85 -37.19 81.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 50.0 109.635 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.5 mtmt -62.41 -24.19 67.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 50.0 109.427 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -77.87 -36.36 49.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 50.0 109.527 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -83.58 -29.46 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.836 . . . . 50.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.459 ' HB2' HD12 ' A' ' 14' ' ' ILE . . . -61.33 -16.54 47.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 50.0 109.607 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -95.19 -30.66 13.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 50.0 109.223 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.517 HG23 ' CG2' ' A' ' 37' ' ' THR . 8.3 mt -58.86 -36.29 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 50.0 109.332 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.503 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 96.3 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.974 -1.012 . . . . 99.989999999999995 109.499 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.512 ' O ' ' NE2' ' A' ' 4' ' ' HIS . 38.8 m-20 -79.82 -6.45 57.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 0.0 109.624 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -81.95 107.91 15.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 25.0 109.534 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.533 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -112.29 173.98 2.57 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 50.0 109.211 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 47.2 Cg_endo -69.4 -22.96 32.99 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.563 2.175 . . . . 50.0 111.232 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -62.87 -34.37 77.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.401 -0.812 . . . . 25.0 109.285 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.97 -46.59 90.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.304 -0.872 . . . . 50.0 109.27 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -48.79 -36.63 17.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.369 -0.832 . . . . 50.0 109.586 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.23 -46.75 87.63 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.26 -0.9 . . . . 16.66 108.638 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 14' ' ' ILE . 57.0 mt-10 -68.08 -38.99 83.0 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.823 -0.806 . . . . 16.66 108.823 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.503 ' NH2' HD13 ' A' ' 77' ' ' LEU . 59.5 mtt-85 -67.99 -40.9 82.97 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.461 -0.774 . . . . 50.0 109.458 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.579 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 22.7 mt-10 -65.71 -40.86 92.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 50.0 109.524 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 15.1 mtp85 -68.18 -40.45 82.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 50.0 109.353 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 10' ' ' GLU . 34.6 mt -71.31 -43.46 73.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.328 -0.858 . . . . 50.0 109.012 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.577 ' CE2' HD13 ' A' ' 26' ' ' ILE . 63.6 t80 -67.39 -36.42 81.28 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.191 -0.943 . . . . 16.66 109.089 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -65.65 -29.67 70.27 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.29 -0.881 . . . . 50.0 109.062 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 28.9 mtt180 -71.24 -37.08 72.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.361 -0.837 . . . . 50.0 109.088 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.571 ' CD1' HD13 ' A' ' 31' ' ' LEU . 43.4 m-85 -69.66 -48.48 59.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -0.797 . . . . 16.66 109.488 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 24.4 t0 -59.18 103.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 16.66 108.713 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -51.39 55.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 50.0 111.273 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -87.87 -29.24 21.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.782 -1.199 . . . . 16.66 109.845 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 92.34 35.85 6.46 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.783 -1.198 . . . . 16.66 110.178 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.477 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.7 p-10 -90.43 4.76 50.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.252 . . . . 16.66 109.284 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.5 -6.73 74.79 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.347 -1.101 . . . . 16.66 110.347 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 15.4 pttt -130.43 141.89 50.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.996 -1.296 . . . . 50.0 110.027 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.577 HD13 ' CE2' ' A' ' 15' ' ' PHE . 5.0 mt -112.31 134.03 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.588 -0.695 . . . . 16.66 109.398 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.427 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 12.9 p -106.79 167.54 9.8 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.392 -0.818 . . . . 50.0 108.899 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.502 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.48 -45.55 56.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.059 -1.026 . . . . 50.0 108.909 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.6 -39.43 76.8 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.328 -0.858 . . . . 50.0 109.598 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.483 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.5 mt-10 -75.05 -53.98 7.95 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.224 -0.923 . . . . 16.66 109.439 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.571 HD13 ' CD1' ' A' ' 18' ' ' PHE . 31.9 tp -62.37 -42.25 99.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.209 -0.932 . . . . 16.66 108.911 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -64.35 -45.33 93.67 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.115 -1.594 . . . . 16.66 109.115 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -57.73 -42.96 84.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -1.104 . . . . 50.0 109.539 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.57 -39.95 64.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.417 -0.957 . . . . 50.0 108.417 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.526 HD12 ' CE ' ' A' ' 49' ' ' MET . 10.3 mt -61.62 -32.77 72.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.578 -0.701 . . . . 99.989999999999995 109.672 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -46.87 -24.55 0.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 99.989999999999995 109.644 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.53 ' CG2' HG22 ' A' ' 83' ' ' ILE . 11.6 t -51.95 -21.52 3.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 99.989999999999995 109.266 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.5 mt -66.64 -29.58 69.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.361 -0.837 . . . . 50.0 109.294 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.75 8.89 50.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 16.66 109.585 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.82 60.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -1.167 . . . . 16.66 109.61 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.73 173.32 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 50.0 109.525 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.38 162.96 37.08 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.712 -0.847 . . . . 16.66 108.712 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.03 -32.49 21.48 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.09 1.86 . . . . 50.0 110.012 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.25 -22.11 64.78 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.642 -0.661 . . . . 50.0 110.043 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -79.99 -36.83 35.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.93 -1.106 . . . . 16.66 108.465 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.519 ' CG2' HD11 ' A' ' 35' ' ' LEU . 54.2 t -68.72 -36.34 73.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.968 -0.753 . . . . 50.0 108.968 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -64.92 -39.9 94.22 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.896 -0.779 . . . . 50.0 108.896 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.55 -43.37 90.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 50.0 109.116 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.526 ' CE ' HD12 ' A' ' 35' ' ' LEU . 70.1 mtm -59.32 -43.39 92.7 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.174 -0.954 . . . . 16.66 108.932 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.516 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 32.4 mtp -61.53 -47.23 86.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.493 -0.754 . . . . 50.0 109.058 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.02 -22.58 50.44 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.318 -0.864 . . . . 50.0 109.116 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.91 -35.89 12.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 16.66 108.942 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.549 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.6 mt -81.09 -30.09 11.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.591 -0.693 . . . . 50.0 109.534 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.4 t0 -62.42 101.36 0.23 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.386 -0.821 . . . . 16.66 109.105 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.47 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 74.0 p -71.65 -47.95 50.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.862 . . . . 50.0 110.614 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 4.2 p-10 -85.85 -33.83 21.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.141 -0.975 . . . . 16.66 109.728 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 97.31 27.4 9.29 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.911 -1.138 . . . . 16.66 111.053 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 p-10 -80.62 -2.5 46.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.725 -1.456 . . . . 50.0 109.248 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.516 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.01 -4.16 60.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.003 -1.239 . . . . 16.66 110.003 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 39.7 m-85 -134.46 156.12 49.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.26 . . . . 50.0 111.125 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 34.3 mm -106.83 128.95 61.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.34 -0.985 . . . . 16.66 108.34 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -96.25 169.51 9.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.083 -1.011 . . . . 16.66 108.832 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.579 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 35.7 t80 -55.8 -43.88 77.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.128 -0.983 . . . . 16.66 108.73 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -60.31 -48.38 82.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.462 -0.774 . . . . 50.0 109.185 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.54 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 63.5 mt-10 -59.91 -46.5 89.18 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.357 -0.839 . . . . 16.66 109.11 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.432 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 56.5 t80 -62.35 -36.53 82.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.443 -0.786 . . . . 16.66 109.079 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 28.9 m -68.51 -48.27 64.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.8 . . . . 50.0 108.979 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -58.08 -37.75 75.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.319 -0.863 . . . . 50.0 109.249 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -78.73 -35.87 44.14 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.41 -0.959 . . . . 50.0 108.41 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.5 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -58.63 -33.9 74.22 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.888 -1.685 . . . . 16.66 108.888 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 67' ' ' THR . 82.1 mtm180 -64.86 -32.3 73.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -1.078 . . . . 50.0 108.53 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.55 -2.54 58.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.538 -0.726 . . . . 50.0 109.227 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.526 ' CA ' HD11 ' A' ' 76' ' ' LEU . 68.4 m-80 -151.69 48.42 0.8 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.311 -0.868 . . . . 50.0 108.668 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -57.8 -47.04 83.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.342 -0.849 . . . . 50.0 108.877 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.2 -21.16 38.46 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.135 -1.586 . . . . 25.0 109.135 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.526 HD11 ' CA ' ' A' ' 73' ' ' ASN . 6.8 mp -79.94 -43.82 21.43 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -1.116 . . . . 50.0 109.366 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.503 HD13 ' NH2' ' A' ' 11' ' ' ARG . 5.9 mt -69.2 -22.38 63.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 50.0 109.968 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -80.03 -26.19 39.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 50.0 109.716 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -89.57 -40.66 12.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.1 -1.0 . . . . 50.0 109.586 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.9 p -67.78 -43.36 86.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.383 -0.823 . . . . 50.0 109.515 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.538 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.96 -37.66 45.86 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.673 -0.642 . . . . 50.0 109.919 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.21 -26.86 67.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 50.0 109.542 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.53 HG22 ' CG2' ' A' ' 37' ' ' THR . 7.8 mt -60.63 -43.9 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.236 -0.915 . . . . 50.0 109.362 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.46 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 89.6 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.961 -1.019 . . . . 99.989999999999995 109.463 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -85.18 7.46 21.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 109.619 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -90.15 116.35 28.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 25.0 109.534 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.605 ' CG ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -118.59 153.17 52.03 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 50.0 108.855 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 4' ' ' HIS . 39.9 Cg_endo -64.4 -19.98 65.87 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.143 1.895 . . . . 50.0 110.362 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -57.69 -41.67 82.12 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.079 -0.711 . . . . 25.0 109.079 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.17 -43.72 92.15 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 50.0 109.363 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -50.62 -36.94 37.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 50.0 109.403 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.15 -46.16 89.1 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.782 -0.822 . . . . 16.66 108.782 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.9 mm-40 -66.38 -44.06 84.17 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.957 -0.757 . . . . 16.66 108.957 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.507 ' NH2' HD13 ' A' ' 77' ' ' LEU . 36.6 mtt-85 -64.95 -39.52 93.62 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.435 -0.79 . . . . 50.0 109.416 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.57 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 13.0 mt-10 -66.21 -42.14 89.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 50.0 109.542 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 47.5 mtp180 -67.01 -40.81 87.36 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.299 -0.876 . . . . 50.0 109.214 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 81' ' ' ALA . 25.8 mt -70.29 -44.54 77.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.359 -0.838 . . . . 50.0 109.033 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' A' ' 26' ' ' ILE . 52.7 t80 -66.72 -35.38 79.97 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.281 -0.887 . . . . 16.66 109.041 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -64.44 -31.34 72.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 50.0 109.388 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 64.8 mtt180 -72.53 -36.07 68.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -0.929 . . . . 50.0 109.15 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.557 ' CD1' HD11 ' A' ' 31' ' ' LEU . 34.4 m-85 -68.72 -45.01 72.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 16.66 109.389 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 22.5 t0 -63.37 103.22 0.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 16.66 108.756 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.445 ' HB1' ' HG2' ' A' ' 30' ' ' GLU . . . -66.17 -51.2 60.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.254 -0.904 . . . . 50.0 111.299 -178.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -89.23 -27.27 20.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.659 -1.276 . . . . 16.66 109.762 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 89.95 35.68 7.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.032 -1.227 . . . . 16.66 110.032 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.468 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 35.5 p-10 -89.52 3.71 51.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -1.2 . . . . 16.66 109.277 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.19 -6.28 68.73 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.367 -1.093 . . . . 16.66 110.367 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.5 pttp -132.37 143.48 49.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.911 -1.346 . . . . 50.0 110.149 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.532 HD13 ' CE2' ' A' ' 15' ' ' PHE . 6.4 mt -111.41 135.06 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 121.426 0.632 . . . . 16.66 109.53 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.434 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 11.4 p -107.77 166.4 10.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.877 -0.786 . . . . 50.0 108.877 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.523 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.81 -45.63 50.21 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.185 -0.947 . . . . 50.0 108.876 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 -38.81 75.99 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.317 -0.864 . . . . 50.0 109.602 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.494 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.2 mt-10 -75.61 -54.1 7.53 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.12 -0.987 . . . . 16.66 109.496 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.557 HD11 ' CD1' ' A' ' 18' ' ' PHE . 14.5 tp -64.03 -38.95 92.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.123 -0.986 . . . . 16.66 108.876 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -66.02 -46.48 80.82 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.993 -1.643 . . . . 16.66 108.993 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -57.27 -42.79 82.31 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.326 -1.102 . . . . 50.0 109.478 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.63 -40.22 63.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.416 -0.957 . . . . 50.0 108.416 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.439 HD11 HG21 ' A' ' 46' ' ' VAL . 5.0 mt -59.94 -32.84 71.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.644 -0.66 . . . . 99.989999999999995 109.595 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -45.61 -25.67 0.5 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.034 -1.041 . . . . 99.989999999999995 109.351 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.522 ' CG2' HG22 ' A' ' 83' ' ' ILE . 11.7 t -50.87 -23.74 3.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.282 -0.886 . . . . 99.989999999999995 109.184 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.525 ' CD1' HD11 ' A' ' 41' ' ' ILE . 22.5 mt -62.15 -32.58 73.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.813 . . . . 50.0 109.264 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.0 6.43 52.67 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.643 -1.383 . . . . 16.66 109.643 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.18 56.63 0.65 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -1.213 . . . . 16.66 109.605 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 38' ' ' LEU . 8.9 tt -142.47 175.25 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -0.962 . . . . 50.0 109.512 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.75 165.71 25.36 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.349 -0.844 . . . . 16.66 108.759 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.426 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 47.4 Cg_endo -69.42 -33.74 17.23 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.09 1.86 . . . . 50.0 110.172 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.17 -22.37 65.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.699 -0.625 . . . . 50.0 110.178 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -82.99 -39.53 21.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.822 -1.173 . . . . 16.66 108.452 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.439 HG21 HD11 ' A' ' 35' ' ' LEU . 75.1 t -66.03 -36.02 76.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.786 -0.82 . . . . 50.0 108.786 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 23.3 mttm -67.6 -39.9 84.79 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.782 -0.822 . . . . 50.0 108.782 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -65.71 -39.51 91.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.407 -0.808 . . . . 50.0 109.149 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.424 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.8 mtt -58.46 -44.77 89.39 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.176 -0.953 . . . . 16.66 108.718 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.523 ' SD ' ' N ' ' A' ' 28' ' ' ALA . 58.1 mtp -62.32 -48.03 81.66 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.524 -0.735 . . . . 50.0 109.188 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.06 -20.17 23.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.301 -0.874 . . . . 50.0 109.05 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -97.14 -35.8 10.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 16.66 109.025 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.573 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.5 mt -81.74 -31.74 11.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.446 -0.784 . . . . 50.0 109.592 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.465 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.3 t0 -60.42 101.24 0.12 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.341 -0.85 . . . . 16.66 109.187 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.466 ' OG1' ' OE2' ' A' ' 65' ' ' GLU . 37.9 p -72.13 -45.03 62.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.374 -0.829 . . . . 50.0 110.582 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.2 p-10 -87.35 -38.92 15.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 16.66 109.485 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 102.17 29.28 6.12 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.86 -1.162 . . . . 16.66 110.675 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.499 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p-10 -81.92 -4.12 55.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.819 -1.401 . . . . 50.0 109.014 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.513 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.1 -2.36 57.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.816 -1.314 . . . . 16.66 109.816 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 31.4 m-85 -136.86 156.59 48.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -1.232 . . . . 50.0 111.275 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.528 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 33.3 mm -106.93 127.24 62.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.328 -0.99 . . . . 16.66 108.328 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.2 167.71 11.38 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.075 -1.016 . . . . 16.66 108.762 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.57 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.3 t80 -55.09 -43.08 73.64 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.154 -0.966 . . . . 16.66 108.693 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.74 -49.3 78.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.976 -0.75 . . . . 50.0 108.976 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 22.5 mt-10 -58.3 -47.31 84.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.836 . . . . 16.66 109.027 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.6 -37.97 85.85 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.52 -0.737 . . . . 16.66 109.306 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 31.2 m -65.74 -47.73 74.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.845 . . . . 50.0 109.257 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -60.38 -38.84 85.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 50.0 109.359 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.13 -38.37 56.87 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.281 -1.007 . . . . 50.0 108.281 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.486 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -56.81 -28.84 57.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.056 -1.617 . . . . 16.66 109.056 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 67' ' ' THR . 78.7 mtm180 -70.39 -29.65 66.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -1.098 . . . . 50.0 108.832 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.65 -23.42 63.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.781 . . . . 50.0 109.155 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.518 ' CB ' HD13 ' A' ' 76' ' ' LEU . 1.7 m-80 -148.83 58.17 1.04 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 50.0 108.991 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -50.63 -30.86 14.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 50.0 108.894 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.17 -30.9 79.01 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.202 -1.559 . . . . 25.0 109.202 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.518 HD13 ' CB ' ' A' ' 73' ' ' ASN . 63.7 mt -66.57 -43.56 84.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -1.071 . . . . 50.0 109.491 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.515 ' N ' HD21 ' A' ' 77' ' ' LEU . 5.3 mt -69.55 -26.49 64.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.415 -0.803 . . . . 50.0 109.862 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -79.37 -24.59 42.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.01 -1.057 . . . . 50.0 109.217 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -92.01 -45.13 8.48 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.393 -0.817 . . . . 50.0 109.333 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.6 p -61.17 -44.52 98.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.808 0.813 . . . . 50.0 109.048 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.545 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -51.49 -39.82 58.32 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.731 -0.606 . . . . 50.0 109.53 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -59.65 -30.8 68.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 50.0 109.702 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.522 HG22 ' CG2' ' A' ' 37' ' ' THR . 41.9 mt -59.37 -32.43 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 50.0 109.43 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 9.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.062 -0.971 . . . . 99.989999999999995 109.439 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -107.71 85.67 2.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.549 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -95.13 111.09 22.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 25.0 109.36 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.508 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -118.49 172.41 4.24 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 50.0 109.33 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 45.9 Cg_endo -68.9 -22.5 36.09 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.573 2.182 . . . . 50.0 111.094 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -63.58 -38.2 90.22 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.485 -0.76 . . . . 25.0 109.252 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.99 -42.06 97.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 50.0 109.344 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -52.8 -36.48 58.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.477 -0.764 . . . . 50.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 13' ' ' ARG . . . -58.68 -45.18 89.98 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.642 -0.873 . . . . 16.66 108.642 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 14' ' ' ILE . 66.7 mt-10 -67.41 -43.49 81.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.838 -0.801 . . . . 16.66 108.838 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.457 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 35.1 mtt-85 -66.24 -39.42 89.52 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.484 -0.76 . . . . 50.0 109.346 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.571 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 14.8 mt-10 -66.98 -41.02 87.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.474 -0.766 . . . . 50.0 109.373 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.4 mtt180 -68.46 -40.16 81.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.358 -0.839 . . . . 50.0 109.117 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.9 mt -70.72 -44.73 76.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.411 -0.805 . . . . 50.0 109.059 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 26' ' ' ILE . 75.0 t80 -65.43 -36.23 83.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 16.66 109.029 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -66.05 -29.48 69.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 50.0 109.151 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 84' ' ' PHE . 33.7 mtt180 -70.46 -39.15 74.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 50.0 109.066 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.551 ' CE1' HD13 ' A' ' 31' ' ' LEU . 46.6 m-85 -68.44 -48.5 64.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 16.66 109.316 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 26.5 t0 -57.36 103.48 0.13 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 16.66 108.604 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -52.28 57.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 50.0 111.457 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 23' ' ' ASP . 31.8 p-10 -88.84 -21.97 23.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.826 -1.171 . . . . 16.66 109.768 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 82.66 40.48 9.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.876 -1.29 . . . . 16.66 109.876 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.5 p-10 -94.11 4.15 54.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -1.221 . . . . 16.66 109.247 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.88 -9.41 65.91 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.516 -1.034 . . . . 16.66 110.516 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 7.6 pttt -130.74 142.69 50.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.932 -1.334 . . . . 50.0 110.118 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.567 HD13 ' CE1' ' A' ' 15' ' ' PHE . 7.6 mt -112.82 134.05 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.409 -0.589 . . . . 16.66 109.409 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.438 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 25.0 p -107.8 168.96 8.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 50.0 108.846 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.509 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.56 -47.18 57.86 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.06 -1.025 . . . . 50.0 108.933 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.39 70.2 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.481 -0.762 . . . . 50.0 109.704 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 55.5 mt-10 -78.39 -53.5 7.2 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.111 -0.993 . . . . 16.66 109.477 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.551 HD13 ' CE1' ' A' ' 18' ' ' PHE . 54.6 tp -63.22 -40.43 97.46 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.175 -0.953 . . . . 16.66 108.976 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.521 ' CA ' HG13 ' A' ' 46' ' ' VAL . . . -64.07 -45.13 94.66 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.162 -1.575 . . . . 16.66 109.162 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -58.64 -42.94 89.48 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.195 -1.179 . . . . 50.0 109.703 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.54 -40.68 61.56 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.053 -1.029 . . . . 50.0 108.404 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.426 HD13 ' HG ' ' A' ' 31' ' ' LEU . 9.5 mt -60.73 -33.13 72.45 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.546 -0.721 . . . . 99.989999999999995 109.463 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -47.12 -24.4 0.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.081 -1.012 . . . . 99.989999999999995 109.437 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.514 ' CG2' HG22 ' A' ' 83' ' ' ILE . 12.2 t -52.54 -22.61 5.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 99.989999999999995 109.19 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.3 mt -61.07 -31.66 71.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -0.832 . . . . 50.0 109.224 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.66 3.52 54.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.733 -1.347 . . . . 16.66 109.733 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.76 65.04 0.59 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -1.197 . . . . 16.66 109.71 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.9 tt -149.63 170.24 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 50.0 109.411 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.66 162.95 28.2 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.311 -0.868 . . . . 16.66 108.706 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.76 -32.4 23.38 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.003 1.802 . . . . 50.0 110.18 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.0 -23.56 65.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.604 -0.685 . . . . 50.0 109.915 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -81.0 -38.92 26.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.887 -1.133 . . . . 16.66 108.298 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.521 HG13 ' CA ' ' A' ' 32' ' ' GLY . 53.8 t -66.09 -36.38 77.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.579 -0.897 . . . . 50.0 108.579 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -69.54 -39.54 77.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.479 -0.934 . . . . 50.0 108.479 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.52 -41.42 88.83 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.96 -0.755 . . . . 50.0 108.96 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.8 mtt -59.05 -44.92 91.86 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.259 -0.9 . . . . 16.66 108.622 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.513 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 30.1 mtp -60.39 -46.13 91.06 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.521 -0.737 . . . . 50.0 109.061 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.77 -23.5 52.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.8 . . . . 50.0 109.316 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -92.84 -35.95 13.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 16.66 108.799 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.58 HG12 ' CD2' ' A' ' 69' ' ' PHE . 84.7 mt -80.37 -29.34 12.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.545 -0.722 . . . . 50.0 109.478 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.2 t0 -63.8 101.6 0.38 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.446 -0.784 . . . . 16.66 109.196 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 76.1 p -73.95 -46.72 42.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.292 -0.88 . . . . 50.0 110.868 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 7.5 p-10 -86.14 -31.24 21.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.069 -1.02 . . . . 16.66 109.645 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 94.73 27.42 11.42 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.798 -1.191 . . . . 16.66 111.066 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.6 p-10 -82.32 -3.49 55.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.73 -1.453 . . . . 50.0 109.321 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.513 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.93 -5.71 59.76 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.243 -1.143 . . . . 16.66 110.243 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.574 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 37.0 m-85 -133.5 155.04 50.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.942 -1.328 . . . . 50.0 111.039 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.545 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 34.5 mm -105.24 127.44 59.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.254 -1.017 . . . . 16.66 108.254 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.3 167.62 11.42 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.2 -0.937 . . . . 16.66 108.91 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.571 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.6 t80 -54.58 -42.77 71.45 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.057 -1.027 . . . . 16.66 108.651 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -60.7 -49.47 77.36 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.115 -0.698 . . . . 50.0 109.115 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.545 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 45.6 mt-10 -58.88 -46.79 86.99 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 16.66 109.013 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -63.74 -36.58 84.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.507 -0.745 . . . . 16.66 109.288 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 52.8 m -66.35 -48.68 69.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.321 -0.862 . . . . 50.0 109.209 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' ' NH1' ' A' ' 71' ' ' ARG . 67.8 m-20 -61.79 -37.38 84.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 50.0 109.3 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.58 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -72.71 -40.15 66.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.538 -0.912 . . . . 50.0 108.538 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.496 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -56.13 -29.19 55.58 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.141 -1.584 . . . . 16.66 109.141 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.484 ' NH1' ' OD1' ' A' ' 68' ' ' ASP . 23.2 mtm180 -71.1 -21.49 62.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 50.0 109.054 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.71 -24.44 38.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.439 -0.788 . . . . 50.0 109.34 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.58 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 2.8 m-80 -145.22 57.68 1.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.861 . . . . 50.0 109.393 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -51.31 -38.72 54.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.894 . . . . 50.0 108.762 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.22 -27.53 65.38 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.316 -1.514 . . . . 25.0 109.316 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.58 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 39.7 mt -69.73 -44.8 69.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -1.093 . . . . 50.0 109.476 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 8.9 mp -63.38 -40.26 96.75 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.422 -0.799 . . . . 50.0 110.002 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 14.4 mtmt -65.83 -20.08 66.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 50.0 109.344 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.36 -53.85 3.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 50.0 109.535 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.2 p -65.89 -44.8 92.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.369 -0.832 . . . . 50.0 109.452 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.558 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -53.67 -36.65 62.37 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.59 -0.693 . . . . 50.0 109.725 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 17.5 mttt -66.95 -25.47 66.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 50.0 109.663 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.514 HG22 ' CG2' ' A' ' 37' ' ' THR . 8.1 mt -59.63 -42.48 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.904 . . . . 50.0 109.444 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.512 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 88.7 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.015 -0.993 . . . . 99.989999999999995 109.47 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -60.71 -28.19 68.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.468 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -93.99 109.01 20.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 25.0 109.37 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.465 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -117.77 171.11 5.35 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 50.0 109.436 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.1 Cg_endo -68.27 -22.78 39.6 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.559 2.173 . . . . 50.0 111.134 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -62.61 -40.03 95.67 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.447 -0.783 . . . . 25.0 109.127 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.84 -42.18 93.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.373 -0.83 . . . . 50.0 109.222 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -52.78 -36.15 57.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.366 -0.833 . . . . 50.0 109.223 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.59 -45.78 84.83 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.587 -0.894 . . . . 16.66 108.587 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 14' ' ' ILE . 56.2 mt-10 -66.33 -44.65 82.72 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.881 -0.785 . . . . 16.66 108.881 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.57 ' NH1' ' CG2' ' A' ' 67' ' ' THR . 75.2 mtm180 -64.52 -38.85 92.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.533 -0.73 . . . . 50.0 109.436 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.619 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 34.8 mt-10 -65.91 -42.34 90.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.329 -0.857 . . . . 50.0 109.469 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 16.9 mtp180 -66.82 -40.17 87.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.281 -0.887 . . . . 50.0 109.218 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 10' ' ' GLU . 30.2 mt -70.17 -46.27 72.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.392 -0.818 . . . . 50.0 108.967 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.565 ' CE1' HD13 ' A' ' 26' ' ' ILE . 70.2 t80 -62.43 -35.58 79.68 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.274 -0.891 . . . . 16.66 108.934 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 60.1 mttm -66.56 -30.06 70.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.858 . . . . 50.0 109.15 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 47.2 mtt180 -68.92 -37.71 79.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.339 -0.851 . . . . 50.0 109.16 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.556 ' CE1' HD13 ' A' ' 31' ' ' LEU . 55.4 m-85 -68.96 -50.41 49.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.785 . . . . 16.66 109.489 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 23.8 t0 -54.66 103.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 16.66 108.651 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.13 -52.03 52.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.274 -0.891 . . . . 50.0 111.29 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -87.88 -23.64 23.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.745 -1.222 . . . . 16.66 109.592 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 84.72 41.47 7.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.034 -1.226 . . . . 16.66 110.034 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.2 p-10 -96.16 5.84 50.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.047 -1.267 . . . . 16.66 109.295 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -9.01 71.19 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.454 -1.058 . . . . 16.66 110.454 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.2 pttp -129.55 141.86 50.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.319 . . . . 50.0 109.808 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.565 HD13 ' CE1' ' A' ' 15' ' ' PHE . 5.5 mt -112.61 134.31 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.687 -0.633 . . . . 16.66 109.381 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.441 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 18.1 p -106.41 167.33 9.91 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.662 -0.866 . . . . 50.0 108.662 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.94 -45.63 51.42 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.12 -0.988 . . . . 50.0 108.997 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.85 -38.45 75.7 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.25 -0.907 . . . . 50.0 109.529 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.2 mt-10 -76.41 -54.31 6.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.163 -0.961 . . . . 16.66 109.281 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.556 HD13 ' CE1' ' A' ' 18' ' ' PHE . 29.0 tp -62.73 -42.09 99.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 16.66 108.912 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -63.85 -44.9 95.46 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.201 -1.559 . . . . 16.66 109.201 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.99 -42.95 86.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.307 -1.113 . . . . 50.0 109.699 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.89 -40.02 63.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.359 -0.978 . . . . 50.0 108.359 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.472 ' CD1' HG23 ' A' ' 46' ' ' VAL . 12.5 mt -60.76 -32.48 71.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.65 -0.656 . . . . 99.989999999999995 109.566 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -46.5 -24.64 0.55 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.082 -1.012 . . . . 99.989999999999995 109.443 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.449 HG22 HG22 ' A' ' 83' ' ' ILE . 10.3 t -51.81 -22.72 3.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.276 -0.89 . . . . 99.989999999999995 109.261 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.494 HD11 ' CD1' ' A' ' 41' ' ' ILE . 21.6 mt -60.2 -33.24 71.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.381 -0.824 . . . . 50.0 109.38 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.21 3.21 56.31 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.633 -1.387 . . . . 16.66 109.633 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.44 61.57 0.62 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -1.181 . . . . 16.66 109.594 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.494 ' CD1' HD11 ' A' ' 38' ' ' LEU . 10.3 tt -146.31 174.54 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 50.0 109.539 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.34 164.47 29.94 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 16.66 108.768 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.54 -32.77 18.81 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.091 1.861 . . . . 50.0 110.241 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.38 -22.85 65.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.654 -0.654 . . . . 50.0 110.055 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -82.34 -38.95 23.49 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.904 -1.123 . . . . 16.66 108.544 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 35' ' ' LEU . 42.2 t -68.05 -37.35 78.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.779 -0.823 . . . . 50.0 108.779 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -66.15 -40.09 90.31 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.829 -0.804 . . . . 50.0 108.829 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.472 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.9 t60 -64.54 -39.47 93.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.454 -0.779 . . . . 50.0 109.128 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.448 ' O ' HG13 ' A' ' 53' ' ' ILE . 13.2 mtt -56.54 -43.15 79.61 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.101 -1.0 . . . . 16.66 108.552 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.519 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 82.3 mtp -61.51 -48.4 81.22 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.944 -0.761 . . . . 50.0 108.944 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.72 -22.08 12.88 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.246 -0.908 . . . . 50.0 109.134 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -99.11 -36.85 9.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 16.66 109.231 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.573 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.9 mt -80.25 -33.49 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.434 -0.791 . . . . 50.0 109.617 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.471 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.6 t0 -59.97 101.47 0.12 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.351 -0.843 . . . . 16.66 109.099 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.53 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 81.8 p -73.76 -47.41 39.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 50.0 110.819 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 7.1 p-10 -85.72 -31.81 22.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.945 . . . . 16.66 109.681 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 95.19 27.65 10.65 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.888 -1.148 . . . . 16.66 111.001 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.1 p-10 -81.66 -3.79 54.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.768 -1.431 . . . . 50.0 109.342 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.519 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.46 -5.43 58.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.14 -1.184 . . . . 16.66 110.14 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 45.2 m-85 -133.1 154.83 50.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.998 -1.295 . . . . 50.0 110.971 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 34.7 mm -105.31 128.73 59.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.364 -0.976 . . . . 16.66 108.364 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.6 165.88 11.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.188 -0.945 . . . . 16.66 108.836 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.619 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.9 t80 -53.56 -43.09 68.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.095 -1.003 . . . . 16.66 108.542 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -59.07 -46.78 87.4 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.09 -0.707 . . . . 50.0 109.09 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.54 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 64.0 mt-10 -63.78 -46.99 82.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.853 . . . . 16.66 109.068 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.463 ' CE1' HD12 ' A' ' 77' ' ' LEU . 27.3 t80 -65.84 -29.03 69.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.428 -0.795 . . . . 16.66 109.182 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.57 ' CG2' ' NH1' ' A' ' 11' ' ' ARG . 63.0 m -69.87 -49.96 47.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.42 -0.8 . . . . 50.0 109.329 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.49 -35.83 81.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 50.0 109.385 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -75.79 -41.18 53.61 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.384 -0.969 . . . . 50.0 108.384 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.522 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -60.56 -30.03 71.02 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.002 -1.639 . . . . 16.66 109.002 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.488 ' HG3' ' NH1' ' A' ' 11' ' ' ARG . 68.4 mtp180 -66.91 -37.25 84.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.445 -1.033 . . . . 50.0 108.826 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.44 -19.02 65.69 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.133 -0.691 . . . . 50.0 109.133 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 76' ' ' LEU . 18.4 m-80 -145.94 53.29 1.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 50.0 109.318 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -49.5 -36.15 22.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 50.0 108.739 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.516 ' HA3' ' CE ' ' A' ' 78' ' ' LYS . . . -61.54 -19.71 58.26 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.398 -1.481 . . . . 25.0 109.398 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 73' ' ' ASN . 25.0 mt -78.33 -44.86 24.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.393 -1.063 . . . . 50.0 109.291 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.522 ' CD1' ' HA2' ' A' ' 70' ' ' GLY . 3.8 mt -71.15 -24.2 62.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.473 -0.767 . . . . 50.0 110.142 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.516 ' CE ' ' HA3' ' A' ' 75' ' ' GLY . 6.7 ptpt -80.06 -28.79 39.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.959 -1.088 . . . . 50.0 109.0 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -87.37 -44.68 11.19 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.488 -0.758 . . . . 50.0 109.274 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 5.4 p -58.71 -44.78 90.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.868 0.842 . . . . 50.0 108.946 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.55 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.5 -41.13 53.07 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.165 -0.614 . . . . 50.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -59.43 -32.25 70.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 50.0 109.499 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 83' ' ' ILE . 26.9 mt -57.44 -32.65 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 50.0 109.278 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.477 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 8.9 m-85 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.96 -1.019 . . . . 99.989999999999995 109.488 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.419 ' O ' ' CD2' ' A' ' 4' ' ' HIS . 91.0 m-20 -72.1 -10.45 59.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.517 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -79.55 111.35 15.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 25.0 109.488 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.487 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -109.87 170.02 5.79 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.913 . . . . 50.0 109.363 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.3 Cg_endo -67.44 -22.3 45.51 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.573 2.182 . . . . 50.0 111.0 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -63.04 -41.72 99.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.613 -0.68 . . . . 25.0 109.234 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -55.97 -47.56 77.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.439 -0.788 . . . . 50.0 109.378 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -48.34 -36.1 13.75 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.429 -0.795 . . . . 50.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.37 -46.38 88.81 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.395 -0.816 . . . . 16.66 108.98 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.474 ' O ' HG13 ' A' ' 14' ' ' ILE . 61.7 mt-10 -66.78 -41.09 88.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.401 -0.812 . . . . 16.66 108.981 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -66.16 -41.1 90.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.453 -0.779 . . . . 50.0 109.452 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.546 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 8.6 mt-10 -64.6 -41.51 96.18 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.519 -0.738 . . . . 50.0 109.399 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 62.1 mtp180 -67.01 -40.6 87.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 50.0 109.273 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 10' ' ' GLU . 31.9 mt -70.55 -44.46 76.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.397 -0.814 . . . . 50.0 108.986 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.582 ' CE2' HD13 ' A' ' 26' ' ' ILE . 58.7 t80 -66.65 -36.2 81.99 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.295 -0.878 . . . . 16.66 109.065 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -65.5 -30.67 71.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 50.0 108.983 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 52.0 mtt85 -70.62 -36.16 73.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.411 -0.806 . . . . 50.0 109.114 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.562 ' CD1' HD11 ' A' ' 31' ' ' LEU . 36.3 m-85 -68.21 -49.22 62.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.823 . . . . 16.66 109.432 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.475 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 23.6 t0 -57.58 103.43 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 16.66 108.715 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.3 -51.3 54.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 50.0 111.26 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -87.31 -30.49 20.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.733 -1.229 . . . . 16.66 109.793 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 93.59 35.6 6.14 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.819 -1.181 . . . . 16.66 110.232 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.483 ' OD2' ' NZ ' ' A' ' 25' ' ' LYS . 38.1 p-10 -90.46 3.96 52.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.246 . . . . 16.66 109.285 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.02 -6.51 72.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.431 -1.068 . . . . 16.66 110.431 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HD3' ' CG ' ' A' ' 60' ' ' PHE . 2.3 ptpp? -131.08 142.65 50.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.944 -1.327 . . . . 50.0 109.939 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.582 HD13 ' CE2' ' A' ' 15' ' ' PHE . 6.1 mt -112.15 133.73 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.605 -0.684 . . . . 16.66 109.652 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.1 p -105.53 166.06 10.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.383 -0.823 . . . . 50.0 108.867 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.92 -44.82 50.48 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.987 -1.071 . . . . 50.0 108.699 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -58.14 -39.77 79.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.189 -0.945 . . . . 50.0 109.347 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.8 mt-10 -74.67 -54.63 7.05 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.132 -0.98 . . . . 16.66 109.24 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.562 HD11 ' CD1' ' A' ' 18' ' ' PHE . 29.9 tp -62.31 -42.31 99.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.145 -0.972 . . . . 16.66 108.94 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -63.92 -45.33 94.38 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.96 -1.656 . . . . 16.66 108.96 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 10.3 mt-10 -56.15 -44.33 79.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.418 -1.048 . . . . 50.0 109.457 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.53 -39.31 67.63 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.331 -0.988 . . . . 50.0 108.331 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.455 HD11 HG21 ' A' ' 46' ' ' VAL . 6.7 mt -59.26 -32.93 70.45 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.545 -0.722 . . . . 99.989999999999995 109.412 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -44.79 -26.03 0.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 99.989999999999995 109.474 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.459 ' OG1' HG22 ' A' ' 83' ' ' ILE . 8.7 t -52.55 -25.04 9.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 99.989999999999995 109.232 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.458 ' CD1' HD11 ' A' ' 41' ' ' ILE . 23.7 mt -57.99 -35.96 71.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 50.0 109.165 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.87 1.97 60.28 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.681 -1.367 . . . . 16.66 109.681 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.15 52.53 0.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.092 -1.24 . . . . 16.66 109.754 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.458 HD11 ' CD1' ' A' ' 38' ' ' LEU . 11.7 tt -136.47 171.77 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 50.0 109.589 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.23 165.89 23.62 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.751 -0.833 . . . . 16.66 108.751 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.91 -33.79 19.17 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.042 1.828 . . . . 50.0 110.188 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -62.1 -28.9 69.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.585 -0.697 . . . . 50.0 109.956 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -81.76 -36.11 28.88 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.949 -1.094 . . . . 16.66 108.288 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.455 HG21 HD11 ' A' ' 35' ' ' LEU . 57.7 t -68.09 -36.59 75.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.948 -0.76 . . . . 50.0 108.948 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -68.88 -38.92 80.0 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.795 -0.817 . . . . 50.0 108.795 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -65.92 -39.78 90.86 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.471 -0.768 . . . . 50.0 109.299 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.443 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.9 mtt -59.19 -44.59 92.22 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.117 -0.989 . . . . 16.66 108.841 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 28' ' ' ALA . 29.3 mtp -62.43 -48.13 81.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.421 -0.799 . . . . 50.0 109.15 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.62 -20.14 30.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 50.0 109.097 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -97.44 -36.47 10.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 16.66 109.199 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.57 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.6 mt -80.78 -31.93 12.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.413 -0.804 . . . . 50.0 109.576 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.48 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.0 t0 -61.76 101.38 0.19 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.439 -0.788 . . . . 16.66 108.938 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 39.6 p -67.95 -45.18 74.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.874 . . . . 50.0 110.461 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.9 p-10 -88.79 -42.71 11.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 16.66 109.642 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.48 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 104.88 30.21 4.93 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.188 -1.165 . . . . 16.66 110.188 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.8 p-10 -81.31 -3.06 51.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.919 -1.342 . . . . 50.0 109.233 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.503 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.6 -1.13 58.3 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.795 -1.322 . . . . 16.66 109.795 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.584 ' CG ' ' HD3' ' A' ' 25' ' ' LYS . 51.1 m-85 -137.44 155.66 49.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -1.233 . . . . 50.0 111.284 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.542 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 30.9 mm -109.83 129.57 64.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.222 -1.029 . . . . 16.66 108.222 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.02 168.13 10.47 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.057 -1.027 . . . . 16.66 108.815 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.546 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 32.4 t80 -54.83 -43.19 72.77 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.102 -0.999 . . . . 16.66 108.728 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -61.1 -46.81 89.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.545 -0.722 . . . . 50.0 109.235 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.542 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 75.0 mt-10 -61.65 -47.67 84.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 16.66 109.198 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.495 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 60.0 t80 -61.44 -36.86 81.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 16.66 109.444 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.471 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 23.1 m -65.54 -47.27 76.45 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.259 -0.901 . . . . 50.0 109.344 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -60.92 -38.87 87.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 50.0 109.6 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.57 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -77.37 -38.6 49.75 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.136 -0.977 . . . . 50.0 108.77 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.417 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -60.36 -32.32 76.81 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.935 -1.666 . . . . 16.66 108.935 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 67' ' ' THR . 64.6 mtp180 -70.97 -34.26 71.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -1.027 . . . . 50.0 109.259 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.47 -4.61 56.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 50.0 109.512 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.517 ' HB3' ' CD1' ' A' ' 76' ' ' LEU . 69.1 m-80 -150.0 46.31 0.92 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.262 -0.899 . . . . 50.0 108.798 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -55.44 -48.87 73.79 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.54 -0.911 . . . . 50.0 108.54 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.27 -24.91 24.2 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.146 -1.581 . . . . 25.0 109.146 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 73' ' ' ASN . 7.1 mp -78.81 -44.67 22.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -1.15 . . . . 50.0 109.357 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.495 HD23 ' CZ ' ' A' ' 66' ' ' PHE . 21.2 mt -60.1 -39.6 86.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.444 -0.785 . . . . 50.0 109.409 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 32.8 mtpt -56.06 -28.23 56.72 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.294 -0.879 . . . . 50.0 109.326 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 52.9 t0 -75.67 -39.19 57.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.381 -0.824 . . . . 50.0 109.775 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -64.85 -37.55 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 50.0 109.378 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.468 ' N ' HG11 ' A' ' 80' ' ' VAL . . . -72.78 -4.26 30.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.556 -0.715 . . . . 50.0 109.65 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 14.4 mttm -74.28 -35.13 63.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 50.0 109.255 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.531 HG22 HD11 ' A' ' 83' ' ' ILE . 35.2 mt -76.75 -32.68 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.309 -0.869 . . . . 50.0 109.453 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 5.4 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.975 -1.012 . . . . 99.989999999999995 109.454 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -77.18 -13.06 60.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -49.4 139.05 12.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 25.0 109.538 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.466 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.19 166.49 28.85 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.296 -0.877 . . . . 50.0 109.468 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 43.2 Cg_endo -66.69 -21.75 51.27 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.526 2.151 . . . . 50.0 110.874 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -60.17 -41.12 92.15 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.532 -0.73 . . . . 25.0 109.143 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -55.17 -55.73 27.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 50.0 109.463 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -44.68 -35.22 2.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.797 . . . . 50.0 109.599 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.59 -45.28 85.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 16.66 108.963 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 14' ' ' ILE . 63.6 mt-10 -67.52 -42.92 82.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.507 -0.746 . . . . 16.66 109.056 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.502 ' NH2' HG21 ' A' ' 67' ' ' THR . 18.2 mtm180 -65.73 -39.19 90.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.506 -0.746 . . . . 50.0 109.421 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 77.7 mt-10 -66.76 -41.36 87.88 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.386 -0.821 . . . . 50.0 109.525 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mtp180 -66.9 -40.7 87.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.339 -0.85 . . . . 50.0 109.234 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.5 mt -70.37 -45.11 76.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.358 -0.839 . . . . 50.0 109.029 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.576 ' CE2' HD13 ' A' ' 26' ' ' ILE . 63.0 t80 -64.98 -35.8 82.34 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.227 -0.92 . . . . 16.66 109.112 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -65.99 -30.37 70.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 50.0 109.268 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 59.1 mtt85 -71.36 -35.08 71.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -0.912 . . . . 50.0 108.974 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.473 ' HB3' HD11 ' A' ' 26' ' ' ILE . 35.8 m-85 -67.56 -49.77 61.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 16.66 109.299 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.471 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 21.5 t0 -56.02 103.11 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.87 . . . . 16.66 108.804 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.05 -51.07 59.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.951 . . . . 50.0 111.028 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -87.78 -31.17 19.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.756 -1.215 . . . . 16.66 109.633 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 94.7 34.92 6.06 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.795 -1.193 . . . . 16.66 110.385 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 41.3 p-10 -89.85 5.5 45.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.003 -1.292 . . . . 16.66 109.258 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.85 -4.91 79.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.282 -1.127 . . . . 16.66 110.282 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.526 ' HB2' ' CB ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -131.08 142.51 50.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.921 -1.341 . . . . 50.0 109.931 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.576 HD13 ' CE2' ' A' ' 15' ' ' PHE . 7.5 mt -111.34 134.56 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.523 -0.735 . . . . 16.66 109.497 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.5 p -107.67 166.71 10.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.725 -0.842 . . . . 50.0 108.725 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.93 -45.56 51.27 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.048 -1.032 . . . . 50.0 108.799 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.29 76.33 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.205 -0.934 . . . . 50.0 109.493 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.482 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.1 mt-10 -75.9 -54.48 6.83 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.152 -0.968 . . . . 16.66 109.354 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.473 ' HG ' ' CD1' ' A' ' 35' ' ' LEU . 9.6 tp -62.15 -42.44 99.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 16.66 108.817 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -64.2 -45.89 92.41 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.841 -1.704 . . . . 16.66 108.841 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.88 -44.27 78.0 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.394 -1.063 . . . . 50.0 109.375 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.11 -39.9 63.06 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.112 -1.07 . . . . 50.0 108.112 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.499 ' CD2' HD13 ' A' ' 38' ' ' LEU . 6.5 mt -59.55 -29.86 68.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.527 -0.733 . . . . 99.989999999999995 109.548 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -45.25 -24.4 0.27 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 99.989999999999995 109.652 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.508 HG22 ' CG2' ' A' ' 83' ' ' ILE . 9.3 t -51.69 -24.39 5.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.215 -0.928 . . . . 99.989999999999995 109.204 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.499 HD13 ' CD2' ' A' ' 35' ' ' LEU . 6.4 mt -62.57 -45.88 90.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.39 -0.819 . . . . 50.0 109.266 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.06 -34.53 3.74 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.746 -1.342 . . . . 16.66 109.746 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.7 p -116.79 52.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -1.188 . . . . 16.66 109.598 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 tp -126.68 164.31 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 50.0 109.501 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.69 163.47 23.95 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.523 -0.917 . . . . 16.66 108.523 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.0 -34.13 23.98 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.941 1.761 . . . . 50.0 110.181 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.28 -20.19 63.91 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.658 -0.651 . . . . 50.0 110.399 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -83.08 -40.64 19.58 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.729 -1.232 . . . . 16.66 108.562 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.448 HG13 ' CA ' ' A' ' 32' ' ' GLY . 41.8 t -65.2 -36.98 79.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.764 -0.828 . . . . 50.0 108.764 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -68.31 -39.7 81.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.793 -0.817 . . . . 50.0 108.793 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.499 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.2 t60 -66.13 -40.23 90.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.423 -0.798 . . . . 50.0 109.056 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.446 ' O ' HG13 ' A' ' 53' ' ' ILE . 15.5 mtm -59.44 -44.74 92.86 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.265 -0.897 . . . . 16.66 108.877 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 28' ' ' ALA . 31.1 mtp -62.51 -47.37 84.25 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.585 -0.697 . . . . 50.0 109.197 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.25 -20.1 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 50.0 108.915 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.499 ' OE2' ' NE2' ' A' ' 48' ' ' HIS . 35.4 mt-10 -95.27 -35.55 11.76 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.986 -0.746 . . . . 16.66 108.986 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.576 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.4 mt -81.89 -31.05 10.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.53 -0.731 . . . . 50.0 109.501 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.47 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 17.3 t0 -61.93 101.09 0.18 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.442 -0.786 . . . . 16.66 109.172 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.452 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 28.3 p -68.46 -43.42 77.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 50.0 110.426 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.1 p-10 -89.85 -46.86 8.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 16.66 109.821 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 108.81 31.71 3.31 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.935 -1.266 . . . . 16.66 109.935 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.7 p-10 -82.69 -5.24 58.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.027 -1.278 . . . . 50.0 109.057 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.452 ' O ' ' HE3' ' A' ' 50' ' ' MET . . . 100.08 -0.3 56.13 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.724 -1.35 . . . . 16.66 109.724 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.526 ' CB ' ' HB2' ' A' ' 25' ' ' LYS . 41.3 m-85 -139.28 156.07 47.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.996 -1.297 . . . . 50.0 111.482 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.541 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 31.4 mm -109.08 129.23 64.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.147 -1.057 . . . . 16.66 108.147 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.1 167.32 10.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.991 -1.068 . . . . 16.66 108.72 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 37.9 t80 -53.35 -42.67 67.05 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.077 -1.049 . . . . 16.66 108.473 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -59.42 -50.66 73.08 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.107 -0.701 . . . . 50.0 109.107 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.541 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 80.2 mt-10 -60.28 -46.38 90.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.354 -0.841 . . . . 16.66 109.023 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.579 ' CZ ' HD12 ' A' ' 77' ' ' LEU . 80.3 t80 -64.66 -35.77 82.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 16.66 109.479 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.502 HG21 ' NH2' ' A' ' 11' ' ' ARG . 21.0 m -67.51 -48.95 65.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.394 -0.816 . . . . 50.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.413 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 77.1 m-20 -62.02 -36.07 80.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -0.901 . . . . 50.0 109.339 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.576 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -74.61 -39.57 62.08 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.669 -0.863 . . . . 50.0 108.669 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.476 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -59.33 -29.05 65.44 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.423 -1.471 . . . . 16.66 109.423 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 67' ' ' THR . 62.6 mtm180 -71.83 -32.28 67.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -1.115 . . . . 50.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.38 -21.08 62.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.34 -0.85 . . . . 50.0 109.343 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.521 ' HB3' ' CD1' ' A' ' 76' ' ' LEU . 31.8 m-80 -140.92 61.02 1.51 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.406 -0.809 . . . . 50.0 109.131 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -52.64 -42.88 65.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.67 -0.863 . . . . 50.0 108.67 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.19 -22.58 29.83 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.352 -1.499 . . . . 25.0 109.352 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 73' ' ' ASN . 47.2 mt -79.97 -43.56 21.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -1.124 . . . . 50.0 109.336 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.579 HD12 ' CZ ' ' A' ' 66' ' ' PHE . 1.1 mm? -61.19 -36.98 81.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.455 -0.778 . . . . 50.0 109.578 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.6 mtmm -73.81 -28.14 61.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.258 -0.901 . . . . 50.0 109.026 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -80.21 -45.3 18.26 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.37 -0.831 . . . . 50.0 109.105 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 76' ' ' LEU . 46.5 t -68.56 -41.32 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 50.0 109.376 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.441 ' HB3' HD12 ' A' ' 14' ' ' ILE . . . -51.4 -46.91 63.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 50.0 109.425 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 22.7 mttm -59.64 -29.25 67.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.345 -0.847 . . . . 50.0 109.34 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.508 ' CG2' HG22 ' A' ' 37' ' ' THR . 59.5 mt -66.73 -35.97 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 50.0 109.394 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 12.5 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.962 -1.018 . . . . 99.989999999999995 109.503 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.48 -28.91 68.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -76.06 137.81 40.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 25.0 109.58 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.469 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -119.29 169.46 8.15 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 50.0 109.57 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 45.8 Cg_endo -68.54 -22.45 38.39 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.56 2.174 . . . . 50.0 110.833 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -61.29 -37.45 83.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.145 -0.687 . . . . 25.0 109.145 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -52.97 -52.38 58.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.401 -0.812 . . . . 50.0 109.369 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -49.15 -35.78 17.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 50.0 109.293 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -53.44 -43.11 67.78 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.572 -0.899 . . . . 16.66 108.572 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.478 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.4 mt-10 -68.51 -39.8 81.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.012 -0.736 . . . . 16.66 109.012 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.5 mtt-85 -67.33 -41.24 85.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.452 -0.78 . . . . 50.0 109.38 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.608 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 60.8 mt-10 -65.07 -39.91 93.91 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.567 -0.708 . . . . 50.0 109.311 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 24.3 mtp180 -67.63 -40.37 84.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.451 -0.781 . . . . 50.0 109.187 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 10' ' ' GLU . 24.6 mt -70.54 -45.62 73.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.365 -0.834 . . . . 50.0 109.015 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.572 ' CE1' HD13 ' A' ' 26' ' ' ILE . 67.8 t80 -64.87 -35.97 82.85 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.295 -0.878 . . . . 16.66 108.975 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 46.1 mttt -65.81 -30.3 70.91 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.324 -0.86 . . . . 50.0 108.983 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 32.7 mtt180 -70.06 -36.09 74.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.831 . . . . 50.0 108.903 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.466 ' HB2' HD12 ' A' ' 26' ' ' ILE . 48.3 m-85 -70.38 -51.41 29.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.438 -0.789 . . . . 16.66 109.487 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 24.8 t0 -56.12 103.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 16.66 108.747 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.42 -52.07 50.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 50.0 111.278 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -87.34 -23.46 24.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.725 -1.235 . . . . 16.66 109.722 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 83.95 41.59 8.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.084 -1.206 . . . . 16.66 110.084 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.482 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.5 p-10 -96.17 5.38 51.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.129 -1.218 . . . . 16.66 109.122 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.06 -9.68 70.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.569 -1.012 . . . . 16.66 110.569 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.588 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.1 pttm -129.65 142.01 50.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.853 -1.381 . . . . 50.0 110.162 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.572 HD13 ' CE1' ' A' ' 15' ' ' PHE . 9.7 mt -112.78 133.6 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.736 -0.602 . . . . 16.66 109.457 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 p -106.12 168.95 8.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.332 -0.855 . . . . 50.0 108.912 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.488 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.27 -46.56 55.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.076 -1.015 . . . . 50.0 109.047 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.5 74.34 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.274 -0.891 . . . . 50.0 109.543 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.2 mt-10 -75.96 -54.03 7.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.137 -0.977 . . . . 16.66 109.269 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.497 ' CD2' HD13 ' A' ' 35' ' ' LEU . 6.9 tt -61.44 -44.84 96.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.253 -0.904 . . . . 16.66 108.969 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' HA3' HG23 ' A' ' 46' ' ' VAL . . . -61.87 -43.79 98.72 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.113 -1.595 . . . . 16.66 109.113 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -56.3 -44.19 79.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -1.096 . . . . 50.0 109.766 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.15 75.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.173 -0.954 . . . . 50.0 108.572 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.497 HD13 ' CD2' ' A' ' 31' ' ' LEU . 9.6 mt -59.02 -35.06 72.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.505 -0.747 . . . . 99.989999999999995 109.929 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.6 mttm -43.86 -27.41 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.135 -0.978 . . . . 99.989999999999995 109.535 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.525 ' CG2' HG23 ' A' ' 83' ' ' ILE . 7.3 t -53.68 -26.51 23.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 99.989999999999995 109.407 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.457 HD13 HD21 ' A' ' 35' ' ' LEU . 21.5 mt -63.94 -33.76 76.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 50.0 109.32 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.43 6.84 50.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.573 -1.411 . . . . 16.66 109.573 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.8 t -154.3 50.77 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.045 -1.268 . . . . 16.66 109.653 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 tp -136.49 154.12 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 50.0 109.243 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.43 165.83 12.86 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 16.66 108.697 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.19 -32.64 20.51 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.058 1.838 . . . . 50.0 109.989 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -62.68 -27.74 69.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.661 -0.649 . . . . 50.0 110.052 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -80.75 -36.56 31.81 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.973 -1.079 . . . . 16.66 108.36 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.468 HG23 ' HA3' ' A' ' 32' ' ' GLY . 74.8 t -64.33 -38.6 82.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.689 -0.856 . . . . 50.0 108.689 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -72.44 -36.75 68.63 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.41 -0.959 . . . . 50.0 108.41 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.471 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 4.0 t60 -67.71 -37.18 81.9 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.939 -0.763 . . . . 50.0 108.939 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.424 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.7 mtt -60.29 -48.23 82.64 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.228 -0.92 . . . . 16.66 108.58 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 28' ' ' ALA . 42.2 mtp -61.61 -48.29 81.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.922 -0.77 . . . . 50.0 108.922 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.72 -19.73 18.24 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.445 -0.784 . . . . 50.0 109.193 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.409 ' OE2' ' NE2' ' A' ' 48' ' ' HIS . 37.6 mt-10 -100.46 -37.03 9.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.89 . . . . 16.66 109.317 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.525 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.8 mt -80.29 -34.02 14.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.392 -0.818 . . . . 50.0 109.563 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.0 t0 -58.77 101.52 0.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.455 -0.778 . . . . 16.66 109.005 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.466 ' OG1' ' OE2' ' A' ' 65' ' ' GLU . 71.1 p -70.02 -47.67 61.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.829 . . . . 50.0 110.922 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.486 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.6 p-10 -86.95 -37.42 17.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.134 -0.979 . . . . 16.66 109.544 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.479 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 100.56 27.97 7.32 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.834 -1.174 . . . . 16.66 110.771 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.486 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 15.6 p-10 -79.58 -2.1 40.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.811 -1.405 . . . . 50.0 109.11 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' ' HE3' ' A' ' 50' ' ' MET . . . 99.46 -6.26 59.16 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.981 -1.248 . . . . 16.66 109.981 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.588 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 28.4 m-85 -133.84 156.16 48.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.003 -1.293 . . . . 50.0 111.373 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.546 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 27.3 mm -107.99 129.97 61.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.217 -1.031 . . . . 16.66 108.217 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.8 m -96.93 167.13 11.27 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.051 -1.03 . . . . 16.66 108.636 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.608 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 36.2 t80 -54.4 -42.29 70.25 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.077 -1.014 . . . . 16.66 108.523 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -61.21 -47.94 83.79 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.515 -0.741 . . . . 50.0 109.286 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.546 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 68.1 mt-10 -60.68 -46.85 88.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.254 -0.904 . . . . 16.66 108.943 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.485 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 57.3 t80 -59.54 -40.88 88.69 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.491 -0.755 . . . . 16.66 109.147 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.456 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.7 m -64.17 -46.51 83.68 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.468 -0.77 . . . . 50.0 109.159 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.59 -39.63 80.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 50.0 109.344 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.541 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -79.95 -36.37 36.32 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.486 -0.931 . . . . 50.0 108.486 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 77' ' ' LEU . . . -60.4 -31.55 74.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.083 -1.607 . . . . 16.66 109.083 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 67' ' ' THR . 64.4 mtm180 -70.34 -35.23 73.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.416 -1.049 . . . . 50.0 109.057 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.68 -2.55 50.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.394 -0.816 . . . . 50.0 109.455 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.526 ' HB3' ' CD2' ' A' ' 76' ' ' LEU . 69.4 m-80 -149.22 46.88 0.98 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.235 -0.916 . . . . 50.0 108.873 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -56.31 -48.51 76.54 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.521 -0.918 . . . . 50.0 108.521 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.24 -24.6 29.91 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.057 -1.617 . . . . 25.0 109.057 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 73' ' ' ASN . 6.5 mp -79.7 -45.12 19.56 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.335 -1.097 . . . . 50.0 109.326 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.485 HD23 ' CZ ' ' A' ' 66' ' ' PHE . 20.9 mt -62.67 -36.61 83.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.804 . . . . 50.0 109.845 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -67.13 -21.23 65.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 50.0 109.607 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.97 -34.55 29.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 50.0 109.476 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.474 ' HA ' HG13 ' A' ' 83' ' ' ILE . 25.1 t -78.39 -33.13 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 50.0 109.743 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.41 -46.46 62.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 50.0 110.128 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -63.91 -24.55 67.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 50.0 109.576 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.525 HG23 ' CG2' ' A' ' 37' ' ' THR . 8.5 mt -66.31 -47.55 83.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.343 -0.848 . . . . 50.0 109.673 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.017 -0.992 . . . . 99.989999999999995 109.446 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 57.1 p-10 -87.74 14.87 7.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -69.35 146.88 51.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.246 -0.909 . . . . 25.0 109.597 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.602 ' CG ' ' HD2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -110.54 153.09 43.69 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.285 -0.885 . . . . 50.0 108.846 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.602 ' HD2' ' CG ' ' A' ' 4' ' ' HIS . 40.1 Cg_endo -64.23 -19.65 66.09 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.089 1.859 . . . . 50.0 110.364 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -59.71 -39.04 83.29 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.099 -0.704 . . . . 25.0 109.099 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.32 -42.04 94.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.463 -0.773 . . . . 50.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -52.6 -37.4 58.12 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.383 -0.823 . . . . 50.0 109.274 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.12 -45.13 87.82 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.32 -0.863 . . . . 16.66 108.701 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.4 mt-10 -66.61 -45.81 77.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.818 -0.808 . . . . 16.66 108.818 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.467 ' NH2' ' CG ' ' A' ' 71' ' ' ARG . 13.7 mtt-85 -64.13 -39.37 93.89 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.447 -0.783 . . . . 50.0 109.336 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 15.9 mt-10 -65.76 -41.16 92.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.555 -0.716 . . . . 50.0 109.104 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.463 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 14.7 mtp180 -67.33 -40.55 85.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 50.0 109.014 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 10' ' ' GLU . 29.1 mt -70.12 -45.94 74.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.454 -0.779 . . . . 50.0 108.942 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.572 ' CE2' HD13 ' A' ' 26' ' ' ILE . 59.5 t80 -66.05 -35.99 82.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.376 -0.827 . . . . 16.66 109.119 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 21.8 mttt -64.48 -31.28 72.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 50.0 109.19 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 40.7 mtt180 -73.29 -33.15 65.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 50.0 109.222 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.518 ' CB ' HD12 ' A' ' 26' ' ' ILE . 37.5 m-85 -71.37 -45.11 63.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 16.66 109.29 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.473 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 24.8 t0 -63.09 103.16 0.44 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.252 -0.905 . . . . 16.66 108.798 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -52.05 60.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.227 -0.921 . . . . 50.0 111.247 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -88.1 -22.44 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.737 -1.227 . . . . 16.66 109.577 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.473 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 82.8 42.76 8.06 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.236 -1.146 . . . . 16.66 110.236 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.494 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.4 p-10 -97.63 5.93 48.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.126 -1.22 . . . . 16.66 109.269 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.87 -10.11 70.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.517 -1.033 . . . . 16.66 110.517 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 14.2 pttp -128.62 141.38 51.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.825 -1.397 . . . . 50.0 110.031 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.572 HD13 ' CE2' ' A' ' 15' ' ' PHE . 4.9 mt -113.53 134.55 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.662 -0.649 . . . . 16.66 109.365 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.453 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 26.6 p -108.03 169.65 8.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.395 -0.816 . . . . 50.0 108.895 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.7 -47.77 58.89 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.113 -0.992 . . . . 50.0 109.023 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.36 68.99 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.372 -0.83 . . . . 50.0 109.683 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.482 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 55.2 mt-10 -79.07 -53.44 7.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 16.66 109.298 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.514 ' CD2' HD11 ' A' ' 35' ' ' LEU . 4.6 tt -62.1 -42.28 99.06 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.291 -0.881 . . . . 16.66 108.83 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.432 ' HA3' HG23 ' A' ' 46' ' ' VAL . . . -63.91 -45.7 93.44 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.023 -1.631 . . . . 16.66 109.023 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -56.03 -43.06 77.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -1.1 . . . . 50.0 109.395 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.66 -39.9 66.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.292 -1.003 . . . . 50.0 108.292 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 38' ' ' LEU . 2.2 mt -59.15 -33.53 71.0 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.605 -0.684 . . . . 99.989999999999995 109.625 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -44.16 -26.43 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.1 -1.0 . . . . 99.989999999999995 109.551 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.527 ' CG2' HG22 ' A' ' 83' ' ' ILE . 8.0 t -48.87 -24.39 1.44 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.217 -0.927 . . . . 99.989999999999995 109.064 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.52 HD13 ' CD2' ' A' ' 35' ' ' LEU . 21.1 mt -66.63 -31.2 71.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.477 -0.764 . . . . 50.0 109.163 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.51 9.37 43.66 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.436 -1.466 . . . . 16.66 109.436 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' A' ' 40' ' ' SER . 9.7 t -156.07 49.15 0.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -1.143 . . . . 16.66 109.587 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.511 HD11 ' CD1' ' A' ' 38' ' ' LEU . 12.4 tt -137.32 169.41 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.257 -0.902 . . . . 50.0 109.475 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.95 166.66 16.98 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.92 . . . . 16.66 109.051 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.69 -32.65 18.41 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.175 1.916 . . . . 50.0 110.189 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -61.63 -29.05 69.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.648 -0.658 . . . . 50.0 110.016 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -81.43 -36.89 28.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.926 -1.109 . . . . 16.66 108.193 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.463 HG12 HD21 ' A' ' 31' ' ' LEU . 55.9 t -65.21 -34.7 72.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.968 -0.753 . . . . 50.0 108.968 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -69.45 -38.39 77.77 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.908 -0.775 . . . . 50.0 108.908 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -68.49 -38.5 81.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.462 -0.774 . . . . 50.0 108.933 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 mtt -62.25 -47.79 82.81 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.306 -0.871 . . . . 16.66 108.792 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.524 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 27.2 mtp -61.62 -46.55 89.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.449 -0.782 . . . . 50.0 109.159 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.24 -19.65 55.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 50.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.61 -35.63 12.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.355 -0.841 . . . . 16.66 108.879 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.8 mt -82.42 -30.92 9.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.561 -0.712 . . . . 50.0 109.669 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.491 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.6 t0 -59.67 101.35 0.11 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.38 -0.825 . . . . 16.66 109.064 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.519 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 71.0 p -72.82 -47.18 48.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -0.89 . . . . 50.0 110.543 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -29.97 24.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.181 -0.949 . . . . 16.66 109.514 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.491 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 92.02 28.19 14.28 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.893 -1.146 . . . . 16.66 110.35 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.14 -3.22 57.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.963 -1.316 . . . . 50.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.524 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.52 -7.29 59.6 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.962 -1.113 . . . . 16.66 110.526 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.6 m-85 -133.02 155.25 49.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.002 -1.293 . . . . 50.0 111.025 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.529 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 34.0 mm -106.24 128.09 60.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.333 -0.988 . . . . 16.66 108.333 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.0 m -94.16 166.11 12.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.235 -0.916 . . . . 16.66 108.602 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.576 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 34.5 t80 -54.48 -42.37 70.63 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.071 -1.018 . . . . 16.66 108.558 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -61.11 -49.47 77.14 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.098 -0.704 . . . . 50.0 109.098 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.529 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 28.8 mt-10 -58.1 -47.27 83.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 16.66 109.09 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' A' ' 77' ' ' LEU . 61.3 t80 -62.08 -40.47 95.94 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.531 -0.731 . . . . 16.66 109.305 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 16.3 m -64.33 -47.32 79.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.353 -0.842 . . . . 50.0 109.099 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.478 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 87.8 m-20 -59.31 -37.77 78.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 50.0 109.424 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.556 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -76.51 -36.76 57.58 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.529 -0.915 . . . . 50.0 108.529 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.13 -30.84 64.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.303 -1.519 . . . . 16.66 109.303 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 68' ' ' ASP . 72.3 mtm180 -69.26 -30.43 68.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -1.108 . . . . 50.0 109.071 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.22 -21.7 64.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -0.809 . . . . 50.0 109.286 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.501 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 2.1 m-80 -149.97 60.12 0.99 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.354 -0.841 . . . . 50.0 108.957 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -50.68 -38.61 47.68 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.737 -0.838 . . . . 50.0 108.737 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.24 -32.29 67.42 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.251 -1.54 . . . . 25.0 109.251 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.501 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 28.2 mt -64.46 -43.8 93.1 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.316 -1.108 . . . . 50.0 109.366 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.578 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.9 mm? -61.41 -41.91 97.9 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.426 -0.796 . . . . 50.0 109.679 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 19.2 mtmm -65.13 -27.66 68.89 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.263 -0.898 . . . . 50.0 109.512 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.66 -50.29 7.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.92 . . . . 50.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.6 p -64.33 -44.5 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.468 -0.77 . . . . 50.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.542 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -48.82 -40.48 29.44 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.54 -0.725 . . . . 50.0 109.385 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 27.2 mttp -65.47 -26.47 67.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 50.0 109.563 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.527 HG22 ' CG2' ' A' ' 37' ' ' THR . 35.0 mt -62.22 -32.7 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 50.0 109.423 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.528 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 5.1 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.001 -0.999 . . . . 99.989999999999995 109.488 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.354 0.597 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -76.34 -26.93 56.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 0.0 109.635 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -80.24 118.15 21.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 25.0 109.583 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -108.77 170.73 5.13 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.268 -0.895 . . . . 50.0 109.391 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 45.5 Cg_endo -67.7 -23.55 42.18 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.59 2.193 . . . . 50.0 111.263 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.487 ' NE2' ' HA ' ' A' ' 6' ' ' GLN . 14.5 mm-40 -63.18 -41.17 99.17 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.362 -0.836 . . . . 25.0 109.162 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -57.39 -43.03 83.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 50.0 109.341 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -51.52 -36.54 45.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 50.0 109.455 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.88 -46.17 88.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.277 -0.89 . . . . 16.66 108.665 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 14' ' ' ILE . 67.9 mm-40 -66.5 -43.95 83.9 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.389 -0.819 . . . . 16.66 108.867 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -64.5 -39.52 93.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.413 -0.804 . . . . 50.0 109.493 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.571 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 13.8 mt-10 -64.06 -40.0 95.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 50.0 109.416 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 21.1 mtp-105 -70.06 -38.22 75.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 50.0 109.034 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.5 mt -71.54 -44.91 70.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.371 -0.831 . . . . 50.0 108.888 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.563 ' CE1' HD13 ' A' ' 26' ' ' ILE . 69.6 t80 -69.23 -36.19 76.93 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.231 -0.918 . . . . 16.66 109.159 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 37.4 mttt -64.99 -30.53 71.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 50.0 109.027 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 65.8 mmt-85 -70.65 -39.14 73.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.365 -0.834 . . . . 50.0 109.005 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.464 ' HB2' HD12 ' A' ' 26' ' ' ILE . 43.6 m-85 -66.21 -47.73 72.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.832 . . . . 16.66 109.344 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 20.4 t0 -60.08 103.15 0.2 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 16.66 108.73 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 -50.6 40.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 50.0 111.092 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -87.3 -30.54 20.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.808 -1.182 . . . . 16.66 109.671 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 93.27 33.41 7.24 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.069 -1.213 . . . . 16.66 110.069 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' OD2' ' CG ' ' A' ' 25' ' ' LYS . 34.8 p-10 -86.76 5.42 36.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.266 . . . . 16.66 109.115 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.95 -3.93 77.79 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.374 -1.09 . . . . 16.66 110.374 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 3.7 pttm -133.67 143.99 48.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.948 -1.325 . . . . 50.0 110.244 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.563 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.3 mt -110.43 132.67 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.459 0.647 . . . . 16.66 109.752 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.459 ' HA ' ' HE2' ' A' ' 50' ' ' MET . 13.0 p -106.56 166.48 10.53 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.917 -0.772 . . . . 50.0 108.917 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.08 -44.98 52.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.124 -0.985 . . . . 50.0 109.032 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -57.19 -39.9 76.31 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.358 -0.838 . . . . 50.0 109.541 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 60.5 mt-10 -75.7 -54.28 7.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.214 -0.929 . . . . 16.66 109.248 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.49 ' CD2' HD13 ' A' ' 35' ' ' LEU . 6.3 tt -61.78 -43.66 98.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.13 -0.981 . . . . 16.66 108.853 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' CA ' HG12 ' A' ' 46' ' ' VAL . . . -63.76 -44.79 95.75 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.009 -1.636 . . . . 16.66 109.009 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 30.1 mt-10 -58.45 -42.23 86.93 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.474 -1.015 . . . . 50.0 109.661 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.55 -39.72 67.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.322 -0.992 . . . . 50.0 108.322 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.49 HD13 ' CD2' ' A' ' 31' ' ' LEU . 3.3 mt -58.23 -31.82 67.73 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.519 -0.738 . . . . 99.989999999999995 109.544 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -45.15 -25.81 0.4 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 99.989999999999995 109.479 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.495 ' OG1' ' CG2' ' A' ' 83' ' ' ILE . 11.6 t -52.94 -26.29 14.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 109.374 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.433 HD13 HD21 ' A' ' 35' ' ' LEU . 26.5 mt -65.35 -29.99 70.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -0.836 . . . . 50.0 109.237 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.66 9.0 42.94 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.734 -1.346 . . . . 16.66 109.734 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.5 49.6 0.54 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.089 -1.242 . . . . 16.66 109.811 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.9 tp -133.31 165.36 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.251 -0.905 . . . . 50.0 109.344 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.87 164.67 16.83 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.168 -0.957 . . . . 16.66 108.741 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.65 -33.72 21.0 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.062 1.841 . . . . 50.0 110.012 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -64.12 -26.0 68.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.592 -0.692 . . . . 50.0 109.955 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.42 -38.62 26.21 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.821 -1.175 . . . . 16.66 108.401 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.531 HG12 ' CA ' ' A' ' 32' ' ' GLY . 61.7 t -63.93 -36.53 77.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.765 -0.828 . . . . 50.0 108.765 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -73.04 -37.52 66.85 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.413 -0.958 . . . . 50.0 108.413 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -68.02 -38.58 82.75 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.922 -0.769 . . . . 50.0 108.922 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.2 mtt -60.88 -47.45 86.34 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.241 -0.912 . . . . 16.66 108.635 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 28' ' ' ALA . 50.6 mtp -60.93 -46.15 91.85 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.141 -0.688 . . . . 50.0 109.141 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.72 -21.01 53.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 50.0 109.194 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -95.89 -36.48 11.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 16.66 109.126 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.55 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.4 mt -80.86 -32.39 12.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.534 -0.729 . . . . 50.0 109.536 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 22.7 t0 -60.41 100.5 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.354 -0.841 . . . . 16.66 109.053 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.457 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 56.6 p -68.04 -46.44 71.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.307 -0.871 . . . . 50.0 110.616 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.502 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 1.7 p-10 -86.37 -37.97 17.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 16.66 109.44 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 100.36 27.03 7.88 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 120.037 -1.078 . . . . 16.66 110.555 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.502 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 7.9 p-10 -78.41 -1.58 34.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.743 -1.446 . . . . 50.0 109.051 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.494 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.52 -4.82 60.1 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.123 -1.191 . . . . 16.66 110.123 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 24.9 m-85 -135.68 157.55 46.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.033 -1.275 . . . . 50.0 111.482 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.552 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 31.5 mm -109.04 129.65 63.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.504 -0.924 . . . . 16.66 108.504 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.2 m -96.42 170.26 9.35 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.095 -1.003 . . . . 16.66 108.637 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.571 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.1 t80 -56.42 -43.97 79.93 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.133 -0.979 . . . . 16.66 108.694 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -60.44 -49.4 77.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.531 -0.731 . . . . 50.0 109.154 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.552 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.9 mt-10 -58.45 -46.07 87.31 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.267 -0.896 . . . . 16.66 109.219 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -63.52 -35.37 80.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 16.66 109.331 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 31.6 m -66.21 -48.41 70.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.444 -0.785 . . . . 50.0 109.279 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.57 -36.26 75.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.356 -0.84 . . . . 50.0 109.394 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.57 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -77.95 -37.14 48.22 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.433 -0.951 . . . . 50.0 108.433 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.424 ' O ' HD22 ' A' ' 77' ' ' LEU . . . -56.46 -27.92 54.75 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.994 -1.643 . . . . 16.66 108.994 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 67' ' ' THR . 82.1 mtm180 -71.49 -27.34 63.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -1.135 . . . . 50.0 108.806 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.19 60.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.441 -0.787 . . . . 50.0 109.291 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.475 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 2.4 m-80 -144.49 59.83 1.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.356 -0.84 . . . . 50.0 109.248 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.482 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 97.3 mtt180 -52.57 -21.63 4.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 50.0 109.123 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.8 -26.74 60.03 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.36 -1.496 . . . . 25.0 109.36 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.475 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 72.1 mt -73.06 -45.02 59.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -1.099 . . . . 50.0 109.618 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -64.41 -42.94 95.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.376 -0.828 . . . . 50.0 109.806 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.9 mtmt -65.37 -34.12 77.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 50.0 109.484 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -79.32 -46.46 17.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 50.0 109.498 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.8 p -64.18 -43.89 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 50.0 109.192 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.548 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.08 -37.92 35.89 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.733 -0.604 . . . . 50.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 61.2 mttp -70.65 -26.43 63.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 50.0 109.413 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.56 HG23 ' CE1' ' A' ' 84' ' ' PHE . 28.3 mt -62.78 -31.23 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 50.0 109.237 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.56 ' CE1' HG23 ' A' ' 83' ' ' ILE . 5.6 m-85 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.965 -1.017 . . . . 99.989999999999995 109.474 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -53.49 -26.58 21.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.513 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 3' ' ' ASP . 48.5 p30 -81.94 164.0 21.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 25.0 109.51 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.53 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -104.05 174.08 2.98 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 50.0 109.176 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.5 Cg_endo -69.16 -22.71 34.42 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.468 2.112 . . . . 50.0 111.218 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -62.33 -37.35 85.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -0.782 . . . . 25.0 109.363 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 8' ' ' LYS . 81.3 m-20 -57.32 -55.57 33.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.393 -0.817 . . . . 50.0 109.627 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 16.2 mttt -43.35 -35.91 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.442 -0.786 . . . . 50.0 109.78 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 12' ' ' GLU . . . -60.9 -45.87 92.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 16.66 109.058 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 14' ' ' ILE . 73.6 mt-10 -70.67 -34.84 72.44 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.383 -0.823 . . . . 16.66 108.822 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.497 ' NH1' HG22 ' A' ' 67' ' ' THR . 70.3 mtm180 -72.31 -40.65 67.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.364 -0.835 . . . . 50.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.567 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 24.6 pt-20 -68.95 -38.34 79.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.291 -0.881 . . . . 50.0 109.184 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.4 mtp180 -66.8 -41.83 86.95 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.889 . . . . 50.0 109.303 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 10' ' ' GLU . 27.4 mt -69.97 -46.01 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.278 -0.889 . . . . 50.0 109.032 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.583 ' CE2' HD13 ' A' ' 26' ' ' ILE . 60.1 t80 -64.62 -35.17 80.13 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.349 -0.844 . . . . 16.66 109.209 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 51.2 mttt -65.78 -31.72 72.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 50.0 109.385 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 65.7 mtt180 -70.68 -36.11 73.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 50.0 109.163 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.496 ' CE1' HD13 ' A' ' 31' ' ' LEU . 43.1 m-85 -66.04 -47.31 74.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.395 -0.816 . . . . 16.66 109.375 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 24.3 t0 -59.79 103.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.279 -0.888 . . . . 16.66 108.848 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.75 -51.67 53.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.179 -0.951 . . . . 50.0 111.191 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -86.59 -28.39 23.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.718 -1.239 . . . . 16.66 109.672 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 90.53 39.14 6.01 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.89 -1.148 . . . . 16.66 110.373 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.482 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.7 p-10 -95.02 5.63 51.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -1.221 . . . . 16.66 109.291 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.59 -8.1 77.09 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.486 -1.046 . . . . 16.66 110.486 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 14.1 pttt -128.54 141.35 51.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.95 -1.324 . . . . 50.0 109.929 -179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.583 HD13 ' CE2' ' A' ' 15' ' ' PHE . 5.6 mt -112.59 133.19 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.655 -0.653 . . . . 16.66 109.528 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 p -103.59 166.18 10.58 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.618 -0.882 . . . . 50.0 108.618 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.18 -44.39 52.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.062 -1.024 . . . . 50.0 108.81 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.54 82.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.354 -0.841 . . . . 50.0 109.419 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.478 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.8 mt-10 -74.25 -54.73 7.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -0.932 . . . . 16.66 109.275 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.496 HD13 ' CE1' ' A' ' 18' ' ' PHE . 40.1 tp -61.92 -43.63 98.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.181 -0.95 . . . . 16.66 108.929 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -62.48 -43.82 98.48 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.084 -1.606 . . . . 16.66 109.084 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -56.49 -44.0 80.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.285 -1.127 . . . . 50.0 109.531 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.72 -39.4 66.96 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.364 -0.976 . . . . 50.0 108.364 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.468 ' CD1' HG23 ' A' ' 46' ' ' VAL . 6.9 mt -59.66 -32.61 70.62 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.532 -0.73 . . . . 99.989999999999995 109.522 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.6 -24.4 0.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 99.989999999999995 109.532 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.7 t -52.93 -23.78 7.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.183 -0.948 . . . . 99.989999999999995 109.151 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.48 HD13 ' CD1' ' A' ' 41' ' ' ILE . 25.5 mt -62.77 -31.81 72.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.42 -0.8 . . . . 50.0 109.343 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.69 6.58 51.17 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 16.66 109.564 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.24 55.15 0.64 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.183 -1.186 . . . . 16.66 109.521 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.48 ' CD1' HD13 ' A' ' 38' ' ' LEU . 12.0 tt -140.53 171.33 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 50.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.52 165.2 27.9 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.714 -0.847 . . . . 16.66 108.714 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.82 -33.47 20.54 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.052 1.834 . . . . 50.0 110.232 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -64.97 -25.3 67.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.708 -0.62 . . . . 50.0 110.149 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' OE1' HG13 ' A' ' 41' ' ' ILE . 94.0 mt-10 -82.59 -38.61 23.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.888 -1.132 . . . . 16.66 108.344 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.468 HG23 ' CD1' ' A' ' 35' ' ' LEU . 41.4 t -65.76 -36.12 76.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.824 -0.806 . . . . 50.0 108.824 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -66.24 -39.14 89.31 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.973 -0.751 . . . . 50.0 108.973 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.495 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.4 t60 -66.92 -41.24 87.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.412 -0.805 . . . . 50.0 109.135 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.465 ' CE ' HD12 ' A' ' 35' ' ' LEU . 48.0 mtm -60.17 -44.92 94.65 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.241 -0.912 . . . . 16.66 108.923 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.529 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 20.1 mtp -61.98 -47.17 86.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.528 -0.733 . . . . 50.0 109.231 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.33 -19.13 54.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 50.0 109.068 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.456 ' OE2' ' NE2' ' A' ' 48' ' ' HIS . 35.8 mt-10 -95.92 -36.72 10.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 16.66 108.975 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.578 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.7 mt -81.33 -32.41 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.476 -0.765 . . . . 50.0 109.482 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.482 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 20.9 t0 -60.66 100.49 0.11 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.399 -0.813 . . . . 16.66 108.905 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.462 ' OG1' ' OE2' ' A' ' 65' ' ' GLU . 71.0 p -66.81 -46.89 73.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.324 -0.86 . . . . 50.0 110.771 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.484 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.9 p-10 -87.94 -40.81 13.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.178 -0.951 . . . . 16.66 109.559 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 103.32 28.99 5.86 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.919 -1.134 . . . . 16.66 110.314 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.484 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.6 p-10 -79.8 -2.79 44.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.862 -1.375 . . . . 50.0 109.135 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.529 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.7 -3.96 57.73 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.783 -1.327 . . . . 16.66 109.783 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 32.4 m-85 -135.91 156.1 49.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.077 -1.249 . . . . 50.0 111.279 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.541 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 29.4 mm -108.89 130.99 60.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.463 -0.94 . . . . 16.66 108.463 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 m -99.58 168.02 10.22 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.988 -1.07 . . . . 16.66 108.775 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.567 ' CE1' ' HA ' ' A' ' 12' ' ' GLU . 36.1 t80 -54.88 -43.73 73.44 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.247 -0.981 . . . . 16.66 108.673 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -59.83 -49.81 76.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.568 -0.707 . . . . 50.0 109.115 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.541 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.5 mt-10 -58.81 -47.29 85.31 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.271 -0.893 . . . . 16.66 108.974 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.445 ' CZ ' HD13 ' A' ' 77' ' ' LEU . 58.7 t80 -63.07 -33.21 74.95 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.401 -0.812 . . . . 16.66 109.241 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.497 HG22 ' NH1' ' A' ' 11' ' ' ARG . 79.7 m -67.24 -49.17 65.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 50.0 109.107 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' OD1' ' NH2' ' A' ' 71' ' ' ARG . 59.4 m-20 -59.26 -36.95 76.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 50.0 109.291 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.578 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -79.46 -37.79 36.11 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.414 -0.958 . . . . 50.0 108.414 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.419 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -60.38 -32.51 77.52 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.096 -1.602 . . . . 16.66 109.096 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.407 ' NH2' ' OD1' ' A' ' 68' ' ' ASP . 65.6 mtm180 -66.16 -36.93 84.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -1.106 . . . . 50.0 108.917 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.04 -19.65 65.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.482 -0.761 . . . . 50.0 109.154 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' LEU . 3.3 m-80 -145.81 55.23 1.18 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 50.0 109.231 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.446 ' HA ' HD21 ' A' ' 77' ' ' LEU . 8.5 ptp85 -49.87 -35.36 23.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -0.848 . . . . 50.0 108.721 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.407 ' HA3' ' HE2' ' A' ' 78' ' ' LYS . . . -65.92 -27.34 72.71 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.492 -1.443 . . . . 25.0 109.492 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ASN . 14.9 mt -67.92 -46.86 70.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.109 . . . . 50.0 109.507 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 74' ' ' ARG . 0.4 OUTLIER -62.9 -42.72 99.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.354 -0.841 . . . . 50.0 109.681 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HE2' ' HA3' ' A' ' 75' ' ' GLY . 32.3 mtmt -61.88 -31.83 72.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 50.0 109.39 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.419 ' O ' HG13 ' A' ' 83' ' ' ILE . 29.7 t0 -76.05 -37.82 57.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.306 -0.871 . . . . 50.0 109.385 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.465 ' HA ' HG13 ' A' ' 83' ' ' ILE . 46.0 t -73.3 -39.1 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 50.0 109.401 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.81 -44.26 59.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.403 -0.81 . . . . 50.0 109.891 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -65.6 -26.73 67.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 50.0 109.463 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.465 HG13 ' HA ' ' A' ' 80' ' ' VAL . 7.9 mt -65.39 -48.2 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.831 . . . . 50.0 109.633 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.015 -0.993 . . . . 99.989999999999995 109.42 179.942 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 56.0 p-10 -85.14 12.92 6.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -74.78 130.96 40.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 25.0 109.404 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -110.13 152.83 43.37 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.224 -0.923 . . . . 50.0 108.93 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 4' ' ' HIS . 39.9 Cg_endo -64.59 -19.86 65.18 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 122.162 1.908 . . . . 50.0 110.224 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -59.59 -38.76 82.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.079 -0.712 . . . . 25.0 109.079 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -59.12 -52.47 65.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.477 -0.765 . . . . 50.0 109.573 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.478 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 39.5 mttp -45.92 -36.31 5.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 50.0 109.326 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.19 91.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.411 -0.806 . . . . 16.66 108.877 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.479 ' O ' HG13 ' A' ' 14' ' ' ILE . 65.5 mt-10 -68.97 -37.02 78.54 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.963 -0.754 . . . . 16.66 108.963 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.505 ' NH2' HG21 ' A' ' 67' ' ' THR . 12.6 mtm180 -70.37 -40.76 73.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.366 -0.834 . . . . 50.0 109.238 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.628 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 38.9 mt-10 -66.65 -41.05 88.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.458 -0.776 . . . . 50.0 109.268 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 13.7 mtp180 -65.37 -41.62 93.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.29 -0.881 . . . . 50.0 109.328 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.5 ' CD1' ' HB1' ' A' ' 81' ' ' ALA . 22.9 mt -69.59 -45.98 76.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.267 -0.896 . . . . 50.0 109.074 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.583 ' CE1' HD13 ' A' ' 26' ' ' ILE . 67.2 t80 -66.06 -35.79 81.47 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.242 -0.911 . . . . 16.66 109.333 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -65.6 -33.39 75.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.211 -0.931 . . . . 50.0 109.325 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 53.6 mtt85 -69.94 -34.53 73.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 50.0 109.238 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.53 ' CB ' HD12 ' A' ' 26' ' ' ILE . 34.1 m-85 -69.85 -47.54 62.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 16.66 109.538 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 25.6 t0 -58.65 103.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 16.66 108.747 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.14 -52.19 50.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.223 -0.923 . . . . 50.0 111.275 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -87.34 -22.02 25.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.747 -1.221 . . . . 16.66 109.483 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 82.53 43.92 7.63 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.271 -1.132 . . . . 16.66 110.271 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.49 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.2 p-10 -99.61 7.0 45.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.082 -1.246 . . . . 16.66 109.236 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.04 -10.88 71.52 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.545 -1.022 . . . . 16.66 110.545 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.6 pttp -127.47 140.77 51.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.866 -1.373 . . . . 50.0 109.975 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.583 HD13 ' CE1' ' A' ' 15' ' ' PHE . 5.4 mt -113.24 134.1 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.6 -0.688 . . . . 16.66 109.395 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.2 p -105.75 168.23 9.24 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.6 -0.889 . . . . 50.0 108.6 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.498 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.34 -46.23 55.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.973 -1.079 . . . . 50.0 108.969 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.38 -38.98 75.1 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.297 -0.877 . . . . 50.0 109.584 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.478 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 56.5 mt-10 -75.58 -53.9 7.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.175 -0.953 . . . . 16.66 109.437 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.49 HD11 ' CD1' ' A' ' 18' ' ' PHE . 9.6 tp -62.51 -42.12 99.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 16.66 108.941 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -62.88 -44.37 97.54 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.079 -1.608 . . . . 16.66 109.079 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -56.86 -44.23 81.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -1.064 . . . . 50.0 109.673 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.39 -39.36 68.05 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.435 -0.95 . . . . 50.0 108.435 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.488 HD11 ' CG2' ' A' ' 46' ' ' VAL . 11.4 mt -58.65 -33.62 70.29 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.548 -0.72 . . . . 99.989999999999995 109.46 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -45.18 -25.72 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 99.989999999999995 109.474 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.465 ' CG2' HG23 ' A' ' 83' ' ' ILE . 7.7 t -52.27 -25.32 9.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.898 . . . . 99.989999999999995 109.305 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 41' ' ' ILE . 39.7 mt -62.17 -31.86 72.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.398 -0.814 . . . . 50.0 109.157 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.56 6.84 51.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.605 -1.398 . . . . 16.66 109.605 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.99 56.41 0.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.164 -1.198 . . . . 16.66 109.6 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.524 ' CD1' HD11 ' A' ' 38' ' ' LEU . 11.6 tt -141.5 172.35 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.971 . . . . 50.0 109.635 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.92 166.24 21.36 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.344 -0.847 . . . . 16.66 108.754 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.79 -33.66 16.03 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.02 1.813 . . . . 50.0 109.952 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.38 -25.97 68.53 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.61 -0.681 . . . . 50.0 109.969 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -80.88 -37.48 29.73 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.876 -1.14 . . . . 16.66 108.329 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.488 ' CG2' HD11 ' A' ' 35' ' ' LEU . 51.9 t -65.0 -36.8 78.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.949 -0.76 . . . . 50.0 108.949 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -68.19 -38.86 82.46 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.762 -0.829 . . . . 50.0 108.762 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -66.7 -41.04 88.68 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.464 -0.772 . . . . 50.0 109.011 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.41 ' O ' HG13 ' A' ' 53' ' ' ILE . 11.8 mtt -60.82 -45.92 92.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.213 -0.929 . . . . 16.66 108.881 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.526 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 34.7 mtp -61.87 -48.25 81.35 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.014 -0.736 . . . . 50.0 109.014 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.62 -20.42 32.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.87 . . . . 50.0 109.172 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -96.86 -35.99 10.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.324 -0.86 . . . . 16.66 109.099 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.562 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.2 mt -82.38 -30.53 9.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.538 -0.726 . . . . 50.0 109.783 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 50' ' ' MET . 18.3 t0 -61.3 101.38 0.16 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.38 -0.825 . . . . 16.66 109.291 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 82.6 p -73.68 -48.16 34.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -0.916 . . . . 50.0 110.851 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 17.1 p-10 -85.0 -28.6 25.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 16.66 109.972 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 91.19 27.91 16.85 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.847 -1.168 . . . . 16.66 110.632 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.474 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 8.9 p-10 -83.36 -4.4 58.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.895 -1.356 . . . . 50.0 109.502 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.526 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 100.11 -7.65 58.78 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.969 -1.11 . . . . 16.66 110.35 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.573 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 43.2 m-85 -131.11 153.37 49.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.016 -1.285 . . . . 50.0 110.918 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.535 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 36.3 mm -104.33 129.5 56.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.183 -1.043 . . . . 16.66 108.183 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.78 165.45 11.94 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.143 -0.973 . . . . 16.66 108.779 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 35.3 t80 -53.61 -42.49 67.76 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.224 -0.99 . . . . 16.66 108.564 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -60.31 -48.56 81.22 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.529 -0.732 . . . . 50.0 109.218 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.535 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 62.0 mt-10 -60.25 -47.3 86.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 16.66 109.1 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -62.72 -35.52 80.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.517 -0.74 . . . . 16.66 109.19 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.505 HG21 ' NH2' ' A' ' 11' ' ' ARG . 12.5 m -67.07 -48.48 68.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.357 -0.839 . . . . 50.0 109.138 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -60.4 -38.24 83.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 50.0 109.237 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.562 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.17 -38.45 51.69 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.505 -0.924 . . . . 50.0 108.505 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -58.17 -27.72 60.49 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.183 -1.567 . . . . 16.66 109.183 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' THR . 58.8 mtm180 -72.53 -31.73 65.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -1.137 . . . . 50.0 108.989 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.1 -20.46 64.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.414 -0.804 . . . . 50.0 109.312 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.522 ' CB ' ' CD1' ' A' ' 76' ' ' LEU . 2.9 m-80 -149.93 56.74 0.96 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -0.863 . . . . 50.0 109.32 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 69.8 mtt180 -50.18 -38.53 40.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 50.0 108.796 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.44 -19.08 39.4 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.432 -1.467 . . . . 25.0 109.432 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.522 ' CD1' ' CB ' ' A' ' 73' ' ' ASN . 43.9 mt -79.52 -43.73 22.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -1.058 . . . . 50.0 109.395 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 77' ' ' LEU . 5.4 mt -70.79 -15.92 62.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.475 -0.766 . . . . 50.0 109.743 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 43.1 mtpt -80.02 -29.27 39.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.15 -0.969 . . . . 50.0 109.206 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.14 -47.35 8.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 50.0 109.529 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.9 p -62.31 -42.55 95.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.371 -0.831 . . . . 50.0 109.304 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.533 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -52.24 -35.96 51.09 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.746 -0.596 . . . . 50.0 110.2 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -75.45 -24.36 57.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.092 -1.005 . . . . 50.0 109.771 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.469 HG13 ' HA ' ' A' ' 80' ' ' VAL . 10.9 mt -59.07 -38.66 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.273 -0.892 . . . . 50.0 109.546 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.438 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 93.1 m-85 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 118.038 -0.982 . . . . 99.989999999999995 109.425 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 45.46 39.66 4.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.65 144.96 55.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 25.0 109.5 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.569 ' CE1' ' OD2' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -112.52 169.94 5.81 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 50.0 109.343 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.7 Cg_endo -68.0 -21.87 42.66 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.548 2.166 . . . . 50.0 111.153 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -64.22 -36.08 82.92 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.478 -0.764 . . . . 25.0 109.34 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.569 ' OD2' ' CE1' ' A' ' 4' ' ' HIS . 28.3 m-20 -62.02 -45.91 91.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 50.0 109.351 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -49.22 -36.34 19.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.825 . . . . 50.0 109.516 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.15 -46.66 87.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.257 -0.902 . . . . 16.66 108.752 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.471 ' O ' HG13 ' A' ' 14' ' ' ILE . 59.6 mm-40 -67.28 -40.37 86.14 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.801 -0.814 . . . . 16.66 108.801 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 45.4 mtt-85 -65.81 -40.49 91.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.557 -0.714 . . . . 50.0 109.649 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.614 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 35.6 mt-10 -64.89 -39.79 94.09 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 50.0 109.571 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 53.2 mtp180 -69.24 -39.26 78.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 50.0 109.21 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.5 mt -71.59 -45.2 68.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.315 -0.866 . . . . 50.0 108.957 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.581 ' CE1' HD13 ' A' ' 26' ' ' ILE . 76.2 t80 -64.48 -36.47 84.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.114 -0.991 . . . . 16.66 108.864 179.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 33.5 mttt -66.12 -28.81 69.09 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.392 -0.818 . . . . 50.0 108.88 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 35.2 mtt85 -68.85 -39.17 80.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 50.0 109.08 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.462 ' HB2' HD12 ' A' ' 26' ' ' ILE . 54.5 m-85 -68.52 -51.33 44.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.458 -0.776 . . . . 16.66 109.373 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 23.5 t0 -54.08 103.14 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -0.842 . . . . 16.66 108.814 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.68 -51.67 46.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.198 -0.939 . . . . 50.0 111.278 -178.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -86.73 -27.48 23.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.812 -1.18 . . . . 16.66 109.693 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 89.28 39.26 6.44 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.145 -1.182 . . . . 16.66 110.145 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -94.34 6.22 49.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.086 -1.244 . . . . 16.66 109.193 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.85 -7.43 76.89 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.513 -1.035 . . . . 16.66 110.513 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 11.7 pttp -130.43 142.32 50.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.891 -1.358 . . . . 50.0 109.971 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.581 HD13 ' CE1' ' A' ' 15' ' ' PHE . 5.5 mt -112.53 133.51 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.613 -0.679 . . . . 16.66 109.567 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 p -105.83 168.22 9.26 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.359 -0.838 . . . . 50.0 108.897 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.2 -46.53 54.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.059 -1.025 . . . . 50.0 108.781 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.28 -41.42 75.85 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.337 -0.852 . . . . 50.0 109.38 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.497 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.8 mt-10 -73.92 -54.08 8.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.187 -0.946 . . . . 16.66 109.302 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.532 ' CD2' HD13 ' A' ' 35' ' ' LEU . 6.6 tt -59.65 -45.89 90.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.218 -0.926 . . . . 16.66 108.9 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.481 ' CA ' HG12 ' A' ' 46' ' ' VAL . . . -61.54 -43.93 98.65 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.559 -1.417 . . . . 16.66 109.559 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -58.04 -40.69 81.56 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.286 -1.126 . . . . 50.0 109.82 -179.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.83 -39.12 69.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.097 -1.002 . . . . 50.0 108.736 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 31' ' ' LEU . 16.0 mt -59.71 -31.86 69.99 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.499 -0.751 . . . . 99.989999999999995 110.116 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.7 mttt -43.55 -28.53 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.08 -1.012 . . . . 99.989999999999995 109.577 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -52.82 -26.97 16.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 99.989999999999995 109.226 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.28 -33.64 69.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.328 -0.857 . . . . 50.0 109.257 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.08 2.0 57.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.773 -1.331 . . . . 16.66 109.773 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.15 57.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -1.18 . . . . 16.66 109.624 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.5 tt -139.1 169.24 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.133 -0.979 . . . . 50.0 109.719 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.81 165.93 21.27 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.774 -0.824 . . . . 16.66 108.774 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.2 -33.53 18.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.03 1.82 . . . . 50.0 110.146 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -63.16 -27.82 69.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.613 -0.68 . . . . 50.0 110.113 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.17 -36.14 30.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.93 -1.106 . . . . 16.66 108.389 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.515 HG23 ' CD1' ' A' ' 35' ' ' LEU . 76.4 t -66.41 -35.04 73.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.098 -0.704 . . . . 50.0 109.098 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -67.95 -38.05 82.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.872 -0.788 . . . . 50.0 108.872 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -67.15 -37.8 84.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.424 -0.797 . . . . 50.0 109.226 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.423 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.6 mtt -61.75 -46.81 88.03 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.196 -0.94 . . . . 16.66 108.854 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.524 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 35.2 mtp -61.96 -47.87 82.94 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.492 -0.755 . . . . 50.0 109.085 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.79 -19.48 41.32 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.365 -0.835 . . . . 50.0 109.231 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -97.42 -36.15 10.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 16.66 109.029 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.565 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.8 mt -82.05 -32.13 10.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.515 -0.741 . . . . 50.0 109.797 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.483 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.0 t0 -59.19 101.63 0.1 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.245 -0.91 . . . . 16.66 108.965 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.511 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 80.9 p -71.04 -48.1 54.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 50.0 110.754 -178.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.405 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -85.79 -30.83 22.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.161 -0.962 . . . . 16.66 109.518 -179.585 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.483 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 92.84 27.91 13.26 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.862 -1.161 . . . . 16.66 110.343 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' OD2' ' OD1' ' A' ' 56' ' ' ASP . 1.4 p30 -81.87 -2.23 50.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.328 . . . . 50.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.524 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.89 -8.57 59.64 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.044 -1.074 . . . . 16.66 110.56 179.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 36.4 m-85 -132.95 156.17 47.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.948 -1.325 . . . . 50.0 111.24 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.542 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 25.5 mm -107.6 129.05 62.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.432 -0.951 . . . . 16.66 108.432 178.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.85 167.41 11.27 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.033 -1.042 . . . . 16.66 108.647 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.614 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 34.2 t80 -54.52 -42.57 71.0 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.025 -1.047 . . . . 16.66 108.545 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -60.52 -49.71 76.46 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.576 -0.702 . . . . 50.0 109.165 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.542 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 61.2 mt-10 -58.91 -46.8 87.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.258 -0.901 . . . . 16.66 109.08 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -63.86 -35.66 81.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.442 -0.786 . . . . 16.66 109.346 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.7 m -66.22 -48.69 69.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.37 -0.832 . . . . 50.0 109.166 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -59.88 -34.98 73.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 50.0 109.395 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.565 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -79.81 -37.65 34.69 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.422 -0.955 . . . . 50.0 108.422 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.434 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -57.88 -27.64 59.61 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.067 -1.613 . . . . 16.66 109.067 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -71.37 -32.2 68.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.445 -1.032 . . . . 50.0 108.811 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.43 -20.94 66.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.463 -0.773 . . . . 50.0 109.276 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.519 ' CB ' HD13 ' A' ' 76' ' ' LEU . 1.6 m-80 -152.12 55.89 0.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -0.84 . . . . 50.0 109.137 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 4.1 ptm180 -48.45 -34.11 10.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.877 . . . . 50.0 108.769 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.62 -31.7 75.92 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.347 -1.501 . . . . 25.0 109.347 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.519 HD13 ' CB ' ' A' ' 73' ' ' ASN . 65.7 mt -66.13 -44.46 84.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -1.147 . . . . 50.0 109.582 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.508 ' N ' HD21 ' A' ' 77' ' ' LEU . 4.6 mt -71.39 -19.13 62.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 50.0 109.843 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 14.5 mtmt -79.96 -28.37 39.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.177 -0.952 . . . . 50.0 109.271 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.92 -46.09 8.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 50.0 109.38 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.2 p -58.44 -44.19 88.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.803 0.811 . . . . 50.0 108.988 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.545 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -51.25 -38.45 52.7 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.297 -0.561 . . . . 50.0 109.767 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -68.77 -27.28 65.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 50.0 109.614 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.452 HG13 ' HA ' ' A' ' 80' ' ' VAL . 8.4 mt -60.66 -43.31 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.31 -0.869 . . . . 50.0 109.422 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.037 -0.982 . . . . 99.989999999999995 109.415 179.895 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -80.72 -20.28 43.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.526 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -57.79 140.27 52.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 25.0 109.409 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.486 ' CD2' ' CG ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -132.75 165.64 35.05 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 50.0 109.466 -179.967 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 45.4 Cg_endo -67.72 -22.02 44.14 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 122.553 2.169 . . . . 50.0 110.857 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.457 ' O ' ' HB1' ' A' ' 9' ' ' ALA . 19.1 mt-30 -58.89 -41.83 88.12 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.573 -0.704 . . . . 25.0 109.141 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.486 ' CG ' ' CD2' ' A' ' 4' ' ' HIS . 79.4 m-20 -53.48 -55.94 21.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.409 -0.807 . . . . 50.0 109.465 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.438 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 11.5 mttt -43.69 -37.48 2.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 50.0 109.633 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -60.53 -46.02 91.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 16.66 108.91 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.482 ' O ' HG13 ' A' ' 14' ' ' ILE . 83.9 mt-10 -69.02 -35.84 77.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.476 -0.765 . . . . 16.66 108.976 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.511 ' NH2' HG21 ' A' ' 67' ' ' THR . 17.0 mtm180 -70.12 -40.45 74.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 50.0 109.309 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.633 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 59.5 mt-10 -66.6 -41.9 87.71 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.394 -0.816 . . . . 50.0 109.411 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 18.9 mtp180 -66.47 -41.31 89.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 50.0 109.457 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 10' ' ' GLU . 41.8 mt -70.04 -43.94 78.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.237 -0.915 . . . . 50.0 109.059 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.583 ' CE1' HD13 ' A' ' 26' ' ' ILE . 70.2 t80 -64.35 -35.98 82.64 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.203 -0.936 . . . . 16.66 109.123 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -66.39 -30.43 70.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 50.0 109.12 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 60.0 mtt85 -69.32 -36.92 77.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 50.0 109.129 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CE1' ' CD1' ' A' ' 31' ' ' LEU . 46.1 m-85 -69.4 -50.82 42.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.421 -0.799 . . . . 16.66 109.475 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 23.6 t0 -55.32 103.43 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 16.66 108.685 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.64 -51.53 48.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.269 -0.894 . . . . 50.0 111.307 -178.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -87.5 -27.59 22.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.759 -1.213 . . . . 16.66 109.753 -179.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 90.23 38.2 6.42 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.767 -1.206 . . . . 16.66 110.242 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.8 p-10 -93.34 6.33 48.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.252 . . . . 16.66 109.192 179.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.6 -7.72 77.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.402 -1.079 . . . . 16.66 110.402 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 24.9 pttt -129.56 141.67 50.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.935 -1.332 . . . . 50.0 109.997 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.583 HD13 ' CE1' ' A' ' 15' ' ' PHE . 5.7 mt -111.85 133.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.642 -0.661 . . . . 16.66 109.547 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.9 p -105.87 166.28 10.59 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.759 -0.83 . . . . 50.0 108.759 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.09 -45.19 52.42 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.049 -1.032 . . . . 50.0 108.841 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.79 -39.55 77.8 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.331 -0.856 . . . . 50.0 109.517 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.2 mt-10 -74.65 -54.17 7.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.157 -0.965 . . . . 16.66 109.398 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.573 ' CD1' ' CE1' ' A' ' 18' ' ' PHE . 30.3 tp -61.77 -43.35 99.02 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.262 -0.899 . . . . 16.66 108.954 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 46' ' ' VAL . . . -62.71 -44.51 97.4 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.139 -1.584 . . . . 16.66 109.139 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 28.8 mt-10 -58.8 -42.74 89.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.355 -1.085 . . . . 50.0 109.868 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.79 -40.24 66.07 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.098 -1.001 . . . . 50.0 108.406 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.518 HD11 ' CG2' ' A' ' 46' ' ' VAL . 10.7 mt -58.71 -28.63 66.0 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.61 -0.681 . . . . 99.989999999999995 109.553 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 2.4 mtmt -44.04 -26.19 0.27 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 109.615 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.425 ' OG1' HG23 ' A' ' 83' ' ' ILE . 6.6 t -51.94 -26.31 10.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.306 -0.872 . . . . 99.989999999999995 109.195 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.9 mt -58.73 -37.19 75.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.438 -0.789 . . . . 50.0 109.199 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.98 -5.6 61.89 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.836 -1.305 . . . . 16.66 109.836 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.7 t -152.0 59.77 0.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.044 -1.268 . . . . 16.66 109.779 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.3 tp -134.0 157.2 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.152 -0.968 . . . . 50.0 109.485 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.11 160.02 27.65 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.461 -0.94 . . . . 16.66 108.461 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.77 -31.97 30.93 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 121.93 1.753 . . . . 50.0 110.066 178.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -72.15 -17.92 61.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.603 -0.685 . . . . 50.0 110.177 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -80.94 -37.51 29.34 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.815 -1.178 . . . . 16.66 108.28 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.518 ' CG2' HD11 ' A' ' 35' ' ' LEU . 65.6 t -68.23 -35.88 72.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.821 -0.807 . . . . 50.0 108.821 179.299 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -65.19 -40.4 94.17 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.797 -0.816 . . . . 50.0 108.797 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.481 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.7 t60 -66.03 -42.33 89.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.484 -0.76 . . . . 50.0 109.051 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.419 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.9 mtt -58.45 -44.42 89.19 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.249 -0.907 . . . . 16.66 108.71 179.482 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.531 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 34.6 mtp -61.69 -46.69 88.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.572 -0.705 . . . . 50.0 109.182 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.82 -21.36 41.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 50.0 109.042 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.85 -36.32 11.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.46 -0.775 . . . . 16.66 109.076 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.572 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.7 mt -80.59 -31.98 12.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.43 -0.794 . . . . 50.0 109.566 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 19.6 t0 -61.42 101.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.5 -0.75 . . . . 16.66 109.066 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.466 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 60.3 p -67.5 -46.42 72.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.269 -0.894 . . . . 50.0 110.692 -179.038 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -88.28 -41.41 12.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 16.66 109.56 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 103.67 29.54 5.56 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.964 -1.112 . . . . 16.66 110.346 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 13.3 p-10 -80.61 -2.57 46.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.877 -1.367 . . . . 50.0 109.112 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.531 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.72 -3.58 57.56 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.943 -1.263 . . . . 16.66 109.943 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.2 m-85 -137.0 156.82 47.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.023 -1.281 . . . . 50.0 111.336 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.546 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 25.1 mm -109.46 130.31 62.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.418 -0.956 . . . . 16.66 108.418 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -99.38 168.52 9.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.057 -1.027 . . . . 16.66 108.571 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.633 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.6 t80 -54.8 -43.73 73.16 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.022 -1.071 . . . . 16.66 108.609 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -58.66 -47.54 84.11 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.626 -0.671 . . . . 50.0 109.261 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.546 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 80.8 mt-10 -62.97 -46.54 87.22 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.29 -0.881 . . . . 16.66 109.221 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -63.81 -32.89 74.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 16.66 109.212 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.511 HG21 ' NH2' ' A' ' 11' ' ' ARG . 31.2 m -67.28 -49.35 64.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 50.0 109.171 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -59.74 -36.46 76.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.31 -0.869 . . . . 50.0 109.137 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.577 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -78.1 -38.91 43.02 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.504 -0.925 . . . . 50.0 108.504 179.706 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.446 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -57.49 -28.65 59.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.038 -1.625 . . . . 16.66 109.038 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 67' ' ' THR . 22.7 mtm180 -70.64 -31.91 69.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -1.076 . . . . 50.0 108.851 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.93 -23.51 62.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 50.0 109.238 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.494 ' CB ' HD11 ' A' ' 76' ' ' LEU . 15.5 m-80 -140.48 58.3 1.57 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 50.0 109.223 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.472 ' NH2' ' OD2' ' A' ' 7' ' ' ASP . 58.3 mtp180 -52.66 -34.86 53.6 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.328 -0.858 . . . . 50.0 108.998 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 78' ' ' LYS . . . -67.97 -24.25 74.42 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.48 -1.448 . . . . 25.0 109.48 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.494 HD11 ' CB ' ' A' ' 73' ' ' ASN . 14.6 mt -71.72 -45.99 60.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -1.148 . . . . 50.0 109.489 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.46 HD21 ' HA ' ' A' ' 74' ' ' ARG . 0.3 OUTLIER -62.86 -42.97 99.95 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.327 -0.858 . . . . 50.0 109.677 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 37.0 pttt -68.36 -31.24 70.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 50.0 109.247 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.454 ' O ' HG13 ' A' ' 83' ' ' ILE . 35.3 m-20 -74.78 -36.8 62.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.333 -0.854 . . . . 50.0 109.256 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.47 ' HA ' HG13 ' A' ' 83' ' ' ILE . 21.9 t -79.26 -35.64 17.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 50.0 109.22 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.97 -42.76 63.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.426 -0.796 . . . . 50.0 109.841 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -69.28 -26.08 64.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 50.0 109.573 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.47 HG13 ' HA ' ' A' ' 80' ' ' VAL . 13.7 mt -63.53 -45.19 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.866 . . . . 50.0 109.527 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.05 -0.976 . . . . 99.989999999999995 109.397 179.966 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.27 -7.68 59.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.225 -0.922 . . . . 0.0 109.561 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' OD1' ' NH2' ' A' ' 74' ' ' ARG . 85.0 m-20 -60.1 140.22 57.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 25.0 109.493 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.602 ' CG ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -113.25 151.84 44.63 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.217 -0.927 . . . . 50.0 108.948 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.602 ' HD2' ' CG ' ' A' ' 4' ' ' HIS . 40.0 Cg_endo -64.59 -20.04 65.29 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.257 1.971 . . . . 50.0 110.309 179.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 6' ' ' GLN . 15.5 mm-40 -59.21 -36.86 76.14 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.017 -0.735 . . . . 25.0 109.017 179.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -64.48 -45.21 88.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.391 -0.818 . . . . 50.0 109.45 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.514 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 13.3 mttp -49.57 -36.09 22.68 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.401 -0.812 . . . . 50.0 109.262 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.25 -46.35 90.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 16.66 108.755 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 14' ' ' ILE . 69.2 mt-10 -69.02 -37.81 78.85 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.876 -0.787 . . . . 16.66 108.876 179.386 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.514 ' NH2' ' HG2' ' A' ' 8' ' ' LYS . 10.8 mtm180 -69.57 -40.28 76.86 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.329 -0.857 . . . . 50.0 109.414 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.579 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 54.2 mt-10 -66.68 -39.73 88.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.406 -0.809 . . . . 50.0 109.476 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -69.11 -39.73 78.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 50.0 109.163 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 10' ' ' GLU . 45.4 mt -71.44 -44.13 71.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.334 -0.854 . . . . 50.0 109.063 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.58 ' CE1' HD13 ' A' ' 26' ' ' ILE . 68.7 t80 -69.91 -36.1 75.11 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.133 -0.979 . . . . 16.66 109.115 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 56.6 mttm -65.83 -31.5 72.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.329 -0.857 . . . . 50.0 109.031 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -71.37 -35.8 71.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 50.0 109.011 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.527 ' CB ' HD12 ' A' ' 26' ' ' ILE . 33.7 m-85 -67.83 -47.58 68.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 16.66 109.243 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 24.3 t0 -59.09 103.36 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 16.66 108.624 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.85 -51.32 56.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 50.0 111.257 -178.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -87.18 -30.64 20.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.739 -1.226 . . . . 16.66 109.872 -179.307 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 93.46 35.6 6.18 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.702 -1.237 . . . . 16.66 110.15 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.479 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.2 p-10 -90.28 4.75 49.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -1.184 . . . . 16.66 109.172 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.91 -6.26 76.55 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.432 -1.067 . . . . 16.66 110.432 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.5 pttp -131.26 142.58 50.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.93 -1.335 . . . . 50.0 110.079 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.58 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.9 mt -112.23 132.86 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.695 -0.628 . . . . 16.66 109.421 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.4 p -104.94 167.76 9.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.339 -0.851 . . . . 50.0 108.963 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.23 -45.34 53.85 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.138 -0.976 . . . . 50.0 108.987 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.53 -40.83 79.67 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.374 -0.829 . . . . 50.0 109.318 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.3 mt-10 -74.01 -54.57 7.59 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.271 -0.893 . . . . 16.66 109.218 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.515 ' CD2' HD13 ' A' ' 35' ' ' LEU . 5.6 tt -59.7 -46.58 88.65 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.209 -0.932 . . . . 16.66 108.806 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.517 ' CA ' HG13 ' A' ' 46' ' ' VAL . . . -60.83 -42.93 99.73 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.45 -1.46 . . . . 16.66 109.45 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -57.98 -41.83 83.78 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.336 -1.096 . . . . 50.0 109.881 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' CB ' ' CD1' ' A' ' 18' ' ' PHE . . . -71.26 -39.02 71.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.15 -0.969 . . . . 50.0 108.719 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.533 ' CD1' HG23 ' A' ' 46' ' ' VAL . 21.3 mt -59.77 -34.62 73.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.54 -0.725 . . . . 99.989999999999995 110.034 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 8.8 mttt -43.78 -28.12 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 99.989999999999995 109.53 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.518 ' OG1' ' CG2' ' A' ' 83' ' ' ILE . 6.6 t -52.48 -25.74 11.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.288 -0.883 . . . . 99.989999999999995 109.208 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.44 -30.36 71.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.301 -0.874 . . . . 50.0 109.317 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.97 6.37 52.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.738 -1.345 . . . . 16.66 109.738 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 t -154.58 58.67 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.164 -1.198 . . . . 16.66 109.713 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.0 tt -144.25 168.42 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.963 . . . . 50.0 109.47 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.41 166.04 20.18 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 16.66 108.786 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.45 -33.4 17.86 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.089 1.859 . . . . 50.0 110.085 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -62.68 -27.86 69.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.662 -0.649 . . . . 50.0 109.908 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -81.73 -35.89 29.21 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.833 -1.167 . . . . 16.66 108.255 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.533 HG23 ' CD1' ' A' ' 35' ' ' LEU . 79.3 t -67.1 -35.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.028 -0.73 . . . . 50.0 109.028 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -68.6 -38.02 80.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.854 -0.795 . . . . 50.0 108.854 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -67.05 -37.04 83.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 50.0 109.132 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.413 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.4 mtt -60.86 -47.56 85.83 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.272 -0.892 . . . . 16.66 108.811 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.525 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 56.5 mtp -61.28 -47.31 86.59 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.566 -0.709 . . . . 50.0 109.125 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.81 -20.74 37.91 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.292 -0.88 . . . . 50.0 109.171 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -98.93 -37.39 9.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 16.66 109.244 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.574 HG12 ' CD2' ' A' ' 69' ' ' PHE . 85.5 mt -80.35 -33.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.471 -0.768 . . . . 50.0 109.685 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.6 t0 -60.44 101.55 0.14 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.405 -0.809 . . . . 16.66 108.891 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.467 HG22 ' HG2' ' A' ' 65' ' ' GLU . 71.8 p -66.53 -47.9 71.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 50.0 110.785 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.2 p-10 -87.57 -38.8 15.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.106 -0.996 . . . . 16.66 109.452 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 101.12 27.65 7.24 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.945 -1.121 . . . . 16.66 110.492 179.403 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 15.6 p-10 -78.45 -0.75 30.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.865 -1.373 . . . . 50.0 109.224 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.525 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.47 -4.84 58.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.015 -1.234 . . . . 16.66 110.015 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 27.0 m-85 -136.86 157.17 47.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.926 -1.337 . . . . 50.0 111.34 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.541 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 23.1 mm -110.08 131.35 61.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.466 -0.939 . . . . 16.66 108.466 178.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 170.82 8.27 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.045 -1.035 . . . . 16.66 108.521 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.579 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 36.2 t80 -56.09 -44.45 79.02 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.121 -1.032 . . . . 16.66 108.657 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -59.04 -49.35 78.23 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.492 -0.755 . . . . 50.0 109.229 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.541 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 78.4 mt-10 -60.23 -46.49 89.59 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.261 -0.899 . . . . 16.66 109.265 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -63.6 -34.07 77.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.418 -0.802 . . . . 16.66 109.337 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.501 HG21 ' NH2' ' A' ' 11' ' ' ARG . 19.6 m -66.56 -48.97 67.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.843 . . . . 50.0 109.203 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -58.85 -36.22 74.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 50.0 109.24 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.574 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -79.88 -37.16 35.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.585 -0.894 . . . . 50.0 108.585 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.525 ' HA2' ' CD1' ' A' ' 77' ' ' LEU . . . -60.15 -28.71 67.05 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.383 -1.487 . . . . 16.66 109.383 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 67' ' ' THR . 75.5 mtm180 -72.68 -34.69 67.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 50.0 109.198 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.82 -18.98 65.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.434 -0.791 . . . . 50.0 109.298 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.49 ' HB3' ' CG ' ' A' ' 76' ' ' LEU . 29.4 m-80 -144.4 56.74 1.3 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.263 -0.898 . . . . 50.0 109.222 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 98.3 mtt180 -51.46 -40.3 59.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.713 -0.847 . . . . 50.0 108.713 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.442 ' HA3' ' HE3' ' A' ' 78' ' ' LYS . . . -60.27 -25.98 63.29 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.454 -1.459 . . . . 25.0 109.454 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.49 ' CG ' ' HB3' ' A' ' 73' ' ' ASN . 18.6 mt -72.7 -45.55 58.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -1.161 . . . . 50.0 109.43 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' CD1' ' HA2' ' A' ' 70' ' ' GLY . 10.5 mt -68.67 -16.46 63.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 50.0 109.777 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 18.6 mtmt -80.05 -24.35 40.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 50.0 109.322 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -91.99 -48.32 6.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.273 -0.892 . . . . 50.0 109.408 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.547 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.3 p -59.15 -44.33 91.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.388 -0.82 . . . . 50.0 109.178 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.547 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -49.62 -40.86 40.69 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.115 -0.634 . . . . 50.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -64.11 -25.74 68.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 50.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.518 ' CG2' ' OG1' ' A' ' 37' ' ' THR . 20.8 mm -66.79 -36.1 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 50.0 109.414 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.009 -0.996 . . . . 99.989999999999995 109.458 -179.999 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -88.94 7.52 34.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.935 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.36 142.02 57.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.9 . . . . 25.0 109.432 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.483 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -119.15 171.8 5.0 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 50.0 109.407 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.2 Cg_endo -68.63 -22.66 37.52 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.65 2.233 . . . . 50.0 111.002 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -63.91 -35.39 80.49 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.457 -0.777 . . . . 25.0 109.234 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -60.89 -44.5 97.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 50.0 109.296 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -51.18 -36.14 39.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 50.0 109.432 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.7 -45.53 85.57 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.655 -0.869 . . . . 16.66 108.655 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 14' ' ' ILE . 58.9 mt-10 -66.43 -43.82 84.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.955 -0.758 . . . . 16.66 108.955 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.477 ' NH2' ' HG2' ' A' ' 71' ' ' ARG . 20.0 mtt-85 -64.49 -39.74 94.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -0.782 . . . . 50.0 109.46 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.568 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 31.6 mt-10 -64.35 -41.62 96.65 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.48 -0.762 . . . . 50.0 109.286 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 52.0 mtp85 -67.99 -39.77 83.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.307 -0.871 . . . . 50.0 109.173 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.502 ' CD1' ' HB1' ' A' ' 81' ' ' ALA . 21.1 mt -70.52 -44.45 76.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.394 -0.816 . . . . 50.0 109.044 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.576 ' CE1' HD13 ' A' ' 26' ' ' ILE . 68.5 t80 -66.66 -36.1 81.73 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.243 -0.911 . . . . 16.66 109.141 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 22.6 mtpt -65.4 -30.22 71.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.352 -0.843 . . . . 50.0 109.089 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.515 ' NH2' ' O ' ' A' ' 84' ' ' PHE . 31.5 mtt180 -71.88 -35.22 69.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 50.0 109.057 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.527 ' CB ' HD12 ' A' ' 26' ' ' ILE . 31.0 m-85 -69.45 -48.77 59.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.448 -0.783 . . . . 16.66 109.298 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 23.2 t0 -58.74 103.09 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.917 . . . . 16.66 108.662 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.57 -51.82 52.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.128 -0.982 . . . . 50.0 111.239 -178.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -86.65 -27.9 23.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.748 -1.22 . . . . 16.66 109.565 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 89.33 38.1 6.83 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.862 -1.161 . . . . 16.66 110.215 179.021 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.474 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.4 p-10 -92.39 5.91 48.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -1.217 . . . . 16.66 109.142 179.168 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.88 -7.13 76.96 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.472 -1.051 . . . . 16.66 110.472 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 15.7 pttt -130.74 142.34 50.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.886 -1.361 . . . . 50.0 110.047 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.576 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.9 mt -112.3 133.23 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.724 -0.61 . . . . 16.66 109.447 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.7 p -106.93 169.74 8.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -0.891 . . . . 50.0 109.054 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.51 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.8 -46.76 59.85 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.108 -0.995 . . . . 50.0 108.985 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.19 74.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.266 -0.896 . . . . 50.0 109.467 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.489 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.4 mt-10 -75.56 -54.22 7.35 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.207 -0.933 . . . . 16.66 109.239 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.526 ' CD2' HD13 ' A' ' 35' ' ' LEU . 7.0 tt -59.58 -46.77 87.93 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.212 -0.93 . . . . 16.66 108.847 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' HA3' HG23 ' A' ' 46' ' ' VAL . . . -60.88 -43.33 99.43 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.461 -1.456 . . . . 16.66 109.461 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.32 -41.36 84.38 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.437 -1.037 . . . . 50.0 109.826 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.35 -39.81 67.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.166 -0.959 . . . . 50.0 108.726 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.526 HD13 ' CD2' ' A' ' 31' ' ' LEU . 14.1 mt -59.55 -32.28 70.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.446 -0.784 . . . . 99.989999999999995 109.832 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.6 mtmt -43.7 -26.32 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.065 -1.022 . . . . 99.989999999999995 109.632 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.463 ' CG2' HG23 ' A' ' 83' ' ' ILE . 7.6 t -52.4 -25.8 10.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 99.989999999999995 109.244 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.494 ' CD1' HD21 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -65.72 -31.86 73.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.372 -0.83 . . . . 50.0 109.201 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.07 11.04 43.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.479 -1.449 . . . . 16.66 109.479 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.33 50.02 0.56 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.242 -1.152 . . . . 16.66 109.54 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 tt -136.95 172.99 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 50.0 109.288 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.78 166.58 19.36 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 16.66 108.696 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.16 -33.81 18.01 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.089 1.859 . . . . 50.0 110.184 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -64.08 -26.14 68.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.635 -0.665 . . . . 50.0 110.117 -179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -82.52 -40.11 21.48 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.814 -1.179 . . . . 16.66 108.173 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.476 HG23 HD13 ' A' ' 35' ' ' LEU . 55.2 t -62.22 -35.93 71.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.692 -0.855 . . . . 50.0 108.692 179.199 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -69.62 -37.37 76.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.752 -0.833 . . . . 50.0 108.752 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.575 ' CD2' ' HG3' ' A' ' 52' ' ' GLU . 13.7 t-160 -67.35 -36.81 82.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.506 -0.746 . . . . 50.0 109.261 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.442 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.4 mtt -61.39 -46.79 88.7 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.18 -0.95 . . . . 16.66 108.789 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.522 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 43.0 mtp -62.26 -48.32 80.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.493 -0.755 . . . . 50.0 109.056 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.93 -19.38 29.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 50.0 109.209 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.575 ' HG3' ' CD2' ' A' ' 48' ' ' HIS . 23.1 mt-10 -99.65 -36.93 9.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 16.66 109.143 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.526 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.7 mt -80.47 -33.4 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.456 -0.777 . . . . 50.0 109.501 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.48 ' OD2' ' HA3' ' A' ' 57' ' ' GLY . 21.6 t0 -59.82 101.69 0.13 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.302 -0.874 . . . . 16.66 108.849 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 49.5 p -68.5 -46.36 69.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 50.0 110.736 -178.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.489 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -88.09 -38.88 15.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 16.66 109.539 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.48 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 101.61 28.34 6.73 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.019 -1.086 . . . . 16.66 110.523 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.489 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.4 p-10 -79.57 -2.0 40.45 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.783 -1.422 . . . . 50.0 109.13 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.522 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.34 -5.59 59.01 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.048 -1.221 . . . . 16.66 110.048 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 31.6 m-85 -134.99 156.59 48.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.008 -1.29 . . . . 50.0 111.407 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.555 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 22.1 mm -109.21 129.8 63.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.365 -0.976 . . . . 16.66 108.365 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -96.26 167.4 11.21 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.083 -1.01 . . . . 16.66 108.55 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.568 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 34.0 t80 -54.32 -42.39 70.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.014 -1.054 . . . . 16.66 108.442 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -61.19 -47.58 85.49 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.584 -0.697 . . . . 50.0 109.335 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.555 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 74.9 mt-10 -61.71 -47.02 87.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.244 -0.91 . . . . 16.66 109.2 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.553 ' CZ ' HD12 ' A' ' 77' ' ' LEU . 80.7 t80 -61.69 -39.11 90.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 16.66 109.375 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.459 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 15.9 m -66.27 -46.53 76.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.414 -0.804 . . . . 50.0 109.325 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -59.01 -36.53 75.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 50.0 109.64 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -78.66 -35.32 45.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.234 -0.917 . . . . 50.0 108.69 179.972 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.28 -28.79 64.91 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.385 -1.486 . . . . 16.66 109.385 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.477 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 35.9 mtm180 -73.46 -30.63 63.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -1.172 . . . . 50.0 109.253 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.47 -15.85 61.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 50.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.514 ' HB2' ' CD1' ' A' ' 76' ' ' LEU . 5.0 p30 -149.56 54.98 0.96 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 50.0 109.189 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -51.19 -43.16 61.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.368 -0.832 . . . . 50.0 108.791 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.85 -24.38 19.15 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.174 -1.57 . . . . 25.0 109.174 179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.514 ' CD1' ' HB2' ' A' ' 73' ' ' ASN . 41.9 mt -80.05 -43.49 21.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -1.091 . . . . 50.0 109.394 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.6 mm? -61.96 -40.03 94.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.411 -0.805 . . . . 50.0 109.845 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 43.3 mtpt -66.19 -33.63 76.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 50.0 109.653 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.19 -46.83 22.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 50.0 109.463 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.8 p -72.63 -40.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.79 0.805 . . . . 50.0 109.393 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 77' ' ' LEU . . . -53.69 -33.96 57.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.744 -0.597 . . . . 50.0 110.487 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 77.1 mttt -79.88 -22.98 42.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.018 . . . . 50.0 109.789 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.467 HG13 ' HA ' ' A' ' 80' ' ' VAL . 10.1 mt -57.59 -35.9 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 50.0 109.48 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.515 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 95.1 m-85 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.021 -0.99 . . . . 99.989999999999995 109.534 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 57.54 41.6 25.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -83.36 115.9 22.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 25.0 109.441 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.534 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -115.98 174.5 2.39 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.953 . . . . 50.0 109.197 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 47.2 Cg_endo -69.58 -22.88 32.3 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.502 2.134 . . . . 50.0 111.246 179.586 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -63.25 -36.32 83.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.364 -0.835 . . . . 25.0 109.297 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.65 -50.05 75.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.392 -0.818 . . . . 50.0 109.457 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -48.53 -36.3 15.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.363 -0.836 . . . . 50.0 109.355 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -56.38 -45.19 80.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.597 -0.89 . . . . 16.66 108.597 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.483 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.4 mt-10 -68.09 -38.61 82.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.47 -0.769 . . . . 16.66 108.947 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.8 mtt-85 -67.49 -40.58 85.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 50.0 109.387 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.621 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 33.2 mt-10 -64.9 -40.98 95.93 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.442 -0.786 . . . . 50.0 109.354 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 59.7 mtp180 -68.27 -39.54 82.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 50.0 109.154 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 10' ' ' GLU . 33.5 mt -70.93 -45.06 75.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.391 -0.818 . . . . 50.0 109.006 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 26' ' ' ILE . 67.2 t80 -64.86 -35.86 82.5 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 16.66 108.903 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -66.56 -29.42 69.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.32 -0.862 . . . . 50.0 108.962 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 39.2 mtt85 -70.04 -36.61 75.14 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.362 -0.836 . . . . 50.0 109.006 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.461 ' HB2' HD12 ' A' ' 26' ' ' ILE . 51.6 m-85 -70.22 -51.18 32.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.448 -0.782 . . . . 16.66 109.352 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' OD2' ' HA3' ' A' ' 22' ' ' GLY . 22.8 t0 -55.47 103.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 16.66 108.744 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.27 48.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.89 . . . . 50.0 111.196 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -87.06 -28.39 22.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.749 -1.219 . . . . 16.66 109.71 -179.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' A' ' 19' ' ' ASP . . . 90.13 37.4 6.73 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.801 -1.19 . . . . 16.66 110.216 178.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.473 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.7 p-10 -91.42 5.49 49.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -1.22 . . . . 16.66 109.157 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.09 -6.2 75.95 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.401 -1.08 . . . . 16.66 110.401 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 16.9 pttt -131.25 142.53 50.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.959 -1.318 . . . . 50.0 110.001 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.579 HD13 ' CE1' ' A' ' 15' ' ' PHE . 5.9 mt -112.52 133.55 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.639 -0.663 . . . . 16.66 109.495 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.0 p -106.47 167.8 9.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.866 . . . . 50.0 108.934 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.15 -45.53 53.29 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.072 -1.017 . . . . 50.0 108.93 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -57.22 -41.4 79.43 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.218 -0.926 . . . . 50.0 109.259 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.5 mt-10 -74.35 -54.85 6.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.346 -0.846 . . . . 16.66 109.001 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.527 ' CD2' HD13 ' A' ' 35' ' ' LEU . 6.1 tt -58.57 -48.58 80.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.869 . . . . 16.66 108.771 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.467 ' HA3' HG23 ' A' ' 46' ' ' VAL . . . -60.02 -43.44 98.2 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.308 -1.517 . . . . 16.66 109.308 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 19.0 mt-10 -56.81 -42.92 80.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.307 -1.114 . . . . 50.0 109.706 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.1 -39.41 68.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.116 -0.99 . . . . 50.0 108.502 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.527 HD13 ' CD2' ' A' ' 31' ' ' LEU . 14.0 mt -59.88 -33.3 71.65 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.56 -0.713 . . . . 99.989999999999995 109.865 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.4 mttm -43.97 -26.45 0.28 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 99.989999999999995 109.593 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.518 ' CG2' HG22 ' A' ' 83' ' ' ILE . 7.0 t -51.9 -24.56 6.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.286 -0.884 . . . . 99.989999999999995 109.288 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.503 ' CD1' HD21 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -61.84 -33.16 73.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 50.0 109.226 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.34 2.48 54.49 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.81 -1.316 . . . . 16.66 109.81 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.09 56.2 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.07 -1.253 . . . . 16.66 110.024 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.439 HD11 HD11 ' A' ' 38' ' ' LEU . 7.3 tt -138.38 167.54 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 50.0 109.41 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.17 165.18 17.0 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.617 -0.883 . . . . 16.66 108.617 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.21 -32.28 21.17 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.115 1.876 . . . . 50.0 110.192 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -64.22 -25.77 68.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.713 -0.617 . . . . 50.0 110.077 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.408 ' OE1' HG13 ' A' ' 41' ' ' ILE . 92.3 mt-10 -81.91 -41.3 21.1 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.854 -1.154 . . . . 16.66 108.133 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 35' ' ' LEU . 69.3 t -62.76 -35.8 72.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.959 -0.756 . . . . 50.0 108.959 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -68.42 -38.21 81.01 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.754 -0.832 . . . . 50.0 108.754 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -66.71 -35.97 81.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.389 -0.819 . . . . 50.0 109.245 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.436 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.2 mtt -60.86 -46.67 89.69 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.147 -0.971 . . . . 16.66 108.622 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.527 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 53.5 mtp -61.92 -48.88 78.46 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.928 -0.767 . . . . 50.0 108.928 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.11 -21.67 13.8 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.282 -0.886 . . . . 50.0 109.177 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -98.5 -36.37 9.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 16.66 109.19 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.561 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.2 mt -81.22 -30.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.548 -0.72 . . . . 50.0 109.766 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.2 t0 -61.66 101.84 0.22 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.439 -0.788 . . . . 16.66 109.363 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.49 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 71.6 p -73.54 -47.78 38.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.28 -0.888 . . . . 50.0 110.868 -179.017 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 10.9 p-10 -85.45 -29.5 24.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.037 -1.039 . . . . 16.66 109.821 -179.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' OD2' ' A' ' 54' ' ' ASP . . . 92.59 27.07 15.64 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.837 -1.173 . . . . 16.66 110.836 178.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.482 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p-10 -82.06 -2.68 52.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.785 -1.42 . . . . 50.0 109.424 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.527 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.3 -5.08 60.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.345 -1.102 . . . . 16.66 110.345 179.284 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 43.0 m-85 -134.28 153.69 51.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.987 -1.302 . . . . 50.0 111.093 -179.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 33.0 mm -105.05 128.62 58.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.516 -0.92 . . . . 16.66 108.516 178.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 m -94.87 167.2 11.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.159 -0.963 . . . . 16.66 108.613 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.621 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 35.5 t80 -54.78 -42.6 71.93 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.059 -1.025 . . . . 16.66 108.625 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -60.74 -48.46 81.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.561 -0.712 . . . . 50.0 109.166 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.54 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 42.8 mt-10 -59.83 -46.9 87.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 16.66 109.224 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.572 ' CZ ' HD12 ' A' ' 77' ' ' LEU . 59.4 t80 -62.49 -38.63 90.65 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.492 -0.755 . . . . 16.66 109.398 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.462 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 16.6 m -66.04 -47.62 73.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.392 -0.818 . . . . 50.0 109.341 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.14 -36.7 75.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 50.0 109.463 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.561 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.82 -36.72 56.71 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.656 -0.868 . . . . 50.0 108.656 179.929 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.13 -31.09 64.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.209 -1.556 . . . . 16.66 109.209 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 67' ' ' THR . 71.6 mtp180 -67.7 -31.17 70.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -1.066 . . . . 50.0 108.957 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.56 -21.9 64.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.506 -0.746 . . . . 50.0 109.356 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.477 ' HB2' ' CG ' ' A' ' 76' ' ' LEU . 4.4 p30 -150.11 58.54 0.97 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 50.0 109.052 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -50.65 -38.2 44.95 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.29 -0.881 . . . . 50.0 108.685 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.16 -32.67 67.76 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.233 -1.547 . . . . 25.0 109.233 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.477 ' CG ' ' HB2' ' A' ' 73' ' ' ASN . 19.0 mt -64.12 -43.38 95.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.446 -1.032 . . . . 50.0 109.372 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.9 mm? -61.13 -40.29 93.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 50.0 109.786 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 15.1 mtpt -63.66 -33.93 76.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 50.0 109.623 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 79' ' ' ASP . 58.4 t0 -78.75 -49.27 13.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 50.0 109.556 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.7 p -64.56 -44.71 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 50.0 109.749 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.546 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -49.64 -39.94 37.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.683 -0.635 . . . . 50.0 109.776 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 75.1 mttt -69.91 -25.19 63.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 50.0 109.615 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.518 HG22 ' CG2' ' A' ' 37' ' ' THR . 9.4 mt -65.03 -44.67 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 50.0 109.561 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.982 -1.008 . . . . 99.989999999999995 109.492 -179.998 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.395 0.617 . . . . 50.0 109.368 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -51.35 -39.5 57.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -0.868 . . . . 50.0 109.392 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.84 -41.45 64.26 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.315 -0.866 . . . . 16.66 108.69 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.9 mm-40 -67.07 -47.06 72.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.527 -0.733 . . . . 16.66 109.069 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.646 ' NH2' HG23 ' A' ' 67' ' ' THR . 11.2 mtm180 -65.34 -39.22 92.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.351 -0.843 . . . . 50.0 109.361 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.598 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 43.8 mt-10 -66.05 -41.31 91.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.438 -0.788 . . . . 50.0 109.228 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.4 mtt180 -66.46 -40.42 89.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.455 -0.778 . . . . 50.0 109.104 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.2 mt -70.18 -46.63 71.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.381 -0.824 . . . . 50.0 108.989 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -66.01 -35.35 80.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 16.66 109.281 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 19.9 mttt -66.08 -32.7 74.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.845 . . . . 50.0 109.351 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.55 ' CZ ' ' HB3' ' A' ' 84' ' ' PHE . 52.7 mtt180 -70.12 -35.45 74.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.877 . . . . 50.0 109.09 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.915 ' HB3' HD13 ' A' ' 26' ' ' ILE . 42.3 m-85 -67.88 -49.07 64.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.385 -0.822 . . . . 16.66 109.338 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.8 t0 -57.75 103.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 16.66 108.75 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.96 -51.49 54.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.274 -0.891 . . . . 50.0 111.185 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -87.78 -26.62 22.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.798 -1.189 . . . . 16.66 109.674 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 88.56 38.87 6.9 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.79 -1.195 . . . . 16.66 110.14 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.492 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -93.72 5.53 51.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.094 -1.239 . . . . 16.66 109.214 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.93 -8.09 73.41 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.485 -1.046 . . . . 16.66 110.485 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.0 pttp -130.13 142.01 50.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.937 -1.331 . . . . 50.0 110.042 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.915 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.0 mt -111.99 133.91 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.618 -0.676 . . . . 16.66 109.538 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.6 p -106.18 166.75 10.29 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.807 -0.812 . . . . 50.0 108.807 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.88 -45.76 51.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.055 -1.028 . . . . 50.0 108.874 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.12 -40.3 76.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.301 -0.874 . . . . 50.0 109.438 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.5 mt-10 -74.44 -54.14 8.17 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.211 -0.931 . . . . 16.66 109.373 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.815 ' HG ' HD12 ' A' ' 35' ' ' LEU . 63.1 tp -62.0 -43.03 99.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 16.66 109.044 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.58 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.41 -44.01 98.24 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.239 -1.545 . . . . 16.66 109.239 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -57.81 -43.48 85.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.355 -1.085 . . . . 50.0 109.729 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.82 -39.67 69.65 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.153 -0.967 . . . . 50.0 108.521 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.994 HD23 HD11 ' A' ' 38' ' ' LEU . 2.2 mt -59.18 -33.12 70.57 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.595 -0.691 . . . . 99.99 109.69 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' LEU . 17.7 mttt -44.85 -26.42 0.4 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.999 -1.063 . . . . 99.99 109.388 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.817 ' CG2' HG21 ' A' ' 83' ' ' ILE . 10.4 t -51.81 -25.54 7.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.244 -0.91 . . . . 99.99 109.258 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.994 HD11 HD23 ' A' ' 35' ' ' LEU . 1.5 mt -63.85 -32.74 74.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -0.843 . . . . 50.0 109.308 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.46 5.76 51.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.724 -1.35 . . . . 16.66 109.724 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.76 52.37 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -1.185 . . . . 16.66 109.715 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.599 HD12 HD13 ' A' ' 38' ' ' LEU . 13.5 tt -137.56 169.89 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 50.0 109.469 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.59 163.51 32.18 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.647 -0.871 . . . . 16.66 108.647 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.23 -33.51 24.2 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.03 1.82 . . . . 50.0 110.049 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -64.46 -24.96 67.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.675 -0.64 . . . . 50.0 109.892 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -83.12 -37.06 24.27 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.862 -1.149 . . . . 16.66 108.282 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.982 HG22 HD13 ' A' ' 35' ' ' LEU . 68.9 t -68.57 -36.73 75.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.927 -0.768 . . . . 50.0 108.927 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -67.9 -39.48 83.61 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.8 -0.815 . . . . 50.0 108.8 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.25 -39.6 92.86 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.441 -0.787 . . . . 50.0 109.194 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.413 ' O ' HG13 ' A' ' 53' ' ' ILE . 11.4 mtt -58.57 -43.78 89.53 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.186 -0.946 . . . . 16.66 108.861 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.528 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 57.7 mtp -61.76 -47.95 82.86 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.535 -0.728 . . . . 50.0 109.124 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.72 -20.76 36.65 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.309 -0.869 . . . . 50.0 109.187 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -97.37 -36.51 10.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 16.66 109.123 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.582 HG22 HD12 ' A' ' 61' ' ' ILE . 83.7 mt -81.8 -32.48 11.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.426 -0.796 . . . . 50.0 109.67 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.7 t0 -60.35 101.42 0.13 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.412 -0.805 . . . . 16.66 108.957 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.471 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 60.0 p -70.19 -46.86 63.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 50.0 110.75 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -86.69 -38.41 17.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.12 -0.987 . . . . 16.66 109.542 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.99 28.82 6.72 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.93 -1.128 . . . . 16.66 110.617 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.49 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.0 p-10 -80.37 -3.22 48.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.751 -1.441 . . . . 50.0 109.155 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.528 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.89 -5.07 57.88 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.922 -1.271 . . . . 16.66 109.922 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 40.8 m-85 -134.38 156.95 47.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.016 -1.285 . . . . 50.0 111.298 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.582 HD12 HG22 ' A' ' 53' ' ' ILE . 36.3 mm -108.2 130.28 61.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.212 -1.033 . . . . 16.66 108.212 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.6 m -99.95 167.68 10.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.998 -1.064 . . . . 16.66 108.673 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 41.3 t80 -54.96 -44.49 74.43 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.177 -1.009 . . . . 16.66 108.576 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -58.37 -47.14 84.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.564 -0.71 . . . . 50.0 109.165 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.548 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.7 mt-10 -62.49 -46.54 88.02 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.27 -0.894 . . . . 16.66 109.145 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.539 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 62.5 t80 -60.31 -37.75 81.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 16.66 109.19 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.646 HG23 ' NH2' ' A' ' 11' ' ' ARG . 12.1 m -65.69 -47.59 74.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.388 -0.82 . . . . 50.0 109.09 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -59.39 -40.48 86.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 50.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.564 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.06 -37.0 58.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.687 -0.857 . . . . 50.0 108.687 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -59.16 -31.98 70.47 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.355 -1.498 . . . . 16.66 109.355 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' THR . 59.5 mtm180 -71.06 -31.12 67.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -1.165 . . . . 50.0 109.399 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.49 -20.29 62.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.366 -0.834 . . . . 50.0 109.501 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.796 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.8 m-80 -149.38 54.95 0.97 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.258 -0.901 . . . . 50.0 109.479 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -51.46 -42.6 61.71 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.163 -0.96 . . . . 50.0 108.622 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.21 -20.6 29.24 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.526 -1.43 . . . . 25.0 109.526 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.796 HD12 ' CB ' ' A' ' 73' ' ' ASN . 33.2 mt -78.62 -43.7 25.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -1.187 . . . . 50.0 109.175 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.539 HD22 ' HZ ' ' A' ' 66' ' ' PHE . 20.8 mt -61.43 -35.95 79.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 50.0 109.699 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.429 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 10.5 mtmm -60.48 -26.96 67.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 50.0 109.382 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -76.21 -37.93 57.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.222 -0.924 . . . . 50.0 109.232 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -78.51 -31.28 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 50.0 109.562 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.88 -14.88 51.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 50.0 109.614 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -96.33 -31.97 12.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.917 . . . . 50.0 108.972 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.817 HG21 ' CG2' ' A' ' 37' ' ' THR . 38.0 mt -58.86 -38.93 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.46 -0.775 . . . . 50.0 109.316 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 17' ' ' ARG . 90.9 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.041 -0.98 . . . . 99.99 109.471 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 8' ' ' LYS . 77.9 m-20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.437 0.637 . . . . 50.0 109.435 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.459 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 30.6 mtpt -43.21 -36.8 1.88 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.804 . . . . 50.0 109.759 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.23 -46.96 87.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.238 -0.914 . . . . 16.66 108.834 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 44.1 mt-10 -68.22 -38.51 81.98 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.887 -0.783 . . . . 16.66 108.887 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.667 ' NH2' HG23 ' A' ' 67' ' ' THR . 13.0 mtm180 -68.37 -39.9 81.62 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.325 -0.859 . . . . 50.0 109.496 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.639 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 13.0 mt-10 -67.4 -41.75 84.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.415 -0.803 . . . . 50.0 109.432 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.8 mtp-105 -66.16 -41.46 90.32 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.3 -0.875 . . . . 50.0 109.299 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 10' ' ' GLU . 38.6 mt -69.83 -45.47 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.247 -0.908 . . . . 50.0 109.023 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.511 ' CE1' HD11 ' A' ' 26' ' ' ILE . 73.8 t80 -63.26 -36.43 83.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.423 -0.911 . . . . 16.66 108.933 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -64.89 -30.78 71.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.384 -0.822 . . . . 50.0 109.08 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 48.2 mtt180 -68.4 -37.09 80.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 50.0 109.12 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.918 ' HB3' HD13 ' A' ' 26' ' ' ILE . 57.3 m-85 -68.67 -50.98 46.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 16.66 109.577 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 21.6 t0 -55.71 103.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 16.66 108.925 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.6 -50.52 43.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.873 . . . . 50.0 111.118 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -87.02 -30.98 20.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.714 -1.241 . . . . 16.66 109.674 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.94 35.55 6.06 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.764 -1.208 . . . . 16.66 110.205 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.496 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 34.7 p-10 -90.79 3.7 53.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.257 . . . . 16.66 109.161 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.86 -5.83 72.98 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.48 -1.048 . . . . 16.66 110.48 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.8 pttp -132.0 143.39 50.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.898 -1.354 . . . . 50.0 110.086 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.2 mt -110.85 133.42 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.375 0.607 . . . . 16.66 109.685 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.409 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 10.5 p -105.83 166.57 10.38 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.491 -0.755 . . . . 50.0 108.973 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.73 -45.78 49.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.01 -1.056 . . . . 50.0 108.843 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -56.77 -41.09 77.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.288 -0.883 . . . . 50.0 109.334 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 60.5 mt-10 -74.5 -54.83 6.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.306 -0.871 . . . . 16.66 109.248 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.884 HD22 HG13 ' A' ' 46' ' ' VAL . 7.4 tt -60.5 -45.66 92.98 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.307 -0.871 . . . . 16.66 108.867 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.715 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.89 -44.74 96.99 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.104 -1.598 . . . . 16.66 109.104 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 24.2 mt-10 -57.65 -42.16 82.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.395 -1.062 . . . . 50.0 109.546 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.88 -39.94 66.0 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.389 -0.967 . . . . 50.0 108.389 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.95 ' CD1' HG22 ' A' ' 46' ' ' VAL . 6.6 mt -58.36 -33.25 69.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.539 -0.725 . . . . 99.99 109.502 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -44.4 -27.83 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 99.99 109.579 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.653 HG21 HG21 ' A' ' 83' ' ' ILE . 6.9 t -50.14 -25.37 3.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.897 . . . . 99.99 109.111 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.948 HD12 HD12 ' A' ' 41' ' ' ILE . 22.8 mt -62.63 -33.2 74.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.467 -0.771 . . . . 50.0 109.281 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.28 6.39 53.55 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 16.66 109.549 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.63 51.78 0.57 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -1.181 . . . . 16.66 109.473 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.948 HD12 HD12 ' A' ' 38' ' ' LEU . 11.8 tt -137.09 170.97 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.95 . . . . 50.0 109.486 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.99 167.22 16.75 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 16.66 108.873 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.28 -33.74 17.71 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.202 1.934 . . . . 50.0 110.192 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.6 -29.83 70.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.625 . . . . 50.0 110.01 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -81.66 -35.81 29.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.979 -1.076 . . . . 16.66 108.314 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.95 HG22 ' CD1' ' A' ' 35' ' ' LEU . 68.4 t -67.69 -35.87 74.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.045 -0.724 . . . . 50.0 109.045 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -70.65 -37.91 73.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.77 -0.826 . . . . 50.0 108.77 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -67.49 -36.72 81.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.506 -0.746 . . . . 50.0 109.125 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.433 ' O ' HG13 ' A' ' 53' ' ' ILE . 5.5 mtt -60.6 -47.35 86.61 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.259 -0.901 . . . . 16.66 108.749 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.631 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 49.7 mtp -62.17 -47.96 82.18 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 50.0 109.1 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.24 -18.63 27.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.291 -0.881 . . . . 50.0 109.146 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -97.95 -36.15 10.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.777 . . . . 16.66 109.106 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.648 HG22 HD12 ' A' ' 61' ' ' ILE . 83.4 mt -82.15 -32.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.532 -0.73 . . . . 50.0 109.733 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.9 t0 -58.62 101.31 0.08 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.403 -0.811 . . . . 16.66 109.2 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 76.8 p -71.07 -47.13 60.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 50.0 110.58 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -85.89 -37.33 19.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.143 -0.973 . . . . 16.66 109.469 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.57 28.32 7.14 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.918 -1.135 . . . . 16.66 110.744 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 9.0 p-10 -80.38 -3.24 48.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.755 -1.438 . . . . 50.0 109.059 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.631 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.76 -3.64 59.08 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.88 -1.288 . . . . 16.66 109.88 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 26.4 m-85 -135.21 157.2 47.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.07 -1.253 . . . . 50.0 111.26 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.648 HD12 HG22 ' A' ' 53' ' ' ILE . 36.6 mm -107.86 129.53 61.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.522 -0.918 . . . . 16.66 108.522 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.18 167.61 10.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.151 -0.968 . . . . 16.66 108.664 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.639 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.5 t80 -54.44 -43.81 71.92 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.113 -1.035 . . . . 16.66 108.526 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -58.26 -50.1 74.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.537 -0.727 . . . . 50.0 109.042 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 76.6 mt-10 -60.43 -46.41 90.13 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.317 -0.864 . . . . 16.66 109.013 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.754 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 62.0 t80 -62.09 -33.63 74.79 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.041 -0.725 . . . . 16.66 109.041 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.667 HG23 ' NH2' ' A' ' 11' ' ' ARG . 6.4 m -70.12 -48.01 59.35 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.366 -0.834 . . . . 50.0 108.952 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -60.27 -39.05 85.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 50.0 109.304 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.595 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -80.01 -38.53 31.86 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.585 -0.895 . . . . 50.0 108.585 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.872 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.69 -25.8 64.02 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.323 -1.511 . . . . 16.66 109.323 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 67' ' ' THR . 69.0 mtm180 -76.8 -35.23 57.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -1.162 . . . . 50.0 109.219 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.04 -17.43 64.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 50.0 109.181 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.621 ' CB ' HD12 ' A' ' 76' ' ' LEU . 6.4 p30 -148.03 51.46 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.78 . . . . 50.0 109.219 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 73.3 mtm180 -48.18 -38.17 17.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.242 -0.911 . . . . 50.0 108.704 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.55 -23.6 49.85 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.374 -1.49 . . . . 25.0 109.374 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.621 HD12 ' CB ' ' A' ' 73' ' ' ASN . 24.8 mt -77.51 -44.96 27.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -1.101 . . . . 50.0 109.342 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.872 HD11 ' HA3' ' A' ' 70' ' ' GLY . 19.0 mt -66.89 -21.16 66.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 50.0 109.842 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 30.6 mtmt -80.02 -19.31 47.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.063 -1.023 . . . . 50.0 109.32 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.21 -36.61 16.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -0.827 . . . . 50.0 109.366 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.465 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 85.4 t -71.83 -36.15 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.395 -0.816 . . . . 50.0 108.913 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.41 -49.12 67.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.382 -0.823 . . . . 50.0 109.368 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -62.19 -28.64 69.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.823 . . . . 50.0 109.583 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.653 HG21 HG21 ' A' ' 37' ' ' THR . 39.9 mt -61.27 -32.42 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -0.968 . . . . 50.0 109.316 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 17.2 m-85 . . . . . 0 C--N 1.302 -1.498 0 CA-C-O 117.977 -1.011 . . . . 99.99 109.499 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.284 -0.635 . . . . 50.0 109.284 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -52.44 -36.91 55.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 50.0 109.462 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.26 -46.27 88.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 16.66 108.751 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' O ' HG13 ' A' ' 14' ' ' ILE . 66.6 mm-40 -66.44 -42.81 87.13 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.911 -0.774 . . . . 16.66 108.911 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.627 ' NH2' HD12 ' A' ' 77' ' ' LEU . 31.7 mtt-85 -65.1 -40.28 94.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.537 -0.727 . . . . 50.0 109.474 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 49.4 mt-10 -63.85 -40.96 97.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.424 -0.797 . . . . 50.0 109.454 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 2.5 mtt-85 -68.46 -38.93 81.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 50.0 109.105 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.542 HG22 ' HE2' ' A' ' 18' ' ' PHE . 29.9 mt -71.31 -45.95 67.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.314 -0.866 . . . . 50.0 109.003 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.533 ' CE1' HD11 ' A' ' 26' ' ' ILE . 68.1 t80 -66.09 -36.07 82.19 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.179 -0.951 . . . . 16.66 109.181 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 39.5 mttt -65.55 -30.5 71.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.289 -0.882 . . . . 50.0 109.113 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -70.29 -37.48 74.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.854 . . . . 50.0 109.007 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.862 ' HB3' HD13 ' A' ' 26' ' ' ILE . 55.5 m-85 -67.56 -48.76 65.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 16.66 109.466 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.0 t0 -58.64 103.37 0.15 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 16.66 108.826 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.04 -51.56 37.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 50.0 111.132 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -85.69 -31.14 22.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.724 -1.235 . . . . 16.66 109.672 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.83 37.66 5.42 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.748 -1.215 . . . . 16.66 110.321 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.488 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.2 p-10 -93.08 6.37 48.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.042 -1.269 . . . . 16.66 109.207 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.61 -6.37 80.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.49 -1.044 . . . . 16.66 110.49 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.6 pttt -130.05 142.02 50.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.024 -1.28 . . . . 50.0 110.002 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.862 HD13 ' HB3' ' A' ' 18' ' ' PHE . 3.8 mt -112.0 133.22 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.437 0.637 . . . . 16.66 109.443 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.403 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 17.1 p -106.31 168.49 9.11 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.415 -0.803 . . . . 50.0 109.108 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.508 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.49 -46.26 56.87 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.144 -0.973 . . . . 50.0 108.853 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.31 75.99 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.345 -0.847 . . . . 50.0 109.394 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.8 mt-10 -75.86 -54.77 6.4 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.267 -0.896 . . . . 16.66 109.122 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.853 HD22 HG13 ' A' ' 46' ' ' VAL . 5.7 tt -60.47 -46.88 88.48 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.184 -0.948 . . . . 16.66 108.939 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.689 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.09 -43.1 99.61 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.28 -1.528 . . . . 16.66 109.28 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.68 -41.86 91.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.266 -1.138 . . . . 50.0 110.011 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.38 73.21 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.163 -0.961 . . . . 50.0 108.832 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.113 HD12 HG22 ' A' ' 46' ' ' VAL . 12.8 mt -60.64 -30.92 70.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.5 -0.75 . . . . 99.99 109.798 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -43.73 -26.43 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.987 . . . . 99.99 109.616 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.447 ' CG2' HG21 ' A' ' 83' ' ' ILE . 6.3 t -52.85 -24.94 10.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.192 -0.942 . . . . 99.99 109.39 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.717 HD13 HD12 ' A' ' 41' ' ' ILE . 5.6 mt -62.38 -32.28 73.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.87 . . . . 50.0 109.269 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.62 6.72 51.4 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.596 -1.402 . . . . 16.66 109.596 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.49 57.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -1.132 . . . . 16.66 109.478 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.717 HD12 HD13 ' A' ' 38' ' ' LEU . 11.1 tt -143.38 174.17 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 50.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.9 165.98 25.29 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.304 -0.872 . . . . 16.66 108.82 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -69.43 -33.54 17.61 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.138 1.892 . . . . 50.0 110.132 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -65.07 -24.57 67.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.657 -0.652 . . . . 50.0 110.077 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -82.16 -36.66 27.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.82 -1.175 . . . . 16.66 108.402 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.113 HG22 HD12 ' A' ' 35' ' ' LEU . 53.9 t -67.57 -35.64 73.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.563 -0.711 . . . . 50.0 109.145 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -65.72 -39.24 90.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.445 -0.785 . . . . 50.0 109.095 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -67.21 -36.73 82.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.335 -0.853 . . . . 50.0 109.309 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.404 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.3 mtt -61.31 -46.22 91.18 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.183 -0.948 . . . . 16.66 108.774 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.544 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 49.2 mtp -62.56 -48.02 81.31 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.566 -0.709 . . . . 50.0 109.147 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.0 -18.73 36.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 50.0 109.123 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -98.33 -36.5 9.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 16.66 109.175 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 61' ' ' ILE . 81.6 mt -82.08 -32.49 11.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.468 -0.77 . . . . 50.0 109.667 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.8 t0 -59.51 101.52 0.11 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.349 -0.844 . . . . 16.66 109.038 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.46 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 61.0 p -68.85 -47.18 66.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -0.875 . . . . 50.0 110.658 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -86.79 -39.1 16.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 16.66 109.448 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 102.08 28.01 6.7 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.878 -1.153 . . . . 16.66 110.444 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.3 p-10 -79.02 -2.35 39.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.786 -1.42 . . . . 50.0 109.016 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.544 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.35 -2.91 59.47 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.709 -1.357 . . . . 16.66 109.709 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 25.5 m-85 -136.47 157.57 46.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.086 -1.244 . . . . 50.0 111.376 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.602 HD12 HG22 ' A' ' 53' ' ' ILE . 29.1 mm -109.76 130.24 63.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.565 -0.902 . . . . 16.66 108.565 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -97.64 168.41 10.36 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.133 -0.979 . . . . 16.66 108.599 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 37.7 t80 -55.36 -43.28 74.91 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.031 -1.043 . . . . 16.66 108.718 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -60.6 -46.4 90.4 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.553 -0.717 . . . . 50.0 109.31 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.571 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 76.7 mt-10 -62.05 -46.83 87.4 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.285 -0.884 . . . . 16.66 109.096 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.495 ' CZ ' ' CD2' ' A' ' 77' ' ' LEU . 49.8 t80 -61.06 -40.52 93.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.444 -0.785 . . . . 16.66 109.25 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.1 m -64.74 -47.32 78.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.362 -0.837 . . . . 50.0 109.209 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -58.45 -38.46 77.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 50.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.91 -35.57 50.5 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.642 -0.873 . . . . 50.0 108.642 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.546 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.14 -29.91 63.26 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.302 -1.519 . . . . 16.66 109.302 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 67' ' ' THR . 83.0 mtm180 -71.51 -29.63 65.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.124 . . . . 50.0 109.165 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' A' ' 73' ' ' ASN . . . -70.41 -21.04 62.88 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.335 -0.853 . . . . 50.0 109.278 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.807 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.4 m-80 -152.1 56.06 0.83 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 50.0 109.299 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -48.71 -38.53 21.77 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.705 -0.85 . . . . 50.0 108.705 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.08 -30.23 63.5 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.329 -1.508 . . . . 25.0 109.329 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.807 HD12 ' CB ' ' A' ' 73' ' ' ASN . 32.3 mt -69.39 -45.69 68.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -1.085 . . . . 50.0 109.464 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.627 HD12 ' NH2' ' A' ' 11' ' ' ARG . 25.4 mt -63.68 -23.11 67.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.814 . . . . 50.0 109.902 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 26.7 mtmt -79.97 -18.54 50.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.105 -0.997 . . . . 50.0 109.49 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.65 -33.39 27.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 50.0 109.3 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 t -85.36 -27.9 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.853 . . . . 50.0 109.147 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.16 -16.05 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 50.0 109.597 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 15.4 mttt -94.34 -32.92 13.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 50.0 109.275 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.447 HG21 ' CG2' ' A' ' 37' ' ' THR . 10.0 mt -58.2 -36.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.366 -0.834 . . . . 50.0 109.35 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.019 -0.991 . . . . 99.99 109.437 -179.92 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.408 0.623 . . . . 50.0 109.32 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -49.43 -36.41 22.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 50.0 109.6 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.79 -45.68 89.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.307 -0.871 . . . . 16.66 108.715 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 67.2 mt-10 -68.2 -40.45 82.17 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.46 -0.775 . . . . 16.66 109.007 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.739 ' NH2' HG23 ' A' ' 67' ' ' THR . 46.5 mtm180 -68.07 -39.95 82.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.37 -0.831 . . . . 50.0 109.33 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.572 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 43.3 mt-10 -66.75 -41.84 87.15 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.478 -0.763 . . . . 50.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 13.3 mtp180 -65.63 -40.84 92.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.28 -0.888 . . . . 50.0 109.201 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 81' ' ' ALA . 30.7 mt -70.26 -46.94 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.305 -0.872 . . . . 50.0 108.91 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -66.32 -34.99 79.24 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.216 -0.928 . . . . 16.66 108.918 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 55.0 mttm -65.15 -34.27 78.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.366 -0.834 . . . . 50.0 109.392 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.584 ' NH2' ' HB1' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -74.48 -26.11 59.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.895 . . . . 50.0 109.227 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.951 ' HB3' HD13 ' A' ' 26' ' ' ILE . 23.3 m-85 -73.45 -43.21 60.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 16.66 109.057 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.6 t0 -63.72 103.26 0.53 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.334 -0.854 . . . . 16.66 108.757 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.13 64.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.161 -0.962 . . . . 50.0 111.248 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -89.49 -27.18 20.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.727 -1.233 . . . . 16.66 109.705 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.66 35.1 8.01 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.096 -1.201 . . . . 16.66 110.096 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 37.1 p-10 -88.85 4.04 49.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -1.198 . . . . 16.66 109.21 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.99 -5.76 72.47 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.381 -1.087 . . . . 16.66 110.381 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.5 pttp -132.34 143.32 49.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.948 -1.325 . . . . 50.0 110.068 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.951 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.8 mt -111.46 134.54 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.652 -0.655 . . . . 16.66 109.45 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.5 p -106.61 166.22 10.72 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.299 -0.876 . . . . 50.0 108.712 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.5 -45.6 47.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.041 -1.037 . . . . 50.0 108.843 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.19 75.82 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.363 -0.836 . . . . 50.0 109.521 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.507 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.8 mt-10 -75.82 -54.51 6.81 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.198 -0.939 . . . . 16.66 109.291 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.636 ' HG ' HD12 ' A' ' 35' ' ' LEU . 58.3 tp -61.84 -43.05 99.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 16.66 108.955 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.528 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.27 -44.29 97.89 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.233 -1.547 . . . . 16.66 109.233 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -58.54 -43.23 89.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.308 -1.113 . . . . 50.0 109.724 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HB1' ' NH2' ' A' ' 17' ' ' ARG . . . -73.06 -40.73 64.83 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.088 -1.007 . . . . 50.0 108.333 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.076 HD13 HG22 ' A' ' 46' ' ' VAL . 7.5 mt -58.64 -32.61 69.21 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.568 -0.707 . . . . 99.99 109.423 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -44.98 -26.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 99.99 109.423 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 t -49.17 -24.87 1.88 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 99.99 109.026 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.82 HD13 HD12 ' A' ' 41' ' ' ILE . 16.7 mt -58.87 -33.45 70.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.499 -0.751 . . . . 50.0 109.101 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.06 -0.39 58.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.885 -1.286 . . . . 16.66 109.885 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.07 58.62 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.251 . . . . 16.66 109.965 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.82 HD12 HD13 ' A' ' 38' ' ' LEU . 10.8 tt -138.1 173.18 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.098 -1.001 . . . . 50.0 109.528 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.27 163.02 40.69 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.642 -0.873 . . . . 16.66 108.642 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.15 -33.27 25.34 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.009 1.806 . . . . 50.0 110.083 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.92 -26.29 68.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.636 -0.665 . . . . 50.0 109.95 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -82.1 -36.87 27.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.855 -1.153 . . . . 16.66 108.431 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.076 HG22 HD13 ' A' ' 35' ' ' LEU . 47.1 t -68.96 -36.67 75.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.038 -0.727 . . . . 50.0 109.038 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -65.65 -40.15 92.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.475 -0.766 . . . . 50.0 109.028 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -65.48 -40.89 93.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 50.0 109.257 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.1 mtt -58.68 -43.52 89.99 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.243 -0.911 . . . . 16.66 108.817 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.723 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 31.7 mtp -61.45 -47.55 85.18 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.451 -0.781 . . . . 50.0 109.245 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.04 -20.56 54.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 50.0 109.28 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -95.4 -36.35 11.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.398 -0.814 . . . . 16.66 109.047 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.576 HG22 HD12 ' A' ' 61' ' ' ILE . 82.4 mt -81.92 -31.46 10.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 50.0 109.699 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.9 t0 -60.93 101.46 0.15 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.439 -0.788 . . . . 16.66 108.989 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.469 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 55.6 p -69.72 -46.1 66.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 50.0 110.71 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.489 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.0 p-10 -87.6 -40.32 14.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.106 -0.996 . . . . 16.66 109.502 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 102.95 29.67 5.73 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.932 -1.128 . . . . 16.66 110.523 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.489 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.8 p-10 -81.41 -3.74 53.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.865 -1.374 . . . . 50.0 109.144 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.723 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.66 -3.41 57.57 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.857 -1.297 . . . . 16.66 109.857 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.8 m-85 -135.85 156.58 48.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.059 -1.259 . . . . 50.0 111.15 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.576 HD12 HG22 ' A' ' 53' ' ' ILE . 35.0 mm -108.88 129.91 62.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.397 -0.964 . . . . 16.66 108.397 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.55 167.42 10.6 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.057 -1.027 . . . . 16.66 108.812 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.5 t80 -54.21 -43.62 70.94 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.297 -0.961 . . . . 16.66 108.521 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -58.93 -47.9 83.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.525 -0.735 . . . . 50.0 109.085 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.559 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 81.2 mt-10 -62.34 -46.94 86.4 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.288 -0.883 . . . . 16.66 109.119 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.626 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 51.2 t80 -59.52 -39.14 82.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.426 -0.796 . . . . 16.66 109.103 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.739 HG23 ' NH2' ' A' ' 11' ' ' ARG . 18.0 m -66.42 -46.68 75.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 50.0 109.089 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.0 -40.76 85.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 50.0 109.246 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.574 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -75.89 -36.8 59.37 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.566 -0.901 . . . . 50.0 108.566 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.688 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.96 -34.17 77.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.2 -1.56 . . . . 16.66 109.2 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 67' ' ' THR . 74.4 mtm180 -65.95 -33.48 75.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -1.12 . . . . 50.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.438 ' O ' ' OD1' ' A' ' 73' ' ' ASN . . . -67.68 -20.99 65.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.834 . . . . 50.0 109.301 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.84 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.7 m-80 -152.24 56.43 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 50.0 109.162 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -49.6 -37.09 26.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.334 -0.854 . . . . 50.0 108.736 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.37 -31.16 69.33 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.22 -1.552 . . . . 25.0 109.22 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.84 HD12 ' CB ' ' A' ' 73' ' ' ASN . 50.6 mt -67.26 -44.88 78.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -1.09 . . . . 50.0 109.419 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.688 HD11 ' HA3' ' A' ' 70' ' ' GLY . 19.9 mt -63.77 -31.43 72.61 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.321 -0.862 . . . . 50.0 109.766 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -64.58 -27.13 68.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 50.0 109.255 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -76.26 -34.65 59.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 50.0 109.517 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.418 HG13 ' HE2' ' A' ' 84' ' ' PHE . 23.4 t -81.03 -31.22 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 50.0 109.601 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 14' ' ' ILE . . . -63.4 -19.02 64.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 50.0 109.691 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -89.39 -30.57 18.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 50.0 109.137 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.8 mt -64.97 -36.59 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.382 -0.824 . . . . 50.0 109.24 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.569 ' CE1' ' NH2' ' A' ' 17' ' ' ARG . 61.2 m-85 . . . . . 0 C--N 1.302 -1.483 0 CA-C-O 117.99 -1.005 . . . . 99.99 109.544 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.404 0.621 . . . . 50.0 109.394 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -53.29 -35.92 60.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 50.0 109.196 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 -45.74 90.26 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.853 -0.795 . . . . 16.66 108.853 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 14' ' ' ILE . 59.7 mm-40 -68.53 -40.55 80.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 16.66 108.832 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.827 ' NH1' HG23 ' A' ' 67' ' ' THR . 19.8 mtm180 -68.11 -38.95 82.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.458 -0.776 . . . . 50.0 109.377 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.641 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 8.7 mt-10 -68.03 -39.83 83.01 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.433 -0.792 . . . . 50.0 109.346 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 5.6 mtt180 -67.08 -40.53 87.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.293 -0.879 . . . . 50.0 109.267 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.641 HG22 ' HE2' ' A' ' 18' ' ' PHE . 25.6 mt -70.28 -46.62 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.383 -0.823 . . . . 50.0 108.865 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.42 ' CE1' HD11 ' A' ' 26' ' ' ILE . 70.5 t80 -63.56 -35.74 81.48 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.339 -0.851 . . . . 16.66 109.097 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -66.19 -30.43 70.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 50.0 109.229 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 74.8 mtt180 -69.17 -38.1 78.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 50.0 109.256 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.805 ' HB3' HD13 ' A' ' 26' ' ' ILE . 67.2 m-85 -67.42 -49.13 65.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 16.66 109.49 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.1 t0 -56.48 103.48 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 16.66 108.746 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.91 -51.56 46.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.274 -0.891 . . . . 50.0 111.247 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -86.92 -30.0 21.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.719 -1.238 . . . . 16.66 109.856 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 92.95 37.39 5.73 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.777 -1.202 . . . . 16.66 110.179 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.492 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 37.7 p-10 -92.87 5.38 51.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -1.2 . . . . 16.66 109.243 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.95 -7.01 76.83 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.138 -1.03 . . . . 16.66 110.568 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.1 pttm -130.49 142.25 50.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.908 -1.348 . . . . 50.0 109.872 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.805 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.1 mt -111.93 133.22 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.36 0.6 . . . . 16.66 109.527 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.9 p -105.02 166.83 10.11 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.856 -0.794 . . . . 50.0 108.856 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.1 -45.29 52.58 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.157 -0.965 . . . . 50.0 108.887 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.39 78.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.317 -0.865 . . . . 50.0 109.474 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.7 mt-10 -74.99 -54.3 7.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.165 -0.959 . . . . 16.66 109.334 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.805 ' O ' HD23 ' A' ' 31' ' ' LEU . 1.9 tt -61.94 -43.98 97.71 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.283 -0.886 . . . . 16.66 108.798 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.755 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -63.66 -44.48 96.36 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.191 -1.564 . . . . 16.66 109.191 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -59.82 -41.45 91.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.324 -1.104 . . . . 50.0 109.892 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.98 -39.87 68.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.129 -0.982 . . . . 50.0 108.732 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.054 HD12 HG22 ' A' ' 46' ' ' VAL . 8.4 mt -60.21 -30.83 69.64 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.5 -0.75 . . . . 99.99 109.865 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -44.31 -25.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -1.0 . . . . 99.99 109.865 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.687 ' CG2' HG21 ' A' ' 83' ' ' ILE . 6.6 t -50.77 -23.15 2.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.156 -0.965 . . . . 99.99 109.22 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.854 HD12 HD12 ' A' ' 41' ' ' ILE . 25.6 mt -60.74 -33.69 73.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 50.0 109.312 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.46 -0.74 59.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.777 -1.329 . . . . 16.66 109.777 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 40' ' ' SER . 2.3 t -155.25 66.45 0.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.114 -1.227 . . . . 16.66 109.654 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.854 HD12 HD12 ' A' ' 38' ' ' LEU . 14.2 tt -149.26 168.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.141 -0.974 . . . . 50.0 109.598 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.83 163.9 22.24 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 16.66 108.872 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 49.8 Cg_endo -70.66 -30.7 17.72 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.078 1.852 . . . . 50.0 109.94 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.75 -23.49 66.1 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.54 -0.725 . . . . 50.0 110.078 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.4 ' OE1' HG13 ' A' ' 41' ' ' ILE . 86.1 mt-10 -79.87 -35.13 38.57 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.891 -1.13 . . . . 16.66 108.505 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.054 HG22 HD12 ' A' ' 35' ' ' LEU . 55.0 t -69.39 -35.75 68.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.909 -0.774 . . . . 50.0 108.909 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 82.7 mttt -62.36 -40.25 95.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.432 -0.792 . . . . 50.0 108.994 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.37 -39.42 92.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.433 -0.792 . . . . 50.0 109.299 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.438 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.9 mtt -59.48 -45.2 92.34 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.239 -0.913 . . . . 16.66 108.854 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.52 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 50.1 mtp -62.27 -48.68 78.83 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.439 -0.788 . . . . 50.0 109.122 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.7 -19.02 24.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 50.0 109.362 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -99.78 -36.3 9.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 16.66 109.306 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.596 HG12 ' CD2' ' A' ' 69' ' ' PHE . 80.2 mt -82.5 -32.93 10.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.451 -0.781 . . . . 50.0 109.816 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.7 t0 -59.52 101.23 0.1 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.289 -0.882 . . . . 16.66 108.999 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.473 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 54.6 p -66.19 -46.37 77.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 50.0 110.64 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -88.85 -42.18 12.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 16.66 109.634 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 104.14 29.82 5.31 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.203 -1.159 . . . . 16.66 110.203 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 13.0 p-10 -80.46 -2.45 45.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.983 -1.304 . . . . 50.0 109.134 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.52 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 100.04 -3.47 57.05 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.767 -1.333 . . . . 16.66 109.767 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.576 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 30.6 m-85 -137.01 156.35 48.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.006 -1.291 . . . . 50.0 111.49 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.543 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 25.5 mm -109.67 130.68 62.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.308 -0.997 . . . . 16.66 108.308 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 m -99.47 168.7 9.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.023 -1.048 . . . . 16.66 108.714 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.641 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 36.5 t80 -54.97 -43.44 73.5 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.169 -1.012 . . . . 16.66 108.655 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -59.92 -48.63 80.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.608 -0.683 . . . . 50.0 109.237 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.543 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 79.6 mt-10 -60.6 -47.03 88.02 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.291 -0.881 . . . . 16.66 109.064 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CE1' HD13 ' A' ' 77' ' ' LEU . 52.4 t80 -63.18 -32.66 74.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.437 -0.789 . . . . 16.66 109.255 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.827 HG23 ' NH1' ' A' ' 11' ' ' ARG . 51.9 m -68.26 -49.11 62.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 50.0 109.302 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -59.35 -36.9 76.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.26 -0.9 . . . . 50.0 109.381 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.74 -37.5 41.12 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.494 -0.928 . . . . 50.0 108.494 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.955 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.69 -29.2 63.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.197 -1.561 . . . . 16.66 109.197 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 67' ' ' THR . 80.5 mtm180 -71.3 -33.12 69.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.348 -1.089 . . . . 50.0 109.051 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.35 -20.81 65.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.832 . . . . 50.0 109.273 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.842 ' CB ' HD12 ' A' ' 76' ' ' LEU . 7.8 m-80 -146.24 58.37 1.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.396 -0.815 . . . . 50.0 109.114 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 65.9 mtm180 -51.35 -37.58 48.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 50.0 108.922 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.37 -27.82 70.01 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.348 -1.501 . . . . 25.0 109.348 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.842 HD12 ' CB ' ' A' ' 73' ' ' ASN . 22.4 mt -69.07 -45.38 70.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.387 -1.067 . . . . 50.0 109.67 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.955 HD11 ' HA3' ' A' ' 70' ' ' GLY . 4.3 mt -70.38 -19.41 63.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.389 -0.819 . . . . 50.0 109.874 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 40.7 mtmt -80.02 -27.05 39.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.104 -0.997 . . . . 50.0 109.508 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -91.41 -43.12 9.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 50.0 109.507 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.4 p -59.58 -45.46 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.776 0.798 . . . . 50.0 109.105 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.552 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -48.78 -38.33 21.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.716 -0.615 . . . . 50.0 109.85 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -69.58 -24.8 63.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 50.0 109.602 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.687 HG21 ' CG2' ' A' ' 37' ' ' THR . 13.6 mt -64.26 -45.43 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.383 -0.823 . . . . 50.0 109.556 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.461 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 80.1 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.02 -0.99 . . . . 99.99 109.362 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.233 -0.654 . . . . 50.0 109.233 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -52.02 -36.91 51.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.429 -0.794 . . . . 50.0 109.387 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.99 -46.16 85.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.567 -0.901 . . . . 16.66 108.567 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 14' ' ' ILE . 64.9 mt-10 -67.73 -39.52 84.25 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.854 -0.795 . . . . 16.66 108.854 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.422 ' NH1' ' HG ' ' A' ' 77' ' ' LEU . 55.2 mtt-85 -65.96 -40.4 91.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 50.0 109.336 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.59 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 44.0 mt-10 -64.86 -40.43 95.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.412 -0.805 . . . . 50.0 109.228 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.473 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 65.4 mtp180 -67.52 -40.48 85.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.347 -0.846 . . . . 50.0 109.236 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 10' ' ' GLU . 22.0 mt -70.37 -45.23 75.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.363 -0.835 . . . . 50.0 108.906 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.52 -36.03 82.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.273 -0.892 . . . . 16.66 109.008 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -65.76 -30.19 70.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.368 -0.832 . . . . 50.0 109.147 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.485 ' CD ' ' HB3' ' A' ' 84' ' ' PHE . 49.7 mtt85 -71.35 -34.76 70.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 50.0 109.22 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.93 ' HB3' HD13 ' A' ' 26' ' ' ILE . 42.9 m-85 -72.83 -47.98 41.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.418 -0.801 . . . . 16.66 109.432 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.468 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.7 t0 -59.22 103.28 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 16.66 108.499 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 -51.72 51.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.891 . . . . 50.0 111.426 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -87.7 -26.14 23.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.754 -1.216 . . . . 16.66 109.799 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 88.04 38.57 7.3 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.747 -1.216 . . . . 16.66 110.091 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -92.84 5.43 51.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -1.215 . . . . 16.66 109.206 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.09 -7.54 72.89 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.346 -1.101 . . . . 16.66 110.346 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 35.5 pttt -130.37 142.23 50.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.927 -1.337 . . . . 50.0 110.023 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.93 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.9 mt -112.33 134.22 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.63 -0.669 . . . . 16.66 109.39 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 p -107.21 167.64 9.77 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.36 -0.837 . . . . 50.0 108.823 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.513 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.28 -45.99 54.86 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.046 -1.034 . . . . 50.0 108.823 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.16 74.29 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.349 -0.844 . . . . 50.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.5 mt-10 -77.14 -54.17 6.85 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -0.947 . . . . 16.66 109.321 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.597 HD12 ' CE1' ' A' ' 18' ' ' PHE . 32.3 tp -63.12 -41.76 99.4 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.202 -0.936 . . . . 16.66 108.93 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.727 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -64.6 -44.9 94.37 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.199 -1.56 . . . . 16.66 109.199 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -59.07 -41.84 88.91 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.346 -1.091 . . . . 50.0 109.709 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.402 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.96 -40.2 65.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.161 -0.962 . . . . 50.0 108.554 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.798 ' CD1' HG22 ' A' ' 46' ' ' VAL . 11.3 mt -60.69 -31.22 70.49 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.52 -0.738 . . . . 99.99 109.564 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' LEU . 5.3 mttt -45.53 -25.56 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.018 -1.051 . . . . 99.99 109.48 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.615 ' CG2' HG21 ' A' ' 83' ' ' ILE . 9.6 t -52.04 -23.78 5.74 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.916 . . . . 99.99 109.183 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.68 HD13 HD12 ' A' ' 41' ' ' ILE . 9.2 mt -59.49 -33.27 71.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.352 -0.843 . . . . 50.0 109.216 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.13 0.75 57.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.719 -1.352 . . . . 16.66 109.719 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 t -154.72 64.64 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -1.204 . . . . 16.66 109.711 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.68 HD12 HD13 ' A' ' 38' ' ' LEU . 9.3 tt -147.09 175.6 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 50.0 109.42 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.91 164.52 34.54 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.254 -0.903 . . . . 16.66 108.781 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 46.7 Cg_endo -69.21 -33.27 19.07 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.117 1.878 . . . . 50.0 110.142 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -66.75 -22.86 66.04 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.25 -0.58 . . . . 50.0 110.102 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -82.33 -39.66 22.51 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.883 -1.135 . . . . 16.66 108.398 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.798 HG22 ' CD1' ' A' ' 35' ' ' LEU . 67.2 t -65.66 -35.91 76.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.69 -0.855 . . . . 50.0 108.69 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 81.4 mttt -67.17 -39.73 86.48 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.909 -0.774 . . . . 50.0 108.909 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.13 -40.92 91.03 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.428 -0.795 . . . . 50.0 109.183 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.421 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.9 mtt -59.65 -44.3 93.59 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.21 -0.931 . . . . 16.66 108.868 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.685 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 28.1 mtp -61.69 -47.15 86.6 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -0.762 . . . . 50.0 109.128 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.75 -22.07 44.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 50.0 109.141 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.19 -35.95 12.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 16.66 108.989 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.571 HG12 ' CD2' ' A' ' 69' ' ' PHE . 85.6 mt -80.77 -30.95 12.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.47 -0.769 . . . . 50.0 109.438 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.1 t0 -61.04 100.78 0.12 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.465 -0.772 . . . . 16.66 109.027 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.503 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 60.7 p -71.41 -46.5 60.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.288 -0.883 . . . . 50.0 110.436 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -31.02 22.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.135 -0.978 . . . . 16.66 109.534 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.477 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 93.11 28.31 12.05 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.847 -1.168 . . . . 16.66 110.222 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.8 -2.94 55.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.93 -1.335 . . . . 50.0 109.414 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.685 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.47 -7.12 59.59 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.999 -1.096 . . . . 16.66 110.457 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 42.1 m-85 -133.76 155.83 49.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.895 -1.356 . . . . 50.0 111.23 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.56 HD12 HG22 ' A' ' 53' ' ' ILE . 28.6 mm -106.68 127.81 61.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.516 -0.92 . . . . 16.66 108.516 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.53 166.27 12.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.158 -0.964 . . . . 16.66 108.626 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.59 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 35.8 t80 -54.3 -41.96 69.54 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.085 -1.009 . . . . 16.66 108.588 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -61.42 -49.68 75.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.969 -0.752 . . . . 50.0 108.969 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.552 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 33.9 mt-10 -58.28 -47.21 84.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 16.66 109.023 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.751 ' CE2' HD11 ' A' ' 77' ' ' LEU . 63.6 t80 -61.48 -40.48 94.71 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.52 -0.737 . . . . 16.66 109.294 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 13.3 m -65.16 -47.04 78.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.405 -0.809 . . . . 50.0 109.242 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -59.72 -37.79 79.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 50.0 109.349 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.71 -37.42 41.53 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.264 -0.897 . . . . 50.0 108.703 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.415 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -60.64 -28.9 68.63 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.361 -1.496 . . . . 16.66 109.361 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 67' ' ' THR . 67.8 mtm180 -73.3 -34.54 65.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -1.126 . . . . 50.0 109.24 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.83 -17.71 65.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 50.0 109.341 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.78 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.2 m-80 -148.33 55.28 1.03 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 50.0 109.275 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 75' ' ' GLY . 10.4 ptm180 -50.58 -41.42 54.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 50.0 108.806 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.444 ' N ' ' HG3' ' A' ' 74' ' ' ARG . . . -54.38 -20.2 15.45 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.343 -1.503 . . . . 25.0 109.343 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.78 HD12 ' CB ' ' A' ' 73' ' ' ASN . 48.5 mt -80.02 -43.0 22.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.313 -1.11 . . . . 50.0 109.373 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.751 HD11 ' CE2' ' A' ' 66' ' ' PHE . 1.8 mm? -61.27 -41.15 96.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.468 -0.77 . . . . 50.0 109.82 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.7 mtpp -63.05 -38.4 91.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 50.0 109.378 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -73.48 -49.44 26.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.41 -0.806 . . . . 50.0 109.57 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 77' ' ' LEU . 4.1 p -66.05 -43.17 92.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.372 -0.83 . . . . 50.0 109.589 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.534 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.25 -39.74 45.85 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.225 -0.59 . . . . 50.0 109.884 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 34.9 mttm -66.86 -26.02 66.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.935 . . . . 50.0 109.686 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.615 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.2 mt -63.17 -45.22 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 50.0 109.466 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.485 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 92.1 m-85 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.997 -1.001 . . . . 99.99 109.435 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.486 ' HB3' ' NH1' ' A' ' 11' ' ' ARG . 59.3 m-20 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.3 -0.63 . . . . 50.0 109.3 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -50.39 -37.48 37.77 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.437 -0.789 . . . . 50.0 109.359 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.99 -45.23 79.07 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.476 -0.935 . . . . 16.66 108.476 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 14' ' ' ILE . 53.0 mt-10 -65.44 -45.35 84.13 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.908 -0.775 . . . . 16.66 108.908 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.486 ' NH1' ' HB3' ' A' ' 7' ' ' ASP . 41.9 mtt180 -63.08 -40.93 99.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.395 -0.815 . . . . 50.0 109.395 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.584 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 7.4 mt-10 -64.88 -43.49 92.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.428 -0.795 . . . . 50.0 109.407 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.477 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.6 mtt180 -65.94 -41.36 91.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.888 . . . . 50.0 109.13 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 77' ' ' LEU . 26.0 mt -69.74 -44.53 79.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.302 -0.874 . . . . 50.0 109.19 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.467 ' CE2' HD11 ' A' ' 26' ' ' ILE . 62.0 t80 -66.91 -35.96 81.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.167 -0.958 . . . . 16.66 109.258 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -63.95 -32.4 73.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 50.0 109.383 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 62.7 mtt180 -70.88 -37.15 73.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 50.0 109.047 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.041 ' HB3' HD13 ' A' ' 26' ' ' ILE . 33.8 m-85 -68.43 -47.0 68.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 16.66 109.595 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.471 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.6 t0 -62.52 103.44 0.41 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 16.66 108.937 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.21 -50.88 43.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 50.0 111.213 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -86.34 -31.09 21.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.714 -1.241 . . . . 16.66 109.688 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.94 36.48 5.76 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.805 -1.188 . . . . 16.66 110.27 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.6 p-10 -92.02 4.01 53.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.074 -1.25 . . . . 16.66 109.377 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.78 -6.15 73.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.367 -1.093 . . . . 16.66 110.367 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 10.1 pttm -131.32 143.02 50.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.926 -1.338 . . . . 50.0 109.991 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.041 HD13 ' HB3' ' A' ' 18' ' ' PHE . 4.6 mt -111.97 133.64 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.462 0.648 . . . . 16.66 109.645 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.406 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 13.3 p -106.67 167.97 9.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.473 -0.767 . . . . 50.0 108.947 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.38 -46.35 56.0 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.066 -1.021 . . . . 50.0 108.822 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -56.31 -40.89 75.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.309 -0.869 . . . . 50.0 109.441 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.3 mt-10 -75.19 -54.44 7.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.23 -0.919 . . . . 16.66 109.251 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.804 HD22 HG13 ' A' ' 46' ' ' VAL . 7.2 tt -60.35 -45.27 94.08 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.295 -0.878 . . . . 16.66 108.799 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.614 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.21 -45.03 96.18 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.048 -1.621 . . . . 16.66 109.048 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 16.8 mt-10 -57.13 -42.89 81.77 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.329 -1.1 . . . . 50.0 109.579 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.06 -39.95 65.47 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.133 -0.979 . . . . 50.0 108.379 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.895 ' CD1' HG22 ' A' ' 46' ' ' VAL . 5.3 mt -59.16 -33.04 70.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.599 -0.688 . . . . 99.99 109.6 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -44.64 -26.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.076 -1.015 . . . . 99.99 109.455 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.505 ' CG2' HG21 ' A' ' 83' ' ' ILE . 8.5 t -53.11 -25.53 13.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 99.99 109.363 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.528 HD12 ' CD1' ' A' ' 41' ' ' ILE . 20.5 mt -61.31 -32.34 72.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 50.0 109.151 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.3 9.76 44.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.591 -1.404 . . . . 16.66 109.591 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.54 51.35 0.51 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -1.184 . . . . 16.66 109.444 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.528 ' CD1' HD12 ' A' ' 38' ' ' LEU . 5.5 tt -140.08 175.82 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 50.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.2 167.37 19.05 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.344 -0.848 . . . . 16.66 108.825 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.96 -34.41 17.44 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.972 1.782 . . . . 50.0 110.028 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.81 -29.24 70.03 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.711 -0.618 . . . . 50.0 109.919 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -80.87 -38.8 27.48 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.999 -1.063 . . . . 16.66 108.214 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.895 HG22 ' CD1' ' A' ' 35' ' ' LEU . 47.9 t -63.73 -36.97 78.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.023 -0.732 . . . . 50.0 109.023 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -70.23 -37.38 74.97 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.761 -0.829 . . . . 50.0 108.761 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.517 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.3 t60 -67.46 -37.75 83.41 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.347 -0.846 . . . . 50.0 109.203 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.3 mtt -60.93 -46.76 89.4 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.092 -1.005 . . . . 16.66 108.871 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.666 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 38.9 mtp -61.74 -47.64 84.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.537 -0.727 . . . . 50.0 109.213 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.03 -19.58 45.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 50.0 109.469 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.433 ' CD ' ' NE2' ' A' ' 48' ' ' HIS . 26.8 mt-10 -97.24 -35.8 10.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 16.66 109.108 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.571 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.6 mt -81.87 -32.5 11.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 50.0 109.658 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.4 t0 -59.11 101.37 0.09 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.352 -0.842 . . . . 16.66 109.094 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 46.5 p -69.54 -46.19 67.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.222 -0.924 . . . . 50.0 110.584 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -87.48 -38.13 16.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.967 . . . . 16.66 109.456 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 101.06 27.93 7.13 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.993 -1.099 . . . . 16.66 110.581 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.487 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 p-10 -79.45 -2.24 41.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.768 -1.43 . . . . 50.0 109.079 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.666 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.86 -4.97 59.5 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.996 -1.242 . . . . 16.66 109.996 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 28.1 m-85 -134.7 157.48 46.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.029 -1.277 . . . . 50.0 111.259 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.558 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 29.9 mm -108.59 128.17 64.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.172 -1.047 . . . . 16.66 108.172 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.406 ' H ' ' HB2' ' A' ' 65' ' ' GLU . 15.2 m -94.54 169.56 10.11 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.143 -0.973 . . . . 16.66 108.761 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.584 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 33.0 t80 -56.34 -43.22 78.84 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.223 -0.923 . . . . 16.66 108.943 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -62.53 -44.83 95.38 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.594 -0.691 . . . . 50.0 109.219 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.558 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 55.1 mt-10 -62.17 -47.43 84.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 16.66 109.157 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 46.1 t80 -62.65 -36.12 81.82 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.398 -0.814 . . . . 16.66 109.296 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.45 HG23 ' CD ' ' A' ' 11' ' ' ARG . 36.7 m -68.4 -47.16 68.05 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.29 -0.881 . . . . 50.0 109.148 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 71' ' ' ARG . 74.2 m-20 -58.95 -36.75 75.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 50.0 109.307 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.31 -36.48 53.99 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.496 -0.927 . . . . 50.0 108.496 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.873 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.02 -30.48 63.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.109 -1.597 . . . . 16.66 109.109 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.518 ' NH2' ' OD1' ' A' ' 68' ' ' ASP . 52.2 mtm180 -69.18 -30.75 69.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -1.067 . . . . 50.0 108.928 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.66 -21.66 63.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.441 -0.787 . . . . 50.0 109.261 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.765 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.4 m-80 -150.58 57.01 0.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.392 -0.818 . . . . 50.0 109.192 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 7.0 ptp85 -49.27 -36.99 22.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.284 -0.885 . . . . 50.0 108.781 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.439 ' HA2' ' HE2' ' A' ' 78' ' ' LYS . . . -60.34 -30.38 71.09 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.294 -1.522 . . . . 25.0 109.294 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.765 HD12 ' CB ' ' A' ' 73' ' ' ASN . 30.7 mt -68.39 -45.57 72.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -1.081 . . . . 50.0 109.485 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.873 HD11 ' HA3' ' A' ' 70' ' ' GLY . 17.4 mt -65.17 -19.43 65.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 50.0 109.678 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 10.6 mtmm -79.54 -21.02 45.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 50.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.1 -40.63 13.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.926 . . . . 50.0 109.37 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 1.4 p -71.97 -38.48 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.469 -0.769 . . . . 50.0 109.339 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.448 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -59.77 -14.81 16.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.66 -0.65 . . . . 50.0 109.703 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 48.6 mttp -98.17 -30.47 12.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.175 -0.953 . . . . 50.0 109.093 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.505 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.3 mt -56.09 -30.32 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.43 -0.794 . . . . 50.0 109.3 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.4 ' HB2' ' NH1' ' A' ' 17' ' ' ARG . 96.7 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.956 -1.021 . . . . 99.99 109.487 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.333 -0.617 . . . . 50.0 109.333 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -49.62 -37.01 26.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.444 -0.785 . . . . 50.0 109.342 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.75 -46.01 85.08 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.709 -0.848 . . . . 16.66 108.709 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 14' ' ' ILE . 60.2 mt-10 -67.29 -38.54 85.2 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.921 -0.77 . . . . 16.66 108.921 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.592 HH22 HD23 ' A' ' 77' ' ' LEU . 43.9 mtt-85 -67.37 -41.48 84.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.341 -0.85 . . . . 50.0 109.388 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.637 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 9.8 mt-10 -64.94 -42.61 94.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.616 -0.678 . . . . 50.0 109.451 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 70.0 mtp180 -64.93 -41.49 95.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 50.0 109.316 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.472 HG22 ' HE2' ' A' ' 18' ' ' PHE . 18.7 mt -69.45 -46.02 77.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.407 -0.808 . . . . 50.0 109.034 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CD2' ' HA ' ' A' ' 63' ' ' PHE . 59.0 t80 -63.62 -35.6 81.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.313 -0.867 . . . . 16.66 109.254 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -65.84 -31.86 73.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.827 . . . . 50.0 109.281 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 48.4 mtt180 -70.68 -33.66 71.15 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.29 -0.882 . . . . 50.0 109.183 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.903 ' HB3' HD13 ' A' ' 26' ' ' ILE . 45.2 m-85 -71.9 -49.12 40.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.348 -0.845 . . . . 16.66 109.498 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 25.7 t0 -57.88 103.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 16.66 108.646 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.18 -52.2 50.41 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.314 -0.866 . . . . 50.0 111.399 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -87.84 -23.49 23.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.84 -1.162 . . . . 16.66 109.688 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 84.84 41.3 7.72 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.001 -1.24 . . . . 16.66 110.001 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.502 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.7 p-10 -96.35 5.5 50.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.255 . . . . 16.66 109.267 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.24 -9.63 69.72 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.451 -1.06 . . . . 16.66 110.451 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.0 pttp -129.27 141.62 51.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.908 -1.348 . . . . 50.0 109.966 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.903 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.4 mt -112.67 134.31 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.693 -0.629 . . . . 16.66 109.444 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.4 p -105.75 166.94 10.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.74 -0.837 . . . . 50.0 108.74 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.04 -45.22 51.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.028 -1.045 . . . . 50.0 108.825 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.2 78.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.401 -0.812 . . . . 50.0 109.524 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.1 mt-10 -75.26 -54.32 7.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.218 -0.926 . . . . 16.66 109.265 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.608 HD12 ' CD1' ' A' ' 18' ' ' PHE . 34.7 tp -62.38 -42.69 99.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 16.66 108.957 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.595 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.67 -44.67 96.06 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.189 -1.564 . . . . 16.66 109.189 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.28 -42.2 86.06 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.312 -1.111 . . . . 50.0 109.655 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -74.56 -40.42 61.68 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.38 -0.97 . . . . 50.0 108.38 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.877 ' CD1' HG22 ' A' ' 46' ' ' VAL . 10.5 mt -60.52 -31.43 70.5 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.592 -0.692 . . . . 99.99 109.578 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -47.21 -23.71 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 99.99 109.527 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 t -52.15 -22.85 4.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 99.99 109.218 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.0 -32.07 73.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.479 -0.763 . . . . 50.0 109.288 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.23 7.13 50.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.674 -1.37 . . . . 16.66 109.674 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t -154.75 55.63 0.67 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -1.203 . . . . 16.66 109.653 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.0 tt -142.87 176.29 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 50.0 109.538 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.52 163.94 39.42 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.857 . . . . 16.66 108.697 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.49 -33.72 21.97 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.164 1.91 . . . . 50.0 110.209 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -65.87 -24.05 66.78 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.581 -0.699 . . . . 50.0 109.972 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -82.13 -38.52 24.64 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.944 -1.097 . . . . 16.66 108.393 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.877 HG22 ' CD1' ' A' ' 35' ' ' LEU . 42.8 t -68.45 -37.35 77.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.02 -0.733 . . . . 50.0 109.02 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -66.16 -40.28 90.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.372 -0.83 . . . . 50.0 108.941 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -64.87 -40.04 94.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.43 -0.794 . . . . 50.0 109.217 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.429 ' O ' HG13 ' A' ' 53' ' ' ILE . 7.1 mtt -57.61 -43.13 84.5 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.184 -0.947 . . . . 16.66 108.857 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.716 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 47.3 mtp -62.06 -48.0 82.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.561 -0.712 . . . . 50.0 109.266 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.58 -20.55 33.11 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.299 -0.876 . . . . 50.0 109.128 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -97.42 -36.42 10.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.455 -0.778 . . . . 16.66 109.184 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.577 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.5 mt -81.62 -32.45 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.352 -0.843 . . . . 50.0 109.569 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.7 t0 -59.74 101.41 0.11 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.393 -0.817 . . . . 16.66 109.047 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.47 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 67.6 p -70.71 -47.11 61.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 50.0 110.751 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.3 p-10 -86.54 -36.61 18.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.082 -1.011 . . . . 16.66 109.556 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 99.86 28.71 7.25 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.881 -1.152 . . . . 16.66 110.76 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.499 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.7 p-10 -81.03 -3.32 51.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.714 -1.463 . . . . 50.0 109.124 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.716 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.1 -4.47 58.85 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.855 -1.298 . . . . 16.66 109.855 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 44.3 m-85 -134.08 156.37 48.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.057 -1.261 . . . . 50.0 111.093 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.561 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 31.5 mm -108.16 129.88 61.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.142 -1.059 . . . . 16.66 108.142 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.5 166.51 11.48 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.103 -0.998 . . . . 16.66 108.709 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.637 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 34.6 t80 -53.48 -42.53 67.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.186 -1.006 . . . . 16.66 108.546 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -60.5 -49.33 77.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.618 -0.676 . . . . 50.0 109.25 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.561 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 75.3 mt-10 -59.86 -47.0 87.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 16.66 109.15 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -62.66 -36.23 82.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 16.66 109.223 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 21.7 m -67.81 -47.92 67.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 50.0 109.013 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.402 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 82.3 m-20 -59.32 -37.93 79.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.4 -0.813 . . . . 50.0 109.249 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.577 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.04 -37.26 55.11 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.503 -0.925 . . . . 50.0 108.503 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.547 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -58.61 -29.73 64.44 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.247 -1.541 . . . . 16.66 109.247 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 67' ' ' THR . 77.2 mtm180 -70.4 -30.84 67.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -1.127 . . . . 50.0 109.056 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.18 63.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.421 -0.799 . . . . 50.0 109.363 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.683 ' CB ' HD12 ' A' ' 76' ' ' LEU . 4.6 p30 -149.7 56.73 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 50.0 109.189 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.579 ' HA ' HD23 ' A' ' 77' ' ' LEU . 12.8 ptm180 -49.57 -37.13 26.16 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.386 -0.821 . . . . 50.0 108.843 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.33 -27.06 71.1 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.73 -1.348 . . . . 25.0 109.73 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.683 HD12 ' CB ' ' A' ' 73' ' ' ASN . 12.6 mt -66.24 -46.73 76.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -1.184 . . . . 50.0 109.653 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.816 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -59.84 -41.16 90.78 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.377 -0.827 . . . . 50.0 109.375 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -59.23 -30.12 68.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 50.0 109.392 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 49.9 t0 -71.22 -36.8 71.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 50.0 109.38 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.451 HG12 ' HE1' ' A' ' 84' ' ' PHE . 3.0 t -89.93 -27.73 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.385 -0.822 . . . . 50.0 109.421 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.13 -18.74 61.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 50.0 109.719 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 37.5 pttt -95.48 -31.05 13.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 50.0 109.309 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 79' ' ' ASP . 9.3 mt -57.88 -33.64 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.856 . . . . 50.0 109.448 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.451 ' HE1' HG12 ' A' ' 80' ' ' VAL . 88.1 m-85 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.075 -0.964 . . . . 99.99 109.494 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.371 -0.603 . . . . 50.0 109.371 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -50.11 -36.86 31.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.808 . . . . 50.0 109.45 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -56.73 -45.57 81.85 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.612 -0.885 . . . . 16.66 108.612 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 49.0 mt-10 -67.1 -38.64 86.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.448 -0.782 . . . . 16.66 109.066 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 67' ' ' THR . 74.5 mtt-85 -67.29 -40.71 86.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 50.0 109.429 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.599 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 37.8 mt-10 -65.45 -41.62 93.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.441 -0.787 . . . . 50.0 109.5 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 58.5 mtp85 -67.42 -40.66 85.55 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.23 -0.919 . . . . 50.0 109.277 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 10' ' ' GLU . 42.7 mt -70.54 -44.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.289 -0.882 . . . . 50.0 109.151 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -68.22 -35.57 78.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.207 -0.933 . . . . 16.66 109.278 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 52.9 mttt -64.33 -31.79 73.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.373 -0.829 . . . . 50.0 109.261 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.512 ' HD3' ' CD2' ' A' ' 84' ' ' PHE . 52.4 mtt180 -72.21 -35.71 68.97 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.901 . . . . 50.0 109.17 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.026 ' HB3' HD13 ' A' ' 26' ' ' ILE . 37.1 m-85 -68.75 -45.31 71.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 16.66 109.531 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 25.7 t0 -64.45 103.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 16.66 108.779 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.73 -52.13 47.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.233 -0.917 . . . . 50.0 111.21 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -85.57 -26.08 26.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.746 -1.221 . . . . 16.66 109.56 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 86.99 42.92 6.15 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.936 -1.126 . . . . 16.66 110.49 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.505 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 41.1 p-10 -99.44 6.0 46.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.25 . . . . 16.66 109.33 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 62' ' ' SER . . . 94.03 -10.88 71.55 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.485 -1.046 . . . . 16.66 110.485 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.587 ' HD2' ' CD2' ' A' ' 60' ' ' PHE . 14.3 pttp -126.69 140.45 52.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.926 -1.338 . . . . 50.0 109.891 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.026 HD13 ' HB3' ' A' ' 18' ' ' PHE . 3.3 mt -113.8 134.18 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.571 -0.706 . . . . 16.66 109.424 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.461 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 25.9 p -107.47 170.53 7.92 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.435 -0.791 . . . . 50.0 109.011 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.518 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -51.14 -47.76 61.98 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.118 -0.989 . . . . 50.0 109.028 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.31 -38.45 71.29 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.335 -0.853 . . . . 50.0 109.485 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 54.8 mt-10 -77.56 -54.49 6.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.251 -0.905 . . . . 16.66 109.154 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.939 HD22 HG13 ' A' ' 46' ' ' VAL . 7.5 tt -60.01 -46.11 90.55 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.212 -0.93 . . . . 16.66 108.853 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.788 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -61.36 -43.95 98.69 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.076 -1.61 . . . . 16.66 109.076 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 16.2 mt-10 -57.06 -44.42 83.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.433 -1.04 . . . . 50.0 109.823 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.26 -39.28 75.08 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.187 -0.946 . . . . 50.0 108.646 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.938 HD12 HG22 ' A' ' 46' ' ' VAL . 8.7 mt -58.7 -32.03 68.79 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.421 -0.799 . . . . 99.99 109.628 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -42.43 -26.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.177 -0.952 . . . . 99.99 109.84 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.774 ' CG2' HG21 ' A' ' 83' ' ' ILE . 6.3 t -49.44 -24.84 2.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.182 -0.949 . . . . 99.99 109.155 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.79 HD13 HD12 ' A' ' 41' ' ' ILE . 2.0 mt -61.28 -36.39 79.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 50.0 109.315 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.7 -3.33 64.4 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.498 -1.441 . . . . 16.66 109.498 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.74 67.7 0.63 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -1.168 . . . . 16.66 109.657 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.79 HD12 HD13 ' A' ' 38' ' ' LEU . 13.3 tt -149.35 168.25 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 50.0 109.545 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.54 167.32 12.42 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 16.66 109.221 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.67 -28.76 16.81 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.276 1.984 . . . . 50.0 109.849 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.25 -28.67 68.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.597 -0.689 . . . . 50.0 109.774 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -80.76 -34.57 34.18 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.069 -1.019 . . . . 16.66 108.353 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.939 HG13 HD22 ' A' ' 31' ' ' LEU . 53.5 t -66.51 -35.42 74.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.108 -0.701 . . . . 50.0 109.108 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -69.06 -37.97 78.81 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.758 -0.83 . . . . 50.0 108.758 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.539 ' CD2' ' HG3' ' A' ' 52' ' ' GLU . 14.8 t-160 -68.07 -39.65 82.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.496 -0.752 . . . . 50.0 109.087 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.43 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.4 mtt -61.9 -47.11 86.43 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.141 -0.975 . . . . 16.66 108.614 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.671 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 48.9 mtp -63.01 -48.3 79.41 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.046 -0.724 . . . . 50.0 109.046 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.72 -17.81 25.96 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.307 -0.871 . . . . 50.0 108.996 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.539 ' HG3' ' CD2' ' A' ' 48' ' ' HIS . 22.7 mt-10 -98.78 -36.2 9.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 16.66 109.203 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.647 HG22 HD12 ' A' ' 61' ' ' ILE . 81.4 mt -82.23 -32.45 10.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.457 -0.777 . . . . 50.0 109.669 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.9 t0 -58.4 100.69 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.441 -0.787 . . . . 16.66 109.126 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 59.1 p -70.0 -46.57 64.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.298 -0.876 . . . . 50.0 110.463 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.91 -31.53 22.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.11 -0.994 . . . . 16.66 109.571 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 93.06 28.53 11.7 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.801 -1.19 . . . . 16.66 110.189 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.48 -3.07 55.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.94 -1.33 . . . . 50.0 109.402 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.671 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 100.44 -8.34 58.56 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.053 -1.07 . . . . 16.66 110.465 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.587 ' CD2' ' HD2' ' A' ' 25' ' ' LYS . 33.9 m-85 -132.81 155.98 47.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.842 -1.387 . . . . 50.0 111.256 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.647 HD12 HG22 ' A' ' 53' ' ' ILE . 32.0 mm -107.43 129.59 61.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.348 -0.982 . . . . 16.66 108.348 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.9 OUTLIER -95.7 166.91 11.59 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.175 -0.953 . . . . 16.66 108.644 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.599 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 32.2 t80 -55.76 -42.86 76.06 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.128 -0.983 . . . . 16.66 108.741 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -62.43 -47.29 84.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.507 -0.745 . . . . 50.0 109.07 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.542 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 51.7 mt-10 -58.54 -48.09 82.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 16.66 108.974 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.484 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 55.5 t80 -59.54 -39.31 83.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.448 -0.782 . . . . 16.66 109.346 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.518 ' O ' ' NH1' ' A' ' 11' ' ' ARG . 16.4 m -65.28 -45.99 82.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.457 -0.777 . . . . 50.0 109.238 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -59.62 -40.07 86.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 50.0 109.515 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -73.0 -36.53 67.04 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.252 -0.905 . . . . 50.0 108.778 179.819 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.686 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.63 -34.45 76.57 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.389 -1.484 . . . . 16.66 109.389 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -65.86 -29.09 69.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -1.137 . . . . 50.0 109.277 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.67 -22.09 60.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 50.0 109.147 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.931 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.8 m-80 -150.24 58.69 0.96 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.428 -0.795 . . . . 50.0 108.997 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -50.76 -39.94 53.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.284 -0.885 . . . . 50.0 108.788 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.23 -29.9 69.69 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.342 -1.503 . . . . 25.0 109.342 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.931 HD12 ' CB ' ' A' ' 73' ' ' ASN . 28.1 mt -66.92 -45.72 77.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 50.0 109.482 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.686 HD11 ' HA3' ' A' ' 70' ' ' GLY . 25.8 mt -60.85 -37.19 81.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 50.0 109.635 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 23.5 mtmt -62.41 -24.19 67.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 50.0 109.427 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -77.87 -36.36 49.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 50.0 109.527 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -83.58 -29.46 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.836 . . . . 50.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.33 -16.54 47.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 50.0 109.607 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -95.19 -30.66 13.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 50.0 109.223 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.774 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.3 mt -58.86 -36.29 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 50.0 109.332 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.512 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 96.3 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.974 -1.012 . . . . 99.99 109.499 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.27 -0.641 . . . . 50.0 109.27 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -48.79 -36.63 17.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.369 -0.832 . . . . 50.0 109.586 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.23 -46.75 87.63 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.26 -0.9 . . . . 16.66 108.638 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 14' ' ' ILE . 57.0 mt-10 -68.08 -38.99 83.0 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.823 -0.806 . . . . 16.66 108.823 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.617 ' NH2' HD12 ' A' ' 77' ' ' LEU . 59.5 mtt-85 -67.99 -40.9 82.97 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.461 -0.774 . . . . 50.0 109.458 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 22.7 mt-10 -65.71 -40.86 92.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 50.0 109.524 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 15.1 mtp85 -68.18 -40.45 82.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 50.0 109.353 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 10' ' ' GLU . 34.6 mt -71.31 -43.46 73.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.328 -0.858 . . . . 50.0 109.012 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -67.39 -36.42 81.28 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.191 -0.943 . . . . 16.66 109.089 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -65.65 -29.67 70.27 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.29 -0.881 . . . . 50.0 109.062 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.481 ' CD ' ' HB3' ' A' ' 84' ' ' PHE . 28.9 mtt180 -71.24 -37.08 72.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.361 -0.837 . . . . 50.0 109.088 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.919 ' HB3' HD13 ' A' ' 26' ' ' ILE . 43.4 m-85 -69.66 -48.48 59.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -0.797 . . . . 16.66 109.488 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.4 t0 -59.18 103.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 16.66 108.713 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -51.39 55.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 50.0 111.273 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -87.87 -29.24 21.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.782 -1.199 . . . . 16.66 109.845 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 92.34 35.85 6.46 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.783 -1.198 . . . . 16.66 110.178 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.7 p-10 -90.43 4.76 50.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.252 . . . . 16.66 109.284 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.5 -6.73 74.79 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.347 -1.101 . . . . 16.66 110.347 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 15.4 pttt -130.43 141.89 50.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.996 -1.296 . . . . 50.0 110.027 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.0 mt -112.31 134.03 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.588 -0.695 . . . . 16.66 109.398 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.4 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 12.9 p -106.79 167.54 9.8 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.392 -0.818 . . . . 50.0 108.899 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.502 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.48 -45.55 56.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.059 -1.026 . . . . 50.0 108.909 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.6 -39.43 76.8 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.328 -0.858 . . . . 50.0 109.598 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.5 mt-10 -75.05 -53.98 7.95 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.224 -0.923 . . . . 16.66 109.439 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.617 HD12 ' CD1' ' A' ' 18' ' ' PHE . 31.9 tp -62.37 -42.25 99.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.209 -0.932 . . . . 16.66 108.911 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.657 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -64.35 -45.33 93.67 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.115 -1.594 . . . . 16.66 109.115 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -57.73 -42.96 84.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -1.104 . . . . 50.0 109.539 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.57 -39.95 64.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.417 -0.957 . . . . 50.0 108.417 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.904 HD12 HG22 ' A' ' 46' ' ' VAL . 10.3 mt -61.62 -32.77 72.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.578 -0.701 . . . . 99.99 109.672 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -46.87 -24.55 0.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 99.99 109.644 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.611 ' CG2' HG21 ' A' ' 83' ' ' ILE . 11.6 t -51.95 -21.52 3.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 99.99 109.266 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 38' ' ' LEU . 25.5 mt -66.64 -29.58 69.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.361 -0.837 . . . . 50.0 109.294 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.75 8.89 50.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 16.66 109.585 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.82 60.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -1.167 . . . . 16.66 109.61 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.73 173.32 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 50.0 109.525 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.38 162.96 37.08 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.712 -0.847 . . . . 16.66 108.712 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.03 -32.49 21.48 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.09 1.86 . . . . 50.0 110.012 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.25 -22.11 64.78 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.642 -0.661 . . . . 50.0 110.043 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -79.99 -36.83 35.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.93 -1.106 . . . . 16.66 108.465 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.904 HG22 HD12 ' A' ' 35' ' ' LEU . 54.2 t -68.72 -36.34 73.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.968 -0.753 . . . . 50.0 108.968 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -64.92 -39.9 94.22 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.896 -0.779 . . . . 50.0 108.896 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.55 -43.37 90.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 50.0 109.116 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.507 ' HE3' ' CD1' ' A' ' 35' ' ' LEU . 70.1 mtm -59.32 -43.39 92.7 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.174 -0.954 . . . . 16.66 108.932 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.697 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 32.4 mtp -61.53 -47.23 86.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.493 -0.754 . . . . 50.0 109.058 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.02 -22.58 50.44 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.318 -0.864 . . . . 50.0 109.116 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.91 -35.89 12.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 16.66 108.942 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.689 HG22 HD12 ' A' ' 61' ' ' ILE . 82.6 mt -81.09 -30.09 11.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.591 -0.693 . . . . 50.0 109.534 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.4 t0 -62.42 101.36 0.23 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.386 -0.821 . . . . 16.66 109.105 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 74.0 p -71.65 -47.95 50.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.862 . . . . 50.0 110.614 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 4.2 p-10 -85.85 -33.83 21.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.141 -0.975 . . . . 16.66 109.728 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 97.31 27.4 9.29 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.911 -1.138 . . . . 16.66 111.053 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 p-10 -80.62 -2.5 46.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.725 -1.456 . . . . 50.0 109.248 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.697 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.01 -4.16 60.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.003 -1.239 . . . . 16.66 110.003 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.576 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 39.7 m-85 -134.46 156.12 49.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.26 . . . . 50.0 111.125 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.689 HD12 HG22 ' A' ' 53' ' ' ILE . 34.3 mm -106.83 128.95 61.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.34 -0.985 . . . . 16.66 108.34 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -96.25 169.51 9.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.083 -1.011 . . . . 16.66 108.832 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 35.7 t80 -55.8 -43.88 77.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.128 -0.983 . . . . 16.66 108.73 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -60.31 -48.38 82.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.462 -0.774 . . . . 50.0 109.185 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 63.5 mt-10 -59.91 -46.5 89.18 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.357 -0.839 . . . . 16.66 109.11 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -62.35 -36.53 82.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.443 -0.786 . . . . 16.66 109.079 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 28.9 m -68.51 -48.27 64.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.8 . . . . 50.0 108.979 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -58.08 -37.75 75.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.319 -0.863 . . . . 50.0 109.249 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.563 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -78.73 -35.87 44.14 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.41 -0.959 . . . . 50.0 108.41 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.89 ' CA ' HD11 ' A' ' 77' ' ' LEU . . . -58.63 -33.9 74.22 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.888 -1.685 . . . . 16.66 108.888 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 67' ' ' THR . 82.1 mtm180 -64.86 -32.3 73.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -1.078 . . . . 50.0 108.53 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.55 -2.54 58.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.538 -0.726 . . . . 50.0 109.227 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.75 ' HB3' HD22 ' A' ' 76' ' ' LEU . 68.4 m-80 -151.69 48.42 0.8 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.311 -0.868 . . . . 50.0 108.668 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -57.8 -47.04 83.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.342 -0.849 . . . . 50.0 108.877 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.2 -21.16 38.46 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.135 -1.586 . . . . 25.0 109.135 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.75 HD22 ' HB3' ' A' ' 73' ' ' ASN . 6.8 mp -79.94 -43.82 21.43 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -1.116 . . . . 50.0 109.366 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.89 HD11 ' CA ' ' A' ' 70' ' ' GLY . 5.9 mt -69.2 -22.38 63.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 50.0 109.968 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -80.03 -26.19 39.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 50.0 109.716 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -89.57 -40.66 12.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.1 -1.0 . . . . 50.0 109.586 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.9 p -67.78 -43.36 86.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.383 -0.823 . . . . 50.0 109.515 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.538 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.96 -37.66 45.86 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.673 -0.642 . . . . 50.0 109.919 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.21 -26.86 67.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 50.0 109.542 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.611 HG21 ' CG2' ' A' ' 37' ' ' THR . 7.8 mt -60.63 -43.9 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.236 -0.915 . . . . 50.0 109.362 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.481 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 89.6 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.961 -1.019 . . . . 99.99 109.463 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.445 0.64 . . . . 50.0 109.363 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -50.62 -36.94 37.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 50.0 109.403 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.15 -46.16 89.1 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.782 -0.822 . . . . 16.66 108.782 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.451 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.9 mm-40 -66.38 -44.06 84.17 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.957 -0.757 . . . . 16.66 108.957 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.622 ' NH2' HD12 ' A' ' 77' ' ' LEU . 36.6 mtt-85 -64.95 -39.52 93.62 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.435 -0.79 . . . . 50.0 109.416 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.592 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 13.0 mt-10 -66.21 -42.14 89.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 50.0 109.542 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 47.5 mtp180 -67.01 -40.81 87.36 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.299 -0.876 . . . . 50.0 109.214 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.8 mt -70.29 -44.54 77.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.359 -0.838 . . . . 50.0 109.033 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' A' ' 63' ' ' PHE . 52.7 t80 -66.72 -35.38 79.97 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.281 -0.887 . . . . 16.66 109.041 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -64.44 -31.34 72.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 50.0 109.388 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 64.8 mtt180 -72.53 -36.07 68.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -0.929 . . . . 50.0 109.15 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.012 ' HB3' HD13 ' A' ' 26' ' ' ILE . 34.4 m-85 -68.72 -45.01 72.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 16.66 109.389 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.5 t0 -63.37 103.22 0.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 16.66 108.756 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.17 -51.2 60.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.254 -0.904 . . . . 50.0 111.299 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -89.23 -27.27 20.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.659 -1.276 . . . . 16.66 109.762 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.95 35.68 7.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.032 -1.227 . . . . 16.66 110.032 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.487 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 35.5 p-10 -89.52 3.71 51.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -1.2 . . . . 16.66 109.277 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.19 -6.28 68.73 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.367 -1.093 . . . . 16.66 110.367 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.5 pttp -132.37 143.48 49.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.911 -1.346 . . . . 50.0 110.149 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.012 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.4 mt -111.41 135.06 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 121.426 0.632 . . . . 16.66 109.53 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.418 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 11.4 p -107.77 166.4 10.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.877 -0.786 . . . . 50.0 108.877 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.523 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.81 -45.63 50.21 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.185 -0.947 . . . . 50.0 108.876 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 -38.81 75.99 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.317 -0.864 . . . . 50.0 109.602 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.505 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.2 mt-10 -75.61 -54.1 7.53 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.12 -0.987 . . . . 16.66 109.496 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.874 HD12 ' CD1' ' A' ' 18' ' ' PHE . 14.5 tp -64.03 -38.95 92.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.123 -0.986 . . . . 16.66 108.876 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.629 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -66.02 -46.48 80.82 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.993 -1.643 . . . . 16.66 108.993 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -57.27 -42.79 82.31 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.326 -1.102 . . . . 50.0 109.478 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.63 -40.22 63.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.416 -0.957 . . . . 50.0 108.416 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.812 ' CD1' HG22 ' A' ' 46' ' ' VAL . 5.0 mt -59.94 -32.84 71.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.644 -0.66 . . . . 99.99 109.595 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -45.61 -25.67 0.5 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.034 -1.041 . . . . 99.99 109.351 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.54 ' CG2' HG21 ' A' ' 83' ' ' ILE . 11.7 t -50.87 -23.74 3.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.282 -0.886 . . . . 99.99 109.184 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 41' ' ' ILE . 22.5 mt -62.15 -32.58 73.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.813 . . . . 50.0 109.264 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.0 6.43 52.67 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.643 -1.383 . . . . 16.66 109.643 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.18 56.63 0.65 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -1.213 . . . . 16.66 109.605 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 38' ' ' LEU . 8.9 tt -142.47 175.25 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -0.962 . . . . 50.0 109.512 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.75 165.71 25.36 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.349 -0.844 . . . . 16.66 108.759 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 47.4 Cg_endo -69.42 -33.74 17.23 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.09 1.86 . . . . 50.0 110.172 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.17 -22.37 65.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.699 -0.625 . . . . 50.0 110.178 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -82.99 -39.53 21.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.822 -1.173 . . . . 16.66 108.452 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.812 HG22 ' CD1' ' A' ' 35' ' ' LEU . 75.1 t -66.03 -36.02 76.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.786 -0.82 . . . . 50.0 108.786 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 23.3 mttm -67.6 -39.9 84.79 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.782 -0.822 . . . . 50.0 108.782 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -65.71 -39.51 91.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.407 -0.808 . . . . 50.0 109.149 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.414 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.8 mtt -58.46 -44.77 89.39 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.176 -0.953 . . . . 16.66 108.718 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.617 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 58.1 mtp -62.32 -48.03 81.66 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.524 -0.735 . . . . 50.0 109.188 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.06 -20.17 23.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.301 -0.874 . . . . 50.0 109.05 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -97.14 -35.8 10.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 16.66 109.025 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.688 HG22 HD12 ' A' ' 61' ' ' ILE . 83.5 mt -81.74 -31.74 11.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.446 -0.784 . . . . 50.0 109.592 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.3 t0 -60.42 101.24 0.12 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.341 -0.85 . . . . 16.66 109.187 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 37.9 p -72.13 -45.03 62.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.374 -0.829 . . . . 50.0 110.582 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.498 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.2 p-10 -87.35 -38.92 15.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 16.66 109.485 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 102.17 29.28 6.12 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.86 -1.162 . . . . 16.66 110.675 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p-10 -81.92 -4.12 55.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.819 -1.401 . . . . 50.0 109.014 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.617 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.1 -2.36 57.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.816 -1.314 . . . . 16.66 109.816 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 31.4 m-85 -136.86 156.59 48.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -1.232 . . . . 50.0 111.275 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.688 HD12 HG22 ' A' ' 53' ' ' ILE . 33.3 mm -106.93 127.24 62.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.328 -0.99 . . . . 16.66 108.328 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -94.2 167.71 11.38 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.075 -1.016 . . . . 16.66 108.762 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.592 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.3 t80 -55.09 -43.08 73.64 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.154 -0.966 . . . . 16.66 108.693 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.74 -49.3 78.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.976 -0.75 . . . . 50.0 108.976 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.538 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 22.5 mt-10 -58.3 -47.31 84.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.836 . . . . 16.66 109.027 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.6 -37.97 85.85 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.52 -0.737 . . . . 16.66 109.306 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 31.2 m -65.74 -47.73 74.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.845 . . . . 50.0 109.257 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -60.38 -38.84 85.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 50.0 109.359 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.586 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.13 -38.37 56.87 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.281 -1.007 . . . . 50.0 108.281 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.905 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -56.81 -28.84 57.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.056 -1.617 . . . . 16.66 109.056 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 67' ' ' THR . 78.7 mtm180 -70.39 -29.65 66.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -1.098 . . . . 50.0 108.832 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.65 -23.42 63.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.781 . . . . 50.0 109.155 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.797 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.7 m-80 -148.83 58.17 1.04 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 50.0 108.991 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -50.63 -30.86 14.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 50.0 108.894 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.17 -30.9 79.01 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.202 -1.559 . . . . 25.0 109.202 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.797 HD12 ' CB ' ' A' ' 73' ' ' ASN . 63.7 mt -66.57 -43.56 84.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -1.071 . . . . 50.0 109.491 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.905 HD11 ' HA3' ' A' ' 70' ' ' GLY . 5.3 mt -69.55 -26.49 64.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.415 -0.803 . . . . 50.0 109.862 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -79.37 -24.59 42.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.01 -1.057 . . . . 50.0 109.217 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -92.01 -45.13 8.48 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.393 -0.817 . . . . 50.0 109.333 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.6 p -61.17 -44.52 98.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.808 0.813 . . . . 50.0 109.048 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.545 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -51.49 -39.82 58.32 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.731 -0.606 . . . . 50.0 109.53 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -59.65 -30.8 68.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 50.0 109.702 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.54 HG21 ' CG2' ' A' ' 37' ' ' THR . 41.9 mt -59.37 -32.43 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 50.0 109.43 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 9.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.062 -0.971 . . . . 99.99 109.439 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.344 -0.613 . . . . 50.0 109.344 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -52.8 -36.48 58.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.477 -0.764 . . . . 50.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.417 ' O ' ' HD2' ' A' ' 13' ' ' ARG . . . -58.68 -45.18 89.98 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.642 -0.873 . . . . 16.66 108.642 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 14' ' ' ILE . 66.7 mt-10 -67.41 -43.49 81.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.838 -0.801 . . . . 16.66 108.838 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.481 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 35.1 mtt-85 -66.24 -39.42 89.52 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.484 -0.76 . . . . 50.0 109.346 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 14.8 mt-10 -66.98 -41.02 87.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.474 -0.766 . . . . 50.0 109.373 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.4 mtt180 -68.46 -40.16 81.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.358 -0.839 . . . . 50.0 109.117 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.9 mt -70.72 -44.73 76.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.411 -0.805 . . . . 50.0 109.059 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -65.43 -36.23 83.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 16.66 109.029 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -66.05 -29.48 69.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 50.0 109.151 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 84' ' ' PHE . 33.7 mtt180 -70.46 -39.15 74.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 50.0 109.066 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.936 ' HB3' HD13 ' A' ' 26' ' ' ILE . 46.6 m-85 -68.44 -48.5 64.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 16.66 109.316 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 26.5 t0 -57.36 103.48 0.13 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 16.66 108.604 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -52.28 57.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 50.0 111.457 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' A' ' 23' ' ' ASP . 31.8 p-10 -88.84 -21.97 23.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.826 -1.171 . . . . 16.66 109.768 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 82.66 40.48 9.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.876 -1.29 . . . . 16.66 109.876 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.507 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.5 p-10 -94.11 4.15 54.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -1.221 . . . . 16.66 109.247 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.88 -9.41 65.91 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.516 -1.034 . . . . 16.66 110.516 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 7.6 pttt -130.74 142.69 50.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.932 -1.334 . . . . 50.0 110.118 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.936 HD13 ' HB3' ' A' ' 18' ' ' PHE . 7.6 mt -112.82 134.05 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.409 -0.589 . . . . 16.66 109.409 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.426 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 25.0 p -107.8 168.96 8.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 50.0 108.846 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.509 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.56 -47.18 57.86 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.06 -1.025 . . . . 50.0 108.933 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.39 70.2 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.481 -0.762 . . . . 50.0 109.704 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.494 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 55.5 mt-10 -78.39 -53.5 7.2 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.111 -0.993 . . . . 16.66 109.477 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.685 HD12 ' CD1' ' A' ' 18' ' ' PHE . 54.6 tp -63.22 -40.43 97.46 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.175 -0.953 . . . . 16.66 108.976 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.658 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -64.07 -45.13 94.66 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.162 -1.575 . . . . 16.66 109.162 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -58.64 -42.94 89.48 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.195 -1.179 . . . . 50.0 109.703 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.54 -40.68 61.56 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.053 -1.029 . . . . 50.0 108.404 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.75 ' CD1' HG22 ' A' ' 46' ' ' VAL . 9.5 mt -60.73 -33.13 72.45 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.546 -0.721 . . . . 99.99 109.463 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -47.12 -24.4 0.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.081 -1.012 . . . . 99.99 109.437 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.56 ' CG2' HG21 ' A' ' 83' ' ' ILE . 12.2 t -52.54 -22.61 5.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 99.99 109.19 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.605 HD12 HD12 ' A' ' 41' ' ' ILE . 39.3 mt -61.07 -31.66 71.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -0.832 . . . . 50.0 109.224 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.66 3.52 54.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.733 -1.347 . . . . 16.66 109.733 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.76 65.04 0.59 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -1.197 . . . . 16.66 109.71 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.605 HD12 HD12 ' A' ' 38' ' ' LEU . 14.9 tt -149.63 170.24 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 50.0 109.411 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.66 162.95 28.2 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.311 -0.868 . . . . 16.66 108.706 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.76 -32.4 23.38 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.003 1.802 . . . . 50.0 110.18 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.0 -23.56 65.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.604 -0.685 . . . . 50.0 109.915 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -81.0 -38.92 26.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.887 -1.133 . . . . 16.66 108.298 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.75 HG22 ' CD1' ' A' ' 35' ' ' LEU . 53.8 t -66.09 -36.38 77.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.579 -0.897 . . . . 50.0 108.579 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -69.54 -39.54 77.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.479 -0.934 . . . . 50.0 108.479 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.52 -41.42 88.83 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.96 -0.755 . . . . 50.0 108.96 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.8 mtt -59.05 -44.92 91.86 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.259 -0.9 . . . . 16.66 108.622 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.689 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 30.1 mtp -60.39 -46.13 91.06 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.521 -0.737 . . . . 50.0 109.061 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.77 -23.5 52.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.8 . . . . 50.0 109.316 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -92.84 -35.95 13.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 16.66 108.799 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.754 HG22 HD12 ' A' ' 61' ' ' ILE . 84.7 mt -80.37 -29.34 12.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.545 -0.722 . . . . 50.0 109.478 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.2 t0 -63.8 101.6 0.38 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.446 -0.784 . . . . 16.66 109.196 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 76.1 p -73.95 -46.72 42.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.292 -0.88 . . . . 50.0 110.868 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 7.5 p-10 -86.14 -31.24 21.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.069 -1.02 . . . . 16.66 109.645 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 94.73 27.42 11.42 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.798 -1.191 . . . . 16.66 111.066 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.6 p-10 -82.32 -3.49 55.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.73 -1.453 . . . . 50.0 109.321 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.689 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.93 -5.71 59.76 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.243 -1.143 . . . . 16.66 110.243 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.57 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 37.0 m-85 -133.5 155.04 50.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.942 -1.328 . . . . 50.0 111.039 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.754 HD12 HG22 ' A' ' 53' ' ' ILE . 34.5 mm -105.24 127.44 59.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.254 -1.017 . . . . 16.66 108.254 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.3 167.62 11.42 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.2 -0.937 . . . . 16.66 108.91 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.597 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.6 t80 -54.58 -42.77 71.45 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.057 -1.027 . . . . 16.66 108.651 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -60.7 -49.47 77.36 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.115 -0.698 . . . . 50.0 109.115 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.555 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 45.6 mt-10 -58.88 -46.79 86.99 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 16.66 109.013 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -63.74 -36.58 84.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.507 -0.745 . . . . 16.66 109.288 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.42 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 52.8 m -66.35 -48.68 69.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.321 -0.862 . . . . 50.0 109.209 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' ' NH1' ' A' ' 71' ' ' ARG . 67.8 m-20 -61.79 -37.38 84.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 50.0 109.3 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.593 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -72.71 -40.15 66.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.538 -0.912 . . . . 50.0 108.538 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.496 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -56.13 -29.19 55.58 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.141 -1.584 . . . . 16.66 109.141 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.484 ' NH1' ' OD1' ' A' ' 68' ' ' ASP . 23.2 mtm180 -71.1 -21.49 62.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 50.0 109.054 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.71 -24.44 38.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.439 -0.788 . . . . 50.0 109.34 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.95 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.8 m-80 -145.22 57.68 1.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.861 . . . . 50.0 109.393 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -51.31 -38.72 54.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.894 . . . . 50.0 108.762 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.22 -27.53 65.38 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.316 -1.514 . . . . 25.0 109.316 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.95 HD12 ' CB ' ' A' ' 73' ' ' ASN . 39.7 mt -69.73 -44.8 69.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -1.093 . . . . 50.0 109.476 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.695 HD12 ' N ' ' A' ' 77' ' ' LEU . 8.9 mp -63.38 -40.26 96.75 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.422 -0.799 . . . . 50.0 110.002 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 14.4 mtmt -65.83 -20.08 66.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 50.0 109.344 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.36 -53.85 3.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 50.0 109.535 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.2 p -65.89 -44.8 92.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.369 -0.832 . . . . 50.0 109.452 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.558 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -53.67 -36.65 62.37 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.59 -0.693 . . . . 50.0 109.725 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 17.5 mttt -66.95 -25.47 66.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 50.0 109.663 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.56 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.1 mt -59.63 -42.48 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.904 . . . . 50.0 109.444 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.512 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 88.7 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.015 -0.993 . . . . 99.99 109.47 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.222 -0.658 . . . . 50.0 109.222 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -52.78 -36.15 57.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.366 -0.833 . . . . 50.0 109.223 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.59 -45.78 84.83 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.587 -0.894 . . . . 16.66 108.587 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 56.2 mt-10 -66.33 -44.65 82.72 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.881 -0.785 . . . . 16.66 108.881 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.78 ' NH1' HG23 ' A' ' 67' ' ' THR . 75.2 mtm180 -64.52 -38.85 92.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.533 -0.73 . . . . 50.0 109.436 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.619 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 34.8 mt-10 -65.91 -42.34 90.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.329 -0.857 . . . . 50.0 109.469 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 16.9 mtp180 -66.82 -40.17 87.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.281 -0.887 . . . . 50.0 109.218 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 10' ' ' GLU . 30.2 mt -70.17 -46.27 72.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.392 -0.818 . . . . 50.0 108.967 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -62.43 -35.58 79.68 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.274 -0.891 . . . . 16.66 108.934 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 60.1 mttm -66.56 -30.06 70.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.858 . . . . 50.0 109.15 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 47.2 mtt180 -68.92 -37.71 79.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.339 -0.851 . . . . 50.0 109.16 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.853 ' HB3' HD13 ' A' ' 26' ' ' ILE . 55.4 m-85 -68.96 -50.41 49.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.785 . . . . 16.66 109.489 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.468 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.8 t0 -54.66 103.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 16.66 108.651 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.13 -52.03 52.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.274 -0.891 . . . . 50.0 111.29 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -87.88 -23.64 23.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.745 -1.222 . . . . 16.66 109.592 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 84.72 41.47 7.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.034 -1.226 . . . . 16.66 110.034 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.505 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.2 p-10 -96.16 5.84 50.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.047 -1.267 . . . . 16.66 109.295 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -9.01 71.19 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.454 -1.058 . . . . 16.66 110.454 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.2 pttp -129.55 141.86 50.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.319 . . . . 50.0 109.808 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.853 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.5 mt -112.61 134.31 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.687 -0.633 . . . . 16.66 109.381 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.46 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 18.1 p -106.41 167.33 9.91 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.662 -0.866 . . . . 50.0 108.662 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.94 -45.63 51.42 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.12 -0.988 . . . . 50.0 108.997 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.85 -38.45 75.7 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.25 -0.907 . . . . 50.0 109.529 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.496 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.2 mt-10 -76.41 -54.31 6.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.163 -0.961 . . . . 16.66 109.281 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.712 HD12 ' CD1' ' A' ' 18' ' ' PHE . 29.0 tp -62.73 -42.09 99.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 16.66 108.912 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.668 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.85 -44.9 95.46 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.201 -1.559 . . . . 16.66 109.201 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.99 -42.95 86.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.307 -1.113 . . . . 50.0 109.699 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.89 -40.02 63.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.359 -0.978 . . . . 50.0 108.359 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.935 ' CD1' HG22 ' A' ' 46' ' ' VAL . 12.5 mt -60.76 -32.48 71.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.65 -0.656 . . . . 99.99 109.566 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -46.5 -24.64 0.55 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.082 -1.012 . . . . 99.99 109.443 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.603 ' CG2' HG21 ' A' ' 83' ' ' ILE . 10.3 t -51.81 -22.72 3.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.276 -0.89 . . . . 99.99 109.261 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.631 HD12 HD12 ' A' ' 41' ' ' ILE . 21.6 mt -60.2 -33.24 71.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.381 -0.824 . . . . 50.0 109.38 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.21 3.21 56.31 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.633 -1.387 . . . . 16.66 109.633 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.44 61.57 0.62 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -1.181 . . . . 16.66 109.594 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.631 HD12 HD12 ' A' ' 38' ' ' LEU . 10.3 tt -146.31 174.54 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 50.0 109.539 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.34 164.47 29.94 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 16.66 108.768 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.54 -32.77 18.81 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.091 1.861 . . . . 50.0 110.241 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.38 -22.85 65.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.654 -0.654 . . . . 50.0 110.055 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -82.34 -38.95 23.49 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.904 -1.123 . . . . 16.66 108.544 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.935 HG22 ' CD1' ' A' ' 35' ' ' LEU . 42.2 t -68.05 -37.35 78.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.779 -0.823 . . . . 50.0 108.779 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -66.15 -40.09 90.31 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.829 -0.804 . . . . 50.0 108.829 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.472 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.9 t60 -64.54 -39.47 93.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.454 -0.779 . . . . 50.0 109.128 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.436 ' O ' HG13 ' A' ' 53' ' ' ILE . 13.2 mtt -56.54 -43.15 79.61 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.101 -1.0 . . . . 16.66 108.552 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.519 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 82.3 mtp -61.51 -48.4 81.22 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.944 -0.761 . . . . 50.0 108.944 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.72 -22.08 12.88 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.246 -0.908 . . . . 50.0 109.134 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -99.11 -36.85 9.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 16.66 109.231 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.672 HG22 HD12 ' A' ' 61' ' ' ILE . 82.9 mt -80.25 -33.49 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.434 -0.791 . . . . 50.0 109.617 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.6 t0 -59.97 101.47 0.12 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.351 -0.843 . . . . 16.66 109.099 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.534 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 81.8 p -73.76 -47.41 39.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 50.0 110.819 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 7.1 p-10 -85.72 -31.81 22.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.945 . . . . 16.66 109.681 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.462 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 95.19 27.65 10.65 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.888 -1.148 . . . . 16.66 111.001 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.482 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.1 p-10 -81.66 -3.79 54.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.768 -1.431 . . . . 50.0 109.342 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.519 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.46 -5.43 58.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.14 -1.184 . . . . 16.66 110.14 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.575 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 45.2 m-85 -133.1 154.83 50.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.998 -1.295 . . . . 50.0 110.971 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.672 HD12 HG22 ' A' ' 53' ' ' ILE . 34.7 mm -105.31 128.73 59.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.364 -0.976 . . . . 16.66 108.364 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.6 165.88 11.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.188 -0.945 . . . . 16.66 108.836 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.619 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.9 t80 -53.56 -43.09 68.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.095 -1.003 . . . . 16.66 108.542 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -59.07 -46.78 87.4 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.09 -0.707 . . . . 50.0 109.09 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.549 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 64.0 mt-10 -63.78 -46.99 82.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.853 . . . . 16.66 109.068 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.779 ' HE1' HD13 ' A' ' 77' ' ' LEU . 27.3 t80 -65.84 -29.03 69.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.428 -0.795 . . . . 16.66 109.182 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.78 HG23 ' NH1' ' A' ' 11' ' ' ARG . 63.0 m -69.87 -49.96 47.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.42 -0.8 . . . . 50.0 109.329 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.49 -35.83 81.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 50.0 109.385 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.583 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -75.79 -41.18 53.61 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.384 -0.969 . . . . 50.0 108.384 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.993 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.56 -30.03 71.02 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.002 -1.639 . . . . 16.66 109.002 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.51 ' HG3' ' NH1' ' A' ' 11' ' ' ARG . 68.4 mtp180 -66.91 -37.25 84.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.445 -1.033 . . . . 50.0 108.826 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.44 -19.02 65.69 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.133 -0.691 . . . . 50.0 109.133 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.769 ' CB ' HD12 ' A' ' 76' ' ' LEU . 18.4 m-80 -145.94 53.29 1.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 50.0 109.318 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -49.5 -36.15 22.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 50.0 108.739 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.523 ' HA2' ' CE ' ' A' ' 78' ' ' LYS . . . -61.54 -19.71 58.26 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.398 -1.481 . . . . 25.0 109.398 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.769 HD12 ' CB ' ' A' ' 73' ' ' ASN . 25.0 mt -78.33 -44.86 24.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.393 -1.063 . . . . 50.0 109.291 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.993 HD11 ' HA3' ' A' ' 70' ' ' GLY . 3.8 mt -71.15 -24.2 62.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.473 -0.767 . . . . 50.0 110.142 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' CE ' ' HA2' ' A' ' 75' ' ' GLY . 6.7 ptpt -80.06 -28.79 39.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.959 -1.088 . . . . 50.0 109.0 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 56.3 m-20 -87.37 -44.68 11.19 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.488 -0.758 . . . . 50.0 109.274 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.552 HG13 ' N ' ' A' ' 81' ' ' ALA . 5.4 p -58.71 -44.78 90.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.868 0.842 . . . . 50.0 108.946 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.552 ' N ' HG13 ' A' ' 80' ' ' VAL . . . -50.5 -41.13 53.07 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.165 -0.614 . . . . 50.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -59.43 -32.25 70.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 50.0 109.499 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.603 HG21 ' CG2' ' A' ' 37' ' ' THR . 26.9 mt -57.44 -32.65 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 50.0 109.278 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.551 ' CE1' HG21 ' A' ' 37' ' ' THR . 8.9 m-85 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.96 -1.019 . . . . 99.99 109.488 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.378 -0.601 . . . . 50.0 109.378 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -48.34 -36.1 13.75 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.429 -0.795 . . . . 50.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.37 -46.38 88.81 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.395 -0.816 . . . . 16.66 108.98 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.46 ' O ' HG13 ' A' ' 14' ' ' ILE . 61.7 mt-10 -66.78 -41.09 88.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.401 -0.812 . . . . 16.66 108.981 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -66.16 -41.1 90.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.453 -0.779 . . . . 50.0 109.452 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.568 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 8.6 mt-10 -64.6 -41.51 96.18 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.519 -0.738 . . . . 50.0 109.399 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 62.1 mtp180 -67.01 -40.6 87.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 50.0 109.273 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 10' ' ' GLU . 31.9 mt -70.55 -44.46 76.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.397 -0.814 . . . . 50.0 108.986 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 63' ' ' PHE . 58.7 t80 -66.65 -36.2 81.99 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.295 -0.878 . . . . 16.66 109.065 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -65.5 -30.67 71.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 50.0 108.983 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 52.0 mtt85 -70.62 -36.16 73.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.411 -0.806 . . . . 50.0 109.114 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.967 ' HB3' HD13 ' A' ' 26' ' ' ILE . 36.3 m-85 -68.21 -49.22 62.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.823 . . . . 16.66 109.432 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.6 t0 -57.58 103.43 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 16.66 108.715 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.3 -51.3 54.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 50.0 111.26 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -87.31 -30.49 20.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.733 -1.229 . . . . 16.66 109.793 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.59 35.6 6.14 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.819 -1.181 . . . . 16.66 110.232 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.1 p-10 -90.46 3.96 52.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.246 . . . . 16.66 109.285 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.02 -6.51 72.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.431 -1.068 . . . . 16.66 110.431 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.609 ' HD3' ' CG ' ' A' ' 60' ' ' PHE . 2.3 ptpp? -131.08 142.65 50.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.944 -1.327 . . . . 50.0 109.939 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.967 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.1 mt -112.15 133.73 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.605 -0.684 . . . . 16.66 109.652 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.1 p -105.53 166.06 10.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.383 -0.823 . . . . 50.0 108.867 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.92 -44.82 50.48 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.987 -1.071 . . . . 50.0 108.699 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -58.14 -39.77 79.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.189 -0.945 . . . . 50.0 109.347 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.8 mt-10 -74.67 -54.63 7.05 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.132 -0.98 . . . . 16.66 109.24 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.541 ' CD1' ' CE1' ' A' ' 18' ' ' PHE . 29.9 tp -62.31 -42.31 99.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.145 -0.972 . . . . 16.66 108.94 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.582 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.92 -45.33 94.38 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.96 -1.656 . . . . 16.66 108.96 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 10.3 mt-10 -56.15 -44.33 79.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.418 -1.048 . . . . 50.0 109.457 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.53 -39.31 67.63 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.331 -0.988 . . . . 50.0 108.331 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.874 ' CD1' HG22 ' A' ' 46' ' ' VAL . 6.7 mt -59.26 -32.93 70.45 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.545 -0.722 . . . . 99.99 109.412 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -44.79 -26.03 0.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 99.99 109.474 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.791 ' OG1' HG21 ' A' ' 83' ' ' ILE . 8.7 t -52.55 -25.04 9.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 99.99 109.232 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.942 HD12 HD12 ' A' ' 41' ' ' ILE . 23.7 mt -57.99 -35.96 71.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 50.0 109.165 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.87 1.97 60.28 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.681 -1.367 . . . . 16.66 109.681 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.15 52.53 0.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.092 -1.24 . . . . 16.66 109.754 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.942 HD12 HD12 ' A' ' 38' ' ' LEU . 11.7 tt -136.47 171.77 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 50.0 109.589 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.23 165.89 23.62 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.751 -0.833 . . . . 16.66 108.751 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.91 -33.79 19.17 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.042 1.828 . . . . 50.0 110.188 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -62.1 -28.9 69.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.585 -0.697 . . . . 50.0 109.956 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -81.76 -36.11 28.88 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.949 -1.094 . . . . 16.66 108.288 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.874 HG22 ' CD1' ' A' ' 35' ' ' LEU . 57.7 t -68.09 -36.59 75.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.948 -0.76 . . . . 50.0 108.948 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -68.88 -38.92 80.0 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.795 -0.817 . . . . 50.0 108.795 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -65.92 -39.78 90.86 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.471 -0.768 . . . . 50.0 109.299 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.431 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.9 mtt -59.19 -44.59 92.22 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.117 -0.989 . . . . 16.66 108.841 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.549 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 29.3 mtp -62.43 -48.13 81.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.421 -0.799 . . . . 50.0 109.15 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.62 -20.14 30.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 50.0 109.097 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -97.44 -36.47 10.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 16.66 109.199 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.587 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.6 mt -80.78 -31.93 12.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.413 -0.804 . . . . 50.0 109.576 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.0 t0 -61.76 101.38 0.19 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.439 -0.788 . . . . 16.66 108.938 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.453 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 39.6 p -67.95 -45.18 74.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.874 . . . . 50.0 110.461 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.9 p-10 -88.79 -42.71 11.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 16.66 109.642 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 104.88 30.21 4.93 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.188 -1.165 . . . . 16.66 110.188 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.8 p-10 -81.31 -3.06 51.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.919 -1.342 . . . . 50.0 109.233 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.549 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.6 -1.13 58.3 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.795 -1.322 . . . . 16.66 109.795 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.609 ' CG ' ' HD3' ' A' ' 25' ' ' LYS . 51.1 m-85 -137.44 155.66 49.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -1.233 . . . . 50.0 111.284 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.55 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 30.9 mm -109.83 129.57 64.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.222 -1.029 . . . . 16.66 108.222 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.02 168.13 10.47 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.057 -1.027 . . . . 16.66 108.815 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.568 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 32.4 t80 -54.83 -43.19 72.77 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.102 -0.999 . . . . 16.66 108.728 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -61.1 -46.81 89.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.545 -0.722 . . . . 50.0 109.235 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 75.0 mt-10 -61.65 -47.67 84.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 16.66 109.198 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.439 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 60.0 t80 -61.44 -36.86 81.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 16.66 109.444 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 23.1 m -65.54 -47.27 76.45 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.259 -0.901 . . . . 50.0 109.344 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -60.92 -38.87 87.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 50.0 109.6 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -77.37 -38.6 49.75 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.136 -0.977 . . . . 50.0 108.77 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.45 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.36 -32.32 76.81 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.935 -1.666 . . . . 16.66 108.935 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 67' ' ' THR . 64.6 mtp180 -70.97 -34.26 71.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -1.027 . . . . 50.0 109.259 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.47 -4.61 56.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 50.0 109.512 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.781 ' HB3' HD13 ' A' ' 76' ' ' LEU . 69.1 m-80 -150.0 46.31 0.92 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.262 -0.899 . . . . 50.0 108.798 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -55.44 -48.87 73.79 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.54 -0.911 . . . . 50.0 108.54 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.27 -24.91 24.2 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.146 -1.581 . . . . 25.0 109.146 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.781 HD13 ' HB3' ' A' ' 73' ' ' ASN . 7.1 mp -78.81 -44.67 22.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -1.15 . . . . 50.0 109.357 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.572 ' O ' HG12 ' A' ' 80' ' ' VAL . 21.2 mt -60.1 -39.6 86.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.444 -0.785 . . . . 50.0 109.409 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 32.8 mtpt -56.06 -28.23 56.72 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.294 -0.879 . . . . 50.0 109.326 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 52.9 t0 -75.67 -39.19 57.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.381 -0.824 . . . . 50.0 109.775 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -64.85 -37.55 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 50.0 109.378 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -72.78 -4.26 30.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.556 -0.715 . . . . 50.0 109.65 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 14.4 mttm -74.28 -35.13 63.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 50.0 109.255 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.791 HG21 ' OG1' ' A' ' 37' ' ' THR . 35.2 mt -76.75 -32.68 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.309 -0.869 . . . . 50.0 109.453 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.732 ' HE1' HG21 ' A' ' 37' ' ' THR . 5.4 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.975 -1.012 . . . . 99.99 109.454 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.435 0.636 . . . . 50.0 109.463 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -44.68 -35.22 2.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.797 . . . . 50.0 109.599 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.59 -45.28 85.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 16.66 108.963 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 14' ' ' ILE . 63.6 mt-10 -67.52 -42.92 82.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.507 -0.746 . . . . 16.66 109.056 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.587 ' NH2' HG23 ' A' ' 67' ' ' THR . 18.2 mtm180 -65.73 -39.19 90.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.506 -0.746 . . . . 50.0 109.421 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.598 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 77.7 mt-10 -66.76 -41.36 87.88 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.386 -0.821 . . . . 50.0 109.525 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mtp180 -66.9 -40.7 87.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.339 -0.85 . . . . 50.0 109.234 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.5 mt -70.37 -45.11 76.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.358 -0.839 . . . . 50.0 109.029 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -64.98 -35.8 82.34 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.227 -0.92 . . . . 16.66 109.112 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -65.99 -30.37 70.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 50.0 109.268 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 59.1 mtt85 -71.36 -35.08 71.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -0.912 . . . . 50.0 108.974 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.004 ' HB3' HD13 ' A' ' 26' ' ' ILE . 35.8 m-85 -67.56 -49.77 61.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 16.66 109.299 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.463 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 21.5 t0 -56.02 103.11 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.87 . . . . 16.66 108.804 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.05 -51.07 59.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.951 . . . . 50.0 111.028 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -87.78 -31.17 19.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.756 -1.215 . . . . 16.66 109.633 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.463 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 94.7 34.92 6.06 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.795 -1.193 . . . . 16.66 110.385 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.502 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 41.3 p-10 -89.85 5.5 45.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.003 -1.292 . . . . 16.66 109.258 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.85 -4.91 79.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.282 -1.127 . . . . 16.66 110.282 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HB2' ' CB ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -131.08 142.51 50.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.921 -1.341 . . . . 50.0 109.931 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.004 HD13 ' HB3' ' A' ' 18' ' ' PHE . 7.5 mt -111.34 134.56 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.523 -0.735 . . . . 16.66 109.497 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.435 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 11.5 p -107.67 166.71 10.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.725 -0.842 . . . . 50.0 108.725 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.93 -45.56 51.27 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.048 -1.032 . . . . 50.0 108.799 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.29 76.33 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.205 -0.934 . . . . 50.0 109.493 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.1 mt-10 -75.9 -54.48 6.83 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.152 -0.968 . . . . 16.66 109.354 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.684 ' HG ' HD12 ' A' ' 35' ' ' LEU . 9.6 tp -62.15 -42.44 99.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 16.66 108.817 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -64.2 -45.89 92.41 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.841 -1.704 . . . . 16.66 108.841 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.88 -44.27 78.0 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.394 -1.063 . . . . 50.0 109.375 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.11 -39.9 63.06 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.112 -1.07 . . . . 50.0 108.112 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.002 HD13 HG22 ' A' ' 46' ' ' VAL . 6.5 mt -59.55 -29.86 68.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.527 -0.733 . . . . 99.99 109.548 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -45.25 -24.4 0.27 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 99.99 109.652 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.633 HG21 HG21 ' A' ' 83' ' ' ILE . 9.3 t -51.69 -24.39 5.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.215 -0.928 . . . . 99.99 109.204 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.49 HD11 ' CD2' ' A' ' 35' ' ' LEU . 6.4 mt -62.57 -45.88 90.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.39 -0.819 . . . . 50.0 109.266 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.06 -34.53 3.74 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.746 -1.342 . . . . 16.66 109.746 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.7 p -116.79 52.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -1.188 . . . . 16.66 109.598 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 41' ' ' ILE . 7.4 tp -126.68 164.31 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 50.0 109.501 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.69 163.47 23.95 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.523 -0.917 . . . . 16.66 108.523 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.0 -34.13 23.98 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.941 1.761 . . . . 50.0 110.181 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.28 -20.19 63.91 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.658 -0.651 . . . . 50.0 110.399 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -83.08 -40.64 19.58 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.729 -1.232 . . . . 16.66 108.562 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.002 HG22 HD13 ' A' ' 35' ' ' LEU . 41.8 t -65.2 -36.98 79.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.764 -0.828 . . . . 50.0 108.764 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -68.31 -39.7 81.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.793 -0.817 . . . . 50.0 108.793 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.499 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.2 t60 -66.13 -40.23 90.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.423 -0.798 . . . . 50.0 109.056 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.447 ' CE ' HD11 ' A' ' 35' ' ' LEU . 15.5 mtm -59.44 -44.74 92.86 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.265 -0.897 . . . . 16.66 108.877 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 28' ' ' ALA . 31.1 mtp -62.51 -47.37 84.25 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.585 -0.697 . . . . 50.0 109.197 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.25 -20.1 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 50.0 108.915 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.27 -35.55 11.76 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.986 -0.746 . . . . 16.66 108.986 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.588 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.4 mt -81.89 -31.05 10.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.53 -0.731 . . . . 50.0 109.501 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 50' ' ' MET . 17.3 t0 -61.93 101.09 0.18 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.442 -0.786 . . . . 16.66 109.172 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 28.3 p -68.46 -43.42 77.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 50.0 110.426 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.1 p-10 -89.85 -46.86 8.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 16.66 109.821 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 108.81 31.71 3.31 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.935 -1.266 . . . . 16.66 109.935 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.478 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.7 p-10 -82.69 -5.24 58.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.027 -1.278 . . . . 50.0 109.057 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 100.08 -0.3 56.13 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.724 -1.35 . . . . 16.66 109.724 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.529 ' CB ' ' HB2' ' A' ' 25' ' ' LYS . 41.3 m-85 -139.28 156.07 47.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.996 -1.297 . . . . 50.0 111.482 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.55 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 31.4 mm -109.08 129.23 64.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.147 -1.057 . . . . 16.66 108.147 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.1 167.32 10.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.991 -1.068 . . . . 16.66 108.72 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 37.9 t80 -53.35 -42.67 67.05 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.077 -1.049 . . . . 16.66 108.473 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -59.42 -50.66 73.08 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.107 -0.701 . . . . 50.0 109.107 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 80.2 mt-10 -60.28 -46.38 90.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.354 -0.841 . . . . 16.66 109.023 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.545 ' CE2' HD11 ' A' ' 77' ' ' LEU . 80.3 t80 -64.66 -35.77 82.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 16.66 109.479 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.587 HG23 ' NH2' ' A' ' 11' ' ' ARG . 21.0 m -67.51 -48.95 65.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.394 -0.816 . . . . 50.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.424 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 77.1 m-20 -62.02 -36.07 80.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -0.901 . . . . 50.0 109.339 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.588 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -74.61 -39.57 62.08 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.669 -0.863 . . . . 50.0 108.669 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.476 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -59.33 -29.05 65.44 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.423 -1.471 . . . . 16.66 109.423 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 67' ' ' THR . 62.6 mtm180 -71.83 -32.28 67.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -1.115 . . . . 50.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.38 -21.08 62.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.34 -0.85 . . . . 50.0 109.343 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.882 ' CB ' HD12 ' A' ' 76' ' ' LEU . 31.8 m-80 -140.92 61.02 1.51 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.406 -0.809 . . . . 50.0 109.131 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -52.64 -42.88 65.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.67 -0.863 . . . . 50.0 108.67 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.19 -22.58 29.83 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.352 -1.499 . . . . 25.0 109.352 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.882 HD12 ' CB ' ' A' ' 73' ' ' ASN . 47.2 mt -79.97 -43.56 21.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -1.124 . . . . 50.0 109.336 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 1.1 mm? -61.19 -36.98 81.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.455 -0.778 . . . . 50.0 109.578 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.6 mtmm -73.81 -28.14 61.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.258 -0.901 . . . . 50.0 109.026 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -80.21 -45.3 18.26 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.37 -0.831 . . . . 50.0 109.105 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 76' ' ' LEU . 46.5 t -68.56 -41.32 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 50.0 109.376 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.4 -46.91 63.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 50.0 109.425 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 22.7 mttm -59.64 -29.25 67.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.345 -0.847 . . . . 50.0 109.34 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 37' ' ' THR . 59.5 mt -66.73 -35.97 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 50.0 109.394 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 12.5 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.962 -1.018 . . . . 99.99 109.503 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.39 0.614 . . . . 50.0 109.369 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -49.15 -35.78 17.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 50.0 109.293 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -53.44 -43.11 67.78 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.572 -0.899 . . . . 16.66 108.572 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.4 mt-10 -68.51 -39.8 81.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.012 -0.736 . . . . 16.66 109.012 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.5 mtt-85 -67.33 -41.24 85.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.452 -0.78 . . . . 50.0 109.38 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.608 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 60.8 mt-10 -65.07 -39.91 93.91 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.567 -0.708 . . . . 50.0 109.311 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 24.3 mtp180 -67.63 -40.37 84.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.451 -0.781 . . . . 50.0 109.187 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 10' ' ' GLU . 24.6 mt -70.54 -45.62 73.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.365 -0.834 . . . . 50.0 109.015 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -64.87 -35.97 82.85 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.295 -0.878 . . . . 16.66 108.975 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 46.1 mttt -65.81 -30.3 70.91 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.324 -0.86 . . . . 50.0 108.983 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 32.7 mtt180 -70.06 -36.09 74.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.831 . . . . 50.0 108.903 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.916 ' HB3' HD13 ' A' ' 26' ' ' ILE . 48.3 m-85 -70.38 -51.41 29.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.438 -0.789 . . . . 16.66 109.487 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.8 t0 -56.12 103.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 16.66 108.747 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.42 -52.07 50.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 50.0 111.278 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -87.34 -23.46 24.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.725 -1.235 . . . . 16.66 109.722 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 83.95 41.59 8.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.084 -1.206 . . . . 16.66 110.084 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.506 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.5 p-10 -96.17 5.38 51.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.129 -1.218 . . . . 16.66 109.122 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.06 -9.68 70.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.569 -1.012 . . . . 16.66 110.569 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.588 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.1 pttm -129.65 142.01 50.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.853 -1.381 . . . . 50.0 110.162 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.916 HD13 ' HB3' ' A' ' 18' ' ' PHE . 9.7 mt -112.78 133.6 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.736 -0.602 . . . . 16.66 109.457 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.408 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 23.3 p -106.12 168.95 8.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.332 -0.855 . . . . 50.0 108.912 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.488 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.27 -46.56 55.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.076 -1.015 . . . . 50.0 109.047 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.5 74.34 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.274 -0.891 . . . . 50.0 109.543 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.2 mt-10 -75.96 -54.03 7.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.137 -0.977 . . . . 16.66 109.269 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.605 ' O ' HD23 ' A' ' 31' ' ' LEU . 6.9 tt -61.44 -44.84 96.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.253 -0.904 . . . . 16.66 108.969 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.676 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -61.87 -43.79 98.72 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.113 -1.595 . . . . 16.66 109.113 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -56.3 -44.19 79.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -1.096 . . . . 50.0 109.766 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.15 75.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.173 -0.954 . . . . 50.0 108.572 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.986 ' CD1' HG22 ' A' ' 46' ' ' VAL . 9.6 mt -59.02 -35.06 72.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.505 -0.747 . . . . 99.99 109.929 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.6 mttm -43.86 -27.41 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.135 -0.978 . . . . 99.99 109.535 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.699 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.3 t -53.68 -26.51 23.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 99.99 109.407 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.5 mt -63.94 -33.76 76.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 50.0 109.32 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.43 6.84 50.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.573 -1.411 . . . . 16.66 109.573 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.8 t -154.3 50.77 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.045 -1.268 . . . . 16.66 109.653 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 tp -136.49 154.12 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 50.0 109.243 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.43 165.83 12.86 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 16.66 108.697 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.19 -32.64 20.51 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.058 1.838 . . . . 50.0 109.989 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -62.68 -27.74 69.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.661 -0.649 . . . . 50.0 110.052 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -80.75 -36.56 31.81 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.973 -1.079 . . . . 16.66 108.36 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.986 HG22 ' CD1' ' A' ' 35' ' ' LEU . 74.8 t -64.33 -38.6 82.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.689 -0.856 . . . . 50.0 108.689 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -72.44 -36.75 68.63 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.41 -0.959 . . . . 50.0 108.41 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.471 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 4.0 t60 -67.71 -37.18 81.9 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.939 -0.763 . . . . 50.0 108.939 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.416 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.7 mtt -60.29 -48.23 82.64 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.228 -0.92 . . . . 16.66 108.58 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.518 ' HE1' ' HA ' ' A' ' 60' ' ' PHE . 42.2 mtp -61.61 -48.29 81.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.922 -0.77 . . . . 50.0 108.922 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.72 -19.73 18.24 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.445 -0.784 . . . . 50.0 109.193 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.409 ' OE2' ' NE2' ' A' ' 48' ' ' HIS . 37.6 mt-10 -100.46 -37.03 9.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.89 . . . . 16.66 109.317 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.536 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.8 mt -80.29 -34.02 14.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.392 -0.818 . . . . 50.0 109.563 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.0 t0 -58.77 101.52 0.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.455 -0.778 . . . . 16.66 109.005 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 71.1 p -70.02 -47.67 61.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.829 . . . . 50.0 110.922 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.481 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.6 p-10 -86.95 -37.42 17.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.134 -0.979 . . . . 16.66 109.544 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.56 27.97 7.32 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.834 -1.174 . . . . 16.66 110.771 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.481 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 15.6 p-10 -79.58 -2.1 40.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.811 -1.405 . . . . 50.0 109.11 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.46 -6.26 59.16 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.981 -1.248 . . . . 16.66 109.981 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.588 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 28.4 m-85 -133.84 156.16 48.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.003 -1.293 . . . . 50.0 111.373 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.554 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 27.3 mm -107.99 129.97 61.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.217 -1.031 . . . . 16.66 108.217 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.8 m -96.93 167.13 11.27 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.051 -1.03 . . . . 16.66 108.636 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.608 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 36.2 t80 -54.4 -42.29 70.25 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.077 -1.014 . . . . 16.66 108.523 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -61.21 -47.94 83.79 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.515 -0.741 . . . . 50.0 109.286 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 68.1 mt-10 -60.68 -46.85 88.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.254 -0.904 . . . . 16.66 108.943 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.45 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 57.3 t80 -59.54 -40.88 88.69 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.491 -0.755 . . . . 16.66 109.147 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.7 m -64.17 -46.51 83.68 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.468 -0.77 . . . . 50.0 109.159 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.59 -39.63 80.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 50.0 109.344 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -79.95 -36.37 36.32 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.486 -0.931 . . . . 50.0 108.486 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.655 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.4 -31.55 74.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.083 -1.607 . . . . 16.66 109.083 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' THR . 64.4 mtm180 -70.34 -35.23 73.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.416 -1.049 . . . . 50.0 109.057 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.68 -2.55 50.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.394 -0.816 . . . . 50.0 109.455 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.775 ' HB3' HD22 ' A' ' 76' ' ' LEU . 69.4 m-80 -149.22 46.88 0.98 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.235 -0.916 . . . . 50.0 108.873 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -56.31 -48.51 76.54 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.521 -0.918 . . . . 50.0 108.521 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.24 -24.6 29.91 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.057 -1.617 . . . . 25.0 109.057 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.775 HD22 ' HB3' ' A' ' 73' ' ' ASN . 6.5 mp -79.7 -45.12 19.56 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.335 -1.097 . . . . 50.0 109.326 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.655 HD11 ' HA3' ' A' ' 70' ' ' GLY . 20.9 mt -62.67 -36.61 83.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.804 . . . . 50.0 109.845 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -67.13 -21.23 65.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 50.0 109.607 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.97 -34.55 29.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 50.0 109.476 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.478 ' HA ' HG13 ' A' ' 83' ' ' ILE . 25.1 t -78.39 -33.13 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 50.0 109.743 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.41 -46.46 62.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 50.0 110.128 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -63.91 -24.55 67.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 50.0 109.576 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.699 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.5 mt -66.31 -47.55 83.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.343 -0.848 . . . . 50.0 109.673 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.017 -0.992 . . . . 99.99 109.446 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.466 -0.568 . . . . 50.0 109.466 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -52.6 -37.4 58.12 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.383 -0.823 . . . . 50.0 109.274 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.12 -45.13 87.82 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.32 -0.863 . . . . 16.66 108.701 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.442 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.4 mt-10 -66.61 -45.81 77.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.818 -0.808 . . . . 16.66 108.818 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.467 ' NH2' ' CG ' ' A' ' 71' ' ' ARG . 13.7 mtt-85 -64.13 -39.37 93.89 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.447 -0.783 . . . . 50.0 109.336 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.601 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 15.9 mt-10 -65.76 -41.16 92.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.555 -0.716 . . . . 50.0 109.104 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 14.7 mtp180 -67.33 -40.55 85.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 50.0 109.014 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 10' ' ' GLU . 29.1 mt -70.12 -45.94 74.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.454 -0.779 . . . . 50.0 108.942 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -66.05 -35.99 82.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.376 -0.827 . . . . 16.66 109.119 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 21.8 mttt -64.48 -31.28 72.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 50.0 109.19 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 40.7 mtt180 -73.29 -33.15 65.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 50.0 109.222 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.993 ' HB3' HD13 ' A' ' 26' ' ' ILE . 37.5 m-85 -71.37 -45.11 63.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 16.66 109.29 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.461 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.8 t0 -63.09 103.16 0.44 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.252 -0.905 . . . . 16.66 108.798 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -52.05 60.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.227 -0.921 . . . . 50.0 111.247 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -88.1 -22.44 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.737 -1.227 . . . . 16.66 109.577 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.461 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 82.8 42.76 8.06 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.236 -1.146 . . . . 16.66 110.236 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.513 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.4 p-10 -97.63 5.93 48.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.126 -1.22 . . . . 16.66 109.269 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 62' ' ' SER . . . 94.87 -10.11 70.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.517 -1.033 . . . . 16.66 110.517 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 14.2 pttp -128.62 141.38 51.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.825 -1.397 . . . . 50.0 110.031 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.993 HD13 ' HB3' ' A' ' 18' ' ' PHE . 4.9 mt -113.53 134.55 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.662 -0.649 . . . . 16.66 109.365 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.441 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 26.6 p -108.03 169.65 8.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.395 -0.816 . . . . 50.0 108.895 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.7 -47.77 58.89 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.113 -0.992 . . . . 50.0 109.023 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.36 68.99 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.372 -0.83 . . . . 50.0 109.683 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 55.2 mt-10 -79.07 -53.44 7.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 16.66 109.298 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 31' ' ' LEU . 4.6 tt -62.1 -42.28 99.06 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.291 -0.881 . . . . 16.66 108.83 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.91 -45.7 93.44 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.023 -1.631 . . . . 16.66 109.023 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -56.03 -43.06 77.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -1.1 . . . . 50.0 109.395 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.66 -39.9 66.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.292 -1.003 . . . . 50.0 108.292 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.902 ' CD1' HG22 ' A' ' 46' ' ' VAL . 2.2 mt -59.15 -33.53 71.0 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.605 -0.684 . . . . 99.99 109.625 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -44.16 -26.43 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.1 -1.0 . . . . 99.99 109.551 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.74 ' CG2' HG21 ' A' ' 83' ' ' ILE . 8.0 t -48.87 -24.39 1.44 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.217 -0.927 . . . . 99.99 109.064 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.79 HD12 HD12 ' A' ' 41' ' ' ILE . 21.1 mt -66.63 -31.2 71.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.477 -0.764 . . . . 50.0 109.163 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.51 9.37 43.66 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.436 -1.466 . . . . 16.66 109.436 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' A' ' 40' ' ' SER . 9.7 t -156.07 49.15 0.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -1.143 . . . . 16.66 109.587 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.79 HD12 HD12 ' A' ' 38' ' ' LEU . 12.4 tt -137.32 169.41 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.257 -0.902 . . . . 50.0 109.475 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.95 166.66 16.98 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.92 . . . . 16.66 109.051 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.69 -32.65 18.41 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.175 1.916 . . . . 50.0 110.189 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -61.63 -29.05 69.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.648 -0.658 . . . . 50.0 110.016 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -81.43 -36.89 28.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.926 -1.109 . . . . 16.66 108.193 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.902 HG22 ' CD1' ' A' ' 35' ' ' LEU . 55.9 t -65.21 -34.7 72.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.968 -0.753 . . . . 50.0 108.968 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -69.45 -38.39 77.77 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.908 -0.775 . . . . 50.0 108.908 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -68.49 -38.5 81.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.462 -0.774 . . . . 50.0 108.933 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 mtt -62.25 -47.79 82.81 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.306 -0.871 . . . . 16.66 108.792 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.693 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 27.2 mtp -61.62 -46.55 89.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.449 -0.782 . . . . 50.0 109.159 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.24 -19.65 55.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 50.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.61 -35.63 12.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.355 -0.841 . . . . 16.66 108.879 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.631 HG22 HD12 ' A' ' 61' ' ' ILE . 81.8 mt -82.42 -30.92 9.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.561 -0.712 . . . . 50.0 109.669 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.6 t0 -59.67 101.35 0.11 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.38 -0.825 . . . . 16.66 109.064 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 71.0 p -72.82 -47.18 48.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -0.89 . . . . 50.0 110.543 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -29.97 24.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.181 -0.949 . . . . 16.66 109.514 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.484 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 92.02 28.19 14.28 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.893 -1.146 . . . . 16.66 110.35 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.14 -3.22 57.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.963 -1.316 . . . . 50.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.693 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.52 -7.29 59.6 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.962 -1.113 . . . . 16.66 110.526 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.573 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.6 m-85 -133.02 155.25 49.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.002 -1.293 . . . . 50.0 111.025 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.631 HD12 HG22 ' A' ' 53' ' ' ILE . 34.0 mm -106.24 128.09 60.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.333 -0.988 . . . . 16.66 108.333 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 18.0 m -94.16 166.11 12.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.235 -0.916 . . . . 16.66 108.602 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 34.5 t80 -54.48 -42.37 70.63 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.071 -1.018 . . . . 16.66 108.558 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -61.11 -49.47 77.14 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.098 -0.704 . . . . 50.0 109.098 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.539 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 28.8 mt-10 -58.1 -47.27 83.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 16.66 109.09 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.799 ' CE2' HD11 ' A' ' 77' ' ' LEU . 61.3 t80 -62.08 -40.47 95.94 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.531 -0.731 . . . . 16.66 109.305 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 16.3 m -64.33 -47.32 79.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.353 -0.842 . . . . 50.0 109.099 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.489 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 87.8 m-20 -59.31 -37.77 78.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 50.0 109.424 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.569 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.51 -36.76 57.58 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.529 -0.915 . . . . 50.0 108.529 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.13 -30.84 64.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.303 -1.519 . . . . 16.66 109.303 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 68' ' ' ASP . 72.3 mtm180 -69.26 -30.43 68.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -1.108 . . . . 50.0 109.071 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.22 -21.7 64.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -0.809 . . . . 50.0 109.286 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.898 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.1 m-80 -149.97 60.12 0.99 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.354 -0.841 . . . . 50.0 108.957 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -50.68 -38.61 47.68 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.737 -0.838 . . . . 50.0 108.737 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.24 -32.29 67.42 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.251 -1.54 . . . . 25.0 109.251 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.898 HD12 ' CB ' ' A' ' 73' ' ' ASN . 28.2 mt -64.46 -43.8 93.1 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.316 -1.108 . . . . 50.0 109.366 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.799 HD11 ' CE2' ' A' ' 66' ' ' PHE . 1.9 mm? -61.41 -41.91 97.9 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.426 -0.796 . . . . 50.0 109.679 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 19.2 mtmm -65.13 -27.66 68.89 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.263 -0.898 . . . . 50.0 109.512 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.66 -50.29 7.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.92 . . . . 50.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.6 p -64.33 -44.5 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.468 -0.77 . . . . 50.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.542 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -48.82 -40.48 29.44 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.54 -0.725 . . . . 50.0 109.385 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 27.2 mttp -65.47 -26.47 67.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 50.0 109.563 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.74 HG21 ' CG2' ' A' ' 37' ' ' THR . 35.0 mt -62.22 -32.7 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 50.0 109.423 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 5.1 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.001 -0.999 . . . . 99.99 109.488 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.428 0.632 . . . . 50.0 109.341 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -51.52 -36.54 45.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 50.0 109.455 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.88 -46.17 88.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.277 -0.89 . . . . 16.66 108.665 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 14' ' ' ILE . 67.9 mm-40 -66.5 -43.95 83.9 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.389 -0.819 . . . . 16.66 108.867 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.405 ' HA ' HD12 ' A' ' 14' ' ' ILE . 30.4 mtt-85 -64.5 -39.52 93.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.413 -0.804 . . . . 50.0 109.493 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 13.8 mt-10 -64.06 -40.0 95.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 50.0 109.416 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 21.1 mtp-105 -70.06 -38.22 75.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 50.0 109.034 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.5 mt -71.54 -44.91 70.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.371 -0.831 . . . . 50.0 108.888 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.533 ' CE1' HD11 ' A' ' 26' ' ' ILE . 69.6 t80 -69.23 -36.19 76.93 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.231 -0.918 . . . . 16.66 109.159 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 37.4 mttt -64.99 -30.53 71.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 50.0 109.027 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 65.8 mmt-85 -70.65 -39.14 73.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.365 -0.834 . . . . 50.0 109.005 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.902 ' HB3' HD13 ' A' ' 26' ' ' ILE . 43.6 m-85 -66.21 -47.73 72.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.832 . . . . 16.66 109.344 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 20.4 t0 -60.08 103.15 0.2 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 16.66 108.73 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 -50.6 40.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 50.0 111.092 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -87.3 -30.54 20.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.808 -1.182 . . . . 16.66 109.671 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.27 33.41 7.24 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.069 -1.213 . . . . 16.66 110.069 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.499 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 34.8 p-10 -86.76 5.42 36.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.266 . . . . 16.66 109.115 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.95 -3.93 77.79 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.374 -1.09 . . . . 16.66 110.374 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 3.7 pttm -133.67 143.99 48.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.948 -1.325 . . . . 50.0 110.244 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.902 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.3 mt -110.43 132.67 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.459 0.647 . . . . 16.66 109.752 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.448 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 13.0 p -106.56 166.48 10.53 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.917 -0.772 . . . . 50.0 108.917 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.08 -44.98 52.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.124 -0.985 . . . . 50.0 109.032 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -57.19 -39.9 76.31 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.358 -0.838 . . . . 50.0 109.541 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.5 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 60.5 mt-10 -75.7 -54.28 7.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.214 -0.929 . . . . 16.66 109.248 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.761 HD22 HG13 ' A' ' 46' ' ' VAL . 6.3 tt -61.78 -43.66 98.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.13 -0.981 . . . . 16.66 108.853 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.707 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.76 -44.79 95.75 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.009 -1.636 . . . . 16.66 109.009 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 30.1 mt-10 -58.45 -42.23 86.93 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.474 -1.015 . . . . 50.0 109.661 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.55 -39.72 67.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.322 -0.992 . . . . 50.0 108.322 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.922 HD12 HG22 ' A' ' 46' ' ' VAL . 3.3 mt -58.23 -31.82 67.73 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.519 -0.738 . . . . 99.99 109.544 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -45.15 -25.81 0.4 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 99.99 109.479 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.617 HG21 HG21 ' A' ' 83' ' ' ILE . 11.6 t -52.94 -26.29 14.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 99.99 109.374 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 38' ' ' LEU . 26.5 mt -65.35 -29.99 70.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -0.836 . . . . 50.0 109.237 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.66 9.0 42.94 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.734 -1.346 . . . . 16.66 109.734 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.5 49.6 0.54 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.089 -1.242 . . . . 16.66 109.811 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 41' ' ' ILE . 6.9 tp -133.31 165.36 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.251 -0.905 . . . . 50.0 109.344 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.87 164.67 16.83 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.168 -0.957 . . . . 16.66 108.741 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.65 -33.72 21.0 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.062 1.841 . . . . 50.0 110.012 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -64.12 -26.0 68.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.592 -0.692 . . . . 50.0 109.955 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.42 -38.62 26.21 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.821 -1.175 . . . . 16.66 108.401 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.922 HG22 HD12 ' A' ' 35' ' ' LEU . 61.7 t -63.93 -36.53 77.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.765 -0.828 . . . . 50.0 108.765 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -73.04 -37.52 66.85 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.413 -0.958 . . . . 50.0 108.413 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -68.02 -38.58 82.75 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.922 -0.769 . . . . 50.0 108.922 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.2 mtt -60.88 -47.45 86.34 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.241 -0.912 . . . . 16.66 108.635 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.591 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 50.6 mtp -60.93 -46.15 91.85 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.141 -0.688 . . . . 50.0 109.141 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.72 -21.01 53.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 50.0 109.194 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -95.89 -36.48 11.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 16.66 109.126 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.644 HG22 HD12 ' A' ' 61' ' ' ILE . 83.4 mt -80.86 -32.39 12.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.534 -0.729 . . . . 50.0 109.536 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 50' ' ' MET . 22.7 t0 -60.41 100.5 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.354 -0.841 . . . . 16.66 109.053 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.462 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 56.6 p -68.04 -46.44 71.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.307 -0.871 . . . . 50.0 110.616 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 1.7 p-10 -86.37 -37.97 17.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 16.66 109.44 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.36 27.03 7.88 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 120.037 -1.078 . . . . 16.66 110.555 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.499 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 7.9 p-10 -78.41 -1.58 34.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.743 -1.446 . . . . 50.0 109.051 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.591 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.52 -4.82 60.1 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.123 -1.191 . . . . 16.66 110.123 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 24.9 m-85 -135.68 157.55 46.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.033 -1.275 . . . . 50.0 111.482 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.644 HD12 HG22 ' A' ' 53' ' ' ILE . 31.5 mm -109.04 129.65 63.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.504 -0.924 . . . . 16.66 108.504 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.2 m -96.42 170.26 9.35 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.095 -1.003 . . . . 16.66 108.637 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.1 t80 -56.42 -43.97 79.93 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.133 -0.979 . . . . 16.66 108.694 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -60.44 -49.4 77.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.531 -0.731 . . . . 50.0 109.154 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.563 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.9 mt-10 -58.45 -46.07 87.31 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.267 -0.896 . . . . 16.66 109.219 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -63.52 -35.37 80.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 16.66 109.331 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 31.6 m -66.21 -48.41 70.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.444 -0.785 . . . . 50.0 109.279 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.57 -36.26 75.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.356 -0.84 . . . . 50.0 109.394 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -77.95 -37.14 48.22 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.433 -0.951 . . . . 50.0 108.433 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.695 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -56.46 -27.92 54.75 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.994 -1.643 . . . . 16.66 108.994 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 67' ' ' THR . 82.1 mtm180 -71.49 -27.34 63.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -1.135 . . . . 50.0 108.806 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.19 60.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.441 -0.787 . . . . 50.0 109.291 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.89 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.4 m-80 -144.49 59.83 1.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.356 -0.84 . . . . 50.0 109.248 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.602 ' HA ' HD23 ' A' ' 77' ' ' LEU . 97.3 mtt180 -52.57 -21.63 4.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 50.0 109.123 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.8 -26.74 60.03 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.36 -1.496 . . . . 25.0 109.36 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.89 HD12 ' CB ' ' A' ' 73' ' ' ASN . 72.1 mt -73.06 -45.02 59.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -1.099 . . . . 50.0 109.618 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -64.41 -42.94 95.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.376 -0.828 . . . . 50.0 109.806 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.9 mtmt -65.37 -34.12 77.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 50.0 109.484 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -79.32 -46.46 17.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 50.0 109.498 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.8 p -64.18 -43.89 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 50.0 109.192 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.548 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.08 -37.92 35.89 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.733 -0.604 . . . . 50.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 61.2 mttp -70.65 -26.43 63.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 50.0 109.413 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.617 HG21 HG21 ' A' ' 37' ' ' THR . 28.3 mt -62.78 -31.23 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 50.0 109.237 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 5.6 m-85 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.965 -1.017 . . . . 99.99 109.474 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 8' ' ' LYS . 81.3 m-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.4 0.619 . . . . 50.0 109.627 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 16.2 mttt -43.35 -35.91 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.442 -0.786 . . . . 50.0 109.78 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 12' ' ' GLU . . . -60.9 -45.87 92.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 16.66 109.058 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 73.6 mt-10 -70.67 -34.84 72.44 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.383 -0.823 . . . . 16.66 108.822 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.718 ' NH1' HG23 ' A' ' 67' ' ' THR . 70.3 mtm180 -72.31 -40.65 67.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.364 -0.835 . . . . 50.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.568 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 24.6 pt-20 -68.95 -38.34 79.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.291 -0.881 . . . . 50.0 109.184 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.541 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.4 mtp180 -66.8 -41.83 86.95 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.889 . . . . 50.0 109.303 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.481 HG22 ' HE2' ' A' ' 18' ' ' PHE . 27.4 mt -69.97 -46.01 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.278 -0.889 . . . . 50.0 109.032 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -64.62 -35.17 80.13 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.349 -0.844 . . . . 16.66 109.209 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 51.2 mttt -65.78 -31.72 72.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 50.0 109.385 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 65.7 mtt180 -70.68 -36.11 73.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 50.0 109.163 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.951 ' HB3' HD13 ' A' ' 26' ' ' ILE . 43.1 m-85 -66.04 -47.31 74.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.395 -0.816 . . . . 16.66 109.375 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.3 t0 -59.79 103.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.279 -0.888 . . . . 16.66 108.848 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.75 -51.67 53.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.179 -0.951 . . . . 50.0 111.191 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -86.59 -28.39 23.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.718 -1.239 . . . . 16.66 109.672 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 90.53 39.14 6.01 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.89 -1.148 . . . . 16.66 110.373 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.503 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.7 p-10 -95.02 5.63 51.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -1.221 . . . . 16.66 109.291 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.59 -8.1 77.09 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.486 -1.046 . . . . 16.66 110.486 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HE3' ' CE1' ' A' ' 60' ' ' PHE . 14.1 pttt -128.54 141.35 51.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.95 -1.324 . . . . 50.0 109.929 -179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.951 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.6 mt -112.59 133.19 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.655 -0.653 . . . . 16.66 109.528 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 p -103.59 166.18 10.58 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.618 -0.882 . . . . 50.0 108.618 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.516 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.18 -44.39 52.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.062 -1.024 . . . . 50.0 108.81 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.54 82.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.354 -0.841 . . . . 50.0 109.419 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.8 mt-10 -74.25 -54.73 7.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -0.932 . . . . 16.66 109.275 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.666 ' HG ' HD12 ' A' ' 35' ' ' LEU . 40.1 tp -61.92 -43.63 98.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.181 -0.95 . . . . 16.66 108.929 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.48 -43.82 98.48 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.084 -1.606 . . . . 16.66 109.084 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -56.49 -44.0 80.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.285 -1.127 . . . . 50.0 109.531 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.72 -39.4 66.96 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.364 -0.976 . . . . 50.0 108.364 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.115 HD13 HG22 ' A' ' 46' ' ' VAL . 6.9 mt -59.66 -32.61 70.62 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.532 -0.73 . . . . 99.99 109.522 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.6 -24.4 0.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 99.99 109.532 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.7 t -52.93 -23.78 7.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.183 -0.948 . . . . 99.99 109.151 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.832 HD12 HD12 ' A' ' 41' ' ' ILE . 25.5 mt -62.77 -31.81 72.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.42 -0.8 . . . . 50.0 109.343 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.69 6.58 51.17 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 16.66 109.564 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.24 55.15 0.64 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.183 -1.186 . . . . 16.66 109.521 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.832 HD12 HD12 ' A' ' 38' ' ' LEU . 12.0 tt -140.53 171.33 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 50.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.52 165.2 27.9 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.714 -0.847 . . . . 16.66 108.714 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.82 -33.47 20.54 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.052 1.834 . . . . 50.0 110.232 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -64.97 -25.3 67.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.708 -0.62 . . . . 50.0 110.149 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.441 ' OE1' HG13 ' A' ' 41' ' ' ILE . 94.0 mt-10 -82.59 -38.61 23.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.888 -1.132 . . . . 16.66 108.344 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.115 HG22 HD13 ' A' ' 35' ' ' LEU . 41.4 t -65.76 -36.12 76.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.824 -0.806 . . . . 50.0 108.824 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -66.24 -39.14 89.31 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.973 -0.751 . . . . 50.0 108.973 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.536 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 3.4 t60 -66.92 -41.24 87.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.412 -0.805 . . . . 50.0 109.135 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.492 ' HE3' HD11 ' A' ' 35' ' ' LEU . 48.0 mtm -60.17 -44.92 94.65 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.241 -0.912 . . . . 16.66 108.923 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.529 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 20.1 mtp -61.98 -47.17 86.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.528 -0.733 . . . . 50.0 109.231 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.33 -19.13 54.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 50.0 109.068 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.536 ' CD ' ' HE2' ' A' ' 48' ' ' HIS . 35.8 mt-10 -95.92 -36.72 10.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 16.66 108.975 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.59 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.7 mt -81.33 -32.41 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.476 -0.765 . . . . 50.0 109.482 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.9 t0 -60.66 100.49 0.11 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.399 -0.813 . . . . 16.66 108.905 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.444 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 71.0 p -66.81 -46.89 73.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.324 -0.86 . . . . 50.0 110.771 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.9 p-10 -87.94 -40.81 13.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.178 -0.951 . . . . 16.66 109.559 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.474 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 103.32 28.99 5.86 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.919 -1.134 . . . . 16.66 110.314 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.478 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.6 p-10 -79.8 -2.79 44.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.862 -1.375 . . . . 50.0 109.135 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.529 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.7 -3.96 57.73 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.783 -1.327 . . . . 16.66 109.783 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CE1' ' HE3' ' A' ' 25' ' ' LYS . 32.4 m-85 -135.91 156.1 49.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.077 -1.249 . . . . 50.0 111.279 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.551 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 29.4 mm -108.89 130.99 60.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.463 -0.94 . . . . 16.66 108.463 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 m -99.58 168.02 10.22 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.988 -1.07 . . . . 16.66 108.775 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.568 ' CE1' ' HA ' ' A' ' 12' ' ' GLU . 36.1 t80 -54.88 -43.73 73.44 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.247 -0.981 . . . . 16.66 108.673 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -59.83 -49.81 76.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.568 -0.707 . . . . 50.0 109.115 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.5 mt-10 -58.81 -47.29 85.31 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.271 -0.893 . . . . 16.66 108.974 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.666 ' HZ ' HD12 ' A' ' 77' ' ' LEU . 58.7 t80 -63.07 -33.21 74.95 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.401 -0.812 . . . . 16.66 109.241 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.718 HG23 ' NH1' ' A' ' 11' ' ' ARG . 79.7 m -67.24 -49.17 65.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 50.0 109.107 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' OD1' ' NH2' ' A' ' 71' ' ' ARG . 59.4 m-20 -59.26 -36.95 76.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 50.0 109.291 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.59 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -79.46 -37.79 36.11 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.414 -0.958 . . . . 50.0 108.414 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.731 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -60.38 -32.51 77.52 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.096 -1.602 . . . . 16.66 109.096 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 67' ' ' THR . 65.6 mtm180 -66.16 -36.93 84.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -1.106 . . . . 50.0 108.917 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.04 -19.65 65.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.482 -0.761 . . . . 50.0 109.154 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.771 ' CB ' HD12 ' A' ' 76' ' ' LEU . 3.3 m-80 -145.81 55.23 1.18 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 50.0 109.231 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.57 ' HA ' HD23 ' A' ' 77' ' ' LEU . 8.5 ptp85 -49.87 -35.36 23.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -0.848 . . . . 50.0 108.721 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.435 ' HA2' ' HE2' ' A' ' 78' ' ' LYS . . . -65.92 -27.34 72.71 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.492 -1.443 . . . . 25.0 109.492 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.771 HD12 ' CB ' ' A' ' 73' ' ' ASN . 14.9 mt -67.92 -46.86 70.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.109 . . . . 50.0 109.507 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.837 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -62.9 -42.72 99.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.354 -0.841 . . . . 50.0 109.681 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HE2' ' HA2' ' A' ' 75' ' ' GLY . 32.3 mtmt -61.88 -31.83 72.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 50.0 109.39 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.44 ' O ' HG13 ' A' ' 83' ' ' ILE . 29.7 t0 -76.05 -37.82 57.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.306 -0.871 . . . . 50.0 109.385 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 76' ' ' LEU . 46.0 t -73.3 -39.1 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 50.0 109.401 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.81 -44.26 59.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.403 -0.81 . . . . 50.0 109.891 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -65.6 -26.73 67.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 50.0 109.463 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.452 HG13 ' HA ' ' A' ' 80' ' ' VAL . 7.9 mt -65.39 -48.2 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.831 . . . . 50.0 109.633 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.015 -0.993 . . . . 99.99 109.42 179.942 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.362 0.601 . . . . 50.0 109.573 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.503 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 39.5 mttp -45.92 -36.31 5.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 50.0 109.326 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.19 91.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.411 -0.806 . . . . 16.66 108.877 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 14' ' ' ILE . 65.5 mt-10 -68.97 -37.02 78.54 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.963 -0.754 . . . . 16.66 108.963 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.538 ' NH2' HG23 ' A' ' 67' ' ' THR . 12.6 mtm180 -70.37 -40.76 73.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.366 -0.834 . . . . 50.0 109.238 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.628 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 38.9 mt-10 -66.65 -41.05 88.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.458 -0.776 . . . . 50.0 109.268 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 13.7 mtp180 -65.37 -41.62 93.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.29 -0.881 . . . . 50.0 109.328 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 81' ' ' ALA . 22.9 mt -69.59 -45.98 76.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.267 -0.896 . . . . 50.0 109.074 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -66.06 -35.79 81.47 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.242 -0.911 . . . . 16.66 109.333 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -65.6 -33.39 75.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.211 -0.931 . . . . 50.0 109.325 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HD3' ' HB3' ' A' ' 84' ' ' PHE . 53.6 mtt85 -69.94 -34.53 73.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 50.0 109.238 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.005 ' HB3' HD13 ' A' ' 26' ' ' ILE . 34.1 m-85 -69.85 -47.54 62.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 16.66 109.538 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 25.6 t0 -58.65 103.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 16.66 108.747 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.14 -52.19 50.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.223 -0.923 . . . . 50.0 111.275 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -87.34 -22.02 25.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.747 -1.221 . . . . 16.66 109.483 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 82.53 43.92 7.63 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.271 -1.132 . . . . 16.66 110.271 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.509 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.2 p-10 -99.61 7.0 45.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.082 -1.246 . . . . 16.66 109.236 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.04 -10.88 71.52 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.545 -1.022 . . . . 16.66 110.545 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.6 pttp -127.47 140.77 51.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.866 -1.373 . . . . 50.0 109.975 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.005 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.4 mt -113.24 134.1 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.6 -0.688 . . . . 16.66 109.395 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.422 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 21.2 p -105.75 168.23 9.24 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.6 -0.889 . . . . 50.0 108.6 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.498 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.34 -46.23 55.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.973 -1.079 . . . . 50.0 108.969 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.38 -38.98 75.1 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.297 -0.877 . . . . 50.0 109.584 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 56.5 mt-10 -75.58 -53.9 7.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.175 -0.953 . . . . 16.66 109.437 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.731 HD12 ' CD1' ' A' ' 18' ' ' PHE . 9.6 tp -62.51 -42.12 99.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 16.66 108.941 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.479 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -62.88 -44.37 97.54 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.079 -1.608 . . . . 16.66 109.079 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -56.86 -44.23 81.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -1.064 . . . . 50.0 109.673 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.49 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.39 -39.36 68.05 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.435 -0.95 . . . . 50.0 108.435 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.99 HD12 HG22 ' A' ' 46' ' ' VAL . 11.4 mt -58.65 -33.62 70.29 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.548 -0.72 . . . . 99.99 109.46 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -45.18 -25.72 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 99.99 109.474 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.457 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.7 t -52.27 -25.32 9.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.898 . . . . 99.99 109.305 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.715 HD12 HD12 ' A' ' 41' ' ' ILE . 39.7 mt -62.17 -31.86 72.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.398 -0.814 . . . . 50.0 109.157 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.56 6.84 51.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.605 -1.398 . . . . 16.66 109.605 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.99 56.41 0.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.164 -1.198 . . . . 16.66 109.6 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.715 HD12 HD12 ' A' ' 38' ' ' LEU . 11.6 tt -141.5 172.35 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.971 . . . . 50.0 109.635 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.92 166.24 21.36 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.344 -0.847 . . . . 16.66 108.754 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.79 -33.66 16.03 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.02 1.813 . . . . 50.0 109.952 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.38 -25.97 68.53 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.61 -0.681 . . . . 50.0 109.969 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -80.88 -37.48 29.73 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.876 -1.14 . . . . 16.66 108.329 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.99 HG22 HD12 ' A' ' 35' ' ' LEU . 51.9 t -65.0 -36.8 78.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.949 -0.76 . . . . 50.0 108.949 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -68.19 -38.86 82.46 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.762 -0.829 . . . . 50.0 108.762 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -66.7 -41.04 88.68 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.464 -0.772 . . . . 50.0 109.011 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.8 mtt -60.82 -45.92 92.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.213 -0.929 . . . . 16.66 108.881 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.529 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 34.7 mtp -61.87 -48.25 81.35 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.014 -0.736 . . . . 50.0 109.014 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.62 -20.42 32.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.87 . . . . 50.0 109.172 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -96.86 -35.99 10.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.324 -0.86 . . . . 16.66 109.099 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.616 HG22 HD12 ' A' ' 61' ' ' ILE . 82.2 mt -82.38 -30.53 9.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.538 -0.726 . . . . 50.0 109.783 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 50' ' ' MET . 18.3 t0 -61.3 101.38 0.16 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.38 -0.825 . . . . 16.66 109.291 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 82.6 p -73.68 -48.16 34.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -0.916 . . . . 50.0 110.851 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 17.1 p-10 -85.0 -28.6 25.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 16.66 109.972 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.464 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 91.19 27.91 16.85 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.847 -1.168 . . . . 16.66 110.632 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 8.9 p-10 -83.36 -4.4 58.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.895 -1.356 . . . . 50.0 109.502 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.529 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 100.11 -7.65 58.78 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.969 -1.11 . . . . 16.66 110.35 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 43.2 m-85 -131.11 153.37 49.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.016 -1.285 . . . . 50.0 110.918 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.616 HD12 HG22 ' A' ' 53' ' ' ILE . 36.3 mm -104.33 129.5 56.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.183 -1.043 . . . . 16.66 108.183 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.78 165.45 11.94 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.143 -0.973 . . . . 16.66 108.779 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 35.3 t80 -53.61 -42.49 67.76 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.224 -0.99 . . . . 16.66 108.564 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -60.31 -48.56 81.22 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.529 -0.732 . . . . 50.0 109.218 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.544 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 62.0 mt-10 -60.25 -47.3 86.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 16.66 109.1 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.425 ' HE1' HD13 ' A' ' 77' ' ' LEU . 54.6 t80 -62.72 -35.52 80.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.517 -0.74 . . . . 16.66 109.19 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.538 HG23 ' NH2' ' A' ' 11' ' ' ARG . 12.5 m -67.07 -48.48 68.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.357 -0.839 . . . . 50.0 109.138 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -60.4 -38.24 83.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 50.0 109.237 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.578 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.17 -38.45 51.69 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.505 -0.924 . . . . 50.0 108.505 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.927 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.17 -27.72 60.49 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.183 -1.567 . . . . 16.66 109.183 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' THR . 58.8 mtm180 -72.53 -31.73 65.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -1.137 . . . . 50.0 108.989 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.1 -20.46 64.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.414 -0.804 . . . . 50.0 109.312 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.806 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.9 m-80 -149.93 56.74 0.96 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -0.863 . . . . 50.0 109.32 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 69.8 mtt180 -50.18 -38.53 40.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 50.0 108.796 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.44 -19.08 39.4 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.432 -1.467 . . . . 25.0 109.432 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.806 HD12 ' CB ' ' A' ' 73' ' ' ASN . 43.9 mt -79.52 -43.73 22.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -1.058 . . . . 50.0 109.395 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.927 HD11 ' HA3' ' A' ' 70' ' ' GLY . 5.4 mt -70.79 -15.92 62.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.475 -0.766 . . . . 50.0 109.743 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 43.1 mtpt -80.02 -29.27 39.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.15 -0.969 . . . . 50.0 109.206 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.14 -47.35 8.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 50.0 109.529 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.9 p -62.31 -42.55 95.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.371 -0.831 . . . . 50.0 109.304 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.542 ' HB2' HD11 ' A' ' 14' ' ' ILE . . . -52.24 -35.96 51.09 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.746 -0.596 . . . . 50.0 110.2 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -75.45 -24.36 57.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.092 -1.005 . . . . 50.0 109.771 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.474 HG13 ' HA ' ' A' ' 80' ' ' VAL . 10.9 mt -59.07 -38.66 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.273 -0.892 . . . . 50.0 109.546 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.465 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 93.1 m-85 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 118.038 -0.982 . . . . 99.99 109.425 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.351 -0.611 . . . . 50.0 109.351 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -49.22 -36.34 19.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.825 . . . . 50.0 109.516 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.15 -46.66 87.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.257 -0.902 . . . . 16.66 108.752 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.46 ' O ' HG13 ' A' ' 14' ' ' ILE . 59.6 mm-40 -67.28 -40.37 86.14 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.801 -0.814 . . . . 16.66 108.801 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.548 ' NH2' HD12 ' A' ' 77' ' ' LEU . 45.4 mtt-85 -65.81 -40.49 91.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.557 -0.714 . . . . 50.0 109.649 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.614 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 35.6 mt-10 -64.89 -39.79 94.09 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 50.0 109.571 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 53.2 mtp180 -69.24 -39.26 78.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 50.0 109.21 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.5 mt -71.59 -45.2 68.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.315 -0.866 . . . . 50.0 108.957 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -64.48 -36.47 84.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.114 -0.991 . . . . 16.66 108.864 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 33.5 mttt -66.12 -28.81 69.09 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.392 -0.818 . . . . 50.0 108.88 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 35.2 mtt85 -68.85 -39.17 80.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 50.0 109.08 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.883 ' HB3' HD13 ' A' ' 26' ' ' ILE . 54.5 m-85 -68.52 -51.33 44.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.458 -0.776 . . . . 16.66 109.373 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.5 t0 -54.08 103.14 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -0.842 . . . . 16.66 108.814 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.68 -51.67 46.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.198 -0.939 . . . . 50.0 111.278 -178.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -86.73 -27.48 23.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.812 -1.18 . . . . 16.66 109.693 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.28 39.26 6.44 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.145 -1.182 . . . . 16.66 110.145 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -94.34 6.22 49.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.086 -1.244 . . . . 16.66 109.193 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.85 -7.43 76.89 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.513 -1.035 . . . . 16.66 110.513 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 11.7 pttp -130.43 142.32 50.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.891 -1.358 . . . . 50.0 109.971 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.883 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.5 mt -112.53 133.51 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.613 -0.679 . . . . 16.66 109.567 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 p -105.83 168.22 9.26 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.359 -0.838 . . . . 50.0 108.897 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.2 -46.53 54.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.059 -1.025 . . . . 50.0 108.781 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.28 -41.42 75.85 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.337 -0.852 . . . . 50.0 109.38 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.506 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.8 mt-10 -73.92 -54.08 8.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.187 -0.946 . . . . 16.66 109.302 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.899 HD22 HG13 ' A' ' 46' ' ' VAL . 6.6 tt -59.65 -45.89 90.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.218 -0.926 . . . . 16.66 108.9 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.591 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -61.54 -43.93 98.65 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.559 -1.417 . . . . 16.66 109.559 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -58.04 -40.69 81.56 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.286 -1.126 . . . . 50.0 109.82 -179.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -71.83 -39.12 69.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.097 -1.002 . . . . 50.0 108.736 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.016 ' CD1' HG22 ' A' ' 46' ' ' VAL . 16.0 mt -59.71 -31.86 69.99 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.499 -0.751 . . . . 99.99 110.116 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.7 mttt -43.55 -28.53 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.08 -1.012 . . . . 99.99 109.577 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -52.82 -26.97 16.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 99.99 109.226 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.03 HD12 HD12 ' A' ' 41' ' ' ILE . 22.1 mt -58.28 -33.64 69.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.328 -0.857 . . . . 50.0 109.257 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.08 2.0 57.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.773 -1.331 . . . . 16.66 109.773 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.15 57.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -1.18 . . . . 16.66 109.624 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.03 HD12 HD12 ' A' ' 38' ' ' LEU . 10.5 tt -139.1 169.24 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.133 -0.979 . . . . 50.0 109.719 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.81 165.93 21.27 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.774 -0.824 . . . . 16.66 108.774 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.2 -33.53 18.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.03 1.82 . . . . 50.0 110.146 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -63.16 -27.82 69.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.613 -0.68 . . . . 50.0 110.113 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.17 -36.14 30.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.93 -1.106 . . . . 16.66 108.389 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.016 HG22 ' CD1' ' A' ' 35' ' ' LEU . 76.4 t -66.41 -35.04 73.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.098 -0.704 . . . . 50.0 109.098 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -67.95 -38.05 82.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.872 -0.788 . . . . 50.0 108.872 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -67.15 -37.8 84.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.424 -0.797 . . . . 50.0 109.226 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.415 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.6 mtt -61.75 -46.81 88.03 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.196 -0.94 . . . . 16.66 108.854 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.699 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 35.2 mtp -61.96 -47.87 82.94 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.492 -0.755 . . . . 50.0 109.085 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.79 -19.48 41.32 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.365 -0.835 . . . . 50.0 109.231 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -97.42 -36.15 10.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 16.66 109.029 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.579 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.8 mt -82.05 -32.13 10.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.515 -0.741 . . . . 50.0 109.797 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.0 t0 -59.19 101.63 0.1 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.245 -0.91 . . . . 16.66 108.965 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.511 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 80.9 p -71.04 -48.1 54.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 50.0 110.754 -178.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -85.79 -30.83 22.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.161 -0.962 . . . . 16.66 109.518 -179.585 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 92.84 27.91 13.26 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.862 -1.161 . . . . 16.66 110.343 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD2' ' OD1' ' A' ' 56' ' ' ASP . 1.4 p30 -81.87 -2.23 50.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.328 . . . . 50.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.699 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.89 -8.57 59.64 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.044 -1.074 . . . . 16.66 110.56 179.121 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 36.4 m-85 -132.95 156.17 47.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.948 -1.325 . . . . 50.0 111.24 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.572 HD12 HG22 ' A' ' 53' ' ' ILE . 25.5 mm -107.6 129.05 62.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.432 -0.951 . . . . 16.66 108.432 178.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.85 167.41 11.27 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.033 -1.042 . . . . 16.66 108.647 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.614 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 34.2 t80 -54.52 -42.57 71.0 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.025 -1.047 . . . . 16.66 108.545 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -60.52 -49.71 76.46 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.576 -0.702 . . . . 50.0 109.165 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 61.2 mt-10 -58.91 -46.8 87.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.258 -0.901 . . . . 16.66 109.08 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.427 ' HE1' HD13 ' A' ' 77' ' ' LEU . 51.1 t80 -63.86 -35.66 81.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.442 -0.786 . . . . 16.66 109.346 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.7 m -66.22 -48.69 69.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.37 -0.832 . . . . 50.0 109.166 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -59.88 -34.98 73.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 50.0 109.395 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.579 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -79.81 -37.65 34.69 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.422 -0.955 . . . . 50.0 108.422 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.825 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -57.88 -27.64 59.61 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.067 -1.613 . . . . 16.66 109.067 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -71.37 -32.2 68.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.445 -1.032 . . . . 50.0 108.811 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.43 -20.94 66.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.463 -0.773 . . . . 50.0 109.276 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.763 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.6 m-80 -152.12 55.89 0.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -0.84 . . . . 50.0 109.137 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 4.1 ptm180 -48.45 -34.11 10.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.877 . . . . 50.0 108.769 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.41 ' HA2' ' HE3' ' A' ' 78' ' ' LYS . . . -60.62 -31.7 75.92 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.347 -1.501 . . . . 25.0 109.347 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.763 HD12 ' CB ' ' A' ' 73' ' ' ASN . 65.7 mt -66.13 -44.46 84.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -1.147 . . . . 50.0 109.582 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.825 HD11 ' HA3' ' A' ' 70' ' ' GLY . 4.6 mt -71.39 -19.13 62.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 50.0 109.843 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 14.5 mtmt -79.96 -28.37 39.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.177 -0.952 . . . . 50.0 109.271 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.92 -46.09 8.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 50.0 109.38 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.2 p -58.44 -44.19 88.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.803 0.811 . . . . 50.0 108.988 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.545 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -51.25 -38.45 52.7 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.297 -0.561 . . . . 50.0 109.767 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -68.77 -27.28 65.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 50.0 109.614 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.449 HG13 ' HA ' ' A' ' 80' ' ' VAL . 8.4 mt -60.66 -43.31 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.31 -0.869 . . . . 50.0 109.422 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.037 -0.982 . . . . 99.99 109.415 179.895 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.472 ' OD2' ' NH2' ' A' ' 74' ' ' ARG . 79.4 m-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.392 0.615 . . . . 50.0 109.465 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.46 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 11.5 mttt -43.69 -37.48 2.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 50.0 109.633 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -60.53 -46.02 91.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 16.66 108.91 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 14' ' ' ILE . 83.9 mt-10 -69.02 -35.84 77.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.476 -0.765 . . . . 16.66 108.976 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.67 ' NH2' HG23 ' A' ' 67' ' ' THR . 17.0 mtm180 -70.12 -40.45 74.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 50.0 109.309 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.633 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 59.5 mt-10 -66.6 -41.9 87.71 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.394 -0.816 . . . . 50.0 109.411 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 18.9 mtp180 -66.47 -41.31 89.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 50.0 109.457 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 10' ' ' GLU . 41.8 mt -70.04 -43.94 78.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.237 -0.915 . . . . 50.0 109.059 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 26' ' ' ILE . 70.2 t80 -64.35 -35.98 82.64 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.203 -0.936 . . . . 16.66 109.123 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -66.39 -30.43 70.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 50.0 109.12 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 60.0 mtt85 -69.32 -36.92 77.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 50.0 109.129 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.907 ' HB3' HD13 ' A' ' 26' ' ' ILE . 46.1 m-85 -69.4 -50.82 42.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.421 -0.799 . . . . 16.66 109.475 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.6 t0 -55.32 103.43 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 16.66 108.685 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.64 -51.53 48.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.269 -0.894 . . . . 50.0 111.307 -178.547 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -87.5 -27.59 22.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.759 -1.213 . . . . 16.66 109.753 -179.404 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 90.23 38.2 6.42 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.767 -1.206 . . . . 16.66 110.242 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.8 p-10 -93.34 6.33 48.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.252 . . . . 16.66 109.192 179.154 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.6 -7.72 77.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.402 -1.079 . . . . 16.66 110.402 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 24.9 pttt -129.56 141.67 50.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.935 -1.332 . . . . 50.0 109.997 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.907 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.7 mt -111.85 133.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.642 -0.661 . . . . 16.66 109.547 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.404 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 10.9 p -105.87 166.28 10.59 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.759 -0.83 . . . . 50.0 108.759 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.09 -45.19 52.42 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.049 -1.032 . . . . 50.0 108.841 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.79 -39.55 77.8 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.331 -0.856 . . . . 50.0 109.517 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.494 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.2 mt-10 -74.65 -54.17 7.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.157 -0.965 . . . . 16.66 109.398 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.584 HD12 ' CE1' ' A' ' 18' ' ' PHE . 30.3 tp -61.77 -43.35 99.02 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.262 -0.899 . . . . 16.66 108.954 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.689 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -62.71 -44.51 97.4 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.139 -1.584 . . . . 16.66 109.139 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 28.8 mt-10 -58.8 -42.74 89.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.355 -1.085 . . . . 50.0 109.868 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.79 -40.24 66.07 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.098 -1.001 . . . . 50.0 108.406 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.987 HD12 HG22 ' A' ' 46' ' ' VAL . 10.7 mt -58.71 -28.63 66.0 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.61 -0.681 . . . . 99.99 109.553 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 2.4 mtmt -44.04 -26.19 0.27 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 99.99 109.615 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.431 ' OG1' HG22 ' A' ' 83' ' ' ILE . 6.6 t -51.94 -26.31 10.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.306 -0.872 . . . . 99.99 109.195 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 38' ' ' LEU . 41.9 mt -58.73 -37.19 75.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.438 -0.789 . . . . 50.0 109.199 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.98 -5.6 61.89 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.836 -1.305 . . . . 16.66 109.836 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.7 t -152.0 59.77 0.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.044 -1.268 . . . . 16.66 109.779 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.3 tp -134.0 157.2 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.152 -0.968 . . . . 50.0 109.485 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.11 160.02 27.65 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.461 -0.94 . . . . 16.66 108.461 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.77 -31.97 30.93 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 121.93 1.753 . . . . 50.0 110.066 178.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -72.15 -17.92 61.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.603 -0.685 . . . . 50.0 110.177 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -80.94 -37.51 29.34 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.815 -1.178 . . . . 16.66 108.28 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.987 HG22 HD12 ' A' ' 35' ' ' LEU . 65.6 t -68.23 -35.88 72.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.821 -0.807 . . . . 50.0 108.821 179.299 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -65.19 -40.4 94.17 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.797 -0.816 . . . . 50.0 108.797 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.481 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.7 t60 -66.03 -42.33 89.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.484 -0.76 . . . . 50.0 109.051 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.9 mtt -58.45 -44.42 89.19 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.249 -0.907 . . . . 16.66 108.71 179.482 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.569 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 34.6 mtp -61.69 -46.69 88.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.572 -0.705 . . . . 50.0 109.182 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.82 -21.36 41.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 50.0 109.042 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.85 -36.32 11.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.46 -0.775 . . . . 16.66 109.076 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.582 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.7 mt -80.59 -31.98 12.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.43 -0.794 . . . . 50.0 109.566 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.6 t0 -61.42 101.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.5 -0.75 . . . . 16.66 109.066 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.474 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 60.3 p -67.5 -46.42 72.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.269 -0.894 . . . . 50.0 110.692 -179.038 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -88.28 -41.41 12.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 16.66 109.56 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 103.67 29.54 5.56 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.964 -1.112 . . . . 16.66 110.346 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 13.3 p-10 -80.61 -2.57 46.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.877 -1.367 . . . . 50.0 109.112 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.569 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.72 -3.58 57.56 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.943 -1.263 . . . . 16.66 109.943 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.575 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.2 m-85 -137.0 156.82 47.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.023 -1.281 . . . . 50.0 111.336 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.554 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 25.1 mm -109.46 130.31 62.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.418 -0.956 . . . . 16.66 108.418 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -99.38 168.52 9.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.057 -1.027 . . . . 16.66 108.571 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.633 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.6 t80 -54.8 -43.73 73.16 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.022 -1.071 . . . . 16.66 108.609 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -58.66 -47.54 84.11 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.626 -0.671 . . . . 50.0 109.261 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 80.8 mt-10 -62.97 -46.54 87.22 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.29 -0.881 . . . . 16.66 109.221 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.536 ' HZ ' HD12 ' A' ' 77' ' ' LEU . 31.9 t80 -63.81 -32.89 74.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 16.66 109.212 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.67 HG23 ' NH2' ' A' ' 11' ' ' ARG . 31.2 m -67.28 -49.35 64.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 50.0 109.171 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -59.74 -36.46 76.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.31 -0.869 . . . . 50.0 109.137 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.582 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.1 -38.91 43.02 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.504 -0.925 . . . . 50.0 108.504 179.706 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.67 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -57.49 -28.65 59.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.038 -1.625 . . . . 16.66 109.038 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 67' ' ' THR . 22.7 mtm180 -70.64 -31.91 69.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -1.076 . . . . 50.0 108.851 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.93 -23.51 62.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 50.0 109.238 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.91 ' CB ' HD12 ' A' ' 76' ' ' LEU . 15.5 m-80 -140.48 58.3 1.57 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 50.0 109.223 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.578 ' HA ' HD23 ' A' ' 77' ' ' LEU . 58.3 mtp180 -52.66 -34.86 53.6 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.328 -0.858 . . . . 50.0 108.998 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 78' ' ' LYS . . . -67.97 -24.25 74.42 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.48 -1.448 . . . . 25.0 109.48 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.91 HD12 ' CB ' ' A' ' 73' ' ' ASN . 14.6 mt -71.72 -45.99 60.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -1.148 . . . . 50.0 109.489 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.826 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -62.86 -42.97 99.95 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.327 -0.858 . . . . 50.0 109.677 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 37.0 pttt -68.36 -31.24 70.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 50.0 109.247 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.473 ' O ' HG13 ' A' ' 83' ' ' ILE . 35.3 m-20 -74.78 -36.8 62.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.333 -0.854 . . . . 50.0 109.256 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 76' ' ' LEU . 21.9 t -79.26 -35.64 17.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 50.0 109.22 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.97 -42.76 63.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.426 -0.796 . . . . 50.0 109.841 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -69.28 -26.08 64.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 50.0 109.573 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 79' ' ' ASP . 13.7 mt -63.53 -45.19 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.866 . . . . 50.0 109.527 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.05 -0.976 . . . . 99.99 109.397 179.966 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.45 -0.574 . . . . 50.0 109.45 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 13.3 mttp -49.57 -36.09 22.68 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.401 -0.812 . . . . 50.0 109.262 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.25 -46.35 90.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 16.66 108.755 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.475 ' O ' HG13 ' A' ' 14' ' ' ILE . 69.2 mt-10 -69.02 -37.81 78.85 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.876 -0.787 . . . . 16.66 108.876 179.386 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH2' ' HG2' ' A' ' 8' ' ' LYS . 10.8 mtm180 -69.57 -40.28 76.86 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.329 -0.857 . . . . 50.0 109.414 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 54.2 mt-10 -66.68 -39.73 88.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.406 -0.809 . . . . 50.0 109.476 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -69.11 -39.73 78.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 50.0 109.163 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' A' ' 81' ' ' ALA . 45.4 mt -71.44 -44.13 71.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.334 -0.854 . . . . 50.0 109.063 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -69.91 -36.1 75.11 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.133 -0.979 . . . . 16.66 109.115 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 56.6 mttm -65.83 -31.5 72.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.329 -0.857 . . . . 50.0 109.031 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -71.37 -35.8 71.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 50.0 109.011 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.022 ' HB3' HD13 ' A' ' 26' ' ' ILE . 33.7 m-85 -67.83 -47.58 68.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 16.66 109.243 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.3 t0 -59.09 103.36 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 16.66 108.624 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.85 -51.32 56.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 50.0 111.257 -178.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -87.18 -30.64 20.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.739 -1.226 . . . . 16.66 109.872 -179.307 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.46 35.6 6.18 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.702 -1.237 . . . . 16.66 110.15 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.2 p-10 -90.28 4.75 49.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -1.184 . . . . 16.66 109.172 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.91 -6.26 76.55 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.432 -1.067 . . . . 16.66 110.432 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.5 pttp -131.26 142.58 50.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.93 -1.335 . . . . 50.0 110.079 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.022 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.9 mt -112.23 132.86 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.695 -0.628 . . . . 16.66 109.421 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.403 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 14.4 p -104.94 167.76 9.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.339 -0.851 . . . . 50.0 108.963 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.23 -45.34 53.85 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.138 -0.976 . . . . 50.0 108.987 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.53 -40.83 79.67 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.374 -0.829 . . . . 50.0 109.318 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.3 mt-10 -74.01 -54.57 7.59 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.271 -0.893 . . . . 16.66 109.218 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.715 HD22 HG13 ' A' ' 46' ' ' VAL . 5.6 tt -59.7 -46.58 88.65 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.209 -0.932 . . . . 16.66 108.806 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.534 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -60.83 -42.93 99.73 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.45 -1.46 . . . . 16.66 109.45 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -57.98 -41.83 83.78 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.336 -1.096 . . . . 50.0 109.881 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.475 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -71.26 -39.02 71.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.15 -0.969 . . . . 50.0 108.719 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.019 ' CD1' HG22 ' A' ' 46' ' ' VAL . 21.3 mt -59.77 -34.62 73.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.54 -0.725 . . . . 99.99 110.034 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 8.8 mttt -43.78 -28.12 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 99.99 109.53 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.996 HG21 HG21 ' A' ' 83' ' ' ILE . 6.6 t -52.48 -25.74 11.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.288 -0.883 . . . . 99.99 109.208 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -64.44 -30.36 71.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.301 -0.874 . . . . 50.0 109.317 179.824 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.97 6.37 52.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.738 -1.345 . . . . 16.66 109.738 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 t -154.58 58.67 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.164 -1.198 . . . . 16.66 109.713 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.57 HD12 HD13 ' A' ' 38' ' ' LEU . 11.0 tt -144.25 168.42 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.963 . . . . 50.0 109.47 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.41 166.04 20.18 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 16.66 108.786 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.45 -33.4 17.86 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.089 1.859 . . . . 50.0 110.085 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -62.68 -27.86 69.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.662 -0.649 . . . . 50.0 109.908 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -81.73 -35.89 29.21 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.833 -1.167 . . . . 16.66 108.255 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.019 HG22 ' CD1' ' A' ' 35' ' ' LEU . 79.3 t -67.1 -35.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.028 -0.73 . . . . 50.0 109.028 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -68.6 -38.02 80.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.854 -0.795 . . . . 50.0 108.854 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -67.05 -37.04 83.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 50.0 109.132 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.402 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.4 mtt -60.86 -47.56 85.83 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.272 -0.892 . . . . 16.66 108.811 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.56 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 56.5 mtp -61.28 -47.31 86.59 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.566 -0.709 . . . . 50.0 109.125 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.81 -20.74 37.91 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.292 -0.88 . . . . 50.0 109.171 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -98.93 -37.39 9.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 16.66 109.244 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.588 HG12 ' CD2' ' A' ' 69' ' ' PHE . 85.5 mt -80.35 -33.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.471 -0.768 . . . . 50.0 109.685 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.6 t0 -60.44 101.55 0.14 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.405 -0.809 . . . . 16.66 108.891 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 71.8 p -66.53 -47.9 71.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 50.0 110.785 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.2 p-10 -87.57 -38.8 15.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.106 -0.996 . . . . 16.66 109.452 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 101.12 27.65 7.24 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.945 -1.121 . . . . 16.66 110.492 179.403 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.474 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 15.6 p-10 -78.45 -0.75 30.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.865 -1.373 . . . . 50.0 109.224 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.56 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.47 -4.84 58.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.015 -1.234 . . . . 16.66 110.015 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.575 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 27.0 m-85 -136.86 157.17 47.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.926 -1.337 . . . . 50.0 111.34 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.555 HD12 HG22 ' A' ' 53' ' ' ILE . 23.1 mm -110.08 131.35 61.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.466 -0.939 . . . . 16.66 108.466 178.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 170.82 8.27 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.045 -1.035 . . . . 16.66 108.521 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 36.2 t80 -56.09 -44.45 79.02 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.121 -1.032 . . . . 16.66 108.657 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -59.04 -49.35 78.23 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.492 -0.755 . . . . 50.0 109.229 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.548 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 78.4 mt-10 -60.23 -46.49 89.59 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.261 -0.899 . . . . 16.66 109.265 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.511 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 64.1 t80 -63.6 -34.07 77.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.418 -0.802 . . . . 16.66 109.337 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.531 HG23 ' NH2' ' A' ' 11' ' ' ARG . 19.6 m -66.56 -48.97 67.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.843 . . . . 50.0 109.203 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -58.85 -36.22 74.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 50.0 109.24 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.588 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -79.88 -37.16 35.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.585 -0.894 . . . . 50.0 108.585 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.922 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.15 -28.71 67.05 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.383 -1.487 . . . . 16.66 109.383 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 67' ' ' THR . 75.5 mtm180 -72.68 -34.69 67.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 50.0 109.198 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.82 -18.98 65.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.434 -0.791 . . . . 50.0 109.298 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.719 ' CB ' HD12 ' A' ' 76' ' ' LEU . 29.4 m-80 -144.4 56.74 1.3 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.263 -0.898 . . . . 50.0 109.222 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 98.3 mtt180 -51.46 -40.3 59.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.713 -0.847 . . . . 50.0 108.713 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.479 ' HA2' ' HE3' ' A' ' 78' ' ' LYS . . . -60.27 -25.98 63.29 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.454 -1.459 . . . . 25.0 109.454 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.719 HD12 ' CB ' ' A' ' 73' ' ' ASN . 18.6 mt -72.7 -45.55 58.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -1.161 . . . . 50.0 109.43 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.922 HD11 ' HA3' ' A' ' 70' ' ' GLY . 10.5 mt -68.67 -16.46 63.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 50.0 109.777 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HE3' ' HA2' ' A' ' 75' ' ' GLY . 18.6 mtmt -80.05 -24.35 40.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 50.0 109.322 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -91.99 -48.32 6.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.273 -0.892 . . . . 50.0 109.408 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.547 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.3 p -59.15 -44.33 91.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.388 -0.82 . . . . 50.0 109.178 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.602 ' HB2' HD11 ' A' ' 14' ' ' ILE . . . -49.62 -40.86 40.69 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.115 -0.634 . . . . 50.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -64.11 -25.74 68.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 50.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.996 HG21 HG21 ' A' ' 37' ' ' THR . 20.8 mm -66.79 -36.1 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 50.0 109.414 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.009 -0.996 . . . . 99.99 109.458 -179.999 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.296 -0.631 . . . . 50.0 109.296 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -51.18 -36.14 39.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 50.0 109.432 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.7 -45.53 85.57 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.655 -0.869 . . . . 16.66 108.655 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 14' ' ' ILE . 58.9 mt-10 -66.43 -43.82 84.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.955 -0.758 . . . . 16.66 108.955 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.5 ' NH2' ' HG2' ' A' ' 71' ' ' ARG . 20.0 mtt-85 -64.49 -39.74 94.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -0.782 . . . . 50.0 109.46 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.586 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 31.6 mt-10 -64.35 -41.62 96.65 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.48 -0.762 . . . . 50.0 109.286 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 52.0 mtp85 -67.99 -39.77 83.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.307 -0.871 . . . . 50.0 109.173 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.1 mt -70.52 -44.45 76.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.394 -0.816 . . . . 50.0 109.044 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -66.66 -36.1 81.73 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.243 -0.911 . . . . 16.66 109.141 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 22.6 mtpt -65.4 -30.22 71.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.352 -0.843 . . . . 50.0 109.089 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.515 ' NH2' ' O ' ' A' ' 84' ' ' PHE . 31.5 mtt180 -71.88 -35.22 69.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 50.0 109.057 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.058 ' HB3' HD13 ' A' ' 26' ' ' ILE . 31.0 m-85 -69.45 -48.77 59.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.448 -0.783 . . . . 16.66 109.298 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.2 t0 -58.74 103.09 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.917 . . . . 16.66 108.662 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.57 -51.82 52.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.128 -0.982 . . . . 50.0 111.239 -178.648 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -86.65 -27.9 23.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.748 -1.22 . . . . 16.66 109.565 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.33 38.1 6.83 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.862 -1.161 . . . . 16.66 110.215 179.021 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.4 p-10 -92.39 5.91 48.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -1.217 . . . . 16.66 109.142 179.168 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.88 -7.13 76.96 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.472 -1.051 . . . . 16.66 110.472 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 15.7 pttt -130.74 142.34 50.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.886 -1.361 . . . . 50.0 110.047 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.058 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.9 mt -112.3 133.23 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.724 -0.61 . . . . 16.66 109.447 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.416 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 23.7 p -106.93 169.74 8.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -0.891 . . . . 50.0 109.054 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.51 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.8 -46.76 59.85 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.108 -0.995 . . . . 50.0 108.985 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.19 74.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.266 -0.896 . . . . 50.0 109.467 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.4 mt-10 -75.56 -54.22 7.35 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.207 -0.933 . . . . 16.66 109.239 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.756 HD22 HG13 ' A' ' 46' ' ' VAL . 7.0 tt -59.58 -46.77 87.93 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.212 -0.93 . . . . 16.66 108.847 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.633 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -60.88 -43.33 99.43 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.461 -1.456 . . . . 16.66 109.461 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.32 -41.36 84.38 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.437 -1.037 . . . . 50.0 109.826 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.4 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.35 -39.81 67.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.166 -0.959 . . . . 50.0 108.726 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.011 HD12 HG22 ' A' ' 46' ' ' VAL . 14.1 mt -59.55 -32.28 70.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.446 -0.784 . . . . 99.99 109.832 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.6 mtmt -43.7 -26.32 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.065 -1.022 . . . . 99.99 109.632 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.456 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.6 t -52.4 -25.8 10.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 99.99 109.244 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -65.72 -31.86 73.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.372 -0.83 . . . . 50.0 109.201 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.07 11.04 43.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.479 -1.449 . . . . 16.66 109.479 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.33 50.02 0.56 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.242 -1.152 . . . . 16.66 109.54 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 tt -136.95 172.99 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 50.0 109.288 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.78 166.58 19.36 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 16.66 108.696 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.16 -33.81 18.01 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.089 1.859 . . . . 50.0 110.184 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -64.08 -26.14 68.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.635 -0.665 . . . . 50.0 110.117 -179.607 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -82.52 -40.11 21.48 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.814 -1.179 . . . . 16.66 108.173 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.011 HG22 HD12 ' A' ' 35' ' ' LEU . 55.2 t -62.22 -35.93 71.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.692 -0.855 . . . . 50.0 108.692 179.199 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -69.62 -37.37 76.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.752 -0.833 . . . . 50.0 108.752 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.581 ' CD2' ' HG3' ' A' ' 52' ' ' GLU . 13.7 t-160 -67.35 -36.81 82.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.506 -0.746 . . . . 50.0 109.261 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.433 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.4 mtt -61.39 -46.79 88.7 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.18 -0.95 . . . . 16.66 108.789 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.702 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 43.0 mtp -62.26 -48.32 80.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.493 -0.755 . . . . 50.0 109.056 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.93 -19.38 29.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 50.0 109.209 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.581 ' HG3' ' CD2' ' A' ' 48' ' ' HIS . 23.1 mt-10 -99.65 -36.93 9.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 16.66 109.143 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.541 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.7 mt -80.47 -33.4 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.456 -0.777 . . . . 50.0 109.501 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.6 t0 -59.82 101.69 0.13 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.302 -0.874 . . . . 16.66 108.849 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.469 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 49.5 p -68.5 -46.36 69.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 50.0 110.736 -178.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -88.09 -38.88 15.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 16.66 109.539 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.472 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 101.61 28.34 6.73 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.019 -1.086 . . . . 16.66 110.523 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.4 p-10 -79.57 -2.0 40.45 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.783 -1.422 . . . . 50.0 109.13 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.702 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.34 -5.59 59.01 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.048 -1.221 . . . . 16.66 110.048 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.573 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 31.6 m-85 -134.99 156.59 48.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.008 -1.29 . . . . 50.0 111.407 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.565 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 22.1 mm -109.21 129.8 63.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.365 -0.976 . . . . 16.66 108.365 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -96.26 167.4 11.21 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.083 -1.01 . . . . 16.66 108.55 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.586 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 34.0 t80 -54.32 -42.39 70.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.014 -1.054 . . . . 16.66 108.442 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -61.19 -47.58 85.49 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.584 -0.697 . . . . 50.0 109.335 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 74.9 mt-10 -61.71 -47.02 87.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.244 -0.91 . . . . 16.66 109.2 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.601 ' CZ ' HD11 ' A' ' 77' ' ' LEU . 80.7 t80 -61.69 -39.11 90.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 16.66 109.375 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 15.9 m -66.27 -46.53 76.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.414 -0.804 . . . . 50.0 109.325 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -59.01 -36.53 75.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 50.0 109.64 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.544 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -78.66 -35.32 45.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.234 -0.917 . . . . 50.0 108.69 179.972 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.28 -28.79 64.91 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.385 -1.486 . . . . 16.66 109.385 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.5 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 35.9 mtm180 -73.46 -30.63 63.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -1.172 . . . . 50.0 109.253 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.47 -15.85 61.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 50.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.718 ' CB ' HD12 ' A' ' 76' ' ' LEU . 5.0 p30 -149.56 54.98 0.96 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 50.0 109.189 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -51.19 -43.16 61.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.368 -0.832 . . . . 50.0 108.791 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.85 -24.38 19.15 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.174 -1.57 . . . . 25.0 109.174 179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.718 HD12 ' CB ' ' A' ' 73' ' ' ASN . 41.9 mt -80.05 -43.49 21.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -1.091 . . . . 50.0 109.394 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 1.6 mm? -61.96 -40.03 94.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.411 -0.805 . . . . 50.0 109.845 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 43.3 mtpt -66.19 -33.63 76.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 50.0 109.653 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.19 -46.83 22.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 50.0 109.463 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 77' ' ' LEU . 2.8 p -72.63 -40.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.79 0.805 . . . . 50.0 109.393 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 77' ' ' LEU . . . -53.69 -33.96 57.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.744 -0.597 . . . . 50.0 110.487 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 77.1 mttt -79.88 -22.98 42.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.018 . . . . 50.0 109.789 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.471 HG13 ' HA ' ' A' ' 80' ' ' VAL . 10.1 mt -57.59 -35.9 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 50.0 109.48 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.515 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 95.1 m-85 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.021 -0.99 . . . . 99.99 109.534 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.336 0.589 . . . . 50.0 109.457 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -48.53 -36.3 15.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.363 -0.836 . . . . 50.0 109.355 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -56.38 -45.19 80.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.597 -0.89 . . . . 16.66 108.597 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.471 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.4 mt-10 -68.09 -38.61 82.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.47 -0.769 . . . . 16.66 108.947 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.8 mtt-85 -67.49 -40.58 85.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 50.0 109.387 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.621 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 33.2 mt-10 -64.9 -40.98 95.93 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.442 -0.786 . . . . 50.0 109.354 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 59.7 mtp180 -68.27 -39.54 82.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 50.0 109.154 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 10' ' ' GLU . 33.5 mt -70.93 -45.06 75.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.391 -0.818 . . . . 50.0 109.006 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 26' ' ' ILE . 67.2 t80 -64.86 -35.86 82.5 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 16.66 108.903 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -66.56 -29.42 69.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.32 -0.862 . . . . 50.0 108.962 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 39.2 mtt85 -70.04 -36.61 75.14 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.362 -0.836 . . . . 50.0 109.006 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.884 ' HB3' HD13 ' A' ' 26' ' ' ILE . 51.6 m-85 -70.22 -51.18 32.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.448 -0.782 . . . . 16.66 109.352 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.8 t0 -55.47 103.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 16.66 108.744 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.27 48.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.89 . . . . 50.0 111.196 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -87.06 -28.39 22.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.749 -1.219 . . . . 16.66 109.71 -179.381 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 90.13 37.4 6.73 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.801 -1.19 . . . . 16.66 110.216 178.974 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.7 p-10 -91.42 5.49 49.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -1.22 . . . . 16.66 109.157 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.09 -6.2 75.95 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.401 -1.08 . . . . 16.66 110.401 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 60' ' ' PHE . 16.9 pttt -131.25 142.53 50.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.959 -1.318 . . . . 50.0 110.001 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.884 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.9 mt -112.52 133.55 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.639 -0.663 . . . . 16.66 109.495 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.0 p -106.47 167.8 9.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.866 . . . . 50.0 108.934 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.15 -45.53 53.29 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.072 -1.017 . . . . 50.0 108.93 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -57.22 -41.4 79.43 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.218 -0.926 . . . . 50.0 109.259 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.5 mt-10 -74.35 -54.85 6.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.346 -0.846 . . . . 16.66 109.001 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.775 HD22 HG13 ' A' ' 46' ' ' VAL . 6.1 tt -58.57 -48.58 80.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.869 . . . . 16.66 108.771 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.719 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -60.02 -43.44 98.2 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.308 -1.517 . . . . 16.66 109.308 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 19.0 mt-10 -56.81 -42.92 80.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.307 -1.114 . . . . 50.0 109.706 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.533 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.1 -39.41 68.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.116 -0.99 . . . . 50.0 108.502 179.526 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.997 HD12 HG22 ' A' ' 46' ' ' VAL . 14.0 mt -59.88 -33.3 71.65 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.56 -0.713 . . . . 99.99 109.865 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.4 mttm -43.97 -26.45 0.28 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 99.99 109.593 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.571 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.0 t -51.9 -24.56 6.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.286 -0.884 . . . . 99.99 109.288 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -61.84 -33.16 73.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 50.0 109.226 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.34 2.48 54.49 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.81 -1.316 . . . . 16.66 109.81 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.09 56.2 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.07 -1.253 . . . . 16.66 110.024 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.421 HG13 ' OE1' ' A' ' 45' ' ' GLU . 7.3 tt -138.38 167.54 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 50.0 109.41 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.17 165.18 17.0 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.617 -0.883 . . . . 16.66 108.617 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.21 -32.28 21.17 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.115 1.876 . . . . 50.0 110.192 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -64.22 -25.77 68.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.713 -0.617 . . . . 50.0 110.077 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' OE1' HG13 ' A' ' 41' ' ' ILE . 92.3 mt-10 -81.91 -41.3 21.1 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.854 -1.154 . . . . 16.66 108.133 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.997 HG22 HD12 ' A' ' 35' ' ' LEU . 69.3 t -62.76 -35.8 72.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.959 -0.756 . . . . 50.0 108.959 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -68.42 -38.21 81.01 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.754 -0.832 . . . . 50.0 108.754 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -66.71 -35.97 81.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.389 -0.819 . . . . 50.0 109.245 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.427 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.2 mtt -60.86 -46.67 89.69 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.147 -0.971 . . . . 16.66 108.622 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.527 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 53.5 mtp -61.92 -48.88 78.46 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.928 -0.767 . . . . 50.0 108.928 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.11 -21.67 13.8 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.282 -0.886 . . . . 50.0 109.177 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -98.5 -36.37 9.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 16.66 109.19 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.648 HG22 HD12 ' A' ' 61' ' ' ILE . 83.2 mt -81.22 -30.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.548 -0.72 . . . . 50.0 109.766 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.2 t0 -61.66 101.84 0.22 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.439 -0.788 . . . . 16.66 109.363 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.496 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 71.6 p -73.54 -47.78 38.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.28 -0.888 . . . . 50.0 110.868 -179.017 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.481 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 10.9 p-10 -85.45 -29.5 24.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.037 -1.039 . . . . 16.66 109.821 -179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 92.59 27.07 15.64 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.837 -1.173 . . . . 16.66 110.836 178.744 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.481 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p-10 -82.06 -2.68 52.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.785 -1.42 . . . . 50.0 109.424 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.527 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.3 -5.08 60.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.345 -1.102 . . . . 16.66 110.345 179.284 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.571 ' CE1' ' HE3' ' A' ' 25' ' ' LYS . 43.0 m-85 -134.28 153.69 51.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.987 -1.302 . . . . 50.0 111.093 -179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.648 HD12 HG22 ' A' ' 53' ' ' ILE . 33.0 mm -105.05 128.62 58.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.516 -0.92 . . . . 16.66 108.516 178.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 m -94.87 167.2 11.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.159 -0.963 . . . . 16.66 108.613 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.621 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 35.5 t80 -54.78 -42.6 71.93 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.059 -1.025 . . . . 16.66 108.625 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -60.74 -48.46 81.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.561 -0.712 . . . . 50.0 109.166 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.549 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 42.8 mt-10 -59.83 -46.9 87.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 16.66 109.224 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.796 ' CE1' HD11 ' A' ' 77' ' ' LEU . 59.4 t80 -62.49 -38.63 90.65 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.492 -0.755 . . . . 16.66 109.398 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 16.6 m -66.04 -47.62 73.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.392 -0.818 . . . . 50.0 109.341 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.14 -36.7 75.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 50.0 109.463 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.577 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.82 -36.72 56.71 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.656 -0.868 . . . . 50.0 108.656 179.929 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.13 -31.09 64.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.209 -1.556 . . . . 16.66 109.209 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 67' ' ' THR . 71.6 mtp180 -67.7 -31.17 70.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -1.066 . . . . 50.0 108.957 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.56 -21.9 64.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.506 -0.746 . . . . 50.0 109.356 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.779 ' CG ' HD12 ' A' ' 76' ' ' LEU . 4.4 p30 -150.11 58.54 0.97 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 50.0 109.052 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -50.65 -38.2 44.95 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.29 -0.881 . . . . 50.0 108.685 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.16 -32.67 67.76 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.233 -1.547 . . . . 25.0 109.233 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.779 HD12 ' CG ' ' A' ' 73' ' ' ASN . 19.0 mt -64.12 -43.38 95.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.446 -1.032 . . . . 50.0 109.372 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.796 HD11 ' CE1' ' A' ' 66' ' ' PHE . 1.9 mm? -61.13 -40.29 93.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 50.0 109.786 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 15.1 mtpt -63.66 -33.93 76.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 50.0 109.623 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 79' ' ' ASP . 58.4 t0 -78.75 -49.27 13.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 50.0 109.556 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.7 p -64.56 -44.71 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 50.0 109.749 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.546 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -49.64 -39.94 37.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.683 -0.635 . . . . 50.0 109.776 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 75.1 mttt -69.91 -25.19 63.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 50.0 109.615 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.571 HG21 ' CG2' ' A' ' 37' ' ' THR . 9.4 mt -65.03 -44.67 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 50.0 109.561 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.982 -1.008 . . . . 99.99 109.492 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.66 -28.56 22.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 109.497 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -68.97 133.19 47.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 25.0 109.391 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.481 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -110.05 170.05 5.74 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 50.0 109.457 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 45.5 Cg_endo -68.36 -22.54 39.42 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.562 2.175 . . . . 50.0 111.002 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -62.51 -40.02 95.4 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.516 -0.74 . . . . 25.0 109.189 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.22 -47.23 86.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 50.0 109.368 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -51.35 -39.5 57.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -0.868 . . . . 50.0 109.392 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.84 -41.45 64.26 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.315 -0.866 . . . . 16.66 108.69 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.9 mm-40 -67.07 -47.06 72.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.527 -0.733 . . . . 16.66 109.069 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.646 ' NH2' HG23 ' A' ' 67' ' ' THR . 11.2 mtm180 -65.34 -39.22 92.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.351 -0.843 . . . . 50.0 109.361 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.598 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 43.8 mt-10 -66.05 -41.31 91.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.438 -0.788 . . . . 50.0 109.228 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.4 mtt180 -66.46 -40.42 89.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.455 -0.778 . . . . 50.0 109.104 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.2 mt -70.18 -46.63 71.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.381 -0.824 . . . . 50.0 108.989 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -66.01 -35.35 80.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 16.66 109.281 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 19.9 mttt -66.08 -32.7 74.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.845 . . . . 50.0 109.351 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.55 ' CZ ' ' HB3' ' A' ' 84' ' ' PHE . 52.7 mtt180 -70.12 -35.45 74.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.877 . . . . 50.0 109.09 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.915 ' HB3' HD13 ' A' ' 26' ' ' ILE . 42.3 m-85 -67.88 -49.07 64.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.385 -0.822 . . . . 16.66 109.338 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.8 t0 -57.75 103.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 16.66 108.75 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.96 -51.49 54.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.274 -0.891 . . . . 50.0 111.185 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -87.78 -26.62 22.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.798 -1.189 . . . . 16.66 109.674 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 88.56 38.87 6.9 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.79 -1.195 . . . . 16.66 110.14 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.492 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -93.72 5.53 51.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.094 -1.239 . . . . 16.66 109.214 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.93 -8.09 73.41 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.485 -1.046 . . . . 16.66 110.485 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.0 pttp -130.13 142.01 50.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.937 -1.331 . . . . 50.0 110.042 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.915 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.0 mt -111.99 133.91 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.618 -0.676 . . . . 16.66 109.538 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.6 p -106.18 166.75 10.29 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.807 -0.812 . . . . 50.0 108.807 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.88 -45.76 51.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.055 -1.028 . . . . 50.0 108.874 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.12 -40.3 76.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.301 -0.874 . . . . 50.0 109.438 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.5 mt-10 -74.44 -54.14 8.17 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.211 -0.931 . . . . 16.66 109.373 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.815 ' HG ' HD12 ' A' ' 35' ' ' LEU . 63.1 tp -62.0 -43.03 99.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 16.66 109.044 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.58 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.41 -44.01 98.24 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.239 -1.545 . . . . 16.66 109.239 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -57.81 -43.48 85.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.355 -1.085 . . . . 50.0 109.729 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.82 -39.67 69.65 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.153 -0.967 . . . . 50.0 108.521 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.994 HD23 HD11 ' A' ' 38' ' ' LEU . 2.2 mt -59.18 -33.12 70.57 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.595 -0.691 . . . . 99.99 109.69 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' LEU . 17.7 mttt -44.85 -26.42 0.4 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.999 -1.063 . . . . 99.99 109.388 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.817 ' CG2' HG21 ' A' ' 83' ' ' ILE . 10.4 t -51.81 -25.54 7.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.244 -0.91 . . . . 99.99 109.258 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.994 HD11 HD23 ' A' ' 35' ' ' LEU . 1.5 mt -63.85 -32.74 74.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -0.843 . . . . 50.0 109.308 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.46 5.76 51.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.724 -1.35 . . . . 16.66 109.724 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.76 52.37 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -1.185 . . . . 16.66 109.715 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.599 HD12 HD13 ' A' ' 38' ' ' LEU . 13.5 tt -137.56 169.89 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 50.0 109.469 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.59 163.51 32.18 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.647 -0.871 . . . . 16.66 108.647 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.23 -33.51 24.2 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.03 1.82 . . . . 50.0 110.049 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -64.46 -24.96 67.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.675 -0.64 . . . . 50.0 109.892 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -83.12 -37.06 24.27 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.862 -1.149 . . . . 16.66 108.282 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.982 HG22 HD13 ' A' ' 35' ' ' LEU . 68.9 t -68.57 -36.73 75.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.927 -0.768 . . . . 50.0 108.927 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -67.9 -39.48 83.61 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.8 -0.815 . . . . 50.0 108.8 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.25 -39.6 92.86 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.441 -0.787 . . . . 50.0 109.194 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.413 ' O ' HG13 ' A' ' 53' ' ' ILE . 11.4 mtt -58.57 -43.78 89.53 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.186 -0.946 . . . . 16.66 108.861 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.528 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 57.7 mtp -61.76 -47.95 82.86 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.535 -0.728 . . . . 50.0 109.124 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.72 -20.76 36.65 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.309 -0.869 . . . . 50.0 109.187 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -97.37 -36.51 10.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 16.66 109.123 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.582 HG22 HD12 ' A' ' 61' ' ' ILE . 83.7 mt -81.8 -32.48 11.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.426 -0.796 . . . . 50.0 109.67 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.7 t0 -60.35 101.42 0.13 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.412 -0.805 . . . . 16.66 108.957 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.471 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 60.0 p -70.19 -46.86 63.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 50.0 110.75 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -86.69 -38.41 17.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.12 -0.987 . . . . 16.66 109.542 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.99 28.82 6.72 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.93 -1.128 . . . . 16.66 110.617 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.49 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.0 p-10 -80.37 -3.22 48.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.751 -1.441 . . . . 50.0 109.155 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.528 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.89 -5.07 57.88 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.922 -1.271 . . . . 16.66 109.922 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 40.8 m-85 -134.38 156.95 47.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.016 -1.285 . . . . 50.0 111.298 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.582 HD12 HG22 ' A' ' 53' ' ' ILE . 36.3 mm -108.2 130.28 61.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.212 -1.033 . . . . 16.66 108.212 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.6 m -99.95 167.68 10.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.998 -1.064 . . . . 16.66 108.673 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 41.3 t80 -54.96 -44.49 74.43 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.177 -1.009 . . . . 16.66 108.576 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -58.37 -47.14 84.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.564 -0.71 . . . . 50.0 109.165 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.548 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.7 mt-10 -62.49 -46.54 88.02 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.27 -0.894 . . . . 16.66 109.145 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.539 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 62.5 t80 -60.31 -37.75 81.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 16.66 109.19 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.646 HG23 ' NH2' ' A' ' 11' ' ' ARG . 12.1 m -65.69 -47.59 74.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.388 -0.82 . . . . 50.0 109.09 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -59.39 -40.48 86.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 50.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.564 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.06 -37.0 58.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.687 -0.857 . . . . 50.0 108.687 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -59.16 -31.98 70.47 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.355 -1.498 . . . . 16.66 109.355 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' THR . 59.5 mtm180 -71.06 -31.12 67.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -1.165 . . . . 50.0 109.399 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.49 -20.29 62.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.366 -0.834 . . . . 50.0 109.501 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.796 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.8 m-80 -149.38 54.95 0.97 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.258 -0.901 . . . . 50.0 109.479 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -51.46 -42.6 61.71 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.163 -0.96 . . . . 50.0 108.622 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.21 -20.6 29.24 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.526 -1.43 . . . . 25.0 109.526 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.796 HD12 ' CB ' ' A' ' 73' ' ' ASN . 33.2 mt -78.62 -43.7 25.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -1.187 . . . . 50.0 109.175 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.539 HD22 ' HZ ' ' A' ' 66' ' ' PHE . 20.8 mt -61.43 -35.95 79.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 50.0 109.699 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.429 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 10.5 mtmm -60.48 -26.96 67.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 50.0 109.382 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -76.21 -37.93 57.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.222 -0.924 . . . . 50.0 109.232 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -78.51 -31.28 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 50.0 109.562 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.88 -14.88 51.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 50.0 109.614 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -96.33 -31.97 12.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.917 . . . . 50.0 108.972 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.817 HG21 ' CG2' ' A' ' 37' ' ' THR . 38.0 mt -58.86 -38.93 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.46 -0.775 . . . . 50.0 109.316 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 17' ' ' ARG . 90.9 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.041 -0.98 . . . . 99.99 109.471 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 3' ' ' ASP . 84.1 m-20 -79.19 -21.44 46.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 2' ' ' ASP . 45.7 p30 -51.08 179.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.226 -0.921 . . . . 25.0 109.559 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.57 ' HE2' ' CG ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -135.51 165.97 32.2 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 50.0 109.375 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 43.3 Cg_endo -67.0 -21.46 49.52 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.463 2.108 . . . . 50.0 110.94 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -60.14 -46.34 89.99 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.527 -0.733 . . . . 25.0 109.252 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.57 ' CG ' ' HE2' ' A' ' 4' ' ' HIS . 77.9 m-20 -56.62 -54.12 49.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 50.0 109.435 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.459 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 30.6 mtpt -43.21 -36.8 1.88 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.804 . . . . 50.0 109.759 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.23 -46.96 87.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.238 -0.914 . . . . 16.66 108.834 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 44.1 mt-10 -68.22 -38.51 81.98 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.887 -0.783 . . . . 16.66 108.887 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.667 ' NH2' HG23 ' A' ' 67' ' ' THR . 13.0 mtm180 -68.37 -39.9 81.62 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.325 -0.859 . . . . 50.0 109.496 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.639 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 13.0 mt-10 -67.4 -41.75 84.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.415 -0.803 . . . . 50.0 109.432 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.8 mtp-105 -66.16 -41.46 90.32 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.3 -0.875 . . . . 50.0 109.299 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 10' ' ' GLU . 38.6 mt -69.83 -45.47 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.247 -0.908 . . . . 50.0 109.023 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.511 ' CE1' HD11 ' A' ' 26' ' ' ILE . 73.8 t80 -63.26 -36.43 83.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.423 -0.911 . . . . 16.66 108.933 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -64.89 -30.78 71.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.384 -0.822 . . . . 50.0 109.08 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 48.2 mtt180 -68.4 -37.09 80.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 50.0 109.12 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.918 ' HB3' HD13 ' A' ' 26' ' ' ILE . 57.3 m-85 -68.67 -50.98 46.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 16.66 109.577 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 21.6 t0 -55.71 103.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 16.66 108.925 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.6 -50.52 43.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.873 . . . . 50.0 111.118 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -87.02 -30.98 20.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.714 -1.241 . . . . 16.66 109.674 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.94 35.55 6.06 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.764 -1.208 . . . . 16.66 110.205 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.496 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 34.7 p-10 -90.79 3.7 53.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.257 . . . . 16.66 109.161 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.86 -5.83 72.98 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.48 -1.048 . . . . 16.66 110.48 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.8 pttp -132.0 143.39 50.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.898 -1.354 . . . . 50.0 110.086 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.2 mt -110.85 133.42 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.375 0.607 . . . . 16.66 109.685 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.409 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 10.5 p -105.83 166.57 10.38 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.491 -0.755 . . . . 50.0 108.973 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.73 -45.78 49.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.01 -1.056 . . . . 50.0 108.843 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -56.77 -41.09 77.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.288 -0.883 . . . . 50.0 109.334 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 60.5 mt-10 -74.5 -54.83 6.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.306 -0.871 . . . . 16.66 109.248 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.884 HD22 HG13 ' A' ' 46' ' ' VAL . 7.4 tt -60.5 -45.66 92.98 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.307 -0.871 . . . . 16.66 108.867 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.715 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.89 -44.74 96.99 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.104 -1.598 . . . . 16.66 109.104 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 24.2 mt-10 -57.65 -42.16 82.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.395 -1.062 . . . . 50.0 109.546 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.88 -39.94 66.0 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.389 -0.967 . . . . 50.0 108.389 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.95 ' CD1' HG22 ' A' ' 46' ' ' VAL . 6.6 mt -58.36 -33.25 69.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.539 -0.725 . . . . 99.99 109.502 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -44.4 -27.83 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 99.99 109.579 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.653 HG21 HG21 ' A' ' 83' ' ' ILE . 6.9 t -50.14 -25.37 3.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.897 . . . . 99.99 109.111 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.948 HD12 HD12 ' A' ' 41' ' ' ILE . 22.8 mt -62.63 -33.2 74.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.467 -0.771 . . . . 50.0 109.281 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.28 6.39 53.55 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 16.66 109.549 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.63 51.78 0.57 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -1.181 . . . . 16.66 109.473 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.948 HD12 HD12 ' A' ' 38' ' ' LEU . 11.8 tt -137.09 170.97 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.95 . . . . 50.0 109.486 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.99 167.22 16.75 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 16.66 108.873 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.28 -33.74 17.71 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.202 1.934 . . . . 50.0 110.192 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.6 -29.83 70.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.625 . . . . 50.0 110.01 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -81.66 -35.81 29.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.979 -1.076 . . . . 16.66 108.314 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.95 HG22 ' CD1' ' A' ' 35' ' ' LEU . 68.4 t -67.69 -35.87 74.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.045 -0.724 . . . . 50.0 109.045 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -70.65 -37.91 73.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.77 -0.826 . . . . 50.0 108.77 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -67.49 -36.72 81.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.506 -0.746 . . . . 50.0 109.125 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.433 ' O ' HG13 ' A' ' 53' ' ' ILE . 5.5 mtt -60.6 -47.35 86.61 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.259 -0.901 . . . . 16.66 108.749 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.631 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 49.7 mtp -62.17 -47.96 82.18 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 50.0 109.1 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.24 -18.63 27.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.291 -0.881 . . . . 50.0 109.146 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -97.95 -36.15 10.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.777 . . . . 16.66 109.106 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.648 HG22 HD12 ' A' ' 61' ' ' ILE . 83.4 mt -82.15 -32.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.532 -0.73 . . . . 50.0 109.733 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.9 t0 -58.62 101.31 0.08 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.403 -0.811 . . . . 16.66 109.2 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 76.8 p -71.07 -47.13 60.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 50.0 110.58 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -85.89 -37.33 19.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.143 -0.973 . . . . 16.66 109.469 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.57 28.32 7.14 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.918 -1.135 . . . . 16.66 110.744 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 9.0 p-10 -80.38 -3.24 48.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.755 -1.438 . . . . 50.0 109.059 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.631 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.76 -3.64 59.08 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.88 -1.288 . . . . 16.66 109.88 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 26.4 m-85 -135.21 157.2 47.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.07 -1.253 . . . . 50.0 111.26 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.648 HD12 HG22 ' A' ' 53' ' ' ILE . 36.6 mm -107.86 129.53 61.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.522 -0.918 . . . . 16.66 108.522 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.18 167.61 10.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.151 -0.968 . . . . 16.66 108.664 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.639 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.5 t80 -54.44 -43.81 71.92 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.113 -1.035 . . . . 16.66 108.526 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -58.26 -50.1 74.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.537 -0.727 . . . . 50.0 109.042 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 76.6 mt-10 -60.43 -46.41 90.13 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.317 -0.864 . . . . 16.66 109.013 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.754 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 62.0 t80 -62.09 -33.63 74.79 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.041 -0.725 . . . . 16.66 109.041 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.667 HG23 ' NH2' ' A' ' 11' ' ' ARG . 6.4 m -70.12 -48.01 59.35 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.366 -0.834 . . . . 50.0 108.952 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -60.27 -39.05 85.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 50.0 109.304 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.595 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -80.01 -38.53 31.86 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.585 -0.895 . . . . 50.0 108.585 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.872 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.69 -25.8 64.02 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.323 -1.511 . . . . 16.66 109.323 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 67' ' ' THR . 69.0 mtm180 -76.8 -35.23 57.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -1.162 . . . . 50.0 109.219 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.04 -17.43 64.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 50.0 109.181 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.621 ' CB ' HD12 ' A' ' 76' ' ' LEU . 6.4 p30 -148.03 51.46 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.78 . . . . 50.0 109.219 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 73.3 mtm180 -48.18 -38.17 17.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.242 -0.911 . . . . 50.0 108.704 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.55 -23.6 49.85 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.374 -1.49 . . . . 25.0 109.374 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.621 HD12 ' CB ' ' A' ' 73' ' ' ASN . 24.8 mt -77.51 -44.96 27.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -1.101 . . . . 50.0 109.342 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.872 HD11 ' HA3' ' A' ' 70' ' ' GLY . 19.0 mt -66.89 -21.16 66.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 50.0 109.842 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 30.6 mtmt -80.02 -19.31 47.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.063 -1.023 . . . . 50.0 109.32 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.21 -36.61 16.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -0.827 . . . . 50.0 109.366 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.465 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 85.4 t -71.83 -36.15 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.395 -0.816 . . . . 50.0 108.913 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.41 -49.12 67.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.382 -0.823 . . . . 50.0 109.368 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -62.19 -28.64 69.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.823 . . . . 50.0 109.583 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.653 HG21 HG21 ' A' ' 37' ' ' THR . 39.9 mt -61.27 -32.42 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -0.968 . . . . 50.0 109.316 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 17.2 m-85 . . . . . 0 C--N 1.302 -1.498 0 CA-C-O 117.977 -1.011 . . . . 99.99 109.499 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -93.37 104.3 16.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -123.14 117.99 26.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 25.0 109.468 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.511 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -112.79 172.1 3.8 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 50.0 109.386 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.2 Cg_endo -68.43 -22.64 38.84 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.565 2.177 . . . . 50.0 111.064 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -62.83 -40.48 97.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.402 -0.811 . . . . 25.0 109.222 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.66 -40.87 98.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.3 -0.875 . . . . 50.0 109.284 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -52.44 -36.91 55.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 50.0 109.462 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.26 -46.27 88.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 16.66 108.751 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' O ' HG13 ' A' ' 14' ' ' ILE . 66.6 mm-40 -66.44 -42.81 87.13 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.911 -0.774 . . . . 16.66 108.911 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.627 ' NH2' HD12 ' A' ' 77' ' ' LEU . 31.7 mtt-85 -65.1 -40.28 94.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.537 -0.727 . . . . 50.0 109.474 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 49.4 mt-10 -63.85 -40.96 97.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.424 -0.797 . . . . 50.0 109.454 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 2.5 mtt-85 -68.46 -38.93 81.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 50.0 109.105 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.542 HG22 ' HE2' ' A' ' 18' ' ' PHE . 29.9 mt -71.31 -45.95 67.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.314 -0.866 . . . . 50.0 109.003 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.533 ' CE1' HD11 ' A' ' 26' ' ' ILE . 68.1 t80 -66.09 -36.07 82.19 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.179 -0.951 . . . . 16.66 109.181 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 39.5 mttt -65.55 -30.5 71.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.289 -0.882 . . . . 50.0 109.113 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -70.29 -37.48 74.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.854 . . . . 50.0 109.007 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.862 ' HB3' HD13 ' A' ' 26' ' ' ILE . 55.5 m-85 -67.56 -48.76 65.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 16.66 109.466 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.0 t0 -58.64 103.37 0.15 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 16.66 108.826 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.04 -51.56 37.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 50.0 111.132 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -85.69 -31.14 22.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.724 -1.235 . . . . 16.66 109.672 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.83 37.66 5.42 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.748 -1.215 . . . . 16.66 110.321 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.488 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.2 p-10 -93.08 6.37 48.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.042 -1.269 . . . . 16.66 109.207 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.61 -6.37 80.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.49 -1.044 . . . . 16.66 110.49 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.6 pttt -130.05 142.02 50.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.024 -1.28 . . . . 50.0 110.002 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.862 HD13 ' HB3' ' A' ' 18' ' ' PHE . 3.8 mt -112.0 133.22 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.437 0.637 . . . . 16.66 109.443 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.403 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 17.1 p -106.31 168.49 9.11 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.415 -0.803 . . . . 50.0 109.108 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.508 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.49 -46.26 56.87 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.144 -0.973 . . . . 50.0 108.853 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.31 75.99 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.345 -0.847 . . . . 50.0 109.394 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.8 mt-10 -75.86 -54.77 6.4 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.267 -0.896 . . . . 16.66 109.122 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.853 HD22 HG13 ' A' ' 46' ' ' VAL . 5.7 tt -60.47 -46.88 88.48 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.184 -0.948 . . . . 16.66 108.939 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.689 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.09 -43.1 99.61 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.28 -1.528 . . . . 16.66 109.28 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.68 -41.86 91.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.266 -1.138 . . . . 50.0 110.011 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.38 73.21 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.163 -0.961 . . . . 50.0 108.832 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.113 HD12 HG22 ' A' ' 46' ' ' VAL . 12.8 mt -60.64 -30.92 70.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.5 -0.75 . . . . 99.99 109.798 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -43.73 -26.43 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.987 . . . . 99.99 109.616 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.447 ' CG2' HG21 ' A' ' 83' ' ' ILE . 6.3 t -52.85 -24.94 10.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.192 -0.942 . . . . 99.99 109.39 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.717 HD13 HD12 ' A' ' 41' ' ' ILE . 5.6 mt -62.38 -32.28 73.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.87 . . . . 50.0 109.269 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.62 6.72 51.4 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.596 -1.402 . . . . 16.66 109.596 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.49 57.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -1.132 . . . . 16.66 109.478 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.717 HD12 HD13 ' A' ' 38' ' ' LEU . 11.1 tt -143.38 174.17 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 50.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.9 165.98 25.29 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.304 -0.872 . . . . 16.66 108.82 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -69.43 -33.54 17.61 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.138 1.892 . . . . 50.0 110.132 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -65.07 -24.57 67.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.657 -0.652 . . . . 50.0 110.077 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -82.16 -36.66 27.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.82 -1.175 . . . . 16.66 108.402 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.113 HG22 HD12 ' A' ' 35' ' ' LEU . 53.9 t -67.57 -35.64 73.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.563 -0.711 . . . . 50.0 109.145 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -65.72 -39.24 90.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.445 -0.785 . . . . 50.0 109.095 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -67.21 -36.73 82.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.335 -0.853 . . . . 50.0 109.309 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.404 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.3 mtt -61.31 -46.22 91.18 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.183 -0.948 . . . . 16.66 108.774 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.544 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 49.2 mtp -62.56 -48.02 81.31 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.566 -0.709 . . . . 50.0 109.147 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.0 -18.73 36.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 50.0 109.123 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -98.33 -36.5 9.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 16.66 109.175 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 61' ' ' ILE . 81.6 mt -82.08 -32.49 11.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.468 -0.77 . . . . 50.0 109.667 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.8 t0 -59.51 101.52 0.11 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.349 -0.844 . . . . 16.66 109.038 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.46 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 61.0 p -68.85 -47.18 66.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -0.875 . . . . 50.0 110.658 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -86.79 -39.1 16.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 16.66 109.448 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 102.08 28.01 6.7 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.878 -1.153 . . . . 16.66 110.444 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.3 p-10 -79.02 -2.35 39.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.786 -1.42 . . . . 50.0 109.016 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.544 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.35 -2.91 59.47 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.709 -1.357 . . . . 16.66 109.709 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 25.5 m-85 -136.47 157.57 46.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.086 -1.244 . . . . 50.0 111.376 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.602 HD12 HG22 ' A' ' 53' ' ' ILE . 29.1 mm -109.76 130.24 63.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.565 -0.902 . . . . 16.66 108.565 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -97.64 168.41 10.36 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.133 -0.979 . . . . 16.66 108.599 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 37.7 t80 -55.36 -43.28 74.91 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.031 -1.043 . . . . 16.66 108.718 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -60.6 -46.4 90.4 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.553 -0.717 . . . . 50.0 109.31 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.571 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 76.7 mt-10 -62.05 -46.83 87.4 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.285 -0.884 . . . . 16.66 109.096 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.495 ' CZ ' ' CD2' ' A' ' 77' ' ' LEU . 49.8 t80 -61.06 -40.52 93.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.444 -0.785 . . . . 16.66 109.25 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.1 m -64.74 -47.32 78.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.362 -0.837 . . . . 50.0 109.209 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -58.45 -38.46 77.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 50.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.91 -35.57 50.5 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.642 -0.873 . . . . 50.0 108.642 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.546 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.14 -29.91 63.26 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.302 -1.519 . . . . 16.66 109.302 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 67' ' ' THR . 83.0 mtm180 -71.51 -29.63 65.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.124 . . . . 50.0 109.165 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' A' ' 73' ' ' ASN . . . -70.41 -21.04 62.88 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.335 -0.853 . . . . 50.0 109.278 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.807 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.4 m-80 -152.1 56.06 0.83 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 50.0 109.299 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -48.71 -38.53 21.77 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.705 -0.85 . . . . 50.0 108.705 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.08 -30.23 63.5 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.329 -1.508 . . . . 25.0 109.329 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.807 HD12 ' CB ' ' A' ' 73' ' ' ASN . 32.3 mt -69.39 -45.69 68.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -1.085 . . . . 50.0 109.464 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.627 HD12 ' NH2' ' A' ' 11' ' ' ARG . 25.4 mt -63.68 -23.11 67.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.814 . . . . 50.0 109.902 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 26.7 mtmt -79.97 -18.54 50.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.105 -0.997 . . . . 50.0 109.49 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.65 -33.39 27.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 50.0 109.3 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 t -85.36 -27.9 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.853 . . . . 50.0 109.147 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.16 -16.05 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 50.0 109.597 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 15.4 mttt -94.34 -32.92 13.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 50.0 109.275 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.447 HG21 ' CG2' ' A' ' 37' ' ' THR . 10.0 mt -58.2 -36.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.366 -0.834 . . . . 50.0 109.35 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.019 -0.991 . . . . 99.99 109.437 -179.92 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -115.02 83.82 1.97 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.19 -0.944 . . . . 0.0 109.49 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.05 120.91 30.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 25.0 109.451 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.487 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -118.12 171.05 5.5 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.185 -0.947 . . . . 50.0 109.417 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.8 Cg_endo -68.99 -22.76 35.16 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.645 2.23 . . . . 50.0 110.979 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -61.61 -38.82 89.02 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.438 -0.788 . . . . 25.0 109.107 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -57.6 -46.32 84.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.429 -0.794 . . . . 50.0 109.32 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -49.43 -36.41 22.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 50.0 109.6 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.79 -45.68 89.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.307 -0.871 . . . . 16.66 108.715 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 67.2 mt-10 -68.2 -40.45 82.17 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.46 -0.775 . . . . 16.66 109.007 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.739 ' NH2' HG23 ' A' ' 67' ' ' THR . 46.5 mtm180 -68.07 -39.95 82.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.37 -0.831 . . . . 50.0 109.33 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.572 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 43.3 mt-10 -66.75 -41.84 87.15 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.478 -0.763 . . . . 50.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 13.3 mtp180 -65.63 -40.84 92.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.28 -0.888 . . . . 50.0 109.201 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 81' ' ' ALA . 30.7 mt -70.26 -46.94 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.305 -0.872 . . . . 50.0 108.91 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -66.32 -34.99 79.24 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.216 -0.928 . . . . 16.66 108.918 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 55.0 mttm -65.15 -34.27 78.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.366 -0.834 . . . . 50.0 109.392 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.584 ' NH2' ' HB1' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -74.48 -26.11 59.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.895 . . . . 50.0 109.227 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.951 ' HB3' HD13 ' A' ' 26' ' ' ILE . 23.3 m-85 -73.45 -43.21 60.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 16.66 109.057 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.6 t0 -63.72 103.26 0.53 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.334 -0.854 . . . . 16.66 108.757 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.13 64.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.161 -0.962 . . . . 50.0 111.248 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -89.49 -27.18 20.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.727 -1.233 . . . . 16.66 109.705 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.66 35.1 8.01 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.096 -1.201 . . . . 16.66 110.096 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 37.1 p-10 -88.85 4.04 49.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -1.198 . . . . 16.66 109.21 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.99 -5.76 72.47 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.381 -1.087 . . . . 16.66 110.381 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.5 pttp -132.34 143.32 49.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.948 -1.325 . . . . 50.0 110.068 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.951 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.8 mt -111.46 134.54 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.652 -0.655 . . . . 16.66 109.45 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.5 p -106.61 166.22 10.72 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.299 -0.876 . . . . 50.0 108.712 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.5 -45.6 47.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.041 -1.037 . . . . 50.0 108.843 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.19 75.82 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.363 -0.836 . . . . 50.0 109.521 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.507 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.8 mt-10 -75.82 -54.51 6.81 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.198 -0.939 . . . . 16.66 109.291 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.636 ' HG ' HD12 ' A' ' 35' ' ' LEU . 58.3 tp -61.84 -43.05 99.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 16.66 108.955 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.528 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.27 -44.29 97.89 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.233 -1.547 . . . . 16.66 109.233 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -58.54 -43.23 89.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.308 -1.113 . . . . 50.0 109.724 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HB1' ' NH2' ' A' ' 17' ' ' ARG . . . -73.06 -40.73 64.83 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.088 -1.007 . . . . 50.0 108.333 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.076 HD13 HG22 ' A' ' 46' ' ' VAL . 7.5 mt -58.64 -32.61 69.21 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.568 -0.707 . . . . 99.99 109.423 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -44.98 -26.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 99.99 109.423 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 t -49.17 -24.87 1.88 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 99.99 109.026 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.82 HD13 HD12 ' A' ' 41' ' ' ILE . 16.7 mt -58.87 -33.45 70.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.499 -0.751 . . . . 50.0 109.101 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.06 -0.39 58.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.885 -1.286 . . . . 16.66 109.885 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.07 58.62 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.251 . . . . 16.66 109.965 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.82 HD12 HD13 ' A' ' 38' ' ' LEU . 10.8 tt -138.1 173.18 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.098 -1.001 . . . . 50.0 109.528 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.27 163.02 40.69 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.642 -0.873 . . . . 16.66 108.642 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.15 -33.27 25.34 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.009 1.806 . . . . 50.0 110.083 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.92 -26.29 68.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.636 -0.665 . . . . 50.0 109.95 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -82.1 -36.87 27.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.855 -1.153 . . . . 16.66 108.431 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.076 HG22 HD13 ' A' ' 35' ' ' LEU . 47.1 t -68.96 -36.67 75.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.038 -0.727 . . . . 50.0 109.038 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -65.65 -40.15 92.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.475 -0.766 . . . . 50.0 109.028 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -65.48 -40.89 93.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 50.0 109.257 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.1 mtt -58.68 -43.52 89.99 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.243 -0.911 . . . . 16.66 108.817 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.723 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 31.7 mtp -61.45 -47.55 85.18 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.451 -0.781 . . . . 50.0 109.245 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.04 -20.56 54.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 50.0 109.28 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -95.4 -36.35 11.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.398 -0.814 . . . . 16.66 109.047 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.576 HG22 HD12 ' A' ' 61' ' ' ILE . 82.4 mt -81.92 -31.46 10.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 50.0 109.699 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.9 t0 -60.93 101.46 0.15 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.439 -0.788 . . . . 16.66 108.989 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.469 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 55.6 p -69.72 -46.1 66.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 50.0 110.71 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.489 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.0 p-10 -87.6 -40.32 14.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.106 -0.996 . . . . 16.66 109.502 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 102.95 29.67 5.73 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.932 -1.128 . . . . 16.66 110.523 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.489 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.8 p-10 -81.41 -3.74 53.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.865 -1.374 . . . . 50.0 109.144 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.723 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.66 -3.41 57.57 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.857 -1.297 . . . . 16.66 109.857 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.8 m-85 -135.85 156.58 48.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.059 -1.259 . . . . 50.0 111.15 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.576 HD12 HG22 ' A' ' 53' ' ' ILE . 35.0 mm -108.88 129.91 62.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.397 -0.964 . . . . 16.66 108.397 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.55 167.42 10.6 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.057 -1.027 . . . . 16.66 108.812 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.5 t80 -54.21 -43.62 70.94 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.297 -0.961 . . . . 16.66 108.521 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -58.93 -47.9 83.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.525 -0.735 . . . . 50.0 109.085 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.559 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 81.2 mt-10 -62.34 -46.94 86.4 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.288 -0.883 . . . . 16.66 109.119 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.626 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 51.2 t80 -59.52 -39.14 82.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.426 -0.796 . . . . 16.66 109.103 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.739 HG23 ' NH2' ' A' ' 11' ' ' ARG . 18.0 m -66.42 -46.68 75.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 50.0 109.089 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.0 -40.76 85.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 50.0 109.246 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.574 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -75.89 -36.8 59.37 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.566 -0.901 . . . . 50.0 108.566 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.688 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.96 -34.17 77.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.2 -1.56 . . . . 16.66 109.2 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 67' ' ' THR . 74.4 mtm180 -65.95 -33.48 75.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -1.12 . . . . 50.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.438 ' O ' ' OD1' ' A' ' 73' ' ' ASN . . . -67.68 -20.99 65.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.834 . . . . 50.0 109.301 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.84 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.7 m-80 -152.24 56.43 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 50.0 109.162 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -49.6 -37.09 26.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.334 -0.854 . . . . 50.0 108.736 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.37 -31.16 69.33 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.22 -1.552 . . . . 25.0 109.22 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.84 HD12 ' CB ' ' A' ' 73' ' ' ASN . 50.6 mt -67.26 -44.88 78.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -1.09 . . . . 50.0 109.419 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.688 HD11 ' HA3' ' A' ' 70' ' ' GLY . 19.9 mt -63.77 -31.43 72.61 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.321 -0.862 . . . . 50.0 109.766 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -64.58 -27.13 68.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 50.0 109.255 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -76.26 -34.65 59.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 50.0 109.517 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.418 HG13 ' HE2' ' A' ' 84' ' ' PHE . 23.4 t -81.03 -31.22 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 50.0 109.601 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 14' ' ' ILE . . . -63.4 -19.02 64.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 50.0 109.691 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -89.39 -30.57 18.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 50.0 109.137 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.8 mt -64.97 -36.59 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.382 -0.824 . . . . 50.0 109.24 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.569 ' CE1' ' NH2' ' A' ' 17' ' ' ARG . 61.2 m-85 . . . . . 0 C--N 1.302 -1.483 0 CA-C-O 117.99 -1.005 . . . . 99.99 109.544 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 40.0 p30 -83.47 -8.98 59.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.525 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -64.35 147.66 52.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 25.0 109.442 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.553 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -114.2 174.24 2.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.289 -0.882 . . . . 50.0 109.236 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 47.7 Cg_endo -69.16 -22.5 34.75 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.506 2.137 . . . . 50.0 111.335 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -62.63 -43.85 97.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.411 -0.805 . . . . 25.0 109.346 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -57.69 -41.22 81.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 50.0 109.394 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -53.29 -35.92 60.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 50.0 109.196 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 -45.74 90.26 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.853 -0.795 . . . . 16.66 108.853 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 14' ' ' ILE . 59.7 mm-40 -68.53 -40.55 80.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 16.66 108.832 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.827 ' NH1' HG23 ' A' ' 67' ' ' THR . 19.8 mtm180 -68.11 -38.95 82.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.458 -0.776 . . . . 50.0 109.377 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.641 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 8.7 mt-10 -68.03 -39.83 83.01 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.433 -0.792 . . . . 50.0 109.346 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 5.6 mtt180 -67.08 -40.53 87.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.293 -0.879 . . . . 50.0 109.267 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.641 HG22 ' HE2' ' A' ' 18' ' ' PHE . 25.6 mt -70.28 -46.62 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.383 -0.823 . . . . 50.0 108.865 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.42 ' CE1' HD11 ' A' ' 26' ' ' ILE . 70.5 t80 -63.56 -35.74 81.48 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.339 -0.851 . . . . 16.66 109.097 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -66.19 -30.43 70.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 50.0 109.229 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 74.8 mtt180 -69.17 -38.1 78.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 50.0 109.256 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.805 ' HB3' HD13 ' A' ' 26' ' ' ILE . 67.2 m-85 -67.42 -49.13 65.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 16.66 109.49 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.1 t0 -56.48 103.48 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 16.66 108.746 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.91 -51.56 46.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.274 -0.891 . . . . 50.0 111.247 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -86.92 -30.0 21.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.719 -1.238 . . . . 16.66 109.856 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 92.95 37.39 5.73 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.777 -1.202 . . . . 16.66 110.179 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.492 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 37.7 p-10 -92.87 5.38 51.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -1.2 . . . . 16.66 109.243 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.95 -7.01 76.83 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.138 -1.03 . . . . 16.66 110.568 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.1 pttm -130.49 142.25 50.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.908 -1.348 . . . . 50.0 109.872 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.805 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.1 mt -111.93 133.22 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.36 0.6 . . . . 16.66 109.527 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.9 p -105.02 166.83 10.11 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.856 -0.794 . . . . 50.0 108.856 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.1 -45.29 52.58 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.157 -0.965 . . . . 50.0 108.887 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.39 78.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.317 -0.865 . . . . 50.0 109.474 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.7 mt-10 -74.99 -54.3 7.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.165 -0.959 . . . . 16.66 109.334 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.805 ' O ' HD23 ' A' ' 31' ' ' LEU . 1.9 tt -61.94 -43.98 97.71 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.283 -0.886 . . . . 16.66 108.798 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.755 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -63.66 -44.48 96.36 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.191 -1.564 . . . . 16.66 109.191 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -59.82 -41.45 91.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.324 -1.104 . . . . 50.0 109.892 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.98 -39.87 68.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.129 -0.982 . . . . 50.0 108.732 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.054 HD12 HG22 ' A' ' 46' ' ' VAL . 8.4 mt -60.21 -30.83 69.64 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.5 -0.75 . . . . 99.99 109.865 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -44.31 -25.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -1.0 . . . . 99.99 109.865 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.687 ' CG2' HG21 ' A' ' 83' ' ' ILE . 6.6 t -50.77 -23.15 2.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.156 -0.965 . . . . 99.99 109.22 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.854 HD12 HD12 ' A' ' 41' ' ' ILE . 25.6 mt -60.74 -33.69 73.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 50.0 109.312 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.46 -0.74 59.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.777 -1.329 . . . . 16.66 109.777 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 40' ' ' SER . 2.3 t -155.25 66.45 0.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.114 -1.227 . . . . 16.66 109.654 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.854 HD12 HD12 ' A' ' 38' ' ' LEU . 14.2 tt -149.26 168.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.141 -0.974 . . . . 50.0 109.598 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.83 163.9 22.24 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 16.66 108.872 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 49.8 Cg_endo -70.66 -30.7 17.72 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.078 1.852 . . . . 50.0 109.94 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.75 -23.49 66.1 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.54 -0.725 . . . . 50.0 110.078 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.4 ' OE1' HG13 ' A' ' 41' ' ' ILE . 86.1 mt-10 -79.87 -35.13 38.57 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.891 -1.13 . . . . 16.66 108.505 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.054 HG22 HD12 ' A' ' 35' ' ' LEU . 55.0 t -69.39 -35.75 68.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.909 -0.774 . . . . 50.0 108.909 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 82.7 mttt -62.36 -40.25 95.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.432 -0.792 . . . . 50.0 108.994 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.37 -39.42 92.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.433 -0.792 . . . . 50.0 109.299 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.438 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.9 mtt -59.48 -45.2 92.34 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.239 -0.913 . . . . 16.66 108.854 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.52 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 50.1 mtp -62.27 -48.68 78.83 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.439 -0.788 . . . . 50.0 109.122 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.7 -19.02 24.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 50.0 109.362 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -99.78 -36.3 9.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 16.66 109.306 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.596 HG12 ' CD2' ' A' ' 69' ' ' PHE . 80.2 mt -82.5 -32.93 10.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.451 -0.781 . . . . 50.0 109.816 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.7 t0 -59.52 101.23 0.1 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.289 -0.882 . . . . 16.66 108.999 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.473 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 54.6 p -66.19 -46.37 77.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 50.0 110.64 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -88.85 -42.18 12.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 16.66 109.634 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 104.14 29.82 5.31 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.203 -1.159 . . . . 16.66 110.203 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 13.0 p-10 -80.46 -2.45 45.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.983 -1.304 . . . . 50.0 109.134 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.52 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 100.04 -3.47 57.05 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.767 -1.333 . . . . 16.66 109.767 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.576 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 30.6 m-85 -137.01 156.35 48.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.006 -1.291 . . . . 50.0 111.49 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.543 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 25.5 mm -109.67 130.68 62.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.308 -0.997 . . . . 16.66 108.308 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 m -99.47 168.7 9.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.023 -1.048 . . . . 16.66 108.714 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.641 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 36.5 t80 -54.97 -43.44 73.5 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.169 -1.012 . . . . 16.66 108.655 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -59.92 -48.63 80.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.608 -0.683 . . . . 50.0 109.237 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.543 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 79.6 mt-10 -60.6 -47.03 88.02 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.291 -0.881 . . . . 16.66 109.064 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CE1' HD13 ' A' ' 77' ' ' LEU . 52.4 t80 -63.18 -32.66 74.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.437 -0.789 . . . . 16.66 109.255 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.827 HG23 ' NH1' ' A' ' 11' ' ' ARG . 51.9 m -68.26 -49.11 62.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 50.0 109.302 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -59.35 -36.9 76.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.26 -0.9 . . . . 50.0 109.381 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.74 -37.5 41.12 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.494 -0.928 . . . . 50.0 108.494 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.955 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.69 -29.2 63.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.197 -1.561 . . . . 16.66 109.197 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 67' ' ' THR . 80.5 mtm180 -71.3 -33.12 69.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.348 -1.089 . . . . 50.0 109.051 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.35 -20.81 65.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.832 . . . . 50.0 109.273 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.842 ' CB ' HD12 ' A' ' 76' ' ' LEU . 7.8 m-80 -146.24 58.37 1.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.396 -0.815 . . . . 50.0 109.114 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 65.9 mtm180 -51.35 -37.58 48.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 50.0 108.922 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.37 -27.82 70.01 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.348 -1.501 . . . . 25.0 109.348 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.842 HD12 ' CB ' ' A' ' 73' ' ' ASN . 22.4 mt -69.07 -45.38 70.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.387 -1.067 . . . . 50.0 109.67 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.955 HD11 ' HA3' ' A' ' 70' ' ' GLY . 4.3 mt -70.38 -19.41 63.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.389 -0.819 . . . . 50.0 109.874 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 40.7 mtmt -80.02 -27.05 39.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.104 -0.997 . . . . 50.0 109.508 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -91.41 -43.12 9.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 50.0 109.507 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.4 p -59.58 -45.46 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.776 0.798 . . . . 50.0 109.105 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.552 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -48.78 -38.33 21.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.716 -0.615 . . . . 50.0 109.85 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -69.58 -24.8 63.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 50.0 109.602 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.687 HG21 ' CG2' ' A' ' 37' ' ' THR . 13.6 mt -64.26 -45.43 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.383 -0.823 . . . . 50.0 109.556 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.461 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 80.1 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.02 -0.99 . . . . 99.99 109.362 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -88.16 8.24 27.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 109.496 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -91.64 111.56 23.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 25.0 109.542 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.538 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -123.43 173.92 4.01 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.285 -0.884 . . . . 50.0 109.128 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.8 Cg_endo -68.61 -22.99 37.16 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.555 2.17 . . . . 50.0 111.34 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -63.39 -37.64 88.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.351 -0.843 . . . . 25.0 109.191 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.4 -41.95 94.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.393 -0.817 . . . . 50.0 109.233 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -52.02 -36.91 51.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.429 -0.794 . . . . 50.0 109.387 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.99 -46.16 85.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.567 -0.901 . . . . 16.66 108.567 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 14' ' ' ILE . 64.9 mt-10 -67.73 -39.52 84.25 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.854 -0.795 . . . . 16.66 108.854 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.422 ' NH1' ' HG ' ' A' ' 77' ' ' LEU . 55.2 mtt-85 -65.96 -40.4 91.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 50.0 109.336 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.59 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 44.0 mt-10 -64.86 -40.43 95.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.412 -0.805 . . . . 50.0 109.228 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.473 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 65.4 mtp180 -67.52 -40.48 85.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.347 -0.846 . . . . 50.0 109.236 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 10' ' ' GLU . 22.0 mt -70.37 -45.23 75.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.363 -0.835 . . . . 50.0 108.906 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.52 -36.03 82.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.273 -0.892 . . . . 16.66 109.008 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -65.76 -30.19 70.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.368 -0.832 . . . . 50.0 109.147 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.485 ' CD ' ' HB3' ' A' ' 84' ' ' PHE . 49.7 mtt85 -71.35 -34.76 70.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 50.0 109.22 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.93 ' HB3' HD13 ' A' ' 26' ' ' ILE . 42.9 m-85 -72.83 -47.98 41.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.418 -0.801 . . . . 16.66 109.432 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.468 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.7 t0 -59.22 103.28 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 16.66 108.499 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 -51.72 51.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.891 . . . . 50.0 111.426 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -87.7 -26.14 23.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.754 -1.216 . . . . 16.66 109.799 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 88.04 38.57 7.3 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.747 -1.216 . . . . 16.66 110.091 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -92.84 5.43 51.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -1.215 . . . . 16.66 109.206 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.09 -7.54 72.89 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.346 -1.101 . . . . 16.66 110.346 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 35.5 pttt -130.37 142.23 50.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.927 -1.337 . . . . 50.0 110.023 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.93 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.9 mt -112.33 134.22 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.63 -0.669 . . . . 16.66 109.39 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 p -107.21 167.64 9.77 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.36 -0.837 . . . . 50.0 108.823 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.513 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.28 -45.99 54.86 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.046 -1.034 . . . . 50.0 108.823 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.16 74.29 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.349 -0.844 . . . . 50.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.5 mt-10 -77.14 -54.17 6.85 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -0.947 . . . . 16.66 109.321 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.597 HD12 ' CE1' ' A' ' 18' ' ' PHE . 32.3 tp -63.12 -41.76 99.4 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.202 -0.936 . . . . 16.66 108.93 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.727 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -64.6 -44.9 94.37 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.199 -1.56 . . . . 16.66 109.199 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -59.07 -41.84 88.91 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.346 -1.091 . . . . 50.0 109.709 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.402 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.96 -40.2 65.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.161 -0.962 . . . . 50.0 108.554 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.798 ' CD1' HG22 ' A' ' 46' ' ' VAL . 11.3 mt -60.69 -31.22 70.49 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.52 -0.738 . . . . 99.99 109.564 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' LEU . 5.3 mttt -45.53 -25.56 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.018 -1.051 . . . . 99.99 109.48 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.615 ' CG2' HG21 ' A' ' 83' ' ' ILE . 9.6 t -52.04 -23.78 5.74 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.916 . . . . 99.99 109.183 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.68 HD13 HD12 ' A' ' 41' ' ' ILE . 9.2 mt -59.49 -33.27 71.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.352 -0.843 . . . . 50.0 109.216 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.13 0.75 57.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.719 -1.352 . . . . 16.66 109.719 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 t -154.72 64.64 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -1.204 . . . . 16.66 109.711 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.68 HD12 HD13 ' A' ' 38' ' ' LEU . 9.3 tt -147.09 175.6 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 50.0 109.42 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.91 164.52 34.54 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.254 -0.903 . . . . 16.66 108.781 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 46.7 Cg_endo -69.21 -33.27 19.07 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.117 1.878 . . . . 50.0 110.142 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -66.75 -22.86 66.04 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.25 -0.58 . . . . 50.0 110.102 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -82.33 -39.66 22.51 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.883 -1.135 . . . . 16.66 108.398 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.798 HG22 ' CD1' ' A' ' 35' ' ' LEU . 67.2 t -65.66 -35.91 76.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.69 -0.855 . . . . 50.0 108.69 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 81.4 mttt -67.17 -39.73 86.48 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.909 -0.774 . . . . 50.0 108.909 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.13 -40.92 91.03 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.428 -0.795 . . . . 50.0 109.183 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.421 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.9 mtt -59.65 -44.3 93.59 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.21 -0.931 . . . . 16.66 108.868 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.685 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 28.1 mtp -61.69 -47.15 86.6 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -0.762 . . . . 50.0 109.128 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.75 -22.07 44.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 50.0 109.141 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.19 -35.95 12.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 16.66 108.989 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.571 HG12 ' CD2' ' A' ' 69' ' ' PHE . 85.6 mt -80.77 -30.95 12.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.47 -0.769 . . . . 50.0 109.438 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.1 t0 -61.04 100.78 0.12 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.465 -0.772 . . . . 16.66 109.027 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.503 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 60.7 p -71.41 -46.5 60.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.288 -0.883 . . . . 50.0 110.436 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -31.02 22.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.135 -0.978 . . . . 16.66 109.534 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.477 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 93.11 28.31 12.05 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.847 -1.168 . . . . 16.66 110.222 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.8 -2.94 55.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.93 -1.335 . . . . 50.0 109.414 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.685 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.47 -7.12 59.59 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.999 -1.096 . . . . 16.66 110.457 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 42.1 m-85 -133.76 155.83 49.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.895 -1.356 . . . . 50.0 111.23 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.56 HD12 HG22 ' A' ' 53' ' ' ILE . 28.6 mm -106.68 127.81 61.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.516 -0.92 . . . . 16.66 108.516 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.53 166.27 12.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.158 -0.964 . . . . 16.66 108.626 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.59 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 35.8 t80 -54.3 -41.96 69.54 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.085 -1.009 . . . . 16.66 108.588 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -61.42 -49.68 75.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.969 -0.752 . . . . 50.0 108.969 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.552 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 33.9 mt-10 -58.28 -47.21 84.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 16.66 109.023 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.751 ' CE2' HD11 ' A' ' 77' ' ' LEU . 63.6 t80 -61.48 -40.48 94.71 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.52 -0.737 . . . . 16.66 109.294 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 13.3 m -65.16 -47.04 78.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.405 -0.809 . . . . 50.0 109.242 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -59.72 -37.79 79.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 50.0 109.349 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.71 -37.42 41.53 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.264 -0.897 . . . . 50.0 108.703 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.415 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -60.64 -28.9 68.63 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.361 -1.496 . . . . 16.66 109.361 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 67' ' ' THR . 67.8 mtm180 -73.3 -34.54 65.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -1.126 . . . . 50.0 109.24 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.83 -17.71 65.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 50.0 109.341 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.78 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.2 m-80 -148.33 55.28 1.03 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 50.0 109.275 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 75' ' ' GLY . 10.4 ptm180 -50.58 -41.42 54.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 50.0 108.806 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.444 ' N ' ' HG3' ' A' ' 74' ' ' ARG . . . -54.38 -20.2 15.45 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.343 -1.503 . . . . 25.0 109.343 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.78 HD12 ' CB ' ' A' ' 73' ' ' ASN . 48.5 mt -80.02 -43.0 22.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.313 -1.11 . . . . 50.0 109.373 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.751 HD11 ' CE2' ' A' ' 66' ' ' PHE . 1.8 mm? -61.27 -41.15 96.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.468 -0.77 . . . . 50.0 109.82 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.7 mtpp -63.05 -38.4 91.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 50.0 109.378 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -73.48 -49.44 26.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.41 -0.806 . . . . 50.0 109.57 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 77' ' ' LEU . 4.1 p -66.05 -43.17 92.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.372 -0.83 . . . . 50.0 109.589 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.534 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.25 -39.74 45.85 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.225 -0.59 . . . . 50.0 109.884 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 34.9 mttm -66.86 -26.02 66.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.935 . . . . 50.0 109.686 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.615 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.2 mt -63.17 -45.22 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 50.0 109.466 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.485 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 92.1 m-85 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.997 -1.001 . . . . 99.99 109.435 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -82.63 -8.75 59.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.561 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.76 119.62 12.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 25.0 109.488 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.499 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -111.31 170.9 4.78 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 50.0 109.325 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.1 Cg_endo -67.16 -22.65 46.74 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.543 2.162 . . . . 50.0 111.079 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -63.96 -35.39 80.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 25.0 109.032 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.486 ' HB3' ' NH1' ' A' ' 11' ' ' ARG . 59.3 m-20 -58.67 -45.94 88.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.329 -0.857 . . . . 50.0 109.3 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -50.39 -37.48 37.77 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.437 -0.789 . . . . 50.0 109.359 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.99 -45.23 79.07 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.476 -0.935 . . . . 16.66 108.476 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 14' ' ' ILE . 53.0 mt-10 -65.44 -45.35 84.13 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.908 -0.775 . . . . 16.66 108.908 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.486 ' NH1' ' HB3' ' A' ' 7' ' ' ASP . 41.9 mtt180 -63.08 -40.93 99.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.395 -0.815 . . . . 50.0 109.395 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.584 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 7.4 mt-10 -64.88 -43.49 92.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.428 -0.795 . . . . 50.0 109.407 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.477 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.6 mtt180 -65.94 -41.36 91.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.888 . . . . 50.0 109.13 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 77' ' ' LEU . 26.0 mt -69.74 -44.53 79.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.302 -0.874 . . . . 50.0 109.19 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.467 ' CE2' HD11 ' A' ' 26' ' ' ILE . 62.0 t80 -66.91 -35.96 81.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.167 -0.958 . . . . 16.66 109.258 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -63.95 -32.4 73.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 50.0 109.383 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 62.7 mtt180 -70.88 -37.15 73.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 50.0 109.047 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.041 ' HB3' HD13 ' A' ' 26' ' ' ILE . 33.8 m-85 -68.43 -47.0 68.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 16.66 109.595 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.471 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.6 t0 -62.52 103.44 0.41 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 16.66 108.937 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.21 -50.88 43.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 50.0 111.213 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -86.34 -31.09 21.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.714 -1.241 . . . . 16.66 109.688 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.94 36.48 5.76 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.805 -1.188 . . . . 16.66 110.27 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.6 p-10 -92.02 4.01 53.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.074 -1.25 . . . . 16.66 109.377 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.78 -6.15 73.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.367 -1.093 . . . . 16.66 110.367 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 10.1 pttm -131.32 143.02 50.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.926 -1.338 . . . . 50.0 109.991 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.041 HD13 ' HB3' ' A' ' 18' ' ' PHE . 4.6 mt -111.97 133.64 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.462 0.648 . . . . 16.66 109.645 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.406 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 13.3 p -106.67 167.97 9.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.473 -0.767 . . . . 50.0 108.947 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.38 -46.35 56.0 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.066 -1.021 . . . . 50.0 108.822 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -56.31 -40.89 75.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.309 -0.869 . . . . 50.0 109.441 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.3 mt-10 -75.19 -54.44 7.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.23 -0.919 . . . . 16.66 109.251 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.804 HD22 HG13 ' A' ' 46' ' ' VAL . 7.2 tt -60.35 -45.27 94.08 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.295 -0.878 . . . . 16.66 108.799 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.614 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.21 -45.03 96.18 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.048 -1.621 . . . . 16.66 109.048 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 16.8 mt-10 -57.13 -42.89 81.77 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.329 -1.1 . . . . 50.0 109.579 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.06 -39.95 65.47 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.133 -0.979 . . . . 50.0 108.379 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.895 ' CD1' HG22 ' A' ' 46' ' ' VAL . 5.3 mt -59.16 -33.04 70.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.599 -0.688 . . . . 99.99 109.6 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -44.64 -26.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.076 -1.015 . . . . 99.99 109.455 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.505 ' CG2' HG21 ' A' ' 83' ' ' ILE . 8.5 t -53.11 -25.53 13.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 99.99 109.363 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.528 HD12 ' CD1' ' A' ' 41' ' ' ILE . 20.5 mt -61.31 -32.34 72.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 50.0 109.151 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.3 9.76 44.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.591 -1.404 . . . . 16.66 109.591 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.54 51.35 0.51 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -1.184 . . . . 16.66 109.444 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.528 ' CD1' HD12 ' A' ' 38' ' ' LEU . 5.5 tt -140.08 175.82 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 50.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.2 167.37 19.05 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.344 -0.848 . . . . 16.66 108.825 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.96 -34.41 17.44 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.972 1.782 . . . . 50.0 110.028 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.81 -29.24 70.03 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.711 -0.618 . . . . 50.0 109.919 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -80.87 -38.8 27.48 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.999 -1.063 . . . . 16.66 108.214 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.895 HG22 ' CD1' ' A' ' 35' ' ' LEU . 47.9 t -63.73 -36.97 78.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.023 -0.732 . . . . 50.0 109.023 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -70.23 -37.38 74.97 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.761 -0.829 . . . . 50.0 108.761 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.517 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.3 t60 -67.46 -37.75 83.41 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.347 -0.846 . . . . 50.0 109.203 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.3 mtt -60.93 -46.76 89.4 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.092 -1.005 . . . . 16.66 108.871 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.666 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 38.9 mtp -61.74 -47.64 84.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.537 -0.727 . . . . 50.0 109.213 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.03 -19.58 45.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 50.0 109.469 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.433 ' CD ' ' NE2' ' A' ' 48' ' ' HIS . 26.8 mt-10 -97.24 -35.8 10.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 16.66 109.108 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.571 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.6 mt -81.87 -32.5 11.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 50.0 109.658 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.4 t0 -59.11 101.37 0.09 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.352 -0.842 . . . . 16.66 109.094 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 46.5 p -69.54 -46.19 67.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.222 -0.924 . . . . 50.0 110.584 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -87.48 -38.13 16.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.967 . . . . 16.66 109.456 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 101.06 27.93 7.13 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.993 -1.099 . . . . 16.66 110.581 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 p-10 -79.45 -2.24 41.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.768 -1.43 . . . . 50.0 109.079 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.666 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.86 -4.97 59.5 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.996 -1.242 . . . . 16.66 109.996 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 28.1 m-85 -134.7 157.48 46.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.029 -1.277 . . . . 50.0 111.259 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.558 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 29.9 mm -108.59 128.17 64.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.172 -1.047 . . . . 16.66 108.172 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.406 ' H ' ' HB2' ' A' ' 65' ' ' GLU . 15.2 m -94.54 169.56 10.11 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.143 -0.973 . . . . 16.66 108.761 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.584 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 33.0 t80 -56.34 -43.22 78.84 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.223 -0.923 . . . . 16.66 108.943 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -62.53 -44.83 95.38 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.594 -0.691 . . . . 50.0 109.219 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.558 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 55.1 mt-10 -62.17 -47.43 84.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 16.66 109.157 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 46.1 t80 -62.65 -36.12 81.82 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.398 -0.814 . . . . 16.66 109.296 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.45 HG23 ' CD ' ' A' ' 11' ' ' ARG . 36.7 m -68.4 -47.16 68.05 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.29 -0.881 . . . . 50.0 109.148 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 71' ' ' ARG . 74.2 m-20 -58.95 -36.75 75.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 50.0 109.307 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.31 -36.48 53.99 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.496 -0.927 . . . . 50.0 108.496 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.873 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.02 -30.48 63.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.109 -1.597 . . . . 16.66 109.109 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.518 ' NH2' ' OD1' ' A' ' 68' ' ' ASP . 52.2 mtm180 -69.18 -30.75 69.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -1.067 . . . . 50.0 108.928 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.66 -21.66 63.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.441 -0.787 . . . . 50.0 109.261 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.765 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.4 m-80 -150.58 57.01 0.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.392 -0.818 . . . . 50.0 109.192 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 7.0 ptp85 -49.27 -36.99 22.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.284 -0.885 . . . . 50.0 108.781 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.439 ' HA2' ' HE2' ' A' ' 78' ' ' LYS . . . -60.34 -30.38 71.09 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.294 -1.522 . . . . 25.0 109.294 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.765 HD12 ' CB ' ' A' ' 73' ' ' ASN . 30.7 mt -68.39 -45.57 72.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -1.081 . . . . 50.0 109.485 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.873 HD11 ' HA3' ' A' ' 70' ' ' GLY . 17.4 mt -65.17 -19.43 65.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 50.0 109.678 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 10.6 mtmm -79.54 -21.02 45.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 50.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.1 -40.63 13.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.926 . . . . 50.0 109.37 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 1.4 p -71.97 -38.48 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.469 -0.769 . . . . 50.0 109.339 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.448 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -59.77 -14.81 16.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.66 -0.65 . . . . 50.0 109.703 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 48.6 mttp -98.17 -30.47 12.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.175 -0.953 . . . . 50.0 109.093 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.505 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.3 mt -56.09 -30.32 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.43 -0.794 . . . . 50.0 109.3 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.4 ' HB2' ' NH1' ' A' ' 17' ' ' ARG . 96.7 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.956 -1.021 . . . . 99.99 109.487 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -81.77 6.58 15.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -73.57 126.92 31.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 25.0 109.457 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.491 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -111.49 170.04 5.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 50.0 109.471 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.3 Cg_endo -67.93 -22.72 41.78 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.608 2.205 . . . . 50.0 111.005 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -62.28 -39.63 93.59 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.43 -0.794 . . . . 25.0 109.091 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -55.24 -46.34 76.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.402 -0.811 . . . . 50.0 109.333 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -49.62 -37.01 26.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.444 -0.785 . . . . 50.0 109.342 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.75 -46.01 85.08 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.709 -0.848 . . . . 16.66 108.709 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 14' ' ' ILE . 60.2 mt-10 -67.29 -38.54 85.2 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.921 -0.77 . . . . 16.66 108.921 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.592 HH22 HD23 ' A' ' 77' ' ' LEU . 43.9 mtt-85 -67.37 -41.48 84.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.341 -0.85 . . . . 50.0 109.388 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.637 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 9.8 mt-10 -64.94 -42.61 94.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.616 -0.678 . . . . 50.0 109.451 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 70.0 mtp180 -64.93 -41.49 95.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 50.0 109.316 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.472 HG22 ' HE2' ' A' ' 18' ' ' PHE . 18.7 mt -69.45 -46.02 77.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.407 -0.808 . . . . 50.0 109.034 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CD2' ' HA ' ' A' ' 63' ' ' PHE . 59.0 t80 -63.62 -35.6 81.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.313 -0.867 . . . . 16.66 109.254 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -65.84 -31.86 73.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.827 . . . . 50.0 109.281 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 48.4 mtt180 -70.68 -33.66 71.15 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.29 -0.882 . . . . 50.0 109.183 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.903 ' HB3' HD13 ' A' ' 26' ' ' ILE . 45.2 m-85 -71.9 -49.12 40.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.348 -0.845 . . . . 16.66 109.498 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 25.7 t0 -57.88 103.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 16.66 108.646 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.18 -52.2 50.41 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.314 -0.866 . . . . 50.0 111.399 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -87.84 -23.49 23.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.84 -1.162 . . . . 16.66 109.688 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 84.84 41.3 7.72 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.001 -1.24 . . . . 16.66 110.001 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.502 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.7 p-10 -96.35 5.5 50.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.255 . . . . 16.66 109.267 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.24 -9.63 69.72 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.451 -1.06 . . . . 16.66 110.451 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.0 pttp -129.27 141.62 51.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.908 -1.348 . . . . 50.0 109.966 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.903 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.4 mt -112.67 134.31 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.693 -0.629 . . . . 16.66 109.444 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.4 p -105.75 166.94 10.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.74 -0.837 . . . . 50.0 108.74 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.04 -45.22 51.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.028 -1.045 . . . . 50.0 108.825 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.2 78.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.401 -0.812 . . . . 50.0 109.524 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.1 mt-10 -75.26 -54.32 7.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.218 -0.926 . . . . 16.66 109.265 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.608 HD12 ' CD1' ' A' ' 18' ' ' PHE . 34.7 tp -62.38 -42.69 99.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 16.66 108.957 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.595 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.67 -44.67 96.06 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.189 -1.564 . . . . 16.66 109.189 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.28 -42.2 86.06 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.312 -1.111 . . . . 50.0 109.655 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -74.56 -40.42 61.68 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.38 -0.97 . . . . 50.0 108.38 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.877 ' CD1' HG22 ' A' ' 46' ' ' VAL . 10.5 mt -60.52 -31.43 70.5 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.592 -0.692 . . . . 99.99 109.578 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -47.21 -23.71 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 99.99 109.527 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 t -52.15 -22.85 4.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 99.99 109.218 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.0 -32.07 73.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.479 -0.763 . . . . 50.0 109.288 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.23 7.13 50.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.674 -1.37 . . . . 16.66 109.674 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t -154.75 55.63 0.67 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -1.203 . . . . 16.66 109.653 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.0 tt -142.87 176.29 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 50.0 109.538 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.52 163.94 39.42 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.857 . . . . 16.66 108.697 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.49 -33.72 21.97 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.164 1.91 . . . . 50.0 110.209 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -65.87 -24.05 66.78 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.581 -0.699 . . . . 50.0 109.972 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -82.13 -38.52 24.64 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.944 -1.097 . . . . 16.66 108.393 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.877 HG22 ' CD1' ' A' ' 35' ' ' LEU . 42.8 t -68.45 -37.35 77.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.02 -0.733 . . . . 50.0 109.02 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -66.16 -40.28 90.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.372 -0.83 . . . . 50.0 108.941 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -64.87 -40.04 94.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.43 -0.794 . . . . 50.0 109.217 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.429 ' O ' HG13 ' A' ' 53' ' ' ILE . 7.1 mtt -57.61 -43.13 84.5 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.184 -0.947 . . . . 16.66 108.857 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.716 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 47.3 mtp -62.06 -48.0 82.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.561 -0.712 . . . . 50.0 109.266 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.58 -20.55 33.11 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.299 -0.876 . . . . 50.0 109.128 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -97.42 -36.42 10.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.455 -0.778 . . . . 16.66 109.184 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.577 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.5 mt -81.62 -32.45 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.352 -0.843 . . . . 50.0 109.569 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.7 t0 -59.74 101.41 0.11 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.393 -0.817 . . . . 16.66 109.047 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.47 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 67.6 p -70.71 -47.11 61.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 50.0 110.751 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.3 p-10 -86.54 -36.61 18.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.082 -1.011 . . . . 16.66 109.556 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 99.86 28.71 7.25 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.881 -1.152 . . . . 16.66 110.76 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.499 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.7 p-10 -81.03 -3.32 51.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.714 -1.463 . . . . 50.0 109.124 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.716 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.1 -4.47 58.85 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.855 -1.298 . . . . 16.66 109.855 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 44.3 m-85 -134.08 156.37 48.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.057 -1.261 . . . . 50.0 111.093 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.561 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 31.5 mm -108.16 129.88 61.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.142 -1.059 . . . . 16.66 108.142 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.5 166.51 11.48 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.103 -0.998 . . . . 16.66 108.709 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.637 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 34.6 t80 -53.48 -42.53 67.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.186 -1.006 . . . . 16.66 108.546 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -60.5 -49.33 77.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.618 -0.676 . . . . 50.0 109.25 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.561 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 75.3 mt-10 -59.86 -47.0 87.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 16.66 109.15 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -62.66 -36.23 82.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 16.66 109.223 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 21.7 m -67.81 -47.92 67.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 50.0 109.013 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.402 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 82.3 m-20 -59.32 -37.93 79.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.4 -0.813 . . . . 50.0 109.249 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.577 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.04 -37.26 55.11 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.503 -0.925 . . . . 50.0 108.503 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.547 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -58.61 -29.73 64.44 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.247 -1.541 . . . . 16.66 109.247 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 67' ' ' THR . 77.2 mtm180 -70.4 -30.84 67.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -1.127 . . . . 50.0 109.056 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.18 63.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.421 -0.799 . . . . 50.0 109.363 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.683 ' CB ' HD12 ' A' ' 76' ' ' LEU . 4.6 p30 -149.7 56.73 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 50.0 109.189 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.579 ' HA ' HD23 ' A' ' 77' ' ' LEU . 12.8 ptm180 -49.57 -37.13 26.16 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.386 -0.821 . . . . 50.0 108.843 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.33 -27.06 71.1 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.73 -1.348 . . . . 25.0 109.73 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.683 HD12 ' CB ' ' A' ' 73' ' ' ASN . 12.6 mt -66.24 -46.73 76.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -1.184 . . . . 50.0 109.653 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.816 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -59.84 -41.16 90.78 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.377 -0.827 . . . . 50.0 109.375 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -59.23 -30.12 68.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 50.0 109.392 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 49.9 t0 -71.22 -36.8 71.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 50.0 109.38 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.451 HG12 ' HE1' ' A' ' 84' ' ' PHE . 3.0 t -89.93 -27.73 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.385 -0.822 . . . . 50.0 109.421 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.13 -18.74 61.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 50.0 109.719 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 37.5 pttt -95.48 -31.05 13.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 50.0 109.309 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 79' ' ' ASP . 9.3 mt -57.88 -33.64 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.856 . . . . 50.0 109.448 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.451 ' HE1' HG12 ' A' ' 80' ' ' VAL . 88.1 m-85 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.075 -0.964 . . . . 99.99 109.494 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -83.84 -9.19 58.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.433 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.16 127.01 29.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 25.0 109.454 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.495 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 0.1 OUTLIER -132.25 166.92 25.13 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 50.0 109.389 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.2 Cg_endo -66.92 -22.3 48.8 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.565 2.177 . . . . 50.0 111.09 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -61.47 -41.89 97.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.523 -0.736 . . . . 25.0 109.288 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.487 ' CG ' ' CD2' ' A' ' 4' ' ' HIS . 85.2 m-20 -61.86 -46.38 89.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.435 -0.79 . . . . 50.0 109.371 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -50.11 -36.86 31.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.808 . . . . 50.0 109.45 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -56.73 -45.57 81.85 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.612 -0.885 . . . . 16.66 108.612 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 49.0 mt-10 -67.1 -38.64 86.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.448 -0.782 . . . . 16.66 109.066 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 67' ' ' THR . 74.5 mtt-85 -67.29 -40.71 86.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 50.0 109.429 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.599 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 37.8 mt-10 -65.45 -41.62 93.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.441 -0.787 . . . . 50.0 109.5 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 58.5 mtp85 -67.42 -40.66 85.55 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.23 -0.919 . . . . 50.0 109.277 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 10' ' ' GLU . 42.7 mt -70.54 -44.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.289 -0.882 . . . . 50.0 109.151 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -68.22 -35.57 78.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.207 -0.933 . . . . 16.66 109.278 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 52.9 mttt -64.33 -31.79 73.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.373 -0.829 . . . . 50.0 109.261 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.512 ' HD3' ' CD2' ' A' ' 84' ' ' PHE . 52.4 mtt180 -72.21 -35.71 68.97 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.901 . . . . 50.0 109.17 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.026 ' HB3' HD13 ' A' ' 26' ' ' ILE . 37.1 m-85 -68.75 -45.31 71.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 16.66 109.531 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 25.7 t0 -64.45 103.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 16.66 108.779 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.73 -52.13 47.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.233 -0.917 . . . . 50.0 111.21 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -85.57 -26.08 26.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.746 -1.221 . . . . 16.66 109.56 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 86.99 42.92 6.15 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.936 -1.126 . . . . 16.66 110.49 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.505 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 41.1 p-10 -99.44 6.0 46.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.25 . . . . 16.66 109.33 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 62' ' ' SER . . . 94.03 -10.88 71.55 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.485 -1.046 . . . . 16.66 110.485 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.587 ' HD2' ' CD2' ' A' ' 60' ' ' PHE . 14.3 pttp -126.69 140.45 52.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.926 -1.338 . . . . 50.0 109.891 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.026 HD13 ' HB3' ' A' ' 18' ' ' PHE . 3.3 mt -113.8 134.18 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.571 -0.706 . . . . 16.66 109.424 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.461 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 25.9 p -107.47 170.53 7.92 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.435 -0.791 . . . . 50.0 109.011 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.518 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -51.14 -47.76 61.98 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.118 -0.989 . . . . 50.0 109.028 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.31 -38.45 71.29 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.335 -0.853 . . . . 50.0 109.485 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 54.8 mt-10 -77.56 -54.49 6.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.251 -0.905 . . . . 16.66 109.154 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.939 HD22 HG13 ' A' ' 46' ' ' VAL . 7.5 tt -60.01 -46.11 90.55 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.212 -0.93 . . . . 16.66 108.853 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.788 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -61.36 -43.95 98.69 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.076 -1.61 . . . . 16.66 109.076 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 16.2 mt-10 -57.06 -44.42 83.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.433 -1.04 . . . . 50.0 109.823 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.26 -39.28 75.08 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.187 -0.946 . . . . 50.0 108.646 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.938 HD12 HG22 ' A' ' 46' ' ' VAL . 8.7 mt -58.7 -32.03 68.79 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.421 -0.799 . . . . 99.99 109.628 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -42.43 -26.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.177 -0.952 . . . . 99.99 109.84 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.774 ' CG2' HG21 ' A' ' 83' ' ' ILE . 6.3 t -49.44 -24.84 2.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.182 -0.949 . . . . 99.99 109.155 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.79 HD13 HD12 ' A' ' 41' ' ' ILE . 2.0 mt -61.28 -36.39 79.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 50.0 109.315 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.7 -3.33 64.4 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.498 -1.441 . . . . 16.66 109.498 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.74 67.7 0.63 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -1.168 . . . . 16.66 109.657 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.79 HD12 HD13 ' A' ' 38' ' ' LEU . 13.3 tt -149.35 168.25 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 50.0 109.545 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.54 167.32 12.42 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 16.66 109.221 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.67 -28.76 16.81 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.276 1.984 . . . . 50.0 109.849 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.25 -28.67 68.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.597 -0.689 . . . . 50.0 109.774 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -80.76 -34.57 34.18 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.069 -1.019 . . . . 16.66 108.353 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.939 HG13 HD22 ' A' ' 31' ' ' LEU . 53.5 t -66.51 -35.42 74.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.108 -0.701 . . . . 50.0 109.108 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -69.06 -37.97 78.81 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.758 -0.83 . . . . 50.0 108.758 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.539 ' CD2' ' HG3' ' A' ' 52' ' ' GLU . 14.8 t-160 -68.07 -39.65 82.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.496 -0.752 . . . . 50.0 109.087 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.43 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.4 mtt -61.9 -47.11 86.43 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.141 -0.975 . . . . 16.66 108.614 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.671 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 48.9 mtp -63.01 -48.3 79.41 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.046 -0.724 . . . . 50.0 109.046 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.72 -17.81 25.96 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.307 -0.871 . . . . 50.0 108.996 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.539 ' HG3' ' CD2' ' A' ' 48' ' ' HIS . 22.7 mt-10 -98.78 -36.2 9.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 16.66 109.203 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.647 HG22 HD12 ' A' ' 61' ' ' ILE . 81.4 mt -82.23 -32.45 10.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.457 -0.777 . . . . 50.0 109.669 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.9 t0 -58.4 100.69 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.441 -0.787 . . . . 16.66 109.126 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 59.1 p -70.0 -46.57 64.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.298 -0.876 . . . . 50.0 110.463 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.91 -31.53 22.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.11 -0.994 . . . . 16.66 109.571 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 93.06 28.53 11.7 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.801 -1.19 . . . . 16.66 110.189 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.48 -3.07 55.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.94 -1.33 . . . . 50.0 109.402 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.671 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 100.44 -8.34 58.56 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.053 -1.07 . . . . 16.66 110.465 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.587 ' CD2' ' HD2' ' A' ' 25' ' ' LYS . 33.9 m-85 -132.81 155.98 47.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.842 -1.387 . . . . 50.0 111.256 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.647 HD12 HG22 ' A' ' 53' ' ' ILE . 32.0 mm -107.43 129.59 61.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.348 -0.982 . . . . 16.66 108.348 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.9 OUTLIER -95.7 166.91 11.59 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.175 -0.953 . . . . 16.66 108.644 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.599 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 32.2 t80 -55.76 -42.86 76.06 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.128 -0.983 . . . . 16.66 108.741 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -62.43 -47.29 84.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.507 -0.745 . . . . 50.0 109.07 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.542 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 51.7 mt-10 -58.54 -48.09 82.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 16.66 108.974 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.484 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 55.5 t80 -59.54 -39.31 83.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.448 -0.782 . . . . 16.66 109.346 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.518 ' O ' ' NH1' ' A' ' 11' ' ' ARG . 16.4 m -65.28 -45.99 82.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.457 -0.777 . . . . 50.0 109.238 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -59.62 -40.07 86.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 50.0 109.515 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -73.0 -36.53 67.04 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.252 -0.905 . . . . 50.0 108.778 179.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.686 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.63 -34.45 76.57 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.389 -1.484 . . . . 16.66 109.389 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -65.86 -29.09 69.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -1.137 . . . . 50.0 109.277 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.67 -22.09 60.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 50.0 109.147 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.931 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.8 m-80 -150.24 58.69 0.96 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.428 -0.795 . . . . 50.0 108.997 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -50.76 -39.94 53.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.284 -0.885 . . . . 50.0 108.788 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.23 -29.9 69.69 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.342 -1.503 . . . . 25.0 109.342 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.931 HD12 ' CB ' ' A' ' 73' ' ' ASN . 28.1 mt -66.92 -45.72 77.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 50.0 109.482 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.686 HD11 ' HA3' ' A' ' 70' ' ' GLY . 25.8 mt -60.85 -37.19 81.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 50.0 109.635 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 23.5 mtmt -62.41 -24.19 67.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 50.0 109.427 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -77.87 -36.36 49.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 50.0 109.527 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -83.58 -29.46 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.836 . . . . 50.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.33 -16.54 47.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 50.0 109.607 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -95.19 -30.66 13.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 50.0 109.223 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.774 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.3 mt -58.86 -36.29 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 50.0 109.332 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.512 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 96.3 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.974 -1.012 . . . . 99.99 109.499 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.512 ' O ' ' NE2' ' A' ' 4' ' ' HIS . 38.8 m-20 -79.82 -6.45 57.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 0.0 109.624 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -81.95 107.91 15.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 25.0 109.534 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.549 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -112.29 173.98 2.57 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 50.0 109.211 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 47.2 Cg_endo -69.4 -22.96 32.99 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.563 2.175 . . . . 50.0 111.232 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -62.87 -34.37 77.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.401 -0.812 . . . . 25.0 109.285 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.97 -46.59 90.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.304 -0.872 . . . . 50.0 109.27 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -48.79 -36.63 17.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.369 -0.832 . . . . 50.0 109.586 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.23 -46.75 87.63 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.26 -0.9 . . . . 16.66 108.638 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 14' ' ' ILE . 57.0 mt-10 -68.08 -38.99 83.0 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.823 -0.806 . . . . 16.66 108.823 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.617 ' NH2' HD12 ' A' ' 77' ' ' LEU . 59.5 mtt-85 -67.99 -40.9 82.97 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.461 -0.774 . . . . 50.0 109.458 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 22.7 mt-10 -65.71 -40.86 92.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 50.0 109.524 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 15.1 mtp85 -68.18 -40.45 82.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 50.0 109.353 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 10' ' ' GLU . 34.6 mt -71.31 -43.46 73.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.328 -0.858 . . . . 50.0 109.012 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -67.39 -36.42 81.28 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.191 -0.943 . . . . 16.66 109.089 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -65.65 -29.67 70.27 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.29 -0.881 . . . . 50.0 109.062 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.481 ' CD ' ' HB3' ' A' ' 84' ' ' PHE . 28.9 mtt180 -71.24 -37.08 72.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.361 -0.837 . . . . 50.0 109.088 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.919 ' HB3' HD13 ' A' ' 26' ' ' ILE . 43.4 m-85 -69.66 -48.48 59.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -0.797 . . . . 16.66 109.488 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.4 t0 -59.18 103.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 16.66 108.713 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -51.39 55.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 50.0 111.273 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -87.87 -29.24 21.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.782 -1.199 . . . . 16.66 109.845 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 92.34 35.85 6.46 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.783 -1.198 . . . . 16.66 110.178 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.7 p-10 -90.43 4.76 50.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.252 . . . . 16.66 109.284 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.5 -6.73 74.79 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.347 -1.101 . . . . 16.66 110.347 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 15.4 pttt -130.43 141.89 50.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.996 -1.296 . . . . 50.0 110.027 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.0 mt -112.31 134.03 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.588 -0.695 . . . . 16.66 109.398 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.4 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 12.9 p -106.79 167.54 9.8 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.392 -0.818 . . . . 50.0 108.899 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.502 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.48 -45.55 56.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.059 -1.026 . . . . 50.0 108.909 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.6 -39.43 76.8 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.328 -0.858 . . . . 50.0 109.598 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.5 mt-10 -75.05 -53.98 7.95 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.224 -0.923 . . . . 16.66 109.439 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.617 HD12 ' CD1' ' A' ' 18' ' ' PHE . 31.9 tp -62.37 -42.25 99.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.209 -0.932 . . . . 16.66 108.911 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.657 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -64.35 -45.33 93.67 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.115 -1.594 . . . . 16.66 109.115 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -57.73 -42.96 84.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -1.104 . . . . 50.0 109.539 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.57 -39.95 64.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.417 -0.957 . . . . 50.0 108.417 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.904 HD12 HG22 ' A' ' 46' ' ' VAL . 10.3 mt -61.62 -32.77 72.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.578 -0.701 . . . . 99.99 109.672 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -46.87 -24.55 0.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 99.99 109.644 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.611 ' CG2' HG21 ' A' ' 83' ' ' ILE . 11.6 t -51.95 -21.52 3.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 99.99 109.266 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 38' ' ' LEU . 25.5 mt -66.64 -29.58 69.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.361 -0.837 . . . . 50.0 109.294 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.75 8.89 50.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 16.66 109.585 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.82 60.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -1.167 . . . . 16.66 109.61 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.73 173.32 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 50.0 109.525 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.38 162.96 37.08 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.712 -0.847 . . . . 16.66 108.712 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.03 -32.49 21.48 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.09 1.86 . . . . 50.0 110.012 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.25 -22.11 64.78 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.642 -0.661 . . . . 50.0 110.043 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -79.99 -36.83 35.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.93 -1.106 . . . . 16.66 108.465 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.904 HG22 HD12 ' A' ' 35' ' ' LEU . 54.2 t -68.72 -36.34 73.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.968 -0.753 . . . . 50.0 108.968 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -64.92 -39.9 94.22 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.896 -0.779 . . . . 50.0 108.896 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.55 -43.37 90.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 50.0 109.116 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.507 ' HE3' ' CD1' ' A' ' 35' ' ' LEU . 70.1 mtm -59.32 -43.39 92.7 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.174 -0.954 . . . . 16.66 108.932 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.697 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 32.4 mtp -61.53 -47.23 86.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.493 -0.754 . . . . 50.0 109.058 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.02 -22.58 50.44 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.318 -0.864 . . . . 50.0 109.116 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.91 -35.89 12.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 16.66 108.942 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.689 HG22 HD12 ' A' ' 61' ' ' ILE . 82.6 mt -81.09 -30.09 11.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.591 -0.693 . . . . 50.0 109.534 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.4 t0 -62.42 101.36 0.23 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.386 -0.821 . . . . 16.66 109.105 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 74.0 p -71.65 -47.95 50.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.862 . . . . 50.0 110.614 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 4.2 p-10 -85.85 -33.83 21.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.141 -0.975 . . . . 16.66 109.728 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 97.31 27.4 9.29 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.911 -1.138 . . . . 16.66 111.053 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 p-10 -80.62 -2.5 46.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.725 -1.456 . . . . 50.0 109.248 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.697 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.01 -4.16 60.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.003 -1.239 . . . . 16.66 110.003 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.576 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 39.7 m-85 -134.46 156.12 49.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.26 . . . . 50.0 111.125 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.689 HD12 HG22 ' A' ' 53' ' ' ILE . 34.3 mm -106.83 128.95 61.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.34 -0.985 . . . . 16.66 108.34 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -96.25 169.51 9.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.083 -1.011 . . . . 16.66 108.832 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 35.7 t80 -55.8 -43.88 77.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.128 -0.983 . . . . 16.66 108.73 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -60.31 -48.38 82.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.462 -0.774 . . . . 50.0 109.185 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 63.5 mt-10 -59.91 -46.5 89.18 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.357 -0.839 . . . . 16.66 109.11 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -62.35 -36.53 82.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.443 -0.786 . . . . 16.66 109.079 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 28.9 m -68.51 -48.27 64.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.8 . . . . 50.0 108.979 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -58.08 -37.75 75.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.319 -0.863 . . . . 50.0 109.249 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.563 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -78.73 -35.87 44.14 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.41 -0.959 . . . . 50.0 108.41 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.89 ' CA ' HD11 ' A' ' 77' ' ' LEU . . . -58.63 -33.9 74.22 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.888 -1.685 . . . . 16.66 108.888 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 67' ' ' THR . 82.1 mtm180 -64.86 -32.3 73.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -1.078 . . . . 50.0 108.53 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.55 -2.54 58.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.538 -0.726 . . . . 50.0 109.227 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.75 ' HB3' HD22 ' A' ' 76' ' ' LEU . 68.4 m-80 -151.69 48.42 0.8 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.311 -0.868 . . . . 50.0 108.668 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -57.8 -47.04 83.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.342 -0.849 . . . . 50.0 108.877 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.2 -21.16 38.46 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.135 -1.586 . . . . 25.0 109.135 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.75 HD22 ' HB3' ' A' ' 73' ' ' ASN . 6.8 mp -79.94 -43.82 21.43 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -1.116 . . . . 50.0 109.366 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.89 HD11 ' CA ' ' A' ' 70' ' ' GLY . 5.9 mt -69.2 -22.38 63.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 50.0 109.968 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -80.03 -26.19 39.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 50.0 109.716 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -89.57 -40.66 12.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.1 -1.0 . . . . 50.0 109.586 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.9 p -67.78 -43.36 86.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.383 -0.823 . . . . 50.0 109.515 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.538 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.96 -37.66 45.86 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.673 -0.642 . . . . 50.0 109.919 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.21 -26.86 67.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 50.0 109.542 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.611 HG21 ' CG2' ' A' ' 37' ' ' THR . 7.8 mt -60.63 -43.9 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.236 -0.915 . . . . 50.0 109.362 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.481 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 89.6 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.961 -1.019 . . . . 99.99 109.463 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -85.18 7.46 21.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 109.619 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -90.15 116.35 28.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 25.0 109.534 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.623 ' CG ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -118.59 153.17 52.03 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 50.0 108.855 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.623 ' HD2' ' CG ' ' A' ' 4' ' ' HIS . 39.9 Cg_endo -64.4 -19.98 65.87 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.143 1.895 . . . . 50.0 110.362 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -57.69 -41.67 82.12 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.079 -0.711 . . . . 25.0 109.079 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.17 -43.72 92.15 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 50.0 109.363 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -50.62 -36.94 37.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 50.0 109.403 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.15 -46.16 89.1 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.782 -0.822 . . . . 16.66 108.782 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.451 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.9 mm-40 -66.38 -44.06 84.17 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.957 -0.757 . . . . 16.66 108.957 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.622 ' NH2' HD12 ' A' ' 77' ' ' LEU . 36.6 mtt-85 -64.95 -39.52 93.62 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.435 -0.79 . . . . 50.0 109.416 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.592 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 13.0 mt-10 -66.21 -42.14 89.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 50.0 109.542 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 47.5 mtp180 -67.01 -40.81 87.36 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.299 -0.876 . . . . 50.0 109.214 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.8 mt -70.29 -44.54 77.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.359 -0.838 . . . . 50.0 109.033 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' A' ' 63' ' ' PHE . 52.7 t80 -66.72 -35.38 79.97 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.281 -0.887 . . . . 16.66 109.041 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -64.44 -31.34 72.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 50.0 109.388 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 64.8 mtt180 -72.53 -36.07 68.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -0.929 . . . . 50.0 109.15 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.012 ' HB3' HD13 ' A' ' 26' ' ' ILE . 34.4 m-85 -68.72 -45.01 72.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 16.66 109.389 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.5 t0 -63.37 103.22 0.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 16.66 108.756 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.17 -51.2 60.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.254 -0.904 . . . . 50.0 111.299 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -89.23 -27.27 20.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.659 -1.276 . . . . 16.66 109.762 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.95 35.68 7.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.032 -1.227 . . . . 16.66 110.032 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.487 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 35.5 p-10 -89.52 3.71 51.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -1.2 . . . . 16.66 109.277 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.19 -6.28 68.73 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.367 -1.093 . . . . 16.66 110.367 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.5 pttp -132.37 143.48 49.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.911 -1.346 . . . . 50.0 110.149 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.012 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.4 mt -111.41 135.06 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 121.426 0.632 . . . . 16.66 109.53 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.418 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 11.4 p -107.77 166.4 10.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.877 -0.786 . . . . 50.0 108.877 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.523 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.81 -45.63 50.21 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.185 -0.947 . . . . 50.0 108.876 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 -38.81 75.99 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.317 -0.864 . . . . 50.0 109.602 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.505 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.2 mt-10 -75.61 -54.1 7.53 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.12 -0.987 . . . . 16.66 109.496 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.874 HD12 ' CD1' ' A' ' 18' ' ' PHE . 14.5 tp -64.03 -38.95 92.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.123 -0.986 . . . . 16.66 108.876 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.629 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -66.02 -46.48 80.82 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.993 -1.643 . . . . 16.66 108.993 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -57.27 -42.79 82.31 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.326 -1.102 . . . . 50.0 109.478 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.63 -40.22 63.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.416 -0.957 . . . . 50.0 108.416 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.812 ' CD1' HG22 ' A' ' 46' ' ' VAL . 5.0 mt -59.94 -32.84 71.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.644 -0.66 . . . . 99.99 109.595 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -45.61 -25.67 0.5 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.034 -1.041 . . . . 99.99 109.351 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.54 ' CG2' HG21 ' A' ' 83' ' ' ILE . 11.7 t -50.87 -23.74 3.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.282 -0.886 . . . . 99.99 109.184 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 41' ' ' ILE . 22.5 mt -62.15 -32.58 73.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.813 . . . . 50.0 109.264 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.0 6.43 52.67 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.643 -1.383 . . . . 16.66 109.643 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.18 56.63 0.65 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -1.213 . . . . 16.66 109.605 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 38' ' ' LEU . 8.9 tt -142.47 175.25 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -0.962 . . . . 50.0 109.512 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.75 165.71 25.36 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.349 -0.844 . . . . 16.66 108.759 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 47.4 Cg_endo -69.42 -33.74 17.23 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.09 1.86 . . . . 50.0 110.172 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.17 -22.37 65.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.699 -0.625 . . . . 50.0 110.178 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -82.99 -39.53 21.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.822 -1.173 . . . . 16.66 108.452 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.812 HG22 ' CD1' ' A' ' 35' ' ' LEU . 75.1 t -66.03 -36.02 76.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.786 -0.82 . . . . 50.0 108.786 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 23.3 mttm -67.6 -39.9 84.79 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.782 -0.822 . . . . 50.0 108.782 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -65.71 -39.51 91.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.407 -0.808 . . . . 50.0 109.149 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.414 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.8 mtt -58.46 -44.77 89.39 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.176 -0.953 . . . . 16.66 108.718 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.617 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 58.1 mtp -62.32 -48.03 81.66 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.524 -0.735 . . . . 50.0 109.188 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.06 -20.17 23.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.301 -0.874 . . . . 50.0 109.05 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -97.14 -35.8 10.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 16.66 109.025 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.688 HG22 HD12 ' A' ' 61' ' ' ILE . 83.5 mt -81.74 -31.74 11.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.446 -0.784 . . . . 50.0 109.592 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.3 t0 -60.42 101.24 0.12 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.341 -0.85 . . . . 16.66 109.187 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 37.9 p -72.13 -45.03 62.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.374 -0.829 . . . . 50.0 110.582 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.498 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.2 p-10 -87.35 -38.92 15.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 16.66 109.485 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 102.17 29.28 6.12 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.86 -1.162 . . . . 16.66 110.675 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p-10 -81.92 -4.12 55.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.819 -1.401 . . . . 50.0 109.014 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.617 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.1 -2.36 57.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.816 -1.314 . . . . 16.66 109.816 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 31.4 m-85 -136.86 156.59 48.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -1.232 . . . . 50.0 111.275 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.688 HD12 HG22 ' A' ' 53' ' ' ILE . 33.3 mm -106.93 127.24 62.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.328 -0.99 . . . . 16.66 108.328 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -94.2 167.71 11.38 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.075 -1.016 . . . . 16.66 108.762 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.592 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.3 t80 -55.09 -43.08 73.64 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.154 -0.966 . . . . 16.66 108.693 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.74 -49.3 78.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.976 -0.75 . . . . 50.0 108.976 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.538 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 22.5 mt-10 -58.3 -47.31 84.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.836 . . . . 16.66 109.027 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.6 -37.97 85.85 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.52 -0.737 . . . . 16.66 109.306 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 31.2 m -65.74 -47.73 74.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.845 . . . . 50.0 109.257 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -60.38 -38.84 85.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 50.0 109.359 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.586 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.13 -38.37 56.87 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.281 -1.007 . . . . 50.0 108.281 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.905 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -56.81 -28.84 57.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.056 -1.617 . . . . 16.66 109.056 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 67' ' ' THR . 78.7 mtm180 -70.39 -29.65 66.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -1.098 . . . . 50.0 108.832 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.65 -23.42 63.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.781 . . . . 50.0 109.155 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.797 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.7 m-80 -148.83 58.17 1.04 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 50.0 108.991 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -50.63 -30.86 14.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 50.0 108.894 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.17 -30.9 79.01 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.202 -1.559 . . . . 25.0 109.202 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.797 HD12 ' CB ' ' A' ' 73' ' ' ASN . 63.7 mt -66.57 -43.56 84.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -1.071 . . . . 50.0 109.491 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.905 HD11 ' HA3' ' A' ' 70' ' ' GLY . 5.3 mt -69.55 -26.49 64.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.415 -0.803 . . . . 50.0 109.862 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -79.37 -24.59 42.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.01 -1.057 . . . . 50.0 109.217 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -92.01 -45.13 8.48 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.393 -0.817 . . . . 50.0 109.333 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.6 p -61.17 -44.52 98.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.808 0.813 . . . . 50.0 109.048 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.545 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -51.49 -39.82 58.32 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.731 -0.606 . . . . 50.0 109.53 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -59.65 -30.8 68.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 50.0 109.702 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.54 HG21 ' CG2' ' A' ' 37' ' ' THR . 41.9 mt -59.37 -32.43 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 50.0 109.43 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 9.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.062 -0.971 . . . . 99.99 109.439 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -107.71 85.67 2.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.549 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -95.13 111.09 22.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 25.0 109.36 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.521 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -118.49 172.41 4.24 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 50.0 109.33 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 45.9 Cg_endo -68.9 -22.5 36.09 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.573 2.182 . . . . 50.0 111.094 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -63.58 -38.2 90.22 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.485 -0.76 . . . . 25.0 109.252 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.99 -42.06 97.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 50.0 109.344 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -52.8 -36.48 58.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.477 -0.764 . . . . 50.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' O ' ' HD2' ' A' ' 13' ' ' ARG . . . -58.68 -45.18 89.98 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.642 -0.873 . . . . 16.66 108.642 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 14' ' ' ILE . 66.7 mt-10 -67.41 -43.49 81.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.838 -0.801 . . . . 16.66 108.838 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.481 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 35.1 mtt-85 -66.24 -39.42 89.52 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.484 -0.76 . . . . 50.0 109.346 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 14.8 mt-10 -66.98 -41.02 87.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.474 -0.766 . . . . 50.0 109.373 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.4 mtt180 -68.46 -40.16 81.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.358 -0.839 . . . . 50.0 109.117 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.9 mt -70.72 -44.73 76.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.411 -0.805 . . . . 50.0 109.059 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -65.43 -36.23 83.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 16.66 109.029 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -66.05 -29.48 69.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 50.0 109.151 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 84' ' ' PHE . 33.7 mtt180 -70.46 -39.15 74.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 50.0 109.066 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.936 ' HB3' HD13 ' A' ' 26' ' ' ILE . 46.6 m-85 -68.44 -48.5 64.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 16.66 109.316 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 26.5 t0 -57.36 103.48 0.13 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 16.66 108.604 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -52.28 57.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 50.0 111.457 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' A' ' 23' ' ' ASP . 31.8 p-10 -88.84 -21.97 23.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.826 -1.171 . . . . 16.66 109.768 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 82.66 40.48 9.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.876 -1.29 . . . . 16.66 109.876 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.507 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.5 p-10 -94.11 4.15 54.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -1.221 . . . . 16.66 109.247 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.88 -9.41 65.91 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.516 -1.034 . . . . 16.66 110.516 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 7.6 pttt -130.74 142.69 50.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.932 -1.334 . . . . 50.0 110.118 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.936 HD13 ' HB3' ' A' ' 18' ' ' PHE . 7.6 mt -112.82 134.05 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.409 -0.589 . . . . 16.66 109.409 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.426 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 25.0 p -107.8 168.96 8.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 50.0 108.846 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.509 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.56 -47.18 57.86 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.06 -1.025 . . . . 50.0 108.933 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.39 70.2 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.481 -0.762 . . . . 50.0 109.704 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.494 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 55.5 mt-10 -78.39 -53.5 7.2 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.111 -0.993 . . . . 16.66 109.477 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.685 HD12 ' CD1' ' A' ' 18' ' ' PHE . 54.6 tp -63.22 -40.43 97.46 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.175 -0.953 . . . . 16.66 108.976 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.658 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -64.07 -45.13 94.66 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.162 -1.575 . . . . 16.66 109.162 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -58.64 -42.94 89.48 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.195 -1.179 . . . . 50.0 109.703 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.54 -40.68 61.56 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.053 -1.029 . . . . 50.0 108.404 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.75 ' CD1' HG22 ' A' ' 46' ' ' VAL . 9.5 mt -60.73 -33.13 72.45 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.546 -0.721 . . . . 99.99 109.463 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -47.12 -24.4 0.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.081 -1.012 . . . . 99.99 109.437 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.56 ' CG2' HG21 ' A' ' 83' ' ' ILE . 12.2 t -52.54 -22.61 5.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 99.99 109.19 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.605 HD12 HD12 ' A' ' 41' ' ' ILE . 39.3 mt -61.07 -31.66 71.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -0.832 . . . . 50.0 109.224 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.66 3.52 54.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.733 -1.347 . . . . 16.66 109.733 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.76 65.04 0.59 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -1.197 . . . . 16.66 109.71 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.605 HD12 HD12 ' A' ' 38' ' ' LEU . 14.9 tt -149.63 170.24 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 50.0 109.411 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.66 162.95 28.2 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.311 -0.868 . . . . 16.66 108.706 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.76 -32.4 23.38 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.003 1.802 . . . . 50.0 110.18 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.0 -23.56 65.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.604 -0.685 . . . . 50.0 109.915 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -81.0 -38.92 26.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.887 -1.133 . . . . 16.66 108.298 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.75 HG22 ' CD1' ' A' ' 35' ' ' LEU . 53.8 t -66.09 -36.38 77.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.579 -0.897 . . . . 50.0 108.579 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -69.54 -39.54 77.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.479 -0.934 . . . . 50.0 108.479 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.52 -41.42 88.83 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.96 -0.755 . . . . 50.0 108.96 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.8 mtt -59.05 -44.92 91.86 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.259 -0.9 . . . . 16.66 108.622 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.689 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 30.1 mtp -60.39 -46.13 91.06 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.521 -0.737 . . . . 50.0 109.061 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.77 -23.5 52.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.8 . . . . 50.0 109.316 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -92.84 -35.95 13.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 16.66 108.799 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.754 HG22 HD12 ' A' ' 61' ' ' ILE . 84.7 mt -80.37 -29.34 12.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.545 -0.722 . . . . 50.0 109.478 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.2 t0 -63.8 101.6 0.38 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.446 -0.784 . . . . 16.66 109.196 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 76.1 p -73.95 -46.72 42.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.292 -0.88 . . . . 50.0 110.868 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 7.5 p-10 -86.14 -31.24 21.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.069 -1.02 . . . . 16.66 109.645 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 94.73 27.42 11.42 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.798 -1.191 . . . . 16.66 111.066 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.6 p-10 -82.32 -3.49 55.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.73 -1.453 . . . . 50.0 109.321 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.689 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.93 -5.71 59.76 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.243 -1.143 . . . . 16.66 110.243 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.57 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 37.0 m-85 -133.5 155.04 50.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.942 -1.328 . . . . 50.0 111.039 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.754 HD12 HG22 ' A' ' 53' ' ' ILE . 34.5 mm -105.24 127.44 59.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.254 -1.017 . . . . 16.66 108.254 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.3 167.62 11.42 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.2 -0.937 . . . . 16.66 108.91 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.597 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.6 t80 -54.58 -42.77 71.45 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.057 -1.027 . . . . 16.66 108.651 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -60.7 -49.47 77.36 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.115 -0.698 . . . . 50.0 109.115 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.555 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 45.6 mt-10 -58.88 -46.79 86.99 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 16.66 109.013 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -63.74 -36.58 84.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.507 -0.745 . . . . 16.66 109.288 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.42 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 52.8 m -66.35 -48.68 69.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.321 -0.862 . . . . 50.0 109.209 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' ' NH1' ' A' ' 71' ' ' ARG . 67.8 m-20 -61.79 -37.38 84.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 50.0 109.3 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.593 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -72.71 -40.15 66.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.538 -0.912 . . . . 50.0 108.538 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.496 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -56.13 -29.19 55.58 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.141 -1.584 . . . . 16.66 109.141 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.484 ' NH1' ' OD1' ' A' ' 68' ' ' ASP . 23.2 mtm180 -71.1 -21.49 62.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 50.0 109.054 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.71 -24.44 38.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.439 -0.788 . . . . 50.0 109.34 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.95 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.8 m-80 -145.22 57.68 1.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.861 . . . . 50.0 109.393 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -51.31 -38.72 54.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.894 . . . . 50.0 108.762 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.22 -27.53 65.38 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.316 -1.514 . . . . 25.0 109.316 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.95 HD12 ' CB ' ' A' ' 73' ' ' ASN . 39.7 mt -69.73 -44.8 69.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -1.093 . . . . 50.0 109.476 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.695 HD12 ' N ' ' A' ' 77' ' ' LEU . 8.9 mp -63.38 -40.26 96.75 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.422 -0.799 . . . . 50.0 110.002 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 14.4 mtmt -65.83 -20.08 66.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 50.0 109.344 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.36 -53.85 3.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 50.0 109.535 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.2 p -65.89 -44.8 92.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.369 -0.832 . . . . 50.0 109.452 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.558 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -53.67 -36.65 62.37 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.59 -0.693 . . . . 50.0 109.725 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 17.5 mttt -66.95 -25.47 66.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 50.0 109.663 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.56 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.1 mt -59.63 -42.48 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.904 . . . . 50.0 109.444 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.512 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 88.7 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.015 -0.993 . . . . 99.99 109.47 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -60.71 -28.19 68.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.468 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -93.99 109.01 20.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 25.0 109.37 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.477 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -117.77 171.11 5.35 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 50.0 109.436 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.1 Cg_endo -68.27 -22.78 39.6 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.559 2.173 . . . . 50.0 111.134 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -62.61 -40.03 95.67 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.447 -0.783 . . . . 25.0 109.127 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.84 -42.18 93.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.373 -0.83 . . . . 50.0 109.222 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -52.78 -36.15 57.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.366 -0.833 . . . . 50.0 109.223 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.59 -45.78 84.83 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.587 -0.894 . . . . 16.66 108.587 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 56.2 mt-10 -66.33 -44.65 82.72 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.881 -0.785 . . . . 16.66 108.881 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.78 ' NH1' HG23 ' A' ' 67' ' ' THR . 75.2 mtm180 -64.52 -38.85 92.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.533 -0.73 . . . . 50.0 109.436 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.619 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 34.8 mt-10 -65.91 -42.34 90.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.329 -0.857 . . . . 50.0 109.469 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 16.9 mtp180 -66.82 -40.17 87.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.281 -0.887 . . . . 50.0 109.218 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 10' ' ' GLU . 30.2 mt -70.17 -46.27 72.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.392 -0.818 . . . . 50.0 108.967 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -62.43 -35.58 79.68 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.274 -0.891 . . . . 16.66 108.934 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 60.1 mttm -66.56 -30.06 70.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.858 . . . . 50.0 109.15 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 47.2 mtt180 -68.92 -37.71 79.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.339 -0.851 . . . . 50.0 109.16 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.853 ' HB3' HD13 ' A' ' 26' ' ' ILE . 55.4 m-85 -68.96 -50.41 49.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.785 . . . . 16.66 109.489 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.468 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.8 t0 -54.66 103.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 16.66 108.651 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.13 -52.03 52.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.274 -0.891 . . . . 50.0 111.29 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -87.88 -23.64 23.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.745 -1.222 . . . . 16.66 109.592 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 84.72 41.47 7.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.034 -1.226 . . . . 16.66 110.034 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.505 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.2 p-10 -96.16 5.84 50.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.047 -1.267 . . . . 16.66 109.295 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -9.01 71.19 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.454 -1.058 . . . . 16.66 110.454 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.2 pttp -129.55 141.86 50.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.319 . . . . 50.0 109.808 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.853 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.5 mt -112.61 134.31 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.687 -0.633 . . . . 16.66 109.381 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.46 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 18.1 p -106.41 167.33 9.91 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.662 -0.866 . . . . 50.0 108.662 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.94 -45.63 51.42 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.12 -0.988 . . . . 50.0 108.997 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.85 -38.45 75.7 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.25 -0.907 . . . . 50.0 109.529 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.496 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.2 mt-10 -76.41 -54.31 6.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.163 -0.961 . . . . 16.66 109.281 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.712 HD12 ' CD1' ' A' ' 18' ' ' PHE . 29.0 tp -62.73 -42.09 99.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 16.66 108.912 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.668 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.85 -44.9 95.46 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.201 -1.559 . . . . 16.66 109.201 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.99 -42.95 86.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.307 -1.113 . . . . 50.0 109.699 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.89 -40.02 63.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.359 -0.978 . . . . 50.0 108.359 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.935 ' CD1' HG22 ' A' ' 46' ' ' VAL . 12.5 mt -60.76 -32.48 71.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.65 -0.656 . . . . 99.99 109.566 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -46.5 -24.64 0.55 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.082 -1.012 . . . . 99.99 109.443 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.603 ' CG2' HG21 ' A' ' 83' ' ' ILE . 10.3 t -51.81 -22.72 3.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.276 -0.89 . . . . 99.99 109.261 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.631 HD12 HD12 ' A' ' 41' ' ' ILE . 21.6 mt -60.2 -33.24 71.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.381 -0.824 . . . . 50.0 109.38 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.21 3.21 56.31 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.633 -1.387 . . . . 16.66 109.633 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.44 61.57 0.62 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -1.181 . . . . 16.66 109.594 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.631 HD12 HD12 ' A' ' 38' ' ' LEU . 10.3 tt -146.31 174.54 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 50.0 109.539 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.34 164.47 29.94 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 16.66 108.768 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.54 -32.77 18.81 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.091 1.861 . . . . 50.0 110.241 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.38 -22.85 65.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.654 -0.654 . . . . 50.0 110.055 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -82.34 -38.95 23.49 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.904 -1.123 . . . . 16.66 108.544 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.935 HG22 ' CD1' ' A' ' 35' ' ' LEU . 42.2 t -68.05 -37.35 78.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.779 -0.823 . . . . 50.0 108.779 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -66.15 -40.09 90.31 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.829 -0.804 . . . . 50.0 108.829 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.472 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.9 t60 -64.54 -39.47 93.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.454 -0.779 . . . . 50.0 109.128 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.436 ' O ' HG13 ' A' ' 53' ' ' ILE . 13.2 mtt -56.54 -43.15 79.61 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.101 -1.0 . . . . 16.66 108.552 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.519 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 82.3 mtp -61.51 -48.4 81.22 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.944 -0.761 . . . . 50.0 108.944 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.72 -22.08 12.88 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.246 -0.908 . . . . 50.0 109.134 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -99.11 -36.85 9.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 16.66 109.231 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.672 HG22 HD12 ' A' ' 61' ' ' ILE . 82.9 mt -80.25 -33.49 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.434 -0.791 . . . . 50.0 109.617 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.6 t0 -59.97 101.47 0.12 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.351 -0.843 . . . . 16.66 109.099 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.534 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 81.8 p -73.76 -47.41 39.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 50.0 110.819 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 7.1 p-10 -85.72 -31.81 22.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.945 . . . . 16.66 109.681 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.462 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 95.19 27.65 10.65 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.888 -1.148 . . . . 16.66 111.001 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.482 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.1 p-10 -81.66 -3.79 54.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.768 -1.431 . . . . 50.0 109.342 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.519 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.46 -5.43 58.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.14 -1.184 . . . . 16.66 110.14 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.575 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 45.2 m-85 -133.1 154.83 50.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.998 -1.295 . . . . 50.0 110.971 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.672 HD12 HG22 ' A' ' 53' ' ' ILE . 34.7 mm -105.31 128.73 59.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.364 -0.976 . . . . 16.66 108.364 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.6 165.88 11.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.188 -0.945 . . . . 16.66 108.836 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.619 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.9 t80 -53.56 -43.09 68.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.095 -1.003 . . . . 16.66 108.542 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -59.07 -46.78 87.4 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.09 -0.707 . . . . 50.0 109.09 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.549 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 64.0 mt-10 -63.78 -46.99 82.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.853 . . . . 16.66 109.068 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.779 ' HE1' HD13 ' A' ' 77' ' ' LEU . 27.3 t80 -65.84 -29.03 69.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.428 -0.795 . . . . 16.66 109.182 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.78 HG23 ' NH1' ' A' ' 11' ' ' ARG . 63.0 m -69.87 -49.96 47.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.42 -0.8 . . . . 50.0 109.329 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.49 -35.83 81.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 50.0 109.385 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.583 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -75.79 -41.18 53.61 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.384 -0.969 . . . . 50.0 108.384 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.993 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.56 -30.03 71.02 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.002 -1.639 . . . . 16.66 109.002 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.51 ' HG3' ' NH1' ' A' ' 11' ' ' ARG . 68.4 mtp180 -66.91 -37.25 84.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.445 -1.033 . . . . 50.0 108.826 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.44 -19.02 65.69 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.133 -0.691 . . . . 50.0 109.133 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.769 ' CB ' HD12 ' A' ' 76' ' ' LEU . 18.4 m-80 -145.94 53.29 1.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 50.0 109.318 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -49.5 -36.15 22.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 50.0 108.739 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.523 ' HA2' ' CE ' ' A' ' 78' ' ' LYS . . . -61.54 -19.71 58.26 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.398 -1.481 . . . . 25.0 109.398 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.769 HD12 ' CB ' ' A' ' 73' ' ' ASN . 25.0 mt -78.33 -44.86 24.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.393 -1.063 . . . . 50.0 109.291 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.993 HD11 ' HA3' ' A' ' 70' ' ' GLY . 3.8 mt -71.15 -24.2 62.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.473 -0.767 . . . . 50.0 110.142 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' CE ' ' HA2' ' A' ' 75' ' ' GLY . 6.7 ptpt -80.06 -28.79 39.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.959 -1.088 . . . . 50.0 109.0 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 56.3 m-20 -87.37 -44.68 11.19 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.488 -0.758 . . . . 50.0 109.274 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.552 HG13 ' N ' ' A' ' 81' ' ' ALA . 5.4 p -58.71 -44.78 90.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.868 0.842 . . . . 50.0 108.946 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.552 ' N ' HG13 ' A' ' 80' ' ' VAL . . . -50.5 -41.13 53.07 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.165 -0.614 . . . . 50.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -59.43 -32.25 70.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 50.0 109.499 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.603 HG21 ' CG2' ' A' ' 37' ' ' THR . 26.9 mt -57.44 -32.65 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 50.0 109.278 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.551 ' CE1' HG21 ' A' ' 37' ' ' THR . 8.9 m-85 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.96 -1.019 . . . . 99.99 109.488 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -72.1 -10.45 59.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.517 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -79.55 111.35 15.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 25.0 109.488 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.504 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -109.87 170.02 5.79 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.913 . . . . 50.0 109.363 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.3 Cg_endo -67.44 -22.3 45.51 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.573 2.182 . . . . 50.0 111.0 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -63.04 -41.72 99.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.613 -0.68 . . . . 25.0 109.234 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -55.97 -47.56 77.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.439 -0.788 . . . . 50.0 109.378 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -48.34 -36.1 13.75 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.429 -0.795 . . . . 50.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.37 -46.38 88.81 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.395 -0.816 . . . . 16.66 108.98 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.46 ' O ' HG13 ' A' ' 14' ' ' ILE . 61.7 mt-10 -66.78 -41.09 88.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.401 -0.812 . . . . 16.66 108.981 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -66.16 -41.1 90.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.453 -0.779 . . . . 50.0 109.452 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.568 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 8.6 mt-10 -64.6 -41.51 96.18 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.519 -0.738 . . . . 50.0 109.399 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 62.1 mtp180 -67.01 -40.6 87.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 50.0 109.273 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 10' ' ' GLU . 31.9 mt -70.55 -44.46 76.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.397 -0.814 . . . . 50.0 108.986 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 63' ' ' PHE . 58.7 t80 -66.65 -36.2 81.99 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.295 -0.878 . . . . 16.66 109.065 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -65.5 -30.67 71.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 50.0 108.983 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 52.0 mtt85 -70.62 -36.16 73.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.411 -0.806 . . . . 50.0 109.114 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.967 ' HB3' HD13 ' A' ' 26' ' ' ILE . 36.3 m-85 -68.21 -49.22 62.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.823 . . . . 16.66 109.432 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.6 t0 -57.58 103.43 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 16.66 108.715 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.3 -51.3 54.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 50.0 111.26 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -87.31 -30.49 20.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.733 -1.229 . . . . 16.66 109.793 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.59 35.6 6.14 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.819 -1.181 . . . . 16.66 110.232 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.1 p-10 -90.46 3.96 52.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.246 . . . . 16.66 109.285 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.02 -6.51 72.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.431 -1.068 . . . . 16.66 110.431 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.609 ' HD3' ' CG ' ' A' ' 60' ' ' PHE . 2.3 ptpp? -131.08 142.65 50.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.944 -1.327 . . . . 50.0 109.939 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.967 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.1 mt -112.15 133.73 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.605 -0.684 . . . . 16.66 109.652 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.1 p -105.53 166.06 10.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.383 -0.823 . . . . 50.0 108.867 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.92 -44.82 50.48 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.987 -1.071 . . . . 50.0 108.699 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -58.14 -39.77 79.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.189 -0.945 . . . . 50.0 109.347 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.8 mt-10 -74.67 -54.63 7.05 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.132 -0.98 . . . . 16.66 109.24 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.541 ' CD1' ' CE1' ' A' ' 18' ' ' PHE . 29.9 tp -62.31 -42.31 99.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.145 -0.972 . . . . 16.66 108.94 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.582 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.92 -45.33 94.38 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.96 -1.656 . . . . 16.66 108.96 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 10.3 mt-10 -56.15 -44.33 79.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.418 -1.048 . . . . 50.0 109.457 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.53 -39.31 67.63 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.331 -0.988 . . . . 50.0 108.331 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.874 ' CD1' HG22 ' A' ' 46' ' ' VAL . 6.7 mt -59.26 -32.93 70.45 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.545 -0.722 . . . . 99.99 109.412 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -44.79 -26.03 0.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 99.99 109.474 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.791 ' OG1' HG21 ' A' ' 83' ' ' ILE . 8.7 t -52.55 -25.04 9.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 99.99 109.232 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.942 HD12 HD12 ' A' ' 41' ' ' ILE . 23.7 mt -57.99 -35.96 71.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 50.0 109.165 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.87 1.97 60.28 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.681 -1.367 . . . . 16.66 109.681 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.15 52.53 0.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.092 -1.24 . . . . 16.66 109.754 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.942 HD12 HD12 ' A' ' 38' ' ' LEU . 11.7 tt -136.47 171.77 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 50.0 109.589 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.23 165.89 23.62 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.751 -0.833 . . . . 16.66 108.751 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.91 -33.79 19.17 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.042 1.828 . . . . 50.0 110.188 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -62.1 -28.9 69.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.585 -0.697 . . . . 50.0 109.956 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -81.76 -36.11 28.88 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.949 -1.094 . . . . 16.66 108.288 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.874 HG22 ' CD1' ' A' ' 35' ' ' LEU . 57.7 t -68.09 -36.59 75.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.948 -0.76 . . . . 50.0 108.948 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -68.88 -38.92 80.0 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.795 -0.817 . . . . 50.0 108.795 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -65.92 -39.78 90.86 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.471 -0.768 . . . . 50.0 109.299 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.431 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.9 mtt -59.19 -44.59 92.22 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.117 -0.989 . . . . 16.66 108.841 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.549 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 29.3 mtp -62.43 -48.13 81.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.421 -0.799 . . . . 50.0 109.15 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.62 -20.14 30.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 50.0 109.097 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -97.44 -36.47 10.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 16.66 109.199 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.587 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.6 mt -80.78 -31.93 12.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.413 -0.804 . . . . 50.0 109.576 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.0 t0 -61.76 101.38 0.19 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.439 -0.788 . . . . 16.66 108.938 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.453 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 39.6 p -67.95 -45.18 74.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.874 . . . . 50.0 110.461 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.9 p-10 -88.79 -42.71 11.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 16.66 109.642 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 104.88 30.21 4.93 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.188 -1.165 . . . . 16.66 110.188 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.8 p-10 -81.31 -3.06 51.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.919 -1.342 . . . . 50.0 109.233 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.549 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.6 -1.13 58.3 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.795 -1.322 . . . . 16.66 109.795 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.609 ' CG ' ' HD3' ' A' ' 25' ' ' LYS . 51.1 m-85 -137.44 155.66 49.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -1.233 . . . . 50.0 111.284 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.55 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 30.9 mm -109.83 129.57 64.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.222 -1.029 . . . . 16.66 108.222 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.02 168.13 10.47 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.057 -1.027 . . . . 16.66 108.815 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.568 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 32.4 t80 -54.83 -43.19 72.77 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.102 -0.999 . . . . 16.66 108.728 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -61.1 -46.81 89.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.545 -0.722 . . . . 50.0 109.235 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 75.0 mt-10 -61.65 -47.67 84.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 16.66 109.198 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.439 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 60.0 t80 -61.44 -36.86 81.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 16.66 109.444 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 23.1 m -65.54 -47.27 76.45 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.259 -0.901 . . . . 50.0 109.344 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -60.92 -38.87 87.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 50.0 109.6 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -77.37 -38.6 49.75 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.136 -0.977 . . . . 50.0 108.77 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.45 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.36 -32.32 76.81 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.935 -1.666 . . . . 16.66 108.935 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 67' ' ' THR . 64.6 mtp180 -70.97 -34.26 71.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -1.027 . . . . 50.0 109.259 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.47 -4.61 56.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 50.0 109.512 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.781 ' HB3' HD13 ' A' ' 76' ' ' LEU . 69.1 m-80 -150.0 46.31 0.92 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.262 -0.899 . . . . 50.0 108.798 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -55.44 -48.87 73.79 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.54 -0.911 . . . . 50.0 108.54 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.27 -24.91 24.2 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.146 -1.581 . . . . 25.0 109.146 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.781 HD13 ' HB3' ' A' ' 73' ' ' ASN . 7.1 mp -78.81 -44.67 22.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -1.15 . . . . 50.0 109.357 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.572 ' O ' HG12 ' A' ' 80' ' ' VAL . 21.2 mt -60.1 -39.6 86.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.444 -0.785 . . . . 50.0 109.409 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 32.8 mtpt -56.06 -28.23 56.72 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.294 -0.879 . . . . 50.0 109.326 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 52.9 t0 -75.67 -39.19 57.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.381 -0.824 . . . . 50.0 109.775 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -64.85 -37.55 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 50.0 109.378 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -72.78 -4.26 30.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.556 -0.715 . . . . 50.0 109.65 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 14.4 mttm -74.28 -35.13 63.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 50.0 109.255 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.791 HG21 ' OG1' ' A' ' 37' ' ' THR . 35.2 mt -76.75 -32.68 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.309 -0.869 . . . . 50.0 109.453 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.732 ' HE1' HG21 ' A' ' 37' ' ' THR . 5.4 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.975 -1.012 . . . . 99.99 109.454 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -77.18 -13.06 60.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -49.4 139.05 12.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 25.0 109.538 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.19 166.49 28.85 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.296 -0.877 . . . . 50.0 109.468 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 43.2 Cg_endo -66.69 -21.75 51.27 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.526 2.151 . . . . 50.0 110.874 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 5.2 mt-30 -60.17 -41.12 92.15 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.532 -0.73 . . . . 25.0 109.143 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -55.17 -55.73 27.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 50.0 109.463 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -44.68 -35.22 2.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.797 . . . . 50.0 109.599 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 6' ' ' GLN . . . -57.59 -45.28 85.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 16.66 108.963 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 14' ' ' ILE . 63.6 mt-10 -67.52 -42.92 82.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.507 -0.746 . . . . 16.66 109.056 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.587 ' NH2' HG23 ' A' ' 67' ' ' THR . 18.2 mtm180 -65.73 -39.19 90.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.506 -0.746 . . . . 50.0 109.421 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.598 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 77.7 mt-10 -66.76 -41.36 87.88 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.386 -0.821 . . . . 50.0 109.525 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mtp180 -66.9 -40.7 87.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.339 -0.85 . . . . 50.0 109.234 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.5 mt -70.37 -45.11 76.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.358 -0.839 . . . . 50.0 109.029 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -64.98 -35.8 82.34 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.227 -0.92 . . . . 16.66 109.112 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -65.99 -30.37 70.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 50.0 109.268 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 59.1 mtt85 -71.36 -35.08 71.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -0.912 . . . . 50.0 108.974 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.004 ' HB3' HD13 ' A' ' 26' ' ' ILE . 35.8 m-85 -67.56 -49.77 61.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 16.66 109.299 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.463 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 21.5 t0 -56.02 103.11 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.87 . . . . 16.66 108.804 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.05 -51.07 59.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.951 . . . . 50.0 111.028 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -87.78 -31.17 19.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.756 -1.215 . . . . 16.66 109.633 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.463 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 94.7 34.92 6.06 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.795 -1.193 . . . . 16.66 110.385 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.502 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 41.3 p-10 -89.85 5.5 45.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.003 -1.292 . . . . 16.66 109.258 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.85 -4.91 79.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.282 -1.127 . . . . 16.66 110.282 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HB2' ' CB ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -131.08 142.51 50.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.921 -1.341 . . . . 50.0 109.931 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.004 HD13 ' HB3' ' A' ' 18' ' ' PHE . 7.5 mt -111.34 134.56 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.523 -0.735 . . . . 16.66 109.497 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.435 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 11.5 p -107.67 166.71 10.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.725 -0.842 . . . . 50.0 108.725 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.93 -45.56 51.27 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.048 -1.032 . . . . 50.0 108.799 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.29 76.33 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.205 -0.934 . . . . 50.0 109.493 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.1 mt-10 -75.9 -54.48 6.83 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.152 -0.968 . . . . 16.66 109.354 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.684 ' HG ' HD12 ' A' ' 35' ' ' LEU . 9.6 tp -62.15 -42.44 99.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 16.66 108.817 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -64.2 -45.89 92.41 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.841 -1.704 . . . . 16.66 108.841 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.88 -44.27 78.0 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.394 -1.063 . . . . 50.0 109.375 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.11 -39.9 63.06 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.112 -1.07 . . . . 50.0 108.112 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.002 HD13 HG22 ' A' ' 46' ' ' VAL . 6.5 mt -59.55 -29.86 68.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.527 -0.733 . . . . 99.99 109.548 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -45.25 -24.4 0.27 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 99.99 109.652 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.633 HG21 HG21 ' A' ' 83' ' ' ILE . 9.3 t -51.69 -24.39 5.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.215 -0.928 . . . . 99.99 109.204 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.49 HD11 ' CD2' ' A' ' 35' ' ' LEU . 6.4 mt -62.57 -45.88 90.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.39 -0.819 . . . . 50.0 109.266 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.06 -34.53 3.74 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.746 -1.342 . . . . 16.66 109.746 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.7 p -116.79 52.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -1.188 . . . . 16.66 109.598 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 41' ' ' ILE . 7.4 tp -126.68 164.31 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 50.0 109.501 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.69 163.47 23.95 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.523 -0.917 . . . . 16.66 108.523 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.0 -34.13 23.98 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.941 1.761 . . . . 50.0 110.181 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.28 -20.19 63.91 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.658 -0.651 . . . . 50.0 110.399 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -83.08 -40.64 19.58 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.729 -1.232 . . . . 16.66 108.562 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.002 HG22 HD13 ' A' ' 35' ' ' LEU . 41.8 t -65.2 -36.98 79.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.764 -0.828 . . . . 50.0 108.764 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -68.31 -39.7 81.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.793 -0.817 . . . . 50.0 108.793 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.499 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.2 t60 -66.13 -40.23 90.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.423 -0.798 . . . . 50.0 109.056 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.447 ' CE ' HD11 ' A' ' 35' ' ' LEU . 15.5 mtm -59.44 -44.74 92.86 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.265 -0.897 . . . . 16.66 108.877 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 28' ' ' ALA . 31.1 mtp -62.51 -47.37 84.25 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.585 -0.697 . . . . 50.0 109.197 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.25 -20.1 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 50.0 108.915 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.27 -35.55 11.76 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.986 -0.746 . . . . 16.66 108.986 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.588 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.4 mt -81.89 -31.05 10.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.53 -0.731 . . . . 50.0 109.501 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 50' ' ' MET . 17.3 t0 -61.93 101.09 0.18 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.442 -0.786 . . . . 16.66 109.172 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 28.3 p -68.46 -43.42 77.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 50.0 110.426 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.1 p-10 -89.85 -46.86 8.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 16.66 109.821 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 108.81 31.71 3.31 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.935 -1.266 . . . . 16.66 109.935 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.478 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.7 p-10 -82.69 -5.24 58.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.027 -1.278 . . . . 50.0 109.057 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 100.08 -0.3 56.13 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.724 -1.35 . . . . 16.66 109.724 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.529 ' CB ' ' HB2' ' A' ' 25' ' ' LYS . 41.3 m-85 -139.28 156.07 47.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.996 -1.297 . . . . 50.0 111.482 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.55 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 31.4 mm -109.08 129.23 64.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.147 -1.057 . . . . 16.66 108.147 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.1 167.32 10.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.991 -1.068 . . . . 16.66 108.72 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 37.9 t80 -53.35 -42.67 67.05 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.077 -1.049 . . . . 16.66 108.473 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -59.42 -50.66 73.08 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.107 -0.701 . . . . 50.0 109.107 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 80.2 mt-10 -60.28 -46.38 90.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.354 -0.841 . . . . 16.66 109.023 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.545 ' CE2' HD11 ' A' ' 77' ' ' LEU . 80.3 t80 -64.66 -35.77 82.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 16.66 109.479 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.587 HG23 ' NH2' ' A' ' 11' ' ' ARG . 21.0 m -67.51 -48.95 65.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.394 -0.816 . . . . 50.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.424 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 77.1 m-20 -62.02 -36.07 80.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -0.901 . . . . 50.0 109.339 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.588 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -74.61 -39.57 62.08 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.669 -0.863 . . . . 50.0 108.669 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.476 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -59.33 -29.05 65.44 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.423 -1.471 . . . . 16.66 109.423 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 67' ' ' THR . 62.6 mtm180 -71.83 -32.28 67.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -1.115 . . . . 50.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.38 -21.08 62.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.34 -0.85 . . . . 50.0 109.343 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.882 ' CB ' HD12 ' A' ' 76' ' ' LEU . 31.8 m-80 -140.92 61.02 1.51 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.406 -0.809 . . . . 50.0 109.131 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -52.64 -42.88 65.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.67 -0.863 . . . . 50.0 108.67 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.19 -22.58 29.83 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.352 -1.499 . . . . 25.0 109.352 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.882 HD12 ' CB ' ' A' ' 73' ' ' ASN . 47.2 mt -79.97 -43.56 21.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -1.124 . . . . 50.0 109.336 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 1.1 mm? -61.19 -36.98 81.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.455 -0.778 . . . . 50.0 109.578 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.6 mtmm -73.81 -28.14 61.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.258 -0.901 . . . . 50.0 109.026 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -80.21 -45.3 18.26 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.37 -0.831 . . . . 50.0 109.105 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 76' ' ' LEU . 46.5 t -68.56 -41.32 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 50.0 109.376 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.4 -46.91 63.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 50.0 109.425 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 22.7 mttm -59.64 -29.25 67.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.345 -0.847 . . . . 50.0 109.34 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 37' ' ' THR . 59.5 mt -66.73 -35.97 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 50.0 109.394 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 12.5 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.962 -1.018 . . . . 99.99 109.503 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.48 -28.91 68.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -76.06 137.81 40.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 25.0 109.58 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -119.29 169.46 8.15 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 50.0 109.57 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 45.8 Cg_endo -68.54 -22.45 38.39 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.56 2.174 . . . . 50.0 110.833 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 16.3 mt-30 -61.29 -37.45 83.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.145 -0.687 . . . . 25.0 109.145 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -52.97 -52.38 58.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.401 -0.812 . . . . 50.0 109.369 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -49.15 -35.78 17.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 50.0 109.293 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 6' ' ' GLN . . . -53.44 -43.11 67.78 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.572 -0.899 . . . . 16.66 108.572 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.4 mt-10 -68.51 -39.8 81.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.012 -0.736 . . . . 16.66 109.012 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.5 mtt-85 -67.33 -41.24 85.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.452 -0.78 . . . . 50.0 109.38 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.608 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 60.8 mt-10 -65.07 -39.91 93.91 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.567 -0.708 . . . . 50.0 109.311 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 24.3 mtp180 -67.63 -40.37 84.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.451 -0.781 . . . . 50.0 109.187 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 10' ' ' GLU . 24.6 mt -70.54 -45.62 73.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.365 -0.834 . . . . 50.0 109.015 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -64.87 -35.97 82.85 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.295 -0.878 . . . . 16.66 108.975 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 46.1 mttt -65.81 -30.3 70.91 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.324 -0.86 . . . . 50.0 108.983 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 32.7 mtt180 -70.06 -36.09 74.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.831 . . . . 50.0 108.903 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.916 ' HB3' HD13 ' A' ' 26' ' ' ILE . 48.3 m-85 -70.38 -51.41 29.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.438 -0.789 . . . . 16.66 109.487 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.8 t0 -56.12 103.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 16.66 108.747 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.42 -52.07 50.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 50.0 111.278 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -87.34 -23.46 24.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.725 -1.235 . . . . 16.66 109.722 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 83.95 41.59 8.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.084 -1.206 . . . . 16.66 110.084 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.506 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.5 p-10 -96.17 5.38 51.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.129 -1.218 . . . . 16.66 109.122 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.06 -9.68 70.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.569 -1.012 . . . . 16.66 110.569 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.588 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.1 pttm -129.65 142.01 50.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.853 -1.381 . . . . 50.0 110.162 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.916 HD13 ' HB3' ' A' ' 18' ' ' PHE . 9.7 mt -112.78 133.6 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.736 -0.602 . . . . 16.66 109.457 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.408 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 23.3 p -106.12 168.95 8.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.332 -0.855 . . . . 50.0 108.912 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.488 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.27 -46.56 55.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.076 -1.015 . . . . 50.0 109.047 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.5 74.34 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.274 -0.891 . . . . 50.0 109.543 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.2 mt-10 -75.96 -54.03 7.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.137 -0.977 . . . . 16.66 109.269 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.605 ' O ' HD23 ' A' ' 31' ' ' LEU . 6.9 tt -61.44 -44.84 96.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.253 -0.904 . . . . 16.66 108.969 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.676 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -61.87 -43.79 98.72 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.113 -1.595 . . . . 16.66 109.113 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -56.3 -44.19 79.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -1.096 . . . . 50.0 109.766 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.15 75.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.173 -0.954 . . . . 50.0 108.572 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.986 ' CD1' HG22 ' A' ' 46' ' ' VAL . 9.6 mt -59.02 -35.06 72.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.505 -0.747 . . . . 99.99 109.929 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.6 mttm -43.86 -27.41 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.135 -0.978 . . . . 99.99 109.535 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.699 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.3 t -53.68 -26.51 23.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 99.99 109.407 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.5 mt -63.94 -33.76 76.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 50.0 109.32 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.43 6.84 50.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.573 -1.411 . . . . 16.66 109.573 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.8 t -154.3 50.77 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.045 -1.268 . . . . 16.66 109.653 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 tp -136.49 154.12 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 50.0 109.243 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.43 165.83 12.86 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 16.66 108.697 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.19 -32.64 20.51 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.058 1.838 . . . . 50.0 109.989 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -62.68 -27.74 69.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.661 -0.649 . . . . 50.0 110.052 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -80.75 -36.56 31.81 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.973 -1.079 . . . . 16.66 108.36 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.986 HG22 ' CD1' ' A' ' 35' ' ' LEU . 74.8 t -64.33 -38.6 82.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.689 -0.856 . . . . 50.0 108.689 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -72.44 -36.75 68.63 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.41 -0.959 . . . . 50.0 108.41 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.471 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 4.0 t60 -67.71 -37.18 81.9 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.939 -0.763 . . . . 50.0 108.939 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.416 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.7 mtt -60.29 -48.23 82.64 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.228 -0.92 . . . . 16.66 108.58 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.518 ' HE1' ' HA ' ' A' ' 60' ' ' PHE . 42.2 mtp -61.61 -48.29 81.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.922 -0.77 . . . . 50.0 108.922 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.72 -19.73 18.24 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.445 -0.784 . . . . 50.0 109.193 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.409 ' OE2' ' NE2' ' A' ' 48' ' ' HIS . 37.6 mt-10 -100.46 -37.03 9.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.89 . . . . 16.66 109.317 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.536 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.8 mt -80.29 -34.02 14.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.392 -0.818 . . . . 50.0 109.563 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.0 t0 -58.77 101.52 0.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.455 -0.778 . . . . 16.66 109.005 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 71.1 p -70.02 -47.67 61.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.829 . . . . 50.0 110.922 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.481 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.6 p-10 -86.95 -37.42 17.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.134 -0.979 . . . . 16.66 109.544 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.56 27.97 7.32 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.834 -1.174 . . . . 16.66 110.771 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.481 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 15.6 p-10 -79.58 -2.1 40.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.811 -1.405 . . . . 50.0 109.11 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.46 -6.26 59.16 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.981 -1.248 . . . . 16.66 109.981 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.588 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 28.4 m-85 -133.84 156.16 48.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.003 -1.293 . . . . 50.0 111.373 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.554 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 27.3 mm -107.99 129.97 61.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.217 -1.031 . . . . 16.66 108.217 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.8 m -96.93 167.13 11.27 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.051 -1.03 . . . . 16.66 108.636 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.608 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 36.2 t80 -54.4 -42.29 70.25 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.077 -1.014 . . . . 16.66 108.523 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -61.21 -47.94 83.79 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.515 -0.741 . . . . 50.0 109.286 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 68.1 mt-10 -60.68 -46.85 88.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.254 -0.904 . . . . 16.66 108.943 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.45 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 57.3 t80 -59.54 -40.88 88.69 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.491 -0.755 . . . . 16.66 109.147 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.7 m -64.17 -46.51 83.68 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.468 -0.77 . . . . 50.0 109.159 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.59 -39.63 80.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 50.0 109.344 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -79.95 -36.37 36.32 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.486 -0.931 . . . . 50.0 108.486 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.655 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.4 -31.55 74.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.083 -1.607 . . . . 16.66 109.083 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' THR . 64.4 mtm180 -70.34 -35.23 73.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.416 -1.049 . . . . 50.0 109.057 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.68 -2.55 50.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.394 -0.816 . . . . 50.0 109.455 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.775 ' HB3' HD22 ' A' ' 76' ' ' LEU . 69.4 m-80 -149.22 46.88 0.98 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.235 -0.916 . . . . 50.0 108.873 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -56.31 -48.51 76.54 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.521 -0.918 . . . . 50.0 108.521 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.24 -24.6 29.91 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.057 -1.617 . . . . 25.0 109.057 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.775 HD22 ' HB3' ' A' ' 73' ' ' ASN . 6.5 mp -79.7 -45.12 19.56 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.335 -1.097 . . . . 50.0 109.326 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.655 HD11 ' HA3' ' A' ' 70' ' ' GLY . 20.9 mt -62.67 -36.61 83.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.804 . . . . 50.0 109.845 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -67.13 -21.23 65.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 50.0 109.607 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.97 -34.55 29.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 50.0 109.476 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.478 ' HA ' HG13 ' A' ' 83' ' ' ILE . 25.1 t -78.39 -33.13 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 50.0 109.743 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.41 -46.46 62.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 50.0 110.128 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -63.91 -24.55 67.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 50.0 109.576 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.699 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.5 mt -66.31 -47.55 83.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.343 -0.848 . . . . 50.0 109.673 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.017 -0.992 . . . . 99.99 109.446 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 57.1 p-10 -87.74 14.87 7.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -69.35 146.88 51.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.246 -0.909 . . . . 25.0 109.597 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.613 ' CG ' ' HD2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -110.54 153.09 43.69 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.285 -0.885 . . . . 50.0 108.846 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HD2' ' CG ' ' A' ' 4' ' ' HIS . 40.1 Cg_endo -64.23 -19.65 66.09 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.089 1.859 . . . . 50.0 110.364 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -59.71 -39.04 83.29 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.099 -0.704 . . . . 25.0 109.099 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.32 -42.04 94.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.463 -0.773 . . . . 50.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -52.6 -37.4 58.12 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.383 -0.823 . . . . 50.0 109.274 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.12 -45.13 87.82 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.32 -0.863 . . . . 16.66 108.701 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.4 mt-10 -66.61 -45.81 77.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.818 -0.808 . . . . 16.66 108.818 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.467 ' NH2' ' CG ' ' A' ' 71' ' ' ARG . 13.7 mtt-85 -64.13 -39.37 93.89 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.447 -0.783 . . . . 50.0 109.336 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.601 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 15.9 mt-10 -65.76 -41.16 92.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.555 -0.716 . . . . 50.0 109.104 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 14.7 mtp180 -67.33 -40.55 85.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 50.0 109.014 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 10' ' ' GLU . 29.1 mt -70.12 -45.94 74.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.454 -0.779 . . . . 50.0 108.942 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -66.05 -35.99 82.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.376 -0.827 . . . . 16.66 109.119 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 21.8 mttt -64.48 -31.28 72.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 50.0 109.19 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 40.7 mtt180 -73.29 -33.15 65.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 50.0 109.222 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.993 ' HB3' HD13 ' A' ' 26' ' ' ILE . 37.5 m-85 -71.37 -45.11 63.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 16.66 109.29 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.8 t0 -63.09 103.16 0.44 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.252 -0.905 . . . . 16.66 108.798 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -52.05 60.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.227 -0.921 . . . . 50.0 111.247 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -88.1 -22.44 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.737 -1.227 . . . . 16.66 109.577 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.461 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 82.8 42.76 8.06 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.236 -1.146 . . . . 16.66 110.236 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.513 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.4 p-10 -97.63 5.93 48.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.126 -1.22 . . . . 16.66 109.269 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 62' ' ' SER . . . 94.87 -10.11 70.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.517 -1.033 . . . . 16.66 110.517 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 14.2 pttp -128.62 141.38 51.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.825 -1.397 . . . . 50.0 110.031 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.993 HD13 ' HB3' ' A' ' 18' ' ' PHE . 4.9 mt -113.53 134.55 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.662 -0.649 . . . . 16.66 109.365 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.441 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 26.6 p -108.03 169.65 8.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.395 -0.816 . . . . 50.0 108.895 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.7 -47.77 58.89 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.113 -0.992 . . . . 50.0 109.023 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.36 68.99 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.372 -0.83 . . . . 50.0 109.683 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 55.2 mt-10 -79.07 -53.44 7.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 16.66 109.298 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 31' ' ' LEU . 4.6 tt -62.1 -42.28 99.06 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.291 -0.881 . . . . 16.66 108.83 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.91 -45.7 93.44 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.023 -1.631 . . . . 16.66 109.023 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -56.03 -43.06 77.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -1.1 . . . . 50.0 109.395 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.66 -39.9 66.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.292 -1.003 . . . . 50.0 108.292 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.902 ' CD1' HG22 ' A' ' 46' ' ' VAL . 2.2 mt -59.15 -33.53 71.0 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.605 -0.684 . . . . 99.99 109.625 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -44.16 -26.43 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.1 -1.0 . . . . 99.99 109.551 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.74 ' CG2' HG21 ' A' ' 83' ' ' ILE . 8.0 t -48.87 -24.39 1.44 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.217 -0.927 . . . . 99.99 109.064 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.79 HD12 HD12 ' A' ' 41' ' ' ILE . 21.1 mt -66.63 -31.2 71.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.477 -0.764 . . . . 50.0 109.163 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.51 9.37 43.66 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.436 -1.466 . . . . 16.66 109.436 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' A' ' 40' ' ' SER . 9.7 t -156.07 49.15 0.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -1.143 . . . . 16.66 109.587 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.79 HD12 HD12 ' A' ' 38' ' ' LEU . 12.4 tt -137.32 169.41 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.257 -0.902 . . . . 50.0 109.475 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.95 166.66 16.98 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.92 . . . . 16.66 109.051 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.69 -32.65 18.41 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.175 1.916 . . . . 50.0 110.189 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -61.63 -29.05 69.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.648 -0.658 . . . . 50.0 110.016 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -81.43 -36.89 28.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.926 -1.109 . . . . 16.66 108.193 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.902 HG22 ' CD1' ' A' ' 35' ' ' LEU . 55.9 t -65.21 -34.7 72.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.968 -0.753 . . . . 50.0 108.968 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -69.45 -38.39 77.77 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.908 -0.775 . . . . 50.0 108.908 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -68.49 -38.5 81.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.462 -0.774 . . . . 50.0 108.933 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 mtt -62.25 -47.79 82.81 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.306 -0.871 . . . . 16.66 108.792 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.693 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 27.2 mtp -61.62 -46.55 89.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.449 -0.782 . . . . 50.0 109.159 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.24 -19.65 55.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 50.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.61 -35.63 12.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.355 -0.841 . . . . 16.66 108.879 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.631 HG22 HD12 ' A' ' 61' ' ' ILE . 81.8 mt -82.42 -30.92 9.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.561 -0.712 . . . . 50.0 109.669 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.6 t0 -59.67 101.35 0.11 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.38 -0.825 . . . . 16.66 109.064 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 71.0 p -72.82 -47.18 48.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -0.89 . . . . 50.0 110.543 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -29.97 24.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.181 -0.949 . . . . 16.66 109.514 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.484 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 92.02 28.19 14.28 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.893 -1.146 . . . . 16.66 110.35 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.14 -3.22 57.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.963 -1.316 . . . . 50.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.693 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.52 -7.29 59.6 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.962 -1.113 . . . . 16.66 110.526 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.573 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.6 m-85 -133.02 155.25 49.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.002 -1.293 . . . . 50.0 111.025 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.631 HD12 HG22 ' A' ' 53' ' ' ILE . 34.0 mm -106.24 128.09 60.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.333 -0.988 . . . . 16.66 108.333 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 18.0 m -94.16 166.11 12.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.235 -0.916 . . . . 16.66 108.602 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 34.5 t80 -54.48 -42.37 70.63 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.071 -1.018 . . . . 16.66 108.558 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -61.11 -49.47 77.14 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.098 -0.704 . . . . 50.0 109.098 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.539 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 28.8 mt-10 -58.1 -47.27 83.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 16.66 109.09 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.799 ' CE2' HD11 ' A' ' 77' ' ' LEU . 61.3 t80 -62.08 -40.47 95.94 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.531 -0.731 . . . . 16.66 109.305 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 16.3 m -64.33 -47.32 79.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.353 -0.842 . . . . 50.0 109.099 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.489 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 87.8 m-20 -59.31 -37.77 78.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 50.0 109.424 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.569 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.51 -36.76 57.58 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.529 -0.915 . . . . 50.0 108.529 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.13 -30.84 64.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.303 -1.519 . . . . 16.66 109.303 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 68' ' ' ASP . 72.3 mtm180 -69.26 -30.43 68.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -1.108 . . . . 50.0 109.071 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.22 -21.7 64.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -0.809 . . . . 50.0 109.286 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.898 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.1 m-80 -149.97 60.12 0.99 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.354 -0.841 . . . . 50.0 108.957 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -50.68 -38.61 47.68 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.737 -0.838 . . . . 50.0 108.737 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.24 -32.29 67.42 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.251 -1.54 . . . . 25.0 109.251 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.898 HD12 ' CB ' ' A' ' 73' ' ' ASN . 28.2 mt -64.46 -43.8 93.1 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.316 -1.108 . . . . 50.0 109.366 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.799 HD11 ' CE2' ' A' ' 66' ' ' PHE . 1.9 mm? -61.41 -41.91 97.9 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.426 -0.796 . . . . 50.0 109.679 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 19.2 mtmm -65.13 -27.66 68.89 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.263 -0.898 . . . . 50.0 109.512 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.66 -50.29 7.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.92 . . . . 50.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.6 p -64.33 -44.5 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.468 -0.77 . . . . 50.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.542 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -48.82 -40.48 29.44 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.54 -0.725 . . . . 50.0 109.385 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 27.2 mttp -65.47 -26.47 67.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 50.0 109.563 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.74 HG21 ' CG2' ' A' ' 37' ' ' THR . 35.0 mt -62.22 -32.7 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 50.0 109.423 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 5.1 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.001 -0.999 . . . . 99.99 109.488 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.354 0.597 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -76.34 -26.93 56.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 0.0 109.635 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -80.24 118.15 21.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 25.0 109.583 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.493 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -108.77 170.73 5.13 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.268 -0.895 . . . . 50.0 109.391 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 45.5 Cg_endo -67.7 -23.55 42.18 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.59 2.193 . . . . 50.0 111.263 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -63.18 -41.17 99.17 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.362 -0.836 . . . . 25.0 109.162 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -57.39 -43.03 83.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 50.0 109.341 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -51.52 -36.54 45.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 50.0 109.455 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.88 -46.17 88.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.277 -0.89 . . . . 16.66 108.665 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 14' ' ' ILE . 67.9 mm-40 -66.5 -43.95 83.9 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.389 -0.819 . . . . 16.66 108.867 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.405 ' HA ' HD12 ' A' ' 14' ' ' ILE . 30.4 mtt-85 -64.5 -39.52 93.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.413 -0.804 . . . . 50.0 109.493 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 13.8 mt-10 -64.06 -40.0 95.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 50.0 109.416 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 21.1 mtp-105 -70.06 -38.22 75.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 50.0 109.034 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.5 mt -71.54 -44.91 70.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.371 -0.831 . . . . 50.0 108.888 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.533 ' CE1' HD11 ' A' ' 26' ' ' ILE . 69.6 t80 -69.23 -36.19 76.93 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.231 -0.918 . . . . 16.66 109.159 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 37.4 mttt -64.99 -30.53 71.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 50.0 109.027 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 65.8 mmt-85 -70.65 -39.14 73.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.365 -0.834 . . . . 50.0 109.005 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.902 ' HB3' HD13 ' A' ' 26' ' ' ILE . 43.6 m-85 -66.21 -47.73 72.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.832 . . . . 16.66 109.344 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 20.4 t0 -60.08 103.15 0.2 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 16.66 108.73 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 -50.6 40.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 50.0 111.092 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -87.3 -30.54 20.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.808 -1.182 . . . . 16.66 109.671 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.27 33.41 7.24 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.069 -1.213 . . . . 16.66 110.069 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.499 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 34.8 p-10 -86.76 5.42 36.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.266 . . . . 16.66 109.115 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.95 -3.93 77.79 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.374 -1.09 . . . . 16.66 110.374 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 3.7 pttm -133.67 143.99 48.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.948 -1.325 . . . . 50.0 110.244 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.902 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.3 mt -110.43 132.67 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.459 0.647 . . . . 16.66 109.752 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.448 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 13.0 p -106.56 166.48 10.53 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.917 -0.772 . . . . 50.0 108.917 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.08 -44.98 52.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.124 -0.985 . . . . 50.0 109.032 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -57.19 -39.9 76.31 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.358 -0.838 . . . . 50.0 109.541 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.5 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 60.5 mt-10 -75.7 -54.28 7.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.214 -0.929 . . . . 16.66 109.248 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.761 HD22 HG13 ' A' ' 46' ' ' VAL . 6.3 tt -61.78 -43.66 98.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.13 -0.981 . . . . 16.66 108.853 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.707 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.76 -44.79 95.75 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.009 -1.636 . . . . 16.66 109.009 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 30.1 mt-10 -58.45 -42.23 86.93 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.474 -1.015 . . . . 50.0 109.661 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.55 -39.72 67.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.322 -0.992 . . . . 50.0 108.322 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.922 HD12 HG22 ' A' ' 46' ' ' VAL . 3.3 mt -58.23 -31.82 67.73 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.519 -0.738 . . . . 99.99 109.544 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -45.15 -25.81 0.4 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 99.99 109.479 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.617 HG21 HG21 ' A' ' 83' ' ' ILE . 11.6 t -52.94 -26.29 14.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 99.99 109.374 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 38' ' ' LEU . 26.5 mt -65.35 -29.99 70.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -0.836 . . . . 50.0 109.237 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.66 9.0 42.94 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.734 -1.346 . . . . 16.66 109.734 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.5 49.6 0.54 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.089 -1.242 . . . . 16.66 109.811 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 41' ' ' ILE . 6.9 tp -133.31 165.36 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.251 -0.905 . . . . 50.0 109.344 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.87 164.67 16.83 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.168 -0.957 . . . . 16.66 108.741 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.65 -33.72 21.0 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.062 1.841 . . . . 50.0 110.012 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -64.12 -26.0 68.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.592 -0.692 . . . . 50.0 109.955 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.42 -38.62 26.21 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.821 -1.175 . . . . 16.66 108.401 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.922 HG22 HD12 ' A' ' 35' ' ' LEU . 61.7 t -63.93 -36.53 77.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.765 -0.828 . . . . 50.0 108.765 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -73.04 -37.52 66.85 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.413 -0.958 . . . . 50.0 108.413 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -68.02 -38.58 82.75 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.922 -0.769 . . . . 50.0 108.922 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.2 mtt -60.88 -47.45 86.34 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.241 -0.912 . . . . 16.66 108.635 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.591 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 50.6 mtp -60.93 -46.15 91.85 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.141 -0.688 . . . . 50.0 109.141 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.72 -21.01 53.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 50.0 109.194 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -95.89 -36.48 11.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 16.66 109.126 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.644 HG22 HD12 ' A' ' 61' ' ' ILE . 83.4 mt -80.86 -32.39 12.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.534 -0.729 . . . . 50.0 109.536 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 50' ' ' MET . 22.7 t0 -60.41 100.5 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.354 -0.841 . . . . 16.66 109.053 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.462 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 56.6 p -68.04 -46.44 71.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.307 -0.871 . . . . 50.0 110.616 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 1.7 p-10 -86.37 -37.97 17.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 16.66 109.44 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.36 27.03 7.88 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 120.037 -1.078 . . . . 16.66 110.555 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.499 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 7.9 p-10 -78.41 -1.58 34.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.743 -1.446 . . . . 50.0 109.051 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.591 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.52 -4.82 60.1 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.123 -1.191 . . . . 16.66 110.123 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 24.9 m-85 -135.68 157.55 46.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.033 -1.275 . . . . 50.0 111.482 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.644 HD12 HG22 ' A' ' 53' ' ' ILE . 31.5 mm -109.04 129.65 63.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.504 -0.924 . . . . 16.66 108.504 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.2 m -96.42 170.26 9.35 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.095 -1.003 . . . . 16.66 108.637 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.1 t80 -56.42 -43.97 79.93 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.133 -0.979 . . . . 16.66 108.694 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -60.44 -49.4 77.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.531 -0.731 . . . . 50.0 109.154 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.563 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.9 mt-10 -58.45 -46.07 87.31 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.267 -0.896 . . . . 16.66 109.219 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -63.52 -35.37 80.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 16.66 109.331 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 31.6 m -66.21 -48.41 70.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.444 -0.785 . . . . 50.0 109.279 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.57 -36.26 75.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.356 -0.84 . . . . 50.0 109.394 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -77.95 -37.14 48.22 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.433 -0.951 . . . . 50.0 108.433 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.695 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -56.46 -27.92 54.75 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.994 -1.643 . . . . 16.66 108.994 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 67' ' ' THR . 82.1 mtm180 -71.49 -27.34 63.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -1.135 . . . . 50.0 108.806 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.19 60.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.441 -0.787 . . . . 50.0 109.291 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.89 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.4 m-80 -144.49 59.83 1.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.356 -0.84 . . . . 50.0 109.248 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.602 ' HA ' HD23 ' A' ' 77' ' ' LEU . 97.3 mtt180 -52.57 -21.63 4.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 50.0 109.123 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.8 -26.74 60.03 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.36 -1.496 . . . . 25.0 109.36 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.89 HD12 ' CB ' ' A' ' 73' ' ' ASN . 72.1 mt -73.06 -45.02 59.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -1.099 . . . . 50.0 109.618 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -64.41 -42.94 95.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.376 -0.828 . . . . 50.0 109.806 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.9 mtmt -65.37 -34.12 77.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 50.0 109.484 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -79.32 -46.46 17.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 50.0 109.498 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.8 p -64.18 -43.89 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 50.0 109.192 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.548 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.08 -37.92 35.89 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.733 -0.604 . . . . 50.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 61.2 mttp -70.65 -26.43 63.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 50.0 109.413 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.617 HG21 HG21 ' A' ' 37' ' ' THR . 28.3 mt -62.78 -31.23 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 50.0 109.237 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 5.6 m-85 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.965 -1.017 . . . . 99.99 109.474 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -53.49 -26.58 21.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.513 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 3' ' ' ASP . 48.5 p30 -81.94 164.0 21.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 25.0 109.51 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -104.05 174.08 2.98 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 50.0 109.176 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.5 Cg_endo -69.16 -22.71 34.42 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.468 2.112 . . . . 50.0 111.218 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -62.33 -37.35 85.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -0.782 . . . . 25.0 109.363 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 8' ' ' LYS . 81.3 m-20 -57.32 -55.57 33.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.393 -0.817 . . . . 50.0 109.627 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 16.2 mttt -43.35 -35.91 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.442 -0.786 . . . . 50.0 109.78 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 12' ' ' GLU . . . -60.9 -45.87 92.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 16.66 109.058 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 73.6 mt-10 -70.67 -34.84 72.44 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.383 -0.823 . . . . 16.66 108.822 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.718 ' NH1' HG23 ' A' ' 67' ' ' THR . 70.3 mtm180 -72.31 -40.65 67.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.364 -0.835 . . . . 50.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.568 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 24.6 pt-20 -68.95 -38.34 79.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.291 -0.881 . . . . 50.0 109.184 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.541 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.4 mtp180 -66.8 -41.83 86.95 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.889 . . . . 50.0 109.303 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.481 HG22 ' HE2' ' A' ' 18' ' ' PHE . 27.4 mt -69.97 -46.01 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.278 -0.889 . . . . 50.0 109.032 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -64.62 -35.17 80.13 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.349 -0.844 . . . . 16.66 109.209 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 51.2 mttt -65.78 -31.72 72.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 50.0 109.385 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 65.7 mtt180 -70.68 -36.11 73.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 50.0 109.163 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.951 ' HB3' HD13 ' A' ' 26' ' ' ILE . 43.1 m-85 -66.04 -47.31 74.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.395 -0.816 . . . . 16.66 109.375 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.3 t0 -59.79 103.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.279 -0.888 . . . . 16.66 108.848 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.75 -51.67 53.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.179 -0.951 . . . . 50.0 111.191 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -86.59 -28.39 23.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.718 -1.239 . . . . 16.66 109.672 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 90.53 39.14 6.01 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.89 -1.148 . . . . 16.66 110.373 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.503 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.7 p-10 -95.02 5.63 51.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -1.221 . . . . 16.66 109.291 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.59 -8.1 77.09 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.486 -1.046 . . . . 16.66 110.486 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HE3' ' CE1' ' A' ' 60' ' ' PHE . 14.1 pttt -128.54 141.35 51.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.95 -1.324 . . . . 50.0 109.929 -179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.951 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.6 mt -112.59 133.19 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.655 -0.653 . . . . 16.66 109.528 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 p -103.59 166.18 10.58 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.618 -0.882 . . . . 50.0 108.618 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.18 -44.39 52.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.062 -1.024 . . . . 50.0 108.81 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.54 82.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.354 -0.841 . . . . 50.0 109.419 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.8 mt-10 -74.25 -54.73 7.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -0.932 . . . . 16.66 109.275 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.666 ' HG ' HD12 ' A' ' 35' ' ' LEU . 40.1 tp -61.92 -43.63 98.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.181 -0.95 . . . . 16.66 108.929 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.48 -43.82 98.48 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.084 -1.606 . . . . 16.66 109.084 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -56.49 -44.0 80.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.285 -1.127 . . . . 50.0 109.531 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.72 -39.4 66.96 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.364 -0.976 . . . . 50.0 108.364 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.115 HD13 HG22 ' A' ' 46' ' ' VAL . 6.9 mt -59.66 -32.61 70.62 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.532 -0.73 . . . . 99.99 109.522 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.6 -24.4 0.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 99.99 109.532 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.7 t -52.93 -23.78 7.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.183 -0.948 . . . . 99.99 109.151 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.832 HD12 HD12 ' A' ' 41' ' ' ILE . 25.5 mt -62.77 -31.81 72.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.42 -0.8 . . . . 50.0 109.343 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.69 6.58 51.17 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 16.66 109.564 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.24 55.15 0.64 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.183 -1.186 . . . . 16.66 109.521 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.832 HD12 HD12 ' A' ' 38' ' ' LEU . 12.0 tt -140.53 171.33 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 50.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.52 165.2 27.9 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.714 -0.847 . . . . 16.66 108.714 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.82 -33.47 20.54 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.052 1.834 . . . . 50.0 110.232 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -64.97 -25.3 67.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.708 -0.62 . . . . 50.0 110.149 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.441 ' OE1' HG13 ' A' ' 41' ' ' ILE . 94.0 mt-10 -82.59 -38.61 23.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.888 -1.132 . . . . 16.66 108.344 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.115 HG22 HD13 ' A' ' 35' ' ' LEU . 41.4 t -65.76 -36.12 76.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.824 -0.806 . . . . 50.0 108.824 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -66.24 -39.14 89.31 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.973 -0.751 . . . . 50.0 108.973 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.536 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 3.4 t60 -66.92 -41.24 87.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.412 -0.805 . . . . 50.0 109.135 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.492 ' HE3' HD11 ' A' ' 35' ' ' LEU . 48.0 mtm -60.17 -44.92 94.65 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.241 -0.912 . . . . 16.66 108.923 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.529 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 20.1 mtp -61.98 -47.17 86.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.528 -0.733 . . . . 50.0 109.231 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.33 -19.13 54.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 50.0 109.068 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.536 ' CD ' ' HE2' ' A' ' 48' ' ' HIS . 35.8 mt-10 -95.92 -36.72 10.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 16.66 108.975 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.59 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.7 mt -81.33 -32.41 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.476 -0.765 . . . . 50.0 109.482 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.9 t0 -60.66 100.49 0.11 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.399 -0.813 . . . . 16.66 108.905 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.444 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 71.0 p -66.81 -46.89 73.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.324 -0.86 . . . . 50.0 110.771 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.9 p-10 -87.94 -40.81 13.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.178 -0.951 . . . . 16.66 109.559 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.474 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 103.32 28.99 5.86 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.919 -1.134 . . . . 16.66 110.314 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.478 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.6 p-10 -79.8 -2.79 44.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.862 -1.375 . . . . 50.0 109.135 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.529 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.7 -3.96 57.73 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.783 -1.327 . . . . 16.66 109.783 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CE1' ' HE3' ' A' ' 25' ' ' LYS . 32.4 m-85 -135.91 156.1 49.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.077 -1.249 . . . . 50.0 111.279 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.551 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 29.4 mm -108.89 130.99 60.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.463 -0.94 . . . . 16.66 108.463 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 m -99.58 168.02 10.22 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.988 -1.07 . . . . 16.66 108.775 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.568 ' CE1' ' HA ' ' A' ' 12' ' ' GLU . 36.1 t80 -54.88 -43.73 73.44 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.247 -0.981 . . . . 16.66 108.673 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -59.83 -49.81 76.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.568 -0.707 . . . . 50.0 109.115 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.5 mt-10 -58.81 -47.29 85.31 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.271 -0.893 . . . . 16.66 108.974 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.666 ' HZ ' HD12 ' A' ' 77' ' ' LEU . 58.7 t80 -63.07 -33.21 74.95 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.401 -0.812 . . . . 16.66 109.241 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.718 HG23 ' NH1' ' A' ' 11' ' ' ARG . 79.7 m -67.24 -49.17 65.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 50.0 109.107 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' OD1' ' NH2' ' A' ' 71' ' ' ARG . 59.4 m-20 -59.26 -36.95 76.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 50.0 109.291 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.59 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -79.46 -37.79 36.11 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.414 -0.958 . . . . 50.0 108.414 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.731 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -60.38 -32.51 77.52 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.096 -1.602 . . . . 16.66 109.096 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 67' ' ' THR . 65.6 mtm180 -66.16 -36.93 84.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -1.106 . . . . 50.0 108.917 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.04 -19.65 65.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.482 -0.761 . . . . 50.0 109.154 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.771 ' CB ' HD12 ' A' ' 76' ' ' LEU . 3.3 m-80 -145.81 55.23 1.18 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 50.0 109.231 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.57 ' HA ' HD23 ' A' ' 77' ' ' LEU . 8.5 ptp85 -49.87 -35.36 23.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -0.848 . . . . 50.0 108.721 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.435 ' HA2' ' HE2' ' A' ' 78' ' ' LYS . . . -65.92 -27.34 72.71 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.492 -1.443 . . . . 25.0 109.492 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.771 HD12 ' CB ' ' A' ' 73' ' ' ASN . 14.9 mt -67.92 -46.86 70.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.109 . . . . 50.0 109.507 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.837 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -62.9 -42.72 99.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.354 -0.841 . . . . 50.0 109.681 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HE2' ' HA2' ' A' ' 75' ' ' GLY . 32.3 mtmt -61.88 -31.83 72.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 50.0 109.39 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.44 ' O ' HG13 ' A' ' 83' ' ' ILE . 29.7 t0 -76.05 -37.82 57.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.306 -0.871 . . . . 50.0 109.385 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 76' ' ' LEU . 46.0 t -73.3 -39.1 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 50.0 109.401 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.81 -44.26 59.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.403 -0.81 . . . . 50.0 109.891 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -65.6 -26.73 67.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 50.0 109.463 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.452 HG13 ' HA ' ' A' ' 80' ' ' VAL . 7.9 mt -65.39 -48.2 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.831 . . . . 50.0 109.633 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.015 -0.993 . . . . 99.99 109.42 179.942 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 56.0 p-10 -85.14 12.92 6.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -74.78 130.96 40.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 25.0 109.404 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.616 ' CG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -110.13 152.83 43.37 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.224 -0.923 . . . . 50.0 108.93 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.616 ' HD2' ' CG ' ' A' ' 4' ' ' HIS . 39.9 Cg_endo -64.59 -19.86 65.18 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 122.162 1.908 . . . . 50.0 110.224 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -59.59 -38.76 82.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.079 -0.712 . . . . 25.0 109.079 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -59.12 -52.47 65.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.477 -0.765 . . . . 50.0 109.573 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.503 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 39.5 mttp -45.92 -36.31 5.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 50.0 109.326 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.19 91.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.411 -0.806 . . . . 16.66 108.877 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 14' ' ' ILE . 65.5 mt-10 -68.97 -37.02 78.54 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.963 -0.754 . . . . 16.66 108.963 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.538 ' NH2' HG23 ' A' ' 67' ' ' THR . 12.6 mtm180 -70.37 -40.76 73.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.366 -0.834 . . . . 50.0 109.238 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.628 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 38.9 mt-10 -66.65 -41.05 88.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.458 -0.776 . . . . 50.0 109.268 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 13.7 mtp180 -65.37 -41.62 93.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.29 -0.881 . . . . 50.0 109.328 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 81' ' ' ALA . 22.9 mt -69.59 -45.98 76.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.267 -0.896 . . . . 50.0 109.074 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -66.06 -35.79 81.47 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.242 -0.911 . . . . 16.66 109.333 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -65.6 -33.39 75.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.211 -0.931 . . . . 50.0 109.325 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HD3' ' HB3' ' A' ' 84' ' ' PHE . 53.6 mtt85 -69.94 -34.53 73.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 50.0 109.238 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.005 ' HB3' HD13 ' A' ' 26' ' ' ILE . 34.1 m-85 -69.85 -47.54 62.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 16.66 109.538 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 25.6 t0 -58.65 103.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 16.66 108.747 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.14 -52.19 50.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.223 -0.923 . . . . 50.0 111.275 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -87.34 -22.02 25.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.747 -1.221 . . . . 16.66 109.483 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 82.53 43.92 7.63 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.271 -1.132 . . . . 16.66 110.271 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.509 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.2 p-10 -99.61 7.0 45.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.082 -1.246 . . . . 16.66 109.236 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.04 -10.88 71.52 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.545 -1.022 . . . . 16.66 110.545 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.6 pttp -127.47 140.77 51.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.866 -1.373 . . . . 50.0 109.975 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.005 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.4 mt -113.24 134.1 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.6 -0.688 . . . . 16.66 109.395 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.422 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 21.2 p -105.75 168.23 9.24 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.6 -0.889 . . . . 50.0 108.6 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.498 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.34 -46.23 55.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.973 -1.079 . . . . 50.0 108.969 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.38 -38.98 75.1 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.297 -0.877 . . . . 50.0 109.584 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 56.5 mt-10 -75.58 -53.9 7.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.175 -0.953 . . . . 16.66 109.437 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.731 HD12 ' CD1' ' A' ' 18' ' ' PHE . 9.6 tp -62.51 -42.12 99.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 16.66 108.941 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.479 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -62.88 -44.37 97.54 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.079 -1.608 . . . . 16.66 109.079 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -56.86 -44.23 81.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -1.064 . . . . 50.0 109.673 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.49 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.39 -39.36 68.05 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.435 -0.95 . . . . 50.0 108.435 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.99 HD12 HG22 ' A' ' 46' ' ' VAL . 11.4 mt -58.65 -33.62 70.29 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.548 -0.72 . . . . 99.99 109.46 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -45.18 -25.72 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 99.99 109.474 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.457 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.7 t -52.27 -25.32 9.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.898 . . . . 99.99 109.305 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.715 HD12 HD12 ' A' ' 41' ' ' ILE . 39.7 mt -62.17 -31.86 72.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.398 -0.814 . . . . 50.0 109.157 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.56 6.84 51.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.605 -1.398 . . . . 16.66 109.605 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.99 56.41 0.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.164 -1.198 . . . . 16.66 109.6 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.715 HD12 HD12 ' A' ' 38' ' ' LEU . 11.6 tt -141.5 172.35 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.971 . . . . 50.0 109.635 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.92 166.24 21.36 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.344 -0.847 . . . . 16.66 108.754 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.79 -33.66 16.03 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.02 1.813 . . . . 50.0 109.952 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.38 -25.97 68.53 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.61 -0.681 . . . . 50.0 109.969 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -80.88 -37.48 29.73 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.876 -1.14 . . . . 16.66 108.329 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.99 HG22 HD12 ' A' ' 35' ' ' LEU . 51.9 t -65.0 -36.8 78.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.949 -0.76 . . . . 50.0 108.949 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -68.19 -38.86 82.46 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.762 -0.829 . . . . 50.0 108.762 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -66.7 -41.04 88.68 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.464 -0.772 . . . . 50.0 109.011 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.8 mtt -60.82 -45.92 92.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.213 -0.929 . . . . 16.66 108.881 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.529 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 34.7 mtp -61.87 -48.25 81.35 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.014 -0.736 . . . . 50.0 109.014 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.62 -20.42 32.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.87 . . . . 50.0 109.172 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -96.86 -35.99 10.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.324 -0.86 . . . . 16.66 109.099 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.616 HG22 HD12 ' A' ' 61' ' ' ILE . 82.2 mt -82.38 -30.53 9.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.538 -0.726 . . . . 50.0 109.783 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 50' ' ' MET . 18.3 t0 -61.3 101.38 0.16 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.38 -0.825 . . . . 16.66 109.291 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 82.6 p -73.68 -48.16 34.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -0.916 . . . . 50.0 110.851 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 17.1 p-10 -85.0 -28.6 25.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 16.66 109.972 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.464 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 91.19 27.91 16.85 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.847 -1.168 . . . . 16.66 110.632 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 8.9 p-10 -83.36 -4.4 58.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.895 -1.356 . . . . 50.0 109.502 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.529 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 100.11 -7.65 58.78 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.969 -1.11 . . . . 16.66 110.35 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 43.2 m-85 -131.11 153.37 49.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.016 -1.285 . . . . 50.0 110.918 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.616 HD12 HG22 ' A' ' 53' ' ' ILE . 36.3 mm -104.33 129.5 56.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.183 -1.043 . . . . 16.66 108.183 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.78 165.45 11.94 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.143 -0.973 . . . . 16.66 108.779 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 35.3 t80 -53.61 -42.49 67.76 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.224 -0.99 . . . . 16.66 108.564 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -60.31 -48.56 81.22 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.529 -0.732 . . . . 50.0 109.218 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.544 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 62.0 mt-10 -60.25 -47.3 86.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 16.66 109.1 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.425 ' HE1' HD13 ' A' ' 77' ' ' LEU . 54.6 t80 -62.72 -35.52 80.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.517 -0.74 . . . . 16.66 109.19 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.538 HG23 ' NH2' ' A' ' 11' ' ' ARG . 12.5 m -67.07 -48.48 68.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.357 -0.839 . . . . 50.0 109.138 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -60.4 -38.24 83.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 50.0 109.237 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.578 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.17 -38.45 51.69 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.505 -0.924 . . . . 50.0 108.505 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.927 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.17 -27.72 60.49 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.183 -1.567 . . . . 16.66 109.183 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' THR . 58.8 mtm180 -72.53 -31.73 65.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -1.137 . . . . 50.0 108.989 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.1 -20.46 64.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.414 -0.804 . . . . 50.0 109.312 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.806 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.9 m-80 -149.93 56.74 0.96 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -0.863 . . . . 50.0 109.32 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 69.8 mtt180 -50.18 -38.53 40.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 50.0 108.796 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.44 -19.08 39.4 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.432 -1.467 . . . . 25.0 109.432 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.806 HD12 ' CB ' ' A' ' 73' ' ' ASN . 43.9 mt -79.52 -43.73 22.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -1.058 . . . . 50.0 109.395 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.927 HD11 ' HA3' ' A' ' 70' ' ' GLY . 5.4 mt -70.79 -15.92 62.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.475 -0.766 . . . . 50.0 109.743 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 43.1 mtpt -80.02 -29.27 39.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.15 -0.969 . . . . 50.0 109.206 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.14 -47.35 8.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 50.0 109.529 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.9 p -62.31 -42.55 95.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.371 -0.831 . . . . 50.0 109.304 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.542 ' HB2' HD11 ' A' ' 14' ' ' ILE . . . -52.24 -35.96 51.09 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.746 -0.596 . . . . 50.0 110.2 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -75.45 -24.36 57.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.092 -1.005 . . . . 50.0 109.771 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.474 HG13 ' HA ' ' A' ' 80' ' ' VAL . 10.9 mt -59.07 -38.66 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.273 -0.892 . . . . 50.0 109.546 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.465 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 93.1 m-85 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 118.038 -0.982 . . . . 99.99 109.425 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 45.46 39.66 4.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.65 144.96 55.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 25.0 109.5 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.569 ' CE1' ' OD2' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -112.52 169.94 5.81 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 50.0 109.343 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.7 Cg_endo -68.0 -21.87 42.66 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.548 2.166 . . . . 50.0 111.153 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -64.22 -36.08 82.92 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.478 -0.764 . . . . 25.0 109.34 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.569 ' OD2' ' CE1' ' A' ' 4' ' ' HIS . 28.3 m-20 -62.02 -45.91 91.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 50.0 109.351 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -49.22 -36.34 19.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.825 . . . . 50.0 109.516 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.15 -46.66 87.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.257 -0.902 . . . . 16.66 108.752 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.46 ' O ' HG13 ' A' ' 14' ' ' ILE . 59.6 mm-40 -67.28 -40.37 86.14 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.801 -0.814 . . . . 16.66 108.801 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.548 ' NH2' HD12 ' A' ' 77' ' ' LEU . 45.4 mtt-85 -65.81 -40.49 91.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.557 -0.714 . . . . 50.0 109.649 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.614 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 35.6 mt-10 -64.89 -39.79 94.09 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 50.0 109.571 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 53.2 mtp180 -69.24 -39.26 78.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 50.0 109.21 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.5 mt -71.59 -45.2 68.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.315 -0.866 . . . . 50.0 108.957 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -64.48 -36.47 84.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.114 -0.991 . . . . 16.66 108.864 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 33.5 mttt -66.12 -28.81 69.09 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.392 -0.818 . . . . 50.0 108.88 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 35.2 mtt85 -68.85 -39.17 80.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 50.0 109.08 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.883 ' HB3' HD13 ' A' ' 26' ' ' ILE . 54.5 m-85 -68.52 -51.33 44.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.458 -0.776 . . . . 16.66 109.373 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.5 t0 -54.08 103.14 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -0.842 . . . . 16.66 108.814 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.68 -51.67 46.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.198 -0.939 . . . . 50.0 111.278 -178.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -86.73 -27.48 23.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.812 -1.18 . . . . 16.66 109.693 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.28 39.26 6.44 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.145 -1.182 . . . . 16.66 110.145 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -94.34 6.22 49.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.086 -1.244 . . . . 16.66 109.193 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.85 -7.43 76.89 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.513 -1.035 . . . . 16.66 110.513 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 11.7 pttp -130.43 142.32 50.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.891 -1.358 . . . . 50.0 109.971 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.883 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.5 mt -112.53 133.51 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.613 -0.679 . . . . 16.66 109.567 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 p -105.83 168.22 9.26 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.359 -0.838 . . . . 50.0 108.897 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.2 -46.53 54.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.059 -1.025 . . . . 50.0 108.781 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.28 -41.42 75.85 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.337 -0.852 . . . . 50.0 109.38 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.506 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.8 mt-10 -73.92 -54.08 8.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.187 -0.946 . . . . 16.66 109.302 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.899 HD22 HG13 ' A' ' 46' ' ' VAL . 6.6 tt -59.65 -45.89 90.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.218 -0.926 . . . . 16.66 108.9 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.591 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -61.54 -43.93 98.65 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.559 -1.417 . . . . 16.66 109.559 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -58.04 -40.69 81.56 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.286 -1.126 . . . . 50.0 109.82 -179.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -71.83 -39.12 69.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.097 -1.002 . . . . 50.0 108.736 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.016 ' CD1' HG22 ' A' ' 46' ' ' VAL . 16.0 mt -59.71 -31.86 69.99 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.499 -0.751 . . . . 99.99 110.116 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.7 mttt -43.55 -28.53 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.08 -1.012 . . . . 99.99 109.577 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -52.82 -26.97 16.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 99.99 109.226 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.03 HD12 HD12 ' A' ' 41' ' ' ILE . 22.1 mt -58.28 -33.64 69.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.328 -0.857 . . . . 50.0 109.257 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.08 2.0 57.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.773 -1.331 . . . . 16.66 109.773 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.15 57.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -1.18 . . . . 16.66 109.624 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.03 HD12 HD12 ' A' ' 38' ' ' LEU . 10.5 tt -139.1 169.24 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.133 -0.979 . . . . 50.0 109.719 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.81 165.93 21.27 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.774 -0.824 . . . . 16.66 108.774 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.2 -33.53 18.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.03 1.82 . . . . 50.0 110.146 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -63.16 -27.82 69.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.613 -0.68 . . . . 50.0 110.113 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.17 -36.14 30.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.93 -1.106 . . . . 16.66 108.389 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.016 HG22 ' CD1' ' A' ' 35' ' ' LEU . 76.4 t -66.41 -35.04 73.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.098 -0.704 . . . . 50.0 109.098 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -67.95 -38.05 82.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.872 -0.788 . . . . 50.0 108.872 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -67.15 -37.8 84.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.424 -0.797 . . . . 50.0 109.226 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.415 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.6 mtt -61.75 -46.81 88.03 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.196 -0.94 . . . . 16.66 108.854 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.699 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 35.2 mtp -61.96 -47.87 82.94 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.492 -0.755 . . . . 50.0 109.085 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.79 -19.48 41.32 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.365 -0.835 . . . . 50.0 109.231 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -97.42 -36.15 10.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 16.66 109.029 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.579 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.8 mt -82.05 -32.13 10.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.515 -0.741 . . . . 50.0 109.797 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.0 t0 -59.19 101.63 0.1 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.245 -0.91 . . . . 16.66 108.965 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.511 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 80.9 p -71.04 -48.1 54.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 50.0 110.754 -178.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.405 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -85.79 -30.83 22.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.161 -0.962 . . . . 16.66 109.518 -179.585 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 92.84 27.91 13.26 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.862 -1.161 . . . . 16.66 110.343 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' OD2' ' OD1' ' A' ' 56' ' ' ASP . 1.4 p30 -81.87 -2.23 50.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.328 . . . . 50.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.699 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.89 -8.57 59.64 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.044 -1.074 . . . . 16.66 110.56 179.121 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 36.4 m-85 -132.95 156.17 47.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.948 -1.325 . . . . 50.0 111.24 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.572 HD12 HG22 ' A' ' 53' ' ' ILE . 25.5 mm -107.6 129.05 62.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.432 -0.951 . . . . 16.66 108.432 178.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.85 167.41 11.27 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.033 -1.042 . . . . 16.66 108.647 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.614 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 34.2 t80 -54.52 -42.57 71.0 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.025 -1.047 . . . . 16.66 108.545 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -60.52 -49.71 76.46 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.576 -0.702 . . . . 50.0 109.165 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 61.2 mt-10 -58.91 -46.8 87.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.258 -0.901 . . . . 16.66 109.08 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.427 ' HE1' HD13 ' A' ' 77' ' ' LEU . 51.1 t80 -63.86 -35.66 81.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.442 -0.786 . . . . 16.66 109.346 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.7 m -66.22 -48.69 69.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.37 -0.832 . . . . 50.0 109.166 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -59.88 -34.98 73.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 50.0 109.395 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.579 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -79.81 -37.65 34.69 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.422 -0.955 . . . . 50.0 108.422 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.825 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -57.88 -27.64 59.61 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.067 -1.613 . . . . 16.66 109.067 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -71.37 -32.2 68.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.445 -1.032 . . . . 50.0 108.811 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.43 -20.94 66.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.463 -0.773 . . . . 50.0 109.276 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.763 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.6 m-80 -152.12 55.89 0.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -0.84 . . . . 50.0 109.137 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 4.1 ptm180 -48.45 -34.11 10.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.877 . . . . 50.0 108.769 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.41 ' HA2' ' HE3' ' A' ' 78' ' ' LYS . . . -60.62 -31.7 75.92 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.347 -1.501 . . . . 25.0 109.347 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.763 HD12 ' CB ' ' A' ' 73' ' ' ASN . 65.7 mt -66.13 -44.46 84.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -1.147 . . . . 50.0 109.582 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.825 HD11 ' HA3' ' A' ' 70' ' ' GLY . 4.6 mt -71.39 -19.13 62.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 50.0 109.843 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 14.5 mtmt -79.96 -28.37 39.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.177 -0.952 . . . . 50.0 109.271 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.92 -46.09 8.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 50.0 109.38 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.2 p -58.44 -44.19 88.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.803 0.811 . . . . 50.0 108.988 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.545 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -51.25 -38.45 52.7 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.297 -0.561 . . . . 50.0 109.767 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -68.77 -27.28 65.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 50.0 109.614 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.449 HG13 ' HA ' ' A' ' 80' ' ' VAL . 8.4 mt -60.66 -43.31 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.31 -0.869 . . . . 50.0 109.422 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.037 -0.982 . . . . 99.99 109.415 179.895 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -80.72 -20.28 43.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.526 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -57.79 140.27 52.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 25.0 109.409 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.493 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 0.2 OUTLIER -132.75 165.64 35.05 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 50.0 109.466 -179.967 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 45.4 Cg_endo -67.72 -22.02 44.14 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 122.553 2.169 . . . . 50.0 110.857 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -58.89 -41.83 88.12 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.573 -0.704 . . . . 25.0 109.141 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.486 ' CG ' ' CD2' ' A' ' 4' ' ' HIS . 79.4 m-20 -53.48 -55.94 21.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.409 -0.807 . . . . 50.0 109.465 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.46 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 11.5 mttt -43.69 -37.48 2.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 50.0 109.633 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -60.53 -46.02 91.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 16.66 108.91 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 14' ' ' ILE . 83.9 mt-10 -69.02 -35.84 77.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.476 -0.765 . . . . 16.66 108.976 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.67 ' NH2' HG23 ' A' ' 67' ' ' THR . 17.0 mtm180 -70.12 -40.45 74.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 50.0 109.309 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.633 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 59.5 mt-10 -66.6 -41.9 87.71 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.394 -0.816 . . . . 50.0 109.411 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 18.9 mtp180 -66.47 -41.31 89.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 50.0 109.457 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 10' ' ' GLU . 41.8 mt -70.04 -43.94 78.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.237 -0.915 . . . . 50.0 109.059 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 26' ' ' ILE . 70.2 t80 -64.35 -35.98 82.64 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.203 -0.936 . . . . 16.66 109.123 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -66.39 -30.43 70.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 50.0 109.12 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 60.0 mtt85 -69.32 -36.92 77.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 50.0 109.129 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.907 ' HB3' HD13 ' A' ' 26' ' ' ILE . 46.1 m-85 -69.4 -50.82 42.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.421 -0.799 . . . . 16.66 109.475 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.6 t0 -55.32 103.43 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 16.66 108.685 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.64 -51.53 48.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.269 -0.894 . . . . 50.0 111.307 -178.547 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -87.5 -27.59 22.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.759 -1.213 . . . . 16.66 109.753 -179.404 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 90.23 38.2 6.42 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.767 -1.206 . . . . 16.66 110.242 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.8 p-10 -93.34 6.33 48.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.252 . . . . 16.66 109.192 179.154 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.6 -7.72 77.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.402 -1.079 . . . . 16.66 110.402 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 24.9 pttt -129.56 141.67 50.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.935 -1.332 . . . . 50.0 109.997 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.907 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.7 mt -111.85 133.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.642 -0.661 . . . . 16.66 109.547 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.404 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 10.9 p -105.87 166.28 10.59 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.759 -0.83 . . . . 50.0 108.759 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.09 -45.19 52.42 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.049 -1.032 . . . . 50.0 108.841 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.79 -39.55 77.8 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.331 -0.856 . . . . 50.0 109.517 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.494 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.2 mt-10 -74.65 -54.17 7.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.157 -0.965 . . . . 16.66 109.398 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.584 HD12 ' CE1' ' A' ' 18' ' ' PHE . 30.3 tp -61.77 -43.35 99.02 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.262 -0.899 . . . . 16.66 108.954 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.689 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -62.71 -44.51 97.4 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.139 -1.584 . . . . 16.66 109.139 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 28.8 mt-10 -58.8 -42.74 89.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.355 -1.085 . . . . 50.0 109.868 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.79 -40.24 66.07 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.098 -1.001 . . . . 50.0 108.406 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.987 HD12 HG22 ' A' ' 46' ' ' VAL . 10.7 mt -58.71 -28.63 66.0 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.61 -0.681 . . . . 99.99 109.553 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 2.4 mtmt -44.04 -26.19 0.27 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 99.99 109.615 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.431 ' OG1' HG22 ' A' ' 83' ' ' ILE . 6.6 t -51.94 -26.31 10.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.306 -0.872 . . . . 99.99 109.195 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 38' ' ' LEU . 41.9 mt -58.73 -37.19 75.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.438 -0.789 . . . . 50.0 109.199 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.98 -5.6 61.89 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.836 -1.305 . . . . 16.66 109.836 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.7 t -152.0 59.77 0.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.044 -1.268 . . . . 16.66 109.779 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.3 tp -134.0 157.2 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.152 -0.968 . . . . 50.0 109.485 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.11 160.02 27.65 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.461 -0.94 . . . . 16.66 108.461 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.77 -31.97 30.93 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 121.93 1.753 . . . . 50.0 110.066 178.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -72.15 -17.92 61.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.603 -0.685 . . . . 50.0 110.177 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -80.94 -37.51 29.34 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.815 -1.178 . . . . 16.66 108.28 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.987 HG22 HD12 ' A' ' 35' ' ' LEU . 65.6 t -68.23 -35.88 72.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.821 -0.807 . . . . 50.0 108.821 179.299 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -65.19 -40.4 94.17 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.797 -0.816 . . . . 50.0 108.797 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.481 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.7 t60 -66.03 -42.33 89.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.484 -0.76 . . . . 50.0 109.051 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.9 mtt -58.45 -44.42 89.19 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.249 -0.907 . . . . 16.66 108.71 179.482 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.569 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 34.6 mtp -61.69 -46.69 88.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.572 -0.705 . . . . 50.0 109.182 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.82 -21.36 41.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 50.0 109.042 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.85 -36.32 11.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.46 -0.775 . . . . 16.66 109.076 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.582 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.7 mt -80.59 -31.98 12.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.43 -0.794 . . . . 50.0 109.566 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.6 t0 -61.42 101.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.5 -0.75 . . . . 16.66 109.066 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.474 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 60.3 p -67.5 -46.42 72.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.269 -0.894 . . . . 50.0 110.692 -179.038 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -88.28 -41.41 12.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 16.66 109.56 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 103.67 29.54 5.56 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.964 -1.112 . . . . 16.66 110.346 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 13.3 p-10 -80.61 -2.57 46.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.877 -1.367 . . . . 50.0 109.112 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.569 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.72 -3.58 57.56 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.943 -1.263 . . . . 16.66 109.943 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.575 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.2 m-85 -137.0 156.82 47.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.023 -1.281 . . . . 50.0 111.336 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.554 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 25.1 mm -109.46 130.31 62.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.418 -0.956 . . . . 16.66 108.418 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -99.38 168.52 9.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.057 -1.027 . . . . 16.66 108.571 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.633 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.6 t80 -54.8 -43.73 73.16 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.022 -1.071 . . . . 16.66 108.609 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -58.66 -47.54 84.11 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.626 -0.671 . . . . 50.0 109.261 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 80.8 mt-10 -62.97 -46.54 87.22 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.29 -0.881 . . . . 16.66 109.221 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.536 ' HZ ' HD12 ' A' ' 77' ' ' LEU . 31.9 t80 -63.81 -32.89 74.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 16.66 109.212 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.67 HG23 ' NH2' ' A' ' 11' ' ' ARG . 31.2 m -67.28 -49.35 64.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 50.0 109.171 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -59.74 -36.46 76.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.31 -0.869 . . . . 50.0 109.137 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.582 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.1 -38.91 43.02 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.504 -0.925 . . . . 50.0 108.504 179.706 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.67 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -57.49 -28.65 59.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.038 -1.625 . . . . 16.66 109.038 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 67' ' ' THR . 22.7 mtm180 -70.64 -31.91 69.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -1.076 . . . . 50.0 108.851 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.93 -23.51 62.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 50.0 109.238 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.91 ' CB ' HD12 ' A' ' 76' ' ' LEU . 15.5 m-80 -140.48 58.3 1.57 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 50.0 109.223 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.578 ' HA ' HD23 ' A' ' 77' ' ' LEU . 58.3 mtp180 -52.66 -34.86 53.6 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.328 -0.858 . . . . 50.0 108.998 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 78' ' ' LYS . . . -67.97 -24.25 74.42 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.48 -1.448 . . . . 25.0 109.48 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.91 HD12 ' CB ' ' A' ' 73' ' ' ASN . 14.6 mt -71.72 -45.99 60.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -1.148 . . . . 50.0 109.489 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.826 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -62.86 -42.97 99.95 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.327 -0.858 . . . . 50.0 109.677 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 37.0 pttt -68.36 -31.24 70.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 50.0 109.247 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.473 ' O ' HG13 ' A' ' 83' ' ' ILE . 35.3 m-20 -74.78 -36.8 62.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.333 -0.854 . . . . 50.0 109.256 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 76' ' ' LEU . 21.9 t -79.26 -35.64 17.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 50.0 109.22 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.97 -42.76 63.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.426 -0.796 . . . . 50.0 109.841 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -69.28 -26.08 64.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 50.0 109.573 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 79' ' ' ASP . 13.7 mt -63.53 -45.19 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.866 . . . . 50.0 109.527 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.05 -0.976 . . . . 99.99 109.397 179.966 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.27 -7.68 59.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.225 -0.922 . . . . 0.0 109.561 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' OD1' ' NH2' ' A' ' 74' ' ' ARG . 85.0 m-20 -60.1 140.22 57.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 25.0 109.493 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.618 ' CG ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -113.25 151.84 44.63 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.217 -0.927 . . . . 50.0 108.948 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.618 ' HD2' ' CG ' ' A' ' 4' ' ' HIS . 40.0 Cg_endo -64.59 -20.04 65.29 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.257 1.971 . . . . 50.0 110.309 179.246 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -59.21 -36.86 76.14 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.017 -0.735 . . . . 25.0 109.017 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -64.48 -45.21 88.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.391 -0.818 . . . . 50.0 109.45 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 13.3 mttp -49.57 -36.09 22.68 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.401 -0.812 . . . . 50.0 109.262 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.25 -46.35 90.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 16.66 108.755 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' O ' HG13 ' A' ' 14' ' ' ILE . 69.2 mt-10 -69.02 -37.81 78.85 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.876 -0.787 . . . . 16.66 108.876 179.386 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH2' ' HG2' ' A' ' 8' ' ' LYS . 10.8 mtm180 -69.57 -40.28 76.86 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.329 -0.857 . . . . 50.0 109.414 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 54.2 mt-10 -66.68 -39.73 88.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.406 -0.809 . . . . 50.0 109.476 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -69.11 -39.73 78.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 50.0 109.163 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' A' ' 81' ' ' ALA . 45.4 mt -71.44 -44.13 71.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.334 -0.854 . . . . 50.0 109.063 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -69.91 -36.1 75.11 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.133 -0.979 . . . . 16.66 109.115 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 56.6 mttm -65.83 -31.5 72.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.329 -0.857 . . . . 50.0 109.031 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -71.37 -35.8 71.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 50.0 109.011 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.022 ' HB3' HD13 ' A' ' 26' ' ' ILE . 33.7 m-85 -67.83 -47.58 68.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 16.66 109.243 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.3 t0 -59.09 103.36 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 16.66 108.624 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.85 -51.32 56.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 50.0 111.257 -178.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -87.18 -30.64 20.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.739 -1.226 . . . . 16.66 109.872 -179.307 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.46 35.6 6.18 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.702 -1.237 . . . . 16.66 110.15 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.2 p-10 -90.28 4.75 49.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -1.184 . . . . 16.66 109.172 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.91 -6.26 76.55 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.432 -1.067 . . . . 16.66 110.432 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.5 pttp -131.26 142.58 50.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.93 -1.335 . . . . 50.0 110.079 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.022 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.9 mt -112.23 132.86 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.695 -0.628 . . . . 16.66 109.421 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.403 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 14.4 p -104.94 167.76 9.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.339 -0.851 . . . . 50.0 108.963 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.23 -45.34 53.85 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.138 -0.976 . . . . 50.0 108.987 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.53 -40.83 79.67 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.374 -0.829 . . . . 50.0 109.318 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.3 mt-10 -74.01 -54.57 7.59 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.271 -0.893 . . . . 16.66 109.218 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.715 HD22 HG13 ' A' ' 46' ' ' VAL . 5.6 tt -59.7 -46.58 88.65 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.209 -0.932 . . . . 16.66 108.806 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.534 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -60.83 -42.93 99.73 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.45 -1.46 . . . . 16.66 109.45 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -57.98 -41.83 83.78 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.336 -1.096 . . . . 50.0 109.881 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.475 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -71.26 -39.02 71.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.15 -0.969 . . . . 50.0 108.719 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.019 ' CD1' HG22 ' A' ' 46' ' ' VAL . 21.3 mt -59.77 -34.62 73.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.54 -0.725 . . . . 99.99 110.034 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 8.8 mttt -43.78 -28.12 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 99.99 109.53 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.996 HG21 HG21 ' A' ' 83' ' ' ILE . 6.6 t -52.48 -25.74 11.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.288 -0.883 . . . . 99.99 109.208 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -64.44 -30.36 71.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.301 -0.874 . . . . 50.0 109.317 179.824 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.97 6.37 52.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.738 -1.345 . . . . 16.66 109.738 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 t -154.58 58.67 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.164 -1.198 . . . . 16.66 109.713 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.57 HD12 HD13 ' A' ' 38' ' ' LEU . 11.0 tt -144.25 168.42 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.963 . . . . 50.0 109.47 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.41 166.04 20.18 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 16.66 108.786 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.45 -33.4 17.86 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.089 1.859 . . . . 50.0 110.085 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -62.68 -27.86 69.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.662 -0.649 . . . . 50.0 109.908 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -81.73 -35.89 29.21 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.833 -1.167 . . . . 16.66 108.255 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.019 HG22 ' CD1' ' A' ' 35' ' ' LEU . 79.3 t -67.1 -35.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.028 -0.73 . . . . 50.0 109.028 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -68.6 -38.02 80.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.854 -0.795 . . . . 50.0 108.854 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -67.05 -37.04 83.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 50.0 109.132 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.402 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.4 mtt -60.86 -47.56 85.83 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.272 -0.892 . . . . 16.66 108.811 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.56 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 56.5 mtp -61.28 -47.31 86.59 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.566 -0.709 . . . . 50.0 109.125 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.81 -20.74 37.91 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.292 -0.88 . . . . 50.0 109.171 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -98.93 -37.39 9.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 16.66 109.244 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.588 HG12 ' CD2' ' A' ' 69' ' ' PHE . 85.5 mt -80.35 -33.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.471 -0.768 . . . . 50.0 109.685 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.6 t0 -60.44 101.55 0.14 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.405 -0.809 . . . . 16.66 108.891 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 71.8 p -66.53 -47.9 71.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 50.0 110.785 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.2 p-10 -87.57 -38.8 15.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.106 -0.996 . . . . 16.66 109.452 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 101.12 27.65 7.24 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.945 -1.121 . . . . 16.66 110.492 179.403 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.474 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 15.6 p-10 -78.45 -0.75 30.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.865 -1.373 . . . . 50.0 109.224 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.56 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.47 -4.84 58.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.015 -1.234 . . . . 16.66 110.015 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.575 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 27.0 m-85 -136.86 157.17 47.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.926 -1.337 . . . . 50.0 111.34 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.555 HD12 HG22 ' A' ' 53' ' ' ILE . 23.1 mm -110.08 131.35 61.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.466 -0.939 . . . . 16.66 108.466 178.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 170.82 8.27 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.045 -1.035 . . . . 16.66 108.521 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 36.2 t80 -56.09 -44.45 79.02 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.121 -1.032 . . . . 16.66 108.657 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -59.04 -49.35 78.23 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.492 -0.755 . . . . 50.0 109.229 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.548 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 78.4 mt-10 -60.23 -46.49 89.59 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.261 -0.899 . . . . 16.66 109.265 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.511 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 64.1 t80 -63.6 -34.07 77.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.418 -0.802 . . . . 16.66 109.337 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.531 HG23 ' NH2' ' A' ' 11' ' ' ARG . 19.6 m -66.56 -48.97 67.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.843 . . . . 50.0 109.203 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -58.85 -36.22 74.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 50.0 109.24 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.588 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -79.88 -37.16 35.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.585 -0.894 . . . . 50.0 108.585 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.922 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.15 -28.71 67.05 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.383 -1.487 . . . . 16.66 109.383 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 67' ' ' THR . 75.5 mtm180 -72.68 -34.69 67.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 50.0 109.198 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.82 -18.98 65.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.434 -0.791 . . . . 50.0 109.298 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.719 ' CB ' HD12 ' A' ' 76' ' ' LEU . 29.4 m-80 -144.4 56.74 1.3 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.263 -0.898 . . . . 50.0 109.222 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 98.3 mtt180 -51.46 -40.3 59.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.713 -0.847 . . . . 50.0 108.713 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.479 ' HA2' ' HE3' ' A' ' 78' ' ' LYS . . . -60.27 -25.98 63.29 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.454 -1.459 . . . . 25.0 109.454 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.719 HD12 ' CB ' ' A' ' 73' ' ' ASN . 18.6 mt -72.7 -45.55 58.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -1.161 . . . . 50.0 109.43 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.922 HD11 ' HA3' ' A' ' 70' ' ' GLY . 10.5 mt -68.67 -16.46 63.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 50.0 109.777 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HE3' ' HA2' ' A' ' 75' ' ' GLY . 18.6 mtmt -80.05 -24.35 40.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 50.0 109.322 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -91.99 -48.32 6.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.273 -0.892 . . . . 50.0 109.408 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.547 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.3 p -59.15 -44.33 91.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.388 -0.82 . . . . 50.0 109.178 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.602 ' HB2' HD11 ' A' ' 14' ' ' ILE . . . -49.62 -40.86 40.69 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.115 -0.634 . . . . 50.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -64.11 -25.74 68.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 50.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.996 HG21 HG21 ' A' ' 37' ' ' THR . 20.8 mm -66.79 -36.1 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 50.0 109.414 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.009 -0.996 . . . . 99.99 109.458 -179.999 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -88.94 7.52 34.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.935 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.36 142.02 57.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.9 . . . . 25.0 109.432 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.496 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -119.15 171.8 5.0 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 50.0 109.407 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.2 Cg_endo -68.63 -22.66 37.52 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.65 2.233 . . . . 50.0 111.002 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -63.91 -35.39 80.49 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.457 -0.777 . . . . 25.0 109.234 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -60.89 -44.5 97.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 50.0 109.296 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -51.18 -36.14 39.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 50.0 109.432 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.7 -45.53 85.57 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.655 -0.869 . . . . 16.66 108.655 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 14' ' ' ILE . 58.9 mt-10 -66.43 -43.82 84.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.955 -0.758 . . . . 16.66 108.955 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.5 ' NH2' ' HG2' ' A' ' 71' ' ' ARG . 20.0 mtt-85 -64.49 -39.74 94.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -0.782 . . . . 50.0 109.46 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.586 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 31.6 mt-10 -64.35 -41.62 96.65 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.48 -0.762 . . . . 50.0 109.286 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 52.0 mtp85 -67.99 -39.77 83.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.307 -0.871 . . . . 50.0 109.173 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.1 mt -70.52 -44.45 76.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.394 -0.816 . . . . 50.0 109.044 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -66.66 -36.1 81.73 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.243 -0.911 . . . . 16.66 109.141 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 22.6 mtpt -65.4 -30.22 71.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.352 -0.843 . . . . 50.0 109.089 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.515 ' NH2' ' O ' ' A' ' 84' ' ' PHE . 31.5 mtt180 -71.88 -35.22 69.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 50.0 109.057 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.058 ' HB3' HD13 ' A' ' 26' ' ' ILE . 31.0 m-85 -69.45 -48.77 59.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.448 -0.783 . . . . 16.66 109.298 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.2 t0 -58.74 103.09 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.917 . . . . 16.66 108.662 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.57 -51.82 52.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.128 -0.982 . . . . 50.0 111.239 -178.648 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -86.65 -27.9 23.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.748 -1.22 . . . . 16.66 109.565 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.33 38.1 6.83 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.862 -1.161 . . . . 16.66 110.215 179.021 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.4 p-10 -92.39 5.91 48.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -1.217 . . . . 16.66 109.142 179.168 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.88 -7.13 76.96 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.472 -1.051 . . . . 16.66 110.472 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 15.7 pttt -130.74 142.34 50.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.886 -1.361 . . . . 50.0 110.047 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.058 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.9 mt -112.3 133.23 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.724 -0.61 . . . . 16.66 109.447 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.416 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 23.7 p -106.93 169.74 8.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -0.891 . . . . 50.0 109.054 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.51 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.8 -46.76 59.85 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.108 -0.995 . . . . 50.0 108.985 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.19 74.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.266 -0.896 . . . . 50.0 109.467 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.4 mt-10 -75.56 -54.22 7.35 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.207 -0.933 . . . . 16.66 109.239 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.756 HD22 HG13 ' A' ' 46' ' ' VAL . 7.0 tt -59.58 -46.77 87.93 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.212 -0.93 . . . . 16.66 108.847 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.633 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -60.88 -43.33 99.43 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.461 -1.456 . . . . 16.66 109.461 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.32 -41.36 84.38 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.437 -1.037 . . . . 50.0 109.826 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.4 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.35 -39.81 67.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.166 -0.959 . . . . 50.0 108.726 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.011 HD12 HG22 ' A' ' 46' ' ' VAL . 14.1 mt -59.55 -32.28 70.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.446 -0.784 . . . . 99.99 109.832 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.6 mtmt -43.7 -26.32 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.065 -1.022 . . . . 99.99 109.632 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.456 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.6 t -52.4 -25.8 10.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 99.99 109.244 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -65.72 -31.86 73.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.372 -0.83 . . . . 50.0 109.201 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.07 11.04 43.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.479 -1.449 . . . . 16.66 109.479 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.33 50.02 0.56 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.242 -1.152 . . . . 16.66 109.54 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 tt -136.95 172.99 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 50.0 109.288 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.78 166.58 19.36 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 16.66 108.696 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.16 -33.81 18.01 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.089 1.859 . . . . 50.0 110.184 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -64.08 -26.14 68.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.635 -0.665 . . . . 50.0 110.117 -179.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -82.52 -40.11 21.48 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.814 -1.179 . . . . 16.66 108.173 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.011 HG22 HD12 ' A' ' 35' ' ' LEU . 55.2 t -62.22 -35.93 71.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.692 -0.855 . . . . 50.0 108.692 179.199 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -69.62 -37.37 76.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.752 -0.833 . . . . 50.0 108.752 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.581 ' CD2' ' HG3' ' A' ' 52' ' ' GLU . 13.7 t-160 -67.35 -36.81 82.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.506 -0.746 . . . . 50.0 109.261 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.433 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.4 mtt -61.39 -46.79 88.7 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.18 -0.95 . . . . 16.66 108.789 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.702 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 43.0 mtp -62.26 -48.32 80.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.493 -0.755 . . . . 50.0 109.056 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.93 -19.38 29.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 50.0 109.209 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.581 ' HG3' ' CD2' ' A' ' 48' ' ' HIS . 23.1 mt-10 -99.65 -36.93 9.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 16.66 109.143 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.541 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.7 mt -80.47 -33.4 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.456 -0.777 . . . . 50.0 109.501 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.6 t0 -59.82 101.69 0.13 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.302 -0.874 . . . . 16.66 108.849 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.469 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 49.5 p -68.5 -46.36 69.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 50.0 110.736 -178.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -88.09 -38.88 15.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 16.66 109.539 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.472 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 101.61 28.34 6.73 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.019 -1.086 . . . . 16.66 110.523 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.4 p-10 -79.57 -2.0 40.45 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.783 -1.422 . . . . 50.0 109.13 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.702 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.34 -5.59 59.01 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.048 -1.221 . . . . 16.66 110.048 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.573 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 31.6 m-85 -134.99 156.59 48.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.008 -1.29 . . . . 50.0 111.407 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.565 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 22.1 mm -109.21 129.8 63.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.365 -0.976 . . . . 16.66 108.365 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -96.26 167.4 11.21 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.083 -1.01 . . . . 16.66 108.55 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.586 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 34.0 t80 -54.32 -42.39 70.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.014 -1.054 . . . . 16.66 108.442 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -61.19 -47.58 85.49 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.584 -0.697 . . . . 50.0 109.335 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 74.9 mt-10 -61.71 -47.02 87.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.244 -0.91 . . . . 16.66 109.2 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.601 ' CZ ' HD11 ' A' ' 77' ' ' LEU . 80.7 t80 -61.69 -39.11 90.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 16.66 109.375 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 15.9 m -66.27 -46.53 76.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.414 -0.804 . . . . 50.0 109.325 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -59.01 -36.53 75.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 50.0 109.64 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.544 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -78.66 -35.32 45.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.234 -0.917 . . . . 50.0 108.69 179.972 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.28 -28.79 64.91 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.385 -1.486 . . . . 16.66 109.385 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.5 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 35.9 mtm180 -73.46 -30.63 63.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -1.172 . . . . 50.0 109.253 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.47 -15.85 61.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 50.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.718 ' CB ' HD12 ' A' ' 76' ' ' LEU . 5.0 p30 -149.56 54.98 0.96 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 50.0 109.189 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -51.19 -43.16 61.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.368 -0.832 . . . . 50.0 108.791 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.85 -24.38 19.15 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.174 -1.57 . . . . 25.0 109.174 179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.718 HD12 ' CB ' ' A' ' 73' ' ' ASN . 41.9 mt -80.05 -43.49 21.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -1.091 . . . . 50.0 109.394 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 1.6 mm? -61.96 -40.03 94.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.411 -0.805 . . . . 50.0 109.845 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 43.3 mtpt -66.19 -33.63 76.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 50.0 109.653 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.19 -46.83 22.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 50.0 109.463 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 77' ' ' LEU . 2.8 p -72.63 -40.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.79 0.805 . . . . 50.0 109.393 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 77' ' ' LEU . . . -53.69 -33.96 57.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.744 -0.597 . . . . 50.0 110.487 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 77.1 mttt -79.88 -22.98 42.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.018 . . . . 50.0 109.789 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.471 HG13 ' HA ' ' A' ' 80' ' ' VAL . 10.1 mt -57.59 -35.9 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 50.0 109.48 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.515 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 95.1 m-85 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.021 -0.99 . . . . 99.99 109.534 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 57.54 41.6 25.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -83.36 115.9 22.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 25.0 109.441 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.548 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -115.98 174.5 2.39 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.953 . . . . 50.0 109.197 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 47.2 Cg_endo -69.58 -22.88 32.3 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.502 2.134 . . . . 50.0 111.246 179.586 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -63.25 -36.32 83.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.364 -0.835 . . . . 25.0 109.297 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.65 -50.05 75.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.392 -0.818 . . . . 50.0 109.457 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -48.53 -36.3 15.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.363 -0.836 . . . . 50.0 109.355 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -56.38 -45.19 80.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.597 -0.89 . . . . 16.66 108.597 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.471 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.4 mt-10 -68.09 -38.61 82.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.47 -0.769 . . . . 16.66 108.947 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.8 mtt-85 -67.49 -40.58 85.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 50.0 109.387 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.621 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 33.2 mt-10 -64.9 -40.98 95.93 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.442 -0.786 . . . . 50.0 109.354 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 59.7 mtp180 -68.27 -39.54 82.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 50.0 109.154 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 10' ' ' GLU . 33.5 mt -70.93 -45.06 75.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.391 -0.818 . . . . 50.0 109.006 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 26' ' ' ILE . 67.2 t80 -64.86 -35.86 82.5 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 16.66 108.903 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -66.56 -29.42 69.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.32 -0.862 . . . . 50.0 108.962 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 39.2 mtt85 -70.04 -36.61 75.14 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.362 -0.836 . . . . 50.0 109.006 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.884 ' HB3' HD13 ' A' ' 26' ' ' ILE . 51.6 m-85 -70.22 -51.18 32.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.448 -0.782 . . . . 16.66 109.352 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.8 t0 -55.47 103.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 16.66 108.744 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.27 48.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.89 . . . . 50.0 111.196 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -87.06 -28.39 22.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.749 -1.219 . . . . 16.66 109.71 -179.381 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 90.13 37.4 6.73 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.801 -1.19 . . . . 16.66 110.216 178.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.7 p-10 -91.42 5.49 49.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -1.22 . . . . 16.66 109.157 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.09 -6.2 75.95 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.401 -1.08 . . . . 16.66 110.401 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 60' ' ' PHE . 16.9 pttt -131.25 142.53 50.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.959 -1.318 . . . . 50.0 110.001 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.884 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.9 mt -112.52 133.55 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.639 -0.663 . . . . 16.66 109.495 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.0 p -106.47 167.8 9.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.866 . . . . 50.0 108.934 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.15 -45.53 53.29 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.072 -1.017 . . . . 50.0 108.93 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -57.22 -41.4 79.43 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.218 -0.926 . . . . 50.0 109.259 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.5 mt-10 -74.35 -54.85 6.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.346 -0.846 . . . . 16.66 109.001 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.775 HD22 HG13 ' A' ' 46' ' ' VAL . 6.1 tt -58.57 -48.58 80.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.869 . . . . 16.66 108.771 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.719 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -60.02 -43.44 98.2 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.308 -1.517 . . . . 16.66 109.308 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 19.0 mt-10 -56.81 -42.92 80.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.307 -1.114 . . . . 50.0 109.706 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.533 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.1 -39.41 68.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.116 -0.99 . . . . 50.0 108.502 179.526 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.997 HD12 HG22 ' A' ' 46' ' ' VAL . 14.0 mt -59.88 -33.3 71.65 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.56 -0.713 . . . . 99.99 109.865 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.4 mttm -43.97 -26.45 0.28 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 99.99 109.593 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.571 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.0 t -51.9 -24.56 6.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.286 -0.884 . . . . 99.99 109.288 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -61.84 -33.16 73.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 50.0 109.226 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.34 2.48 54.49 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.81 -1.316 . . . . 16.66 109.81 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.09 56.2 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.07 -1.253 . . . . 16.66 110.024 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.421 HG13 ' OE1' ' A' ' 45' ' ' GLU . 7.3 tt -138.38 167.54 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 50.0 109.41 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.17 165.18 17.0 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.617 -0.883 . . . . 16.66 108.617 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.21 -32.28 21.17 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.115 1.876 . . . . 50.0 110.192 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -64.22 -25.77 68.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.713 -0.617 . . . . 50.0 110.077 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' OE1' HG13 ' A' ' 41' ' ' ILE . 92.3 mt-10 -81.91 -41.3 21.1 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.854 -1.154 . . . . 16.66 108.133 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.997 HG22 HD12 ' A' ' 35' ' ' LEU . 69.3 t -62.76 -35.8 72.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.959 -0.756 . . . . 50.0 108.959 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -68.42 -38.21 81.01 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.754 -0.832 . . . . 50.0 108.754 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -66.71 -35.97 81.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.389 -0.819 . . . . 50.0 109.245 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.427 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.2 mtt -60.86 -46.67 89.69 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.147 -0.971 . . . . 16.66 108.622 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.527 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 53.5 mtp -61.92 -48.88 78.46 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.928 -0.767 . . . . 50.0 108.928 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.11 -21.67 13.8 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.282 -0.886 . . . . 50.0 109.177 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -98.5 -36.37 9.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 16.66 109.19 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.648 HG22 HD12 ' A' ' 61' ' ' ILE . 83.2 mt -81.22 -30.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.548 -0.72 . . . . 50.0 109.766 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.2 t0 -61.66 101.84 0.22 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.439 -0.788 . . . . 16.66 109.363 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.496 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 71.6 p -73.54 -47.78 38.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.28 -0.888 . . . . 50.0 110.868 -179.017 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.481 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 10.9 p-10 -85.45 -29.5 24.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.037 -1.039 . . . . 16.66 109.821 -179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 92.59 27.07 15.64 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.837 -1.173 . . . . 16.66 110.836 178.744 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.481 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p-10 -82.06 -2.68 52.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.785 -1.42 . . . . 50.0 109.424 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.527 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.3 -5.08 60.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.345 -1.102 . . . . 16.66 110.345 179.284 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.571 ' CE1' ' HE3' ' A' ' 25' ' ' LYS . 43.0 m-85 -134.28 153.69 51.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.987 -1.302 . . . . 50.0 111.093 -179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.648 HD12 HG22 ' A' ' 53' ' ' ILE . 33.0 mm -105.05 128.62 58.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.516 -0.92 . . . . 16.66 108.516 178.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 m -94.87 167.2 11.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.159 -0.963 . . . . 16.66 108.613 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.621 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 35.5 t80 -54.78 -42.6 71.93 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.059 -1.025 . . . . 16.66 108.625 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -60.74 -48.46 81.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.561 -0.712 . . . . 50.0 109.166 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.549 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 42.8 mt-10 -59.83 -46.9 87.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 16.66 109.224 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.796 ' CE1' HD11 ' A' ' 77' ' ' LEU . 59.4 t80 -62.49 -38.63 90.65 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.492 -0.755 . . . . 16.66 109.398 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 16.6 m -66.04 -47.62 73.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.392 -0.818 . . . . 50.0 109.341 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.14 -36.7 75.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 50.0 109.463 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.577 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.82 -36.72 56.71 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.656 -0.868 . . . . 50.0 108.656 179.929 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.13 -31.09 64.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.209 -1.556 . . . . 16.66 109.209 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 67' ' ' THR . 71.6 mtp180 -67.7 -31.17 70.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -1.066 . . . . 50.0 108.957 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.56 -21.9 64.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.506 -0.746 . . . . 50.0 109.356 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.779 ' CG ' HD12 ' A' ' 76' ' ' LEU . 4.4 p30 -150.11 58.54 0.97 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 50.0 109.052 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -50.65 -38.2 44.95 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.29 -0.881 . . . . 50.0 108.685 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.16 -32.67 67.76 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.233 -1.547 . . . . 25.0 109.233 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.779 HD12 ' CG ' ' A' ' 73' ' ' ASN . 19.0 mt -64.12 -43.38 95.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.446 -1.032 . . . . 50.0 109.372 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.796 HD11 ' CE1' ' A' ' 66' ' ' PHE . 1.9 mm? -61.13 -40.29 93.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 50.0 109.786 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 15.1 mtpt -63.66 -33.93 76.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 50.0 109.623 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 79' ' ' ASP . 58.4 t0 -78.75 -49.27 13.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 50.0 109.556 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.7 p -64.56 -44.71 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 50.0 109.749 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.546 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -49.64 -39.94 37.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.683 -0.635 . . . . 50.0 109.776 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 75.1 mttt -69.91 -25.19 63.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 50.0 109.615 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.571 HG21 ' CG2' ' A' ' 37' ' ' THR . 9.4 mt -65.03 -44.67 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 50.0 109.561 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.982 -1.008 . . . . 99.99 109.492 -179.998 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.395 0.617 . . . . 50.0 109.368 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -51.35 -39.5 57.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -0.868 . . . . 50.0 109.392 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.84 -41.45 64.26 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.315 -0.866 . . . . 16.66 108.69 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.9 mm-40 -67.07 -47.06 72.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.527 -0.733 . . . . 16.66 109.069 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.646 ' NH2' HG23 ' A' ' 67' ' ' THR . 11.2 mtm180 -65.34 -39.22 92.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.351 -0.843 . . . . 50.0 109.361 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.598 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 43.8 mt-10 -66.05 -41.31 91.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.438 -0.788 . . . . 50.0 109.228 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.4 mtt180 -66.46 -40.42 89.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.455 -0.778 . . . . 50.0 109.104 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.2 mt -70.18 -46.63 71.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.381 -0.824 . . . . 50.0 108.989 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -66.01 -35.35 80.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 16.66 109.281 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 19.9 mttt -66.08 -32.7 74.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.845 . . . . 50.0 109.351 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.55 ' CZ ' ' HB3' ' A' ' 84' ' ' PHE . 52.7 mtt180 -70.12 -35.45 74.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.877 . . . . 50.0 109.09 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.915 ' HB3' HD13 ' A' ' 26' ' ' ILE . 42.3 m-85 -67.88 -49.07 64.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.385 -0.822 . . . . 16.66 109.338 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.8 t0 -57.75 103.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 16.66 108.75 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.96 -51.49 54.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.274 -0.891 . . . . 50.0 111.185 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -87.78 -26.62 22.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.798 -1.189 . . . . 16.66 109.674 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 88.56 38.87 6.9 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.79 -1.195 . . . . 16.66 110.14 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.492 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -93.72 5.53 51.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.094 -1.239 . . . . 16.66 109.214 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.93 -8.09 73.41 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.485 -1.046 . . . . 16.66 110.485 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.0 pttp -130.13 142.01 50.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.937 -1.331 . . . . 50.0 110.042 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.915 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.0 mt -111.99 133.91 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.618 -0.676 . . . . 16.66 109.538 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.6 p -106.18 166.75 10.29 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.807 -0.812 . . . . 50.0 108.807 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.88 -45.76 51.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.055 -1.028 . . . . 50.0 108.874 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.12 -40.3 76.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.301 -0.874 . . . . 50.0 109.438 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.5 mt-10 -74.44 -54.14 8.17 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.211 -0.931 . . . . 16.66 109.373 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.815 ' HG ' HD12 ' A' ' 35' ' ' LEU . 63.1 tp -62.0 -43.03 99.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 16.66 109.044 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.58 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.41 -44.01 98.24 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.239 -1.545 . . . . 16.66 109.239 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -57.81 -43.48 85.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.355 -1.085 . . . . 50.0 109.729 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.82 -39.67 69.65 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.153 -0.967 . . . . 50.0 108.521 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.994 HD23 HD11 ' A' ' 38' ' ' LEU . 2.2 mt -59.18 -33.12 70.57 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.595 -0.691 . . . . 99.99 109.69 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' LEU . 17.7 mttt -44.85 -26.42 0.4 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.999 -1.063 . . . . 99.99 109.388 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.817 ' CG2' HG21 ' A' ' 83' ' ' ILE . 10.4 t -51.81 -25.54 7.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.244 -0.91 . . . . 99.99 109.258 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.994 HD11 HD23 ' A' ' 35' ' ' LEU . 1.5 mt -63.85 -32.74 74.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -0.843 . . . . 50.0 109.308 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.46 5.76 51.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.724 -1.35 . . . . 16.66 109.724 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.76 52.37 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -1.185 . . . . 16.66 109.715 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.599 HD12 HD13 ' A' ' 38' ' ' LEU . 13.5 tt -137.56 169.89 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 50.0 109.469 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.59 163.51 32.18 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.647 -0.871 . . . . 16.66 108.647 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.23 -33.51 24.2 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.03 1.82 . . . . 50.0 110.049 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -64.46 -24.96 67.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.675 -0.64 . . . . 50.0 109.892 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -83.12 -37.06 24.27 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.862 -1.149 . . . . 16.66 108.282 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.982 HG22 HD13 ' A' ' 35' ' ' LEU . 68.9 t -68.57 -36.73 75.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.927 -0.768 . . . . 50.0 108.927 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -67.9 -39.48 83.61 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.8 -0.815 . . . . 50.0 108.8 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.25 -39.6 92.86 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.441 -0.787 . . . . 50.0 109.194 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.413 ' O ' HG13 ' A' ' 53' ' ' ILE . 11.4 mtt -58.57 -43.78 89.53 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.186 -0.946 . . . . 16.66 108.861 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.528 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 57.7 mtp -61.76 -47.95 82.86 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.535 -0.728 . . . . 50.0 109.124 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.72 -20.76 36.65 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.309 -0.869 . . . . 50.0 109.187 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -97.37 -36.51 10.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 16.66 109.123 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.582 HG22 HD12 ' A' ' 61' ' ' ILE . 83.7 mt -81.8 -32.48 11.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.426 -0.796 . . . . 50.0 109.67 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.7 t0 -60.35 101.42 0.13 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.412 -0.805 . . . . 16.66 108.957 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.471 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 60.0 p -70.19 -46.86 63.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 50.0 110.75 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -86.69 -38.41 17.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.12 -0.987 . . . . 16.66 109.542 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.99 28.82 6.72 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.93 -1.128 . . . . 16.66 110.617 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.49 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.0 p-10 -80.37 -3.22 48.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.751 -1.441 . . . . 50.0 109.155 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.528 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.89 -5.07 57.88 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.922 -1.271 . . . . 16.66 109.922 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 40.8 m-85 -134.38 156.95 47.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.016 -1.285 . . . . 50.0 111.298 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.582 HD12 HG22 ' A' ' 53' ' ' ILE . 36.3 mm -108.2 130.28 61.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.212 -1.033 . . . . 16.66 108.212 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.6 m -99.95 167.68 10.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.998 -1.064 . . . . 16.66 108.673 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 41.3 t80 -54.96 -44.49 74.43 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.177 -1.009 . . . . 16.66 108.576 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -58.37 -47.14 84.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.564 -0.71 . . . . 50.0 109.165 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.548 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.7 mt-10 -62.49 -46.54 88.02 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.27 -0.894 . . . . 16.66 109.145 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.539 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 62.5 t80 -60.31 -37.75 81.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 16.66 109.19 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.646 HG23 ' NH2' ' A' ' 11' ' ' ARG . 12.1 m -65.69 -47.59 74.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.388 -0.82 . . . . 50.0 109.09 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -59.39 -40.48 86.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 50.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.564 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.06 -37.0 58.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.687 -0.857 . . . . 50.0 108.687 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -59.16 -31.98 70.47 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.355 -1.498 . . . . 16.66 109.355 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' THR . 59.5 mtm180 -71.06 -31.12 67.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -1.165 . . . . 50.0 109.399 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.49 -20.29 62.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.366 -0.834 . . . . 50.0 109.501 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.796 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.8 m-80 -149.38 54.95 0.97 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.258 -0.901 . . . . 50.0 109.479 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -51.46 -42.6 61.71 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.163 -0.96 . . . . 50.0 108.622 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.21 -20.6 29.24 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.526 -1.43 . . . . 25.0 109.526 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.796 HD12 ' CB ' ' A' ' 73' ' ' ASN . 33.2 mt -78.62 -43.7 25.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -1.187 . . . . 50.0 109.175 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.539 HD22 ' HZ ' ' A' ' 66' ' ' PHE . 20.8 mt -61.43 -35.95 79.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 50.0 109.699 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.429 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 10.5 mtmm -60.48 -26.96 67.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 50.0 109.382 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -76.21 -37.93 57.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.222 -0.924 . . . . 50.0 109.232 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -78.51 -31.28 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 50.0 109.562 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.88 -14.88 51.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 50.0 109.614 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -96.33 -31.97 12.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.917 . . . . 50.0 108.972 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.817 HG21 ' CG2' ' A' ' 37' ' ' THR . 38.0 mt -58.86 -38.93 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.46 -0.775 . . . . 50.0 109.316 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 17' ' ' ARG . 90.9 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.041 -0.98 . . . . 99.99 109.471 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 8' ' ' LYS . 77.9 m-20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.437 0.637 . . . . 50.0 109.435 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.459 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 30.6 mtpt -43.21 -36.8 1.88 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.804 . . . . 50.0 109.759 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.23 -46.96 87.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.238 -0.914 . . . . 16.66 108.834 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 44.1 mt-10 -68.22 -38.51 81.98 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.887 -0.783 . . . . 16.66 108.887 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.667 ' NH2' HG23 ' A' ' 67' ' ' THR . 13.0 mtm180 -68.37 -39.9 81.62 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.325 -0.859 . . . . 50.0 109.496 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.639 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 13.0 mt-10 -67.4 -41.75 84.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.415 -0.803 . . . . 50.0 109.432 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.8 mtp-105 -66.16 -41.46 90.32 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.3 -0.875 . . . . 50.0 109.299 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 10' ' ' GLU . 38.6 mt -69.83 -45.47 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.247 -0.908 . . . . 50.0 109.023 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.511 ' CE1' HD11 ' A' ' 26' ' ' ILE . 73.8 t80 -63.26 -36.43 83.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.423 -0.911 . . . . 16.66 108.933 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -64.89 -30.78 71.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.384 -0.822 . . . . 50.0 109.08 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 48.2 mtt180 -68.4 -37.09 80.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 50.0 109.12 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.918 ' HB3' HD13 ' A' ' 26' ' ' ILE . 57.3 m-85 -68.67 -50.98 46.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 16.66 109.577 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 21.6 t0 -55.71 103.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 16.66 108.925 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.6 -50.52 43.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.873 . . . . 50.0 111.118 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -87.02 -30.98 20.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.714 -1.241 . . . . 16.66 109.674 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.94 35.55 6.06 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.764 -1.208 . . . . 16.66 110.205 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.496 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 34.7 p-10 -90.79 3.7 53.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.257 . . . . 16.66 109.161 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.86 -5.83 72.98 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.48 -1.048 . . . . 16.66 110.48 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.8 pttp -132.0 143.39 50.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.898 -1.354 . . . . 50.0 110.086 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.2 mt -110.85 133.42 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.375 0.607 . . . . 16.66 109.685 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.409 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 10.5 p -105.83 166.57 10.38 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.491 -0.755 . . . . 50.0 108.973 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.73 -45.78 49.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.01 -1.056 . . . . 50.0 108.843 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -56.77 -41.09 77.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.288 -0.883 . . . . 50.0 109.334 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 60.5 mt-10 -74.5 -54.83 6.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.306 -0.871 . . . . 16.66 109.248 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.884 HD22 HG13 ' A' ' 46' ' ' VAL . 7.4 tt -60.5 -45.66 92.98 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.307 -0.871 . . . . 16.66 108.867 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.715 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.89 -44.74 96.99 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.104 -1.598 . . . . 16.66 109.104 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 24.2 mt-10 -57.65 -42.16 82.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.395 -1.062 . . . . 50.0 109.546 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.88 -39.94 66.0 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.389 -0.967 . . . . 50.0 108.389 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.95 ' CD1' HG22 ' A' ' 46' ' ' VAL . 6.6 mt -58.36 -33.25 69.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.539 -0.725 . . . . 99.99 109.502 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -44.4 -27.83 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 99.99 109.579 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.653 HG21 HG21 ' A' ' 83' ' ' ILE . 6.9 t -50.14 -25.37 3.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.897 . . . . 99.99 109.111 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.948 HD12 HD12 ' A' ' 41' ' ' ILE . 22.8 mt -62.63 -33.2 74.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.467 -0.771 . . . . 50.0 109.281 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.28 6.39 53.55 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 16.66 109.549 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.63 51.78 0.57 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -1.181 . . . . 16.66 109.473 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.948 HD12 HD12 ' A' ' 38' ' ' LEU . 11.8 tt -137.09 170.97 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.95 . . . . 50.0 109.486 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.99 167.22 16.75 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 16.66 108.873 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.28 -33.74 17.71 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.202 1.934 . . . . 50.0 110.192 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.6 -29.83 70.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.625 . . . . 50.0 110.01 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -81.66 -35.81 29.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.979 -1.076 . . . . 16.66 108.314 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.95 HG22 ' CD1' ' A' ' 35' ' ' LEU . 68.4 t -67.69 -35.87 74.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.045 -0.724 . . . . 50.0 109.045 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -70.65 -37.91 73.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.77 -0.826 . . . . 50.0 108.77 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -67.49 -36.72 81.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.506 -0.746 . . . . 50.0 109.125 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.433 ' O ' HG13 ' A' ' 53' ' ' ILE . 5.5 mtt -60.6 -47.35 86.61 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.259 -0.901 . . . . 16.66 108.749 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.631 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 49.7 mtp -62.17 -47.96 82.18 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 50.0 109.1 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.24 -18.63 27.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.291 -0.881 . . . . 50.0 109.146 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -97.95 -36.15 10.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.777 . . . . 16.66 109.106 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.648 HG22 HD12 ' A' ' 61' ' ' ILE . 83.4 mt -82.15 -32.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.532 -0.73 . . . . 50.0 109.733 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.9 t0 -58.62 101.31 0.08 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.403 -0.811 . . . . 16.66 109.2 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 76.8 p -71.07 -47.13 60.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 50.0 110.58 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -85.89 -37.33 19.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.143 -0.973 . . . . 16.66 109.469 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.57 28.32 7.14 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.918 -1.135 . . . . 16.66 110.744 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 9.0 p-10 -80.38 -3.24 48.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.755 -1.438 . . . . 50.0 109.059 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.631 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.76 -3.64 59.08 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.88 -1.288 . . . . 16.66 109.88 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 26.4 m-85 -135.21 157.2 47.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.07 -1.253 . . . . 50.0 111.26 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.648 HD12 HG22 ' A' ' 53' ' ' ILE . 36.6 mm -107.86 129.53 61.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.522 -0.918 . . . . 16.66 108.522 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.18 167.61 10.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.151 -0.968 . . . . 16.66 108.664 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.639 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.5 t80 -54.44 -43.81 71.92 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.113 -1.035 . . . . 16.66 108.526 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -58.26 -50.1 74.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.537 -0.727 . . . . 50.0 109.042 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 76.6 mt-10 -60.43 -46.41 90.13 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.317 -0.864 . . . . 16.66 109.013 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.754 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 62.0 t80 -62.09 -33.63 74.79 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.041 -0.725 . . . . 16.66 109.041 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.667 HG23 ' NH2' ' A' ' 11' ' ' ARG . 6.4 m -70.12 -48.01 59.35 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.366 -0.834 . . . . 50.0 108.952 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -60.27 -39.05 85.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 50.0 109.304 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.595 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -80.01 -38.53 31.86 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.585 -0.895 . . . . 50.0 108.585 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.872 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.69 -25.8 64.02 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.323 -1.511 . . . . 16.66 109.323 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 67' ' ' THR . 69.0 mtm180 -76.8 -35.23 57.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -1.162 . . . . 50.0 109.219 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.04 -17.43 64.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 50.0 109.181 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.621 ' CB ' HD12 ' A' ' 76' ' ' LEU . 6.4 p30 -148.03 51.46 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.78 . . . . 50.0 109.219 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 73.3 mtm180 -48.18 -38.17 17.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.242 -0.911 . . . . 50.0 108.704 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.55 -23.6 49.85 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.374 -1.49 . . . . 25.0 109.374 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.621 HD12 ' CB ' ' A' ' 73' ' ' ASN . 24.8 mt -77.51 -44.96 27.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -1.101 . . . . 50.0 109.342 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.872 HD11 ' HA3' ' A' ' 70' ' ' GLY . 19.0 mt -66.89 -21.16 66.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 50.0 109.842 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 30.6 mtmt -80.02 -19.31 47.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.063 -1.023 . . . . 50.0 109.32 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.21 -36.61 16.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -0.827 . . . . 50.0 109.366 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.465 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 85.4 t -71.83 -36.15 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.395 -0.816 . . . . 50.0 108.913 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.41 -49.12 67.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.382 -0.823 . . . . 50.0 109.368 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -62.19 -28.64 69.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.823 . . . . 50.0 109.583 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.653 HG21 HG21 ' A' ' 37' ' ' THR . 39.9 mt -61.27 -32.42 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -0.968 . . . . 50.0 109.316 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 17.2 m-85 . . . . . 0 C--N 1.302 -1.498 0 CA-C-O 117.977 -1.011 . . . . 99.99 109.499 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.284 -0.635 . . . . 50.0 109.284 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -52.44 -36.91 55.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 50.0 109.462 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.26 -46.27 88.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 16.66 108.751 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' O ' HG13 ' A' ' 14' ' ' ILE . 66.6 mm-40 -66.44 -42.81 87.13 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.911 -0.774 . . . . 16.66 108.911 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.627 ' NH2' HD12 ' A' ' 77' ' ' LEU . 31.7 mtt-85 -65.1 -40.28 94.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.537 -0.727 . . . . 50.0 109.474 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 49.4 mt-10 -63.85 -40.96 97.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.424 -0.797 . . . . 50.0 109.454 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 2.5 mtt-85 -68.46 -38.93 81.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 50.0 109.105 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.542 HG22 ' HE2' ' A' ' 18' ' ' PHE . 29.9 mt -71.31 -45.95 67.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.314 -0.866 . . . . 50.0 109.003 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.533 ' CE1' HD11 ' A' ' 26' ' ' ILE . 68.1 t80 -66.09 -36.07 82.19 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.179 -0.951 . . . . 16.66 109.181 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 39.5 mttt -65.55 -30.5 71.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.289 -0.882 . . . . 50.0 109.113 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -70.29 -37.48 74.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.854 . . . . 50.0 109.007 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.862 ' HB3' HD13 ' A' ' 26' ' ' ILE . 55.5 m-85 -67.56 -48.76 65.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 16.66 109.466 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.0 t0 -58.64 103.37 0.15 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 16.66 108.826 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.04 -51.56 37.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 50.0 111.132 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -85.69 -31.14 22.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.724 -1.235 . . . . 16.66 109.672 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.83 37.66 5.42 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.748 -1.215 . . . . 16.66 110.321 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.488 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.2 p-10 -93.08 6.37 48.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.042 -1.269 . . . . 16.66 109.207 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.61 -6.37 80.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.49 -1.044 . . . . 16.66 110.49 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.6 pttt -130.05 142.02 50.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.024 -1.28 . . . . 50.0 110.002 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.862 HD13 ' HB3' ' A' ' 18' ' ' PHE . 3.8 mt -112.0 133.22 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.437 0.637 . . . . 16.66 109.443 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.403 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 17.1 p -106.31 168.49 9.11 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.415 -0.803 . . . . 50.0 109.108 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.508 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.49 -46.26 56.87 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.144 -0.973 . . . . 50.0 108.853 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.31 75.99 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.345 -0.847 . . . . 50.0 109.394 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.8 mt-10 -75.86 -54.77 6.4 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.267 -0.896 . . . . 16.66 109.122 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.853 HD22 HG13 ' A' ' 46' ' ' VAL . 5.7 tt -60.47 -46.88 88.48 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.184 -0.948 . . . . 16.66 108.939 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.689 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.09 -43.1 99.61 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.28 -1.528 . . . . 16.66 109.28 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.68 -41.86 91.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.266 -1.138 . . . . 50.0 110.011 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.38 73.21 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.163 -0.961 . . . . 50.0 108.832 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.113 HD12 HG22 ' A' ' 46' ' ' VAL . 12.8 mt -60.64 -30.92 70.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.5 -0.75 . . . . 99.99 109.798 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -43.73 -26.43 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.987 . . . . 99.99 109.616 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.447 ' CG2' HG21 ' A' ' 83' ' ' ILE . 6.3 t -52.85 -24.94 10.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.192 -0.942 . . . . 99.99 109.39 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.717 HD13 HD12 ' A' ' 41' ' ' ILE . 5.6 mt -62.38 -32.28 73.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.87 . . . . 50.0 109.269 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.62 6.72 51.4 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.596 -1.402 . . . . 16.66 109.596 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.49 57.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -1.132 . . . . 16.66 109.478 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.717 HD12 HD13 ' A' ' 38' ' ' LEU . 11.1 tt -143.38 174.17 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 50.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.9 165.98 25.29 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.304 -0.872 . . . . 16.66 108.82 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -69.43 -33.54 17.61 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.138 1.892 . . . . 50.0 110.132 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -65.07 -24.57 67.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.657 -0.652 . . . . 50.0 110.077 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -82.16 -36.66 27.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.82 -1.175 . . . . 16.66 108.402 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.113 HG22 HD12 ' A' ' 35' ' ' LEU . 53.9 t -67.57 -35.64 73.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.563 -0.711 . . . . 50.0 109.145 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -65.72 -39.24 90.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.445 -0.785 . . . . 50.0 109.095 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -67.21 -36.73 82.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.335 -0.853 . . . . 50.0 109.309 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.404 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.3 mtt -61.31 -46.22 91.18 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.183 -0.948 . . . . 16.66 108.774 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.544 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 49.2 mtp -62.56 -48.02 81.31 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.566 -0.709 . . . . 50.0 109.147 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.0 -18.73 36.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 50.0 109.123 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -98.33 -36.5 9.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 16.66 109.175 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 61' ' ' ILE . 81.6 mt -82.08 -32.49 11.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.468 -0.77 . . . . 50.0 109.667 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.8 t0 -59.51 101.52 0.11 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.349 -0.844 . . . . 16.66 109.038 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.46 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 61.0 p -68.85 -47.18 66.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -0.875 . . . . 50.0 110.658 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -86.79 -39.1 16.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 16.66 109.448 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 102.08 28.01 6.7 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.878 -1.153 . . . . 16.66 110.444 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.3 p-10 -79.02 -2.35 39.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.786 -1.42 . . . . 50.0 109.016 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.544 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.35 -2.91 59.47 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.709 -1.357 . . . . 16.66 109.709 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 25.5 m-85 -136.47 157.57 46.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.086 -1.244 . . . . 50.0 111.376 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.602 HD12 HG22 ' A' ' 53' ' ' ILE . 29.1 mm -109.76 130.24 63.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.565 -0.902 . . . . 16.66 108.565 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -97.64 168.41 10.36 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.133 -0.979 . . . . 16.66 108.599 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 37.7 t80 -55.36 -43.28 74.91 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.031 -1.043 . . . . 16.66 108.718 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -60.6 -46.4 90.4 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.553 -0.717 . . . . 50.0 109.31 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.571 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 76.7 mt-10 -62.05 -46.83 87.4 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.285 -0.884 . . . . 16.66 109.096 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.495 ' CZ ' ' CD2' ' A' ' 77' ' ' LEU . 49.8 t80 -61.06 -40.52 93.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.444 -0.785 . . . . 16.66 109.25 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.1 m -64.74 -47.32 78.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.362 -0.837 . . . . 50.0 109.209 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -58.45 -38.46 77.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 50.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.91 -35.57 50.5 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.642 -0.873 . . . . 50.0 108.642 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.546 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.14 -29.91 63.26 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.302 -1.519 . . . . 16.66 109.302 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 67' ' ' THR . 83.0 mtm180 -71.51 -29.63 65.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.124 . . . . 50.0 109.165 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' A' ' 73' ' ' ASN . . . -70.41 -21.04 62.88 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.335 -0.853 . . . . 50.0 109.278 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.807 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.4 m-80 -152.1 56.06 0.83 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 50.0 109.299 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -48.71 -38.53 21.77 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.705 -0.85 . . . . 50.0 108.705 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.08 -30.23 63.5 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.329 -1.508 . . . . 25.0 109.329 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.807 HD12 ' CB ' ' A' ' 73' ' ' ASN . 32.3 mt -69.39 -45.69 68.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -1.085 . . . . 50.0 109.464 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.627 HD12 ' NH2' ' A' ' 11' ' ' ARG . 25.4 mt -63.68 -23.11 67.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.814 . . . . 50.0 109.902 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 26.7 mtmt -79.97 -18.54 50.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.105 -0.997 . . . . 50.0 109.49 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.65 -33.39 27.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 50.0 109.3 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 t -85.36 -27.9 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.853 . . . . 50.0 109.147 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.16 -16.05 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 50.0 109.597 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 15.4 mttt -94.34 -32.92 13.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 50.0 109.275 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.447 HG21 ' CG2' ' A' ' 37' ' ' THR . 10.0 mt -58.2 -36.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.366 -0.834 . . . . 50.0 109.35 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.019 -0.991 . . . . 99.99 109.437 -179.92 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.408 0.623 . . . . 50.0 109.32 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -49.43 -36.41 22.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 50.0 109.6 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.79 -45.68 89.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.307 -0.871 . . . . 16.66 108.715 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 67.2 mt-10 -68.2 -40.45 82.17 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.46 -0.775 . . . . 16.66 109.007 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.739 ' NH2' HG23 ' A' ' 67' ' ' THR . 46.5 mtm180 -68.07 -39.95 82.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.37 -0.831 . . . . 50.0 109.33 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.572 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 43.3 mt-10 -66.75 -41.84 87.15 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.478 -0.763 . . . . 50.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 13.3 mtp180 -65.63 -40.84 92.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.28 -0.888 . . . . 50.0 109.201 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 81' ' ' ALA . 30.7 mt -70.26 -46.94 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.305 -0.872 . . . . 50.0 108.91 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -66.32 -34.99 79.24 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.216 -0.928 . . . . 16.66 108.918 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 55.0 mttm -65.15 -34.27 78.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.366 -0.834 . . . . 50.0 109.392 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.584 ' NH2' ' HB1' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -74.48 -26.11 59.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.895 . . . . 50.0 109.227 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.951 ' HB3' HD13 ' A' ' 26' ' ' ILE . 23.3 m-85 -73.45 -43.21 60.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 16.66 109.057 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.6 t0 -63.72 103.26 0.53 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.334 -0.854 . . . . 16.66 108.757 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.13 64.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.161 -0.962 . . . . 50.0 111.248 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -89.49 -27.18 20.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.727 -1.233 . . . . 16.66 109.705 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.66 35.1 8.01 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.096 -1.201 . . . . 16.66 110.096 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 37.1 p-10 -88.85 4.04 49.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -1.198 . . . . 16.66 109.21 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.99 -5.76 72.47 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.381 -1.087 . . . . 16.66 110.381 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.5 pttp -132.34 143.32 49.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.948 -1.325 . . . . 50.0 110.068 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.951 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.8 mt -111.46 134.54 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.652 -0.655 . . . . 16.66 109.45 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.5 p -106.61 166.22 10.72 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.299 -0.876 . . . . 50.0 108.712 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.5 -45.6 47.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.041 -1.037 . . . . 50.0 108.843 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.19 75.82 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.363 -0.836 . . . . 50.0 109.521 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.507 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.8 mt-10 -75.82 -54.51 6.81 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.198 -0.939 . . . . 16.66 109.291 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.636 ' HG ' HD12 ' A' ' 35' ' ' LEU . 58.3 tp -61.84 -43.05 99.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 16.66 108.955 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.528 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.27 -44.29 97.89 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.233 -1.547 . . . . 16.66 109.233 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -58.54 -43.23 89.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.308 -1.113 . . . . 50.0 109.724 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HB1' ' NH2' ' A' ' 17' ' ' ARG . . . -73.06 -40.73 64.83 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.088 -1.007 . . . . 50.0 108.333 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.076 HD13 HG22 ' A' ' 46' ' ' VAL . 7.5 mt -58.64 -32.61 69.21 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.568 -0.707 . . . . 99.99 109.423 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -44.98 -26.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 99.99 109.423 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 t -49.17 -24.87 1.88 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 99.99 109.026 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.82 HD13 HD12 ' A' ' 41' ' ' ILE . 16.7 mt -58.87 -33.45 70.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.499 -0.751 . . . . 50.0 109.101 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.06 -0.39 58.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.885 -1.286 . . . . 16.66 109.885 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.07 58.62 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.251 . . . . 16.66 109.965 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.82 HD12 HD13 ' A' ' 38' ' ' LEU . 10.8 tt -138.1 173.18 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.098 -1.001 . . . . 50.0 109.528 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.27 163.02 40.69 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.642 -0.873 . . . . 16.66 108.642 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.15 -33.27 25.34 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.009 1.806 . . . . 50.0 110.083 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.92 -26.29 68.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.636 -0.665 . . . . 50.0 109.95 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -82.1 -36.87 27.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.855 -1.153 . . . . 16.66 108.431 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.076 HG22 HD13 ' A' ' 35' ' ' LEU . 47.1 t -68.96 -36.67 75.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.038 -0.727 . . . . 50.0 109.038 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -65.65 -40.15 92.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.475 -0.766 . . . . 50.0 109.028 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -65.48 -40.89 93.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 50.0 109.257 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.1 mtt -58.68 -43.52 89.99 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.243 -0.911 . . . . 16.66 108.817 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.723 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 31.7 mtp -61.45 -47.55 85.18 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.451 -0.781 . . . . 50.0 109.245 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.04 -20.56 54.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 50.0 109.28 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -95.4 -36.35 11.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.398 -0.814 . . . . 16.66 109.047 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.576 HG22 HD12 ' A' ' 61' ' ' ILE . 82.4 mt -81.92 -31.46 10.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 50.0 109.699 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.9 t0 -60.93 101.46 0.15 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.439 -0.788 . . . . 16.66 108.989 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.469 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 55.6 p -69.72 -46.1 66.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 50.0 110.71 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.489 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.0 p-10 -87.6 -40.32 14.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.106 -0.996 . . . . 16.66 109.502 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 102.95 29.67 5.73 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.932 -1.128 . . . . 16.66 110.523 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.489 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.8 p-10 -81.41 -3.74 53.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.865 -1.374 . . . . 50.0 109.144 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.723 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.66 -3.41 57.57 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.857 -1.297 . . . . 16.66 109.857 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.8 m-85 -135.85 156.58 48.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.059 -1.259 . . . . 50.0 111.15 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.576 HD12 HG22 ' A' ' 53' ' ' ILE . 35.0 mm -108.88 129.91 62.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.397 -0.964 . . . . 16.66 108.397 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.55 167.42 10.6 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.057 -1.027 . . . . 16.66 108.812 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.5 t80 -54.21 -43.62 70.94 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.297 -0.961 . . . . 16.66 108.521 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -58.93 -47.9 83.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.525 -0.735 . . . . 50.0 109.085 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.559 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 81.2 mt-10 -62.34 -46.94 86.4 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.288 -0.883 . . . . 16.66 109.119 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.626 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 51.2 t80 -59.52 -39.14 82.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.426 -0.796 . . . . 16.66 109.103 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.739 HG23 ' NH2' ' A' ' 11' ' ' ARG . 18.0 m -66.42 -46.68 75.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 50.0 109.089 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.0 -40.76 85.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 50.0 109.246 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.574 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -75.89 -36.8 59.37 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.566 -0.901 . . . . 50.0 108.566 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.688 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.96 -34.17 77.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.2 -1.56 . . . . 16.66 109.2 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 67' ' ' THR . 74.4 mtm180 -65.95 -33.48 75.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -1.12 . . . . 50.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.438 ' O ' ' OD1' ' A' ' 73' ' ' ASN . . . -67.68 -20.99 65.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.834 . . . . 50.0 109.301 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.84 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.7 m-80 -152.24 56.43 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 50.0 109.162 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -49.6 -37.09 26.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.334 -0.854 . . . . 50.0 108.736 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.37 -31.16 69.33 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.22 -1.552 . . . . 25.0 109.22 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.84 HD12 ' CB ' ' A' ' 73' ' ' ASN . 50.6 mt -67.26 -44.88 78.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -1.09 . . . . 50.0 109.419 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.688 HD11 ' HA3' ' A' ' 70' ' ' GLY . 19.9 mt -63.77 -31.43 72.61 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.321 -0.862 . . . . 50.0 109.766 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -64.58 -27.13 68.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 50.0 109.255 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -76.26 -34.65 59.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 50.0 109.517 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.418 HG13 ' HE2' ' A' ' 84' ' ' PHE . 23.4 t -81.03 -31.22 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 50.0 109.601 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 14' ' ' ILE . . . -63.4 -19.02 64.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 50.0 109.691 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -89.39 -30.57 18.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 50.0 109.137 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.8 mt -64.97 -36.59 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.382 -0.824 . . . . 50.0 109.24 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.569 ' CE1' ' NH2' ' A' ' 17' ' ' ARG . 61.2 m-85 . . . . . 0 C--N 1.302 -1.483 0 CA-C-O 117.99 -1.005 . . . . 99.99 109.544 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.404 0.621 . . . . 50.0 109.394 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -53.29 -35.92 60.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 50.0 109.196 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 -45.74 90.26 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.853 -0.795 . . . . 16.66 108.853 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 14' ' ' ILE . 59.7 mm-40 -68.53 -40.55 80.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 16.66 108.832 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.827 ' NH1' HG23 ' A' ' 67' ' ' THR . 19.8 mtm180 -68.11 -38.95 82.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.458 -0.776 . . . . 50.0 109.377 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.641 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 8.7 mt-10 -68.03 -39.83 83.01 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.433 -0.792 . . . . 50.0 109.346 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 5.6 mtt180 -67.08 -40.53 87.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.293 -0.879 . . . . 50.0 109.267 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.641 HG22 ' HE2' ' A' ' 18' ' ' PHE . 25.6 mt -70.28 -46.62 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.383 -0.823 . . . . 50.0 108.865 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.42 ' CE1' HD11 ' A' ' 26' ' ' ILE . 70.5 t80 -63.56 -35.74 81.48 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.339 -0.851 . . . . 16.66 109.097 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -66.19 -30.43 70.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 50.0 109.229 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 74.8 mtt180 -69.17 -38.1 78.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 50.0 109.256 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.805 ' HB3' HD13 ' A' ' 26' ' ' ILE . 67.2 m-85 -67.42 -49.13 65.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 16.66 109.49 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.1 t0 -56.48 103.48 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 16.66 108.746 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.91 -51.56 46.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.274 -0.891 . . . . 50.0 111.247 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -86.92 -30.0 21.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.719 -1.238 . . . . 16.66 109.856 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 92.95 37.39 5.73 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.777 -1.202 . . . . 16.66 110.179 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.492 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 37.7 p-10 -92.87 5.38 51.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -1.2 . . . . 16.66 109.243 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.95 -7.01 76.83 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.138 -1.03 . . . . 16.66 110.568 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.1 pttm -130.49 142.25 50.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.908 -1.348 . . . . 50.0 109.872 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.805 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.1 mt -111.93 133.22 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.36 0.6 . . . . 16.66 109.527 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.9 p -105.02 166.83 10.11 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.856 -0.794 . . . . 50.0 108.856 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.1 -45.29 52.58 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.157 -0.965 . . . . 50.0 108.887 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.39 78.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.317 -0.865 . . . . 50.0 109.474 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.7 mt-10 -74.99 -54.3 7.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.165 -0.959 . . . . 16.66 109.334 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.805 ' O ' HD23 ' A' ' 31' ' ' LEU . 1.9 tt -61.94 -43.98 97.71 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.283 -0.886 . . . . 16.66 108.798 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.755 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -63.66 -44.48 96.36 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.191 -1.564 . . . . 16.66 109.191 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -59.82 -41.45 91.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.324 -1.104 . . . . 50.0 109.892 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.98 -39.87 68.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.129 -0.982 . . . . 50.0 108.732 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.054 HD12 HG22 ' A' ' 46' ' ' VAL . 8.4 mt -60.21 -30.83 69.64 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.5 -0.75 . . . . 99.99 109.865 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -44.31 -25.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -1.0 . . . . 99.99 109.865 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.687 ' CG2' HG21 ' A' ' 83' ' ' ILE . 6.6 t -50.77 -23.15 2.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.156 -0.965 . . . . 99.99 109.22 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.854 HD12 HD12 ' A' ' 41' ' ' ILE . 25.6 mt -60.74 -33.69 73.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 50.0 109.312 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.46 -0.74 59.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.777 -1.329 . . . . 16.66 109.777 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 40' ' ' SER . 2.3 t -155.25 66.45 0.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.114 -1.227 . . . . 16.66 109.654 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.854 HD12 HD12 ' A' ' 38' ' ' LEU . 14.2 tt -149.26 168.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.141 -0.974 . . . . 50.0 109.598 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.83 163.9 22.24 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 16.66 108.872 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 49.8 Cg_endo -70.66 -30.7 17.72 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.078 1.852 . . . . 50.0 109.94 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.75 -23.49 66.1 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.54 -0.725 . . . . 50.0 110.078 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.4 ' OE1' HG13 ' A' ' 41' ' ' ILE . 86.1 mt-10 -79.87 -35.13 38.57 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.891 -1.13 . . . . 16.66 108.505 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.054 HG22 HD12 ' A' ' 35' ' ' LEU . 55.0 t -69.39 -35.75 68.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.909 -0.774 . . . . 50.0 108.909 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 82.7 mttt -62.36 -40.25 95.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.432 -0.792 . . . . 50.0 108.994 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.37 -39.42 92.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.433 -0.792 . . . . 50.0 109.299 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.438 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.9 mtt -59.48 -45.2 92.34 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.239 -0.913 . . . . 16.66 108.854 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.52 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 50.1 mtp -62.27 -48.68 78.83 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.439 -0.788 . . . . 50.0 109.122 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.7 -19.02 24.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 50.0 109.362 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -99.78 -36.3 9.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 16.66 109.306 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.596 HG12 ' CD2' ' A' ' 69' ' ' PHE . 80.2 mt -82.5 -32.93 10.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.451 -0.781 . . . . 50.0 109.816 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.7 t0 -59.52 101.23 0.1 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.289 -0.882 . . . . 16.66 108.999 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.473 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 54.6 p -66.19 -46.37 77.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 50.0 110.64 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -88.85 -42.18 12.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 16.66 109.634 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 104.14 29.82 5.31 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.203 -1.159 . . . . 16.66 110.203 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 13.0 p-10 -80.46 -2.45 45.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.983 -1.304 . . . . 50.0 109.134 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.52 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 100.04 -3.47 57.05 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.767 -1.333 . . . . 16.66 109.767 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.576 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 30.6 m-85 -137.01 156.35 48.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.006 -1.291 . . . . 50.0 111.49 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.543 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 25.5 mm -109.67 130.68 62.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.308 -0.997 . . . . 16.66 108.308 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 m -99.47 168.7 9.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.023 -1.048 . . . . 16.66 108.714 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.641 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 36.5 t80 -54.97 -43.44 73.5 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.169 -1.012 . . . . 16.66 108.655 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -59.92 -48.63 80.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.608 -0.683 . . . . 50.0 109.237 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.543 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 79.6 mt-10 -60.6 -47.03 88.02 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.291 -0.881 . . . . 16.66 109.064 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CE1' HD13 ' A' ' 77' ' ' LEU . 52.4 t80 -63.18 -32.66 74.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.437 -0.789 . . . . 16.66 109.255 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.827 HG23 ' NH1' ' A' ' 11' ' ' ARG . 51.9 m -68.26 -49.11 62.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 50.0 109.302 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -59.35 -36.9 76.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.26 -0.9 . . . . 50.0 109.381 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.74 -37.5 41.12 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.494 -0.928 . . . . 50.0 108.494 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.955 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.69 -29.2 63.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.197 -1.561 . . . . 16.66 109.197 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 67' ' ' THR . 80.5 mtm180 -71.3 -33.12 69.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.348 -1.089 . . . . 50.0 109.051 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.35 -20.81 65.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.832 . . . . 50.0 109.273 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.842 ' CB ' HD12 ' A' ' 76' ' ' LEU . 7.8 m-80 -146.24 58.37 1.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.396 -0.815 . . . . 50.0 109.114 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 65.9 mtm180 -51.35 -37.58 48.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 50.0 108.922 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.37 -27.82 70.01 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.348 -1.501 . . . . 25.0 109.348 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.842 HD12 ' CB ' ' A' ' 73' ' ' ASN . 22.4 mt -69.07 -45.38 70.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.387 -1.067 . . . . 50.0 109.67 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.955 HD11 ' HA3' ' A' ' 70' ' ' GLY . 4.3 mt -70.38 -19.41 63.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.389 -0.819 . . . . 50.0 109.874 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 40.7 mtmt -80.02 -27.05 39.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.104 -0.997 . . . . 50.0 109.508 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -91.41 -43.12 9.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 50.0 109.507 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.4 p -59.58 -45.46 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.776 0.798 . . . . 50.0 109.105 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.552 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -48.78 -38.33 21.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.716 -0.615 . . . . 50.0 109.85 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -69.58 -24.8 63.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 50.0 109.602 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.687 HG21 ' CG2' ' A' ' 37' ' ' THR . 13.6 mt -64.26 -45.43 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.383 -0.823 . . . . 50.0 109.556 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.461 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 80.1 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.02 -0.99 . . . . 99.99 109.362 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.233 -0.654 . . . . 50.0 109.233 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -52.02 -36.91 51.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.429 -0.794 . . . . 50.0 109.387 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.99 -46.16 85.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.567 -0.901 . . . . 16.66 108.567 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 14' ' ' ILE . 64.9 mt-10 -67.73 -39.52 84.25 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.854 -0.795 . . . . 16.66 108.854 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.422 ' NH1' ' HG ' ' A' ' 77' ' ' LEU . 55.2 mtt-85 -65.96 -40.4 91.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 50.0 109.336 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.59 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 44.0 mt-10 -64.86 -40.43 95.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.412 -0.805 . . . . 50.0 109.228 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.473 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 65.4 mtp180 -67.52 -40.48 85.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.347 -0.846 . . . . 50.0 109.236 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 10' ' ' GLU . 22.0 mt -70.37 -45.23 75.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.363 -0.835 . . . . 50.0 108.906 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.52 -36.03 82.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.273 -0.892 . . . . 16.66 109.008 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -65.76 -30.19 70.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.368 -0.832 . . . . 50.0 109.147 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.485 ' CD ' ' HB3' ' A' ' 84' ' ' PHE . 49.7 mtt85 -71.35 -34.76 70.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 50.0 109.22 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.93 ' HB3' HD13 ' A' ' 26' ' ' ILE . 42.9 m-85 -72.83 -47.98 41.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.418 -0.801 . . . . 16.66 109.432 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.468 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.7 t0 -59.22 103.28 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 16.66 108.499 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 -51.72 51.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.891 . . . . 50.0 111.426 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -87.7 -26.14 23.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.754 -1.216 . . . . 16.66 109.799 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 88.04 38.57 7.3 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.747 -1.216 . . . . 16.66 110.091 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -92.84 5.43 51.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -1.215 . . . . 16.66 109.206 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.09 -7.54 72.89 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.346 -1.101 . . . . 16.66 110.346 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 35.5 pttt -130.37 142.23 50.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.927 -1.337 . . . . 50.0 110.023 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.93 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.9 mt -112.33 134.22 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.63 -0.669 . . . . 16.66 109.39 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 p -107.21 167.64 9.77 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.36 -0.837 . . . . 50.0 108.823 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.513 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.28 -45.99 54.86 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.046 -1.034 . . . . 50.0 108.823 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.16 74.29 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.349 -0.844 . . . . 50.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.5 mt-10 -77.14 -54.17 6.85 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -0.947 . . . . 16.66 109.321 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.597 HD12 ' CE1' ' A' ' 18' ' ' PHE . 32.3 tp -63.12 -41.76 99.4 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.202 -0.936 . . . . 16.66 108.93 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.727 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -64.6 -44.9 94.37 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.199 -1.56 . . . . 16.66 109.199 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -59.07 -41.84 88.91 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.346 -1.091 . . . . 50.0 109.709 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.402 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.96 -40.2 65.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.161 -0.962 . . . . 50.0 108.554 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.798 ' CD1' HG22 ' A' ' 46' ' ' VAL . 11.3 mt -60.69 -31.22 70.49 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.52 -0.738 . . . . 99.99 109.564 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' LEU . 5.3 mttt -45.53 -25.56 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.018 -1.051 . . . . 99.99 109.48 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.615 ' CG2' HG21 ' A' ' 83' ' ' ILE . 9.6 t -52.04 -23.78 5.74 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.916 . . . . 99.99 109.183 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.68 HD13 HD12 ' A' ' 41' ' ' ILE . 9.2 mt -59.49 -33.27 71.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.352 -0.843 . . . . 50.0 109.216 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.13 0.75 57.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.719 -1.352 . . . . 16.66 109.719 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 t -154.72 64.64 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -1.204 . . . . 16.66 109.711 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.68 HD12 HD13 ' A' ' 38' ' ' LEU . 9.3 tt -147.09 175.6 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 50.0 109.42 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.91 164.52 34.54 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.254 -0.903 . . . . 16.66 108.781 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 46.7 Cg_endo -69.21 -33.27 19.07 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.117 1.878 . . . . 50.0 110.142 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -66.75 -22.86 66.04 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.25 -0.58 . . . . 50.0 110.102 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -82.33 -39.66 22.51 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.883 -1.135 . . . . 16.66 108.398 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.798 HG22 ' CD1' ' A' ' 35' ' ' LEU . 67.2 t -65.66 -35.91 76.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.69 -0.855 . . . . 50.0 108.69 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 81.4 mttt -67.17 -39.73 86.48 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.909 -0.774 . . . . 50.0 108.909 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.13 -40.92 91.03 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.428 -0.795 . . . . 50.0 109.183 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.421 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.9 mtt -59.65 -44.3 93.59 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.21 -0.931 . . . . 16.66 108.868 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.685 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 28.1 mtp -61.69 -47.15 86.6 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -0.762 . . . . 50.0 109.128 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.75 -22.07 44.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 50.0 109.141 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.19 -35.95 12.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 16.66 108.989 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.571 HG12 ' CD2' ' A' ' 69' ' ' PHE . 85.6 mt -80.77 -30.95 12.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.47 -0.769 . . . . 50.0 109.438 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.1 t0 -61.04 100.78 0.12 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.465 -0.772 . . . . 16.66 109.027 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.503 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 60.7 p -71.41 -46.5 60.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.288 -0.883 . . . . 50.0 110.436 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -31.02 22.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.135 -0.978 . . . . 16.66 109.534 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.477 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 93.11 28.31 12.05 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.847 -1.168 . . . . 16.66 110.222 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.8 -2.94 55.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.93 -1.335 . . . . 50.0 109.414 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.685 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.47 -7.12 59.59 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.999 -1.096 . . . . 16.66 110.457 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 42.1 m-85 -133.76 155.83 49.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.895 -1.356 . . . . 50.0 111.23 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.56 HD12 HG22 ' A' ' 53' ' ' ILE . 28.6 mm -106.68 127.81 61.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.516 -0.92 . . . . 16.66 108.516 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.53 166.27 12.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.158 -0.964 . . . . 16.66 108.626 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.59 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 35.8 t80 -54.3 -41.96 69.54 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.085 -1.009 . . . . 16.66 108.588 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -61.42 -49.68 75.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.969 -0.752 . . . . 50.0 108.969 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.552 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 33.9 mt-10 -58.28 -47.21 84.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 16.66 109.023 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.751 ' CE2' HD11 ' A' ' 77' ' ' LEU . 63.6 t80 -61.48 -40.48 94.71 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.52 -0.737 . . . . 16.66 109.294 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 13.3 m -65.16 -47.04 78.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.405 -0.809 . . . . 50.0 109.242 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -59.72 -37.79 79.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 50.0 109.349 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.71 -37.42 41.53 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.264 -0.897 . . . . 50.0 108.703 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.415 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -60.64 -28.9 68.63 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.361 -1.496 . . . . 16.66 109.361 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 67' ' ' THR . 67.8 mtm180 -73.3 -34.54 65.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -1.126 . . . . 50.0 109.24 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.83 -17.71 65.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 50.0 109.341 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.78 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.2 m-80 -148.33 55.28 1.03 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 50.0 109.275 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 75' ' ' GLY . 10.4 ptm180 -50.58 -41.42 54.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 50.0 108.806 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.444 ' N ' ' HG3' ' A' ' 74' ' ' ARG . . . -54.38 -20.2 15.45 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.343 -1.503 . . . . 25.0 109.343 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.78 HD12 ' CB ' ' A' ' 73' ' ' ASN . 48.5 mt -80.02 -43.0 22.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.313 -1.11 . . . . 50.0 109.373 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.751 HD11 ' CE2' ' A' ' 66' ' ' PHE . 1.8 mm? -61.27 -41.15 96.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.468 -0.77 . . . . 50.0 109.82 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.7 mtpp -63.05 -38.4 91.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 50.0 109.378 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -73.48 -49.44 26.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.41 -0.806 . . . . 50.0 109.57 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 77' ' ' LEU . 4.1 p -66.05 -43.17 92.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.372 -0.83 . . . . 50.0 109.589 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.534 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.25 -39.74 45.85 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.225 -0.59 . . . . 50.0 109.884 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 34.9 mttm -66.86 -26.02 66.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.935 . . . . 50.0 109.686 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.615 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.2 mt -63.17 -45.22 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 50.0 109.466 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.485 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 92.1 m-85 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.997 -1.001 . . . . 99.99 109.435 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.486 ' HB3' ' NH1' ' A' ' 11' ' ' ARG . 59.3 m-20 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.3 -0.63 . . . . 50.0 109.3 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -50.39 -37.48 37.77 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.437 -0.789 . . . . 50.0 109.359 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.99 -45.23 79.07 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.476 -0.935 . . . . 16.66 108.476 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 14' ' ' ILE . 53.0 mt-10 -65.44 -45.35 84.13 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.908 -0.775 . . . . 16.66 108.908 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.486 ' NH1' ' HB3' ' A' ' 7' ' ' ASP . 41.9 mtt180 -63.08 -40.93 99.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.395 -0.815 . . . . 50.0 109.395 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.584 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 7.4 mt-10 -64.88 -43.49 92.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.428 -0.795 . . . . 50.0 109.407 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.477 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.6 mtt180 -65.94 -41.36 91.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.888 . . . . 50.0 109.13 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 77' ' ' LEU . 26.0 mt -69.74 -44.53 79.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.302 -0.874 . . . . 50.0 109.19 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.467 ' CE2' HD11 ' A' ' 26' ' ' ILE . 62.0 t80 -66.91 -35.96 81.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.167 -0.958 . . . . 16.66 109.258 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -63.95 -32.4 73.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 50.0 109.383 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 62.7 mtt180 -70.88 -37.15 73.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 50.0 109.047 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.041 ' HB3' HD13 ' A' ' 26' ' ' ILE . 33.8 m-85 -68.43 -47.0 68.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 16.66 109.595 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.471 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.6 t0 -62.52 103.44 0.41 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 16.66 108.937 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.21 -50.88 43.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 50.0 111.213 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -86.34 -31.09 21.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.714 -1.241 . . . . 16.66 109.688 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.94 36.48 5.76 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.805 -1.188 . . . . 16.66 110.27 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.6 p-10 -92.02 4.01 53.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.074 -1.25 . . . . 16.66 109.377 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.78 -6.15 73.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.367 -1.093 . . . . 16.66 110.367 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 10.1 pttm -131.32 143.02 50.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.926 -1.338 . . . . 50.0 109.991 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.041 HD13 ' HB3' ' A' ' 18' ' ' PHE . 4.6 mt -111.97 133.64 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.462 0.648 . . . . 16.66 109.645 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.406 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 13.3 p -106.67 167.97 9.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.473 -0.767 . . . . 50.0 108.947 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.38 -46.35 56.0 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.066 -1.021 . . . . 50.0 108.822 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -56.31 -40.89 75.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.309 -0.869 . . . . 50.0 109.441 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.3 mt-10 -75.19 -54.44 7.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.23 -0.919 . . . . 16.66 109.251 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.804 HD22 HG13 ' A' ' 46' ' ' VAL . 7.2 tt -60.35 -45.27 94.08 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.295 -0.878 . . . . 16.66 108.799 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.614 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.21 -45.03 96.18 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.048 -1.621 . . . . 16.66 109.048 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 16.8 mt-10 -57.13 -42.89 81.77 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.329 -1.1 . . . . 50.0 109.579 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.06 -39.95 65.47 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.133 -0.979 . . . . 50.0 108.379 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.895 ' CD1' HG22 ' A' ' 46' ' ' VAL . 5.3 mt -59.16 -33.04 70.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.599 -0.688 . . . . 99.99 109.6 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -44.64 -26.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.076 -1.015 . . . . 99.99 109.455 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.505 ' CG2' HG21 ' A' ' 83' ' ' ILE . 8.5 t -53.11 -25.53 13.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 99.99 109.363 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.528 HD12 ' CD1' ' A' ' 41' ' ' ILE . 20.5 mt -61.31 -32.34 72.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 50.0 109.151 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.3 9.76 44.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.591 -1.404 . . . . 16.66 109.591 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.54 51.35 0.51 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -1.184 . . . . 16.66 109.444 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.528 ' CD1' HD12 ' A' ' 38' ' ' LEU . 5.5 tt -140.08 175.82 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 50.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.2 167.37 19.05 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.344 -0.848 . . . . 16.66 108.825 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.96 -34.41 17.44 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.972 1.782 . . . . 50.0 110.028 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.81 -29.24 70.03 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.711 -0.618 . . . . 50.0 109.919 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -80.87 -38.8 27.48 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.999 -1.063 . . . . 16.66 108.214 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.895 HG22 ' CD1' ' A' ' 35' ' ' LEU . 47.9 t -63.73 -36.97 78.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.023 -0.732 . . . . 50.0 109.023 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -70.23 -37.38 74.97 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.761 -0.829 . . . . 50.0 108.761 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.517 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.3 t60 -67.46 -37.75 83.41 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.347 -0.846 . . . . 50.0 109.203 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.3 mtt -60.93 -46.76 89.4 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.092 -1.005 . . . . 16.66 108.871 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.666 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 38.9 mtp -61.74 -47.64 84.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.537 -0.727 . . . . 50.0 109.213 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.03 -19.58 45.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 50.0 109.469 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.433 ' CD ' ' NE2' ' A' ' 48' ' ' HIS . 26.8 mt-10 -97.24 -35.8 10.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 16.66 109.108 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.571 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.6 mt -81.87 -32.5 11.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 50.0 109.658 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.4 t0 -59.11 101.37 0.09 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.352 -0.842 . . . . 16.66 109.094 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 46.5 p -69.54 -46.19 67.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.222 -0.924 . . . . 50.0 110.584 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -87.48 -38.13 16.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.967 . . . . 16.66 109.456 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 101.06 27.93 7.13 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.993 -1.099 . . . . 16.66 110.581 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.487 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 p-10 -79.45 -2.24 41.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.768 -1.43 . . . . 50.0 109.079 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.666 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.86 -4.97 59.5 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.996 -1.242 . . . . 16.66 109.996 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 28.1 m-85 -134.7 157.48 46.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.029 -1.277 . . . . 50.0 111.259 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.558 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 29.9 mm -108.59 128.17 64.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.172 -1.047 . . . . 16.66 108.172 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.406 ' H ' ' HB2' ' A' ' 65' ' ' GLU . 15.2 m -94.54 169.56 10.11 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.143 -0.973 . . . . 16.66 108.761 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.584 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 33.0 t80 -56.34 -43.22 78.84 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.223 -0.923 . . . . 16.66 108.943 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -62.53 -44.83 95.38 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.594 -0.691 . . . . 50.0 109.219 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.558 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 55.1 mt-10 -62.17 -47.43 84.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 16.66 109.157 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 46.1 t80 -62.65 -36.12 81.82 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.398 -0.814 . . . . 16.66 109.296 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.45 HG23 ' CD ' ' A' ' 11' ' ' ARG . 36.7 m -68.4 -47.16 68.05 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.29 -0.881 . . . . 50.0 109.148 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 71' ' ' ARG . 74.2 m-20 -58.95 -36.75 75.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 50.0 109.307 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.31 -36.48 53.99 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.496 -0.927 . . . . 50.0 108.496 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.873 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.02 -30.48 63.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.109 -1.597 . . . . 16.66 109.109 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.518 ' NH2' ' OD1' ' A' ' 68' ' ' ASP . 52.2 mtm180 -69.18 -30.75 69.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -1.067 . . . . 50.0 108.928 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.66 -21.66 63.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.441 -0.787 . . . . 50.0 109.261 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.765 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.4 m-80 -150.58 57.01 0.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.392 -0.818 . . . . 50.0 109.192 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 7.0 ptp85 -49.27 -36.99 22.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.284 -0.885 . . . . 50.0 108.781 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.439 ' HA2' ' HE2' ' A' ' 78' ' ' LYS . . . -60.34 -30.38 71.09 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.294 -1.522 . . . . 25.0 109.294 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.765 HD12 ' CB ' ' A' ' 73' ' ' ASN . 30.7 mt -68.39 -45.57 72.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -1.081 . . . . 50.0 109.485 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.873 HD11 ' HA3' ' A' ' 70' ' ' GLY . 17.4 mt -65.17 -19.43 65.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 50.0 109.678 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 10.6 mtmm -79.54 -21.02 45.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 50.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.1 -40.63 13.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.926 . . . . 50.0 109.37 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 1.4 p -71.97 -38.48 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.469 -0.769 . . . . 50.0 109.339 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.448 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -59.77 -14.81 16.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.66 -0.65 . . . . 50.0 109.703 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 48.6 mttp -98.17 -30.47 12.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.175 -0.953 . . . . 50.0 109.093 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.505 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.3 mt -56.09 -30.32 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.43 -0.794 . . . . 50.0 109.3 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.4 ' HB2' ' NH1' ' A' ' 17' ' ' ARG . 96.7 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.956 -1.021 . . . . 99.99 109.487 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.333 -0.617 . . . . 50.0 109.333 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -49.62 -37.01 26.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.444 -0.785 . . . . 50.0 109.342 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.75 -46.01 85.08 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.709 -0.848 . . . . 16.66 108.709 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 14' ' ' ILE . 60.2 mt-10 -67.29 -38.54 85.2 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.921 -0.77 . . . . 16.66 108.921 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.592 HH22 HD23 ' A' ' 77' ' ' LEU . 43.9 mtt-85 -67.37 -41.48 84.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.341 -0.85 . . . . 50.0 109.388 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.637 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 9.8 mt-10 -64.94 -42.61 94.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.616 -0.678 . . . . 50.0 109.451 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 70.0 mtp180 -64.93 -41.49 95.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 50.0 109.316 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.472 HG22 ' HE2' ' A' ' 18' ' ' PHE . 18.7 mt -69.45 -46.02 77.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.407 -0.808 . . . . 50.0 109.034 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CD2' ' HA ' ' A' ' 63' ' ' PHE . 59.0 t80 -63.62 -35.6 81.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.313 -0.867 . . . . 16.66 109.254 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -65.84 -31.86 73.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.827 . . . . 50.0 109.281 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 48.4 mtt180 -70.68 -33.66 71.15 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.29 -0.882 . . . . 50.0 109.183 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.903 ' HB3' HD13 ' A' ' 26' ' ' ILE . 45.2 m-85 -71.9 -49.12 40.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.348 -0.845 . . . . 16.66 109.498 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 25.7 t0 -57.88 103.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 16.66 108.646 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.18 -52.2 50.41 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.314 -0.866 . . . . 50.0 111.399 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -87.84 -23.49 23.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.84 -1.162 . . . . 16.66 109.688 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 84.84 41.3 7.72 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.001 -1.24 . . . . 16.66 110.001 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.502 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.7 p-10 -96.35 5.5 50.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.255 . . . . 16.66 109.267 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.24 -9.63 69.72 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.451 -1.06 . . . . 16.66 110.451 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.0 pttp -129.27 141.62 51.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.908 -1.348 . . . . 50.0 109.966 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.903 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.4 mt -112.67 134.31 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.693 -0.629 . . . . 16.66 109.444 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.4 p -105.75 166.94 10.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.74 -0.837 . . . . 50.0 108.74 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.04 -45.22 51.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.028 -1.045 . . . . 50.0 108.825 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.2 78.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.401 -0.812 . . . . 50.0 109.524 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.1 mt-10 -75.26 -54.32 7.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.218 -0.926 . . . . 16.66 109.265 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.608 HD12 ' CD1' ' A' ' 18' ' ' PHE . 34.7 tp -62.38 -42.69 99.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 16.66 108.957 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.595 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.67 -44.67 96.06 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.189 -1.564 . . . . 16.66 109.189 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.28 -42.2 86.06 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.312 -1.111 . . . . 50.0 109.655 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -74.56 -40.42 61.68 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.38 -0.97 . . . . 50.0 108.38 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.877 ' CD1' HG22 ' A' ' 46' ' ' VAL . 10.5 mt -60.52 -31.43 70.5 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.592 -0.692 . . . . 99.99 109.578 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -47.21 -23.71 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 99.99 109.527 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 t -52.15 -22.85 4.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 99.99 109.218 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.0 -32.07 73.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.479 -0.763 . . . . 50.0 109.288 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.23 7.13 50.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.674 -1.37 . . . . 16.66 109.674 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t -154.75 55.63 0.67 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -1.203 . . . . 16.66 109.653 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.0 tt -142.87 176.29 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 50.0 109.538 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.52 163.94 39.42 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.857 . . . . 16.66 108.697 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.49 -33.72 21.97 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.164 1.91 . . . . 50.0 110.209 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -65.87 -24.05 66.78 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.581 -0.699 . . . . 50.0 109.972 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -82.13 -38.52 24.64 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.944 -1.097 . . . . 16.66 108.393 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.877 HG22 ' CD1' ' A' ' 35' ' ' LEU . 42.8 t -68.45 -37.35 77.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.02 -0.733 . . . . 50.0 109.02 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -66.16 -40.28 90.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.372 -0.83 . . . . 50.0 108.941 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -64.87 -40.04 94.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.43 -0.794 . . . . 50.0 109.217 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.429 ' O ' HG13 ' A' ' 53' ' ' ILE . 7.1 mtt -57.61 -43.13 84.5 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.184 -0.947 . . . . 16.66 108.857 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.716 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 47.3 mtp -62.06 -48.0 82.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.561 -0.712 . . . . 50.0 109.266 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.58 -20.55 33.11 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.299 -0.876 . . . . 50.0 109.128 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -97.42 -36.42 10.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.455 -0.778 . . . . 16.66 109.184 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.577 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.5 mt -81.62 -32.45 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.352 -0.843 . . . . 50.0 109.569 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.7 t0 -59.74 101.41 0.11 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.393 -0.817 . . . . 16.66 109.047 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.47 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 67.6 p -70.71 -47.11 61.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 50.0 110.751 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.3 p-10 -86.54 -36.61 18.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.082 -1.011 . . . . 16.66 109.556 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 99.86 28.71 7.25 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.881 -1.152 . . . . 16.66 110.76 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.499 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.7 p-10 -81.03 -3.32 51.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.714 -1.463 . . . . 50.0 109.124 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.716 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.1 -4.47 58.85 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.855 -1.298 . . . . 16.66 109.855 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 44.3 m-85 -134.08 156.37 48.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.057 -1.261 . . . . 50.0 111.093 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.561 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 31.5 mm -108.16 129.88 61.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.142 -1.059 . . . . 16.66 108.142 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.5 166.51 11.48 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.103 -0.998 . . . . 16.66 108.709 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.637 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 34.6 t80 -53.48 -42.53 67.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.186 -1.006 . . . . 16.66 108.546 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -60.5 -49.33 77.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.618 -0.676 . . . . 50.0 109.25 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.561 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 75.3 mt-10 -59.86 -47.0 87.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 16.66 109.15 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -62.66 -36.23 82.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 16.66 109.223 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 21.7 m -67.81 -47.92 67.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 50.0 109.013 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.402 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 82.3 m-20 -59.32 -37.93 79.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.4 -0.813 . . . . 50.0 109.249 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.577 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.04 -37.26 55.11 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.503 -0.925 . . . . 50.0 108.503 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.547 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -58.61 -29.73 64.44 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.247 -1.541 . . . . 16.66 109.247 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 67' ' ' THR . 77.2 mtm180 -70.4 -30.84 67.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -1.127 . . . . 50.0 109.056 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.18 63.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.421 -0.799 . . . . 50.0 109.363 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.683 ' CB ' HD12 ' A' ' 76' ' ' LEU . 4.6 p30 -149.7 56.73 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 50.0 109.189 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.579 ' HA ' HD23 ' A' ' 77' ' ' LEU . 12.8 ptm180 -49.57 -37.13 26.16 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.386 -0.821 . . . . 50.0 108.843 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.33 -27.06 71.1 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.73 -1.348 . . . . 25.0 109.73 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.683 HD12 ' CB ' ' A' ' 73' ' ' ASN . 12.6 mt -66.24 -46.73 76.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -1.184 . . . . 50.0 109.653 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.816 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -59.84 -41.16 90.78 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.377 -0.827 . . . . 50.0 109.375 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -59.23 -30.12 68.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 50.0 109.392 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 49.9 t0 -71.22 -36.8 71.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 50.0 109.38 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.451 HG12 ' HE1' ' A' ' 84' ' ' PHE . 3.0 t -89.93 -27.73 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.385 -0.822 . . . . 50.0 109.421 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.13 -18.74 61.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 50.0 109.719 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 37.5 pttt -95.48 -31.05 13.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 50.0 109.309 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 79' ' ' ASP . 9.3 mt -57.88 -33.64 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.856 . . . . 50.0 109.448 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.451 ' HE1' HG12 ' A' ' 80' ' ' VAL . 88.1 m-85 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.075 -0.964 . . . . 99.99 109.494 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.371 -0.603 . . . . 50.0 109.371 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -50.11 -36.86 31.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.808 . . . . 50.0 109.45 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -56.73 -45.57 81.85 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.612 -0.885 . . . . 16.66 108.612 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 49.0 mt-10 -67.1 -38.64 86.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.448 -0.782 . . . . 16.66 109.066 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 67' ' ' THR . 74.5 mtt-85 -67.29 -40.71 86.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 50.0 109.429 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.599 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 37.8 mt-10 -65.45 -41.62 93.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.441 -0.787 . . . . 50.0 109.5 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 58.5 mtp85 -67.42 -40.66 85.55 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.23 -0.919 . . . . 50.0 109.277 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 10' ' ' GLU . 42.7 mt -70.54 -44.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.289 -0.882 . . . . 50.0 109.151 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -68.22 -35.57 78.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.207 -0.933 . . . . 16.66 109.278 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 52.9 mttt -64.33 -31.79 73.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.373 -0.829 . . . . 50.0 109.261 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.512 ' HD3' ' CD2' ' A' ' 84' ' ' PHE . 52.4 mtt180 -72.21 -35.71 68.97 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.901 . . . . 50.0 109.17 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.026 ' HB3' HD13 ' A' ' 26' ' ' ILE . 37.1 m-85 -68.75 -45.31 71.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 16.66 109.531 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 25.7 t0 -64.45 103.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 16.66 108.779 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.73 -52.13 47.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.233 -0.917 . . . . 50.0 111.21 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -85.57 -26.08 26.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.746 -1.221 . . . . 16.66 109.56 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 86.99 42.92 6.15 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.936 -1.126 . . . . 16.66 110.49 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.505 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 41.1 p-10 -99.44 6.0 46.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.25 . . . . 16.66 109.33 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 62' ' ' SER . . . 94.03 -10.88 71.55 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.485 -1.046 . . . . 16.66 110.485 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.587 ' HD2' ' CD2' ' A' ' 60' ' ' PHE . 14.3 pttp -126.69 140.45 52.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.926 -1.338 . . . . 50.0 109.891 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.026 HD13 ' HB3' ' A' ' 18' ' ' PHE . 3.3 mt -113.8 134.18 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.571 -0.706 . . . . 16.66 109.424 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.461 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 25.9 p -107.47 170.53 7.92 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.435 -0.791 . . . . 50.0 109.011 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.518 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -51.14 -47.76 61.98 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.118 -0.989 . . . . 50.0 109.028 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.31 -38.45 71.29 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.335 -0.853 . . . . 50.0 109.485 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 54.8 mt-10 -77.56 -54.49 6.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.251 -0.905 . . . . 16.66 109.154 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.939 HD22 HG13 ' A' ' 46' ' ' VAL . 7.5 tt -60.01 -46.11 90.55 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.212 -0.93 . . . . 16.66 108.853 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.788 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -61.36 -43.95 98.69 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.076 -1.61 . . . . 16.66 109.076 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 16.2 mt-10 -57.06 -44.42 83.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.433 -1.04 . . . . 50.0 109.823 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.26 -39.28 75.08 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.187 -0.946 . . . . 50.0 108.646 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.938 HD12 HG22 ' A' ' 46' ' ' VAL . 8.7 mt -58.7 -32.03 68.79 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.421 -0.799 . . . . 99.99 109.628 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -42.43 -26.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.177 -0.952 . . . . 99.99 109.84 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.774 ' CG2' HG21 ' A' ' 83' ' ' ILE . 6.3 t -49.44 -24.84 2.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.182 -0.949 . . . . 99.99 109.155 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.79 HD13 HD12 ' A' ' 41' ' ' ILE . 2.0 mt -61.28 -36.39 79.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 50.0 109.315 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.7 -3.33 64.4 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.498 -1.441 . . . . 16.66 109.498 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.74 67.7 0.63 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -1.168 . . . . 16.66 109.657 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.79 HD12 HD13 ' A' ' 38' ' ' LEU . 13.3 tt -149.35 168.25 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 50.0 109.545 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.54 167.32 12.42 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 16.66 109.221 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.67 -28.76 16.81 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.276 1.984 . . . . 50.0 109.849 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.25 -28.67 68.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.597 -0.689 . . . . 50.0 109.774 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -80.76 -34.57 34.18 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.069 -1.019 . . . . 16.66 108.353 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.939 HG13 HD22 ' A' ' 31' ' ' LEU . 53.5 t -66.51 -35.42 74.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.108 -0.701 . . . . 50.0 109.108 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -69.06 -37.97 78.81 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.758 -0.83 . . . . 50.0 108.758 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.539 ' CD2' ' HG3' ' A' ' 52' ' ' GLU . 14.8 t-160 -68.07 -39.65 82.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.496 -0.752 . . . . 50.0 109.087 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.43 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.4 mtt -61.9 -47.11 86.43 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.141 -0.975 . . . . 16.66 108.614 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.671 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 48.9 mtp -63.01 -48.3 79.41 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.046 -0.724 . . . . 50.0 109.046 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.72 -17.81 25.96 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.307 -0.871 . . . . 50.0 108.996 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.539 ' HG3' ' CD2' ' A' ' 48' ' ' HIS . 22.7 mt-10 -98.78 -36.2 9.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 16.66 109.203 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.647 HG22 HD12 ' A' ' 61' ' ' ILE . 81.4 mt -82.23 -32.45 10.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.457 -0.777 . . . . 50.0 109.669 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.9 t0 -58.4 100.69 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.441 -0.787 . . . . 16.66 109.126 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 59.1 p -70.0 -46.57 64.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.298 -0.876 . . . . 50.0 110.463 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.91 -31.53 22.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.11 -0.994 . . . . 16.66 109.571 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 93.06 28.53 11.7 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.801 -1.19 . . . . 16.66 110.189 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.48 -3.07 55.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.94 -1.33 . . . . 50.0 109.402 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.671 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 100.44 -8.34 58.56 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.053 -1.07 . . . . 16.66 110.465 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.587 ' CD2' ' HD2' ' A' ' 25' ' ' LYS . 33.9 m-85 -132.81 155.98 47.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.842 -1.387 . . . . 50.0 111.256 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.647 HD12 HG22 ' A' ' 53' ' ' ILE . 32.0 mm -107.43 129.59 61.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.348 -0.982 . . . . 16.66 108.348 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.9 OUTLIER -95.7 166.91 11.59 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.175 -0.953 . . . . 16.66 108.644 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.599 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 32.2 t80 -55.76 -42.86 76.06 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.128 -0.983 . . . . 16.66 108.741 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -62.43 -47.29 84.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.507 -0.745 . . . . 50.0 109.07 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.542 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 51.7 mt-10 -58.54 -48.09 82.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 16.66 108.974 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.484 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 55.5 t80 -59.54 -39.31 83.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.448 -0.782 . . . . 16.66 109.346 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.518 ' O ' ' NH1' ' A' ' 11' ' ' ARG . 16.4 m -65.28 -45.99 82.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.457 -0.777 . . . . 50.0 109.238 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -59.62 -40.07 86.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 50.0 109.515 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -73.0 -36.53 67.04 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.252 -0.905 . . . . 50.0 108.778 179.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.686 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.63 -34.45 76.57 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.389 -1.484 . . . . 16.66 109.389 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -65.86 -29.09 69.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -1.137 . . . . 50.0 109.277 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.67 -22.09 60.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 50.0 109.147 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.931 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.8 m-80 -150.24 58.69 0.96 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.428 -0.795 . . . . 50.0 108.997 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -50.76 -39.94 53.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.284 -0.885 . . . . 50.0 108.788 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.23 -29.9 69.69 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.342 -1.503 . . . . 25.0 109.342 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.931 HD12 ' CB ' ' A' ' 73' ' ' ASN . 28.1 mt -66.92 -45.72 77.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 50.0 109.482 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.686 HD11 ' HA3' ' A' ' 70' ' ' GLY . 25.8 mt -60.85 -37.19 81.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 50.0 109.635 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 23.5 mtmt -62.41 -24.19 67.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 50.0 109.427 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -77.87 -36.36 49.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 50.0 109.527 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -83.58 -29.46 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.836 . . . . 50.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.33 -16.54 47.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 50.0 109.607 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -95.19 -30.66 13.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 50.0 109.223 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.774 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.3 mt -58.86 -36.29 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 50.0 109.332 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.512 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 96.3 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.974 -1.012 . . . . 99.99 109.499 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.27 -0.641 . . . . 50.0 109.27 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -48.79 -36.63 17.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.369 -0.832 . . . . 50.0 109.586 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.23 -46.75 87.63 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.26 -0.9 . . . . 16.66 108.638 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 14' ' ' ILE . 57.0 mt-10 -68.08 -38.99 83.0 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.823 -0.806 . . . . 16.66 108.823 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.617 ' NH2' HD12 ' A' ' 77' ' ' LEU . 59.5 mtt-85 -67.99 -40.9 82.97 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.461 -0.774 . . . . 50.0 109.458 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 22.7 mt-10 -65.71 -40.86 92.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 50.0 109.524 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 15.1 mtp85 -68.18 -40.45 82.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 50.0 109.353 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 10' ' ' GLU . 34.6 mt -71.31 -43.46 73.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.328 -0.858 . . . . 50.0 109.012 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -67.39 -36.42 81.28 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.191 -0.943 . . . . 16.66 109.089 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -65.65 -29.67 70.27 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.29 -0.881 . . . . 50.0 109.062 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.481 ' CD ' ' HB3' ' A' ' 84' ' ' PHE . 28.9 mtt180 -71.24 -37.08 72.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.361 -0.837 . . . . 50.0 109.088 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.919 ' HB3' HD13 ' A' ' 26' ' ' ILE . 43.4 m-85 -69.66 -48.48 59.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -0.797 . . . . 16.66 109.488 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.4 t0 -59.18 103.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 16.66 108.713 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -51.39 55.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 50.0 111.273 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -87.87 -29.24 21.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.782 -1.199 . . . . 16.66 109.845 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 92.34 35.85 6.46 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.783 -1.198 . . . . 16.66 110.178 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.7 p-10 -90.43 4.76 50.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.252 . . . . 16.66 109.284 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.5 -6.73 74.79 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.347 -1.101 . . . . 16.66 110.347 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 15.4 pttt -130.43 141.89 50.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.996 -1.296 . . . . 50.0 110.027 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.0 mt -112.31 134.03 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.588 -0.695 . . . . 16.66 109.398 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.4 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 12.9 p -106.79 167.54 9.8 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.392 -0.818 . . . . 50.0 108.899 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.502 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.48 -45.55 56.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.059 -1.026 . . . . 50.0 108.909 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.6 -39.43 76.8 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.328 -0.858 . . . . 50.0 109.598 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.5 mt-10 -75.05 -53.98 7.95 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.224 -0.923 . . . . 16.66 109.439 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.617 HD12 ' CD1' ' A' ' 18' ' ' PHE . 31.9 tp -62.37 -42.25 99.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.209 -0.932 . . . . 16.66 108.911 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.657 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -64.35 -45.33 93.67 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.115 -1.594 . . . . 16.66 109.115 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -57.73 -42.96 84.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -1.104 . . . . 50.0 109.539 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.57 -39.95 64.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.417 -0.957 . . . . 50.0 108.417 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.904 HD12 HG22 ' A' ' 46' ' ' VAL . 10.3 mt -61.62 -32.77 72.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.578 -0.701 . . . . 99.99 109.672 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -46.87 -24.55 0.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 99.99 109.644 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.611 ' CG2' HG21 ' A' ' 83' ' ' ILE . 11.6 t -51.95 -21.52 3.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 99.99 109.266 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 38' ' ' LEU . 25.5 mt -66.64 -29.58 69.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.361 -0.837 . . . . 50.0 109.294 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.75 8.89 50.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 16.66 109.585 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.82 60.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -1.167 . . . . 16.66 109.61 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.73 173.32 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 50.0 109.525 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.38 162.96 37.08 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.712 -0.847 . . . . 16.66 108.712 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.03 -32.49 21.48 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.09 1.86 . . . . 50.0 110.012 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.25 -22.11 64.78 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.642 -0.661 . . . . 50.0 110.043 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -79.99 -36.83 35.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.93 -1.106 . . . . 16.66 108.465 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.904 HG22 HD12 ' A' ' 35' ' ' LEU . 54.2 t -68.72 -36.34 73.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.968 -0.753 . . . . 50.0 108.968 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -64.92 -39.9 94.22 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.896 -0.779 . . . . 50.0 108.896 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.55 -43.37 90.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 50.0 109.116 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.507 ' HE3' ' CD1' ' A' ' 35' ' ' LEU . 70.1 mtm -59.32 -43.39 92.7 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.174 -0.954 . . . . 16.66 108.932 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.697 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 32.4 mtp -61.53 -47.23 86.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.493 -0.754 . . . . 50.0 109.058 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.02 -22.58 50.44 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.318 -0.864 . . . . 50.0 109.116 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.91 -35.89 12.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 16.66 108.942 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.689 HG22 HD12 ' A' ' 61' ' ' ILE . 82.6 mt -81.09 -30.09 11.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.591 -0.693 . . . . 50.0 109.534 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.4 t0 -62.42 101.36 0.23 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.386 -0.821 . . . . 16.66 109.105 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 74.0 p -71.65 -47.95 50.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.862 . . . . 50.0 110.614 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 4.2 p-10 -85.85 -33.83 21.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.141 -0.975 . . . . 16.66 109.728 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 97.31 27.4 9.29 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.911 -1.138 . . . . 16.66 111.053 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 p-10 -80.62 -2.5 46.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.725 -1.456 . . . . 50.0 109.248 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.697 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.01 -4.16 60.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.003 -1.239 . . . . 16.66 110.003 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.576 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 39.7 m-85 -134.46 156.12 49.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.26 . . . . 50.0 111.125 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.689 HD12 HG22 ' A' ' 53' ' ' ILE . 34.3 mm -106.83 128.95 61.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.34 -0.985 . . . . 16.66 108.34 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -96.25 169.51 9.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.083 -1.011 . . . . 16.66 108.832 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 35.7 t80 -55.8 -43.88 77.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.128 -0.983 . . . . 16.66 108.73 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -60.31 -48.38 82.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.462 -0.774 . . . . 50.0 109.185 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 63.5 mt-10 -59.91 -46.5 89.18 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.357 -0.839 . . . . 16.66 109.11 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -62.35 -36.53 82.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.443 -0.786 . . . . 16.66 109.079 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 28.9 m -68.51 -48.27 64.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.8 . . . . 50.0 108.979 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -58.08 -37.75 75.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.319 -0.863 . . . . 50.0 109.249 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.563 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -78.73 -35.87 44.14 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.41 -0.959 . . . . 50.0 108.41 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.89 ' CA ' HD11 ' A' ' 77' ' ' LEU . . . -58.63 -33.9 74.22 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.888 -1.685 . . . . 16.66 108.888 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 67' ' ' THR . 82.1 mtm180 -64.86 -32.3 73.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -1.078 . . . . 50.0 108.53 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.55 -2.54 58.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.538 -0.726 . . . . 50.0 109.227 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.75 ' HB3' HD22 ' A' ' 76' ' ' LEU . 68.4 m-80 -151.69 48.42 0.8 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.311 -0.868 . . . . 50.0 108.668 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -57.8 -47.04 83.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.342 -0.849 . . . . 50.0 108.877 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.2 -21.16 38.46 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.135 -1.586 . . . . 25.0 109.135 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.75 HD22 ' HB3' ' A' ' 73' ' ' ASN . 6.8 mp -79.94 -43.82 21.43 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -1.116 . . . . 50.0 109.366 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.89 HD11 ' CA ' ' A' ' 70' ' ' GLY . 5.9 mt -69.2 -22.38 63.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 50.0 109.968 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -80.03 -26.19 39.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 50.0 109.716 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -89.57 -40.66 12.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.1 -1.0 . . . . 50.0 109.586 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.9 p -67.78 -43.36 86.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.383 -0.823 . . . . 50.0 109.515 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.538 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.96 -37.66 45.86 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.673 -0.642 . . . . 50.0 109.919 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.21 -26.86 67.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 50.0 109.542 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.611 HG21 ' CG2' ' A' ' 37' ' ' THR . 7.8 mt -60.63 -43.9 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.236 -0.915 . . . . 50.0 109.362 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.481 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 89.6 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.961 -1.019 . . . . 99.99 109.463 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.445 0.64 . . . . 50.0 109.363 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -50.62 -36.94 37.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 50.0 109.403 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.15 -46.16 89.1 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.782 -0.822 . . . . 16.66 108.782 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.451 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.9 mm-40 -66.38 -44.06 84.17 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.957 -0.757 . . . . 16.66 108.957 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.622 ' NH2' HD12 ' A' ' 77' ' ' LEU . 36.6 mtt-85 -64.95 -39.52 93.62 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.435 -0.79 . . . . 50.0 109.416 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.592 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 13.0 mt-10 -66.21 -42.14 89.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 50.0 109.542 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 47.5 mtp180 -67.01 -40.81 87.36 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.299 -0.876 . . . . 50.0 109.214 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.8 mt -70.29 -44.54 77.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.359 -0.838 . . . . 50.0 109.033 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' A' ' 63' ' ' PHE . 52.7 t80 -66.72 -35.38 79.97 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.281 -0.887 . . . . 16.66 109.041 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -64.44 -31.34 72.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 50.0 109.388 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 64.8 mtt180 -72.53 -36.07 68.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -0.929 . . . . 50.0 109.15 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.012 ' HB3' HD13 ' A' ' 26' ' ' ILE . 34.4 m-85 -68.72 -45.01 72.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 16.66 109.389 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.5 t0 -63.37 103.22 0.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 16.66 108.756 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.17 -51.2 60.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.254 -0.904 . . . . 50.0 111.299 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -89.23 -27.27 20.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.659 -1.276 . . . . 16.66 109.762 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.95 35.68 7.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.032 -1.227 . . . . 16.66 110.032 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.487 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 35.5 p-10 -89.52 3.71 51.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -1.2 . . . . 16.66 109.277 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.19 -6.28 68.73 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.367 -1.093 . . . . 16.66 110.367 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.5 pttp -132.37 143.48 49.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.911 -1.346 . . . . 50.0 110.149 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.012 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.4 mt -111.41 135.06 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 121.426 0.632 . . . . 16.66 109.53 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.418 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 11.4 p -107.77 166.4 10.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.877 -0.786 . . . . 50.0 108.877 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.523 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.81 -45.63 50.21 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.185 -0.947 . . . . 50.0 108.876 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 -38.81 75.99 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.317 -0.864 . . . . 50.0 109.602 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.505 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.2 mt-10 -75.61 -54.1 7.53 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.12 -0.987 . . . . 16.66 109.496 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.874 HD12 ' CD1' ' A' ' 18' ' ' PHE . 14.5 tp -64.03 -38.95 92.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.123 -0.986 . . . . 16.66 108.876 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.629 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -66.02 -46.48 80.82 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.993 -1.643 . . . . 16.66 108.993 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -57.27 -42.79 82.31 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.326 -1.102 . . . . 50.0 109.478 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.63 -40.22 63.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.416 -0.957 . . . . 50.0 108.416 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.812 ' CD1' HG22 ' A' ' 46' ' ' VAL . 5.0 mt -59.94 -32.84 71.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.644 -0.66 . . . . 99.99 109.595 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -45.61 -25.67 0.5 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.034 -1.041 . . . . 99.99 109.351 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.54 ' CG2' HG21 ' A' ' 83' ' ' ILE . 11.7 t -50.87 -23.74 3.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.282 -0.886 . . . . 99.99 109.184 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 41' ' ' ILE . 22.5 mt -62.15 -32.58 73.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.813 . . . . 50.0 109.264 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.0 6.43 52.67 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.643 -1.383 . . . . 16.66 109.643 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.18 56.63 0.65 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -1.213 . . . . 16.66 109.605 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 38' ' ' LEU . 8.9 tt -142.47 175.25 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -0.962 . . . . 50.0 109.512 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.75 165.71 25.36 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.349 -0.844 . . . . 16.66 108.759 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 47.4 Cg_endo -69.42 -33.74 17.23 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.09 1.86 . . . . 50.0 110.172 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.17 -22.37 65.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.699 -0.625 . . . . 50.0 110.178 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -82.99 -39.53 21.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.822 -1.173 . . . . 16.66 108.452 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.812 HG22 ' CD1' ' A' ' 35' ' ' LEU . 75.1 t -66.03 -36.02 76.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.786 -0.82 . . . . 50.0 108.786 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 23.3 mttm -67.6 -39.9 84.79 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.782 -0.822 . . . . 50.0 108.782 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -65.71 -39.51 91.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.407 -0.808 . . . . 50.0 109.149 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.414 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.8 mtt -58.46 -44.77 89.39 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.176 -0.953 . . . . 16.66 108.718 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.617 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 58.1 mtp -62.32 -48.03 81.66 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.524 -0.735 . . . . 50.0 109.188 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.06 -20.17 23.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.301 -0.874 . . . . 50.0 109.05 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -97.14 -35.8 10.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 16.66 109.025 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.688 HG22 HD12 ' A' ' 61' ' ' ILE . 83.5 mt -81.74 -31.74 11.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.446 -0.784 . . . . 50.0 109.592 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.3 t0 -60.42 101.24 0.12 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.341 -0.85 . . . . 16.66 109.187 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 37.9 p -72.13 -45.03 62.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.374 -0.829 . . . . 50.0 110.582 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.498 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.2 p-10 -87.35 -38.92 15.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 16.66 109.485 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 102.17 29.28 6.12 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.86 -1.162 . . . . 16.66 110.675 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p-10 -81.92 -4.12 55.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.819 -1.401 . . . . 50.0 109.014 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.617 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.1 -2.36 57.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.816 -1.314 . . . . 16.66 109.816 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 31.4 m-85 -136.86 156.59 48.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -1.232 . . . . 50.0 111.275 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.688 HD12 HG22 ' A' ' 53' ' ' ILE . 33.3 mm -106.93 127.24 62.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.328 -0.99 . . . . 16.66 108.328 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -94.2 167.71 11.38 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.075 -1.016 . . . . 16.66 108.762 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.592 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.3 t80 -55.09 -43.08 73.64 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.154 -0.966 . . . . 16.66 108.693 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.74 -49.3 78.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.976 -0.75 . . . . 50.0 108.976 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.538 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 22.5 mt-10 -58.3 -47.31 84.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.836 . . . . 16.66 109.027 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.6 -37.97 85.85 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.52 -0.737 . . . . 16.66 109.306 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 31.2 m -65.74 -47.73 74.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.845 . . . . 50.0 109.257 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -60.38 -38.84 85.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 50.0 109.359 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.586 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.13 -38.37 56.87 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.281 -1.007 . . . . 50.0 108.281 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.905 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -56.81 -28.84 57.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.056 -1.617 . . . . 16.66 109.056 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 67' ' ' THR . 78.7 mtm180 -70.39 -29.65 66.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -1.098 . . . . 50.0 108.832 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.65 -23.42 63.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.781 . . . . 50.0 109.155 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.797 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.7 m-80 -148.83 58.17 1.04 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 50.0 108.991 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -50.63 -30.86 14.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 50.0 108.894 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.17 -30.9 79.01 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.202 -1.559 . . . . 25.0 109.202 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.797 HD12 ' CB ' ' A' ' 73' ' ' ASN . 63.7 mt -66.57 -43.56 84.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -1.071 . . . . 50.0 109.491 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.905 HD11 ' HA3' ' A' ' 70' ' ' GLY . 5.3 mt -69.55 -26.49 64.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.415 -0.803 . . . . 50.0 109.862 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -79.37 -24.59 42.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.01 -1.057 . . . . 50.0 109.217 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -92.01 -45.13 8.48 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.393 -0.817 . . . . 50.0 109.333 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.6 p -61.17 -44.52 98.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.808 0.813 . . . . 50.0 109.048 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.545 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -51.49 -39.82 58.32 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.731 -0.606 . . . . 50.0 109.53 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -59.65 -30.8 68.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 50.0 109.702 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.54 HG21 ' CG2' ' A' ' 37' ' ' THR . 41.9 mt -59.37 -32.43 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 50.0 109.43 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 9.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.062 -0.971 . . . . 99.99 109.439 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.344 -0.613 . . . . 50.0 109.344 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -52.8 -36.48 58.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.477 -0.764 . . . . 50.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.417 ' O ' ' HD2' ' A' ' 13' ' ' ARG . . . -58.68 -45.18 89.98 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.642 -0.873 . . . . 16.66 108.642 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 14' ' ' ILE . 66.7 mt-10 -67.41 -43.49 81.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.838 -0.801 . . . . 16.66 108.838 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.481 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 35.1 mtt-85 -66.24 -39.42 89.52 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.484 -0.76 . . . . 50.0 109.346 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 14.8 mt-10 -66.98 -41.02 87.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.474 -0.766 . . . . 50.0 109.373 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.4 mtt180 -68.46 -40.16 81.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.358 -0.839 . . . . 50.0 109.117 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.9 mt -70.72 -44.73 76.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.411 -0.805 . . . . 50.0 109.059 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -65.43 -36.23 83.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 16.66 109.029 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -66.05 -29.48 69.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 50.0 109.151 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 84' ' ' PHE . 33.7 mtt180 -70.46 -39.15 74.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 50.0 109.066 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.936 ' HB3' HD13 ' A' ' 26' ' ' ILE . 46.6 m-85 -68.44 -48.5 64.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 16.66 109.316 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 26.5 t0 -57.36 103.48 0.13 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 16.66 108.604 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -52.28 57.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 50.0 111.457 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' A' ' 23' ' ' ASP . 31.8 p-10 -88.84 -21.97 23.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.826 -1.171 . . . . 16.66 109.768 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 82.66 40.48 9.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.876 -1.29 . . . . 16.66 109.876 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.507 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.5 p-10 -94.11 4.15 54.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -1.221 . . . . 16.66 109.247 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.88 -9.41 65.91 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.516 -1.034 . . . . 16.66 110.516 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 7.6 pttt -130.74 142.69 50.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.932 -1.334 . . . . 50.0 110.118 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.936 HD13 ' HB3' ' A' ' 18' ' ' PHE . 7.6 mt -112.82 134.05 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.409 -0.589 . . . . 16.66 109.409 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.426 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 25.0 p -107.8 168.96 8.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 50.0 108.846 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.509 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.56 -47.18 57.86 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.06 -1.025 . . . . 50.0 108.933 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.39 70.2 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.481 -0.762 . . . . 50.0 109.704 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.494 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 55.5 mt-10 -78.39 -53.5 7.2 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.111 -0.993 . . . . 16.66 109.477 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.685 HD12 ' CD1' ' A' ' 18' ' ' PHE . 54.6 tp -63.22 -40.43 97.46 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.175 -0.953 . . . . 16.66 108.976 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.658 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -64.07 -45.13 94.66 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.162 -1.575 . . . . 16.66 109.162 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -58.64 -42.94 89.48 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.195 -1.179 . . . . 50.0 109.703 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.54 -40.68 61.56 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.053 -1.029 . . . . 50.0 108.404 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.75 ' CD1' HG22 ' A' ' 46' ' ' VAL . 9.5 mt -60.73 -33.13 72.45 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.546 -0.721 . . . . 99.99 109.463 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -47.12 -24.4 0.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.081 -1.012 . . . . 99.99 109.437 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.56 ' CG2' HG21 ' A' ' 83' ' ' ILE . 12.2 t -52.54 -22.61 5.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 99.99 109.19 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.605 HD12 HD12 ' A' ' 41' ' ' ILE . 39.3 mt -61.07 -31.66 71.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -0.832 . . . . 50.0 109.224 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.66 3.52 54.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.733 -1.347 . . . . 16.66 109.733 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.76 65.04 0.59 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -1.197 . . . . 16.66 109.71 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.605 HD12 HD12 ' A' ' 38' ' ' LEU . 14.9 tt -149.63 170.24 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 50.0 109.411 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.66 162.95 28.2 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.311 -0.868 . . . . 16.66 108.706 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.76 -32.4 23.38 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.003 1.802 . . . . 50.0 110.18 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.0 -23.56 65.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.604 -0.685 . . . . 50.0 109.915 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -81.0 -38.92 26.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.887 -1.133 . . . . 16.66 108.298 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.75 HG22 ' CD1' ' A' ' 35' ' ' LEU . 53.8 t -66.09 -36.38 77.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.579 -0.897 . . . . 50.0 108.579 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -69.54 -39.54 77.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.479 -0.934 . . . . 50.0 108.479 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.52 -41.42 88.83 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.96 -0.755 . . . . 50.0 108.96 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.8 mtt -59.05 -44.92 91.86 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.259 -0.9 . . . . 16.66 108.622 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.689 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 30.1 mtp -60.39 -46.13 91.06 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.521 -0.737 . . . . 50.0 109.061 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.77 -23.5 52.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.8 . . . . 50.0 109.316 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -92.84 -35.95 13.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 16.66 108.799 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.754 HG22 HD12 ' A' ' 61' ' ' ILE . 84.7 mt -80.37 -29.34 12.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.545 -0.722 . . . . 50.0 109.478 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.2 t0 -63.8 101.6 0.38 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.446 -0.784 . . . . 16.66 109.196 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 76.1 p -73.95 -46.72 42.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.292 -0.88 . . . . 50.0 110.868 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 7.5 p-10 -86.14 -31.24 21.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.069 -1.02 . . . . 16.66 109.645 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 94.73 27.42 11.42 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.798 -1.191 . . . . 16.66 111.066 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.6 p-10 -82.32 -3.49 55.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.73 -1.453 . . . . 50.0 109.321 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.689 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.93 -5.71 59.76 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.243 -1.143 . . . . 16.66 110.243 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.57 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 37.0 m-85 -133.5 155.04 50.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.942 -1.328 . . . . 50.0 111.039 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.754 HD12 HG22 ' A' ' 53' ' ' ILE . 34.5 mm -105.24 127.44 59.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.254 -1.017 . . . . 16.66 108.254 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.3 167.62 11.42 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.2 -0.937 . . . . 16.66 108.91 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.597 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.6 t80 -54.58 -42.77 71.45 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.057 -1.027 . . . . 16.66 108.651 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -60.7 -49.47 77.36 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.115 -0.698 . . . . 50.0 109.115 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.555 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 45.6 mt-10 -58.88 -46.79 86.99 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 16.66 109.013 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -63.74 -36.58 84.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.507 -0.745 . . . . 16.66 109.288 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.42 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 52.8 m -66.35 -48.68 69.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.321 -0.862 . . . . 50.0 109.209 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' ' NH1' ' A' ' 71' ' ' ARG . 67.8 m-20 -61.79 -37.38 84.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 50.0 109.3 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.593 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -72.71 -40.15 66.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.538 -0.912 . . . . 50.0 108.538 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.496 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -56.13 -29.19 55.58 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.141 -1.584 . . . . 16.66 109.141 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.484 ' NH1' ' OD1' ' A' ' 68' ' ' ASP . 23.2 mtm180 -71.1 -21.49 62.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 50.0 109.054 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.71 -24.44 38.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.439 -0.788 . . . . 50.0 109.34 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.95 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.8 m-80 -145.22 57.68 1.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.861 . . . . 50.0 109.393 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -51.31 -38.72 54.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.894 . . . . 50.0 108.762 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.22 -27.53 65.38 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.316 -1.514 . . . . 25.0 109.316 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.95 HD12 ' CB ' ' A' ' 73' ' ' ASN . 39.7 mt -69.73 -44.8 69.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -1.093 . . . . 50.0 109.476 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.695 HD12 ' N ' ' A' ' 77' ' ' LEU . 8.9 mp -63.38 -40.26 96.75 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.422 -0.799 . . . . 50.0 110.002 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 14.4 mtmt -65.83 -20.08 66.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 50.0 109.344 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.36 -53.85 3.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 50.0 109.535 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.2 p -65.89 -44.8 92.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.369 -0.832 . . . . 50.0 109.452 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.558 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -53.67 -36.65 62.37 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.59 -0.693 . . . . 50.0 109.725 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 17.5 mttt -66.95 -25.47 66.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 50.0 109.663 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.56 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.1 mt -59.63 -42.48 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.904 . . . . 50.0 109.444 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.512 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 88.7 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.015 -0.993 . . . . 99.99 109.47 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.222 -0.658 . . . . 50.0 109.222 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -52.78 -36.15 57.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.366 -0.833 . . . . 50.0 109.223 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.59 -45.78 84.83 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.587 -0.894 . . . . 16.66 108.587 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 56.2 mt-10 -66.33 -44.65 82.72 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.881 -0.785 . . . . 16.66 108.881 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.78 ' NH1' HG23 ' A' ' 67' ' ' THR . 75.2 mtm180 -64.52 -38.85 92.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.533 -0.73 . . . . 50.0 109.436 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.619 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 34.8 mt-10 -65.91 -42.34 90.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.329 -0.857 . . . . 50.0 109.469 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 16.9 mtp180 -66.82 -40.17 87.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.281 -0.887 . . . . 50.0 109.218 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 10' ' ' GLU . 30.2 mt -70.17 -46.27 72.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.392 -0.818 . . . . 50.0 108.967 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -62.43 -35.58 79.68 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.274 -0.891 . . . . 16.66 108.934 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 60.1 mttm -66.56 -30.06 70.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.858 . . . . 50.0 109.15 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 47.2 mtt180 -68.92 -37.71 79.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.339 -0.851 . . . . 50.0 109.16 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.853 ' HB3' HD13 ' A' ' 26' ' ' ILE . 55.4 m-85 -68.96 -50.41 49.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.785 . . . . 16.66 109.489 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.468 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.8 t0 -54.66 103.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 16.66 108.651 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.13 -52.03 52.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.274 -0.891 . . . . 50.0 111.29 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -87.88 -23.64 23.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.745 -1.222 . . . . 16.66 109.592 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 84.72 41.47 7.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.034 -1.226 . . . . 16.66 110.034 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.505 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.2 p-10 -96.16 5.84 50.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.047 -1.267 . . . . 16.66 109.295 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -9.01 71.19 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.454 -1.058 . . . . 16.66 110.454 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.2 pttp -129.55 141.86 50.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.319 . . . . 50.0 109.808 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.853 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.5 mt -112.61 134.31 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.687 -0.633 . . . . 16.66 109.381 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.46 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 18.1 p -106.41 167.33 9.91 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.662 -0.866 . . . . 50.0 108.662 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.94 -45.63 51.42 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.12 -0.988 . . . . 50.0 108.997 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.85 -38.45 75.7 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.25 -0.907 . . . . 50.0 109.529 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.496 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.2 mt-10 -76.41 -54.31 6.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.163 -0.961 . . . . 16.66 109.281 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.712 HD12 ' CD1' ' A' ' 18' ' ' PHE . 29.0 tp -62.73 -42.09 99.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 16.66 108.912 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.668 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.85 -44.9 95.46 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.201 -1.559 . . . . 16.66 109.201 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.99 -42.95 86.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.307 -1.113 . . . . 50.0 109.699 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.89 -40.02 63.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.359 -0.978 . . . . 50.0 108.359 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.935 ' CD1' HG22 ' A' ' 46' ' ' VAL . 12.5 mt -60.76 -32.48 71.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.65 -0.656 . . . . 99.99 109.566 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -46.5 -24.64 0.55 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.082 -1.012 . . . . 99.99 109.443 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.603 ' CG2' HG21 ' A' ' 83' ' ' ILE . 10.3 t -51.81 -22.72 3.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.276 -0.89 . . . . 99.99 109.261 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.631 HD12 HD12 ' A' ' 41' ' ' ILE . 21.6 mt -60.2 -33.24 71.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.381 -0.824 . . . . 50.0 109.38 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.21 3.21 56.31 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.633 -1.387 . . . . 16.66 109.633 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.44 61.57 0.62 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -1.181 . . . . 16.66 109.594 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.631 HD12 HD12 ' A' ' 38' ' ' LEU . 10.3 tt -146.31 174.54 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 50.0 109.539 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.34 164.47 29.94 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 16.66 108.768 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.54 -32.77 18.81 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.091 1.861 . . . . 50.0 110.241 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.38 -22.85 65.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.654 -0.654 . . . . 50.0 110.055 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -82.34 -38.95 23.49 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.904 -1.123 . . . . 16.66 108.544 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.935 HG22 ' CD1' ' A' ' 35' ' ' LEU . 42.2 t -68.05 -37.35 78.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.779 -0.823 . . . . 50.0 108.779 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -66.15 -40.09 90.31 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.829 -0.804 . . . . 50.0 108.829 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.472 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.9 t60 -64.54 -39.47 93.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.454 -0.779 . . . . 50.0 109.128 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.436 ' O ' HG13 ' A' ' 53' ' ' ILE . 13.2 mtt -56.54 -43.15 79.61 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.101 -1.0 . . . . 16.66 108.552 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.519 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 82.3 mtp -61.51 -48.4 81.22 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.944 -0.761 . . . . 50.0 108.944 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.72 -22.08 12.88 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.246 -0.908 . . . . 50.0 109.134 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -99.11 -36.85 9.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 16.66 109.231 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.672 HG22 HD12 ' A' ' 61' ' ' ILE . 82.9 mt -80.25 -33.49 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.434 -0.791 . . . . 50.0 109.617 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.6 t0 -59.97 101.47 0.12 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.351 -0.843 . . . . 16.66 109.099 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.534 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 81.8 p -73.76 -47.41 39.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 50.0 110.819 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 7.1 p-10 -85.72 -31.81 22.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.945 . . . . 16.66 109.681 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.462 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 95.19 27.65 10.65 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.888 -1.148 . . . . 16.66 111.001 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.482 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.1 p-10 -81.66 -3.79 54.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.768 -1.431 . . . . 50.0 109.342 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.519 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.46 -5.43 58.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.14 -1.184 . . . . 16.66 110.14 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.575 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 45.2 m-85 -133.1 154.83 50.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.998 -1.295 . . . . 50.0 110.971 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.672 HD12 HG22 ' A' ' 53' ' ' ILE . 34.7 mm -105.31 128.73 59.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.364 -0.976 . . . . 16.66 108.364 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.6 165.88 11.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.188 -0.945 . . . . 16.66 108.836 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.619 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.9 t80 -53.56 -43.09 68.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.095 -1.003 . . . . 16.66 108.542 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -59.07 -46.78 87.4 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.09 -0.707 . . . . 50.0 109.09 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.549 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 64.0 mt-10 -63.78 -46.99 82.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.853 . . . . 16.66 109.068 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.779 ' HE1' HD13 ' A' ' 77' ' ' LEU . 27.3 t80 -65.84 -29.03 69.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.428 -0.795 . . . . 16.66 109.182 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.78 HG23 ' NH1' ' A' ' 11' ' ' ARG . 63.0 m -69.87 -49.96 47.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.42 -0.8 . . . . 50.0 109.329 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.49 -35.83 81.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 50.0 109.385 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.583 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -75.79 -41.18 53.61 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.384 -0.969 . . . . 50.0 108.384 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.993 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.56 -30.03 71.02 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.002 -1.639 . . . . 16.66 109.002 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.51 ' HG3' ' NH1' ' A' ' 11' ' ' ARG . 68.4 mtp180 -66.91 -37.25 84.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.445 -1.033 . . . . 50.0 108.826 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.44 -19.02 65.69 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.133 -0.691 . . . . 50.0 109.133 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.769 ' CB ' HD12 ' A' ' 76' ' ' LEU . 18.4 m-80 -145.94 53.29 1.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 50.0 109.318 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -49.5 -36.15 22.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 50.0 108.739 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.523 ' HA2' ' CE ' ' A' ' 78' ' ' LYS . . . -61.54 -19.71 58.26 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.398 -1.481 . . . . 25.0 109.398 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.769 HD12 ' CB ' ' A' ' 73' ' ' ASN . 25.0 mt -78.33 -44.86 24.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.393 -1.063 . . . . 50.0 109.291 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.993 HD11 ' HA3' ' A' ' 70' ' ' GLY . 3.8 mt -71.15 -24.2 62.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.473 -0.767 . . . . 50.0 110.142 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' CE ' ' HA2' ' A' ' 75' ' ' GLY . 6.7 ptpt -80.06 -28.79 39.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.959 -1.088 . . . . 50.0 109.0 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 56.3 m-20 -87.37 -44.68 11.19 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.488 -0.758 . . . . 50.0 109.274 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.552 HG13 ' N ' ' A' ' 81' ' ' ALA . 5.4 p -58.71 -44.78 90.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.868 0.842 . . . . 50.0 108.946 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.552 ' N ' HG13 ' A' ' 80' ' ' VAL . . . -50.5 -41.13 53.07 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.165 -0.614 . . . . 50.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -59.43 -32.25 70.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 50.0 109.499 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.603 HG21 ' CG2' ' A' ' 37' ' ' THR . 26.9 mt -57.44 -32.65 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 50.0 109.278 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.551 ' CE1' HG21 ' A' ' 37' ' ' THR . 8.9 m-85 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.96 -1.019 . . . . 99.99 109.488 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.378 -0.601 . . . . 50.0 109.378 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -48.34 -36.1 13.75 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.429 -0.795 . . . . 50.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.37 -46.38 88.81 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.395 -0.816 . . . . 16.66 108.98 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.46 ' O ' HG13 ' A' ' 14' ' ' ILE . 61.7 mt-10 -66.78 -41.09 88.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.401 -0.812 . . . . 16.66 108.981 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -66.16 -41.1 90.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.453 -0.779 . . . . 50.0 109.452 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.568 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 8.6 mt-10 -64.6 -41.51 96.18 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.519 -0.738 . . . . 50.0 109.399 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 62.1 mtp180 -67.01 -40.6 87.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 50.0 109.273 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 10' ' ' GLU . 31.9 mt -70.55 -44.46 76.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.397 -0.814 . . . . 50.0 108.986 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 63' ' ' PHE . 58.7 t80 -66.65 -36.2 81.99 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.295 -0.878 . . . . 16.66 109.065 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -65.5 -30.67 71.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 50.0 108.983 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 52.0 mtt85 -70.62 -36.16 73.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.411 -0.806 . . . . 50.0 109.114 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.967 ' HB3' HD13 ' A' ' 26' ' ' ILE . 36.3 m-85 -68.21 -49.22 62.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.823 . . . . 16.66 109.432 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.6 t0 -57.58 103.43 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 16.66 108.715 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.3 -51.3 54.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 50.0 111.26 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -87.31 -30.49 20.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.733 -1.229 . . . . 16.66 109.793 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.59 35.6 6.14 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.819 -1.181 . . . . 16.66 110.232 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.1 p-10 -90.46 3.96 52.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.246 . . . . 16.66 109.285 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.02 -6.51 72.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.431 -1.068 . . . . 16.66 110.431 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.609 ' HD3' ' CG ' ' A' ' 60' ' ' PHE . 2.3 ptpp? -131.08 142.65 50.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.944 -1.327 . . . . 50.0 109.939 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.967 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.1 mt -112.15 133.73 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.605 -0.684 . . . . 16.66 109.652 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.1 p -105.53 166.06 10.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.383 -0.823 . . . . 50.0 108.867 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.92 -44.82 50.48 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.987 -1.071 . . . . 50.0 108.699 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -58.14 -39.77 79.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.189 -0.945 . . . . 50.0 109.347 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.8 mt-10 -74.67 -54.63 7.05 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.132 -0.98 . . . . 16.66 109.24 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.541 ' CD1' ' CE1' ' A' ' 18' ' ' PHE . 29.9 tp -62.31 -42.31 99.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.145 -0.972 . . . . 16.66 108.94 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.582 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.92 -45.33 94.38 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.96 -1.656 . . . . 16.66 108.96 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 10.3 mt-10 -56.15 -44.33 79.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.418 -1.048 . . . . 50.0 109.457 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.53 -39.31 67.63 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.331 -0.988 . . . . 50.0 108.331 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.874 ' CD1' HG22 ' A' ' 46' ' ' VAL . 6.7 mt -59.26 -32.93 70.45 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.545 -0.722 . . . . 99.99 109.412 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -44.79 -26.03 0.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 99.99 109.474 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.791 ' OG1' HG21 ' A' ' 83' ' ' ILE . 8.7 t -52.55 -25.04 9.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 99.99 109.232 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.942 HD12 HD12 ' A' ' 41' ' ' ILE . 23.7 mt -57.99 -35.96 71.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 50.0 109.165 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.87 1.97 60.28 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.681 -1.367 . . . . 16.66 109.681 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.15 52.53 0.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.092 -1.24 . . . . 16.66 109.754 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.942 HD12 HD12 ' A' ' 38' ' ' LEU . 11.7 tt -136.47 171.77 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 50.0 109.589 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.23 165.89 23.62 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.751 -0.833 . . . . 16.66 108.751 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.91 -33.79 19.17 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.042 1.828 . . . . 50.0 110.188 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -62.1 -28.9 69.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.585 -0.697 . . . . 50.0 109.956 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -81.76 -36.11 28.88 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.949 -1.094 . . . . 16.66 108.288 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.874 HG22 ' CD1' ' A' ' 35' ' ' LEU . 57.7 t -68.09 -36.59 75.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.948 -0.76 . . . . 50.0 108.948 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -68.88 -38.92 80.0 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.795 -0.817 . . . . 50.0 108.795 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -65.92 -39.78 90.86 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.471 -0.768 . . . . 50.0 109.299 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.431 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.9 mtt -59.19 -44.59 92.22 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.117 -0.989 . . . . 16.66 108.841 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.549 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 29.3 mtp -62.43 -48.13 81.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.421 -0.799 . . . . 50.0 109.15 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.62 -20.14 30.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 50.0 109.097 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -97.44 -36.47 10.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 16.66 109.199 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.587 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.6 mt -80.78 -31.93 12.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.413 -0.804 . . . . 50.0 109.576 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.0 t0 -61.76 101.38 0.19 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.439 -0.788 . . . . 16.66 108.938 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.453 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 39.6 p -67.95 -45.18 74.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.874 . . . . 50.0 110.461 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.9 p-10 -88.79 -42.71 11.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 16.66 109.642 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 104.88 30.21 4.93 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.188 -1.165 . . . . 16.66 110.188 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.8 p-10 -81.31 -3.06 51.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.919 -1.342 . . . . 50.0 109.233 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.549 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.6 -1.13 58.3 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.795 -1.322 . . . . 16.66 109.795 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.609 ' CG ' ' HD3' ' A' ' 25' ' ' LYS . 51.1 m-85 -137.44 155.66 49.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -1.233 . . . . 50.0 111.284 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.55 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 30.9 mm -109.83 129.57 64.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.222 -1.029 . . . . 16.66 108.222 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.02 168.13 10.47 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.057 -1.027 . . . . 16.66 108.815 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.568 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 32.4 t80 -54.83 -43.19 72.77 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.102 -0.999 . . . . 16.66 108.728 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -61.1 -46.81 89.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.545 -0.722 . . . . 50.0 109.235 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 75.0 mt-10 -61.65 -47.67 84.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 16.66 109.198 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.439 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 60.0 t80 -61.44 -36.86 81.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 16.66 109.444 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 23.1 m -65.54 -47.27 76.45 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.259 -0.901 . . . . 50.0 109.344 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -60.92 -38.87 87.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 50.0 109.6 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -77.37 -38.6 49.75 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.136 -0.977 . . . . 50.0 108.77 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.45 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.36 -32.32 76.81 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.935 -1.666 . . . . 16.66 108.935 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 67' ' ' THR . 64.6 mtp180 -70.97 -34.26 71.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -1.027 . . . . 50.0 109.259 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.47 -4.61 56.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 50.0 109.512 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.781 ' HB3' HD13 ' A' ' 76' ' ' LEU . 69.1 m-80 -150.0 46.31 0.92 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.262 -0.899 . . . . 50.0 108.798 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -55.44 -48.87 73.79 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.54 -0.911 . . . . 50.0 108.54 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.27 -24.91 24.2 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.146 -1.581 . . . . 25.0 109.146 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.781 HD13 ' HB3' ' A' ' 73' ' ' ASN . 7.1 mp -78.81 -44.67 22.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -1.15 . . . . 50.0 109.357 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.572 ' O ' HG12 ' A' ' 80' ' ' VAL . 21.2 mt -60.1 -39.6 86.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.444 -0.785 . . . . 50.0 109.409 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 32.8 mtpt -56.06 -28.23 56.72 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.294 -0.879 . . . . 50.0 109.326 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 52.9 t0 -75.67 -39.19 57.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.381 -0.824 . . . . 50.0 109.775 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -64.85 -37.55 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 50.0 109.378 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -72.78 -4.26 30.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.556 -0.715 . . . . 50.0 109.65 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 14.4 mttm -74.28 -35.13 63.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 50.0 109.255 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.791 HG21 ' OG1' ' A' ' 37' ' ' THR . 35.2 mt -76.75 -32.68 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.309 -0.869 . . . . 50.0 109.453 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.732 ' HE1' HG21 ' A' ' 37' ' ' THR . 5.4 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.975 -1.012 . . . . 99.99 109.454 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.435 0.636 . . . . 50.0 109.463 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -44.68 -35.22 2.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.797 . . . . 50.0 109.599 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.59 -45.28 85.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 16.66 108.963 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 14' ' ' ILE . 63.6 mt-10 -67.52 -42.92 82.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.507 -0.746 . . . . 16.66 109.056 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.587 ' NH2' HG23 ' A' ' 67' ' ' THR . 18.2 mtm180 -65.73 -39.19 90.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.506 -0.746 . . . . 50.0 109.421 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.598 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 77.7 mt-10 -66.76 -41.36 87.88 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.386 -0.821 . . . . 50.0 109.525 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mtp180 -66.9 -40.7 87.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.339 -0.85 . . . . 50.0 109.234 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.5 mt -70.37 -45.11 76.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.358 -0.839 . . . . 50.0 109.029 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -64.98 -35.8 82.34 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.227 -0.92 . . . . 16.66 109.112 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -65.99 -30.37 70.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 50.0 109.268 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 59.1 mtt85 -71.36 -35.08 71.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -0.912 . . . . 50.0 108.974 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.004 ' HB3' HD13 ' A' ' 26' ' ' ILE . 35.8 m-85 -67.56 -49.77 61.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 16.66 109.299 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.463 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 21.5 t0 -56.02 103.11 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.87 . . . . 16.66 108.804 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.05 -51.07 59.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.951 . . . . 50.0 111.028 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -87.78 -31.17 19.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.756 -1.215 . . . . 16.66 109.633 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.463 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 94.7 34.92 6.06 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.795 -1.193 . . . . 16.66 110.385 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.502 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 41.3 p-10 -89.85 5.5 45.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.003 -1.292 . . . . 16.66 109.258 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.85 -4.91 79.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.282 -1.127 . . . . 16.66 110.282 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HB2' ' CB ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -131.08 142.51 50.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.921 -1.341 . . . . 50.0 109.931 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.004 HD13 ' HB3' ' A' ' 18' ' ' PHE . 7.5 mt -111.34 134.56 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.523 -0.735 . . . . 16.66 109.497 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.435 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 11.5 p -107.67 166.71 10.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.725 -0.842 . . . . 50.0 108.725 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.93 -45.56 51.27 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.048 -1.032 . . . . 50.0 108.799 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.29 76.33 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.205 -0.934 . . . . 50.0 109.493 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.1 mt-10 -75.9 -54.48 6.83 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.152 -0.968 . . . . 16.66 109.354 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.684 ' HG ' HD12 ' A' ' 35' ' ' LEU . 9.6 tp -62.15 -42.44 99.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 16.66 108.817 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -64.2 -45.89 92.41 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.841 -1.704 . . . . 16.66 108.841 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.88 -44.27 78.0 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.394 -1.063 . . . . 50.0 109.375 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.11 -39.9 63.06 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.112 -1.07 . . . . 50.0 108.112 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.002 HD13 HG22 ' A' ' 46' ' ' VAL . 6.5 mt -59.55 -29.86 68.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.527 -0.733 . . . . 99.99 109.548 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -45.25 -24.4 0.27 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 99.99 109.652 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.633 HG21 HG21 ' A' ' 83' ' ' ILE . 9.3 t -51.69 -24.39 5.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.215 -0.928 . . . . 99.99 109.204 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.49 HD11 ' CD2' ' A' ' 35' ' ' LEU . 6.4 mt -62.57 -45.88 90.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.39 -0.819 . . . . 50.0 109.266 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.06 -34.53 3.74 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.746 -1.342 . . . . 16.66 109.746 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.7 p -116.79 52.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -1.188 . . . . 16.66 109.598 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 41' ' ' ILE . 7.4 tp -126.68 164.31 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 50.0 109.501 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.69 163.47 23.95 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.523 -0.917 . . . . 16.66 108.523 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.0 -34.13 23.98 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.941 1.761 . . . . 50.0 110.181 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.28 -20.19 63.91 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.658 -0.651 . . . . 50.0 110.399 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -83.08 -40.64 19.58 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.729 -1.232 . . . . 16.66 108.562 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.002 HG22 HD13 ' A' ' 35' ' ' LEU . 41.8 t -65.2 -36.98 79.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.764 -0.828 . . . . 50.0 108.764 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -68.31 -39.7 81.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.793 -0.817 . . . . 50.0 108.793 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.499 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.2 t60 -66.13 -40.23 90.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.423 -0.798 . . . . 50.0 109.056 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.447 ' CE ' HD11 ' A' ' 35' ' ' LEU . 15.5 mtm -59.44 -44.74 92.86 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.265 -0.897 . . . . 16.66 108.877 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 28' ' ' ALA . 31.1 mtp -62.51 -47.37 84.25 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.585 -0.697 . . . . 50.0 109.197 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.25 -20.1 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 50.0 108.915 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.27 -35.55 11.76 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.986 -0.746 . . . . 16.66 108.986 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.588 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.4 mt -81.89 -31.05 10.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.53 -0.731 . . . . 50.0 109.501 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 50' ' ' MET . 17.3 t0 -61.93 101.09 0.18 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.442 -0.786 . . . . 16.66 109.172 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 28.3 p -68.46 -43.42 77.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 50.0 110.426 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.1 p-10 -89.85 -46.86 8.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 16.66 109.821 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 108.81 31.71 3.31 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.935 -1.266 . . . . 16.66 109.935 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.478 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.7 p-10 -82.69 -5.24 58.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.027 -1.278 . . . . 50.0 109.057 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 100.08 -0.3 56.13 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.724 -1.35 . . . . 16.66 109.724 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.529 ' CB ' ' HB2' ' A' ' 25' ' ' LYS . 41.3 m-85 -139.28 156.07 47.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.996 -1.297 . . . . 50.0 111.482 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.55 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 31.4 mm -109.08 129.23 64.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.147 -1.057 . . . . 16.66 108.147 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.1 167.32 10.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.991 -1.068 . . . . 16.66 108.72 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 37.9 t80 -53.35 -42.67 67.05 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.077 -1.049 . . . . 16.66 108.473 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -59.42 -50.66 73.08 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.107 -0.701 . . . . 50.0 109.107 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 80.2 mt-10 -60.28 -46.38 90.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.354 -0.841 . . . . 16.66 109.023 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.545 ' CE2' HD11 ' A' ' 77' ' ' LEU . 80.3 t80 -64.66 -35.77 82.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 16.66 109.479 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.587 HG23 ' NH2' ' A' ' 11' ' ' ARG . 21.0 m -67.51 -48.95 65.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.394 -0.816 . . . . 50.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.424 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 77.1 m-20 -62.02 -36.07 80.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -0.901 . . . . 50.0 109.339 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.588 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -74.61 -39.57 62.08 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.669 -0.863 . . . . 50.0 108.669 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.476 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -59.33 -29.05 65.44 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.423 -1.471 . . . . 16.66 109.423 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 67' ' ' THR . 62.6 mtm180 -71.83 -32.28 67.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -1.115 . . . . 50.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.38 -21.08 62.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.34 -0.85 . . . . 50.0 109.343 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.882 ' CB ' HD12 ' A' ' 76' ' ' LEU . 31.8 m-80 -140.92 61.02 1.51 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.406 -0.809 . . . . 50.0 109.131 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -52.64 -42.88 65.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.67 -0.863 . . . . 50.0 108.67 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.19 -22.58 29.83 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.352 -1.499 . . . . 25.0 109.352 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.882 HD12 ' CB ' ' A' ' 73' ' ' ASN . 47.2 mt -79.97 -43.56 21.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -1.124 . . . . 50.0 109.336 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 1.1 mm? -61.19 -36.98 81.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.455 -0.778 . . . . 50.0 109.578 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.6 mtmm -73.81 -28.14 61.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.258 -0.901 . . . . 50.0 109.026 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -80.21 -45.3 18.26 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.37 -0.831 . . . . 50.0 109.105 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 76' ' ' LEU . 46.5 t -68.56 -41.32 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 50.0 109.376 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.4 -46.91 63.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 50.0 109.425 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 22.7 mttm -59.64 -29.25 67.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.345 -0.847 . . . . 50.0 109.34 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 37' ' ' THR . 59.5 mt -66.73 -35.97 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 50.0 109.394 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 12.5 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.962 -1.018 . . . . 99.99 109.503 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.39 0.614 . . . . 50.0 109.369 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -49.15 -35.78 17.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 50.0 109.293 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -53.44 -43.11 67.78 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.572 -0.899 . . . . 16.66 108.572 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.4 mt-10 -68.51 -39.8 81.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.012 -0.736 . . . . 16.66 109.012 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.5 mtt-85 -67.33 -41.24 85.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.452 -0.78 . . . . 50.0 109.38 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.608 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 60.8 mt-10 -65.07 -39.91 93.91 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.567 -0.708 . . . . 50.0 109.311 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 24.3 mtp180 -67.63 -40.37 84.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.451 -0.781 . . . . 50.0 109.187 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 10' ' ' GLU . 24.6 mt -70.54 -45.62 73.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.365 -0.834 . . . . 50.0 109.015 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -64.87 -35.97 82.85 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.295 -0.878 . . . . 16.66 108.975 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 46.1 mttt -65.81 -30.3 70.91 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.324 -0.86 . . . . 50.0 108.983 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 32.7 mtt180 -70.06 -36.09 74.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.831 . . . . 50.0 108.903 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.916 ' HB3' HD13 ' A' ' 26' ' ' ILE . 48.3 m-85 -70.38 -51.41 29.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.438 -0.789 . . . . 16.66 109.487 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.8 t0 -56.12 103.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 16.66 108.747 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.42 -52.07 50.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 50.0 111.278 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -87.34 -23.46 24.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.725 -1.235 . . . . 16.66 109.722 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 83.95 41.59 8.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.084 -1.206 . . . . 16.66 110.084 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.506 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.5 p-10 -96.17 5.38 51.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.129 -1.218 . . . . 16.66 109.122 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.06 -9.68 70.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.569 -1.012 . . . . 16.66 110.569 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.588 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.1 pttm -129.65 142.01 50.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.853 -1.381 . . . . 50.0 110.162 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.916 HD13 ' HB3' ' A' ' 18' ' ' PHE . 9.7 mt -112.78 133.6 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.736 -0.602 . . . . 16.66 109.457 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.408 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 23.3 p -106.12 168.95 8.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.332 -0.855 . . . . 50.0 108.912 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.488 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.27 -46.56 55.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.076 -1.015 . . . . 50.0 109.047 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.5 74.34 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.274 -0.891 . . . . 50.0 109.543 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.2 mt-10 -75.96 -54.03 7.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.137 -0.977 . . . . 16.66 109.269 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.605 ' O ' HD23 ' A' ' 31' ' ' LEU . 6.9 tt -61.44 -44.84 96.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.253 -0.904 . . . . 16.66 108.969 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.676 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -61.87 -43.79 98.72 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.113 -1.595 . . . . 16.66 109.113 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -56.3 -44.19 79.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -1.096 . . . . 50.0 109.766 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.15 75.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.173 -0.954 . . . . 50.0 108.572 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.986 ' CD1' HG22 ' A' ' 46' ' ' VAL . 9.6 mt -59.02 -35.06 72.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.505 -0.747 . . . . 99.99 109.929 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.6 mttm -43.86 -27.41 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.135 -0.978 . . . . 99.99 109.535 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.699 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.3 t -53.68 -26.51 23.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 99.99 109.407 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.5 mt -63.94 -33.76 76.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 50.0 109.32 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.43 6.84 50.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.573 -1.411 . . . . 16.66 109.573 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.8 t -154.3 50.77 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.045 -1.268 . . . . 16.66 109.653 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 tp -136.49 154.12 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 50.0 109.243 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.43 165.83 12.86 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 16.66 108.697 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.19 -32.64 20.51 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.058 1.838 . . . . 50.0 109.989 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -62.68 -27.74 69.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.661 -0.649 . . . . 50.0 110.052 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -80.75 -36.56 31.81 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.973 -1.079 . . . . 16.66 108.36 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.986 HG22 ' CD1' ' A' ' 35' ' ' LEU . 74.8 t -64.33 -38.6 82.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.689 -0.856 . . . . 50.0 108.689 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -72.44 -36.75 68.63 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.41 -0.959 . . . . 50.0 108.41 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.471 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 4.0 t60 -67.71 -37.18 81.9 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.939 -0.763 . . . . 50.0 108.939 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.416 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.7 mtt -60.29 -48.23 82.64 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.228 -0.92 . . . . 16.66 108.58 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.518 ' HE1' ' HA ' ' A' ' 60' ' ' PHE . 42.2 mtp -61.61 -48.29 81.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.922 -0.77 . . . . 50.0 108.922 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.72 -19.73 18.24 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.445 -0.784 . . . . 50.0 109.193 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.409 ' OE2' ' NE2' ' A' ' 48' ' ' HIS . 37.6 mt-10 -100.46 -37.03 9.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.89 . . . . 16.66 109.317 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.536 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.8 mt -80.29 -34.02 14.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.392 -0.818 . . . . 50.0 109.563 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.0 t0 -58.77 101.52 0.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.455 -0.778 . . . . 16.66 109.005 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 71.1 p -70.02 -47.67 61.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.829 . . . . 50.0 110.922 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.481 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.6 p-10 -86.95 -37.42 17.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.134 -0.979 . . . . 16.66 109.544 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.56 27.97 7.32 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.834 -1.174 . . . . 16.66 110.771 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.481 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 15.6 p-10 -79.58 -2.1 40.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.811 -1.405 . . . . 50.0 109.11 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.46 -6.26 59.16 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.981 -1.248 . . . . 16.66 109.981 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.588 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 28.4 m-85 -133.84 156.16 48.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.003 -1.293 . . . . 50.0 111.373 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.554 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 27.3 mm -107.99 129.97 61.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.217 -1.031 . . . . 16.66 108.217 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.8 m -96.93 167.13 11.27 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.051 -1.03 . . . . 16.66 108.636 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.608 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 36.2 t80 -54.4 -42.29 70.25 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.077 -1.014 . . . . 16.66 108.523 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -61.21 -47.94 83.79 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.515 -0.741 . . . . 50.0 109.286 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 68.1 mt-10 -60.68 -46.85 88.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.254 -0.904 . . . . 16.66 108.943 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.45 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 57.3 t80 -59.54 -40.88 88.69 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.491 -0.755 . . . . 16.66 109.147 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.7 m -64.17 -46.51 83.68 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.468 -0.77 . . . . 50.0 109.159 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.59 -39.63 80.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 50.0 109.344 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -79.95 -36.37 36.32 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.486 -0.931 . . . . 50.0 108.486 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.655 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.4 -31.55 74.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.083 -1.607 . . . . 16.66 109.083 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' THR . 64.4 mtm180 -70.34 -35.23 73.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.416 -1.049 . . . . 50.0 109.057 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.68 -2.55 50.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.394 -0.816 . . . . 50.0 109.455 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.775 ' HB3' HD22 ' A' ' 76' ' ' LEU . 69.4 m-80 -149.22 46.88 0.98 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.235 -0.916 . . . . 50.0 108.873 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -56.31 -48.51 76.54 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.521 -0.918 . . . . 50.0 108.521 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.24 -24.6 29.91 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.057 -1.617 . . . . 25.0 109.057 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.775 HD22 ' HB3' ' A' ' 73' ' ' ASN . 6.5 mp -79.7 -45.12 19.56 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.335 -1.097 . . . . 50.0 109.326 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.655 HD11 ' HA3' ' A' ' 70' ' ' GLY . 20.9 mt -62.67 -36.61 83.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.804 . . . . 50.0 109.845 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -67.13 -21.23 65.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 50.0 109.607 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.97 -34.55 29.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 50.0 109.476 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.478 ' HA ' HG13 ' A' ' 83' ' ' ILE . 25.1 t -78.39 -33.13 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 50.0 109.743 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.41 -46.46 62.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 50.0 110.128 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -63.91 -24.55 67.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 50.0 109.576 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.699 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.5 mt -66.31 -47.55 83.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.343 -0.848 . . . . 50.0 109.673 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.017 -0.992 . . . . 99.99 109.446 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.466 -0.568 . . . . 50.0 109.466 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -52.6 -37.4 58.12 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.383 -0.823 . . . . 50.0 109.274 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.12 -45.13 87.82 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.32 -0.863 . . . . 16.66 108.701 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.442 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.4 mt-10 -66.61 -45.81 77.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.818 -0.808 . . . . 16.66 108.818 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.467 ' NH2' ' CG ' ' A' ' 71' ' ' ARG . 13.7 mtt-85 -64.13 -39.37 93.89 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.447 -0.783 . . . . 50.0 109.336 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.601 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 15.9 mt-10 -65.76 -41.16 92.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.555 -0.716 . . . . 50.0 109.104 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 14.7 mtp180 -67.33 -40.55 85.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 50.0 109.014 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 10' ' ' GLU . 29.1 mt -70.12 -45.94 74.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.454 -0.779 . . . . 50.0 108.942 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -66.05 -35.99 82.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.376 -0.827 . . . . 16.66 109.119 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 21.8 mttt -64.48 -31.28 72.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 50.0 109.19 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 40.7 mtt180 -73.29 -33.15 65.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 50.0 109.222 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.993 ' HB3' HD13 ' A' ' 26' ' ' ILE . 37.5 m-85 -71.37 -45.11 63.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 16.66 109.29 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.461 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.8 t0 -63.09 103.16 0.44 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.252 -0.905 . . . . 16.66 108.798 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -52.05 60.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.227 -0.921 . . . . 50.0 111.247 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -88.1 -22.44 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.737 -1.227 . . . . 16.66 109.577 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.461 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 82.8 42.76 8.06 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.236 -1.146 . . . . 16.66 110.236 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.513 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.4 p-10 -97.63 5.93 48.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.126 -1.22 . . . . 16.66 109.269 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 62' ' ' SER . . . 94.87 -10.11 70.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.517 -1.033 . . . . 16.66 110.517 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 14.2 pttp -128.62 141.38 51.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.825 -1.397 . . . . 50.0 110.031 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.993 HD13 ' HB3' ' A' ' 18' ' ' PHE . 4.9 mt -113.53 134.55 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.662 -0.649 . . . . 16.66 109.365 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.441 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 26.6 p -108.03 169.65 8.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.395 -0.816 . . . . 50.0 108.895 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.7 -47.77 58.89 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.113 -0.992 . . . . 50.0 109.023 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.36 68.99 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.372 -0.83 . . . . 50.0 109.683 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 55.2 mt-10 -79.07 -53.44 7.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 16.66 109.298 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 31' ' ' LEU . 4.6 tt -62.1 -42.28 99.06 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.291 -0.881 . . . . 16.66 108.83 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.91 -45.7 93.44 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.023 -1.631 . . . . 16.66 109.023 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -56.03 -43.06 77.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -1.1 . . . . 50.0 109.395 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.66 -39.9 66.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.292 -1.003 . . . . 50.0 108.292 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.902 ' CD1' HG22 ' A' ' 46' ' ' VAL . 2.2 mt -59.15 -33.53 71.0 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.605 -0.684 . . . . 99.99 109.625 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -44.16 -26.43 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.1 -1.0 . . . . 99.99 109.551 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.74 ' CG2' HG21 ' A' ' 83' ' ' ILE . 8.0 t -48.87 -24.39 1.44 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.217 -0.927 . . . . 99.99 109.064 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.79 HD12 HD12 ' A' ' 41' ' ' ILE . 21.1 mt -66.63 -31.2 71.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.477 -0.764 . . . . 50.0 109.163 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.51 9.37 43.66 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.436 -1.466 . . . . 16.66 109.436 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' A' ' 40' ' ' SER . 9.7 t -156.07 49.15 0.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -1.143 . . . . 16.66 109.587 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.79 HD12 HD12 ' A' ' 38' ' ' LEU . 12.4 tt -137.32 169.41 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.257 -0.902 . . . . 50.0 109.475 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.95 166.66 16.98 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.92 . . . . 16.66 109.051 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.69 -32.65 18.41 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.175 1.916 . . . . 50.0 110.189 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -61.63 -29.05 69.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.648 -0.658 . . . . 50.0 110.016 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -81.43 -36.89 28.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.926 -1.109 . . . . 16.66 108.193 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.902 HG22 ' CD1' ' A' ' 35' ' ' LEU . 55.9 t -65.21 -34.7 72.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.968 -0.753 . . . . 50.0 108.968 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -69.45 -38.39 77.77 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.908 -0.775 . . . . 50.0 108.908 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -68.49 -38.5 81.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.462 -0.774 . . . . 50.0 108.933 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 mtt -62.25 -47.79 82.81 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.306 -0.871 . . . . 16.66 108.792 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.693 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 27.2 mtp -61.62 -46.55 89.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.449 -0.782 . . . . 50.0 109.159 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.24 -19.65 55.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 50.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.61 -35.63 12.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.355 -0.841 . . . . 16.66 108.879 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.631 HG22 HD12 ' A' ' 61' ' ' ILE . 81.8 mt -82.42 -30.92 9.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.561 -0.712 . . . . 50.0 109.669 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.6 t0 -59.67 101.35 0.11 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.38 -0.825 . . . . 16.66 109.064 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 71.0 p -72.82 -47.18 48.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -0.89 . . . . 50.0 110.543 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -29.97 24.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.181 -0.949 . . . . 16.66 109.514 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.484 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 92.02 28.19 14.28 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.893 -1.146 . . . . 16.66 110.35 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.14 -3.22 57.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.963 -1.316 . . . . 50.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.693 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.52 -7.29 59.6 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.962 -1.113 . . . . 16.66 110.526 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.573 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.6 m-85 -133.02 155.25 49.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.002 -1.293 . . . . 50.0 111.025 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.631 HD12 HG22 ' A' ' 53' ' ' ILE . 34.0 mm -106.24 128.09 60.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.333 -0.988 . . . . 16.66 108.333 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 18.0 m -94.16 166.11 12.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.235 -0.916 . . . . 16.66 108.602 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 34.5 t80 -54.48 -42.37 70.63 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.071 -1.018 . . . . 16.66 108.558 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -61.11 -49.47 77.14 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.098 -0.704 . . . . 50.0 109.098 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.539 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 28.8 mt-10 -58.1 -47.27 83.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 16.66 109.09 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.799 ' CE2' HD11 ' A' ' 77' ' ' LEU . 61.3 t80 -62.08 -40.47 95.94 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.531 -0.731 . . . . 16.66 109.305 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 16.3 m -64.33 -47.32 79.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.353 -0.842 . . . . 50.0 109.099 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.489 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 87.8 m-20 -59.31 -37.77 78.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 50.0 109.424 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.569 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.51 -36.76 57.58 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.529 -0.915 . . . . 50.0 108.529 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.13 -30.84 64.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.303 -1.519 . . . . 16.66 109.303 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 68' ' ' ASP . 72.3 mtm180 -69.26 -30.43 68.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -1.108 . . . . 50.0 109.071 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.22 -21.7 64.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -0.809 . . . . 50.0 109.286 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.898 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.1 m-80 -149.97 60.12 0.99 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.354 -0.841 . . . . 50.0 108.957 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -50.68 -38.61 47.68 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.737 -0.838 . . . . 50.0 108.737 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.24 -32.29 67.42 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.251 -1.54 . . . . 25.0 109.251 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.898 HD12 ' CB ' ' A' ' 73' ' ' ASN . 28.2 mt -64.46 -43.8 93.1 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.316 -1.108 . . . . 50.0 109.366 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.799 HD11 ' CE2' ' A' ' 66' ' ' PHE . 1.9 mm? -61.41 -41.91 97.9 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.426 -0.796 . . . . 50.0 109.679 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 19.2 mtmm -65.13 -27.66 68.89 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.263 -0.898 . . . . 50.0 109.512 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.66 -50.29 7.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.92 . . . . 50.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.6 p -64.33 -44.5 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.468 -0.77 . . . . 50.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.542 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -48.82 -40.48 29.44 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.54 -0.725 . . . . 50.0 109.385 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 27.2 mttp -65.47 -26.47 67.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 50.0 109.563 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.74 HG21 ' CG2' ' A' ' 37' ' ' THR . 35.0 mt -62.22 -32.7 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 50.0 109.423 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 5.1 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.001 -0.999 . . . . 99.99 109.488 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.428 0.632 . . . . 50.0 109.341 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -51.52 -36.54 45.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 50.0 109.455 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.88 -46.17 88.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.277 -0.89 . . . . 16.66 108.665 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 14' ' ' ILE . 67.9 mm-40 -66.5 -43.95 83.9 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.389 -0.819 . . . . 16.66 108.867 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.405 ' HA ' HD12 ' A' ' 14' ' ' ILE . 30.4 mtt-85 -64.5 -39.52 93.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.413 -0.804 . . . . 50.0 109.493 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 13.8 mt-10 -64.06 -40.0 95.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 50.0 109.416 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 21.1 mtp-105 -70.06 -38.22 75.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 50.0 109.034 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.5 mt -71.54 -44.91 70.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.371 -0.831 . . . . 50.0 108.888 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.533 ' CE1' HD11 ' A' ' 26' ' ' ILE . 69.6 t80 -69.23 -36.19 76.93 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.231 -0.918 . . . . 16.66 109.159 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 37.4 mttt -64.99 -30.53 71.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 50.0 109.027 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 65.8 mmt-85 -70.65 -39.14 73.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.365 -0.834 . . . . 50.0 109.005 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.902 ' HB3' HD13 ' A' ' 26' ' ' ILE . 43.6 m-85 -66.21 -47.73 72.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.832 . . . . 16.66 109.344 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 20.4 t0 -60.08 103.15 0.2 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 16.66 108.73 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 -50.6 40.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 50.0 111.092 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -87.3 -30.54 20.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.808 -1.182 . . . . 16.66 109.671 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.27 33.41 7.24 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.069 -1.213 . . . . 16.66 110.069 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.499 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 34.8 p-10 -86.76 5.42 36.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.266 . . . . 16.66 109.115 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.95 -3.93 77.79 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.374 -1.09 . . . . 16.66 110.374 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 3.7 pttm -133.67 143.99 48.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.948 -1.325 . . . . 50.0 110.244 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.902 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.3 mt -110.43 132.67 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.459 0.647 . . . . 16.66 109.752 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.448 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 13.0 p -106.56 166.48 10.53 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.917 -0.772 . . . . 50.0 108.917 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.08 -44.98 52.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.124 -0.985 . . . . 50.0 109.032 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -57.19 -39.9 76.31 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.358 -0.838 . . . . 50.0 109.541 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.5 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 60.5 mt-10 -75.7 -54.28 7.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.214 -0.929 . . . . 16.66 109.248 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.761 HD22 HG13 ' A' ' 46' ' ' VAL . 6.3 tt -61.78 -43.66 98.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.13 -0.981 . . . . 16.66 108.853 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.707 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.76 -44.79 95.75 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.009 -1.636 . . . . 16.66 109.009 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 30.1 mt-10 -58.45 -42.23 86.93 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.474 -1.015 . . . . 50.0 109.661 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.55 -39.72 67.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.322 -0.992 . . . . 50.0 108.322 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.922 HD12 HG22 ' A' ' 46' ' ' VAL . 3.3 mt -58.23 -31.82 67.73 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.519 -0.738 . . . . 99.99 109.544 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -45.15 -25.81 0.4 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 99.99 109.479 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.617 HG21 HG21 ' A' ' 83' ' ' ILE . 11.6 t -52.94 -26.29 14.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 99.99 109.374 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 38' ' ' LEU . 26.5 mt -65.35 -29.99 70.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -0.836 . . . . 50.0 109.237 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.66 9.0 42.94 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.734 -1.346 . . . . 16.66 109.734 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.5 49.6 0.54 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.089 -1.242 . . . . 16.66 109.811 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 41' ' ' ILE . 6.9 tp -133.31 165.36 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.251 -0.905 . . . . 50.0 109.344 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.87 164.67 16.83 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.168 -0.957 . . . . 16.66 108.741 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.65 -33.72 21.0 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.062 1.841 . . . . 50.0 110.012 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -64.12 -26.0 68.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.592 -0.692 . . . . 50.0 109.955 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.42 -38.62 26.21 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.821 -1.175 . . . . 16.66 108.401 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.922 HG22 HD12 ' A' ' 35' ' ' LEU . 61.7 t -63.93 -36.53 77.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.765 -0.828 . . . . 50.0 108.765 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -73.04 -37.52 66.85 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.413 -0.958 . . . . 50.0 108.413 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -68.02 -38.58 82.75 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.922 -0.769 . . . . 50.0 108.922 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.2 mtt -60.88 -47.45 86.34 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.241 -0.912 . . . . 16.66 108.635 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.591 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 50.6 mtp -60.93 -46.15 91.85 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.141 -0.688 . . . . 50.0 109.141 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.72 -21.01 53.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 50.0 109.194 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -95.89 -36.48 11.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 16.66 109.126 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.644 HG22 HD12 ' A' ' 61' ' ' ILE . 83.4 mt -80.86 -32.39 12.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.534 -0.729 . . . . 50.0 109.536 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 50' ' ' MET . 22.7 t0 -60.41 100.5 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.354 -0.841 . . . . 16.66 109.053 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.462 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 56.6 p -68.04 -46.44 71.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.307 -0.871 . . . . 50.0 110.616 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 1.7 p-10 -86.37 -37.97 17.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 16.66 109.44 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.36 27.03 7.88 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 120.037 -1.078 . . . . 16.66 110.555 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.499 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 7.9 p-10 -78.41 -1.58 34.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.743 -1.446 . . . . 50.0 109.051 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.591 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.52 -4.82 60.1 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.123 -1.191 . . . . 16.66 110.123 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 24.9 m-85 -135.68 157.55 46.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.033 -1.275 . . . . 50.0 111.482 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.644 HD12 HG22 ' A' ' 53' ' ' ILE . 31.5 mm -109.04 129.65 63.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.504 -0.924 . . . . 16.66 108.504 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.2 m -96.42 170.26 9.35 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.095 -1.003 . . . . 16.66 108.637 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.1 t80 -56.42 -43.97 79.93 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.133 -0.979 . . . . 16.66 108.694 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -60.44 -49.4 77.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.531 -0.731 . . . . 50.0 109.154 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.563 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.9 mt-10 -58.45 -46.07 87.31 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.267 -0.896 . . . . 16.66 109.219 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -63.52 -35.37 80.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 16.66 109.331 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 31.6 m -66.21 -48.41 70.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.444 -0.785 . . . . 50.0 109.279 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.57 -36.26 75.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.356 -0.84 . . . . 50.0 109.394 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -77.95 -37.14 48.22 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.433 -0.951 . . . . 50.0 108.433 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.695 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -56.46 -27.92 54.75 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.994 -1.643 . . . . 16.66 108.994 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 67' ' ' THR . 82.1 mtm180 -71.49 -27.34 63.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -1.135 . . . . 50.0 108.806 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.19 60.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.441 -0.787 . . . . 50.0 109.291 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.89 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.4 m-80 -144.49 59.83 1.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.356 -0.84 . . . . 50.0 109.248 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.602 ' HA ' HD23 ' A' ' 77' ' ' LEU . 97.3 mtt180 -52.57 -21.63 4.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 50.0 109.123 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.8 -26.74 60.03 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.36 -1.496 . . . . 25.0 109.36 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.89 HD12 ' CB ' ' A' ' 73' ' ' ASN . 72.1 mt -73.06 -45.02 59.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -1.099 . . . . 50.0 109.618 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -64.41 -42.94 95.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.376 -0.828 . . . . 50.0 109.806 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.9 mtmt -65.37 -34.12 77.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 50.0 109.484 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -79.32 -46.46 17.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 50.0 109.498 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.8 p -64.18 -43.89 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 50.0 109.192 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.548 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.08 -37.92 35.89 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.733 -0.604 . . . . 50.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 61.2 mttp -70.65 -26.43 63.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 50.0 109.413 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.617 HG21 HG21 ' A' ' 37' ' ' THR . 28.3 mt -62.78 -31.23 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 50.0 109.237 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 5.6 m-85 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.965 -1.017 . . . . 99.99 109.474 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 8' ' ' LYS . 81.3 m-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.4 0.619 . . . . 50.0 109.627 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 16.2 mttt -43.35 -35.91 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.442 -0.786 . . . . 50.0 109.78 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 12' ' ' GLU . . . -60.9 -45.87 92.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 16.66 109.058 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 73.6 mt-10 -70.67 -34.84 72.44 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.383 -0.823 . . . . 16.66 108.822 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.718 ' NH1' HG23 ' A' ' 67' ' ' THR . 70.3 mtm180 -72.31 -40.65 67.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.364 -0.835 . . . . 50.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.568 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 24.6 pt-20 -68.95 -38.34 79.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.291 -0.881 . . . . 50.0 109.184 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.541 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.4 mtp180 -66.8 -41.83 86.95 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.889 . . . . 50.0 109.303 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.481 HG22 ' HE2' ' A' ' 18' ' ' PHE . 27.4 mt -69.97 -46.01 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.278 -0.889 . . . . 50.0 109.032 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -64.62 -35.17 80.13 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.349 -0.844 . . . . 16.66 109.209 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 51.2 mttt -65.78 -31.72 72.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 50.0 109.385 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 65.7 mtt180 -70.68 -36.11 73.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 50.0 109.163 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.951 ' HB3' HD13 ' A' ' 26' ' ' ILE . 43.1 m-85 -66.04 -47.31 74.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.395 -0.816 . . . . 16.66 109.375 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.3 t0 -59.79 103.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.279 -0.888 . . . . 16.66 108.848 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.75 -51.67 53.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.179 -0.951 . . . . 50.0 111.191 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -86.59 -28.39 23.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.718 -1.239 . . . . 16.66 109.672 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 90.53 39.14 6.01 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.89 -1.148 . . . . 16.66 110.373 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.503 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.7 p-10 -95.02 5.63 51.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -1.221 . . . . 16.66 109.291 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.59 -8.1 77.09 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.486 -1.046 . . . . 16.66 110.486 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HE3' ' CE1' ' A' ' 60' ' ' PHE . 14.1 pttt -128.54 141.35 51.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.95 -1.324 . . . . 50.0 109.929 -179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.951 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.6 mt -112.59 133.19 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.655 -0.653 . . . . 16.66 109.528 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 p -103.59 166.18 10.58 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.618 -0.882 . . . . 50.0 108.618 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.516 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.18 -44.39 52.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.062 -1.024 . . . . 50.0 108.81 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.54 82.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.354 -0.841 . . . . 50.0 109.419 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.8 mt-10 -74.25 -54.73 7.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -0.932 . . . . 16.66 109.275 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.666 ' HG ' HD12 ' A' ' 35' ' ' LEU . 40.1 tp -61.92 -43.63 98.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.181 -0.95 . . . . 16.66 108.929 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.48 -43.82 98.48 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.084 -1.606 . . . . 16.66 109.084 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -56.49 -44.0 80.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.285 -1.127 . . . . 50.0 109.531 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.72 -39.4 66.96 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.364 -0.976 . . . . 50.0 108.364 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.115 HD13 HG22 ' A' ' 46' ' ' VAL . 6.9 mt -59.66 -32.61 70.62 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.532 -0.73 . . . . 99.99 109.522 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.6 -24.4 0.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 99.99 109.532 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.7 t -52.93 -23.78 7.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.183 -0.948 . . . . 99.99 109.151 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.832 HD12 HD12 ' A' ' 41' ' ' ILE . 25.5 mt -62.77 -31.81 72.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.42 -0.8 . . . . 50.0 109.343 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.69 6.58 51.17 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 16.66 109.564 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.24 55.15 0.64 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.183 -1.186 . . . . 16.66 109.521 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.832 HD12 HD12 ' A' ' 38' ' ' LEU . 12.0 tt -140.53 171.33 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 50.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.52 165.2 27.9 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.714 -0.847 . . . . 16.66 108.714 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.82 -33.47 20.54 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.052 1.834 . . . . 50.0 110.232 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -64.97 -25.3 67.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.708 -0.62 . . . . 50.0 110.149 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.441 ' OE1' HG13 ' A' ' 41' ' ' ILE . 94.0 mt-10 -82.59 -38.61 23.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.888 -1.132 . . . . 16.66 108.344 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.115 HG22 HD13 ' A' ' 35' ' ' LEU . 41.4 t -65.76 -36.12 76.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.824 -0.806 . . . . 50.0 108.824 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -66.24 -39.14 89.31 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.973 -0.751 . . . . 50.0 108.973 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.536 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 3.4 t60 -66.92 -41.24 87.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.412 -0.805 . . . . 50.0 109.135 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.492 ' HE3' HD11 ' A' ' 35' ' ' LEU . 48.0 mtm -60.17 -44.92 94.65 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.241 -0.912 . . . . 16.66 108.923 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.529 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 20.1 mtp -61.98 -47.17 86.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.528 -0.733 . . . . 50.0 109.231 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.33 -19.13 54.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 50.0 109.068 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.536 ' CD ' ' HE2' ' A' ' 48' ' ' HIS . 35.8 mt-10 -95.92 -36.72 10.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 16.66 108.975 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.59 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.7 mt -81.33 -32.41 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.476 -0.765 . . . . 50.0 109.482 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.9 t0 -60.66 100.49 0.11 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.399 -0.813 . . . . 16.66 108.905 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.444 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 71.0 p -66.81 -46.89 73.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.324 -0.86 . . . . 50.0 110.771 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.9 p-10 -87.94 -40.81 13.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.178 -0.951 . . . . 16.66 109.559 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.474 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 103.32 28.99 5.86 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.919 -1.134 . . . . 16.66 110.314 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.478 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.6 p-10 -79.8 -2.79 44.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.862 -1.375 . . . . 50.0 109.135 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.529 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.7 -3.96 57.73 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.783 -1.327 . . . . 16.66 109.783 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CE1' ' HE3' ' A' ' 25' ' ' LYS . 32.4 m-85 -135.91 156.1 49.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.077 -1.249 . . . . 50.0 111.279 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.551 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 29.4 mm -108.89 130.99 60.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.463 -0.94 . . . . 16.66 108.463 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 m -99.58 168.02 10.22 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.988 -1.07 . . . . 16.66 108.775 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.568 ' CE1' ' HA ' ' A' ' 12' ' ' GLU . 36.1 t80 -54.88 -43.73 73.44 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.247 -0.981 . . . . 16.66 108.673 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -59.83 -49.81 76.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.568 -0.707 . . . . 50.0 109.115 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.5 mt-10 -58.81 -47.29 85.31 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.271 -0.893 . . . . 16.66 108.974 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.666 ' HZ ' HD12 ' A' ' 77' ' ' LEU . 58.7 t80 -63.07 -33.21 74.95 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.401 -0.812 . . . . 16.66 109.241 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.718 HG23 ' NH1' ' A' ' 11' ' ' ARG . 79.7 m -67.24 -49.17 65.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 50.0 109.107 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' OD1' ' NH2' ' A' ' 71' ' ' ARG . 59.4 m-20 -59.26 -36.95 76.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 50.0 109.291 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.59 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -79.46 -37.79 36.11 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.414 -0.958 . . . . 50.0 108.414 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.731 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -60.38 -32.51 77.52 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.096 -1.602 . . . . 16.66 109.096 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 67' ' ' THR . 65.6 mtm180 -66.16 -36.93 84.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -1.106 . . . . 50.0 108.917 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.04 -19.65 65.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.482 -0.761 . . . . 50.0 109.154 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.771 ' CB ' HD12 ' A' ' 76' ' ' LEU . 3.3 m-80 -145.81 55.23 1.18 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 50.0 109.231 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.57 ' HA ' HD23 ' A' ' 77' ' ' LEU . 8.5 ptp85 -49.87 -35.36 23.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -0.848 . . . . 50.0 108.721 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.435 ' HA2' ' HE2' ' A' ' 78' ' ' LYS . . . -65.92 -27.34 72.71 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.492 -1.443 . . . . 25.0 109.492 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.771 HD12 ' CB ' ' A' ' 73' ' ' ASN . 14.9 mt -67.92 -46.86 70.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.109 . . . . 50.0 109.507 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.837 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -62.9 -42.72 99.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.354 -0.841 . . . . 50.0 109.681 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HE2' ' HA2' ' A' ' 75' ' ' GLY . 32.3 mtmt -61.88 -31.83 72.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 50.0 109.39 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.44 ' O ' HG13 ' A' ' 83' ' ' ILE . 29.7 t0 -76.05 -37.82 57.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.306 -0.871 . . . . 50.0 109.385 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 76' ' ' LEU . 46.0 t -73.3 -39.1 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 50.0 109.401 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.81 -44.26 59.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.403 -0.81 . . . . 50.0 109.891 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -65.6 -26.73 67.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 50.0 109.463 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.452 HG13 ' HA ' ' A' ' 80' ' ' VAL . 7.9 mt -65.39 -48.2 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.831 . . . . 50.0 109.633 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.015 -0.993 . . . . 99.99 109.42 179.942 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.362 0.601 . . . . 50.0 109.573 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.503 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 39.5 mttp -45.92 -36.31 5.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 50.0 109.326 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.19 91.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.411 -0.806 . . . . 16.66 108.877 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 14' ' ' ILE . 65.5 mt-10 -68.97 -37.02 78.54 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.963 -0.754 . . . . 16.66 108.963 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.538 ' NH2' HG23 ' A' ' 67' ' ' THR . 12.6 mtm180 -70.37 -40.76 73.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.366 -0.834 . . . . 50.0 109.238 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.628 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 38.9 mt-10 -66.65 -41.05 88.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.458 -0.776 . . . . 50.0 109.268 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 13.7 mtp180 -65.37 -41.62 93.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.29 -0.881 . . . . 50.0 109.328 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 81' ' ' ALA . 22.9 mt -69.59 -45.98 76.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.267 -0.896 . . . . 50.0 109.074 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -66.06 -35.79 81.47 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.242 -0.911 . . . . 16.66 109.333 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -65.6 -33.39 75.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.211 -0.931 . . . . 50.0 109.325 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HD3' ' HB3' ' A' ' 84' ' ' PHE . 53.6 mtt85 -69.94 -34.53 73.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 50.0 109.238 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.005 ' HB3' HD13 ' A' ' 26' ' ' ILE . 34.1 m-85 -69.85 -47.54 62.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 16.66 109.538 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 25.6 t0 -58.65 103.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 16.66 108.747 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.14 -52.19 50.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.223 -0.923 . . . . 50.0 111.275 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -87.34 -22.02 25.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.747 -1.221 . . . . 16.66 109.483 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 82.53 43.92 7.63 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.271 -1.132 . . . . 16.66 110.271 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.509 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.2 p-10 -99.61 7.0 45.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.082 -1.246 . . . . 16.66 109.236 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.04 -10.88 71.52 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.545 -1.022 . . . . 16.66 110.545 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.6 pttp -127.47 140.77 51.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.866 -1.373 . . . . 50.0 109.975 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.005 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.4 mt -113.24 134.1 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.6 -0.688 . . . . 16.66 109.395 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.422 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 21.2 p -105.75 168.23 9.24 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.6 -0.889 . . . . 50.0 108.6 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.498 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.34 -46.23 55.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.973 -1.079 . . . . 50.0 108.969 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.38 -38.98 75.1 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.297 -0.877 . . . . 50.0 109.584 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 56.5 mt-10 -75.58 -53.9 7.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.175 -0.953 . . . . 16.66 109.437 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.731 HD12 ' CD1' ' A' ' 18' ' ' PHE . 9.6 tp -62.51 -42.12 99.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 16.66 108.941 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.479 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -62.88 -44.37 97.54 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.079 -1.608 . . . . 16.66 109.079 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -56.86 -44.23 81.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -1.064 . . . . 50.0 109.673 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.49 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.39 -39.36 68.05 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.435 -0.95 . . . . 50.0 108.435 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.99 HD12 HG22 ' A' ' 46' ' ' VAL . 11.4 mt -58.65 -33.62 70.29 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.548 -0.72 . . . . 99.99 109.46 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -45.18 -25.72 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 99.99 109.474 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.457 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.7 t -52.27 -25.32 9.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.898 . . . . 99.99 109.305 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.715 HD12 HD12 ' A' ' 41' ' ' ILE . 39.7 mt -62.17 -31.86 72.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.398 -0.814 . . . . 50.0 109.157 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.56 6.84 51.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.605 -1.398 . . . . 16.66 109.605 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.99 56.41 0.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.164 -1.198 . . . . 16.66 109.6 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.715 HD12 HD12 ' A' ' 38' ' ' LEU . 11.6 tt -141.5 172.35 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.971 . . . . 50.0 109.635 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.92 166.24 21.36 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.344 -0.847 . . . . 16.66 108.754 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.79 -33.66 16.03 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.02 1.813 . . . . 50.0 109.952 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.38 -25.97 68.53 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.61 -0.681 . . . . 50.0 109.969 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -80.88 -37.48 29.73 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.876 -1.14 . . . . 16.66 108.329 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.99 HG22 HD12 ' A' ' 35' ' ' LEU . 51.9 t -65.0 -36.8 78.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.949 -0.76 . . . . 50.0 108.949 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -68.19 -38.86 82.46 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.762 -0.829 . . . . 50.0 108.762 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -66.7 -41.04 88.68 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.464 -0.772 . . . . 50.0 109.011 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.8 mtt -60.82 -45.92 92.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.213 -0.929 . . . . 16.66 108.881 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.529 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 34.7 mtp -61.87 -48.25 81.35 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.014 -0.736 . . . . 50.0 109.014 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.62 -20.42 32.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.87 . . . . 50.0 109.172 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -96.86 -35.99 10.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.324 -0.86 . . . . 16.66 109.099 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.616 HG22 HD12 ' A' ' 61' ' ' ILE . 82.2 mt -82.38 -30.53 9.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.538 -0.726 . . . . 50.0 109.783 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 50' ' ' MET . 18.3 t0 -61.3 101.38 0.16 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.38 -0.825 . . . . 16.66 109.291 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 82.6 p -73.68 -48.16 34.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -0.916 . . . . 50.0 110.851 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 17.1 p-10 -85.0 -28.6 25.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 16.66 109.972 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.464 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 91.19 27.91 16.85 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.847 -1.168 . . . . 16.66 110.632 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 8.9 p-10 -83.36 -4.4 58.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.895 -1.356 . . . . 50.0 109.502 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.529 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 100.11 -7.65 58.78 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.969 -1.11 . . . . 16.66 110.35 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 43.2 m-85 -131.11 153.37 49.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.016 -1.285 . . . . 50.0 110.918 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.616 HD12 HG22 ' A' ' 53' ' ' ILE . 36.3 mm -104.33 129.5 56.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.183 -1.043 . . . . 16.66 108.183 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.78 165.45 11.94 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.143 -0.973 . . . . 16.66 108.779 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 35.3 t80 -53.61 -42.49 67.76 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.224 -0.99 . . . . 16.66 108.564 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -60.31 -48.56 81.22 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.529 -0.732 . . . . 50.0 109.218 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.544 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 62.0 mt-10 -60.25 -47.3 86.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 16.66 109.1 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.425 ' HE1' HD13 ' A' ' 77' ' ' LEU . 54.6 t80 -62.72 -35.52 80.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.517 -0.74 . . . . 16.66 109.19 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.538 HG23 ' NH2' ' A' ' 11' ' ' ARG . 12.5 m -67.07 -48.48 68.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.357 -0.839 . . . . 50.0 109.138 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -60.4 -38.24 83.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 50.0 109.237 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.578 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.17 -38.45 51.69 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.505 -0.924 . . . . 50.0 108.505 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.927 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.17 -27.72 60.49 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.183 -1.567 . . . . 16.66 109.183 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' THR . 58.8 mtm180 -72.53 -31.73 65.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -1.137 . . . . 50.0 108.989 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.1 -20.46 64.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.414 -0.804 . . . . 50.0 109.312 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.806 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.9 m-80 -149.93 56.74 0.96 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -0.863 . . . . 50.0 109.32 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 69.8 mtt180 -50.18 -38.53 40.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 50.0 108.796 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.44 -19.08 39.4 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.432 -1.467 . . . . 25.0 109.432 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.806 HD12 ' CB ' ' A' ' 73' ' ' ASN . 43.9 mt -79.52 -43.73 22.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -1.058 . . . . 50.0 109.395 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.927 HD11 ' HA3' ' A' ' 70' ' ' GLY . 5.4 mt -70.79 -15.92 62.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.475 -0.766 . . . . 50.0 109.743 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 43.1 mtpt -80.02 -29.27 39.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.15 -0.969 . . . . 50.0 109.206 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.14 -47.35 8.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 50.0 109.529 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.9 p -62.31 -42.55 95.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.371 -0.831 . . . . 50.0 109.304 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.542 ' HB2' HD11 ' A' ' 14' ' ' ILE . . . -52.24 -35.96 51.09 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.746 -0.596 . . . . 50.0 110.2 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -75.45 -24.36 57.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.092 -1.005 . . . . 50.0 109.771 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.474 HG13 ' HA ' ' A' ' 80' ' ' VAL . 10.9 mt -59.07 -38.66 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.273 -0.892 . . . . 50.0 109.546 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.465 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 93.1 m-85 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 118.038 -0.982 . . . . 99.99 109.425 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.351 -0.611 . . . . 50.0 109.351 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -49.22 -36.34 19.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.825 . . . . 50.0 109.516 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.15 -46.66 87.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.257 -0.902 . . . . 16.66 108.752 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.46 ' O ' HG13 ' A' ' 14' ' ' ILE . 59.6 mm-40 -67.28 -40.37 86.14 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.801 -0.814 . . . . 16.66 108.801 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.548 ' NH2' HD12 ' A' ' 77' ' ' LEU . 45.4 mtt-85 -65.81 -40.49 91.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.557 -0.714 . . . . 50.0 109.649 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.614 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 35.6 mt-10 -64.89 -39.79 94.09 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 50.0 109.571 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 53.2 mtp180 -69.24 -39.26 78.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 50.0 109.21 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.5 mt -71.59 -45.2 68.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.315 -0.866 . . . . 50.0 108.957 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -64.48 -36.47 84.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.114 -0.991 . . . . 16.66 108.864 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 33.5 mttt -66.12 -28.81 69.09 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.392 -0.818 . . . . 50.0 108.88 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 35.2 mtt85 -68.85 -39.17 80.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 50.0 109.08 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.883 ' HB3' HD13 ' A' ' 26' ' ' ILE . 54.5 m-85 -68.52 -51.33 44.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.458 -0.776 . . . . 16.66 109.373 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.5 t0 -54.08 103.14 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -0.842 . . . . 16.66 108.814 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.68 -51.67 46.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.198 -0.939 . . . . 50.0 111.278 -178.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -86.73 -27.48 23.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.812 -1.18 . . . . 16.66 109.693 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.28 39.26 6.44 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.145 -1.182 . . . . 16.66 110.145 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -94.34 6.22 49.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.086 -1.244 . . . . 16.66 109.193 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.85 -7.43 76.89 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.513 -1.035 . . . . 16.66 110.513 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 11.7 pttp -130.43 142.32 50.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.891 -1.358 . . . . 50.0 109.971 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.883 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.5 mt -112.53 133.51 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.613 -0.679 . . . . 16.66 109.567 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 p -105.83 168.22 9.26 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.359 -0.838 . . . . 50.0 108.897 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.2 -46.53 54.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.059 -1.025 . . . . 50.0 108.781 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.28 -41.42 75.85 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.337 -0.852 . . . . 50.0 109.38 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.506 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.8 mt-10 -73.92 -54.08 8.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.187 -0.946 . . . . 16.66 109.302 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.899 HD22 HG13 ' A' ' 46' ' ' VAL . 6.6 tt -59.65 -45.89 90.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.218 -0.926 . . . . 16.66 108.9 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.591 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -61.54 -43.93 98.65 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.559 -1.417 . . . . 16.66 109.559 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -58.04 -40.69 81.56 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.286 -1.126 . . . . 50.0 109.82 -179.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -71.83 -39.12 69.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.097 -1.002 . . . . 50.0 108.736 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.016 ' CD1' HG22 ' A' ' 46' ' ' VAL . 16.0 mt -59.71 -31.86 69.99 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.499 -0.751 . . . . 99.99 110.116 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.7 mttt -43.55 -28.53 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.08 -1.012 . . . . 99.99 109.577 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -52.82 -26.97 16.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 99.99 109.226 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.03 HD12 HD12 ' A' ' 41' ' ' ILE . 22.1 mt -58.28 -33.64 69.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.328 -0.857 . . . . 50.0 109.257 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.08 2.0 57.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.773 -1.331 . . . . 16.66 109.773 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.15 57.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -1.18 . . . . 16.66 109.624 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.03 HD12 HD12 ' A' ' 38' ' ' LEU . 10.5 tt -139.1 169.24 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.133 -0.979 . . . . 50.0 109.719 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.81 165.93 21.27 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.774 -0.824 . . . . 16.66 108.774 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.2 -33.53 18.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.03 1.82 . . . . 50.0 110.146 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -63.16 -27.82 69.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.613 -0.68 . . . . 50.0 110.113 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.17 -36.14 30.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.93 -1.106 . . . . 16.66 108.389 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.016 HG22 ' CD1' ' A' ' 35' ' ' LEU . 76.4 t -66.41 -35.04 73.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.098 -0.704 . . . . 50.0 109.098 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -67.95 -38.05 82.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.872 -0.788 . . . . 50.0 108.872 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -67.15 -37.8 84.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.424 -0.797 . . . . 50.0 109.226 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.415 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.6 mtt -61.75 -46.81 88.03 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.196 -0.94 . . . . 16.66 108.854 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.699 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 35.2 mtp -61.96 -47.87 82.94 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.492 -0.755 . . . . 50.0 109.085 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.79 -19.48 41.32 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.365 -0.835 . . . . 50.0 109.231 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -97.42 -36.15 10.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 16.66 109.029 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.579 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.8 mt -82.05 -32.13 10.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.515 -0.741 . . . . 50.0 109.797 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.0 t0 -59.19 101.63 0.1 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.245 -0.91 . . . . 16.66 108.965 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.511 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 80.9 p -71.04 -48.1 54.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 50.0 110.754 -178.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -85.79 -30.83 22.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.161 -0.962 . . . . 16.66 109.518 -179.585 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 92.84 27.91 13.26 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.862 -1.161 . . . . 16.66 110.343 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD2' ' OD1' ' A' ' 56' ' ' ASP . 1.4 p30 -81.87 -2.23 50.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.328 . . . . 50.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.699 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.89 -8.57 59.64 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.044 -1.074 . . . . 16.66 110.56 179.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 36.4 m-85 -132.95 156.17 47.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.948 -1.325 . . . . 50.0 111.24 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.572 HD12 HG22 ' A' ' 53' ' ' ILE . 25.5 mm -107.6 129.05 62.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.432 -0.951 . . . . 16.66 108.432 178.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.85 167.41 11.27 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.033 -1.042 . . . . 16.66 108.647 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.614 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 34.2 t80 -54.52 -42.57 71.0 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.025 -1.047 . . . . 16.66 108.545 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -60.52 -49.71 76.46 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.576 -0.702 . . . . 50.0 109.165 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 61.2 mt-10 -58.91 -46.8 87.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.258 -0.901 . . . . 16.66 109.08 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.427 ' HE1' HD13 ' A' ' 77' ' ' LEU . 51.1 t80 -63.86 -35.66 81.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.442 -0.786 . . . . 16.66 109.346 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.7 m -66.22 -48.69 69.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.37 -0.832 . . . . 50.0 109.166 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -59.88 -34.98 73.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 50.0 109.395 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.579 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -79.81 -37.65 34.69 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.422 -0.955 . . . . 50.0 108.422 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.825 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -57.88 -27.64 59.61 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.067 -1.613 . . . . 16.66 109.067 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -71.37 -32.2 68.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.445 -1.032 . . . . 50.0 108.811 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.43 -20.94 66.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.463 -0.773 . . . . 50.0 109.276 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.763 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.6 m-80 -152.12 55.89 0.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -0.84 . . . . 50.0 109.137 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 4.1 ptm180 -48.45 -34.11 10.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.877 . . . . 50.0 108.769 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.41 ' HA2' ' HE3' ' A' ' 78' ' ' LYS . . . -60.62 -31.7 75.92 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.347 -1.501 . . . . 25.0 109.347 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.763 HD12 ' CB ' ' A' ' 73' ' ' ASN . 65.7 mt -66.13 -44.46 84.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -1.147 . . . . 50.0 109.582 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.825 HD11 ' HA3' ' A' ' 70' ' ' GLY . 4.6 mt -71.39 -19.13 62.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 50.0 109.843 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 14.5 mtmt -79.96 -28.37 39.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.177 -0.952 . . . . 50.0 109.271 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.92 -46.09 8.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 50.0 109.38 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.2 p -58.44 -44.19 88.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.803 0.811 . . . . 50.0 108.988 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.545 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -51.25 -38.45 52.7 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.297 -0.561 . . . . 50.0 109.767 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -68.77 -27.28 65.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 50.0 109.614 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.449 HG13 ' HA ' ' A' ' 80' ' ' VAL . 8.4 mt -60.66 -43.31 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.31 -0.869 . . . . 50.0 109.422 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.037 -0.982 . . . . 99.99 109.415 179.895 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.472 ' OD2' ' NH2' ' A' ' 74' ' ' ARG . 79.4 m-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.392 0.615 . . . . 50.0 109.465 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.46 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 11.5 mttt -43.69 -37.48 2.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 50.0 109.633 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -60.53 -46.02 91.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 16.66 108.91 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 14' ' ' ILE . 83.9 mt-10 -69.02 -35.84 77.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.476 -0.765 . . . . 16.66 108.976 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.67 ' NH2' HG23 ' A' ' 67' ' ' THR . 17.0 mtm180 -70.12 -40.45 74.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 50.0 109.309 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.633 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 59.5 mt-10 -66.6 -41.9 87.71 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.394 -0.816 . . . . 50.0 109.411 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 18.9 mtp180 -66.47 -41.31 89.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 50.0 109.457 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 10' ' ' GLU . 41.8 mt -70.04 -43.94 78.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.237 -0.915 . . . . 50.0 109.059 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 26' ' ' ILE . 70.2 t80 -64.35 -35.98 82.64 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.203 -0.936 . . . . 16.66 109.123 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -66.39 -30.43 70.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 50.0 109.12 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 60.0 mtt85 -69.32 -36.92 77.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 50.0 109.129 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.907 ' HB3' HD13 ' A' ' 26' ' ' ILE . 46.1 m-85 -69.4 -50.82 42.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.421 -0.799 . . . . 16.66 109.475 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.6 t0 -55.32 103.43 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 16.66 108.685 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.64 -51.53 48.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.269 -0.894 . . . . 50.0 111.307 -178.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -87.5 -27.59 22.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.759 -1.213 . . . . 16.66 109.753 -179.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 90.23 38.2 6.42 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.767 -1.206 . . . . 16.66 110.242 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.8 p-10 -93.34 6.33 48.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.252 . . . . 16.66 109.192 179.154 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.6 -7.72 77.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.402 -1.079 . . . . 16.66 110.402 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 24.9 pttt -129.56 141.67 50.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.935 -1.332 . . . . 50.0 109.997 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.907 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.7 mt -111.85 133.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.642 -0.661 . . . . 16.66 109.547 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.404 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 10.9 p -105.87 166.28 10.59 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.759 -0.83 . . . . 50.0 108.759 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.09 -45.19 52.42 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.049 -1.032 . . . . 50.0 108.841 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.79 -39.55 77.8 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.331 -0.856 . . . . 50.0 109.517 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.494 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.2 mt-10 -74.65 -54.17 7.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.157 -0.965 . . . . 16.66 109.398 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.584 HD12 ' CE1' ' A' ' 18' ' ' PHE . 30.3 tp -61.77 -43.35 99.02 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.262 -0.899 . . . . 16.66 108.954 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.689 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -62.71 -44.51 97.4 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.139 -1.584 . . . . 16.66 109.139 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 28.8 mt-10 -58.8 -42.74 89.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.355 -1.085 . . . . 50.0 109.868 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.79 -40.24 66.07 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.098 -1.001 . . . . 50.0 108.406 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.987 HD12 HG22 ' A' ' 46' ' ' VAL . 10.7 mt -58.71 -28.63 66.0 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.61 -0.681 . . . . 99.99 109.553 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 2.4 mtmt -44.04 -26.19 0.27 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 99.99 109.615 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.431 ' OG1' HG22 ' A' ' 83' ' ' ILE . 6.6 t -51.94 -26.31 10.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.306 -0.872 . . . . 99.99 109.195 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 38' ' ' LEU . 41.9 mt -58.73 -37.19 75.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.438 -0.789 . . . . 50.0 109.199 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.98 -5.6 61.89 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.836 -1.305 . . . . 16.66 109.836 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.7 t -152.0 59.77 0.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.044 -1.268 . . . . 16.66 109.779 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.3 tp -134.0 157.2 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.152 -0.968 . . . . 50.0 109.485 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.11 160.02 27.65 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.461 -0.94 . . . . 16.66 108.461 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.77 -31.97 30.93 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 121.93 1.753 . . . . 50.0 110.066 178.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -72.15 -17.92 61.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.603 -0.685 . . . . 50.0 110.177 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -80.94 -37.51 29.34 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.815 -1.178 . . . . 16.66 108.28 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.987 HG22 HD12 ' A' ' 35' ' ' LEU . 65.6 t -68.23 -35.88 72.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.821 -0.807 . . . . 50.0 108.821 179.299 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -65.19 -40.4 94.17 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.797 -0.816 . . . . 50.0 108.797 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.481 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.7 t60 -66.03 -42.33 89.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.484 -0.76 . . . . 50.0 109.051 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.9 mtt -58.45 -44.42 89.19 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.249 -0.907 . . . . 16.66 108.71 179.482 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.569 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 34.6 mtp -61.69 -46.69 88.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.572 -0.705 . . . . 50.0 109.182 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.82 -21.36 41.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 50.0 109.042 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.85 -36.32 11.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.46 -0.775 . . . . 16.66 109.076 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.582 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.7 mt -80.59 -31.98 12.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.43 -0.794 . . . . 50.0 109.566 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.6 t0 -61.42 101.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.5 -0.75 . . . . 16.66 109.066 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.474 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 60.3 p -67.5 -46.42 72.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.269 -0.894 . . . . 50.0 110.692 -179.038 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -88.28 -41.41 12.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 16.66 109.56 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 103.67 29.54 5.56 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.964 -1.112 . . . . 16.66 110.346 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 13.3 p-10 -80.61 -2.57 46.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.877 -1.367 . . . . 50.0 109.112 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.569 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.72 -3.58 57.56 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.943 -1.263 . . . . 16.66 109.943 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.575 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.2 m-85 -137.0 156.82 47.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.023 -1.281 . . . . 50.0 111.336 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.554 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 25.1 mm -109.46 130.31 62.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.418 -0.956 . . . . 16.66 108.418 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -99.38 168.52 9.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.057 -1.027 . . . . 16.66 108.571 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.633 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.6 t80 -54.8 -43.73 73.16 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.022 -1.071 . . . . 16.66 108.609 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -58.66 -47.54 84.11 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.626 -0.671 . . . . 50.0 109.261 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 80.8 mt-10 -62.97 -46.54 87.22 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.29 -0.881 . . . . 16.66 109.221 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.536 ' HZ ' HD12 ' A' ' 77' ' ' LEU . 31.9 t80 -63.81 -32.89 74.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 16.66 109.212 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.67 HG23 ' NH2' ' A' ' 11' ' ' ARG . 31.2 m -67.28 -49.35 64.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 50.0 109.171 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -59.74 -36.46 76.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.31 -0.869 . . . . 50.0 109.137 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.582 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.1 -38.91 43.02 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.504 -0.925 . . . . 50.0 108.504 179.706 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.67 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -57.49 -28.65 59.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.038 -1.625 . . . . 16.66 109.038 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 67' ' ' THR . 22.7 mtm180 -70.64 -31.91 69.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -1.076 . . . . 50.0 108.851 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.93 -23.51 62.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 50.0 109.238 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.91 ' CB ' HD12 ' A' ' 76' ' ' LEU . 15.5 m-80 -140.48 58.3 1.57 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 50.0 109.223 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.578 ' HA ' HD23 ' A' ' 77' ' ' LEU . 58.3 mtp180 -52.66 -34.86 53.6 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.328 -0.858 . . . . 50.0 108.998 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 78' ' ' LYS . . . -67.97 -24.25 74.42 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.48 -1.448 . . . . 25.0 109.48 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.91 HD12 ' CB ' ' A' ' 73' ' ' ASN . 14.6 mt -71.72 -45.99 60.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -1.148 . . . . 50.0 109.489 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.826 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -62.86 -42.97 99.95 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.327 -0.858 . . . . 50.0 109.677 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 37.0 pttt -68.36 -31.24 70.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 50.0 109.247 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.473 ' O ' HG13 ' A' ' 83' ' ' ILE . 35.3 m-20 -74.78 -36.8 62.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.333 -0.854 . . . . 50.0 109.256 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 76' ' ' LEU . 21.9 t -79.26 -35.64 17.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 50.0 109.22 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.97 -42.76 63.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.426 -0.796 . . . . 50.0 109.841 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -69.28 -26.08 64.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 50.0 109.573 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 79' ' ' ASP . 13.7 mt -63.53 -45.19 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.866 . . . . 50.0 109.527 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.05 -0.976 . . . . 99.99 109.397 179.966 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.45 -0.574 . . . . 50.0 109.45 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 13.3 mttp -49.57 -36.09 22.68 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.401 -0.812 . . . . 50.0 109.262 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.25 -46.35 90.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 16.66 108.755 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.475 ' O ' HG13 ' A' ' 14' ' ' ILE . 69.2 mt-10 -69.02 -37.81 78.85 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.876 -0.787 . . . . 16.66 108.876 179.386 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH2' ' HG2' ' A' ' 8' ' ' LYS . 10.8 mtm180 -69.57 -40.28 76.86 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.329 -0.857 . . . . 50.0 109.414 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 54.2 mt-10 -66.68 -39.73 88.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.406 -0.809 . . . . 50.0 109.476 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -69.11 -39.73 78.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 50.0 109.163 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' A' ' 81' ' ' ALA . 45.4 mt -71.44 -44.13 71.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.334 -0.854 . . . . 50.0 109.063 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -69.91 -36.1 75.11 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.133 -0.979 . . . . 16.66 109.115 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 56.6 mttm -65.83 -31.5 72.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.329 -0.857 . . . . 50.0 109.031 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -71.37 -35.8 71.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 50.0 109.011 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.022 ' HB3' HD13 ' A' ' 26' ' ' ILE . 33.7 m-85 -67.83 -47.58 68.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 16.66 109.243 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.3 t0 -59.09 103.36 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 16.66 108.624 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.85 -51.32 56.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 50.0 111.257 -178.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -87.18 -30.64 20.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.739 -1.226 . . . . 16.66 109.872 -179.307 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.46 35.6 6.18 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.702 -1.237 . . . . 16.66 110.15 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.2 p-10 -90.28 4.75 49.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -1.184 . . . . 16.66 109.172 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.91 -6.26 76.55 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.432 -1.067 . . . . 16.66 110.432 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.5 pttp -131.26 142.58 50.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.93 -1.335 . . . . 50.0 110.079 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.022 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.9 mt -112.23 132.86 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.695 -0.628 . . . . 16.66 109.421 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.403 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 14.4 p -104.94 167.76 9.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.339 -0.851 . . . . 50.0 108.963 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.23 -45.34 53.85 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.138 -0.976 . . . . 50.0 108.987 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.53 -40.83 79.67 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.374 -0.829 . . . . 50.0 109.318 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.3 mt-10 -74.01 -54.57 7.59 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.271 -0.893 . . . . 16.66 109.218 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.715 HD22 HG13 ' A' ' 46' ' ' VAL . 5.6 tt -59.7 -46.58 88.65 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.209 -0.932 . . . . 16.66 108.806 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.534 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -60.83 -42.93 99.73 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.45 -1.46 . . . . 16.66 109.45 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -57.98 -41.83 83.78 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.336 -1.096 . . . . 50.0 109.881 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.475 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -71.26 -39.02 71.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.15 -0.969 . . . . 50.0 108.719 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.019 ' CD1' HG22 ' A' ' 46' ' ' VAL . 21.3 mt -59.77 -34.62 73.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.54 -0.725 . . . . 99.99 110.034 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 8.8 mttt -43.78 -28.12 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 99.99 109.53 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.996 HG21 HG21 ' A' ' 83' ' ' ILE . 6.6 t -52.48 -25.74 11.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.288 -0.883 . . . . 99.99 109.208 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -64.44 -30.36 71.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.301 -0.874 . . . . 50.0 109.317 179.824 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.97 6.37 52.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.738 -1.345 . . . . 16.66 109.738 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 t -154.58 58.67 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.164 -1.198 . . . . 16.66 109.713 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.57 HD12 HD13 ' A' ' 38' ' ' LEU . 11.0 tt -144.25 168.42 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.963 . . . . 50.0 109.47 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.41 166.04 20.18 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 16.66 108.786 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.45 -33.4 17.86 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.089 1.859 . . . . 50.0 110.085 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -62.68 -27.86 69.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.662 -0.649 . . . . 50.0 109.908 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -81.73 -35.89 29.21 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.833 -1.167 . . . . 16.66 108.255 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.019 HG22 ' CD1' ' A' ' 35' ' ' LEU . 79.3 t -67.1 -35.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.028 -0.73 . . . . 50.0 109.028 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -68.6 -38.02 80.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.854 -0.795 . . . . 50.0 108.854 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -67.05 -37.04 83.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 50.0 109.132 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.402 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.4 mtt -60.86 -47.56 85.83 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.272 -0.892 . . . . 16.66 108.811 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.56 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 56.5 mtp -61.28 -47.31 86.59 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.566 -0.709 . . . . 50.0 109.125 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.81 -20.74 37.91 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.292 -0.88 . . . . 50.0 109.171 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -98.93 -37.39 9.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 16.66 109.244 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.588 HG12 ' CD2' ' A' ' 69' ' ' PHE . 85.5 mt -80.35 -33.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.471 -0.768 . . . . 50.0 109.685 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.6 t0 -60.44 101.55 0.14 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.405 -0.809 . . . . 16.66 108.891 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 71.8 p -66.53 -47.9 71.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 50.0 110.785 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.2 p-10 -87.57 -38.8 15.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.106 -0.996 . . . . 16.66 109.452 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 101.12 27.65 7.24 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.945 -1.121 . . . . 16.66 110.492 179.403 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.474 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 15.6 p-10 -78.45 -0.75 30.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.865 -1.373 . . . . 50.0 109.224 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.56 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.47 -4.84 58.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.015 -1.234 . . . . 16.66 110.015 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.575 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 27.0 m-85 -136.86 157.17 47.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.926 -1.337 . . . . 50.0 111.34 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.555 HD12 HG22 ' A' ' 53' ' ' ILE . 23.1 mm -110.08 131.35 61.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.466 -0.939 . . . . 16.66 108.466 178.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 170.82 8.27 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.045 -1.035 . . . . 16.66 108.521 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 36.2 t80 -56.09 -44.45 79.02 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.121 -1.032 . . . . 16.66 108.657 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -59.04 -49.35 78.23 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.492 -0.755 . . . . 50.0 109.229 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.548 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 78.4 mt-10 -60.23 -46.49 89.59 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.261 -0.899 . . . . 16.66 109.265 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.511 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 64.1 t80 -63.6 -34.07 77.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.418 -0.802 . . . . 16.66 109.337 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.531 HG23 ' NH2' ' A' ' 11' ' ' ARG . 19.6 m -66.56 -48.97 67.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.843 . . . . 50.0 109.203 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -58.85 -36.22 74.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 50.0 109.24 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.588 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -79.88 -37.16 35.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.585 -0.894 . . . . 50.0 108.585 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.922 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.15 -28.71 67.05 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.383 -1.487 . . . . 16.66 109.383 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 67' ' ' THR . 75.5 mtm180 -72.68 -34.69 67.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 50.0 109.198 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.82 -18.98 65.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.434 -0.791 . . . . 50.0 109.298 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.719 ' CB ' HD12 ' A' ' 76' ' ' LEU . 29.4 m-80 -144.4 56.74 1.3 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.263 -0.898 . . . . 50.0 109.222 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 98.3 mtt180 -51.46 -40.3 59.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.713 -0.847 . . . . 50.0 108.713 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.479 ' HA2' ' HE3' ' A' ' 78' ' ' LYS . . . -60.27 -25.98 63.29 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.454 -1.459 . . . . 25.0 109.454 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.719 HD12 ' CB ' ' A' ' 73' ' ' ASN . 18.6 mt -72.7 -45.55 58.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -1.161 . . . . 50.0 109.43 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.922 HD11 ' HA3' ' A' ' 70' ' ' GLY . 10.5 mt -68.67 -16.46 63.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 50.0 109.777 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HE3' ' HA2' ' A' ' 75' ' ' GLY . 18.6 mtmt -80.05 -24.35 40.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 50.0 109.322 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -91.99 -48.32 6.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.273 -0.892 . . . . 50.0 109.408 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.547 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.3 p -59.15 -44.33 91.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.388 -0.82 . . . . 50.0 109.178 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.602 ' HB2' HD11 ' A' ' 14' ' ' ILE . . . -49.62 -40.86 40.69 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.115 -0.634 . . . . 50.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -64.11 -25.74 68.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 50.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.996 HG21 HG21 ' A' ' 37' ' ' THR . 20.8 mm -66.79 -36.1 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 50.0 109.414 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.009 -0.996 . . . . 99.99 109.458 -179.999 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.296 -0.631 . . . . 50.0 109.296 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -51.18 -36.14 39.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 50.0 109.432 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.7 -45.53 85.57 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.655 -0.869 . . . . 16.66 108.655 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 14' ' ' ILE . 58.9 mt-10 -66.43 -43.82 84.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.955 -0.758 . . . . 16.66 108.955 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.5 ' NH2' ' HG2' ' A' ' 71' ' ' ARG . 20.0 mtt-85 -64.49 -39.74 94.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -0.782 . . . . 50.0 109.46 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.586 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 31.6 mt-10 -64.35 -41.62 96.65 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.48 -0.762 . . . . 50.0 109.286 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 52.0 mtp85 -67.99 -39.77 83.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.307 -0.871 . . . . 50.0 109.173 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.1 mt -70.52 -44.45 76.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.394 -0.816 . . . . 50.0 109.044 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -66.66 -36.1 81.73 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.243 -0.911 . . . . 16.66 109.141 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 22.6 mtpt -65.4 -30.22 71.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.352 -0.843 . . . . 50.0 109.089 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.515 ' NH2' ' O ' ' A' ' 84' ' ' PHE . 31.5 mtt180 -71.88 -35.22 69.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 50.0 109.057 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.058 ' HB3' HD13 ' A' ' 26' ' ' ILE . 31.0 m-85 -69.45 -48.77 59.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.448 -0.783 . . . . 16.66 109.298 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.2 t0 -58.74 103.09 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.917 . . . . 16.66 108.662 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.57 -51.82 52.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.128 -0.982 . . . . 50.0 111.239 -178.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -86.65 -27.9 23.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.748 -1.22 . . . . 16.66 109.565 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.33 38.1 6.83 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.862 -1.161 . . . . 16.66 110.215 179.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.4 p-10 -92.39 5.91 48.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -1.217 . . . . 16.66 109.142 179.168 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.88 -7.13 76.96 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.472 -1.051 . . . . 16.66 110.472 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 15.7 pttt -130.74 142.34 50.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.886 -1.361 . . . . 50.0 110.047 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.058 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.9 mt -112.3 133.23 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.724 -0.61 . . . . 16.66 109.447 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.416 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 23.7 p -106.93 169.74 8.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -0.891 . . . . 50.0 109.054 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.51 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.8 -46.76 59.85 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.108 -0.995 . . . . 50.0 108.985 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.19 74.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.266 -0.896 . . . . 50.0 109.467 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.4 mt-10 -75.56 -54.22 7.35 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.207 -0.933 . . . . 16.66 109.239 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.756 HD22 HG13 ' A' ' 46' ' ' VAL . 7.0 tt -59.58 -46.77 87.93 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.212 -0.93 . . . . 16.66 108.847 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.633 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -60.88 -43.33 99.43 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.461 -1.456 . . . . 16.66 109.461 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.32 -41.36 84.38 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.437 -1.037 . . . . 50.0 109.826 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.4 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.35 -39.81 67.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.166 -0.959 . . . . 50.0 108.726 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.011 HD12 HG22 ' A' ' 46' ' ' VAL . 14.1 mt -59.55 -32.28 70.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.446 -0.784 . . . . 99.99 109.832 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.6 mtmt -43.7 -26.32 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.065 -1.022 . . . . 99.99 109.632 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.456 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.6 t -52.4 -25.8 10.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 99.99 109.244 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -65.72 -31.86 73.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.372 -0.83 . . . . 50.0 109.201 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.07 11.04 43.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.479 -1.449 . . . . 16.66 109.479 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.33 50.02 0.56 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.242 -1.152 . . . . 16.66 109.54 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 tt -136.95 172.99 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 50.0 109.288 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.78 166.58 19.36 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 16.66 108.696 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.16 -33.81 18.01 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.089 1.859 . . . . 50.0 110.184 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -64.08 -26.14 68.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.635 -0.665 . . . . 50.0 110.117 -179.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -82.52 -40.11 21.48 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.814 -1.179 . . . . 16.66 108.173 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.011 HG22 HD12 ' A' ' 35' ' ' LEU . 55.2 t -62.22 -35.93 71.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.692 -0.855 . . . . 50.0 108.692 179.199 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -69.62 -37.37 76.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.752 -0.833 . . . . 50.0 108.752 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.581 ' CD2' ' HG3' ' A' ' 52' ' ' GLU . 13.7 t-160 -67.35 -36.81 82.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.506 -0.746 . . . . 50.0 109.261 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.433 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.4 mtt -61.39 -46.79 88.7 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.18 -0.95 . . . . 16.66 108.789 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.702 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 43.0 mtp -62.26 -48.32 80.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.493 -0.755 . . . . 50.0 109.056 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.93 -19.38 29.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 50.0 109.209 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.581 ' HG3' ' CD2' ' A' ' 48' ' ' HIS . 23.1 mt-10 -99.65 -36.93 9.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 16.66 109.143 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.541 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.7 mt -80.47 -33.4 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.456 -0.777 . . . . 50.0 109.501 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.6 t0 -59.82 101.69 0.13 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.302 -0.874 . . . . 16.66 108.849 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.469 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 49.5 p -68.5 -46.36 69.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 50.0 110.736 -178.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -88.09 -38.88 15.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 16.66 109.539 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.472 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 101.61 28.34 6.73 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.019 -1.086 . . . . 16.66 110.523 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.4 p-10 -79.57 -2.0 40.45 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.783 -1.422 . . . . 50.0 109.13 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.702 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.34 -5.59 59.01 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.048 -1.221 . . . . 16.66 110.048 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.573 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 31.6 m-85 -134.99 156.59 48.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.008 -1.29 . . . . 50.0 111.407 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.565 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 22.1 mm -109.21 129.8 63.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.365 -0.976 . . . . 16.66 108.365 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -96.26 167.4 11.21 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.083 -1.01 . . . . 16.66 108.55 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.586 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 34.0 t80 -54.32 -42.39 70.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.014 -1.054 . . . . 16.66 108.442 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -61.19 -47.58 85.49 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.584 -0.697 . . . . 50.0 109.335 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 74.9 mt-10 -61.71 -47.02 87.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.244 -0.91 . . . . 16.66 109.2 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.601 ' CZ ' HD11 ' A' ' 77' ' ' LEU . 80.7 t80 -61.69 -39.11 90.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 16.66 109.375 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 15.9 m -66.27 -46.53 76.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.414 -0.804 . . . . 50.0 109.325 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -59.01 -36.53 75.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 50.0 109.64 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.544 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -78.66 -35.32 45.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.234 -0.917 . . . . 50.0 108.69 179.972 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.28 -28.79 64.91 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.385 -1.486 . . . . 16.66 109.385 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.5 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 35.9 mtm180 -73.46 -30.63 63.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -1.172 . . . . 50.0 109.253 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.47 -15.85 61.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 50.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.718 ' CB ' HD12 ' A' ' 76' ' ' LEU . 5.0 p30 -149.56 54.98 0.96 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 50.0 109.189 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -51.19 -43.16 61.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.368 -0.832 . . . . 50.0 108.791 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.85 -24.38 19.15 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.174 -1.57 . . . . 25.0 109.174 179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.718 HD12 ' CB ' ' A' ' 73' ' ' ASN . 41.9 mt -80.05 -43.49 21.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -1.091 . . . . 50.0 109.394 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 1.6 mm? -61.96 -40.03 94.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.411 -0.805 . . . . 50.0 109.845 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 43.3 mtpt -66.19 -33.63 76.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 50.0 109.653 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.19 -46.83 22.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 50.0 109.463 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 77' ' ' LEU . 2.8 p -72.63 -40.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.79 0.805 . . . . 50.0 109.393 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 77' ' ' LEU . . . -53.69 -33.96 57.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.744 -0.597 . . . . 50.0 110.487 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 77.1 mttt -79.88 -22.98 42.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.018 . . . . 50.0 109.789 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.471 HG13 ' HA ' ' A' ' 80' ' ' VAL . 10.1 mt -57.59 -35.9 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 50.0 109.48 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.515 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 95.1 m-85 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.021 -0.99 . . . . 99.99 109.534 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.336 0.589 . . . . 50.0 109.457 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -48.53 -36.3 15.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.363 -0.836 . . . . 50.0 109.355 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -56.38 -45.19 80.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.597 -0.89 . . . . 16.66 108.597 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.471 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.4 mt-10 -68.09 -38.61 82.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.47 -0.769 . . . . 16.66 108.947 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.8 mtt-85 -67.49 -40.58 85.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 50.0 109.387 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.621 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 33.2 mt-10 -64.9 -40.98 95.93 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.442 -0.786 . . . . 50.0 109.354 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 59.7 mtp180 -68.27 -39.54 82.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 50.0 109.154 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 10' ' ' GLU . 33.5 mt -70.93 -45.06 75.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.391 -0.818 . . . . 50.0 109.006 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 26' ' ' ILE . 67.2 t80 -64.86 -35.86 82.5 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 16.66 108.903 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -66.56 -29.42 69.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.32 -0.862 . . . . 50.0 108.962 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 39.2 mtt85 -70.04 -36.61 75.14 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.362 -0.836 . . . . 50.0 109.006 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.884 ' HB3' HD13 ' A' ' 26' ' ' ILE . 51.6 m-85 -70.22 -51.18 32.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.448 -0.782 . . . . 16.66 109.352 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.8 t0 -55.47 103.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 16.66 108.744 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.27 48.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.89 . . . . 50.0 111.196 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -87.06 -28.39 22.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.749 -1.219 . . . . 16.66 109.71 -179.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 90.13 37.4 6.73 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.801 -1.19 . . . . 16.66 110.216 178.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.7 p-10 -91.42 5.49 49.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -1.22 . . . . 16.66 109.157 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.09 -6.2 75.95 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.401 -1.08 . . . . 16.66 110.401 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 60' ' ' PHE . 16.9 pttt -131.25 142.53 50.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.959 -1.318 . . . . 50.0 110.001 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.884 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.9 mt -112.52 133.55 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.639 -0.663 . . . . 16.66 109.495 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.0 p -106.47 167.8 9.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.866 . . . . 50.0 108.934 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.15 -45.53 53.29 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.072 -1.017 . . . . 50.0 108.93 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -57.22 -41.4 79.43 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.218 -0.926 . . . . 50.0 109.259 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.5 mt-10 -74.35 -54.85 6.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.346 -0.846 . . . . 16.66 109.001 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.775 HD22 HG13 ' A' ' 46' ' ' VAL . 6.1 tt -58.57 -48.58 80.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.869 . . . . 16.66 108.771 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.719 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -60.02 -43.44 98.2 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.308 -1.517 . . . . 16.66 109.308 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 19.0 mt-10 -56.81 -42.92 80.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.307 -1.114 . . . . 50.0 109.706 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.533 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.1 -39.41 68.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.116 -0.99 . . . . 50.0 108.502 179.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.997 HD12 HG22 ' A' ' 46' ' ' VAL . 14.0 mt -59.88 -33.3 71.65 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.56 -0.713 . . . . 99.99 109.865 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.4 mttm -43.97 -26.45 0.28 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 99.99 109.593 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.571 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.0 t -51.9 -24.56 6.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.286 -0.884 . . . . 99.99 109.288 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -61.84 -33.16 73.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 50.0 109.226 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.34 2.48 54.49 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.81 -1.316 . . . . 16.66 109.81 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.09 56.2 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.07 -1.253 . . . . 16.66 110.024 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.421 HG13 ' OE1' ' A' ' 45' ' ' GLU . 7.3 tt -138.38 167.54 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 50.0 109.41 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.17 165.18 17.0 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.617 -0.883 . . . . 16.66 108.617 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.21 -32.28 21.17 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.115 1.876 . . . . 50.0 110.192 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -64.22 -25.77 68.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.713 -0.617 . . . . 50.0 110.077 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' OE1' HG13 ' A' ' 41' ' ' ILE . 92.3 mt-10 -81.91 -41.3 21.1 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.854 -1.154 . . . . 16.66 108.133 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.997 HG22 HD12 ' A' ' 35' ' ' LEU . 69.3 t -62.76 -35.8 72.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.959 -0.756 . . . . 50.0 108.959 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -68.42 -38.21 81.01 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.754 -0.832 . . . . 50.0 108.754 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -66.71 -35.97 81.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.389 -0.819 . . . . 50.0 109.245 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.427 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.2 mtt -60.86 -46.67 89.69 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.147 -0.971 . . . . 16.66 108.622 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.527 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 53.5 mtp -61.92 -48.88 78.46 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.928 -0.767 . . . . 50.0 108.928 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.11 -21.67 13.8 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.282 -0.886 . . . . 50.0 109.177 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -98.5 -36.37 9.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 16.66 109.19 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.648 HG22 HD12 ' A' ' 61' ' ' ILE . 83.2 mt -81.22 -30.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.548 -0.72 . . . . 50.0 109.766 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.2 t0 -61.66 101.84 0.22 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.439 -0.788 . . . . 16.66 109.363 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.496 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 71.6 p -73.54 -47.78 38.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.28 -0.888 . . . . 50.0 110.868 -179.017 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.481 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 10.9 p-10 -85.45 -29.5 24.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.037 -1.039 . . . . 16.66 109.821 -179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 92.59 27.07 15.64 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.837 -1.173 . . . . 16.66 110.836 178.744 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.481 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p-10 -82.06 -2.68 52.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.785 -1.42 . . . . 50.0 109.424 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.527 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.3 -5.08 60.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.345 -1.102 . . . . 16.66 110.345 179.284 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.571 ' CE1' ' HE3' ' A' ' 25' ' ' LYS . 43.0 m-85 -134.28 153.69 51.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.987 -1.302 . . . . 50.0 111.093 -179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.648 HD12 HG22 ' A' ' 53' ' ' ILE . 33.0 mm -105.05 128.62 58.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.516 -0.92 . . . . 16.66 108.516 178.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 m -94.87 167.2 11.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.159 -0.963 . . . . 16.66 108.613 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.621 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 35.5 t80 -54.78 -42.6 71.93 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.059 -1.025 . . . . 16.66 108.625 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -60.74 -48.46 81.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.561 -0.712 . . . . 50.0 109.166 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.549 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 42.8 mt-10 -59.83 -46.9 87.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 16.66 109.224 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.796 ' CE1' HD11 ' A' ' 77' ' ' LEU . 59.4 t80 -62.49 -38.63 90.65 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.492 -0.755 . . . . 16.66 109.398 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 16.6 m -66.04 -47.62 73.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.392 -0.818 . . . . 50.0 109.341 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.14 -36.7 75.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 50.0 109.463 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.577 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.82 -36.72 56.71 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.656 -0.868 . . . . 50.0 108.656 179.929 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.13 -31.09 64.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.209 -1.556 . . . . 16.66 109.209 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 67' ' ' THR . 71.6 mtp180 -67.7 -31.17 70.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -1.066 . . . . 50.0 108.957 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.56 -21.9 64.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.506 -0.746 . . . . 50.0 109.356 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.779 ' CG ' HD12 ' A' ' 76' ' ' LEU . 4.4 p30 -150.11 58.54 0.97 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 50.0 109.052 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -50.65 -38.2 44.95 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.29 -0.881 . . . . 50.0 108.685 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.16 -32.67 67.76 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.233 -1.547 . . . . 25.0 109.233 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.779 HD12 ' CG ' ' A' ' 73' ' ' ASN . 19.0 mt -64.12 -43.38 95.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.446 -1.032 . . . . 50.0 109.372 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.796 HD11 ' CE1' ' A' ' 66' ' ' PHE . 1.9 mm? -61.13 -40.29 93.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 50.0 109.786 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 15.1 mtpt -63.66 -33.93 76.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 50.0 109.623 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 79' ' ' ASP . 58.4 t0 -78.75 -49.27 13.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 50.0 109.556 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.7 p -64.56 -44.71 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 50.0 109.749 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.546 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -49.64 -39.94 37.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.683 -0.635 . . . . 50.0 109.776 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 75.1 mttt -69.91 -25.19 63.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 50.0 109.615 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.571 HG21 ' CG2' ' A' ' 37' ' ' THR . 9.4 mt -65.03 -44.67 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 50.0 109.561 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.982 -1.008 . . . . 99.99 109.492 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.66 -28.56 22.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 109.497 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -68.97 133.19 47.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 25.0 109.391 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.481 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -110.05 170.05 5.74 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 50.0 109.457 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 45.5 Cg_endo -68.36 -22.54 39.42 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.562 2.175 . . . . 50.0 111.002 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -62.51 -40.02 95.4 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.516 -0.74 . . . . 25.0 109.189 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.22 -47.23 86.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 50.0 109.368 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -51.35 -39.5 57.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -0.868 . . . . 50.0 109.392 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.84 -41.45 64.26 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.315 -0.866 . . . . 16.66 108.69 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.9 mm-40 -67.07 -47.06 72.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.527 -0.733 . . . . 16.66 109.069 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.646 ' NH2' HG23 ' A' ' 67' ' ' THR . 11.2 mtm180 -65.34 -39.22 92.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.351 -0.843 . . . . 50.0 109.361 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.598 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 43.8 mt-10 -66.05 -41.31 91.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.438 -0.788 . . . . 50.0 109.228 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.4 mtt180 -66.46 -40.42 89.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.455 -0.778 . . . . 50.0 109.104 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.2 mt -70.18 -46.63 71.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.381 -0.824 . . . . 50.0 108.989 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -66.01 -35.35 80.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 16.66 109.281 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 19.9 mttt -66.08 -32.7 74.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.845 . . . . 50.0 109.351 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.55 ' CZ ' ' HB3' ' A' ' 84' ' ' PHE . 52.7 mtt180 -70.12 -35.45 74.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.877 . . . . 50.0 109.09 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.915 ' HB3' HD13 ' A' ' 26' ' ' ILE . 42.3 m-85 -67.88 -49.07 64.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.385 -0.822 . . . . 16.66 109.338 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.8 t0 -57.75 103.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 16.66 108.75 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.96 -51.49 54.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.274 -0.891 . . . . 50.0 111.185 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -87.78 -26.62 22.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.798 -1.189 . . . . 16.66 109.674 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 88.56 38.87 6.9 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.79 -1.195 . . . . 16.66 110.14 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.492 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -93.72 5.53 51.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.094 -1.239 . . . . 16.66 109.214 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.93 -8.09 73.41 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.485 -1.046 . . . . 16.66 110.485 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.0 pttp -130.13 142.01 50.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.937 -1.331 . . . . 50.0 110.042 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.915 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.0 mt -111.99 133.91 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.618 -0.676 . . . . 16.66 109.538 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.6 p -106.18 166.75 10.29 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.807 -0.812 . . . . 50.0 108.807 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.88 -45.76 51.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.055 -1.028 . . . . 50.0 108.874 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.12 -40.3 76.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.301 -0.874 . . . . 50.0 109.438 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.5 mt-10 -74.44 -54.14 8.17 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.211 -0.931 . . . . 16.66 109.373 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.815 ' HG ' HD12 ' A' ' 35' ' ' LEU . 63.1 tp -62.0 -43.03 99.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 16.66 109.044 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.58 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.41 -44.01 98.24 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.239 -1.545 . . . . 16.66 109.239 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -57.81 -43.48 85.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.355 -1.085 . . . . 50.0 109.729 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.82 -39.67 69.65 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.153 -0.967 . . . . 50.0 108.521 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.994 HD23 HD11 ' A' ' 38' ' ' LEU . 2.2 mt -59.18 -33.12 70.57 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.595 -0.691 . . . . 99.99 109.69 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' LEU . 17.7 mttt -44.85 -26.42 0.4 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.999 -1.063 . . . . 99.99 109.388 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.817 ' CG2' HG21 ' A' ' 83' ' ' ILE . 10.4 t -51.81 -25.54 7.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.244 -0.91 . . . . 99.99 109.258 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.994 HD11 HD23 ' A' ' 35' ' ' LEU . 1.5 mt -63.85 -32.74 74.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -0.843 . . . . 50.0 109.308 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.46 5.76 51.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.724 -1.35 . . . . 16.66 109.724 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.76 52.37 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -1.185 . . . . 16.66 109.715 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.599 HD12 HD13 ' A' ' 38' ' ' LEU . 13.5 tt -137.56 169.89 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 50.0 109.469 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.59 163.51 32.18 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.647 -0.871 . . . . 16.66 108.647 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.23 -33.51 24.2 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.03 1.82 . . . . 50.0 110.049 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -64.46 -24.96 67.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.675 -0.64 . . . . 50.0 109.892 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -83.12 -37.06 24.27 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.862 -1.149 . . . . 16.66 108.282 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.982 HG22 HD13 ' A' ' 35' ' ' LEU . 68.9 t -68.57 -36.73 75.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.927 -0.768 . . . . 50.0 108.927 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -67.9 -39.48 83.61 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.8 -0.815 . . . . 50.0 108.8 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.25 -39.6 92.86 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.441 -0.787 . . . . 50.0 109.194 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.413 ' O ' HG13 ' A' ' 53' ' ' ILE . 11.4 mtt -58.57 -43.78 89.53 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.186 -0.946 . . . . 16.66 108.861 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.528 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 57.7 mtp -61.76 -47.95 82.86 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.535 -0.728 . . . . 50.0 109.124 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.72 -20.76 36.65 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.309 -0.869 . . . . 50.0 109.187 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -97.37 -36.51 10.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 16.66 109.123 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.582 HG22 HD12 ' A' ' 61' ' ' ILE . 83.7 mt -81.8 -32.48 11.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.426 -0.796 . . . . 50.0 109.67 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.7 t0 -60.35 101.42 0.13 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.412 -0.805 . . . . 16.66 108.957 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.471 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 60.0 p -70.19 -46.86 63.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 50.0 110.75 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -86.69 -38.41 17.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.12 -0.987 . . . . 16.66 109.542 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.99 28.82 6.72 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.93 -1.128 . . . . 16.66 110.617 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.49 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.0 p-10 -80.37 -3.22 48.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.751 -1.441 . . . . 50.0 109.155 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.528 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.89 -5.07 57.88 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.922 -1.271 . . . . 16.66 109.922 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 40.8 m-85 -134.38 156.95 47.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.016 -1.285 . . . . 50.0 111.298 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.582 HD12 HG22 ' A' ' 53' ' ' ILE . 36.3 mm -108.2 130.28 61.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.212 -1.033 . . . . 16.66 108.212 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.6 m -99.95 167.68 10.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.998 -1.064 . . . . 16.66 108.673 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 41.3 t80 -54.96 -44.49 74.43 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.177 -1.009 . . . . 16.66 108.576 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -58.37 -47.14 84.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.564 -0.71 . . . . 50.0 109.165 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.548 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.7 mt-10 -62.49 -46.54 88.02 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.27 -0.894 . . . . 16.66 109.145 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.539 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 62.5 t80 -60.31 -37.75 81.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 16.66 109.19 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.646 HG23 ' NH2' ' A' ' 11' ' ' ARG . 12.1 m -65.69 -47.59 74.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.388 -0.82 . . . . 50.0 109.09 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -59.39 -40.48 86.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 50.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.564 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.06 -37.0 58.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.687 -0.857 . . . . 50.0 108.687 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -59.16 -31.98 70.47 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.355 -1.498 . . . . 16.66 109.355 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' THR . 59.5 mtm180 -71.06 -31.12 67.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -1.165 . . . . 50.0 109.399 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.49 -20.29 62.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.366 -0.834 . . . . 50.0 109.501 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.796 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.8 m-80 -149.38 54.95 0.97 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.258 -0.901 . . . . 50.0 109.479 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -51.46 -42.6 61.71 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.163 -0.96 . . . . 50.0 108.622 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.21 -20.6 29.24 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.526 -1.43 . . . . 25.0 109.526 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.796 HD12 ' CB ' ' A' ' 73' ' ' ASN . 33.2 mt -78.62 -43.7 25.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -1.187 . . . . 50.0 109.175 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.539 HD22 ' HZ ' ' A' ' 66' ' ' PHE . 20.8 mt -61.43 -35.95 79.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 50.0 109.699 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.429 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 10.5 mtmm -60.48 -26.96 67.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 50.0 109.382 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -76.21 -37.93 57.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.222 -0.924 . . . . 50.0 109.232 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -78.51 -31.28 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 50.0 109.562 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.88 -14.88 51.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 50.0 109.614 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -96.33 -31.97 12.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.917 . . . . 50.0 108.972 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.817 HG21 ' CG2' ' A' ' 37' ' ' THR . 38.0 mt -58.86 -38.93 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.46 -0.775 . . . . 50.0 109.316 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 17' ' ' ARG . 90.9 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.041 -0.98 . . . . 99.99 109.471 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 3' ' ' ASP . 84.1 m-20 -79.19 -21.44 46.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 2' ' ' ASP . 45.7 p30 -51.08 179.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.226 -0.921 . . . . 25.0 109.559 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.57 ' HE2' ' CG ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -135.51 165.97 32.2 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 50.0 109.375 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 43.3 Cg_endo -67.0 -21.46 49.52 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.463 2.108 . . . . 50.0 110.94 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -60.14 -46.34 89.99 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.527 -0.733 . . . . 25.0 109.252 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.57 ' CG ' ' HE2' ' A' ' 4' ' ' HIS . 77.9 m-20 -56.62 -54.12 49.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 50.0 109.435 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.459 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 30.6 mtpt -43.21 -36.8 1.88 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.804 . . . . 50.0 109.759 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.23 -46.96 87.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.238 -0.914 . . . . 16.66 108.834 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 44.1 mt-10 -68.22 -38.51 81.98 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.887 -0.783 . . . . 16.66 108.887 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.667 ' NH2' HG23 ' A' ' 67' ' ' THR . 13.0 mtm180 -68.37 -39.9 81.62 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.325 -0.859 . . . . 50.0 109.496 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.639 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 13.0 mt-10 -67.4 -41.75 84.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.415 -0.803 . . . . 50.0 109.432 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.8 mtp-105 -66.16 -41.46 90.32 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.3 -0.875 . . . . 50.0 109.299 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 10' ' ' GLU . 38.6 mt -69.83 -45.47 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.247 -0.908 . . . . 50.0 109.023 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.511 ' CE1' HD11 ' A' ' 26' ' ' ILE . 73.8 t80 -63.26 -36.43 83.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.423 -0.911 . . . . 16.66 108.933 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -64.89 -30.78 71.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.384 -0.822 . . . . 50.0 109.08 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 48.2 mtt180 -68.4 -37.09 80.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 50.0 109.12 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.918 ' HB3' HD13 ' A' ' 26' ' ' ILE . 57.3 m-85 -68.67 -50.98 46.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 16.66 109.577 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 21.6 t0 -55.71 103.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 16.66 108.925 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.6 -50.52 43.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.873 . . . . 50.0 111.118 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -87.02 -30.98 20.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.714 -1.241 . . . . 16.66 109.674 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.94 35.55 6.06 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.764 -1.208 . . . . 16.66 110.205 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.496 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 34.7 p-10 -90.79 3.7 53.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.257 . . . . 16.66 109.161 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.86 -5.83 72.98 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.48 -1.048 . . . . 16.66 110.48 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.8 pttp -132.0 143.39 50.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.898 -1.354 . . . . 50.0 110.086 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.2 mt -110.85 133.42 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.375 0.607 . . . . 16.66 109.685 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.409 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 10.5 p -105.83 166.57 10.38 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.491 -0.755 . . . . 50.0 108.973 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.73 -45.78 49.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.01 -1.056 . . . . 50.0 108.843 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -56.77 -41.09 77.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.288 -0.883 . . . . 50.0 109.334 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 60.5 mt-10 -74.5 -54.83 6.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.306 -0.871 . . . . 16.66 109.248 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.884 HD22 HG13 ' A' ' 46' ' ' VAL . 7.4 tt -60.5 -45.66 92.98 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.307 -0.871 . . . . 16.66 108.867 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.715 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.89 -44.74 96.99 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.104 -1.598 . . . . 16.66 109.104 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 24.2 mt-10 -57.65 -42.16 82.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.395 -1.062 . . . . 50.0 109.546 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.88 -39.94 66.0 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.389 -0.967 . . . . 50.0 108.389 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.95 ' CD1' HG22 ' A' ' 46' ' ' VAL . 6.6 mt -58.36 -33.25 69.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.539 -0.725 . . . . 99.99 109.502 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -44.4 -27.83 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 99.99 109.579 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.653 HG21 HG21 ' A' ' 83' ' ' ILE . 6.9 t -50.14 -25.37 3.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.897 . . . . 99.99 109.111 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.948 HD12 HD12 ' A' ' 41' ' ' ILE . 22.8 mt -62.63 -33.2 74.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.467 -0.771 . . . . 50.0 109.281 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.28 6.39 53.55 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.549 -1.42 . . . . 16.66 109.549 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.63 51.78 0.57 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -1.181 . . . . 16.66 109.473 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.948 HD12 HD12 ' A' ' 38' ' ' LEU . 11.8 tt -137.09 170.97 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.95 . . . . 50.0 109.486 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.99 167.22 16.75 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 16.66 108.873 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.28 -33.74 17.71 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.202 1.934 . . . . 50.0 110.192 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.6 -29.83 70.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.625 . . . . 50.0 110.01 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -81.66 -35.81 29.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.979 -1.076 . . . . 16.66 108.314 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.95 HG22 ' CD1' ' A' ' 35' ' ' LEU . 68.4 t -67.69 -35.87 74.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.045 -0.724 . . . . 50.0 109.045 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -70.65 -37.91 73.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.77 -0.826 . . . . 50.0 108.77 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -67.49 -36.72 81.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.506 -0.746 . . . . 50.0 109.125 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.433 ' O ' HG13 ' A' ' 53' ' ' ILE . 5.5 mtt -60.6 -47.35 86.61 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.259 -0.901 . . . . 16.66 108.749 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.631 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 49.7 mtp -62.17 -47.96 82.18 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.475 -0.766 . . . . 50.0 109.1 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.24 -18.63 27.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.291 -0.881 . . . . 50.0 109.146 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -97.95 -36.15 10.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.777 . . . . 16.66 109.106 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.648 HG22 HD12 ' A' ' 61' ' ' ILE . 83.4 mt -82.15 -32.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.532 -0.73 . . . . 50.0 109.733 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.9 t0 -58.62 101.31 0.08 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.403 -0.811 . . . . 16.66 109.2 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 76.8 p -71.07 -47.13 60.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 50.0 110.58 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -85.89 -37.33 19.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.143 -0.973 . . . . 16.66 109.469 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.57 28.32 7.14 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.918 -1.135 . . . . 16.66 110.744 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 9.0 p-10 -80.38 -3.24 48.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.755 -1.438 . . . . 50.0 109.059 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.631 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.76 -3.64 59.08 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.88 -1.288 . . . . 16.66 109.88 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 26.4 m-85 -135.21 157.2 47.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.07 -1.253 . . . . 50.0 111.26 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.648 HD12 HG22 ' A' ' 53' ' ' ILE . 36.6 mm -107.86 129.53 61.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.522 -0.918 . . . . 16.66 108.522 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.18 167.61 10.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.151 -0.968 . . . . 16.66 108.664 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.639 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.5 t80 -54.44 -43.81 71.92 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.113 -1.035 . . . . 16.66 108.526 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -58.26 -50.1 74.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.537 -0.727 . . . . 50.0 109.042 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 76.6 mt-10 -60.43 -46.41 90.13 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.317 -0.864 . . . . 16.66 109.013 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.754 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 62.0 t80 -62.09 -33.63 74.79 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.041 -0.725 . . . . 16.66 109.041 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.667 HG23 ' NH2' ' A' ' 11' ' ' ARG . 6.4 m -70.12 -48.01 59.35 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.366 -0.834 . . . . 50.0 108.952 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -60.27 -39.05 85.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 50.0 109.304 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.595 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -80.01 -38.53 31.86 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.585 -0.895 . . . . 50.0 108.585 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.872 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.69 -25.8 64.02 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.323 -1.511 . . . . 16.66 109.323 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 67' ' ' THR . 69.0 mtm180 -76.8 -35.23 57.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -1.162 . . . . 50.0 109.219 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.04 -17.43 64.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 50.0 109.181 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.621 ' CB ' HD12 ' A' ' 76' ' ' LEU . 6.4 p30 -148.03 51.46 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.78 . . . . 50.0 109.219 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 73.3 mtm180 -48.18 -38.17 17.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.242 -0.911 . . . . 50.0 108.704 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.55 -23.6 49.85 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.374 -1.49 . . . . 25.0 109.374 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.621 HD12 ' CB ' ' A' ' 73' ' ' ASN . 24.8 mt -77.51 -44.96 27.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -1.101 . . . . 50.0 109.342 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.872 HD11 ' HA3' ' A' ' 70' ' ' GLY . 19.0 mt -66.89 -21.16 66.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 50.0 109.842 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 30.6 mtmt -80.02 -19.31 47.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.063 -1.023 . . . . 50.0 109.32 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.21 -36.61 16.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -0.827 . . . . 50.0 109.366 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.465 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 85.4 t -71.83 -36.15 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.395 -0.816 . . . . 50.0 108.913 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.41 -49.12 67.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.382 -0.823 . . . . 50.0 109.368 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -62.19 -28.64 69.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.823 . . . . 50.0 109.583 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.653 HG21 HG21 ' A' ' 37' ' ' THR . 39.9 mt -61.27 -32.42 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -0.968 . . . . 50.0 109.316 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 17.2 m-85 . . . . . 0 C--N 1.302 -1.498 0 CA-C-O 117.977 -1.011 . . . . 99.99 109.499 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -93.37 104.3 16.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -123.14 117.99 26.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 25.0 109.468 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.511 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -112.79 172.1 3.8 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 50.0 109.386 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.2 Cg_endo -68.43 -22.64 38.84 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.565 2.177 . . . . 50.0 111.064 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -62.83 -40.48 97.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.402 -0.811 . . . . 25.0 109.222 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.66 -40.87 98.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.3 -0.875 . . . . 50.0 109.284 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -52.44 -36.91 55.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 50.0 109.462 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.26 -46.27 88.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 16.66 108.751 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' O ' HG13 ' A' ' 14' ' ' ILE . 66.6 mm-40 -66.44 -42.81 87.13 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.911 -0.774 . . . . 16.66 108.911 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.627 ' NH2' HD12 ' A' ' 77' ' ' LEU . 31.7 mtt-85 -65.1 -40.28 94.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.537 -0.727 . . . . 50.0 109.474 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 49.4 mt-10 -63.85 -40.96 97.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.424 -0.797 . . . . 50.0 109.454 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 2.5 mtt-85 -68.46 -38.93 81.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 50.0 109.105 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.542 HG22 ' HE2' ' A' ' 18' ' ' PHE . 29.9 mt -71.31 -45.95 67.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.314 -0.866 . . . . 50.0 109.003 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.533 ' CE1' HD11 ' A' ' 26' ' ' ILE . 68.1 t80 -66.09 -36.07 82.19 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.179 -0.951 . . . . 16.66 109.181 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 39.5 mttt -65.55 -30.5 71.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.289 -0.882 . . . . 50.0 109.113 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -70.29 -37.48 74.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.854 . . . . 50.0 109.007 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.862 ' HB3' HD13 ' A' ' 26' ' ' ILE . 55.5 m-85 -67.56 -48.76 65.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 16.66 109.466 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.0 t0 -58.64 103.37 0.15 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 16.66 108.826 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.04 -51.56 37.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 50.0 111.132 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -85.69 -31.14 22.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.724 -1.235 . . . . 16.66 109.672 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.83 37.66 5.42 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.748 -1.215 . . . . 16.66 110.321 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.488 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.2 p-10 -93.08 6.37 48.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.042 -1.269 . . . . 16.66 109.207 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.61 -6.37 80.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.49 -1.044 . . . . 16.66 110.49 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.6 pttt -130.05 142.02 50.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.024 -1.28 . . . . 50.0 110.002 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.862 HD13 ' HB3' ' A' ' 18' ' ' PHE . 3.8 mt -112.0 133.22 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.437 0.637 . . . . 16.66 109.443 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.403 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 17.1 p -106.31 168.49 9.11 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.415 -0.803 . . . . 50.0 109.108 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.508 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.49 -46.26 56.87 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.144 -0.973 . . . . 50.0 108.853 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.31 75.99 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.345 -0.847 . . . . 50.0 109.394 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.8 mt-10 -75.86 -54.77 6.4 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.267 -0.896 . . . . 16.66 109.122 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.853 HD22 HG13 ' A' ' 46' ' ' VAL . 5.7 tt -60.47 -46.88 88.48 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.184 -0.948 . . . . 16.66 108.939 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.689 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.09 -43.1 99.61 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.28 -1.528 . . . . 16.66 109.28 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.68 -41.86 91.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.266 -1.138 . . . . 50.0 110.011 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.38 73.21 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.163 -0.961 . . . . 50.0 108.832 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.113 HD12 HG22 ' A' ' 46' ' ' VAL . 12.8 mt -60.64 -30.92 70.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.5 -0.75 . . . . 99.99 109.798 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -43.73 -26.43 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.987 . . . . 99.99 109.616 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.447 ' CG2' HG21 ' A' ' 83' ' ' ILE . 6.3 t -52.85 -24.94 10.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.192 -0.942 . . . . 99.99 109.39 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.717 HD13 HD12 ' A' ' 41' ' ' ILE . 5.6 mt -62.38 -32.28 73.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.87 . . . . 50.0 109.269 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.62 6.72 51.4 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.596 -1.402 . . . . 16.66 109.596 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.49 57.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -1.132 . . . . 16.66 109.478 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.717 HD12 HD13 ' A' ' 38' ' ' LEU . 11.1 tt -143.38 174.17 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 50.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.9 165.98 25.29 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.304 -0.872 . . . . 16.66 108.82 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -69.43 -33.54 17.61 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.138 1.892 . . . . 50.0 110.132 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -65.07 -24.57 67.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.657 -0.652 . . . . 50.0 110.077 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -82.16 -36.66 27.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.82 -1.175 . . . . 16.66 108.402 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.113 HG22 HD12 ' A' ' 35' ' ' LEU . 53.9 t -67.57 -35.64 73.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.563 -0.711 . . . . 50.0 109.145 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -65.72 -39.24 90.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.445 -0.785 . . . . 50.0 109.095 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -67.21 -36.73 82.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.335 -0.853 . . . . 50.0 109.309 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.404 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.3 mtt -61.31 -46.22 91.18 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.183 -0.948 . . . . 16.66 108.774 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.544 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 49.2 mtp -62.56 -48.02 81.31 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.566 -0.709 . . . . 50.0 109.147 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.0 -18.73 36.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 50.0 109.123 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -98.33 -36.5 9.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 16.66 109.175 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 61' ' ' ILE . 81.6 mt -82.08 -32.49 11.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.468 -0.77 . . . . 50.0 109.667 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.8 t0 -59.51 101.52 0.11 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.349 -0.844 . . . . 16.66 109.038 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.46 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 61.0 p -68.85 -47.18 66.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -0.875 . . . . 50.0 110.658 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -86.79 -39.1 16.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 16.66 109.448 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 102.08 28.01 6.7 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.878 -1.153 . . . . 16.66 110.444 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.3 p-10 -79.02 -2.35 39.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.786 -1.42 . . . . 50.0 109.016 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.544 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.35 -2.91 59.47 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.709 -1.357 . . . . 16.66 109.709 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 25.5 m-85 -136.47 157.57 46.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.086 -1.244 . . . . 50.0 111.376 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.602 HD12 HG22 ' A' ' 53' ' ' ILE . 29.1 mm -109.76 130.24 63.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.565 -0.902 . . . . 16.66 108.565 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -97.64 168.41 10.36 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.133 -0.979 . . . . 16.66 108.599 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 37.7 t80 -55.36 -43.28 74.91 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.031 -1.043 . . . . 16.66 108.718 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -60.6 -46.4 90.4 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.553 -0.717 . . . . 50.0 109.31 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.571 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 76.7 mt-10 -62.05 -46.83 87.4 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.285 -0.884 . . . . 16.66 109.096 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.495 ' CZ ' ' CD2' ' A' ' 77' ' ' LEU . 49.8 t80 -61.06 -40.52 93.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.444 -0.785 . . . . 16.66 109.25 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.1 m -64.74 -47.32 78.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.362 -0.837 . . . . 50.0 109.209 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -58.45 -38.46 77.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 50.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.91 -35.57 50.5 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.642 -0.873 . . . . 50.0 108.642 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.546 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.14 -29.91 63.26 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.302 -1.519 . . . . 16.66 109.302 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 67' ' ' THR . 83.0 mtm180 -71.51 -29.63 65.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.124 . . . . 50.0 109.165 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' A' ' 73' ' ' ASN . . . -70.41 -21.04 62.88 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.335 -0.853 . . . . 50.0 109.278 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.807 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.4 m-80 -152.1 56.06 0.83 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 50.0 109.299 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -48.71 -38.53 21.77 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.705 -0.85 . . . . 50.0 108.705 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.08 -30.23 63.5 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.329 -1.508 . . . . 25.0 109.329 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.807 HD12 ' CB ' ' A' ' 73' ' ' ASN . 32.3 mt -69.39 -45.69 68.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -1.085 . . . . 50.0 109.464 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.627 HD12 ' NH2' ' A' ' 11' ' ' ARG . 25.4 mt -63.68 -23.11 67.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.814 . . . . 50.0 109.902 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 26.7 mtmt -79.97 -18.54 50.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.105 -0.997 . . . . 50.0 109.49 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.65 -33.39 27.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 50.0 109.3 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 t -85.36 -27.9 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.853 . . . . 50.0 109.147 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.16 -16.05 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 50.0 109.597 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 15.4 mttt -94.34 -32.92 13.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 50.0 109.275 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.447 HG21 ' CG2' ' A' ' 37' ' ' THR . 10.0 mt -58.2 -36.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.366 -0.834 . . . . 50.0 109.35 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.019 -0.991 . . . . 99.99 109.437 -179.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -115.02 83.82 1.97 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.19 -0.944 . . . . 0.0 109.49 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.05 120.91 30.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 25.0 109.451 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.487 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -118.12 171.05 5.5 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.185 -0.947 . . . . 50.0 109.417 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.8 Cg_endo -68.99 -22.76 35.16 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.645 2.23 . . . . 50.0 110.979 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -61.61 -38.82 89.02 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.438 -0.788 . . . . 25.0 109.107 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -57.6 -46.32 84.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.429 -0.794 . . . . 50.0 109.32 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -49.43 -36.41 22.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 50.0 109.6 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.79 -45.68 89.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.307 -0.871 . . . . 16.66 108.715 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 67.2 mt-10 -68.2 -40.45 82.17 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.46 -0.775 . . . . 16.66 109.007 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.739 ' NH2' HG23 ' A' ' 67' ' ' THR . 46.5 mtm180 -68.07 -39.95 82.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.37 -0.831 . . . . 50.0 109.33 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.572 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 43.3 mt-10 -66.75 -41.84 87.15 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.478 -0.763 . . . . 50.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 13.3 mtp180 -65.63 -40.84 92.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.28 -0.888 . . . . 50.0 109.201 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 81' ' ' ALA . 30.7 mt -70.26 -46.94 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.305 -0.872 . . . . 50.0 108.91 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -66.32 -34.99 79.24 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.216 -0.928 . . . . 16.66 108.918 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 55.0 mttm -65.15 -34.27 78.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.366 -0.834 . . . . 50.0 109.392 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.584 ' NH2' ' HB1' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -74.48 -26.11 59.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.895 . . . . 50.0 109.227 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.951 ' HB3' HD13 ' A' ' 26' ' ' ILE . 23.3 m-85 -73.45 -43.21 60.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 16.66 109.057 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.6 t0 -63.72 103.26 0.53 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.334 -0.854 . . . . 16.66 108.757 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.13 64.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.161 -0.962 . . . . 50.0 111.248 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -89.49 -27.18 20.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.727 -1.233 . . . . 16.66 109.705 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.66 35.1 8.01 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.096 -1.201 . . . . 16.66 110.096 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 37.1 p-10 -88.85 4.04 49.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -1.198 . . . . 16.66 109.21 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.99 -5.76 72.47 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.381 -1.087 . . . . 16.66 110.381 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.5 pttp -132.34 143.32 49.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.948 -1.325 . . . . 50.0 110.068 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.951 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.8 mt -111.46 134.54 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.652 -0.655 . . . . 16.66 109.45 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.5 p -106.61 166.22 10.72 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.299 -0.876 . . . . 50.0 108.712 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.5 -45.6 47.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.041 -1.037 . . . . 50.0 108.843 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.19 75.82 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.363 -0.836 . . . . 50.0 109.521 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.507 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.8 mt-10 -75.82 -54.51 6.81 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.198 -0.939 . . . . 16.66 109.291 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.636 ' HG ' HD12 ' A' ' 35' ' ' LEU . 58.3 tp -61.84 -43.05 99.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 16.66 108.955 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.528 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -62.27 -44.29 97.89 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.233 -1.547 . . . . 16.66 109.233 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -58.54 -43.23 89.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.308 -1.113 . . . . 50.0 109.724 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HB1' ' NH2' ' A' ' 17' ' ' ARG . . . -73.06 -40.73 64.83 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.088 -1.007 . . . . 50.0 108.333 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.076 HD13 HG22 ' A' ' 46' ' ' VAL . 7.5 mt -58.64 -32.61 69.21 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.568 -0.707 . . . . 99.99 109.423 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -44.98 -26.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 99.99 109.423 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 t -49.17 -24.87 1.88 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 99.99 109.026 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.82 HD13 HD12 ' A' ' 41' ' ' ILE . 16.7 mt -58.87 -33.45 70.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.499 -0.751 . . . . 50.0 109.101 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.06 -0.39 58.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.885 -1.286 . . . . 16.66 109.885 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.07 58.62 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.251 . . . . 16.66 109.965 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.82 HD12 HD13 ' A' ' 38' ' ' LEU . 10.8 tt -138.1 173.18 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.098 -1.001 . . . . 50.0 109.528 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.27 163.02 40.69 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.642 -0.873 . . . . 16.66 108.642 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.15 -33.27 25.34 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.009 1.806 . . . . 50.0 110.083 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.92 -26.29 68.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.636 -0.665 . . . . 50.0 109.95 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -82.1 -36.87 27.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.855 -1.153 . . . . 16.66 108.431 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.076 HG22 HD13 ' A' ' 35' ' ' LEU . 47.1 t -68.96 -36.67 75.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.038 -0.727 . . . . 50.0 109.038 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -65.65 -40.15 92.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.475 -0.766 . . . . 50.0 109.028 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -65.48 -40.89 93.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 50.0 109.257 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.1 mtt -58.68 -43.52 89.99 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.243 -0.911 . . . . 16.66 108.817 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.723 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 31.7 mtp -61.45 -47.55 85.18 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.451 -0.781 . . . . 50.0 109.245 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.04 -20.56 54.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 50.0 109.28 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -95.4 -36.35 11.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.398 -0.814 . . . . 16.66 109.047 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.576 HG22 HD12 ' A' ' 61' ' ' ILE . 82.4 mt -81.92 -31.46 10.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 50.0 109.699 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.9 t0 -60.93 101.46 0.15 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.439 -0.788 . . . . 16.66 108.989 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.469 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 55.6 p -69.72 -46.1 66.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 50.0 110.71 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.489 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.0 p-10 -87.6 -40.32 14.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.106 -0.996 . . . . 16.66 109.502 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 102.95 29.67 5.73 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.932 -1.128 . . . . 16.66 110.523 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.489 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.8 p-10 -81.41 -3.74 53.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.865 -1.374 . . . . 50.0 109.144 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.723 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.66 -3.41 57.57 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.857 -1.297 . . . . 16.66 109.857 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.8 m-85 -135.85 156.58 48.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.059 -1.259 . . . . 50.0 111.15 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.576 HD12 HG22 ' A' ' 53' ' ' ILE . 35.0 mm -108.88 129.91 62.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.397 -0.964 . . . . 16.66 108.397 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.55 167.42 10.6 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.057 -1.027 . . . . 16.66 108.812 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.5 t80 -54.21 -43.62 70.94 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.297 -0.961 . . . . 16.66 108.521 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -58.93 -47.9 83.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.525 -0.735 . . . . 50.0 109.085 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.559 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 81.2 mt-10 -62.34 -46.94 86.4 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.288 -0.883 . . . . 16.66 109.119 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.626 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 51.2 t80 -59.52 -39.14 82.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.426 -0.796 . . . . 16.66 109.103 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.739 HG23 ' NH2' ' A' ' 11' ' ' ARG . 18.0 m -66.42 -46.68 75.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 50.0 109.089 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.0 -40.76 85.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 50.0 109.246 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.574 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -75.89 -36.8 59.37 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.566 -0.901 . . . . 50.0 108.566 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.688 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.96 -34.17 77.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.2 -1.56 . . . . 16.66 109.2 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 67' ' ' THR . 74.4 mtm180 -65.95 -33.48 75.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -1.12 . . . . 50.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.438 ' O ' ' OD1' ' A' ' 73' ' ' ASN . . . -67.68 -20.99 65.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.834 . . . . 50.0 109.301 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.84 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.7 m-80 -152.24 56.43 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 50.0 109.162 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -49.6 -37.09 26.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.334 -0.854 . . . . 50.0 108.736 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.37 -31.16 69.33 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.22 -1.552 . . . . 25.0 109.22 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.84 HD12 ' CB ' ' A' ' 73' ' ' ASN . 50.6 mt -67.26 -44.88 78.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -1.09 . . . . 50.0 109.419 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.688 HD11 ' HA3' ' A' ' 70' ' ' GLY . 19.9 mt -63.77 -31.43 72.61 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.321 -0.862 . . . . 50.0 109.766 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -64.58 -27.13 68.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 50.0 109.255 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -76.26 -34.65 59.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 50.0 109.517 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.418 HG13 ' HE2' ' A' ' 84' ' ' PHE . 23.4 t -81.03 -31.22 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 50.0 109.601 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 14' ' ' ILE . . . -63.4 -19.02 64.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 50.0 109.691 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -89.39 -30.57 18.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 50.0 109.137 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.8 mt -64.97 -36.59 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.382 -0.824 . . . . 50.0 109.24 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.569 ' CE1' ' NH2' ' A' ' 17' ' ' ARG . 61.2 m-85 . . . . . 0 C--N 1.302 -1.483 0 CA-C-O 117.99 -1.005 . . . . 99.99 109.544 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 40.0 p30 -83.47 -8.98 59.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.525 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -64.35 147.66 52.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 25.0 109.442 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.553 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -114.2 174.24 2.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.289 -0.882 . . . . 50.0 109.236 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 47.7 Cg_endo -69.16 -22.5 34.75 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.506 2.137 . . . . 50.0 111.335 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -62.63 -43.85 97.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.411 -0.805 . . . . 25.0 109.346 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -57.69 -41.22 81.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 50.0 109.394 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -53.29 -35.92 60.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 50.0 109.196 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 -45.74 90.26 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.853 -0.795 . . . . 16.66 108.853 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 14' ' ' ILE . 59.7 mm-40 -68.53 -40.55 80.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 16.66 108.832 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.827 ' NH1' HG23 ' A' ' 67' ' ' THR . 19.8 mtm180 -68.11 -38.95 82.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.458 -0.776 . . . . 50.0 109.377 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.641 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 8.7 mt-10 -68.03 -39.83 83.01 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.433 -0.792 . . . . 50.0 109.346 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 5.6 mtt180 -67.08 -40.53 87.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.293 -0.879 . . . . 50.0 109.267 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.641 HG22 ' HE2' ' A' ' 18' ' ' PHE . 25.6 mt -70.28 -46.62 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.383 -0.823 . . . . 50.0 108.865 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.42 ' CE1' HD11 ' A' ' 26' ' ' ILE . 70.5 t80 -63.56 -35.74 81.48 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.339 -0.851 . . . . 16.66 109.097 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -66.19 -30.43 70.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 50.0 109.229 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 74.8 mtt180 -69.17 -38.1 78.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 50.0 109.256 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.805 ' HB3' HD13 ' A' ' 26' ' ' ILE . 67.2 m-85 -67.42 -49.13 65.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 16.66 109.49 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.1 t0 -56.48 103.48 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 16.66 108.746 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.91 -51.56 46.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.274 -0.891 . . . . 50.0 111.247 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -86.92 -30.0 21.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.719 -1.238 . . . . 16.66 109.856 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 92.95 37.39 5.73 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.777 -1.202 . . . . 16.66 110.179 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.492 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 37.7 p-10 -92.87 5.38 51.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -1.2 . . . . 16.66 109.243 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.95 -7.01 76.83 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.138 -1.03 . . . . 16.66 110.568 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 5.1 pttm -130.49 142.25 50.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.908 -1.348 . . . . 50.0 109.872 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.805 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.1 mt -111.93 133.22 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.36 0.6 . . . . 16.66 109.527 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.9 p -105.02 166.83 10.11 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.856 -0.794 . . . . 50.0 108.856 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.1 -45.29 52.58 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.157 -0.965 . . . . 50.0 108.887 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.39 78.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.317 -0.865 . . . . 50.0 109.474 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.7 mt-10 -74.99 -54.3 7.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.165 -0.959 . . . . 16.66 109.334 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.805 ' O ' HD23 ' A' ' 31' ' ' LEU . 1.9 tt -61.94 -43.98 97.71 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.283 -0.886 . . . . 16.66 108.798 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.755 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -63.66 -44.48 96.36 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.191 -1.564 . . . . 16.66 109.191 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -59.82 -41.45 91.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.324 -1.104 . . . . 50.0 109.892 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.98 -39.87 68.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.129 -0.982 . . . . 50.0 108.732 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.054 HD12 HG22 ' A' ' 46' ' ' VAL . 8.4 mt -60.21 -30.83 69.64 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.5 -0.75 . . . . 99.99 109.865 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -44.31 -25.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -1.0 . . . . 99.99 109.865 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.687 ' CG2' HG21 ' A' ' 83' ' ' ILE . 6.6 t -50.77 -23.15 2.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.156 -0.965 . . . . 99.99 109.22 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.854 HD12 HD12 ' A' ' 41' ' ' ILE . 25.6 mt -60.74 -33.69 73.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 50.0 109.312 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.46 -0.74 59.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.777 -1.329 . . . . 16.66 109.777 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 40' ' ' SER . 2.3 t -155.25 66.45 0.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.114 -1.227 . . . . 16.66 109.654 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.854 HD12 HD12 ' A' ' 38' ' ' LEU . 14.2 tt -149.26 168.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.141 -0.974 . . . . 50.0 109.598 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.83 163.9 22.24 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 16.66 108.872 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 49.8 Cg_endo -70.66 -30.7 17.72 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.078 1.852 . . . . 50.0 109.94 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.75 -23.49 66.1 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.54 -0.725 . . . . 50.0 110.078 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.4 ' OE1' HG13 ' A' ' 41' ' ' ILE . 86.1 mt-10 -79.87 -35.13 38.57 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.891 -1.13 . . . . 16.66 108.505 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.054 HG22 HD12 ' A' ' 35' ' ' LEU . 55.0 t -69.39 -35.75 68.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.909 -0.774 . . . . 50.0 108.909 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 82.7 mttt -62.36 -40.25 95.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.432 -0.792 . . . . 50.0 108.994 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.37 -39.42 92.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.433 -0.792 . . . . 50.0 109.299 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.438 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.9 mtt -59.48 -45.2 92.34 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.239 -0.913 . . . . 16.66 108.854 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.52 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 50.1 mtp -62.27 -48.68 78.83 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.439 -0.788 . . . . 50.0 109.122 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.7 -19.02 24.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 50.0 109.362 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -99.78 -36.3 9.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 16.66 109.306 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.596 HG12 ' CD2' ' A' ' 69' ' ' PHE . 80.2 mt -82.5 -32.93 10.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.451 -0.781 . . . . 50.0 109.816 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.7 t0 -59.52 101.23 0.1 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.289 -0.882 . . . . 16.66 108.999 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.473 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 54.6 p -66.19 -46.37 77.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 50.0 110.64 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -88.85 -42.18 12.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 16.66 109.634 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 104.14 29.82 5.31 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.203 -1.159 . . . . 16.66 110.203 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 13.0 p-10 -80.46 -2.45 45.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.983 -1.304 . . . . 50.0 109.134 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.52 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 100.04 -3.47 57.05 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.767 -1.333 . . . . 16.66 109.767 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.576 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 30.6 m-85 -137.01 156.35 48.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.006 -1.291 . . . . 50.0 111.49 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.543 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 25.5 mm -109.67 130.68 62.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.308 -0.997 . . . . 16.66 108.308 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 m -99.47 168.7 9.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.023 -1.048 . . . . 16.66 108.714 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.641 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 36.5 t80 -54.97 -43.44 73.5 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.169 -1.012 . . . . 16.66 108.655 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -59.92 -48.63 80.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.608 -0.683 . . . . 50.0 109.237 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.543 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 79.6 mt-10 -60.6 -47.03 88.02 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.291 -0.881 . . . . 16.66 109.064 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CE1' HD13 ' A' ' 77' ' ' LEU . 52.4 t80 -63.18 -32.66 74.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.437 -0.789 . . . . 16.66 109.255 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.827 HG23 ' NH1' ' A' ' 11' ' ' ARG . 51.9 m -68.26 -49.11 62.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 50.0 109.302 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -59.35 -36.9 76.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.26 -0.9 . . . . 50.0 109.381 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.74 -37.5 41.12 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.494 -0.928 . . . . 50.0 108.494 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.955 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.69 -29.2 63.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.197 -1.561 . . . . 16.66 109.197 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 67' ' ' THR . 80.5 mtm180 -71.3 -33.12 69.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.348 -1.089 . . . . 50.0 109.051 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.35 -20.81 65.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.832 . . . . 50.0 109.273 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.842 ' CB ' HD12 ' A' ' 76' ' ' LEU . 7.8 m-80 -146.24 58.37 1.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.396 -0.815 . . . . 50.0 109.114 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 65.9 mtm180 -51.35 -37.58 48.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 50.0 108.922 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.37 -27.82 70.01 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.348 -1.501 . . . . 25.0 109.348 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.842 HD12 ' CB ' ' A' ' 73' ' ' ASN . 22.4 mt -69.07 -45.38 70.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.387 -1.067 . . . . 50.0 109.67 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.955 HD11 ' HA3' ' A' ' 70' ' ' GLY . 4.3 mt -70.38 -19.41 63.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.389 -0.819 . . . . 50.0 109.874 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 40.7 mtmt -80.02 -27.05 39.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.104 -0.997 . . . . 50.0 109.508 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -91.41 -43.12 9.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 50.0 109.507 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.4 p -59.58 -45.46 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.776 0.798 . . . . 50.0 109.105 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.552 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -48.78 -38.33 21.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.716 -0.615 . . . . 50.0 109.85 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -69.58 -24.8 63.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 50.0 109.602 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.687 HG21 ' CG2' ' A' ' 37' ' ' THR . 13.6 mt -64.26 -45.43 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.383 -0.823 . . . . 50.0 109.556 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.461 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 80.1 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.02 -0.99 . . . . 99.99 109.362 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -88.16 8.24 27.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 109.496 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -91.64 111.56 23.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 25.0 109.542 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.538 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -123.43 173.92 4.01 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.285 -0.884 . . . . 50.0 109.128 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.8 Cg_endo -68.61 -22.99 37.16 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.555 2.17 . . . . 50.0 111.34 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -63.39 -37.64 88.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.351 -0.843 . . . . 25.0 109.191 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.4 -41.95 94.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.393 -0.817 . . . . 50.0 109.233 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -52.02 -36.91 51.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.429 -0.794 . . . . 50.0 109.387 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.99 -46.16 85.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.567 -0.901 . . . . 16.66 108.567 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 14' ' ' ILE . 64.9 mt-10 -67.73 -39.52 84.25 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.854 -0.795 . . . . 16.66 108.854 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.422 ' NH1' ' HG ' ' A' ' 77' ' ' LEU . 55.2 mtt-85 -65.96 -40.4 91.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 50.0 109.336 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.59 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 44.0 mt-10 -64.86 -40.43 95.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.412 -0.805 . . . . 50.0 109.228 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.473 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 65.4 mtp180 -67.52 -40.48 85.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.347 -0.846 . . . . 50.0 109.236 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 10' ' ' GLU . 22.0 mt -70.37 -45.23 75.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.363 -0.835 . . . . 50.0 108.906 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.52 -36.03 82.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.273 -0.892 . . . . 16.66 109.008 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -65.76 -30.19 70.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.368 -0.832 . . . . 50.0 109.147 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.485 ' CD ' ' HB3' ' A' ' 84' ' ' PHE . 49.7 mtt85 -71.35 -34.76 70.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 50.0 109.22 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.93 ' HB3' HD13 ' A' ' 26' ' ' ILE . 42.9 m-85 -72.83 -47.98 41.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.418 -0.801 . . . . 16.66 109.432 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.468 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.7 t0 -59.22 103.28 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 16.66 108.499 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 -51.72 51.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.891 . . . . 50.0 111.426 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -87.7 -26.14 23.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.754 -1.216 . . . . 16.66 109.799 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 88.04 38.57 7.3 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.747 -1.216 . . . . 16.66 110.091 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -92.84 5.43 51.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -1.215 . . . . 16.66 109.206 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.09 -7.54 72.89 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.346 -1.101 . . . . 16.66 110.346 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 35.5 pttt -130.37 142.23 50.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.927 -1.337 . . . . 50.0 110.023 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.93 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.9 mt -112.33 134.22 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.63 -0.669 . . . . 16.66 109.39 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 p -107.21 167.64 9.77 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.36 -0.837 . . . . 50.0 108.823 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.513 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.28 -45.99 54.86 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.046 -1.034 . . . . 50.0 108.823 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.16 74.29 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.349 -0.844 . . . . 50.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.5 mt-10 -77.14 -54.17 6.85 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -0.947 . . . . 16.66 109.321 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.597 HD12 ' CE1' ' A' ' 18' ' ' PHE . 32.3 tp -63.12 -41.76 99.4 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.202 -0.936 . . . . 16.66 108.93 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.727 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -64.6 -44.9 94.37 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.199 -1.56 . . . . 16.66 109.199 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -59.07 -41.84 88.91 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.346 -1.091 . . . . 50.0 109.709 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.402 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.96 -40.2 65.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.161 -0.962 . . . . 50.0 108.554 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.798 ' CD1' HG22 ' A' ' 46' ' ' VAL . 11.3 mt -60.69 -31.22 70.49 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.52 -0.738 . . . . 99.99 109.564 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' LEU . 5.3 mttt -45.53 -25.56 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.018 -1.051 . . . . 99.99 109.48 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.615 ' CG2' HG21 ' A' ' 83' ' ' ILE . 9.6 t -52.04 -23.78 5.74 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.916 . . . . 99.99 109.183 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.68 HD13 HD12 ' A' ' 41' ' ' ILE . 9.2 mt -59.49 -33.27 71.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.352 -0.843 . . . . 50.0 109.216 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.13 0.75 57.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.719 -1.352 . . . . 16.66 109.719 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 t -154.72 64.64 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -1.204 . . . . 16.66 109.711 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.68 HD12 HD13 ' A' ' 38' ' ' LEU . 9.3 tt -147.09 175.6 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 50.0 109.42 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.91 164.52 34.54 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.254 -0.903 . . . . 16.66 108.781 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 46.7 Cg_endo -69.21 -33.27 19.07 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.117 1.878 . . . . 50.0 110.142 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -66.75 -22.86 66.04 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.25 -0.58 . . . . 50.0 110.102 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -82.33 -39.66 22.51 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.883 -1.135 . . . . 16.66 108.398 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.798 HG22 ' CD1' ' A' ' 35' ' ' LEU . 67.2 t -65.66 -35.91 76.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.69 -0.855 . . . . 50.0 108.69 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 81.4 mttt -67.17 -39.73 86.48 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.909 -0.774 . . . . 50.0 108.909 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.13 -40.92 91.03 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.428 -0.795 . . . . 50.0 109.183 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.421 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.9 mtt -59.65 -44.3 93.59 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.21 -0.931 . . . . 16.66 108.868 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.685 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 28.1 mtp -61.69 -47.15 86.6 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -0.762 . . . . 50.0 109.128 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.75 -22.07 44.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 50.0 109.141 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.19 -35.95 12.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 16.66 108.989 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.571 HG12 ' CD2' ' A' ' 69' ' ' PHE . 85.6 mt -80.77 -30.95 12.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.47 -0.769 . . . . 50.0 109.438 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.1 t0 -61.04 100.78 0.12 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.465 -0.772 . . . . 16.66 109.027 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.503 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 60.7 p -71.41 -46.5 60.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.288 -0.883 . . . . 50.0 110.436 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -31.02 22.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.135 -0.978 . . . . 16.66 109.534 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.477 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 93.11 28.31 12.05 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.847 -1.168 . . . . 16.66 110.222 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.8 -2.94 55.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.93 -1.335 . . . . 50.0 109.414 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.685 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.47 -7.12 59.59 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.999 -1.096 . . . . 16.66 110.457 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 42.1 m-85 -133.76 155.83 49.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.895 -1.356 . . . . 50.0 111.23 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.56 HD12 HG22 ' A' ' 53' ' ' ILE . 28.6 mm -106.68 127.81 61.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.516 -0.92 . . . . 16.66 108.516 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.53 166.27 12.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.158 -0.964 . . . . 16.66 108.626 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.59 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 35.8 t80 -54.3 -41.96 69.54 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.085 -1.009 . . . . 16.66 108.588 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -61.42 -49.68 75.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.969 -0.752 . . . . 50.0 108.969 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.552 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 33.9 mt-10 -58.28 -47.21 84.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 16.66 109.023 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.751 ' CE2' HD11 ' A' ' 77' ' ' LEU . 63.6 t80 -61.48 -40.48 94.71 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.52 -0.737 . . . . 16.66 109.294 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 13.3 m -65.16 -47.04 78.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.405 -0.809 . . . . 50.0 109.242 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -59.72 -37.79 79.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 50.0 109.349 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.71 -37.42 41.53 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.264 -0.897 . . . . 50.0 108.703 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.415 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -60.64 -28.9 68.63 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.361 -1.496 . . . . 16.66 109.361 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 67' ' ' THR . 67.8 mtm180 -73.3 -34.54 65.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -1.126 . . . . 50.0 109.24 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.83 -17.71 65.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 50.0 109.341 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.78 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.2 m-80 -148.33 55.28 1.03 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 50.0 109.275 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 75' ' ' GLY . 10.4 ptm180 -50.58 -41.42 54.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 50.0 108.806 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.444 ' N ' ' HG3' ' A' ' 74' ' ' ARG . . . -54.38 -20.2 15.45 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.343 -1.503 . . . . 25.0 109.343 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.78 HD12 ' CB ' ' A' ' 73' ' ' ASN . 48.5 mt -80.02 -43.0 22.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.313 -1.11 . . . . 50.0 109.373 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.751 HD11 ' CE2' ' A' ' 66' ' ' PHE . 1.8 mm? -61.27 -41.15 96.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.468 -0.77 . . . . 50.0 109.82 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.7 mtpp -63.05 -38.4 91.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 50.0 109.378 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -73.48 -49.44 26.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.41 -0.806 . . . . 50.0 109.57 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 77' ' ' LEU . 4.1 p -66.05 -43.17 92.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.372 -0.83 . . . . 50.0 109.589 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.534 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.25 -39.74 45.85 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.225 -0.59 . . . . 50.0 109.884 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 34.9 mttm -66.86 -26.02 66.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.935 . . . . 50.0 109.686 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.615 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.2 mt -63.17 -45.22 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 50.0 109.466 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.485 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 92.1 m-85 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.997 -1.001 . . . . 99.99 109.435 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -82.63 -8.75 59.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.561 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.76 119.62 12.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 25.0 109.488 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.499 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -111.31 170.9 4.78 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 50.0 109.325 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.1 Cg_endo -67.16 -22.65 46.74 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.543 2.162 . . . . 50.0 111.079 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -63.96 -35.39 80.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 25.0 109.032 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.486 ' HB3' ' NH1' ' A' ' 11' ' ' ARG . 59.3 m-20 -58.67 -45.94 88.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.329 -0.857 . . . . 50.0 109.3 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -50.39 -37.48 37.77 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.437 -0.789 . . . . 50.0 109.359 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.99 -45.23 79.07 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.476 -0.935 . . . . 16.66 108.476 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 14' ' ' ILE . 53.0 mt-10 -65.44 -45.35 84.13 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.908 -0.775 . . . . 16.66 108.908 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.486 ' NH1' ' HB3' ' A' ' 7' ' ' ASP . 41.9 mtt180 -63.08 -40.93 99.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.395 -0.815 . . . . 50.0 109.395 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.584 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 7.4 mt-10 -64.88 -43.49 92.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.428 -0.795 . . . . 50.0 109.407 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.477 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.6 mtt180 -65.94 -41.36 91.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.888 . . . . 50.0 109.13 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 77' ' ' LEU . 26.0 mt -69.74 -44.53 79.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.302 -0.874 . . . . 50.0 109.19 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.467 ' CE2' HD11 ' A' ' 26' ' ' ILE . 62.0 t80 -66.91 -35.96 81.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.167 -0.958 . . . . 16.66 109.258 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -63.95 -32.4 73.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 50.0 109.383 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 62.7 mtt180 -70.88 -37.15 73.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 50.0 109.047 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.041 ' HB3' HD13 ' A' ' 26' ' ' ILE . 33.8 m-85 -68.43 -47.0 68.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 16.66 109.595 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.471 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.6 t0 -62.52 103.44 0.41 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 16.66 108.937 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.21 -50.88 43.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 50.0 111.213 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -86.34 -31.09 21.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.714 -1.241 . . . . 16.66 109.688 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.94 36.48 5.76 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.805 -1.188 . . . . 16.66 110.27 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.6 p-10 -92.02 4.01 53.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.074 -1.25 . . . . 16.66 109.377 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.78 -6.15 73.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.367 -1.093 . . . . 16.66 110.367 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 10.1 pttm -131.32 143.02 50.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.926 -1.338 . . . . 50.0 109.991 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.041 HD13 ' HB3' ' A' ' 18' ' ' PHE . 4.6 mt -111.97 133.64 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.462 0.648 . . . . 16.66 109.645 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.406 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 13.3 p -106.67 167.97 9.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.473 -0.767 . . . . 50.0 108.947 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.38 -46.35 56.0 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.066 -1.021 . . . . 50.0 108.822 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -56.31 -40.89 75.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.309 -0.869 . . . . 50.0 109.441 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.3 mt-10 -75.19 -54.44 7.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.23 -0.919 . . . . 16.66 109.251 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.804 HD22 HG13 ' A' ' 46' ' ' VAL . 7.2 tt -60.35 -45.27 94.08 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.295 -0.878 . . . . 16.66 108.799 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.614 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.21 -45.03 96.18 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.048 -1.621 . . . . 16.66 109.048 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 16.8 mt-10 -57.13 -42.89 81.77 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.329 -1.1 . . . . 50.0 109.579 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.06 -39.95 65.47 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.133 -0.979 . . . . 50.0 108.379 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.895 ' CD1' HG22 ' A' ' 46' ' ' VAL . 5.3 mt -59.16 -33.04 70.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.599 -0.688 . . . . 99.99 109.6 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -44.64 -26.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.076 -1.015 . . . . 99.99 109.455 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.505 ' CG2' HG21 ' A' ' 83' ' ' ILE . 8.5 t -53.11 -25.53 13.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 99.99 109.363 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.528 HD12 ' CD1' ' A' ' 41' ' ' ILE . 20.5 mt -61.31 -32.34 72.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 50.0 109.151 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.3 9.76 44.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.591 -1.404 . . . . 16.66 109.591 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.54 51.35 0.51 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -1.184 . . . . 16.66 109.444 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.528 ' CD1' HD12 ' A' ' 38' ' ' LEU . 5.5 tt -140.08 175.82 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 50.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.2 167.37 19.05 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.344 -0.848 . . . . 16.66 108.825 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.96 -34.41 17.44 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.972 1.782 . . . . 50.0 110.028 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.81 -29.24 70.03 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.711 -0.618 . . . . 50.0 109.919 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -80.87 -38.8 27.48 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.999 -1.063 . . . . 16.66 108.214 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.895 HG22 ' CD1' ' A' ' 35' ' ' LEU . 47.9 t -63.73 -36.97 78.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.023 -0.732 . . . . 50.0 109.023 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -70.23 -37.38 74.97 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.761 -0.829 . . . . 50.0 108.761 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.517 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.3 t60 -67.46 -37.75 83.41 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.347 -0.846 . . . . 50.0 109.203 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.3 mtt -60.93 -46.76 89.4 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.092 -1.005 . . . . 16.66 108.871 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.666 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 38.9 mtp -61.74 -47.64 84.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.537 -0.727 . . . . 50.0 109.213 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.03 -19.58 45.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 50.0 109.469 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.433 ' CD ' ' NE2' ' A' ' 48' ' ' HIS . 26.8 mt-10 -97.24 -35.8 10.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 16.66 109.108 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.571 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.6 mt -81.87 -32.5 11.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 50.0 109.658 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.4 t0 -59.11 101.37 0.09 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.352 -0.842 . . . . 16.66 109.094 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 46.5 p -69.54 -46.19 67.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.222 -0.924 . . . . 50.0 110.584 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -87.48 -38.13 16.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.967 . . . . 16.66 109.456 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 101.06 27.93 7.13 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.993 -1.099 . . . . 16.66 110.581 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 p-10 -79.45 -2.24 41.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.768 -1.43 . . . . 50.0 109.079 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.666 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.86 -4.97 59.5 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.996 -1.242 . . . . 16.66 109.996 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 28.1 m-85 -134.7 157.48 46.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.029 -1.277 . . . . 50.0 111.259 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.558 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 29.9 mm -108.59 128.17 64.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.172 -1.047 . . . . 16.66 108.172 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.406 ' H ' ' HB2' ' A' ' 65' ' ' GLU . 15.2 m -94.54 169.56 10.11 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.143 -0.973 . . . . 16.66 108.761 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.584 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 33.0 t80 -56.34 -43.22 78.84 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.223 -0.923 . . . . 16.66 108.943 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -62.53 -44.83 95.38 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.594 -0.691 . . . . 50.0 109.219 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.558 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 55.1 mt-10 -62.17 -47.43 84.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 16.66 109.157 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 46.1 t80 -62.65 -36.12 81.82 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.398 -0.814 . . . . 16.66 109.296 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.45 HG23 ' CD ' ' A' ' 11' ' ' ARG . 36.7 m -68.4 -47.16 68.05 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.29 -0.881 . . . . 50.0 109.148 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 71' ' ' ARG . 74.2 m-20 -58.95 -36.75 75.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 50.0 109.307 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.31 -36.48 53.99 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.496 -0.927 . . . . 50.0 108.496 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.873 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.02 -30.48 63.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.109 -1.597 . . . . 16.66 109.109 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.518 ' NH2' ' OD1' ' A' ' 68' ' ' ASP . 52.2 mtm180 -69.18 -30.75 69.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -1.067 . . . . 50.0 108.928 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.66 -21.66 63.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.441 -0.787 . . . . 50.0 109.261 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.765 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.4 m-80 -150.58 57.01 0.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.392 -0.818 . . . . 50.0 109.192 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 7.0 ptp85 -49.27 -36.99 22.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.284 -0.885 . . . . 50.0 108.781 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.439 ' HA2' ' HE2' ' A' ' 78' ' ' LYS . . . -60.34 -30.38 71.09 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.294 -1.522 . . . . 25.0 109.294 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.765 HD12 ' CB ' ' A' ' 73' ' ' ASN . 30.7 mt -68.39 -45.57 72.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -1.081 . . . . 50.0 109.485 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.873 HD11 ' HA3' ' A' ' 70' ' ' GLY . 17.4 mt -65.17 -19.43 65.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 50.0 109.678 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 10.6 mtmm -79.54 -21.02 45.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 50.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.1 -40.63 13.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.926 . . . . 50.0 109.37 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 1.4 p -71.97 -38.48 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.469 -0.769 . . . . 50.0 109.339 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.448 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -59.77 -14.81 16.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.66 -0.65 . . . . 50.0 109.703 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 48.6 mttp -98.17 -30.47 12.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.175 -0.953 . . . . 50.0 109.093 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.505 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.3 mt -56.09 -30.32 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.43 -0.794 . . . . 50.0 109.3 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.4 ' HB2' ' NH1' ' A' ' 17' ' ' ARG . 96.7 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.956 -1.021 . . . . 99.99 109.487 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -81.77 6.58 15.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -73.57 126.92 31.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 25.0 109.457 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.496 ' CE1' ' OD1' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -111.49 170.04 5.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 50.0 109.471 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.3 Cg_endo -67.93 -22.72 41.78 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.608 2.205 . . . . 50.0 111.005 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -62.28 -39.63 93.59 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.43 -0.794 . . . . 25.0 109.091 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' OD1' ' CE1' ' A' ' 4' ' ' HIS . 91.5 m-20 -55.24 -46.34 76.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.402 -0.811 . . . . 50.0 109.333 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -49.62 -37.01 26.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.444 -0.785 . . . . 50.0 109.342 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.75 -46.01 85.08 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.709 -0.848 . . . . 16.66 108.709 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 14' ' ' ILE . 60.2 mt-10 -67.29 -38.54 85.2 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.921 -0.77 . . . . 16.66 108.921 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.592 HH22 HD23 ' A' ' 77' ' ' LEU . 43.9 mtt-85 -67.37 -41.48 84.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.341 -0.85 . . . . 50.0 109.388 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.637 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 9.8 mt-10 -64.94 -42.61 94.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.616 -0.678 . . . . 50.0 109.451 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 70.0 mtp180 -64.93 -41.49 95.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 50.0 109.316 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.472 HG22 ' HE2' ' A' ' 18' ' ' PHE . 18.7 mt -69.45 -46.02 77.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.407 -0.808 . . . . 50.0 109.034 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CD2' ' HA ' ' A' ' 63' ' ' PHE . 59.0 t80 -63.62 -35.6 81.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.313 -0.867 . . . . 16.66 109.254 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -65.84 -31.86 73.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.827 . . . . 50.0 109.281 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 48.4 mtt180 -70.68 -33.66 71.15 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.29 -0.882 . . . . 50.0 109.183 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.903 ' HB3' HD13 ' A' ' 26' ' ' ILE . 45.2 m-85 -71.9 -49.12 40.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.348 -0.845 . . . . 16.66 109.498 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 25.7 t0 -57.88 103.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 16.66 108.646 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.18 -52.2 50.41 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.314 -0.866 . . . . 50.0 111.399 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -87.84 -23.49 23.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.84 -1.162 . . . . 16.66 109.688 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 84.84 41.3 7.72 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.001 -1.24 . . . . 16.66 110.001 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.502 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.7 p-10 -96.35 5.5 50.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.255 . . . . 16.66 109.267 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.24 -9.63 69.72 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.451 -1.06 . . . . 16.66 110.451 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.0 pttp -129.27 141.62 51.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.908 -1.348 . . . . 50.0 109.966 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.903 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.4 mt -112.67 134.31 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.693 -0.629 . . . . 16.66 109.444 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.4 p -105.75 166.94 10.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.74 -0.837 . . . . 50.0 108.74 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.04 -45.22 51.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.028 -1.045 . . . . 50.0 108.825 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.2 78.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.401 -0.812 . . . . 50.0 109.524 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.1 mt-10 -75.26 -54.32 7.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.218 -0.926 . . . . 16.66 109.265 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.608 HD12 ' CD1' ' A' ' 18' ' ' PHE . 34.7 tp -62.38 -42.69 99.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 16.66 108.957 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.595 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.67 -44.67 96.06 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.189 -1.564 . . . . 16.66 109.189 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.28 -42.2 86.06 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.312 -1.111 . . . . 50.0 109.655 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -74.56 -40.42 61.68 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.38 -0.97 . . . . 50.0 108.38 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.877 ' CD1' HG22 ' A' ' 46' ' ' VAL . 10.5 mt -60.52 -31.43 70.5 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.592 -0.692 . . . . 99.99 109.578 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -47.21 -23.71 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 99.99 109.527 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 t -52.15 -22.85 4.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 99.99 109.218 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.0 -32.07 73.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.479 -0.763 . . . . 50.0 109.288 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.23 7.13 50.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.674 -1.37 . . . . 16.66 109.674 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t -154.75 55.63 0.67 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -1.203 . . . . 16.66 109.653 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.0 tt -142.87 176.29 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 50.0 109.538 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.52 163.94 39.42 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.857 . . . . 16.66 108.697 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.49 -33.72 21.97 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.164 1.91 . . . . 50.0 110.209 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -65.87 -24.05 66.78 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.581 -0.699 . . . . 50.0 109.972 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -82.13 -38.52 24.64 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.944 -1.097 . . . . 16.66 108.393 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.877 HG22 ' CD1' ' A' ' 35' ' ' LEU . 42.8 t -68.45 -37.35 77.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.02 -0.733 . . . . 50.0 109.02 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -66.16 -40.28 90.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.372 -0.83 . . . . 50.0 108.941 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -64.87 -40.04 94.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.43 -0.794 . . . . 50.0 109.217 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.429 ' O ' HG13 ' A' ' 53' ' ' ILE . 7.1 mtt -57.61 -43.13 84.5 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.184 -0.947 . . . . 16.66 108.857 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.716 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 47.3 mtp -62.06 -48.0 82.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.561 -0.712 . . . . 50.0 109.266 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.58 -20.55 33.11 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.299 -0.876 . . . . 50.0 109.128 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -97.42 -36.42 10.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.455 -0.778 . . . . 16.66 109.184 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.577 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.5 mt -81.62 -32.45 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.352 -0.843 . . . . 50.0 109.569 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.7 t0 -59.74 101.41 0.11 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.393 -0.817 . . . . 16.66 109.047 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.47 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 67.6 p -70.71 -47.11 61.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 50.0 110.751 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.3 p-10 -86.54 -36.61 18.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.082 -1.011 . . . . 16.66 109.556 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 99.86 28.71 7.25 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.881 -1.152 . . . . 16.66 110.76 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.499 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.7 p-10 -81.03 -3.32 51.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.714 -1.463 . . . . 50.0 109.124 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.716 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.1 -4.47 58.85 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.855 -1.298 . . . . 16.66 109.855 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 44.3 m-85 -134.08 156.37 48.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.057 -1.261 . . . . 50.0 111.093 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.561 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 31.5 mm -108.16 129.88 61.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.142 -1.059 . . . . 16.66 108.142 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.5 166.51 11.48 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.103 -0.998 . . . . 16.66 108.709 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.637 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 34.6 t80 -53.48 -42.53 67.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.186 -1.006 . . . . 16.66 108.546 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -60.5 -49.33 77.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.618 -0.676 . . . . 50.0 109.25 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.561 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 75.3 mt-10 -59.86 -47.0 87.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 16.66 109.15 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -62.66 -36.23 82.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 16.66 109.223 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 21.7 m -67.81 -47.92 67.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 50.0 109.013 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.402 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 82.3 m-20 -59.32 -37.93 79.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.4 -0.813 . . . . 50.0 109.249 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.577 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.04 -37.26 55.11 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.503 -0.925 . . . . 50.0 108.503 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.547 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -58.61 -29.73 64.44 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.247 -1.541 . . . . 16.66 109.247 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 67' ' ' THR . 77.2 mtm180 -70.4 -30.84 67.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -1.127 . . . . 50.0 109.056 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.18 63.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.421 -0.799 . . . . 50.0 109.363 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.683 ' CB ' HD12 ' A' ' 76' ' ' LEU . 4.6 p30 -149.7 56.73 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 50.0 109.189 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.579 ' HA ' HD23 ' A' ' 77' ' ' LEU . 12.8 ptm180 -49.57 -37.13 26.16 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.386 -0.821 . . . . 50.0 108.843 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.33 -27.06 71.1 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.73 -1.348 . . . . 25.0 109.73 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.683 HD12 ' CB ' ' A' ' 73' ' ' ASN . 12.6 mt -66.24 -46.73 76.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -1.184 . . . . 50.0 109.653 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.816 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -59.84 -41.16 90.78 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.377 -0.827 . . . . 50.0 109.375 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -59.23 -30.12 68.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 50.0 109.392 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 49.9 t0 -71.22 -36.8 71.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 50.0 109.38 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.451 HG12 ' HE1' ' A' ' 84' ' ' PHE . 3.0 t -89.93 -27.73 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.385 -0.822 . . . . 50.0 109.421 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.13 -18.74 61.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 50.0 109.719 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 37.5 pttt -95.48 -31.05 13.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 50.0 109.309 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 79' ' ' ASP . 9.3 mt -57.88 -33.64 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.856 . . . . 50.0 109.448 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.451 ' HE1' HG12 ' A' ' 80' ' ' VAL . 88.1 m-85 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.075 -0.964 . . . . 99.99 109.494 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -83.84 -9.19 58.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.433 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.16 127.01 29.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 25.0 109.454 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.495 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 0.1 OUTLIER -132.25 166.92 25.13 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 50.0 109.389 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.2 Cg_endo -66.92 -22.3 48.8 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.565 2.177 . . . . 50.0 111.09 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.512 ' NE2' ' HA ' ' A' ' 6' ' ' GLN . 15.7 mm-40 -61.47 -41.89 97.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.523 -0.736 . . . . 25.0 109.288 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.487 ' CG ' ' CD2' ' A' ' 4' ' ' HIS . 85.2 m-20 -61.86 -46.38 89.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.435 -0.79 . . . . 50.0 109.371 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -50.11 -36.86 31.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.808 . . . . 50.0 109.45 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -56.73 -45.57 81.85 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.612 -0.885 . . . . 16.66 108.612 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 49.0 mt-10 -67.1 -38.64 86.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.448 -0.782 . . . . 16.66 109.066 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 67' ' ' THR . 74.5 mtt-85 -67.29 -40.71 86.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 50.0 109.429 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.599 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 37.8 mt-10 -65.45 -41.62 93.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.441 -0.787 . . . . 50.0 109.5 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 58.5 mtp85 -67.42 -40.66 85.55 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.23 -0.919 . . . . 50.0 109.277 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 10' ' ' GLU . 42.7 mt -70.54 -44.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.289 -0.882 . . . . 50.0 109.151 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -68.22 -35.57 78.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.207 -0.933 . . . . 16.66 109.278 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 52.9 mttt -64.33 -31.79 73.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.373 -0.829 . . . . 50.0 109.261 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.512 ' HD3' ' CD2' ' A' ' 84' ' ' PHE . 52.4 mtt180 -72.21 -35.71 68.97 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.901 . . . . 50.0 109.17 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.026 ' HB3' HD13 ' A' ' 26' ' ' ILE . 37.1 m-85 -68.75 -45.31 71.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 16.66 109.531 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 25.7 t0 -64.45 103.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 16.66 108.779 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.73 -52.13 47.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.233 -0.917 . . . . 50.0 111.21 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -85.57 -26.08 26.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.746 -1.221 . . . . 16.66 109.56 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 86.99 42.92 6.15 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.936 -1.126 . . . . 16.66 110.49 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.505 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 41.1 p-10 -99.44 6.0 46.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.25 . . . . 16.66 109.33 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 62' ' ' SER . . . 94.03 -10.88 71.55 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.485 -1.046 . . . . 16.66 110.485 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.587 ' HD2' ' CD2' ' A' ' 60' ' ' PHE . 14.3 pttp -126.69 140.45 52.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.926 -1.338 . . . . 50.0 109.891 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.026 HD13 ' HB3' ' A' ' 18' ' ' PHE . 3.3 mt -113.8 134.18 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.571 -0.706 . . . . 16.66 109.424 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.461 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 25.9 p -107.47 170.53 7.92 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.435 -0.791 . . . . 50.0 109.011 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.518 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -51.14 -47.76 61.98 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.118 -0.989 . . . . 50.0 109.028 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.31 -38.45 71.29 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.335 -0.853 . . . . 50.0 109.485 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 54.8 mt-10 -77.56 -54.49 6.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.251 -0.905 . . . . 16.66 109.154 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.939 HD22 HG13 ' A' ' 46' ' ' VAL . 7.5 tt -60.01 -46.11 90.55 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.212 -0.93 . . . . 16.66 108.853 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.788 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -61.36 -43.95 98.69 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.076 -1.61 . . . . 16.66 109.076 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 16.2 mt-10 -57.06 -44.42 83.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.433 -1.04 . . . . 50.0 109.823 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.26 -39.28 75.08 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.187 -0.946 . . . . 50.0 108.646 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.938 HD12 HG22 ' A' ' 46' ' ' VAL . 8.7 mt -58.7 -32.03 68.79 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.421 -0.799 . . . . 99.99 109.628 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -42.43 -26.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.177 -0.952 . . . . 99.99 109.84 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.774 ' CG2' HG21 ' A' ' 83' ' ' ILE . 6.3 t -49.44 -24.84 2.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.182 -0.949 . . . . 99.99 109.155 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.79 HD13 HD12 ' A' ' 41' ' ' ILE . 2.0 mt -61.28 -36.39 79.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 50.0 109.315 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.7 -3.33 64.4 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.498 -1.441 . . . . 16.66 109.498 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.74 67.7 0.63 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -1.168 . . . . 16.66 109.657 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.79 HD12 HD13 ' A' ' 38' ' ' LEU . 13.3 tt -149.35 168.25 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 50.0 109.545 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.54 167.32 12.42 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 16.66 109.221 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.67 -28.76 16.81 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.276 1.984 . . . . 50.0 109.849 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -60.25 -28.67 68.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.597 -0.689 . . . . 50.0 109.774 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -80.76 -34.57 34.18 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.069 -1.019 . . . . 16.66 108.353 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.939 HG13 HD22 ' A' ' 31' ' ' LEU . 53.5 t -66.51 -35.42 74.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.108 -0.701 . . . . 50.0 109.108 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -69.06 -37.97 78.81 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.758 -0.83 . . . . 50.0 108.758 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.539 ' CD2' ' HG3' ' A' ' 52' ' ' GLU . 14.8 t-160 -68.07 -39.65 82.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.496 -0.752 . . . . 50.0 109.087 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.43 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.4 mtt -61.9 -47.11 86.43 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.141 -0.975 . . . . 16.66 108.614 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.671 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 48.9 mtp -63.01 -48.3 79.41 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.046 -0.724 . . . . 50.0 109.046 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.72 -17.81 25.96 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.307 -0.871 . . . . 50.0 108.996 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.539 ' HG3' ' CD2' ' A' ' 48' ' ' HIS . 22.7 mt-10 -98.78 -36.2 9.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 16.66 109.203 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.647 HG22 HD12 ' A' ' 61' ' ' ILE . 81.4 mt -82.23 -32.45 10.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.457 -0.777 . . . . 50.0 109.669 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.9 t0 -58.4 100.69 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.441 -0.787 . . . . 16.66 109.126 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 59.1 p -70.0 -46.57 64.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.298 -0.876 . . . . 50.0 110.463 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.91 -31.53 22.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.11 -0.994 . . . . 16.66 109.571 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 93.06 28.53 11.7 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.801 -1.19 . . . . 16.66 110.189 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.48 -3.07 55.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.94 -1.33 . . . . 50.0 109.402 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.671 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 100.44 -8.34 58.56 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.053 -1.07 . . . . 16.66 110.465 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.587 ' CD2' ' HD2' ' A' ' 25' ' ' LYS . 33.9 m-85 -132.81 155.98 47.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.842 -1.387 . . . . 50.0 111.256 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.647 HD12 HG22 ' A' ' 53' ' ' ILE . 32.0 mm -107.43 129.59 61.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.348 -0.982 . . . . 16.66 108.348 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.9 OUTLIER -95.7 166.91 11.59 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.175 -0.953 . . . . 16.66 108.644 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.599 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 32.2 t80 -55.76 -42.86 76.06 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.128 -0.983 . . . . 16.66 108.741 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -62.43 -47.29 84.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.507 -0.745 . . . . 50.0 109.07 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.542 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 51.7 mt-10 -58.54 -48.09 82.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 16.66 108.974 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.484 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 55.5 t80 -59.54 -39.31 83.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.448 -0.782 . . . . 16.66 109.346 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.518 ' O ' ' NH1' ' A' ' 11' ' ' ARG . 16.4 m -65.28 -45.99 82.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.457 -0.777 . . . . 50.0 109.238 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -59.62 -40.07 86.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 50.0 109.515 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -73.0 -36.53 67.04 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.252 -0.905 . . . . 50.0 108.778 179.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.686 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.63 -34.45 76.57 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.389 -1.484 . . . . 16.66 109.389 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -65.86 -29.09 69.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -1.137 . . . . 50.0 109.277 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.67 -22.09 60.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 50.0 109.147 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.931 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.8 m-80 -150.24 58.69 0.96 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.428 -0.795 . . . . 50.0 108.997 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -50.76 -39.94 53.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.284 -0.885 . . . . 50.0 108.788 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.23 -29.9 69.69 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.342 -1.503 . . . . 25.0 109.342 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.931 HD12 ' CB ' ' A' ' 73' ' ' ASN . 28.1 mt -66.92 -45.72 77.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 50.0 109.482 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.686 HD11 ' HA3' ' A' ' 70' ' ' GLY . 25.8 mt -60.85 -37.19 81.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 50.0 109.635 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 23.5 mtmt -62.41 -24.19 67.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 50.0 109.427 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -77.87 -36.36 49.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 50.0 109.527 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -83.58 -29.46 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.836 . . . . 50.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.33 -16.54 47.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 50.0 109.607 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -95.19 -30.66 13.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 50.0 109.223 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.774 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.3 mt -58.86 -36.29 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 50.0 109.332 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.512 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 96.3 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.974 -1.012 . . . . 99.99 109.499 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.512 ' O ' ' NE2' ' A' ' 4' ' ' HIS . 38.8 m-20 -79.82 -6.45 57.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 0.0 109.624 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -81.95 107.91 15.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 25.0 109.534 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.549 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -112.29 173.98 2.57 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 50.0 109.211 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 47.2 Cg_endo -69.4 -22.96 32.99 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.563 2.175 . . . . 50.0 111.232 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -62.87 -34.37 77.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.401 -0.812 . . . . 25.0 109.285 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.97 -46.59 90.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.304 -0.872 . . . . 50.0 109.27 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -48.79 -36.63 17.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.369 -0.832 . . . . 50.0 109.586 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.23 -46.75 87.63 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.26 -0.9 . . . . 16.66 108.638 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 14' ' ' ILE . 57.0 mt-10 -68.08 -38.99 83.0 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.823 -0.806 . . . . 16.66 108.823 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.617 ' NH2' HD12 ' A' ' 77' ' ' LEU . 59.5 mtt-85 -67.99 -40.9 82.97 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.461 -0.774 . . . . 50.0 109.458 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 22.7 mt-10 -65.71 -40.86 92.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 50.0 109.524 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 15.1 mtp85 -68.18 -40.45 82.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 50.0 109.353 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 10' ' ' GLU . 34.6 mt -71.31 -43.46 73.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.328 -0.858 . . . . 50.0 109.012 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -67.39 -36.42 81.28 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.191 -0.943 . . . . 16.66 109.089 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -65.65 -29.67 70.27 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.29 -0.881 . . . . 50.0 109.062 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.481 ' CD ' ' HB3' ' A' ' 84' ' ' PHE . 28.9 mtt180 -71.24 -37.08 72.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.361 -0.837 . . . . 50.0 109.088 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.919 ' HB3' HD13 ' A' ' 26' ' ' ILE . 43.4 m-85 -69.66 -48.48 59.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -0.797 . . . . 16.66 109.488 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.4 t0 -59.18 103.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 16.66 108.713 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -51.39 55.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 50.0 111.273 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -87.87 -29.24 21.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.782 -1.199 . . . . 16.66 109.845 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 92.34 35.85 6.46 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.783 -1.198 . . . . 16.66 110.178 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.7 p-10 -90.43 4.76 50.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.252 . . . . 16.66 109.284 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.5 -6.73 74.79 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.347 -1.101 . . . . 16.66 110.347 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 15.4 pttt -130.43 141.89 50.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.996 -1.296 . . . . 50.0 110.027 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.0 mt -112.31 134.03 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.588 -0.695 . . . . 16.66 109.398 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.4 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 12.9 p -106.79 167.54 9.8 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.392 -0.818 . . . . 50.0 108.899 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.502 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.48 -45.55 56.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.059 -1.026 . . . . 50.0 108.909 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.6 -39.43 76.8 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.328 -0.858 . . . . 50.0 109.598 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.5 mt-10 -75.05 -53.98 7.95 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.224 -0.923 . . . . 16.66 109.439 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.617 HD12 ' CD1' ' A' ' 18' ' ' PHE . 31.9 tp -62.37 -42.25 99.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.209 -0.932 . . . . 16.66 108.911 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.657 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -64.35 -45.33 93.67 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.115 -1.594 . . . . 16.66 109.115 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -57.73 -42.96 84.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -1.104 . . . . 50.0 109.539 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.57 -39.95 64.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.417 -0.957 . . . . 50.0 108.417 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.904 HD12 HG22 ' A' ' 46' ' ' VAL . 10.3 mt -61.62 -32.77 72.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.578 -0.701 . . . . 99.99 109.672 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -46.87 -24.55 0.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 99.99 109.644 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.611 ' CG2' HG21 ' A' ' 83' ' ' ILE . 11.6 t -51.95 -21.52 3.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 99.99 109.266 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 38' ' ' LEU . 25.5 mt -66.64 -29.58 69.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.361 -0.837 . . . . 50.0 109.294 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.75 8.89 50.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 16.66 109.585 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.82 60.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -1.167 . . . . 16.66 109.61 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.73 173.32 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 50.0 109.525 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.38 162.96 37.08 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.712 -0.847 . . . . 16.66 108.712 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.03 -32.49 21.48 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.09 1.86 . . . . 50.0 110.012 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.25 -22.11 64.78 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.642 -0.661 . . . . 50.0 110.043 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -79.99 -36.83 35.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.93 -1.106 . . . . 16.66 108.465 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.904 HG22 HD12 ' A' ' 35' ' ' LEU . 54.2 t -68.72 -36.34 73.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.968 -0.753 . . . . 50.0 108.968 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -64.92 -39.9 94.22 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.896 -0.779 . . . . 50.0 108.896 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.55 -43.37 90.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 50.0 109.116 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.507 ' HE3' ' CD1' ' A' ' 35' ' ' LEU . 70.1 mtm -59.32 -43.39 92.7 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.174 -0.954 . . . . 16.66 108.932 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.697 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 32.4 mtp -61.53 -47.23 86.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.493 -0.754 . . . . 50.0 109.058 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.02 -22.58 50.44 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.318 -0.864 . . . . 50.0 109.116 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.91 -35.89 12.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 16.66 108.942 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.689 HG22 HD12 ' A' ' 61' ' ' ILE . 82.6 mt -81.09 -30.09 11.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.591 -0.693 . . . . 50.0 109.534 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.4 t0 -62.42 101.36 0.23 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.386 -0.821 . . . . 16.66 109.105 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 74.0 p -71.65 -47.95 50.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.862 . . . . 50.0 110.614 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 4.2 p-10 -85.85 -33.83 21.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.141 -0.975 . . . . 16.66 109.728 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 97.31 27.4 9.29 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.911 -1.138 . . . . 16.66 111.053 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 p-10 -80.62 -2.5 46.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.725 -1.456 . . . . 50.0 109.248 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.697 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.01 -4.16 60.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.003 -1.239 . . . . 16.66 110.003 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.576 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 39.7 m-85 -134.46 156.12 49.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.26 . . . . 50.0 111.125 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.689 HD12 HG22 ' A' ' 53' ' ' ILE . 34.3 mm -106.83 128.95 61.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.34 -0.985 . . . . 16.66 108.34 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -96.25 169.51 9.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.083 -1.011 . . . . 16.66 108.832 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 35.7 t80 -55.8 -43.88 77.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.128 -0.983 . . . . 16.66 108.73 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -60.31 -48.38 82.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.462 -0.774 . . . . 50.0 109.185 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 63.5 mt-10 -59.91 -46.5 89.18 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.357 -0.839 . . . . 16.66 109.11 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -62.35 -36.53 82.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.443 -0.786 . . . . 16.66 109.079 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 28.9 m -68.51 -48.27 64.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.8 . . . . 50.0 108.979 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -58.08 -37.75 75.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.319 -0.863 . . . . 50.0 109.249 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.563 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -78.73 -35.87 44.14 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.41 -0.959 . . . . 50.0 108.41 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.89 ' CA ' HD11 ' A' ' 77' ' ' LEU . . . -58.63 -33.9 74.22 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.888 -1.685 . . . . 16.66 108.888 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 67' ' ' THR . 82.1 mtm180 -64.86 -32.3 73.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -1.078 . . . . 50.0 108.53 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.55 -2.54 58.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.538 -0.726 . . . . 50.0 109.227 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.75 ' HB3' HD22 ' A' ' 76' ' ' LEU . 68.4 m-80 -151.69 48.42 0.8 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.311 -0.868 . . . . 50.0 108.668 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -57.8 -47.04 83.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.342 -0.849 . . . . 50.0 108.877 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.2 -21.16 38.46 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.135 -1.586 . . . . 25.0 109.135 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.75 HD22 ' HB3' ' A' ' 73' ' ' ASN . 6.8 mp -79.94 -43.82 21.43 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -1.116 . . . . 50.0 109.366 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.89 HD11 ' CA ' ' A' ' 70' ' ' GLY . 5.9 mt -69.2 -22.38 63.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 50.0 109.968 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -80.03 -26.19 39.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 50.0 109.716 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -89.57 -40.66 12.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.1 -1.0 . . . . 50.0 109.586 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.9 p -67.78 -43.36 86.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.383 -0.823 . . . . 50.0 109.515 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.538 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.96 -37.66 45.86 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.673 -0.642 . . . . 50.0 109.919 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.21 -26.86 67.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 50.0 109.542 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.611 HG21 ' CG2' ' A' ' 37' ' ' THR . 7.8 mt -60.63 -43.9 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.236 -0.915 . . . . 50.0 109.362 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.481 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 89.6 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.961 -1.019 . . . . 99.99 109.463 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -85.18 7.46 21.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 109.619 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -90.15 116.35 28.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 25.0 109.534 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.623 ' CG ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -118.59 153.17 52.03 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.188 -0.945 . . . . 50.0 108.855 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.623 ' HD2' ' CG ' ' A' ' 4' ' ' HIS . 39.9 Cg_endo -64.4 -19.98 65.87 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.143 1.895 . . . . 50.0 110.362 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -57.69 -41.67 82.12 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.079 -0.711 . . . . 25.0 109.079 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.17 -43.72 92.15 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.434 -0.791 . . . . 50.0 109.363 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -50.62 -36.94 37.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 50.0 109.403 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.15 -46.16 89.1 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.782 -0.822 . . . . 16.66 108.782 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.451 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.9 mm-40 -66.38 -44.06 84.17 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.957 -0.757 . . . . 16.66 108.957 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.622 ' NH2' HD12 ' A' ' 77' ' ' LEU . 36.6 mtt-85 -64.95 -39.52 93.62 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.435 -0.79 . . . . 50.0 109.416 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.592 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 13.0 mt-10 -66.21 -42.14 89.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 50.0 109.542 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 47.5 mtp180 -67.01 -40.81 87.36 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.299 -0.876 . . . . 50.0 109.214 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.8 mt -70.29 -44.54 77.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.359 -0.838 . . . . 50.0 109.033 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' A' ' 63' ' ' PHE . 52.7 t80 -66.72 -35.38 79.97 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.281 -0.887 . . . . 16.66 109.041 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -64.44 -31.34 72.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 50.0 109.388 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 64.8 mtt180 -72.53 -36.07 68.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -0.929 . . . . 50.0 109.15 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.012 ' HB3' HD13 ' A' ' 26' ' ' ILE . 34.4 m-85 -68.72 -45.01 72.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 16.66 109.389 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.5 t0 -63.37 103.22 0.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 16.66 108.756 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.17 -51.2 60.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.254 -0.904 . . . . 50.0 111.299 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -89.23 -27.27 20.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.659 -1.276 . . . . 16.66 109.762 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.95 35.68 7.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.032 -1.227 . . . . 16.66 110.032 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.487 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 35.5 p-10 -89.52 3.71 51.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -1.2 . . . . 16.66 109.277 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.19 -6.28 68.73 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.367 -1.093 . . . . 16.66 110.367 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 12.5 pttp -132.37 143.48 49.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.911 -1.346 . . . . 50.0 110.149 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.012 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.4 mt -111.41 135.06 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 121.426 0.632 . . . . 16.66 109.53 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.418 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 11.4 p -107.77 166.4 10.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.877 -0.786 . . . . 50.0 108.877 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.523 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.81 -45.63 50.21 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.185 -0.947 . . . . 50.0 108.876 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 -38.81 75.99 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.317 -0.864 . . . . 50.0 109.602 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.505 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.2 mt-10 -75.61 -54.1 7.53 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.12 -0.987 . . . . 16.66 109.496 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.874 HD12 ' CD1' ' A' ' 18' ' ' PHE . 14.5 tp -64.03 -38.95 92.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.123 -0.986 . . . . 16.66 108.876 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.629 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -66.02 -46.48 80.82 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.993 -1.643 . . . . 16.66 108.993 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -57.27 -42.79 82.31 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.326 -1.102 . . . . 50.0 109.478 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.63 -40.22 63.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.416 -0.957 . . . . 50.0 108.416 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.812 ' CD1' HG22 ' A' ' 46' ' ' VAL . 5.0 mt -59.94 -32.84 71.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.644 -0.66 . . . . 99.99 109.595 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -45.61 -25.67 0.5 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.034 -1.041 . . . . 99.99 109.351 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.54 ' CG2' HG21 ' A' ' 83' ' ' ILE . 11.7 t -50.87 -23.74 3.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.282 -0.886 . . . . 99.99 109.184 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 41' ' ' ILE . 22.5 mt -62.15 -32.58 73.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.813 . . . . 50.0 109.264 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.0 6.43 52.67 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.643 -1.383 . . . . 16.66 109.643 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.18 56.63 0.65 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -1.213 . . . . 16.66 109.605 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 38' ' ' LEU . 8.9 tt -142.47 175.25 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -0.962 . . . . 50.0 109.512 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.75 165.71 25.36 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.349 -0.844 . . . . 16.66 108.759 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 47.4 Cg_endo -69.42 -33.74 17.23 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.09 1.86 . . . . 50.0 110.172 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.17 -22.37 65.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.699 -0.625 . . . . 50.0 110.178 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -82.99 -39.53 21.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.822 -1.173 . . . . 16.66 108.452 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.812 HG22 ' CD1' ' A' ' 35' ' ' LEU . 75.1 t -66.03 -36.02 76.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.786 -0.82 . . . . 50.0 108.786 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 43' ' ' PRO . 23.3 mttm -67.6 -39.9 84.79 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.782 -0.822 . . . . 50.0 108.782 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -65.71 -39.51 91.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.407 -0.808 . . . . 50.0 109.149 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.414 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.8 mtt -58.46 -44.77 89.39 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.176 -0.953 . . . . 16.66 108.718 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.617 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 58.1 mtp -62.32 -48.03 81.66 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.524 -0.735 . . . . 50.0 109.188 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.06 -20.17 23.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.301 -0.874 . . . . 50.0 109.05 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -97.14 -35.8 10.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 16.66 109.025 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.688 HG22 HD12 ' A' ' 61' ' ' ILE . 83.5 mt -81.74 -31.74 11.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.446 -0.784 . . . . 50.0 109.592 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.3 t0 -60.42 101.24 0.12 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.341 -0.85 . . . . 16.66 109.187 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 37.9 p -72.13 -45.03 62.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.374 -0.829 . . . . 50.0 110.582 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.498 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.2 p-10 -87.35 -38.92 15.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 16.66 109.485 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 102.17 29.28 6.12 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.86 -1.162 . . . . 16.66 110.675 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p-10 -81.92 -4.12 55.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.819 -1.401 . . . . 50.0 109.014 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.617 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.1 -2.36 57.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.816 -1.314 . . . . 16.66 109.816 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 31.4 m-85 -136.86 156.59 48.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -1.232 . . . . 50.0 111.275 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.688 HD12 HG22 ' A' ' 53' ' ' ILE . 33.3 mm -106.93 127.24 62.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.328 -0.99 . . . . 16.66 108.328 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -94.2 167.71 11.38 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.075 -1.016 . . . . 16.66 108.762 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.592 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.3 t80 -55.09 -43.08 73.64 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.154 -0.966 . . . . 16.66 108.693 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.74 -49.3 78.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.976 -0.75 . . . . 50.0 108.976 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.538 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 22.5 mt-10 -58.3 -47.31 84.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.836 . . . . 16.66 109.027 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.6 -37.97 85.85 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.52 -0.737 . . . . 16.66 109.306 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 31.2 m -65.74 -47.73 74.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.845 . . . . 50.0 109.257 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -60.38 -38.84 85.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 50.0 109.359 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.586 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.13 -38.37 56.87 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.281 -1.007 . . . . 50.0 108.281 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.905 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -56.81 -28.84 57.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.056 -1.617 . . . . 16.66 109.056 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 67' ' ' THR . 78.7 mtm180 -70.39 -29.65 66.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -1.098 . . . . 50.0 108.832 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.65 -23.42 63.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.781 . . . . 50.0 109.155 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.797 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.7 m-80 -148.83 58.17 1.04 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 50.0 108.991 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -50.63 -30.86 14.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 50.0 108.894 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.17 -30.9 79.01 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.202 -1.559 . . . . 25.0 109.202 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.797 HD12 ' CB ' ' A' ' 73' ' ' ASN . 63.7 mt -66.57 -43.56 84.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -1.071 . . . . 50.0 109.491 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.905 HD11 ' HA3' ' A' ' 70' ' ' GLY . 5.3 mt -69.55 -26.49 64.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.415 -0.803 . . . . 50.0 109.862 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -79.37 -24.59 42.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.01 -1.057 . . . . 50.0 109.217 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -92.01 -45.13 8.48 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.393 -0.817 . . . . 50.0 109.333 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.6 p -61.17 -44.52 98.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.808 0.813 . . . . 50.0 109.048 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.545 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -51.49 -39.82 58.32 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.731 -0.606 . . . . 50.0 109.53 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -59.65 -30.8 68.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 50.0 109.702 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.54 HG21 ' CG2' ' A' ' 37' ' ' THR . 41.9 mt -59.37 -32.43 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 50.0 109.43 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 9.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.062 -0.971 . . . . 99.99 109.439 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -107.71 85.67 2.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.549 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -95.13 111.09 22.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 25.0 109.36 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.521 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -118.49 172.41 4.24 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 50.0 109.33 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 45.9 Cg_endo -68.9 -22.5 36.09 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.573 2.182 . . . . 50.0 111.094 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -63.58 -38.2 90.22 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.485 -0.76 . . . . 25.0 109.252 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.99 -42.06 97.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 50.0 109.344 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -52.8 -36.48 58.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.477 -0.764 . . . . 50.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' O ' ' HD2' ' A' ' 13' ' ' ARG . . . -58.68 -45.18 89.98 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.642 -0.873 . . . . 16.66 108.642 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 14' ' ' ILE . 66.7 mt-10 -67.41 -43.49 81.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.838 -0.801 . . . . 16.66 108.838 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.481 ' NH1' ' HG2' ' A' ' 71' ' ' ARG . 35.1 mtt-85 -66.24 -39.42 89.52 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.484 -0.76 . . . . 50.0 109.346 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 14.8 mt-10 -66.98 -41.02 87.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.474 -0.766 . . . . 50.0 109.373 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.4 mtt180 -68.46 -40.16 81.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.358 -0.839 . . . . 50.0 109.117 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.9 mt -70.72 -44.73 76.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.411 -0.805 . . . . 50.0 109.059 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -65.43 -36.23 83.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 16.66 109.029 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -66.05 -29.48 69.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 50.0 109.151 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 84' ' ' PHE . 33.7 mtt180 -70.46 -39.15 74.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 50.0 109.066 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.936 ' HB3' HD13 ' A' ' 26' ' ' ILE . 46.6 m-85 -68.44 -48.5 64.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 16.66 109.316 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 26.5 t0 -57.36 103.48 0.13 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 16.66 108.604 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -52.28 57.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 50.0 111.457 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' A' ' 23' ' ' ASP . 31.8 p-10 -88.84 -21.97 23.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.826 -1.171 . . . . 16.66 109.768 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 82.66 40.48 9.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.876 -1.29 . . . . 16.66 109.876 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.507 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.5 p-10 -94.11 4.15 54.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -1.221 . . . . 16.66 109.247 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.88 -9.41 65.91 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.516 -1.034 . . . . 16.66 110.516 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 7.6 pttt -130.74 142.69 50.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.932 -1.334 . . . . 50.0 110.118 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.936 HD13 ' HB3' ' A' ' 18' ' ' PHE . 7.6 mt -112.82 134.05 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.409 -0.589 . . . . 16.66 109.409 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.426 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 25.0 p -107.8 168.96 8.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 50.0 108.846 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.509 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.56 -47.18 57.86 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.06 -1.025 . . . . 50.0 108.933 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.39 70.2 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.481 -0.762 . . . . 50.0 109.704 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.494 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 55.5 mt-10 -78.39 -53.5 7.2 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.111 -0.993 . . . . 16.66 109.477 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.685 HD12 ' CD1' ' A' ' 18' ' ' PHE . 54.6 tp -63.22 -40.43 97.46 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.175 -0.953 . . . . 16.66 108.976 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.658 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -64.07 -45.13 94.66 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.162 -1.575 . . . . 16.66 109.162 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -58.64 -42.94 89.48 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.195 -1.179 . . . . 50.0 109.703 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.54 -40.68 61.56 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.053 -1.029 . . . . 50.0 108.404 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.75 ' CD1' HG22 ' A' ' 46' ' ' VAL . 9.5 mt -60.73 -33.13 72.45 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.546 -0.721 . . . . 99.99 109.463 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -47.12 -24.4 0.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.081 -1.012 . . . . 99.99 109.437 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.56 ' CG2' HG21 ' A' ' 83' ' ' ILE . 12.2 t -52.54 -22.61 5.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 99.99 109.19 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.605 HD12 HD12 ' A' ' 41' ' ' ILE . 39.3 mt -61.07 -31.66 71.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -0.832 . . . . 50.0 109.224 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.66 3.52 54.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.733 -1.347 . . . . 16.66 109.733 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.76 65.04 0.59 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -1.197 . . . . 16.66 109.71 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.605 HD12 HD12 ' A' ' 38' ' ' LEU . 14.9 tt -149.63 170.24 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 50.0 109.411 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.66 162.95 28.2 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.311 -0.868 . . . . 16.66 108.706 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.76 -32.4 23.38 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.003 1.802 . . . . 50.0 110.18 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.0 -23.56 65.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.604 -0.685 . . . . 50.0 109.915 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -81.0 -38.92 26.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.887 -1.133 . . . . 16.66 108.298 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.75 HG22 ' CD1' ' A' ' 35' ' ' LEU . 53.8 t -66.09 -36.38 77.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.579 -0.897 . . . . 50.0 108.579 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -69.54 -39.54 77.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.479 -0.934 . . . . 50.0 108.479 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.52 -41.42 88.83 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.96 -0.755 . . . . 50.0 108.96 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.8 mtt -59.05 -44.92 91.86 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.259 -0.9 . . . . 16.66 108.622 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.689 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 30.1 mtp -60.39 -46.13 91.06 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.521 -0.737 . . . . 50.0 109.061 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.77 -23.5 52.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.8 . . . . 50.0 109.316 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -92.84 -35.95 13.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 16.66 108.799 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.754 HG22 HD12 ' A' ' 61' ' ' ILE . 84.7 mt -80.37 -29.34 12.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.545 -0.722 . . . . 50.0 109.478 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.2 t0 -63.8 101.6 0.38 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.446 -0.784 . . . . 16.66 109.196 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 76.1 p -73.95 -46.72 42.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.292 -0.88 . . . . 50.0 110.868 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 7.5 p-10 -86.14 -31.24 21.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.069 -1.02 . . . . 16.66 109.645 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 94.73 27.42 11.42 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.798 -1.191 . . . . 16.66 111.066 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.6 p-10 -82.32 -3.49 55.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.73 -1.453 . . . . 50.0 109.321 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.689 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.93 -5.71 59.76 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.243 -1.143 . . . . 16.66 110.243 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.57 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 37.0 m-85 -133.5 155.04 50.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.942 -1.328 . . . . 50.0 111.039 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.754 HD12 HG22 ' A' ' 53' ' ' ILE . 34.5 mm -105.24 127.44 59.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.254 -1.017 . . . . 16.66 108.254 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.3 167.62 11.42 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.2 -0.937 . . . . 16.66 108.91 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.597 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.6 t80 -54.58 -42.77 71.45 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.057 -1.027 . . . . 16.66 108.651 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -60.7 -49.47 77.36 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.115 -0.698 . . . . 50.0 109.115 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.555 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 45.6 mt-10 -58.88 -46.79 86.99 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 16.66 109.013 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -63.74 -36.58 84.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.507 -0.745 . . . . 16.66 109.288 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.42 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 52.8 m -66.35 -48.68 69.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.321 -0.862 . . . . 50.0 109.209 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' ' NH1' ' A' ' 71' ' ' ARG . 67.8 m-20 -61.79 -37.38 84.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 50.0 109.3 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.593 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -72.71 -40.15 66.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.538 -0.912 . . . . 50.0 108.538 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.496 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -56.13 -29.19 55.58 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.141 -1.584 . . . . 16.66 109.141 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.484 ' NH1' ' OD1' ' A' ' 68' ' ' ASP . 23.2 mtm180 -71.1 -21.49 62.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 50.0 109.054 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.71 -24.44 38.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.439 -0.788 . . . . 50.0 109.34 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.95 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.8 m-80 -145.22 57.68 1.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.861 . . . . 50.0 109.393 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -51.31 -38.72 54.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.894 . . . . 50.0 108.762 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.22 -27.53 65.38 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.316 -1.514 . . . . 25.0 109.316 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.95 HD12 ' CB ' ' A' ' 73' ' ' ASN . 39.7 mt -69.73 -44.8 69.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -1.093 . . . . 50.0 109.476 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.695 HD12 ' N ' ' A' ' 77' ' ' LEU . 8.9 mp -63.38 -40.26 96.75 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.422 -0.799 . . . . 50.0 110.002 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 14.4 mtmt -65.83 -20.08 66.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 50.0 109.344 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.36 -53.85 3.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 50.0 109.535 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.2 p -65.89 -44.8 92.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.369 -0.832 . . . . 50.0 109.452 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.558 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -53.67 -36.65 62.37 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.59 -0.693 . . . . 50.0 109.725 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 17.5 mttt -66.95 -25.47 66.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 50.0 109.663 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.56 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.1 mt -59.63 -42.48 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.904 . . . . 50.0 109.444 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.512 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 88.7 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.015 -0.993 . . . . 99.99 109.47 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -60.71 -28.19 68.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.468 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -93.99 109.01 20.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 25.0 109.37 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.477 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -117.77 171.11 5.35 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 50.0 109.436 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.1 Cg_endo -68.27 -22.78 39.6 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.559 2.173 . . . . 50.0 111.134 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -62.61 -40.03 95.67 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.447 -0.783 . . . . 25.0 109.127 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.84 -42.18 93.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.373 -0.83 . . . . 50.0 109.222 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -52.78 -36.15 57.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.366 -0.833 . . . . 50.0 109.223 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.59 -45.78 84.83 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.587 -0.894 . . . . 16.66 108.587 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 56.2 mt-10 -66.33 -44.65 82.72 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.881 -0.785 . . . . 16.66 108.881 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.78 ' NH1' HG23 ' A' ' 67' ' ' THR . 75.2 mtm180 -64.52 -38.85 92.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.533 -0.73 . . . . 50.0 109.436 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.619 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 34.8 mt-10 -65.91 -42.34 90.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.329 -0.857 . . . . 50.0 109.469 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 16.9 mtp180 -66.82 -40.17 87.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.281 -0.887 . . . . 50.0 109.218 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 10' ' ' GLU . 30.2 mt -70.17 -46.27 72.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.392 -0.818 . . . . 50.0 108.967 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -62.43 -35.58 79.68 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.274 -0.891 . . . . 16.66 108.934 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 60.1 mttm -66.56 -30.06 70.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.858 . . . . 50.0 109.15 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 47.2 mtt180 -68.92 -37.71 79.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.339 -0.851 . . . . 50.0 109.16 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.853 ' HB3' HD13 ' A' ' 26' ' ' ILE . 55.4 m-85 -68.96 -50.41 49.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.785 . . . . 16.66 109.489 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.468 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.8 t0 -54.66 103.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 16.66 108.651 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.13 -52.03 52.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.274 -0.891 . . . . 50.0 111.29 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -87.88 -23.64 23.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.745 -1.222 . . . . 16.66 109.592 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 84.72 41.47 7.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.034 -1.226 . . . . 16.66 110.034 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.505 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.2 p-10 -96.16 5.84 50.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.047 -1.267 . . . . 16.66 109.295 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -9.01 71.19 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.454 -1.058 . . . . 16.66 110.454 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.2 pttp -129.55 141.86 50.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.319 . . . . 50.0 109.808 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.853 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.5 mt -112.61 134.31 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.687 -0.633 . . . . 16.66 109.381 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.46 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 18.1 p -106.41 167.33 9.91 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.662 -0.866 . . . . 50.0 108.662 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.94 -45.63 51.42 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.12 -0.988 . . . . 50.0 108.997 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.85 -38.45 75.7 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.25 -0.907 . . . . 50.0 109.529 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.496 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.2 mt-10 -76.41 -54.31 6.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.163 -0.961 . . . . 16.66 109.281 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.712 HD12 ' CD1' ' A' ' 18' ' ' PHE . 29.0 tp -62.73 -42.09 99.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 16.66 108.912 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.668 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.85 -44.9 95.46 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.201 -1.559 . . . . 16.66 109.201 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.99 -42.95 86.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.307 -1.113 . . . . 50.0 109.699 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.89 -40.02 63.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.359 -0.978 . . . . 50.0 108.359 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.935 ' CD1' HG22 ' A' ' 46' ' ' VAL . 12.5 mt -60.76 -32.48 71.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.65 -0.656 . . . . 99.99 109.566 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -46.5 -24.64 0.55 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.082 -1.012 . . . . 99.99 109.443 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.603 ' CG2' HG21 ' A' ' 83' ' ' ILE . 10.3 t -51.81 -22.72 3.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.276 -0.89 . . . . 99.99 109.261 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.631 HD12 HD12 ' A' ' 41' ' ' ILE . 21.6 mt -60.2 -33.24 71.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.381 -0.824 . . . . 50.0 109.38 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.21 3.21 56.31 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.633 -1.387 . . . . 16.66 109.633 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.44 61.57 0.62 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -1.181 . . . . 16.66 109.594 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.631 HD12 HD12 ' A' ' 38' ' ' LEU . 10.3 tt -146.31 174.54 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 50.0 109.539 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.34 164.47 29.94 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 16.66 108.768 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.54 -32.77 18.81 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.091 1.861 . . . . 50.0 110.241 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.38 -22.85 65.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.654 -0.654 . . . . 50.0 110.055 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -82.34 -38.95 23.49 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.904 -1.123 . . . . 16.66 108.544 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.935 HG22 ' CD1' ' A' ' 35' ' ' LEU . 42.2 t -68.05 -37.35 78.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.779 -0.823 . . . . 50.0 108.779 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -66.15 -40.09 90.31 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.829 -0.804 . . . . 50.0 108.829 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.472 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.9 t60 -64.54 -39.47 93.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.454 -0.779 . . . . 50.0 109.128 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.436 ' O ' HG13 ' A' ' 53' ' ' ILE . 13.2 mtt -56.54 -43.15 79.61 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.101 -1.0 . . . . 16.66 108.552 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.519 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 82.3 mtp -61.51 -48.4 81.22 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.944 -0.761 . . . . 50.0 108.944 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.72 -22.08 12.88 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.246 -0.908 . . . . 50.0 109.134 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -99.11 -36.85 9.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 16.66 109.231 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.672 HG22 HD12 ' A' ' 61' ' ' ILE . 82.9 mt -80.25 -33.49 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.434 -0.791 . . . . 50.0 109.617 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.6 t0 -59.97 101.47 0.12 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.351 -0.843 . . . . 16.66 109.099 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.534 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 81.8 p -73.76 -47.41 39.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 50.0 110.819 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 7.1 p-10 -85.72 -31.81 22.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.945 . . . . 16.66 109.681 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.462 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 95.19 27.65 10.65 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.888 -1.148 . . . . 16.66 111.001 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.482 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.1 p-10 -81.66 -3.79 54.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.768 -1.431 . . . . 50.0 109.342 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.519 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.46 -5.43 58.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.14 -1.184 . . . . 16.66 110.14 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.575 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 45.2 m-85 -133.1 154.83 50.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.998 -1.295 . . . . 50.0 110.971 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.672 HD12 HG22 ' A' ' 53' ' ' ILE . 34.7 mm -105.31 128.73 59.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.364 -0.976 . . . . 16.66 108.364 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.6 165.88 11.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.188 -0.945 . . . . 16.66 108.836 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.619 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.9 t80 -53.56 -43.09 68.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.095 -1.003 . . . . 16.66 108.542 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -59.07 -46.78 87.4 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.09 -0.707 . . . . 50.0 109.09 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.549 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 64.0 mt-10 -63.78 -46.99 82.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.853 . . . . 16.66 109.068 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.779 ' HE1' HD13 ' A' ' 77' ' ' LEU . 27.3 t80 -65.84 -29.03 69.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.428 -0.795 . . . . 16.66 109.182 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.78 HG23 ' NH1' ' A' ' 11' ' ' ARG . 63.0 m -69.87 -49.96 47.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.42 -0.8 . . . . 50.0 109.329 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.49 -35.83 81.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 50.0 109.385 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.583 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -75.79 -41.18 53.61 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.384 -0.969 . . . . 50.0 108.384 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.993 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.56 -30.03 71.02 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.002 -1.639 . . . . 16.66 109.002 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.51 ' HG3' ' NH1' ' A' ' 11' ' ' ARG . 68.4 mtp180 -66.91 -37.25 84.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.445 -1.033 . . . . 50.0 108.826 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.44 -19.02 65.69 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.133 -0.691 . . . . 50.0 109.133 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.769 ' CB ' HD12 ' A' ' 76' ' ' LEU . 18.4 m-80 -145.94 53.29 1.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 50.0 109.318 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -49.5 -36.15 22.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 50.0 108.739 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.523 ' HA2' ' CE ' ' A' ' 78' ' ' LYS . . . -61.54 -19.71 58.26 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.398 -1.481 . . . . 25.0 109.398 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.769 HD12 ' CB ' ' A' ' 73' ' ' ASN . 25.0 mt -78.33 -44.86 24.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.393 -1.063 . . . . 50.0 109.291 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.993 HD11 ' HA3' ' A' ' 70' ' ' GLY . 3.8 mt -71.15 -24.2 62.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.473 -0.767 . . . . 50.0 110.142 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' CE ' ' HA2' ' A' ' 75' ' ' GLY . 6.7 ptpt -80.06 -28.79 39.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.959 -1.088 . . . . 50.0 109.0 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 56.3 m-20 -87.37 -44.68 11.19 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.488 -0.758 . . . . 50.0 109.274 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.552 HG13 ' N ' ' A' ' 81' ' ' ALA . 5.4 p -58.71 -44.78 90.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.868 0.842 . . . . 50.0 108.946 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.552 ' N ' HG13 ' A' ' 80' ' ' VAL . . . -50.5 -41.13 53.07 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.165 -0.614 . . . . 50.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -59.43 -32.25 70.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 50.0 109.499 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.603 HG21 ' CG2' ' A' ' 37' ' ' THR . 26.9 mt -57.44 -32.65 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 50.0 109.278 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.551 ' CE1' HG21 ' A' ' 37' ' ' THR . 8.9 m-85 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.96 -1.019 . . . . 99.99 109.488 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.419 ' O ' ' CD2' ' A' ' 4' ' ' HIS . 91.0 m-20 -72.1 -10.45 59.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.517 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -79.55 111.35 15.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 25.0 109.488 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.504 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -109.87 170.02 5.79 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.913 . . . . 50.0 109.363 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.3 Cg_endo -67.44 -22.3 45.51 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.573 2.182 . . . . 50.0 111.0 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -63.04 -41.72 99.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.613 -0.68 . . . . 25.0 109.234 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -55.97 -47.56 77.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.439 -0.788 . . . . 50.0 109.378 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -48.34 -36.1 13.75 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.429 -0.795 . . . . 50.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.37 -46.38 88.81 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.395 -0.816 . . . . 16.66 108.98 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.46 ' O ' HG13 ' A' ' 14' ' ' ILE . 61.7 mt-10 -66.78 -41.09 88.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.401 -0.812 . . . . 16.66 108.981 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -66.16 -41.1 90.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.453 -0.779 . . . . 50.0 109.452 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.568 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 8.6 mt-10 -64.6 -41.51 96.18 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.519 -0.738 . . . . 50.0 109.399 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 62.1 mtp180 -67.01 -40.6 87.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 50.0 109.273 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 10' ' ' GLU . 31.9 mt -70.55 -44.46 76.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.397 -0.814 . . . . 50.0 108.986 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 63' ' ' PHE . 58.7 t80 -66.65 -36.2 81.99 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.295 -0.878 . . . . 16.66 109.065 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -65.5 -30.67 71.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 50.0 108.983 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 52.0 mtt85 -70.62 -36.16 73.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.411 -0.806 . . . . 50.0 109.114 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.967 ' HB3' HD13 ' A' ' 26' ' ' ILE . 36.3 m-85 -68.21 -49.22 62.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.823 . . . . 16.66 109.432 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.6 t0 -57.58 103.43 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 16.66 108.715 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.3 -51.3 54.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 50.0 111.26 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -87.31 -30.49 20.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.733 -1.229 . . . . 16.66 109.793 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.59 35.6 6.14 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.819 -1.181 . . . . 16.66 110.232 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.1 p-10 -90.46 3.96 52.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.246 . . . . 16.66 109.285 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.02 -6.51 72.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.431 -1.068 . . . . 16.66 110.431 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.609 ' HD3' ' CG ' ' A' ' 60' ' ' PHE . 2.3 ptpp? -131.08 142.65 50.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.944 -1.327 . . . . 50.0 109.939 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.967 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.1 mt -112.15 133.73 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.605 -0.684 . . . . 16.66 109.652 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.1 p -105.53 166.06 10.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.383 -0.823 . . . . 50.0 108.867 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.92 -44.82 50.48 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.987 -1.071 . . . . 50.0 108.699 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -58.14 -39.77 79.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.189 -0.945 . . . . 50.0 109.347 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.8 mt-10 -74.67 -54.63 7.05 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.132 -0.98 . . . . 16.66 109.24 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.541 ' CD1' ' CE1' ' A' ' 18' ' ' PHE . 29.9 tp -62.31 -42.31 99.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.145 -0.972 . . . . 16.66 108.94 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.582 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.92 -45.33 94.38 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.96 -1.656 . . . . 16.66 108.96 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 10.3 mt-10 -56.15 -44.33 79.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.418 -1.048 . . . . 50.0 109.457 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.53 -39.31 67.63 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.331 -0.988 . . . . 50.0 108.331 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.874 ' CD1' HG22 ' A' ' 46' ' ' VAL . 6.7 mt -59.26 -32.93 70.45 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.545 -0.722 . . . . 99.99 109.412 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -44.79 -26.03 0.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 99.99 109.474 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.791 ' OG1' HG21 ' A' ' 83' ' ' ILE . 8.7 t -52.55 -25.04 9.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 99.99 109.232 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.942 HD12 HD12 ' A' ' 41' ' ' ILE . 23.7 mt -57.99 -35.96 71.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 50.0 109.165 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.87 1.97 60.28 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.681 -1.367 . . . . 16.66 109.681 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.15 52.53 0.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.092 -1.24 . . . . 16.66 109.754 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.942 HD12 HD12 ' A' ' 38' ' ' LEU . 11.7 tt -136.47 171.77 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 50.0 109.589 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.23 165.89 23.62 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.751 -0.833 . . . . 16.66 108.751 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.91 -33.79 19.17 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.042 1.828 . . . . 50.0 110.188 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -62.1 -28.9 69.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.585 -0.697 . . . . 50.0 109.956 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -81.76 -36.11 28.88 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.949 -1.094 . . . . 16.66 108.288 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.874 HG22 ' CD1' ' A' ' 35' ' ' LEU . 57.7 t -68.09 -36.59 75.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.948 -0.76 . . . . 50.0 108.948 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -68.88 -38.92 80.0 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.795 -0.817 . . . . 50.0 108.795 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -65.92 -39.78 90.86 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.471 -0.768 . . . . 50.0 109.299 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.431 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.9 mtt -59.19 -44.59 92.22 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.117 -0.989 . . . . 16.66 108.841 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.549 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 29.3 mtp -62.43 -48.13 81.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.421 -0.799 . . . . 50.0 109.15 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.62 -20.14 30.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 50.0 109.097 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -97.44 -36.47 10.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 16.66 109.199 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.587 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.6 mt -80.78 -31.93 12.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.413 -0.804 . . . . 50.0 109.576 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.0 t0 -61.76 101.38 0.19 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.439 -0.788 . . . . 16.66 108.938 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.453 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 39.6 p -67.95 -45.18 74.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.874 . . . . 50.0 110.461 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.9 p-10 -88.79 -42.71 11.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 16.66 109.642 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 104.88 30.21 4.93 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.188 -1.165 . . . . 16.66 110.188 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.8 p-10 -81.31 -3.06 51.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.919 -1.342 . . . . 50.0 109.233 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.549 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.6 -1.13 58.3 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.795 -1.322 . . . . 16.66 109.795 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.609 ' CG ' ' HD3' ' A' ' 25' ' ' LYS . 51.1 m-85 -137.44 155.66 49.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -1.233 . . . . 50.0 111.284 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.55 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 30.9 mm -109.83 129.57 64.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.222 -1.029 . . . . 16.66 108.222 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.02 168.13 10.47 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.057 -1.027 . . . . 16.66 108.815 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.568 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 32.4 t80 -54.83 -43.19 72.77 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.102 -0.999 . . . . 16.66 108.728 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -61.1 -46.81 89.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.545 -0.722 . . . . 50.0 109.235 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 75.0 mt-10 -61.65 -47.67 84.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 16.66 109.198 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.439 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 60.0 t80 -61.44 -36.86 81.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 16.66 109.444 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 23.1 m -65.54 -47.27 76.45 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.259 -0.901 . . . . 50.0 109.344 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -60.92 -38.87 87.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 50.0 109.6 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -77.37 -38.6 49.75 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.136 -0.977 . . . . 50.0 108.77 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.45 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.36 -32.32 76.81 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.935 -1.666 . . . . 16.66 108.935 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 67' ' ' THR . 64.6 mtp180 -70.97 -34.26 71.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -1.027 . . . . 50.0 109.259 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.47 -4.61 56.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 50.0 109.512 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.781 ' HB3' HD13 ' A' ' 76' ' ' LEU . 69.1 m-80 -150.0 46.31 0.92 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.262 -0.899 . . . . 50.0 108.798 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -55.44 -48.87 73.79 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.54 -0.911 . . . . 50.0 108.54 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.27 -24.91 24.2 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.146 -1.581 . . . . 25.0 109.146 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.781 HD13 ' HB3' ' A' ' 73' ' ' ASN . 7.1 mp -78.81 -44.67 22.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -1.15 . . . . 50.0 109.357 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.572 ' O ' HG12 ' A' ' 80' ' ' VAL . 21.2 mt -60.1 -39.6 86.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.444 -0.785 . . . . 50.0 109.409 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 32.8 mtpt -56.06 -28.23 56.72 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.294 -0.879 . . . . 50.0 109.326 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 52.9 t0 -75.67 -39.19 57.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.381 -0.824 . . . . 50.0 109.775 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -64.85 -37.55 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 50.0 109.378 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -72.78 -4.26 30.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.556 -0.715 . . . . 50.0 109.65 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 14.4 mttm -74.28 -35.13 63.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 50.0 109.255 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.791 HG21 ' OG1' ' A' ' 37' ' ' THR . 35.2 mt -76.75 -32.68 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.309 -0.869 . . . . 50.0 109.453 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.732 ' HE1' HG21 ' A' ' 37' ' ' THR . 5.4 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.975 -1.012 . . . . 99.99 109.454 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -77.18 -13.06 60.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -49.4 139.05 12.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 25.0 109.538 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.19 166.49 28.85 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.296 -0.877 . . . . 50.0 109.468 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 43.2 Cg_endo -66.69 -21.75 51.27 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.526 2.151 . . . . 50.0 110.874 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 5.2 mt-30 -60.17 -41.12 92.15 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.532 -0.73 . . . . 25.0 109.143 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -55.17 -55.73 27.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 50.0 109.463 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -44.68 -35.22 2.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.797 . . . . 50.0 109.599 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 6' ' ' GLN . . . -57.59 -45.28 85.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 16.66 108.963 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 14' ' ' ILE . 63.6 mt-10 -67.52 -42.92 82.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.507 -0.746 . . . . 16.66 109.056 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.587 ' NH2' HG23 ' A' ' 67' ' ' THR . 18.2 mtm180 -65.73 -39.19 90.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.506 -0.746 . . . . 50.0 109.421 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.598 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 77.7 mt-10 -66.76 -41.36 87.88 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.386 -0.821 . . . . 50.0 109.525 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mtp180 -66.9 -40.7 87.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.339 -0.85 . . . . 50.0 109.234 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.5 mt -70.37 -45.11 76.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.358 -0.839 . . . . 50.0 109.029 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -64.98 -35.8 82.34 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.227 -0.92 . . . . 16.66 109.112 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -65.99 -30.37 70.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 50.0 109.268 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 59.1 mtt85 -71.36 -35.08 71.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -0.912 . . . . 50.0 108.974 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.004 ' HB3' HD13 ' A' ' 26' ' ' ILE . 35.8 m-85 -67.56 -49.77 61.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 16.66 109.299 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.463 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 21.5 t0 -56.02 103.11 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.87 . . . . 16.66 108.804 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.05 -51.07 59.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.951 . . . . 50.0 111.028 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -87.78 -31.17 19.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.756 -1.215 . . . . 16.66 109.633 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.463 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 94.7 34.92 6.06 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.795 -1.193 . . . . 16.66 110.385 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.502 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 41.3 p-10 -89.85 5.5 45.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.003 -1.292 . . . . 16.66 109.258 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.85 -4.91 79.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.282 -1.127 . . . . 16.66 110.282 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HB2' ' CB ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -131.08 142.51 50.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.921 -1.341 . . . . 50.0 109.931 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.004 HD13 ' HB3' ' A' ' 18' ' ' PHE . 7.5 mt -111.34 134.56 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.523 -0.735 . . . . 16.66 109.497 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.435 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 11.5 p -107.67 166.71 10.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.725 -0.842 . . . . 50.0 108.725 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.515 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -49.93 -45.56 51.27 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.048 -1.032 . . . . 50.0 108.799 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.29 76.33 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.205 -0.934 . . . . 50.0 109.493 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.1 mt-10 -75.9 -54.48 6.83 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.152 -0.968 . . . . 16.66 109.354 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.684 ' HG ' HD12 ' A' ' 35' ' ' LEU . 9.6 tp -62.15 -42.44 99.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 16.66 108.817 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -64.2 -45.89 92.41 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.841 -1.704 . . . . 16.66 108.841 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.88 -44.27 78.0 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.394 -1.063 . . . . 50.0 109.375 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.11 -39.9 63.06 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.112 -1.07 . . . . 50.0 108.112 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.002 HD13 HG22 ' A' ' 46' ' ' VAL . 6.5 mt -59.55 -29.86 68.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.527 -0.733 . . . . 99.99 109.548 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -45.25 -24.4 0.27 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 99.99 109.652 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.633 HG21 HG21 ' A' ' 83' ' ' ILE . 9.3 t -51.69 -24.39 5.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.215 -0.928 . . . . 99.99 109.204 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.49 HD11 ' CD2' ' A' ' 35' ' ' LEU . 6.4 mt -62.57 -45.88 90.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.39 -0.819 . . . . 50.0 109.266 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.06 -34.53 3.74 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.746 -1.342 . . . . 16.66 109.746 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.7 p -116.79 52.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -1.188 . . . . 16.66 109.598 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 41' ' ' ILE . 7.4 tp -126.68 164.31 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 50.0 109.501 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.69 163.47 23.95 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.523 -0.917 . . . . 16.66 108.523 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.0 -34.13 23.98 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.941 1.761 . . . . 50.0 110.181 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.28 -20.19 63.91 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.658 -0.651 . . . . 50.0 110.399 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -83.08 -40.64 19.58 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.729 -1.232 . . . . 16.66 108.562 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.002 HG22 HD13 ' A' ' 35' ' ' LEU . 41.8 t -65.2 -36.98 79.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.764 -0.828 . . . . 50.0 108.764 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -68.31 -39.7 81.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.793 -0.817 . . . . 50.0 108.793 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.499 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.2 t60 -66.13 -40.23 90.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.423 -0.798 . . . . 50.0 109.056 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.447 ' CE ' HD11 ' A' ' 35' ' ' LEU . 15.5 mtm -59.44 -44.74 92.86 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.265 -0.897 . . . . 16.66 108.877 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 28' ' ' ALA . 31.1 mtp -62.51 -47.37 84.25 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.585 -0.697 . . . . 50.0 109.197 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.25 -20.1 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 50.0 108.915 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.27 -35.55 11.76 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.986 -0.746 . . . . 16.66 108.986 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.588 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.4 mt -81.89 -31.05 10.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.53 -0.731 . . . . 50.0 109.501 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 50' ' ' MET . 17.3 t0 -61.93 101.09 0.18 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.442 -0.786 . . . . 16.66 109.172 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 28.3 p -68.46 -43.42 77.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 50.0 110.426 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.1 p-10 -89.85 -46.86 8.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 16.66 109.821 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 108.81 31.71 3.31 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.935 -1.266 . . . . 16.66 109.935 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.478 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.7 p-10 -82.69 -5.24 58.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.027 -1.278 . . . . 50.0 109.057 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 100.08 -0.3 56.13 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.724 -1.35 . . . . 16.66 109.724 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.529 ' CB ' ' HB2' ' A' ' 25' ' ' LYS . 41.3 m-85 -139.28 156.07 47.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.996 -1.297 . . . . 50.0 111.482 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.55 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 31.4 mm -109.08 129.23 64.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.147 -1.057 . . . . 16.66 108.147 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.1 167.32 10.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.991 -1.068 . . . . 16.66 108.72 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 37.9 t80 -53.35 -42.67 67.05 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.077 -1.049 . . . . 16.66 108.473 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -59.42 -50.66 73.08 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.107 -0.701 . . . . 50.0 109.107 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 80.2 mt-10 -60.28 -46.38 90.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.354 -0.841 . . . . 16.66 109.023 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.545 ' CE2' HD11 ' A' ' 77' ' ' LEU . 80.3 t80 -64.66 -35.77 82.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 16.66 109.479 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.587 HG23 ' NH2' ' A' ' 11' ' ' ARG . 21.0 m -67.51 -48.95 65.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.394 -0.816 . . . . 50.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.424 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 77.1 m-20 -62.02 -36.07 80.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -0.901 . . . . 50.0 109.339 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.588 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -74.61 -39.57 62.08 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.669 -0.863 . . . . 50.0 108.669 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.476 ' N ' ' CD1' ' A' ' 69' ' ' PHE . . . -59.33 -29.05 65.44 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.423 -1.471 . . . . 16.66 109.423 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 67' ' ' THR . 62.6 mtm180 -71.83 -32.28 67.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -1.115 . . . . 50.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.38 -21.08 62.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.34 -0.85 . . . . 50.0 109.343 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.882 ' CB ' HD12 ' A' ' 76' ' ' LEU . 31.8 m-80 -140.92 61.02 1.51 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.406 -0.809 . . . . 50.0 109.131 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -52.64 -42.88 65.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.67 -0.863 . . . . 50.0 108.67 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.19 -22.58 29.83 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.352 -1.499 . . . . 25.0 109.352 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.882 HD12 ' CB ' ' A' ' 73' ' ' ASN . 47.2 mt -79.97 -43.56 21.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -1.124 . . . . 50.0 109.336 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 1.1 mm? -61.19 -36.98 81.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.455 -0.778 . . . . 50.0 109.578 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.6 mtmm -73.81 -28.14 61.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.258 -0.901 . . . . 50.0 109.026 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -80.21 -45.3 18.26 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.37 -0.831 . . . . 50.0 109.105 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 76' ' ' LEU . 46.5 t -68.56 -41.32 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 50.0 109.376 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.4 -46.91 63.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 50.0 109.425 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 22.7 mttm -59.64 -29.25 67.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.345 -0.847 . . . . 50.0 109.34 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 37' ' ' THR . 59.5 mt -66.73 -35.97 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 50.0 109.394 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 12.5 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.962 -1.018 . . . . 99.99 109.503 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.48 -28.91 68.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -76.06 137.81 40.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 25.0 109.58 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -119.29 169.46 8.15 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 50.0 109.57 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 45.8 Cg_endo -68.54 -22.45 38.39 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.56 2.174 . . . . 50.0 110.833 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 16.3 mt-30 -61.29 -37.45 83.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.145 -0.687 . . . . 25.0 109.145 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -52.97 -52.38 58.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.401 -0.812 . . . . 50.0 109.369 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -49.15 -35.78 17.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 50.0 109.293 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 6' ' ' GLN . . . -53.44 -43.11 67.78 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.572 -0.899 . . . . 16.66 108.572 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.4 mt-10 -68.51 -39.8 81.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.012 -0.736 . . . . 16.66 109.012 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.5 mtt-85 -67.33 -41.24 85.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.452 -0.78 . . . . 50.0 109.38 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.608 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 60.8 mt-10 -65.07 -39.91 93.91 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.567 -0.708 . . . . 50.0 109.311 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 24.3 mtp180 -67.63 -40.37 84.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.451 -0.781 . . . . 50.0 109.187 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 10' ' ' GLU . 24.6 mt -70.54 -45.62 73.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.365 -0.834 . . . . 50.0 109.015 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -64.87 -35.97 82.85 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.295 -0.878 . . . . 16.66 108.975 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 46.1 mttt -65.81 -30.3 70.91 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.324 -0.86 . . . . 50.0 108.983 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 32.7 mtt180 -70.06 -36.09 74.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.831 . . . . 50.0 108.903 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.916 ' HB3' HD13 ' A' ' 26' ' ' ILE . 48.3 m-85 -70.38 -51.41 29.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.438 -0.789 . . . . 16.66 109.487 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.8 t0 -56.12 103.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 16.66 108.747 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.42 -52.07 50.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 50.0 111.278 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -87.34 -23.46 24.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.725 -1.235 . . . . 16.66 109.722 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 83.95 41.59 8.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.084 -1.206 . . . . 16.66 110.084 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.506 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 36.5 p-10 -96.17 5.38 51.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.129 -1.218 . . . . 16.66 109.122 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.06 -9.68 70.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.569 -1.012 . . . . 16.66 110.569 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.588 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.1 pttm -129.65 142.01 50.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.853 -1.381 . . . . 50.0 110.162 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.916 HD13 ' HB3' ' A' ' 18' ' ' PHE . 9.7 mt -112.78 133.6 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.736 -0.602 . . . . 16.66 109.457 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.408 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 23.3 p -106.12 168.95 8.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.332 -0.855 . . . . 50.0 108.912 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.488 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.27 -46.56 55.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.076 -1.015 . . . . 50.0 109.047 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.5 74.34 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.274 -0.891 . . . . 50.0 109.543 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.2 mt-10 -75.96 -54.03 7.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.137 -0.977 . . . . 16.66 109.269 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.605 ' O ' HD23 ' A' ' 31' ' ' LEU . 6.9 tt -61.44 -44.84 96.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.253 -0.904 . . . . 16.66 108.969 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.676 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -61.87 -43.79 98.72 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.113 -1.595 . . . . 16.66 109.113 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -56.3 -44.19 79.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -1.096 . . . . 50.0 109.766 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.15 75.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.173 -0.954 . . . . 50.0 108.572 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.986 ' CD1' HG22 ' A' ' 46' ' ' VAL . 9.6 mt -59.02 -35.06 72.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.505 -0.747 . . . . 99.99 109.929 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.6 mttm -43.86 -27.41 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.135 -0.978 . . . . 99.99 109.535 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.699 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.3 t -53.68 -26.51 23.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 99.99 109.407 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.5 mt -63.94 -33.76 76.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 50.0 109.32 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.43 6.84 50.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.573 -1.411 . . . . 16.66 109.573 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.8 t -154.3 50.77 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.045 -1.268 . . . . 16.66 109.653 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 tp -136.49 154.12 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 50.0 109.243 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.43 165.83 12.86 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 16.66 108.697 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.19 -32.64 20.51 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.058 1.838 . . . . 50.0 109.989 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -62.68 -27.74 69.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.661 -0.649 . . . . 50.0 110.052 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -80.75 -36.56 31.81 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.973 -1.079 . . . . 16.66 108.36 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.986 HG22 ' CD1' ' A' ' 35' ' ' LEU . 74.8 t -64.33 -38.6 82.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.689 -0.856 . . . . 50.0 108.689 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -72.44 -36.75 68.63 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.41 -0.959 . . . . 50.0 108.41 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.471 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 4.0 t60 -67.71 -37.18 81.9 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.939 -0.763 . . . . 50.0 108.939 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.416 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.7 mtt -60.29 -48.23 82.64 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.228 -0.92 . . . . 16.66 108.58 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.518 ' HE1' ' HA ' ' A' ' 60' ' ' PHE . 42.2 mtp -61.61 -48.29 81.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.922 -0.77 . . . . 50.0 108.922 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.72 -19.73 18.24 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.445 -0.784 . . . . 50.0 109.193 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.409 ' OE2' ' NE2' ' A' ' 48' ' ' HIS . 37.6 mt-10 -100.46 -37.03 9.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.89 . . . . 16.66 109.317 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.536 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.8 mt -80.29 -34.02 14.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.392 -0.818 . . . . 50.0 109.563 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.0 t0 -58.77 101.52 0.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.455 -0.778 . . . . 16.66 109.005 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 71.1 p -70.02 -47.67 61.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.829 . . . . 50.0 110.922 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.481 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 3.6 p-10 -86.95 -37.42 17.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.134 -0.979 . . . . 16.66 109.544 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.56 27.97 7.32 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.834 -1.174 . . . . 16.66 110.771 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.481 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 15.6 p-10 -79.58 -2.1 40.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.811 -1.405 . . . . 50.0 109.11 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.46 -6.26 59.16 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.981 -1.248 . . . . 16.66 109.981 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.588 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 28.4 m-85 -133.84 156.16 48.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.003 -1.293 . . . . 50.0 111.373 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.554 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 27.3 mm -107.99 129.97 61.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.217 -1.031 . . . . 16.66 108.217 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.8 m -96.93 167.13 11.27 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.051 -1.03 . . . . 16.66 108.636 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.608 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 36.2 t80 -54.4 -42.29 70.25 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.077 -1.014 . . . . 16.66 108.523 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -61.21 -47.94 83.79 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.515 -0.741 . . . . 50.0 109.286 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 68.1 mt-10 -60.68 -46.85 88.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.254 -0.904 . . . . 16.66 108.943 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.45 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 57.3 t80 -59.54 -40.88 88.69 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.491 -0.755 . . . . 16.66 109.147 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.7 m -64.17 -46.51 83.68 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.468 -0.77 . . . . 50.0 109.159 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.59 -39.63 80.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 50.0 109.344 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -79.95 -36.37 36.32 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.486 -0.931 . . . . 50.0 108.486 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.655 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.4 -31.55 74.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.083 -1.607 . . . . 16.66 109.083 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' THR . 64.4 mtm180 -70.34 -35.23 73.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.416 -1.049 . . . . 50.0 109.057 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.68 -2.55 50.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.394 -0.816 . . . . 50.0 109.455 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.775 ' HB3' HD22 ' A' ' 76' ' ' LEU . 69.4 m-80 -149.22 46.88 0.98 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.235 -0.916 . . . . 50.0 108.873 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -56.31 -48.51 76.54 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.521 -0.918 . . . . 50.0 108.521 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.24 -24.6 29.91 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.057 -1.617 . . . . 25.0 109.057 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.775 HD22 ' HB3' ' A' ' 73' ' ' ASN . 6.5 mp -79.7 -45.12 19.56 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.335 -1.097 . . . . 50.0 109.326 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.655 HD11 ' HA3' ' A' ' 70' ' ' GLY . 20.9 mt -62.67 -36.61 83.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.804 . . . . 50.0 109.845 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -67.13 -21.23 65.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 50.0 109.607 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.97 -34.55 29.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 50.0 109.476 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.478 ' HA ' HG13 ' A' ' 83' ' ' ILE . 25.1 t -78.39 -33.13 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 50.0 109.743 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.41 -46.46 62.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 50.0 110.128 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -63.91 -24.55 67.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 50.0 109.576 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.699 HG21 ' CG2' ' A' ' 37' ' ' THR . 8.5 mt -66.31 -47.55 83.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.343 -0.848 . . . . 50.0 109.673 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.017 -0.992 . . . . 99.99 109.446 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 57.1 p-10 -87.74 14.87 7.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -69.35 146.88 51.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.246 -0.909 . . . . 25.0 109.597 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.613 ' CG ' ' HD2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -110.54 153.09 43.69 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.285 -0.885 . . . . 50.0 108.846 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HD2' ' CG ' ' A' ' 4' ' ' HIS . 40.1 Cg_endo -64.23 -19.65 66.09 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.089 1.859 . . . . 50.0 110.364 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -59.71 -39.04 83.29 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.099 -0.704 . . . . 25.0 109.099 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.32 -42.04 94.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.463 -0.773 . . . . 50.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -52.6 -37.4 58.12 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.383 -0.823 . . . . 50.0 109.274 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.12 -45.13 87.82 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.32 -0.863 . . . . 16.66 108.701 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.4 mt-10 -66.61 -45.81 77.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.818 -0.808 . . . . 16.66 108.818 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.467 ' NH2' ' CG ' ' A' ' 71' ' ' ARG . 13.7 mtt-85 -64.13 -39.37 93.89 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.447 -0.783 . . . . 50.0 109.336 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.601 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 15.9 mt-10 -65.76 -41.16 92.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.555 -0.716 . . . . 50.0 109.104 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 14.7 mtp180 -67.33 -40.55 85.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 50.0 109.014 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 10' ' ' GLU . 29.1 mt -70.12 -45.94 74.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.454 -0.779 . . . . 50.0 108.942 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -66.05 -35.99 82.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.376 -0.827 . . . . 16.66 109.119 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 21.8 mttt -64.48 -31.28 72.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 50.0 109.19 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 40.7 mtt180 -73.29 -33.15 65.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 50.0 109.222 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.993 ' HB3' HD13 ' A' ' 26' ' ' ILE . 37.5 m-85 -71.37 -45.11 63.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 16.66 109.29 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.8 t0 -63.09 103.16 0.44 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.252 -0.905 . . . . 16.66 108.798 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -52.05 60.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.227 -0.921 . . . . 50.0 111.247 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -88.1 -22.44 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.737 -1.227 . . . . 16.66 109.577 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.461 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 82.8 42.76 8.06 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.236 -1.146 . . . . 16.66 110.236 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.513 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.4 p-10 -97.63 5.93 48.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.126 -1.22 . . . . 16.66 109.269 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 62' ' ' SER . . . 94.87 -10.11 70.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.517 -1.033 . . . . 16.66 110.517 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 14.2 pttp -128.62 141.38 51.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.825 -1.397 . . . . 50.0 110.031 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.993 HD13 ' HB3' ' A' ' 18' ' ' PHE . 4.9 mt -113.53 134.55 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.662 -0.649 . . . . 16.66 109.365 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.441 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 26.6 p -108.03 169.65 8.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.395 -0.816 . . . . 50.0 108.895 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.7 -47.77 58.89 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.113 -0.992 . . . . 50.0 109.023 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.36 68.99 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.372 -0.83 . . . . 50.0 109.683 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 55.2 mt-10 -79.07 -53.44 7.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 16.66 109.298 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 31' ' ' LEU . 4.6 tt -62.1 -42.28 99.06 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.291 -0.881 . . . . 16.66 108.83 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.91 -45.7 93.44 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.023 -1.631 . . . . 16.66 109.023 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -56.03 -43.06 77.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -1.1 . . . . 50.0 109.395 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.66 -39.9 66.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.292 -1.003 . . . . 50.0 108.292 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.902 ' CD1' HG22 ' A' ' 46' ' ' VAL . 2.2 mt -59.15 -33.53 71.0 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.605 -0.684 . . . . 99.99 109.625 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -44.16 -26.43 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.1 -1.0 . . . . 99.99 109.551 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.74 ' CG2' HG21 ' A' ' 83' ' ' ILE . 8.0 t -48.87 -24.39 1.44 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.217 -0.927 . . . . 99.99 109.064 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.79 HD12 HD12 ' A' ' 41' ' ' ILE . 21.1 mt -66.63 -31.2 71.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.477 -0.764 . . . . 50.0 109.163 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.51 9.37 43.66 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.436 -1.466 . . . . 16.66 109.436 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' A' ' 40' ' ' SER . 9.7 t -156.07 49.15 0.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -1.143 . . . . 16.66 109.587 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.79 HD12 HD12 ' A' ' 38' ' ' LEU . 12.4 tt -137.32 169.41 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.257 -0.902 . . . . 50.0 109.475 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.95 166.66 16.98 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.92 . . . . 16.66 109.051 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.69 -32.65 18.41 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.175 1.916 . . . . 50.0 110.189 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -61.63 -29.05 69.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.648 -0.658 . . . . 50.0 110.016 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -81.43 -36.89 28.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.926 -1.109 . . . . 16.66 108.193 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.902 HG22 ' CD1' ' A' ' 35' ' ' LEU . 55.9 t -65.21 -34.7 72.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.968 -0.753 . . . . 50.0 108.968 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -69.45 -38.39 77.77 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.908 -0.775 . . . . 50.0 108.908 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -68.49 -38.5 81.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.462 -0.774 . . . . 50.0 108.933 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 mtt -62.25 -47.79 82.81 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.306 -0.871 . . . . 16.66 108.792 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.693 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 27.2 mtp -61.62 -46.55 89.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.449 -0.782 . . . . 50.0 109.159 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.24 -19.65 55.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 50.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.61 -35.63 12.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.355 -0.841 . . . . 16.66 108.879 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.631 HG22 HD12 ' A' ' 61' ' ' ILE . 81.8 mt -82.42 -30.92 9.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.561 -0.712 . . . . 50.0 109.669 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.6 t0 -59.67 101.35 0.11 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.38 -0.825 . . . . 16.66 109.064 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 71.0 p -72.82 -47.18 48.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -0.89 . . . . 50.0 110.543 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -29.97 24.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.181 -0.949 . . . . 16.66 109.514 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.484 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 92.02 28.19 14.28 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.893 -1.146 . . . . 16.66 110.35 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.14 -3.22 57.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.963 -1.316 . . . . 50.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.693 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.52 -7.29 59.6 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.962 -1.113 . . . . 16.66 110.526 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.573 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.6 m-85 -133.02 155.25 49.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.002 -1.293 . . . . 50.0 111.025 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.631 HD12 HG22 ' A' ' 53' ' ' ILE . 34.0 mm -106.24 128.09 60.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.333 -0.988 . . . . 16.66 108.333 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 18.0 m -94.16 166.11 12.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.235 -0.916 . . . . 16.66 108.602 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 34.5 t80 -54.48 -42.37 70.63 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.071 -1.018 . . . . 16.66 108.558 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -61.11 -49.47 77.14 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.098 -0.704 . . . . 50.0 109.098 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.539 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 28.8 mt-10 -58.1 -47.27 83.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 16.66 109.09 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.799 ' CE2' HD11 ' A' ' 77' ' ' LEU . 61.3 t80 -62.08 -40.47 95.94 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.531 -0.731 . . . . 16.66 109.305 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 16.3 m -64.33 -47.32 79.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.353 -0.842 . . . . 50.0 109.099 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.489 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 87.8 m-20 -59.31 -37.77 78.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 50.0 109.424 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.569 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.51 -36.76 57.58 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.529 -0.915 . . . . 50.0 108.529 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.13 -30.84 64.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.303 -1.519 . . . . 16.66 109.303 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 68' ' ' ASP . 72.3 mtm180 -69.26 -30.43 68.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -1.108 . . . . 50.0 109.071 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.22 -21.7 64.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -0.809 . . . . 50.0 109.286 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.898 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.1 m-80 -149.97 60.12 0.99 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.354 -0.841 . . . . 50.0 108.957 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -50.68 -38.61 47.68 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.737 -0.838 . . . . 50.0 108.737 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.24 -32.29 67.42 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.251 -1.54 . . . . 25.0 109.251 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.898 HD12 ' CB ' ' A' ' 73' ' ' ASN . 28.2 mt -64.46 -43.8 93.1 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.316 -1.108 . . . . 50.0 109.366 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.799 HD11 ' CE2' ' A' ' 66' ' ' PHE . 1.9 mm? -61.41 -41.91 97.9 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.426 -0.796 . . . . 50.0 109.679 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 19.2 mtmm -65.13 -27.66 68.89 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.263 -0.898 . . . . 50.0 109.512 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.66 -50.29 7.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.92 . . . . 50.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.6 p -64.33 -44.5 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.468 -0.77 . . . . 50.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.542 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -48.82 -40.48 29.44 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.54 -0.725 . . . . 50.0 109.385 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 27.2 mttp -65.47 -26.47 67.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 50.0 109.563 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.74 HG21 ' CG2' ' A' ' 37' ' ' THR . 35.0 mt -62.22 -32.7 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 50.0 109.423 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 5.1 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.001 -0.999 . . . . 99.99 109.488 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.354 0.597 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -76.34 -26.93 56.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 0.0 109.635 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -80.24 118.15 21.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 25.0 109.583 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.493 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -108.77 170.73 5.13 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.268 -0.895 . . . . 50.0 109.391 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 45.5 Cg_endo -67.7 -23.55 42.18 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.59 2.193 . . . . 50.0 111.263 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.494 ' NE2' ' HA ' ' A' ' 6' ' ' GLN . 14.5 mm-40 -63.18 -41.17 99.17 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.362 -0.836 . . . . 25.0 109.162 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -57.39 -43.03 83.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 50.0 109.341 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -51.52 -36.54 45.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 50.0 109.455 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.88 -46.17 88.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.277 -0.89 . . . . 16.66 108.665 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 14' ' ' ILE . 67.9 mm-40 -66.5 -43.95 83.9 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.389 -0.819 . . . . 16.66 108.867 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.405 ' HA ' HD12 ' A' ' 14' ' ' ILE . 30.4 mtt-85 -64.5 -39.52 93.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.413 -0.804 . . . . 50.0 109.493 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 13.8 mt-10 -64.06 -40.0 95.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 50.0 109.416 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 21.1 mtp-105 -70.06 -38.22 75.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 50.0 109.034 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.5 mt -71.54 -44.91 70.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.371 -0.831 . . . . 50.0 108.888 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.533 ' CE1' HD11 ' A' ' 26' ' ' ILE . 69.6 t80 -69.23 -36.19 76.93 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.231 -0.918 . . . . 16.66 109.159 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 37.4 mttt -64.99 -30.53 71.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 50.0 109.027 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 65.8 mmt-85 -70.65 -39.14 73.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.365 -0.834 . . . . 50.0 109.005 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.902 ' HB3' HD13 ' A' ' 26' ' ' ILE . 43.6 m-85 -66.21 -47.73 72.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.832 . . . . 16.66 109.344 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 20.4 t0 -60.08 103.15 0.2 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 16.66 108.73 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 -50.6 40.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 50.0 111.092 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -87.3 -30.54 20.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.808 -1.182 . . . . 16.66 109.671 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.27 33.41 7.24 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.069 -1.213 . . . . 16.66 110.069 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.499 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 34.8 p-10 -86.76 5.42 36.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.266 . . . . 16.66 109.115 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.95 -3.93 77.79 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.374 -1.09 . . . . 16.66 110.374 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.578 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 3.7 pttm -133.67 143.99 48.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.948 -1.325 . . . . 50.0 110.244 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.902 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.3 mt -110.43 132.67 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.459 0.647 . . . . 16.66 109.752 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.448 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 13.0 p -106.56 166.48 10.53 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.917 -0.772 . . . . 50.0 108.917 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.08 -44.98 52.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.124 -0.985 . . . . 50.0 109.032 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -57.19 -39.9 76.31 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.358 -0.838 . . . . 50.0 109.541 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.5 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 60.5 mt-10 -75.7 -54.28 7.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.214 -0.929 . . . . 16.66 109.248 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.761 HD22 HG13 ' A' ' 46' ' ' VAL . 6.3 tt -61.78 -43.66 98.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.13 -0.981 . . . . 16.66 108.853 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.707 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -63.76 -44.79 95.75 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.009 -1.636 . . . . 16.66 109.009 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 30.1 mt-10 -58.45 -42.23 86.93 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.474 -1.015 . . . . 50.0 109.661 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.55 -39.72 67.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.322 -0.992 . . . . 50.0 108.322 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.922 HD12 HG22 ' A' ' 46' ' ' VAL . 3.3 mt -58.23 -31.82 67.73 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.519 -0.738 . . . . 99.99 109.544 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -45.15 -25.81 0.4 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 99.99 109.479 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.617 HG21 HG21 ' A' ' 83' ' ' ILE . 11.6 t -52.94 -26.29 14.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 99.99 109.374 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 38' ' ' LEU . 26.5 mt -65.35 -29.99 70.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -0.836 . . . . 50.0 109.237 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.66 9.0 42.94 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.734 -1.346 . . . . 16.66 109.734 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.5 49.6 0.54 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.089 -1.242 . . . . 16.66 109.811 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 41' ' ' ILE . 6.9 tp -133.31 165.36 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.251 -0.905 . . . . 50.0 109.344 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.87 164.67 16.83 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.168 -0.957 . . . . 16.66 108.741 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.65 -33.72 21.0 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.062 1.841 . . . . 50.0 110.012 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -64.12 -26.0 68.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.592 -0.692 . . . . 50.0 109.955 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.42 -38.62 26.21 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.821 -1.175 . . . . 16.66 108.401 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.922 HG22 HD12 ' A' ' 35' ' ' LEU . 61.7 t -63.93 -36.53 77.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.765 -0.828 . . . . 50.0 108.765 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -73.04 -37.52 66.85 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.413 -0.958 . . . . 50.0 108.413 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -68.02 -38.58 82.75 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.922 -0.769 . . . . 50.0 108.922 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.2 mtt -60.88 -47.45 86.34 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.241 -0.912 . . . . 16.66 108.635 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.591 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 50.6 mtp -60.93 -46.15 91.85 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.141 -0.688 . . . . 50.0 109.141 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.72 -21.01 53.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 50.0 109.194 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -95.89 -36.48 11.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 16.66 109.126 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.644 HG22 HD12 ' A' ' 61' ' ' ILE . 83.4 mt -80.86 -32.39 12.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.534 -0.729 . . . . 50.0 109.536 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 50' ' ' MET . 22.7 t0 -60.41 100.5 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.354 -0.841 . . . . 16.66 109.053 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.462 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 56.6 p -68.04 -46.44 71.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.307 -0.871 . . . . 50.0 110.616 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 1.7 p-10 -86.37 -37.97 17.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 16.66 109.44 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 100.36 27.03 7.88 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 120.037 -1.078 . . . . 16.66 110.555 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.499 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 7.9 p-10 -78.41 -1.58 34.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.743 -1.446 . . . . 50.0 109.051 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.591 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 98.52 -4.82 60.1 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.123 -1.191 . . . . 16.66 110.123 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 24.9 m-85 -135.68 157.55 46.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.033 -1.275 . . . . 50.0 111.482 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.644 HD12 HG22 ' A' ' 53' ' ' ILE . 31.5 mm -109.04 129.65 63.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.504 -0.924 . . . . 16.66 108.504 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.2 m -96.42 170.26 9.35 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.095 -1.003 . . . . 16.66 108.637 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 36.1 t80 -56.42 -43.97 79.93 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.133 -0.979 . . . . 16.66 108.694 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -60.44 -49.4 77.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.531 -0.731 . . . . 50.0 109.154 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.563 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.9 mt-10 -58.45 -46.07 87.31 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.267 -0.896 . . . . 16.66 109.219 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -63.52 -35.37 80.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 16.66 109.331 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 31.6 m -66.21 -48.41 70.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.444 -0.785 . . . . 50.0 109.279 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.57 -36.26 75.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.356 -0.84 . . . . 50.0 109.394 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -77.95 -37.14 48.22 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.433 -0.951 . . . . 50.0 108.433 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.695 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -56.46 -27.92 54.75 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.994 -1.643 . . . . 16.66 108.994 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 67' ' ' THR . 82.1 mtm180 -71.49 -27.34 63.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -1.135 . . . . 50.0 108.806 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.19 60.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.441 -0.787 . . . . 50.0 109.291 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.89 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.4 m-80 -144.49 59.83 1.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.356 -0.84 . . . . 50.0 109.248 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.602 ' HA ' HD23 ' A' ' 77' ' ' LEU . 97.3 mtt180 -52.57 -21.63 4.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 50.0 109.123 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.8 -26.74 60.03 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.36 -1.496 . . . . 25.0 109.36 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.89 HD12 ' CB ' ' A' ' 73' ' ' ASN . 72.1 mt -73.06 -45.02 59.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -1.099 . . . . 50.0 109.618 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -64.41 -42.94 95.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.376 -0.828 . . . . 50.0 109.806 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.9 mtmt -65.37 -34.12 77.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 50.0 109.484 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -79.32 -46.46 17.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 50.0 109.498 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.8 p -64.18 -43.89 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 50.0 109.192 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.548 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -50.08 -37.92 35.89 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.733 -0.604 . . . . 50.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 61.2 mttp -70.65 -26.43 63.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 50.0 109.413 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.617 HG21 HG21 ' A' ' 37' ' ' THR . 28.3 mt -62.78 -31.23 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 50.0 109.237 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 5.6 m-85 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.965 -1.017 . . . . 99.99 109.474 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -53.49 -26.58 21.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.513 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 3' ' ' ASP . 48.5 p30 -81.94 164.0 21.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 25.0 109.51 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -104.05 174.08 2.98 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 50.0 109.176 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.5 Cg_endo -69.16 -22.71 34.42 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.468 2.112 . . . . 50.0 111.218 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -62.33 -37.35 85.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -0.782 . . . . 25.0 109.363 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 8' ' ' LYS . 81.3 m-20 -57.32 -55.57 33.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.393 -0.817 . . . . 50.0 109.627 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 16.2 mttt -43.35 -35.91 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.442 -0.786 . . . . 50.0 109.78 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 12' ' ' GLU . . . -60.9 -45.87 92.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 16.66 109.058 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 73.6 mt-10 -70.67 -34.84 72.44 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.383 -0.823 . . . . 16.66 108.822 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.718 ' NH1' HG23 ' A' ' 67' ' ' THR . 70.3 mtm180 -72.31 -40.65 67.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.364 -0.835 . . . . 50.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.568 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 24.6 pt-20 -68.95 -38.34 79.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.291 -0.881 . . . . 50.0 109.184 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.541 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.4 mtp180 -66.8 -41.83 86.95 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.889 . . . . 50.0 109.303 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.481 HG22 ' HE2' ' A' ' 18' ' ' PHE . 27.4 mt -69.97 -46.01 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.278 -0.889 . . . . 50.0 109.032 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -64.62 -35.17 80.13 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.349 -0.844 . . . . 16.66 109.209 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 51.2 mttt -65.78 -31.72 72.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 50.0 109.385 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 65.7 mtt180 -70.68 -36.11 73.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 50.0 109.163 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.951 ' HB3' HD13 ' A' ' 26' ' ' ILE . 43.1 m-85 -66.04 -47.31 74.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.395 -0.816 . . . . 16.66 109.375 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.3 t0 -59.79 103.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.279 -0.888 . . . . 16.66 108.848 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.75 -51.67 53.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.179 -0.951 . . . . 50.0 111.191 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -86.59 -28.39 23.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.718 -1.239 . . . . 16.66 109.672 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 90.53 39.14 6.01 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.89 -1.148 . . . . 16.66 110.373 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.503 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.7 p-10 -95.02 5.63 51.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -1.221 . . . . 16.66 109.291 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.59 -8.1 77.09 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.486 -1.046 . . . . 16.66 110.486 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HE3' ' CE1' ' A' ' 60' ' ' PHE . 14.1 pttt -128.54 141.35 51.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.95 -1.324 . . . . 50.0 109.929 -179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.951 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.6 mt -112.59 133.19 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.655 -0.653 . . . . 16.66 109.528 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 p -103.59 166.18 10.58 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.618 -0.882 . . . . 50.0 108.618 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.18 -44.39 52.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.062 -1.024 . . . . 50.0 108.81 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.54 82.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.354 -0.841 . . . . 50.0 109.419 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 57.8 mt-10 -74.25 -54.73 7.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -0.932 . . . . 16.66 109.275 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.666 ' HG ' HD12 ' A' ' 35' ' ' LEU . 40.1 tp -61.92 -43.63 98.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.181 -0.95 . . . . 16.66 108.929 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.48 -43.82 98.48 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.084 -1.606 . . . . 16.66 109.084 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -56.49 -44.0 80.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.285 -1.127 . . . . 50.0 109.531 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.72 -39.4 66.96 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.364 -0.976 . . . . 50.0 108.364 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.115 HD13 HG22 ' A' ' 46' ' ' VAL . 6.9 mt -59.66 -32.61 70.62 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.532 -0.73 . . . . 99.99 109.522 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.6 -24.4 0.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 99.99 109.532 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.7 t -52.93 -23.78 7.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.183 -0.948 . . . . 99.99 109.151 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.832 HD12 HD12 ' A' ' 41' ' ' ILE . 25.5 mt -62.77 -31.81 72.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.42 -0.8 . . . . 50.0 109.343 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.69 6.58 51.17 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 16.66 109.564 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.24 55.15 0.64 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.183 -1.186 . . . . 16.66 109.521 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.832 HD12 HD12 ' A' ' 38' ' ' LEU . 12.0 tt -140.53 171.33 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 50.0 109.526 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.52 165.2 27.9 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.714 -0.847 . . . . 16.66 108.714 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.82 -33.47 20.54 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.052 1.834 . . . . 50.0 110.232 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -64.97 -25.3 67.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.708 -0.62 . . . . 50.0 110.149 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.441 ' OE1' HG13 ' A' ' 41' ' ' ILE . 94.0 mt-10 -82.59 -38.61 23.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.888 -1.132 . . . . 16.66 108.344 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.115 HG22 HD13 ' A' ' 35' ' ' LEU . 41.4 t -65.76 -36.12 76.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.824 -0.806 . . . . 50.0 108.824 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -66.24 -39.14 89.31 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.973 -0.751 . . . . 50.0 108.973 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.536 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 3.4 t60 -66.92 -41.24 87.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.412 -0.805 . . . . 50.0 109.135 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.492 ' HE3' HD11 ' A' ' 35' ' ' LEU . 48.0 mtm -60.17 -44.92 94.65 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.241 -0.912 . . . . 16.66 108.923 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.529 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 20.1 mtp -61.98 -47.17 86.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.528 -0.733 . . . . 50.0 109.231 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.33 -19.13 54.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 50.0 109.068 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.536 ' CD ' ' HE2' ' A' ' 48' ' ' HIS . 35.8 mt-10 -95.92 -36.72 10.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 16.66 108.975 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.59 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.7 mt -81.33 -32.41 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.476 -0.765 . . . . 50.0 109.482 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 50' ' ' MET . 20.9 t0 -60.66 100.49 0.11 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.399 -0.813 . . . . 16.66 108.905 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.444 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 71.0 p -66.81 -46.89 73.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.324 -0.86 . . . . 50.0 110.771 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.9 p-10 -87.94 -40.81 13.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.178 -0.951 . . . . 16.66 109.559 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.474 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 103.32 28.99 5.86 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.919 -1.134 . . . . 16.66 110.314 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.478 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.6 p-10 -79.8 -2.79 44.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.862 -1.375 . . . . 50.0 109.135 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.529 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 99.7 -3.96 57.73 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.783 -1.327 . . . . 16.66 109.783 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CE1' ' HE3' ' A' ' 25' ' ' LYS . 32.4 m-85 -135.91 156.1 49.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.077 -1.249 . . . . 50.0 111.279 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.551 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 29.4 mm -108.89 130.99 60.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.463 -0.94 . . . . 16.66 108.463 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 m -99.58 168.02 10.22 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.988 -1.07 . . . . 16.66 108.775 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.568 ' CE1' ' HA ' ' A' ' 12' ' ' GLU . 36.1 t80 -54.88 -43.73 73.44 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.247 -0.981 . . . . 16.66 108.673 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -59.83 -49.81 76.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.568 -0.707 . . . . 50.0 109.115 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 77.5 mt-10 -58.81 -47.29 85.31 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.271 -0.893 . . . . 16.66 108.974 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.666 ' HZ ' HD12 ' A' ' 77' ' ' LEU . 58.7 t80 -63.07 -33.21 74.95 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.401 -0.812 . . . . 16.66 109.241 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.718 HG23 ' NH1' ' A' ' 11' ' ' ARG . 79.7 m -67.24 -49.17 65.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 50.0 109.107 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' OD1' ' NH2' ' A' ' 71' ' ' ARG . 59.4 m-20 -59.26 -36.95 76.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 50.0 109.291 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.59 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -79.46 -37.79 36.11 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.414 -0.958 . . . . 50.0 108.414 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.731 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -60.38 -32.51 77.52 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.096 -1.602 . . . . 16.66 109.096 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 67' ' ' THR . 65.6 mtm180 -66.16 -36.93 84.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -1.106 . . . . 50.0 108.917 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.04 -19.65 65.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.482 -0.761 . . . . 50.0 109.154 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.771 ' CB ' HD12 ' A' ' 76' ' ' LEU . 3.3 m-80 -145.81 55.23 1.18 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 50.0 109.231 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.57 ' HA ' HD23 ' A' ' 77' ' ' LEU . 8.5 ptp85 -49.87 -35.36 23.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -0.848 . . . . 50.0 108.721 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.435 ' HA2' ' HE2' ' A' ' 78' ' ' LYS . . . -65.92 -27.34 72.71 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.492 -1.443 . . . . 25.0 109.492 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.771 HD12 ' CB ' ' A' ' 73' ' ' ASN . 14.9 mt -67.92 -46.86 70.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.109 . . . . 50.0 109.507 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.837 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -62.9 -42.72 99.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.354 -0.841 . . . . 50.0 109.681 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HE2' ' HA2' ' A' ' 75' ' ' GLY . 32.3 mtmt -61.88 -31.83 72.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 50.0 109.39 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.44 ' O ' HG13 ' A' ' 83' ' ' ILE . 29.7 t0 -76.05 -37.82 57.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.306 -0.871 . . . . 50.0 109.385 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 76' ' ' LEU . 46.0 t -73.3 -39.1 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 50.0 109.401 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.81 -44.26 59.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.403 -0.81 . . . . 50.0 109.891 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -65.6 -26.73 67.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 50.0 109.463 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.452 HG13 ' HA ' ' A' ' 80' ' ' VAL . 7.9 mt -65.39 -48.2 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.831 . . . . 50.0 109.633 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.015 -0.993 . . . . 99.99 109.42 179.942 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 56.0 p-10 -85.14 12.92 6.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -74.78 130.96 40.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 25.0 109.404 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.616 ' CG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -110.13 152.83 43.37 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.224 -0.923 . . . . 50.0 108.93 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.616 ' HD2' ' CG ' ' A' ' 4' ' ' HIS . 39.9 Cg_endo -64.59 -19.86 65.18 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 122.162 1.908 . . . . 50.0 110.224 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -59.59 -38.76 82.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.079 -0.712 . . . . 25.0 109.079 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -59.12 -52.47 65.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.477 -0.765 . . . . 50.0 109.573 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.503 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 39.5 mttp -45.92 -36.31 5.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 50.0 109.326 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.19 91.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.411 -0.806 . . . . 16.66 108.877 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 14' ' ' ILE . 65.5 mt-10 -68.97 -37.02 78.54 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.963 -0.754 . . . . 16.66 108.963 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.538 ' NH2' HG23 ' A' ' 67' ' ' THR . 12.6 mtm180 -70.37 -40.76 73.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.366 -0.834 . . . . 50.0 109.238 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.628 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 38.9 mt-10 -66.65 -41.05 88.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.458 -0.776 . . . . 50.0 109.268 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 13.7 mtp180 -65.37 -41.62 93.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.29 -0.881 . . . . 50.0 109.328 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 81' ' ' ALA . 22.9 mt -69.59 -45.98 76.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.267 -0.896 . . . . 50.0 109.074 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -66.06 -35.79 81.47 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.242 -0.911 . . . . 16.66 109.333 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -65.6 -33.39 75.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.211 -0.931 . . . . 50.0 109.325 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' HD3' ' HB3' ' A' ' 84' ' ' PHE . 53.6 mtt85 -69.94 -34.53 73.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 50.0 109.238 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.005 ' HB3' HD13 ' A' ' 26' ' ' ILE . 34.1 m-85 -69.85 -47.54 62.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 16.66 109.538 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 25.6 t0 -58.65 103.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 16.66 108.747 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.14 -52.19 50.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.223 -0.923 . . . . 50.0 111.275 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -87.34 -22.02 25.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.747 -1.221 . . . . 16.66 109.483 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 82.53 43.92 7.63 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.271 -1.132 . . . . 16.66 110.271 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.509 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.2 p-10 -99.61 7.0 45.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.082 -1.246 . . . . 16.66 109.236 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.04 -10.88 71.52 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.545 -1.022 . . . . 16.66 110.545 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.6 pttp -127.47 140.77 51.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.866 -1.373 . . . . 50.0 109.975 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.005 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.4 mt -113.24 134.1 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.6 -0.688 . . . . 16.66 109.395 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.422 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 21.2 p -105.75 168.23 9.24 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.6 -0.889 . . . . 50.0 108.6 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.498 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.34 -46.23 55.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.973 -1.079 . . . . 50.0 108.969 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.38 -38.98 75.1 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.297 -0.877 . . . . 50.0 109.584 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 56.5 mt-10 -75.58 -53.9 7.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.175 -0.953 . . . . 16.66 109.437 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.731 HD12 ' CD1' ' A' ' 18' ' ' PHE . 9.6 tp -62.51 -42.12 99.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 16.66 108.941 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.479 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -62.88 -44.37 97.54 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.079 -1.608 . . . . 16.66 109.079 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -56.86 -44.23 81.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -1.064 . . . . 50.0 109.673 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.49 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.39 -39.36 68.05 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.435 -0.95 . . . . 50.0 108.435 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.99 HD12 HG22 ' A' ' 46' ' ' VAL . 11.4 mt -58.65 -33.62 70.29 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.548 -0.72 . . . . 99.99 109.46 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -45.18 -25.72 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 99.99 109.474 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.457 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.7 t -52.27 -25.32 9.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.898 . . . . 99.99 109.305 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.715 HD12 HD12 ' A' ' 41' ' ' ILE . 39.7 mt -62.17 -31.86 72.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.398 -0.814 . . . . 50.0 109.157 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.56 6.84 51.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.605 -1.398 . . . . 16.66 109.605 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.99 56.41 0.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.164 -1.198 . . . . 16.66 109.6 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.715 HD12 HD12 ' A' ' 38' ' ' LEU . 11.6 tt -141.5 172.35 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.971 . . . . 50.0 109.635 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.92 166.24 21.36 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.344 -0.847 . . . . 16.66 108.754 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.79 -33.66 16.03 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.02 1.813 . . . . 50.0 109.952 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.38 -25.97 68.53 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.61 -0.681 . . . . 50.0 109.969 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -80.88 -37.48 29.73 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.876 -1.14 . . . . 16.66 108.329 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.99 HG22 HD12 ' A' ' 35' ' ' LEU . 51.9 t -65.0 -36.8 78.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.949 -0.76 . . . . 50.0 108.949 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -68.19 -38.86 82.46 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.762 -0.829 . . . . 50.0 108.762 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -66.7 -41.04 88.68 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.464 -0.772 . . . . 50.0 109.011 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.8 mtt -60.82 -45.92 92.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.213 -0.929 . . . . 16.66 108.881 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.529 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 34.7 mtp -61.87 -48.25 81.35 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.014 -0.736 . . . . 50.0 109.014 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.62 -20.42 32.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.87 . . . . 50.0 109.172 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -96.86 -35.99 10.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.324 -0.86 . . . . 16.66 109.099 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.616 HG22 HD12 ' A' ' 61' ' ' ILE . 82.2 mt -82.38 -30.53 9.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.538 -0.726 . . . . 50.0 109.783 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 50' ' ' MET . 18.3 t0 -61.3 101.38 0.16 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.38 -0.825 . . . . 16.66 109.291 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 82.6 p -73.68 -48.16 34.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -0.916 . . . . 50.0 110.851 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 17.1 p-10 -85.0 -28.6 25.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 16.66 109.972 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.464 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 91.19 27.91 16.85 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.847 -1.168 . . . . 16.66 110.632 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 8.9 p-10 -83.36 -4.4 58.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.895 -1.356 . . . . 50.0 109.502 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.529 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 100.11 -7.65 58.78 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.969 -1.11 . . . . 16.66 110.35 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 43.2 m-85 -131.11 153.37 49.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.016 -1.285 . . . . 50.0 110.918 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.616 HD12 HG22 ' A' ' 53' ' ' ILE . 36.3 mm -104.33 129.5 56.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.183 -1.043 . . . . 16.66 108.183 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.78 165.45 11.94 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.143 -0.973 . . . . 16.66 108.779 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 35.3 t80 -53.61 -42.49 67.76 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.224 -0.99 . . . . 16.66 108.564 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -60.31 -48.56 81.22 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.529 -0.732 . . . . 50.0 109.218 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.544 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 62.0 mt-10 -60.25 -47.3 86.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 16.66 109.1 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.425 ' HE1' HD13 ' A' ' 77' ' ' LEU . 54.6 t80 -62.72 -35.52 80.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.517 -0.74 . . . . 16.66 109.19 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.538 HG23 ' NH2' ' A' ' 11' ' ' ARG . 12.5 m -67.07 -48.48 68.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.357 -0.839 . . . . 50.0 109.138 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -60.4 -38.24 83.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 50.0 109.237 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.578 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.17 -38.45 51.69 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.505 -0.924 . . . . 50.0 108.505 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.927 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -58.17 -27.72 60.49 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.183 -1.567 . . . . 16.66 109.183 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' THR . 58.8 mtm180 -72.53 -31.73 65.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -1.137 . . . . 50.0 108.989 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.1 -20.46 64.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.414 -0.804 . . . . 50.0 109.312 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.806 ' CB ' HD12 ' A' ' 76' ' ' LEU . 2.9 m-80 -149.93 56.74 0.96 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -0.863 . . . . 50.0 109.32 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 69.8 mtt180 -50.18 -38.53 40.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 50.0 108.796 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.44 -19.08 39.4 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.432 -1.467 . . . . 25.0 109.432 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.806 HD12 ' CB ' ' A' ' 73' ' ' ASN . 43.9 mt -79.52 -43.73 22.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -1.058 . . . . 50.0 109.395 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.927 HD11 ' HA3' ' A' ' 70' ' ' GLY . 5.4 mt -70.79 -15.92 62.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.475 -0.766 . . . . 50.0 109.743 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 43.1 mtpt -80.02 -29.27 39.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.15 -0.969 . . . . 50.0 109.206 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.14 -47.35 8.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 50.0 109.529 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 2.9 p -62.31 -42.55 95.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.371 -0.831 . . . . 50.0 109.304 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.542 ' HB2' HD11 ' A' ' 14' ' ' ILE . . . -52.24 -35.96 51.09 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.746 -0.596 . . . . 50.0 110.2 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -75.45 -24.36 57.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.092 -1.005 . . . . 50.0 109.771 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.474 HG13 ' HA ' ' A' ' 80' ' ' VAL . 10.9 mt -59.07 -38.66 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.273 -0.892 . . . . 50.0 109.546 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.465 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 93.1 m-85 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 118.038 -0.982 . . . . 99.99 109.425 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 45.46 39.66 4.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -62.65 144.96 55.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 25.0 109.5 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.569 ' CE1' ' OD2' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -112.52 169.94 5.81 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 50.0 109.343 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 44.7 Cg_endo -68.0 -21.87 42.66 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.548 2.166 . . . . 50.0 111.153 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -64.22 -36.08 82.92 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.478 -0.764 . . . . 25.0 109.34 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.569 ' OD2' ' CE1' ' A' ' 4' ' ' HIS . 28.3 m-20 -62.02 -45.91 91.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 50.0 109.351 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -49.22 -36.34 19.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.825 . . . . 50.0 109.516 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -59.15 -46.66 87.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.257 -0.902 . . . . 16.66 108.752 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.46 ' O ' HG13 ' A' ' 14' ' ' ILE . 59.6 mm-40 -67.28 -40.37 86.14 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.801 -0.814 . . . . 16.66 108.801 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.548 ' NH2' HD12 ' A' ' 77' ' ' LEU . 45.4 mtt-85 -65.81 -40.49 91.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.557 -0.714 . . . . 50.0 109.649 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.614 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 35.6 mt-10 -64.89 -39.79 94.09 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 50.0 109.571 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 53.2 mtp180 -69.24 -39.26 78.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 50.0 109.21 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 10' ' ' GLU . 25.5 mt -71.59 -45.2 68.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.315 -0.866 . . . . 50.0 108.957 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -64.48 -36.47 84.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.114 -0.991 . . . . 16.66 108.864 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 33.5 mttt -66.12 -28.81 69.09 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.392 -0.818 . . . . 50.0 108.88 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 35.2 mtt85 -68.85 -39.17 80.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 50.0 109.08 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.883 ' HB3' HD13 ' A' ' 26' ' ' ILE . 54.5 m-85 -68.52 -51.33 44.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.458 -0.776 . . . . 16.66 109.373 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.5 t0 -54.08 103.14 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -0.842 . . . . 16.66 108.814 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.68 -51.67 46.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.198 -0.939 . . . . 50.0 111.278 -178.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -86.73 -27.48 23.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.812 -1.18 . . . . 16.66 109.693 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.28 39.26 6.44 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.145 -1.182 . . . . 16.66 110.145 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.5 p-10 -94.34 6.22 49.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.086 -1.244 . . . . 16.66 109.193 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.85 -7.43 76.89 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.513 -1.035 . . . . 16.66 110.513 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 11.7 pttp -130.43 142.32 50.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.891 -1.358 . . . . 50.0 109.971 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.883 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.5 mt -112.53 133.51 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.613 -0.679 . . . . 16.66 109.567 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 p -105.83 168.22 9.26 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.359 -0.838 . . . . 50.0 108.897 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.2 -46.53 54.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.059 -1.025 . . . . 50.0 108.781 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.28 -41.42 75.85 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.337 -0.852 . . . . 50.0 109.38 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.506 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.8 mt-10 -73.92 -54.08 8.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.187 -0.946 . . . . 16.66 109.302 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.899 HD22 HG13 ' A' ' 46' ' ' VAL . 6.6 tt -59.65 -45.89 90.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.218 -0.926 . . . . 16.66 108.9 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.591 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -61.54 -43.93 98.65 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.559 -1.417 . . . . 16.66 109.559 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -58.04 -40.69 81.56 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.286 -1.126 . . . . 50.0 109.82 -179.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -71.83 -39.12 69.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.097 -1.002 . . . . 50.0 108.736 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.016 ' CD1' HG22 ' A' ' 46' ' ' VAL . 16.0 mt -59.71 -31.86 69.99 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.499 -0.751 . . . . 99.99 110.116 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.7 mttt -43.55 -28.53 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.08 -1.012 . . . . 99.99 109.577 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -52.82 -26.97 16.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 99.99 109.226 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.03 HD12 HD12 ' A' ' 41' ' ' ILE . 22.1 mt -58.28 -33.64 69.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.328 -0.857 . . . . 50.0 109.257 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.08 2.0 57.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.773 -1.331 . . . . 16.66 109.773 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.15 57.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -1.18 . . . . 16.66 109.624 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.03 HD12 HD12 ' A' ' 38' ' ' LEU . 10.5 tt -139.1 169.24 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.133 -0.979 . . . . 50.0 109.719 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.81 165.93 21.27 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.774 -0.824 . . . . 16.66 108.774 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.2 -33.53 18.5 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.03 1.82 . . . . 50.0 110.146 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -63.16 -27.82 69.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.613 -0.68 . . . . 50.0 110.113 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.17 -36.14 30.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.93 -1.106 . . . . 16.66 108.389 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.016 HG22 ' CD1' ' A' ' 35' ' ' LEU . 76.4 t -66.41 -35.04 73.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.098 -0.704 . . . . 50.0 109.098 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -67.95 -38.05 82.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.872 -0.788 . . . . 50.0 108.872 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -67.15 -37.8 84.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.424 -0.797 . . . . 50.0 109.226 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.415 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.6 mtt -61.75 -46.81 88.03 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.196 -0.94 . . . . 16.66 108.854 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.699 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 35.2 mtp -61.96 -47.87 82.94 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.492 -0.755 . . . . 50.0 109.085 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.79 -19.48 41.32 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.365 -0.835 . . . . 50.0 109.231 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -97.42 -36.15 10.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 16.66 109.029 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.579 HG12 ' CD2' ' A' ' 69' ' ' PHE . 81.8 mt -82.05 -32.13 10.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.515 -0.741 . . . . 50.0 109.797 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.0 t0 -59.19 101.63 0.1 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.245 -0.91 . . . . 16.66 108.965 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.511 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 80.9 p -71.04 -48.1 54.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 50.0 110.754 -178.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.405 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -85.79 -30.83 22.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.161 -0.962 . . . . 16.66 109.518 -179.585 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 92.84 27.91 13.26 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.862 -1.161 . . . . 16.66 110.343 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' OD2' ' OD1' ' A' ' 56' ' ' ASP . 1.4 p30 -81.87 -2.23 50.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.328 . . . . 50.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.699 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.89 -8.57 59.64 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.044 -1.074 . . . . 16.66 110.56 179.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 36.4 m-85 -132.95 156.17 47.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.948 -1.325 . . . . 50.0 111.24 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.572 HD12 HG22 ' A' ' 53' ' ' ILE . 25.5 mm -107.6 129.05 62.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.432 -0.951 . . . . 16.66 108.432 178.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.85 167.41 11.27 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.033 -1.042 . . . . 16.66 108.647 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.614 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 34.2 t80 -54.52 -42.57 71.0 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.025 -1.047 . . . . 16.66 108.545 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -60.52 -49.71 76.46 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.576 -0.702 . . . . 50.0 109.165 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 61.2 mt-10 -58.91 -46.8 87.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.258 -0.901 . . . . 16.66 109.08 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.427 ' HE1' HD13 ' A' ' 77' ' ' LEU . 51.1 t80 -63.86 -35.66 81.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.442 -0.786 . . . . 16.66 109.346 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.7 m -66.22 -48.69 69.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.37 -0.832 . . . . 50.0 109.166 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -59.88 -34.98 73.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 50.0 109.395 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.579 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -79.81 -37.65 34.69 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.422 -0.955 . . . . 50.0 108.422 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.825 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -57.88 -27.64 59.61 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.067 -1.613 . . . . 16.66 109.067 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -71.37 -32.2 68.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.445 -1.032 . . . . 50.0 108.811 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.43 -20.94 66.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.463 -0.773 . . . . 50.0 109.276 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.763 ' CB ' HD12 ' A' ' 76' ' ' LEU . 1.6 m-80 -152.12 55.89 0.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -0.84 . . . . 50.0 109.137 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 4.1 ptm180 -48.45 -34.11 10.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.877 . . . . 50.0 108.769 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.41 ' HA2' ' HE3' ' A' ' 78' ' ' LYS . . . -60.62 -31.7 75.92 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.347 -1.501 . . . . 25.0 109.347 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.763 HD12 ' CB ' ' A' ' 73' ' ' ASN . 65.7 mt -66.13 -44.46 84.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -1.147 . . . . 50.0 109.582 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.825 HD11 ' HA3' ' A' ' 70' ' ' GLY . 4.6 mt -71.39 -19.13 62.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 50.0 109.843 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 14.5 mtmt -79.96 -28.37 39.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.177 -0.952 . . . . 50.0 109.271 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.92 -46.09 8.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 50.0 109.38 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.2 p -58.44 -44.19 88.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.803 0.811 . . . . 50.0 108.988 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.545 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -51.25 -38.45 52.7 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.297 -0.561 . . . . 50.0 109.767 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -68.77 -27.28 65.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 50.0 109.614 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.449 HG13 ' HA ' ' A' ' 80' ' ' VAL . 8.4 mt -60.66 -43.31 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.31 -0.869 . . . . 50.0 109.422 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.037 -0.982 . . . . 99.99 109.415 179.895 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -80.72 -20.28 43.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.526 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -57.79 140.27 52.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 25.0 109.409 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.493 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 0.2 OUTLIER -132.75 165.64 35.05 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 50.0 109.466 -179.967 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 45.4 Cg_endo -67.72 -22.02 44.14 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 122.553 2.169 . . . . 50.0 110.857 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -58.89 -41.83 88.12 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.573 -0.704 . . . . 25.0 109.141 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.486 ' CG ' ' CD2' ' A' ' 4' ' ' HIS . 79.4 m-20 -53.48 -55.94 21.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.409 -0.807 . . . . 50.0 109.465 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.46 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 11.5 mttt -43.69 -37.48 2.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 50.0 109.633 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -60.53 -46.02 91.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 16.66 108.91 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 14' ' ' ILE . 83.9 mt-10 -69.02 -35.84 77.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.476 -0.765 . . . . 16.66 108.976 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.67 ' NH2' HG23 ' A' ' 67' ' ' THR . 17.0 mtm180 -70.12 -40.45 74.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 50.0 109.309 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.633 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 59.5 mt-10 -66.6 -41.9 87.71 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.394 -0.816 . . . . 50.0 109.411 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 18.9 mtp180 -66.47 -41.31 89.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 50.0 109.457 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 10' ' ' GLU . 41.8 mt -70.04 -43.94 78.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.237 -0.915 . . . . 50.0 109.059 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 26' ' ' ILE . 70.2 t80 -64.35 -35.98 82.64 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.203 -0.936 . . . . 16.66 109.123 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -66.39 -30.43 70.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 50.0 109.12 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 60.0 mtt85 -69.32 -36.92 77.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 50.0 109.129 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.907 ' HB3' HD13 ' A' ' 26' ' ' ILE . 46.1 m-85 -69.4 -50.82 42.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.421 -0.799 . . . . 16.66 109.475 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.6 t0 -55.32 103.43 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 16.66 108.685 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.64 -51.53 48.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.269 -0.894 . . . . 50.0 111.307 -178.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -87.5 -27.59 22.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.759 -1.213 . . . . 16.66 109.753 -179.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 90.23 38.2 6.42 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.767 -1.206 . . . . 16.66 110.242 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.8 p-10 -93.34 6.33 48.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.252 . . . . 16.66 109.192 179.154 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.6 -7.72 77.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.402 -1.079 . . . . 16.66 110.402 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 24.9 pttt -129.56 141.67 50.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.935 -1.332 . . . . 50.0 109.997 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.907 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.7 mt -111.85 133.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.642 -0.661 . . . . 16.66 109.547 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.404 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 10.9 p -105.87 166.28 10.59 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.759 -0.83 . . . . 50.0 108.759 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.09 -45.19 52.42 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.049 -1.032 . . . . 50.0 108.841 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.79 -39.55 77.8 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.331 -0.856 . . . . 50.0 109.517 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.494 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 58.2 mt-10 -74.65 -54.17 7.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.157 -0.965 . . . . 16.66 109.398 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.584 HD12 ' CE1' ' A' ' 18' ' ' PHE . 30.3 tp -61.77 -43.35 99.02 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.262 -0.899 . . . . 16.66 108.954 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.689 ' HA2' HG21 ' A' ' 46' ' ' VAL . . . -62.71 -44.51 97.4 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.139 -1.584 . . . . 16.66 109.139 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 28.8 mt-10 -58.8 -42.74 89.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.355 -1.085 . . . . 50.0 109.868 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.79 -40.24 66.07 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.098 -1.001 . . . . 50.0 108.406 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.987 HD12 HG22 ' A' ' 46' ' ' VAL . 10.7 mt -58.71 -28.63 66.0 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.61 -0.681 . . . . 99.99 109.553 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 2.4 mtmt -44.04 -26.19 0.27 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 99.99 109.615 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.431 ' OG1' HG22 ' A' ' 83' ' ' ILE . 6.6 t -51.94 -26.31 10.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.306 -0.872 . . . . 99.99 109.195 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 38' ' ' LEU . 41.9 mt -58.73 -37.19 75.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.438 -0.789 . . . . 50.0 109.199 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.98 -5.6 61.89 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.836 -1.305 . . . . 16.66 109.836 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.7 t -152.0 59.77 0.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.044 -1.268 . . . . 16.66 109.779 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.3 tp -134.0 157.2 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.152 -0.968 . . . . 50.0 109.485 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.11 160.02 27.65 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.461 -0.94 . . . . 16.66 108.461 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.77 -31.97 30.93 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 121.93 1.753 . . . . 50.0 110.066 178.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -72.15 -17.92 61.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.603 -0.685 . . . . 50.0 110.177 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -80.94 -37.51 29.34 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.815 -1.178 . . . . 16.66 108.28 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.987 HG22 HD12 ' A' ' 35' ' ' LEU . 65.6 t -68.23 -35.88 72.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.821 -0.807 . . . . 50.0 108.821 179.299 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -65.19 -40.4 94.17 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.797 -0.816 . . . . 50.0 108.797 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.481 ' CD2' ' C ' ' A' ' 48' ' ' HIS . 3.7 t60 -66.03 -42.33 89.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.484 -0.76 . . . . 50.0 109.051 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.9 mtt -58.45 -44.42 89.19 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.249 -0.907 . . . . 16.66 108.71 179.482 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.569 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 34.6 mtp -61.69 -46.69 88.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.572 -0.705 . . . . 50.0 109.182 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.82 -21.36 41.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 50.0 109.042 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.85 -36.32 11.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.46 -0.775 . . . . 16.66 109.076 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.582 HG12 ' CD2' ' A' ' 69' ' ' PHE . 83.7 mt -80.59 -31.98 12.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.43 -0.794 . . . . 50.0 109.566 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.6 t0 -61.42 101.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.5 -0.75 . . . . 16.66 109.066 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.474 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 60.3 p -67.5 -46.42 72.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.269 -0.894 . . . . 50.0 110.692 -179.038 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.7 p-10 -88.28 -41.41 12.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 16.66 109.56 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 103.67 29.54 5.56 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.964 -1.112 . . . . 16.66 110.346 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 13.3 p-10 -80.61 -2.57 46.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.877 -1.367 . . . . 50.0 109.112 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.569 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.72 -3.58 57.56 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.943 -1.263 . . . . 16.66 109.943 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.575 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 38.2 m-85 -137.0 156.82 47.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.023 -1.281 . . . . 50.0 111.336 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.554 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 25.1 mm -109.46 130.31 62.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.418 -0.956 . . . . 16.66 108.418 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -99.38 168.52 9.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.057 -1.027 . . . . 16.66 108.571 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.633 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 40.6 t80 -54.8 -43.73 73.16 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.022 -1.071 . . . . 16.66 108.609 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -58.66 -47.54 84.11 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.626 -0.671 . . . . 50.0 109.261 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 80.8 mt-10 -62.97 -46.54 87.22 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.29 -0.881 . . . . 16.66 109.221 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.536 ' HZ ' HD12 ' A' ' 77' ' ' LEU . 31.9 t80 -63.81 -32.89 74.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 16.66 109.212 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.67 HG23 ' NH2' ' A' ' 11' ' ' ARG . 31.2 m -67.28 -49.35 64.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 50.0 109.171 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -59.74 -36.46 76.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.31 -0.869 . . . . 50.0 109.137 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.582 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -78.1 -38.91 43.02 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.504 -0.925 . . . . 50.0 108.504 179.706 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.67 ' HA2' HD21 ' A' ' 77' ' ' LEU . . . -57.49 -28.65 59.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.038 -1.625 . . . . 16.66 109.038 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 67' ' ' THR . 22.7 mtm180 -70.64 -31.91 69.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -1.076 . . . . 50.0 108.851 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.93 -23.51 62.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 50.0 109.238 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.91 ' CB ' HD12 ' A' ' 76' ' ' LEU . 15.5 m-80 -140.48 58.3 1.57 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 50.0 109.223 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.578 ' HA ' HD23 ' A' ' 77' ' ' LEU . 58.3 mtp180 -52.66 -34.86 53.6 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.328 -0.858 . . . . 50.0 108.998 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 78' ' ' LYS . . . -67.97 -24.25 74.42 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.48 -1.448 . . . . 25.0 109.48 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.91 HD12 ' CB ' ' A' ' 73' ' ' ASN . 14.6 mt -71.72 -45.99 60.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -1.148 . . . . 50.0 109.489 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.826 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -62.86 -42.97 99.95 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.327 -0.858 . . . . 50.0 109.677 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 37.0 pttt -68.36 -31.24 70.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 50.0 109.247 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.473 ' O ' HG13 ' A' ' 83' ' ' ILE . 35.3 m-20 -74.78 -36.8 62.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.333 -0.854 . . . . 50.0 109.256 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 76' ' ' LEU . 21.9 t -79.26 -35.64 17.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 50.0 109.22 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.97 -42.76 63.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.426 -0.796 . . . . 50.0 109.841 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -69.28 -26.08 64.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 50.0 109.573 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 79' ' ' ASP . 13.7 mt -63.53 -45.19 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.866 . . . . 50.0 109.527 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.05 -0.976 . . . . 99.99 109.397 179.966 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.27 -7.68 59.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.225 -0.922 . . . . 0.0 109.561 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' OD1' ' NH2' ' A' ' 74' ' ' ARG . 85.0 m-20 -60.1 140.22 57.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 25.0 109.493 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.618 ' CG ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -113.25 151.84 44.63 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.217 -0.927 . . . . 50.0 108.948 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.618 ' HD2' ' CG ' ' A' ' 4' ' ' HIS . 40.0 Cg_endo -64.59 -20.04 65.29 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.257 1.971 . . . . 50.0 110.309 179.246 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.504 ' NE2' ' HA ' ' A' ' 6' ' ' GLN . 15.5 mm-40 -59.21 -36.86 76.14 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.017 -0.735 . . . . 25.0 109.017 179.147 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -64.48 -45.21 88.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.391 -0.818 . . . . 50.0 109.45 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 13.3 mttp -49.57 -36.09 22.68 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.401 -0.812 . . . . 50.0 109.262 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.25 -46.35 90.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 16.66 108.755 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' O ' HG13 ' A' ' 14' ' ' ILE . 69.2 mt-10 -69.02 -37.81 78.85 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.876 -0.787 . . . . 16.66 108.876 179.386 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH2' ' HG2' ' A' ' 8' ' ' LYS . 10.8 mtm180 -69.57 -40.28 76.86 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.329 -0.857 . . . . 50.0 109.414 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 54.2 mt-10 -66.68 -39.73 88.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.406 -0.809 . . . . 50.0 109.476 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -69.11 -39.73 78.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 50.0 109.163 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' A' ' 81' ' ' ALA . 45.4 mt -71.44 -44.13 71.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.334 -0.854 . . . . 50.0 109.063 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -69.91 -36.1 75.11 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.133 -0.979 . . . . 16.66 109.115 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 56.6 mttm -65.83 -31.5 72.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.329 -0.857 . . . . 50.0 109.031 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -71.37 -35.8 71.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 50.0 109.011 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.022 ' HB3' HD13 ' A' ' 26' ' ' ILE . 33.7 m-85 -67.83 -47.58 68.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 16.66 109.243 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 24.3 t0 -59.09 103.36 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 16.66 108.624 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.85 -51.32 56.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 50.0 111.257 -178.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -87.18 -30.64 20.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.739 -1.226 . . . . 16.66 109.872 -179.307 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 93.46 35.6 6.18 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.702 -1.237 . . . . 16.66 110.15 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 38.2 p-10 -90.28 4.75 49.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -1.184 . . . . 16.66 109.172 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.91 -6.26 76.55 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.432 -1.067 . . . . 16.66 110.432 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 13.5 pttp -131.26 142.58 50.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.93 -1.335 . . . . 50.0 110.079 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.022 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.9 mt -112.23 132.86 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.695 -0.628 . . . . 16.66 109.421 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.403 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 14.4 p -104.94 167.76 9.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.339 -0.851 . . . . 50.0 108.963 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.23 -45.34 53.85 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.138 -0.976 . . . . 50.0 108.987 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.53 -40.83 79.67 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.374 -0.829 . . . . 50.0 109.318 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.3 mt-10 -74.01 -54.57 7.59 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.271 -0.893 . . . . 16.66 109.218 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.715 HD22 HG13 ' A' ' 46' ' ' VAL . 5.6 tt -59.7 -46.58 88.65 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.209 -0.932 . . . . 16.66 108.806 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.534 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -60.83 -42.93 99.73 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.45 -1.46 . . . . 16.66 109.45 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -57.98 -41.83 83.78 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.336 -1.096 . . . . 50.0 109.881 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.475 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -71.26 -39.02 71.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.15 -0.969 . . . . 50.0 108.719 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.019 ' CD1' HG22 ' A' ' 46' ' ' VAL . 21.3 mt -59.77 -34.62 73.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.54 -0.725 . . . . 99.99 110.034 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 8.8 mttt -43.78 -28.12 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 99.99 109.53 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.996 HG21 HG21 ' A' ' 83' ' ' ILE . 6.6 t -52.48 -25.74 11.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.288 -0.883 . . . . 99.99 109.208 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -64.44 -30.36 71.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.301 -0.874 . . . . 50.0 109.317 179.824 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.97 6.37 52.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.738 -1.345 . . . . 16.66 109.738 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 t -154.58 58.67 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.164 -1.198 . . . . 16.66 109.713 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.57 HD12 HD13 ' A' ' 38' ' ' LEU . 11.0 tt -144.25 168.42 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.963 . . . . 50.0 109.47 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.41 166.04 20.18 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 16.66 108.786 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.45 -33.4 17.86 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.089 1.859 . . . . 50.0 110.085 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -62.68 -27.86 69.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.662 -0.649 . . . . 50.0 109.908 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -81.73 -35.89 29.21 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.833 -1.167 . . . . 16.66 108.255 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.019 HG22 ' CD1' ' A' ' 35' ' ' LEU . 79.3 t -67.1 -35.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.028 -0.73 . . . . 50.0 109.028 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -68.6 -38.02 80.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.854 -0.795 . . . . 50.0 108.854 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -67.05 -37.04 83.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 50.0 109.132 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.402 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.4 mtt -60.86 -47.56 85.83 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.272 -0.892 . . . . 16.66 108.811 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.56 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 56.5 mtp -61.28 -47.31 86.59 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.566 -0.709 . . . . 50.0 109.125 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.81 -20.74 37.91 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.292 -0.88 . . . . 50.0 109.171 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -98.93 -37.39 9.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 16.66 109.244 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.588 HG12 ' CD2' ' A' ' 69' ' ' PHE . 85.5 mt -80.35 -33.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.471 -0.768 . . . . 50.0 109.685 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.6 t0 -60.44 101.55 0.14 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.405 -0.809 . . . . 16.66 108.891 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 71.8 p -66.53 -47.9 71.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 50.0 110.785 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.2 p-10 -87.57 -38.8 15.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.106 -0.996 . . . . 16.66 109.452 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 101.12 27.65 7.24 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.945 -1.121 . . . . 16.66 110.492 179.403 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.474 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 15.6 p-10 -78.45 -0.75 30.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.865 -1.373 . . . . 50.0 109.224 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.56 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.47 -4.84 58.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.015 -1.234 . . . . 16.66 110.015 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.575 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 27.0 m-85 -136.86 157.17 47.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.926 -1.337 . . . . 50.0 111.34 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.555 HD12 HG22 ' A' ' 53' ' ' ILE . 23.1 mm -110.08 131.35 61.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.466 -0.939 . . . . 16.66 108.466 178.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 170.82 8.27 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.045 -1.035 . . . . 16.66 108.521 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 12' ' ' GLU . 36.2 t80 -56.09 -44.45 79.02 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.121 -1.032 . . . . 16.66 108.657 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -59.04 -49.35 78.23 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.492 -0.755 . . . . 50.0 109.229 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.548 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 78.4 mt-10 -60.23 -46.49 89.59 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.261 -0.899 . . . . 16.66 109.265 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.511 ' HZ ' HD22 ' A' ' 77' ' ' LEU . 64.1 t80 -63.6 -34.07 77.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.418 -0.802 . . . . 16.66 109.337 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.531 HG23 ' NH2' ' A' ' 11' ' ' ARG . 19.6 m -66.56 -48.97 67.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.843 . . . . 50.0 109.203 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -58.85 -36.22 74.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 50.0 109.24 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.588 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -79.88 -37.16 35.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.585 -0.894 . . . . 50.0 108.585 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.922 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -60.15 -28.71 67.05 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.383 -1.487 . . . . 16.66 109.383 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 67' ' ' THR . 75.5 mtm180 -72.68 -34.69 67.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 50.0 109.198 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.82 -18.98 65.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.434 -0.791 . . . . 50.0 109.298 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.719 ' CB ' HD12 ' A' ' 76' ' ' LEU . 29.4 m-80 -144.4 56.74 1.3 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.263 -0.898 . . . . 50.0 109.222 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 98.3 mtt180 -51.46 -40.3 59.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.713 -0.847 . . . . 50.0 108.713 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.479 ' HA2' ' HE3' ' A' ' 78' ' ' LYS . . . -60.27 -25.98 63.29 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.454 -1.459 . . . . 25.0 109.454 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.719 HD12 ' CB ' ' A' ' 73' ' ' ASN . 18.6 mt -72.7 -45.55 58.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -1.161 . . . . 50.0 109.43 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.922 HD11 ' HA3' ' A' ' 70' ' ' GLY . 10.5 mt -68.67 -16.46 63.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 50.0 109.777 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HE3' ' HA2' ' A' ' 75' ' ' GLY . 18.6 mtmt -80.05 -24.35 40.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 50.0 109.322 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -91.99 -48.32 6.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.273 -0.892 . . . . 50.0 109.408 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.547 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 4.3 p -59.15 -44.33 91.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.388 -0.82 . . . . 50.0 109.178 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.602 ' HB2' HD11 ' A' ' 14' ' ' ILE . . . -49.62 -40.86 40.69 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.115 -0.634 . . . . 50.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -64.11 -25.74 68.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 50.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.996 HG21 HG21 ' A' ' 37' ' ' THR . 20.8 mm -66.79 -36.1 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 50.0 109.414 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.009 -0.996 . . . . 99.99 109.458 -179.999 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -88.94 7.52 34.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.935 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.36 142.02 57.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.9 . . . . 25.0 109.432 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.496 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -119.15 171.8 5.0 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 50.0 109.407 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 46.2 Cg_endo -68.63 -22.66 37.52 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.65 2.233 . . . . 50.0 111.002 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -63.91 -35.39 80.49 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.457 -0.777 . . . . 25.0 109.234 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -60.89 -44.5 97.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 50.0 109.296 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -51.18 -36.14 39.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 50.0 109.432 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -57.7 -45.53 85.57 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.655 -0.869 . . . . 16.66 108.655 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 14' ' ' ILE . 58.9 mt-10 -66.43 -43.82 84.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.955 -0.758 . . . . 16.66 108.955 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.5 ' NH2' ' HG2' ' A' ' 71' ' ' ARG . 20.0 mtt-85 -64.49 -39.74 94.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.448 -0.782 . . . . 50.0 109.46 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.586 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 31.6 mt-10 -64.35 -41.62 96.65 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.48 -0.762 . . . . 50.0 109.286 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 52.0 mtp85 -67.99 -39.77 83.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.307 -0.871 . . . . 50.0 109.173 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 10' ' ' GLU . 21.1 mt -70.52 -44.45 76.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.394 -0.816 . . . . 50.0 109.044 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -66.66 -36.1 81.73 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.243 -0.911 . . . . 16.66 109.141 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 22.6 mtpt -65.4 -30.22 71.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.352 -0.843 . . . . 50.0 109.089 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.515 ' NH2' ' O ' ' A' ' 84' ' ' PHE . 31.5 mtt180 -71.88 -35.22 69.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 50.0 109.057 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.058 ' HB3' HD13 ' A' ' 26' ' ' ILE . 31.0 m-85 -69.45 -48.77 59.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.448 -0.783 . . . . 16.66 109.298 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 23.2 t0 -58.74 103.09 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.917 . . . . 16.66 108.662 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.57 -51.82 52.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.128 -0.982 . . . . 50.0 111.239 -178.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -86.65 -27.9 23.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.748 -1.22 . . . . 16.66 109.565 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 89.33 38.1 6.83 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.862 -1.161 . . . . 16.66 110.215 179.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.4 p-10 -92.39 5.91 48.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -1.217 . . . . 16.66 109.142 179.168 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.88 -7.13 76.96 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.472 -1.051 . . . . 16.66 110.472 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HD2' ' CG ' ' A' ' 60' ' ' PHE . 15.7 pttt -130.74 142.34 50.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.886 -1.361 . . . . 50.0 110.047 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.058 HD13 ' HB3' ' A' ' 18' ' ' PHE . 6.9 mt -112.3 133.23 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.724 -0.61 . . . . 16.66 109.447 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.416 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 23.7 p -106.93 169.74 8.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -0.891 . . . . 50.0 109.054 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.51 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.8 -46.76 59.85 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.108 -0.995 . . . . 50.0 108.985 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.19 74.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.266 -0.896 . . . . 50.0 109.467 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.499 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.4 mt-10 -75.56 -54.22 7.35 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.207 -0.933 . . . . 16.66 109.239 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.756 HD22 HG13 ' A' ' 46' ' ' VAL . 7.0 tt -59.58 -46.77 87.93 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.212 -0.93 . . . . 16.66 108.847 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.633 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -60.88 -43.33 99.43 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.461 -1.456 . . . . 16.66 109.461 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.32 -41.36 84.38 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.437 -1.037 . . . . 50.0 109.826 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.4 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.35 -39.81 67.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.166 -0.959 . . . . 50.0 108.726 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.011 HD12 HG22 ' A' ' 46' ' ' VAL . 14.1 mt -59.55 -32.28 70.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.446 -0.784 . . . . 99.99 109.832 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.6 mtmt -43.7 -26.32 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.065 -1.022 . . . . 99.99 109.632 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.456 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.6 t -52.4 -25.8 10.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 99.99 109.244 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -65.72 -31.86 73.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.372 -0.83 . . . . 50.0 109.201 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.07 11.04 43.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.479 -1.449 . . . . 16.66 109.479 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.33 50.02 0.56 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.242 -1.152 . . . . 16.66 109.54 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 tt -136.95 172.99 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 50.0 109.288 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.78 166.58 19.36 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 16.66 108.696 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.16 -33.81 18.01 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.089 1.859 . . . . 50.0 110.184 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -64.08 -26.14 68.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.635 -0.665 . . . . 50.0 110.117 -179.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -82.52 -40.11 21.48 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.814 -1.179 . . . . 16.66 108.173 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.011 HG22 HD12 ' A' ' 35' ' ' LEU . 55.2 t -62.22 -35.93 71.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.692 -0.855 . . . . 50.0 108.692 179.199 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -69.62 -37.37 76.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.752 -0.833 . . . . 50.0 108.752 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.581 ' CD2' ' HG3' ' A' ' 52' ' ' GLU . 13.7 t-160 -67.35 -36.81 82.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.506 -0.746 . . . . 50.0 109.261 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.433 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.4 mtt -61.39 -46.79 88.7 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.18 -0.95 . . . . 16.66 108.789 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.702 ' HE1' ' O ' ' A' ' 59' ' ' GLY . 43.0 mtp -62.26 -48.32 80.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.493 -0.755 . . . . 50.0 109.056 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.93 -19.38 29.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 50.0 109.209 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.581 ' HG3' ' CD2' ' A' ' 48' ' ' HIS . 23.1 mt-10 -99.65 -36.93 9.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 16.66 109.143 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.541 HG12 ' CD2' ' A' ' 69' ' ' PHE . 82.7 mt -80.47 -33.4 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.456 -0.777 . . . . 50.0 109.501 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 50' ' ' MET . 21.6 t0 -59.82 101.69 0.13 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.302 -0.874 . . . . 16.66 108.849 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.469 ' OG1' ' HG2' ' A' ' 65' ' ' GLU . 49.5 p -68.5 -46.36 69.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 50.0 110.736 -178.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 2.8 p-10 -88.09 -38.88 15.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 16.66 109.539 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.472 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 101.61 28.34 6.73 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.019 -1.086 . . . . 16.66 110.523 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 12.4 p-10 -79.57 -2.0 40.45 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.783 -1.422 . . . . 50.0 109.13 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.702 ' O ' ' HE1' ' A' ' 50' ' ' MET . . . 99.34 -5.59 59.01 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.048 -1.221 . . . . 16.66 110.048 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.573 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 31.6 m-85 -134.99 156.59 48.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.008 -1.29 . . . . 50.0 111.407 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.565 ' HA ' ' OE1' ' A' ' 65' ' ' GLU . 22.1 mm -109.21 129.8 63.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.365 -0.976 . . . . 16.66 108.365 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -96.26 167.4 11.21 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.083 -1.01 . . . . 16.66 108.55 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.586 ' CZ ' ' HG3' ' A' ' 12' ' ' GLU . 34.0 t80 -54.32 -42.39 70.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.014 -1.054 . . . . 16.66 108.442 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -61.19 -47.58 85.49 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.584 -0.697 . . . . 50.0 109.335 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 74.9 mt-10 -61.71 -47.02 87.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.244 -0.91 . . . . 16.66 109.2 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.601 ' CZ ' HD11 ' A' ' 77' ' ' LEU . 80.7 t80 -61.69 -39.11 90.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 16.66 109.375 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 15.9 m -66.27 -46.53 76.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.414 -0.804 . . . . 50.0 109.325 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -59.01 -36.53 75.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 50.0 109.64 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.544 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -78.66 -35.32 45.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.234 -0.917 . . . . 50.0 108.69 179.972 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.28 -28.79 64.91 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.385 -1.486 . . . . 16.66 109.385 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.5 ' HG2' ' NH2' ' A' ' 11' ' ' ARG . 35.9 mtm180 -73.46 -30.63 63.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -1.172 . . . . 50.0 109.253 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.47 -15.85 61.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 50.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.718 ' CB ' HD12 ' A' ' 76' ' ' LEU . 5.0 p30 -149.56 54.98 0.96 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 50.0 109.189 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -51.19 -43.16 61.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.368 -0.832 . . . . 50.0 108.791 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.85 -24.38 19.15 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.174 -1.57 . . . . 25.0 109.174 179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.718 HD12 ' CB ' ' A' ' 73' ' ' ASN . 41.9 mt -80.05 -43.49 21.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -1.091 . . . . 50.0 109.394 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 1.6 mm? -61.96 -40.03 94.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.411 -0.805 . . . . 50.0 109.845 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 43.3 mtpt -66.19 -33.63 76.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 50.0 109.653 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.19 -46.83 22.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 50.0 109.463 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 77' ' ' LEU . 2.8 p -72.63 -40.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.79 0.805 . . . . 50.0 109.393 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 77' ' ' LEU . . . -53.69 -33.96 57.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.744 -0.597 . . . . 50.0 110.487 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 77.1 mttt -79.88 -22.98 42.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.018 . . . . 50.0 109.789 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.471 HG13 ' HA ' ' A' ' 80' ' ' VAL . 10.1 mt -57.59 -35.9 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 50.0 109.48 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.515 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 95.1 m-85 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.021 -0.99 . . . . 99.99 109.534 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 57.54 41.6 25.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -83.36 115.9 22.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 25.0 109.441 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.548 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -115.98 174.5 2.39 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.953 . . . . 50.0 109.197 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 4' ' ' HIS . 47.2 Cg_endo -69.58 -22.88 32.3 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.502 2.134 . . . . 50.0 111.246 179.586 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -63.25 -36.32 83.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.364 -0.835 . . . . 25.0 109.297 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.65 -50.05 75.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.392 -0.818 . . . . 50.0 109.457 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -48.53 -36.3 15.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.363 -0.836 . . . . 50.0 109.355 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -56.38 -45.19 80.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.597 -0.89 . . . . 16.66 108.597 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.471 ' O ' HG13 ' A' ' 14' ' ' ILE . 68.4 mt-10 -68.09 -38.61 82.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.47 -0.769 . . . . 16.66 108.947 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.8 mtt-85 -67.49 -40.58 85.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 50.0 109.387 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.621 ' CG ' ' CZ ' ' A' ' 63' ' ' PHE . 33.2 mt-10 -64.9 -40.98 95.93 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.442 -0.786 . . . . 50.0 109.354 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 59.7 mtp180 -68.27 -39.54 82.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 50.0 109.154 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 10' ' ' GLU . 33.5 mt -70.93 -45.06 75.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.391 -0.818 . . . . 50.0 109.006 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 26' ' ' ILE . 67.2 t80 -64.86 -35.86 82.5 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 16.66 108.903 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -66.56 -29.42 69.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.32 -0.862 . . . . 50.0 108.962 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 13' ' ' ARG . 39.2 mtt85 -70.04 -36.61 75.14 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.362 -0.836 . . . . 50.0 109.006 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.884 ' HB3' HD13 ' A' ' 26' ' ' ILE . 51.6 m-85 -70.22 -51.18 32.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.448 -0.782 . . . . 16.66 109.352 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 22' ' ' GLY . 22.8 t0 -55.47 103.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 16.66 108.744 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.27 48.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.89 . . . . 50.0 111.196 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -87.06 -28.39 22.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.749 -1.219 . . . . 16.66 109.71 -179.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 19' ' ' ASP . . . 90.13 37.4 6.73 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.801 -1.19 . . . . 16.66 110.216 178.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 25' ' ' LYS . 39.7 p-10 -91.42 5.49 49.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -1.22 . . . . 16.66 109.157 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.09 -6.2 75.95 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.401 -1.08 . . . . 16.66 110.401 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 60' ' ' PHE . 16.9 pttt -131.25 142.53 50.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.959 -1.318 . . . . 50.0 110.001 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.884 HD13 ' HB3' ' A' ' 18' ' ' PHE . 5.9 mt -112.52 133.55 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.639 -0.663 . . . . 16.66 109.495 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.0 p -106.47 167.8 9.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.866 . . . . 50.0 108.934 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -50.15 -45.53 53.29 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.072 -1.017 . . . . 50.0 108.93 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -57.22 -41.4 79.43 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.218 -0.926 . . . . 50.0 109.259 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 26' ' ' ILE . 59.5 mt-10 -74.35 -54.85 6.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.346 -0.846 . . . . 16.66 109.001 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.775 HD22 HG13 ' A' ' 46' ' ' VAL . 6.1 tt -58.57 -48.58 80.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.869 . . . . 16.66 108.771 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.719 ' CA ' HG11 ' A' ' 46' ' ' VAL . . . -60.02 -43.44 98.2 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.308 -1.517 . . . . 16.66 109.308 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 19.0 mt-10 -56.81 -42.92 80.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.307 -1.114 . . . . 50.0 109.706 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.533 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -72.1 -39.41 68.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.116 -0.99 . . . . 50.0 108.502 179.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.997 HD12 HG22 ' A' ' 46' ' ' VAL . 14.0 mt -59.88 -33.3 71.65 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.56 -0.713 . . . . 99.99 109.865 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.4 mttm -43.97 -26.45 0.28 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 99.99 109.593 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.571 ' CG2' HG21 ' A' ' 83' ' ' ILE . 7.0 t -51.9 -24.56 6.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.286 -0.884 . . . . 99.99 109.288 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -61.84 -33.16 73.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 50.0 109.226 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.34 2.48 54.49 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.81 -1.316 . . . . 16.66 109.81 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.09 56.2 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.07 -1.253 . . . . 16.66 110.024 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.421 HG13 ' OE1' ' A' ' 45' ' ' GLU . 7.3 tt -138.38 167.54 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 50.0 109.41 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.17 165.18 17.0 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.617 -0.883 . . . . 16.66 108.617 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.21 -32.28 21.17 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.115 1.876 . . . . 50.0 110.192 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -64.22 -25.77 68.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.713 -0.617 . . . . 50.0 110.077 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' OE1' HG13 ' A' ' 41' ' ' ILE . 92.3 mt-10 -81.91 -41.3 21.1 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.854 -1.154 . . . . 16.66 108.133 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.997 HG22 HD12 ' A' ' 35' ' ' LEU . 69.3 t -62.76 -35.8 72.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.959 -0.756 . . . . 50.0 108.959 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -68.42 -38.21 81.01 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.754 -0.832 . . . . 50.0 108.754 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -66.71 -35.97 81.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.389 -0.819 . . . . 50.0 109.245 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.427 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.2 mtt -60.86 -46.67 89.69 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.147 -0.971 . . . . 16.66 108.622 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.527 ' CE ' ' O ' ' A' ' 59' ' ' GLY . 53.5 mtp -61.92 -48.88 78.46 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.928 -0.767 . . . . 50.0 108.928 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.11 -21.67 13.8 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.282 -0.886 . . . . 50.0 109.177 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -98.5 -36.37 9.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 16.66 109.19 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.648 HG22 HD12 ' A' ' 61' ' ' ILE . 83.2 mt -81.22 -30.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.548 -0.72 . . . . 50.0 109.766 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 50' ' ' MET . 19.2 t0 -61.66 101.84 0.22 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.439 -0.788 . . . . 16.66 109.363 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.496 ' CG2' ' HG2' ' A' ' 65' ' ' GLU . 71.6 p -73.54 -47.78 38.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.28 -0.888 . . . . 50.0 110.868 -179.017 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.481 ' OD2' ' HB3' ' A' ' 58' ' ' ASP . 10.9 p-10 -85.45 -29.5 24.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.037 -1.039 . . . . 16.66 109.821 -179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 54' ' ' ASP . . . 92.59 27.07 15.64 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.837 -1.173 . . . . 16.66 110.836 178.744 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.481 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p-10 -82.06 -2.68 52.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.785 -1.42 . . . . 50.0 109.424 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.527 ' O ' ' CE ' ' A' ' 50' ' ' MET . . . 98.3 -5.08 60.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.345 -1.102 . . . . 16.66 110.345 179.284 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.571 ' CE1' ' HE3' ' A' ' 25' ' ' LYS . 43.0 m-85 -134.28 153.69 51.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.987 -1.302 . . . . 50.0 111.093 -179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.648 HD12 HG22 ' A' ' 53' ' ' ILE . 33.0 mm -105.05 128.62 58.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.516 -0.92 . . . . 16.66 108.516 178.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 m -94.87 167.2 11.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.159 -0.963 . . . . 16.66 108.613 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.621 ' CZ ' ' CG ' ' A' ' 12' ' ' GLU . 35.5 t80 -54.78 -42.6 71.93 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.059 -1.025 . . . . 16.66 108.625 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -60.74 -48.46 81.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.561 -0.712 . . . . 50.0 109.166 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.549 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 42.8 mt-10 -59.83 -46.9 87.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 16.66 109.224 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.796 ' CE1' HD11 ' A' ' 77' ' ' LEU . 59.4 t80 -62.49 -38.63 90.65 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.492 -0.755 . . . . 16.66 109.398 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 16.6 m -66.04 -47.62 73.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.392 -0.818 . . . . 50.0 109.341 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.14 -36.7 75.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 50.0 109.463 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.577 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -76.82 -36.72 56.71 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.656 -0.868 . . . . 50.0 108.656 179.929 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.13 -31.09 64.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.209 -1.556 . . . . 16.66 109.209 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 67' ' ' THR . 71.6 mtp180 -67.7 -31.17 70.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -1.066 . . . . 50.0 108.957 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.56 -21.9 64.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.506 -0.746 . . . . 50.0 109.356 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.779 ' CG ' HD12 ' A' ' 76' ' ' LEU . 4.4 p30 -150.11 58.54 0.97 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 50.0 109.052 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -50.65 -38.2 44.95 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.29 -0.881 . . . . 50.0 108.685 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.16 -32.67 67.76 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.233 -1.547 . . . . 25.0 109.233 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.779 HD12 ' CG ' ' A' ' 73' ' ' ASN . 19.0 mt -64.12 -43.38 95.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.446 -1.032 . . . . 50.0 109.372 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.796 HD11 ' CE1' ' A' ' 66' ' ' PHE . 1.9 mm? -61.13 -40.29 93.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 50.0 109.786 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 15.1 mtpt -63.66 -33.93 76.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 50.0 109.623 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.402 ' OD1' ' C ' ' A' ' 79' ' ' ASP . 58.4 t0 -78.75 -49.27 13.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 50.0 109.556 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' A' ' 81' ' ' ALA . 3.7 p -64.56 -44.71 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 50.0 109.749 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.546 ' N ' ' CG1' ' A' ' 80' ' ' VAL . . . -49.64 -39.94 37.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.683 -0.635 . . . . 50.0 109.776 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 75.1 mttt -69.91 -25.19 63.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 50.0 109.615 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.571 HG21 ' CG2' ' A' ' 37' ' ' THR . 9.4 mt -65.03 -44.67 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 50.0 109.561 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.982 -1.008 . . . . 99.99 109.492 -179.998 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A 1085 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A 1086 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_